Citrus Sinensis ID: 015592

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400----
Protein Sequence
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMVSTFDDRTSLLCSYLVCFHARIGILALT
Secondary Structure (PSIPRED)
cccEEcccEEEEEEEccccccEEEEEEEEccccEEEEcccccccccccHHHHHHHHHHHcccccccEEEEEcccccEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEccccccEEEEEEcccEEEEEccccccEEccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccHHHHHcccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHcccccccEEEcEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccEEEEEEc
Secondary Structure Prediction (SSPRO)
cccEEcccEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEcccccccHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEccccEHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccHHHcccEEEccccccEEcEccccccEccccEccccccccccccHHHHHcEcccHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccHHHHccccccHHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHcHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEc
Coil and Loop (DISEMBL)
meprvgnkfrlgrkigsgsfgeiylgtniqtNEEVAIKLEnvktkhpqlQYEAKLYKILqggtgipnlrwfgvegdYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEfvhsksflhrdikpdnflmglgrraNQVYIIDFGLAkryrdtathqhipyrenknltgTARYASMNTHLGIEQSRRDDLESLGYVLMYFLrgslpwqglkagtkkqkYEKISEKKVSTSIEALCRGYPTEFASYFHYCRslrfddkpdyaYLKRLFRDLFIregfqfdyvFDWTILKYQqsqvstparaigpgagpssgmppaaanvdrqsgaeegrhtgwssadpsrrrnsgplgnsanlskqkspmandpafskdamvstfdDRTSLLCSYLVCFHARIGILALT
Flexible Loop (DISEMBL)
meprvgnkfrlgrkigsgsfgeiylgtNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFvhsksflhrdiKPDNFLMGLGRRANQVYIIDFGLAKRYRDTathqhipyrenknltGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRgslpwqglkagtkkqkyekisekkvstsieALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGrhtgwssadpsrrrnsgplgnsanlskqkspmANDPAFSKDAMVSTFDDRTSLLCSYLVCFHARIGILALT
Low Complexity Region (SEG)
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTkkqkyekisekkVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTparaigpgagpssgmppaaaNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMVSTFDDRTSLLCSYLVCFHARIGILALT
Disordered region (IsUnstruct)
**********LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK*KYEKI**KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ*********************************************************************************STFDDRTSLLCSYLVCFHARIGILA**
Disordered Region (DISOPRED)
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAI**********QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT*********************************************************************************************************RIGILAL*
Disordered Region (DISEMBL)
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG******************STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARAIGPG****************************************PLGNSANLSKQKSPMANDPAFSKDAMVSTFDDRTSLLCSYLVCFHARIGILALT
Disordered Region (DISPRO)
*EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS*************************************************************************************************A*IGILALT
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMVSTFDDRTSLLCSYLVCFHARIGILALT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	404	2.2.26 [Sep-21-2011]
P42158	450	Casein kinase I isoform d	no	no	0.915	0.822	0.813	0.0
Q06486	415	Casein kinase I isoform d	yes	no	0.737	0.718	0.775	1e-144
Q9DC28	415	Casein kinase I isoform d	yes	no	0.737	0.718	0.775	1e-144
P48730	415	Casein kinase I isoform d	yes	no	0.737	0.718	0.775	1e-144
P35508	415	Casein kinase I isoform d	yes	no	0.737	0.718	0.775	1e-144
Q5BP74	415	Casein kinase I isoform d	N/A	no	0.737	0.718	0.771	1e-144
Q5ZLL1	416	Casein kinase I isoform e	no	no	0.730	0.709	0.779	1e-144
Q9JMK2	416	Casein kinase I isoform e	no	no	0.730	0.709	0.776	1e-144
P49674	416	Casein kinase I isoform e	no	no	0.834	0.810	0.663	1e-144
Q6P647	415	Casein kinase I isoform d	no	no	0.730	0.710	0.776	1e-144

>sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2

 Score =  653 bits (1684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/380 (81%), Positives = 343/380 (90%), Gaps = 10/380 (2%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61  GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +  P+RA+ P  G S+ +PP  +N+DR +G EEGR       + SRRR SG L NS N+S
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356

Query: 360 KQKSPMANDPAFSKDAMVST 379
            Q +  +     ++D+M+ +
Sbjct: 357 NQPTSSS-----ARDSMIPS 371

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 231/298 (77%), Positives = 271/298 (90%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 231/298 (77%), Positives = 271/298 (90%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 231/298 (77%), Positives = 271/298 (90%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 231/298 (77%), Positives = 271/298 (90%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2

 Score =  511 bits (1317), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 230/298 (77%), Positives = 272/298 (91%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I  +EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2

 Score =  511 bits (1315), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 230/295 (77%), Positives = 270/295 (91%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKLE VKTKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
           C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 229/295 (77%), Positives = 270/295 (91%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
           C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 243/366 (66%), Positives = 291/366 (79%), Gaps = 29/366 (7%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ- 299
           C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  ++ 
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300

Query: 300 --------------------VSTPARAIGPGAGPSSGMPPAAANVDR-QSGAEEGRHTGW 338
                                 +  RA+ PG       PP  A  +R +S AE    T  
Sbjct: 301 PEDVDRERREHEREERMGQLRGSATRALPPG-------PPTGATANRLRSAAEPVASTPA 353

Query: 339 SSADPS 344
           S   P+
Sbjct: 354 SRIQPA 359

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 229/295 (77%), Positives = 270/295 (91%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
255560729	472	casein kinase, putative [Ricinus communi	0.935	0.800	0.907	0.0
357454569	475	Casein kinase I isoform delta-like prote	0.938	0.797	0.873	0.0
359482807	471	PREDICTED: casein kinase I isoform delta	0.928	0.796	0.896	0.0
356550412	472	PREDICTED: casein kinase I isoform delta	0.933	0.798	0.873	0.0
363807148	471	uncharacterized protein LOC100795570 [Gl	0.933	0.800	0.864	0.0
359484471	474	PREDICTED: casein kinase I isoform delta	0.928	0.791	0.892	0.0
356530395	456	PREDICTED: casein kinase I isoform delta	0.935	0.828	0.860	0.0
224128674	470	predicted protein [Populus trichocarpa]	0.960	0.825	0.867	0.0
356556296	456	PREDICTED: casein kinase I isoform delta	0.935	0.828	0.860	0.0
357513741	474	Casein kinase I isoform delta-like prote	0.935	0.797	0.858	0.0

>gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis]

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/380 (90%), Positives = 361/380 (95%), Gaps = 2/380 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +  P RA+GPGAGPSSGMPP+ AN+DRQ G EEGR T W S DP+RRRNSGP+ +S N S
Sbjct: 301 ANPPTRALGPGAGPSSGMPPSGANIDRQPGGEEGRPT-WPSMDPTRRRNSGPITSSVNFS 359

Query: 360 KQKSPMANDPAFSKDAMVST 379
           KQK P+AND   SKDA +S+
Sbjct: 360 KQKGPVANDLPLSKDAKLSS 379

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357454569|ref|XP_003597565.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486613|gb|AES67816.1| Casein kinase I isoform delta-like protein [Medicago truncatula]

 Score =  715 bits (1845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/380 (87%), Positives = 362/380 (95%), Gaps = 1/380 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPR+GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN+KTKHPQL YE+KLYK+LQ
Sbjct: 1   MEPRIGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYKVLQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++H
Sbjct: 61  GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 STP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +TP ARAIG GAGPSSG+PPA  + +R SG E+GRH GWSS+DP+RRRNSGP+ N  NLS
Sbjct: 301 ATPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNLS 360

Query: 360 KQKSPMANDPAFSKDAMVST 379
           +QK+P+ +D   SK+ M+S+
Sbjct: 361 RQKAPVPSDSNGSKEVMLSS 380

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera]

 Score =  714 bits (1843), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/377 (89%), Positives = 360/377 (95%), Gaps = 2/377 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 S-TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           S  P+RA+GPGAGPS G+PPA AN+DRQSG E+GR +GWSSADPSRRR + P  N  +L 
Sbjct: 301 SGPPSRALGPGAGPSHGIPPAVANMDRQSGGEDGRPSGWSSADPSRRRTTVPALNLGSL- 359

Query: 360 KQKSPMANDPAFSKDAM 376
           KQKSP+AND   +KD++
Sbjct: 360 KQKSPVANDSTMAKDSL 376

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550412|ref|XP_003543581.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  709 bits (1831), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/378 (87%), Positives = 355/378 (93%), Gaps = 1/378 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRV NKFRLGRKIGSGSFGEIYLGTN QTNEEVA+KLENVKTKHPQL YE+KLYKILQ
Sbjct: 1   MEPRVANKFRLGRKIGSGSFGEIYLGTNTQTNEEVAVKLENVKTKHPQLLYESKLYKILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK++RDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKHRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CR YP+EFASYFHYCRSL+FDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRSYPSEFASYFHYCRSLQFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +T PARAIGP AGPSSG+PPA  N DRQ+G E  RHTGWSS+DP+RRRNSGP+ N   LS
Sbjct: 301 ATPPARAIGPAAGPSSGLPPAVVNADRQTGGENSRHTGWSSSDPARRRNSGPIANDGMLS 360

Query: 360 KQKSPMANDPAFSKDAMV 377
           +QK+P  +D   SKD M+
Sbjct: 361 RQKAPFPSDSTRSKDVML 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807148|ref|NP_001242599.1| uncharacterized protein LOC100795570 [Glycine max] gi|255641648|gb|ACU21096.1| unknown [Glycine max]

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/377 (86%), Positives = 349/377 (92%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRV NKFRLGRKIGSGS  EIYLGTN QTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1   MEPRVANKFRLGRKIGSGSSCEIYLGTNTQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFG+EGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61  GGTGIPNVRWFGIEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 360
           +TP R I P AG SSG+PPA  N DRQ+G    RHTGWSS+DP+RRRNSGP+ N    S+
Sbjct: 301 ATPVRVIVPTAGQSSGLPPAVVNADRQTGGVNSRHTGWSSSDPARRRNSGPIANDGMSSR 360

Query: 361 QKSPMANDPAFSKDAMV 377
           QK+P+ +D   SKD M+
Sbjct: 361 QKAPVPSDSTGSKDVML 377

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera]

 Score =  699 bits (1805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/381 (89%), Positives = 359/381 (94%), Gaps = 6/381 (1%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDTATHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query: 301 ST-PARAIGPGAGPSSGM-PPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
           +T P+R +GPGAG SSG+ PPA AN DRQSG EEGR  G SS DPSRRR S   G+   L
Sbjct: 301 ATPPSRVLGPGAGTSSGLPPPAVANADRQSG-EEGRPAGLSSMDPSRRRIS---GDGGGL 356

Query: 359 SKQKSPMANDPAFSKDAMVST 379
           SKQKSP+A+D A SKDAM+S+
Sbjct: 357 SKQKSPVASDLAVSKDAMLSS 377

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530395|ref|XP_003533767.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  694 bits (1791), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/379 (86%), Positives = 352/379 (92%), Gaps = 1/379 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPR+GNKFRLGRKIGSGSFGEIYLGTN QTNEEVAIKLENVKTKHPQL YE+KLY++LQ
Sbjct: 1   MEPRIGNKFRLGRKIGSGSFGEIYLGTNNQTNEEVAIKLENVKTKHPQLLYESKLYRVLQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIP++RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPDVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGL RRANQVY IDFGLAK+YRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLRRRANQVYCIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDD+PDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDRPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +  PARAIGP  G SS +PPA  N DRQ+G EEGR  G  S D +RRR +GP+ NS N+S
Sbjct: 301 AAPPARAIGPNVGTSSALPPAVTNADRQTGEEEGRPPGLVSGDSTRRRMTGPIPNSVNIS 360

Query: 360 KQKSPMANDPAFSKDAMVS 378
           KQK+P+  D A +K+AM+S
Sbjct: 361 KQKNPVTTDAALNKEAMLS 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128674|ref|XP_002329062.1| predicted protein [Populus trichocarpa] gi|222839733|gb|EEE78056.1| predicted protein [Populus trichocarpa]

 Score =  694 bits (1790), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/391 (86%), Positives = 359/391 (91%), Gaps = 3/391 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLG NIQTNEEVAIKLENVKT+HPQL YE+KLYK+LQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGANIQTNEEVAIKLENVKTRHPQLLYESKLYKMLQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 STP-ARAIGPGAGPSSGMPPAAA-NVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
           + P  RA GPGAGPSSG+PP  A N DRQS   E    GW S D +RRRNSGP+ NS NL
Sbjct: 301 ANPTTRAHGPGAGPSSGIPPPGANNADRQS-GGEEGGPGWPSIDHARRRNSGPIVNSGNL 359

Query: 359 SKQKSPMANDPAFSKDAMVSTFDDRTSLLCS 389
           SKQKSP+ ND + SKDA +S+ +   S++ S
Sbjct: 360 SKQKSPVTNDLSLSKDATLSSSNFLRSIVSS 390

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356556296|ref|XP_003546462.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/379 (86%), Positives = 351/379 (92%), Gaps = 1/379 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY++LQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRVLQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIP++RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLAD MINRVEFVH
Sbjct: 61  GGTGIPDVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADHMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYCIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLES+G+VLMYFLRGSLPWQGLKAGTKK KYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESVGFVLMYFLRGSLPWQGLKAGTKKHKYERISEKKVSTSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDD+PDYAYLKR+F DLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDRPDYAYLKRIFCDLFIREGFQFDYVFDWTILKYQQSQL 300

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
           +  PARAIGP  G SS MPPA  N DRQ+G EEGR  G  S D +RRR SGP+ NS N+S
Sbjct: 301 AAPPARAIGPNVGTSSAMPPAVTNADRQTGEEEGRPPGLVSGDSTRRRMSGPITNSVNIS 360

Query: 360 KQKSPMANDPAFSKDAMVS 378
           KQK+P+  D A +K+AM+S
Sbjct: 361 KQKNPVTTDAALNKEAMLS 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357513741|ref|XP_003627159.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355521181|gb|AET01635.1| Casein kinase I isoform delta-like protein [Medicago truncatula]

 Score =  691 bits (1783), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/381 (85%), Positives = 358/381 (93%), Gaps = 3/381 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPR+GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YEAKLYKILQ
Sbjct: 1   MEPRIGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYEAKLYKILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN++W GVEG+YN+LV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVKWSGVEGEYNILVMDLLGPSLEDLFNFCNRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           +KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK++RD+A HQHIPYRENKNLTGTARYA
Sbjct: 121 TKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKFRDSA-HQHIPYRENKNLTGTARYA 179

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+L
Sbjct: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 239

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRL RDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLLRDLFIREGFQFDYVFDWTILKYQQSQI 299

Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQS-GAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
           +T P+R IG  AGPSSG+P A+AN D QS G ++GR+ GWSS+DP+RRR SGP+ N   L
Sbjct: 300 ATPPSRGIGLAAGPSSGLPLASANADGQSGGGKDGRNIGWSSSDPTRRRTSGPIANDGIL 359

Query: 359 SKQKSPMANDPAFSKDAMVST 379
           S++K+P+ ND   SKDAM+S+
Sbjct: 360 SREKAPLTNDLTGSKDAMLSS 380

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
TAIR|locus:2030170	465	CKL2 "casein kinase 1-like pro	0.930	0.808	0.786	6.5e-161
TAIR|locus:2120765	450	CK1 "casein kinase 1" [Arabido	0.900	0.808	0.786	1.9e-154
TAIR|locus:504954933	435	ckl12 "casein kinase I-like 12	0.920	0.855	0.758	1.2e-152
TAIR|locus:2050409	433	ckl5 "casein kinase I-like 5"	0.740	0.690	0.822	2.1e-141
TAIR|locus:2167634	476	ckl7 "casein kinase I-like 7"	0.915	0.777	0.664	6e-135
TAIR|locus:2024147	471	ADK1 "dual specificity kinase	0.913	0.783	0.664	3.3e-134
TAIR|locus:2090875	442	ckl10 "casein kinase I-like 10	0.737	0.674	0.771	5e-131
UNIPROTKB|Q6K9N1	463	OJ1234_B11.27 "Os02g0622100 pr	0.720	0.628	0.783	1.5e-129
UNIPROTKB|Q70YQ4	463	Q70YQ4 "Putative casein kinase	0.720	0.628	0.780	1.4e-128
TAIR|locus:2121338	479	CKL6 "casein kinase I-like 6"	0.737	0.622	0.758	7.6e-128

TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1567 (556.7 bits), Expect = 6.5e-161, P = 6.5e-161
 Identities = 299/380 (78%), Positives = 327/380 (86%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYK+LQ
Sbjct:     1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTG+PN++W+GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH
Sbjct:    61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
              KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD+  HQHIPYRENKNLTGTARYA
Sbjct:   121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS-NHQHIPYRENKNLTGTARYA 179

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             SMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG             VSTSIEAL
Sbjct:   180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
             CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct:   240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 299

Query:   301 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
             ST                     + +R SG +E R +GWSS  P  RRNSG + NS +L+
Sbjct:   300 STPPPRHHGPVVGPSSALPPAITSAERPSGGDEARPSGWSSGIP--RRNSGQIFNSGSLA 357

Query:   360 KQKSPMANDPAFSKDAMVST 379
             KQK+P+++DPA SKD ++S+
Sbjct:   358 KQKAPVSSDPAISKDVVLSS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1506 (535.2 bits), Expect = 1.9e-154, P = 1.9e-154
 Identities = 291/370 (78%), Positives = 312/370 (84%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct:    61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct:   121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT            VSTSIEAL
Sbjct:   181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
             CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct:   241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query:   301 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
             +                      N+DR +G EEGR       + SRRR SG L NS N+S
Sbjct:   301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356

Query:   360 KQK-SPMAND 368
              Q  S  A D
Sbjct:   357 NQPTSSSARD 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
 Identities = 286/377 (75%), Positives = 312/377 (82%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct:     1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTG+PN++WFGVEGDYN LV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ H
Sbjct:    61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             SKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct:   121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT            VSTSIE+L
Sbjct:   181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
             CRGYP+EFASYFHYCRSLRFDDKPDY YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct:   241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query:   301 STXXXXXXXXXXXXXXXXX--XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
             +                       ++DR  G EEG   G    D SRRR SG L NS NL
Sbjct:   301 TAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEG---GRPPMDSSRRRMSGALENSGNL 357

Query:   359 SKQKSPMANDPAFSKDA 375
             S +   M +   F++ A
Sbjct:   358 SSRGPMMPSSSLFAQSA 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1363 (484.9 bits), Expect = 2.1e-141, Sum P(2) = 2.1e-141
 Identities = 246/299 (82%), Positives = 278/299 (92%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKLE+VKT HPQL YE+++Y++LQ
Sbjct:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTGIPN++W+GVEGDYNVLV+DLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+H
Sbjct:    61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             SKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAK+YRD++TH+HIPYRENK+L GT RYA
Sbjct:   121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG             VSTSIE L
Sbjct:   181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
             CRG+PTEFASYFHYCRSLRFDDKPDYAYLKRLFR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct:   241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQ 299

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1322 (470.4 bits), Expect = 6.0e-135, P = 6.0e-135
 Identities = 250/376 (66%), Positives = 295/376 (78%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             M+  +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KLENVKTKHPQL YE+KLY +LQ
Sbjct:     1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GG+GIPN++WFGVEGDY+V+VIDLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H
Sbjct:    61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             ++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT            VST IE L
Sbjct:   181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
             C+  P+EF SYFHYCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q   
Sbjct:   241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG- 299

Query:   301 STXXXXXXXXXXXXXXXXXXXXNVDRQS---GAEEGRHTGWSSADPSRRRNSGPLGNSAN 357
             S+                     ++RQ    G E  R+    + +   RR+  P   S+ 
Sbjct:   300 SSSGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRH--PTTTSSP 357

Query:   358 LSKQKSPMANDPAFSK 373
               + +S  ++D  FSK
Sbjct:   358 RDRSRSRNSDDGPFSK 373

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1315 (468.0 bits), Expect = 3.3e-134, P = 3.3e-134
 Identities = 249/375 (66%), Positives = 292/375 (77%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             M+  +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YE+KLY +LQ
Sbjct:     1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTG+PNL+W+GVEGDYNV+VIDLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H
Sbjct:    61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             ++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT            V+T IE L
Sbjct:   181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
             C+  P+EF SYF YCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q   
Sbjct:   241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300

Query:   301 STXXXXXXXXXXXXXXXXXXXXNVDRQS--GAEEGRHTGWSSADP--SRRR--NSGPLGN 354
             S+                    ++++Q     +E R   +S A    SRR    S     
Sbjct:   301 SSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTRDR 360

Query:   355 SANLSKQKSPMANDP 369
             SA+ +    P++  P
Sbjct:   361 SASRNSVDGPLSKHP 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IDA

GO:0007165 "signal transduction" evidence=TAS

TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
 Identities = 230/298 (77%), Positives = 265/298 (88%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             M+  +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KLE VKTKHPQL YE+K+Y +LQ
Sbjct:     1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTG+P+++WFGVEG+YN + IDLLGPSLEDLFN+C+R  SLKTVLMLADQ+INRVE++H
Sbjct:    61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAK+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT            + T +E L
Sbjct:   181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
             C+ YP+EF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWTILKY QS
Sbjct:   241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
 Identities = 228/291 (78%), Positives = 263/291 (90%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             ME  +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct:     1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct:    61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             ++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAK+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT            + T +E L
Sbjct:   181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 291
             C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT
Sbjct:   241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT 291

GO:0005634 "nucleus" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009850 "auxin metabolic process" evidence=IMP

GO:0048364 "root development" evidence=IMP

UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
 Identities = 227/291 (78%), Positives = 262/291 (90%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             ME  +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct:     1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct:    61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             ++ FLHRDIKPDNFLMGLGR+A+QVY+ID+ LAK+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT            + T +E L
Sbjct:   181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 291
             C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT
Sbjct:   241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT 291

GO:0005634 "nucleus" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009850 "auxin metabolic process" evidence=IMP

GO:0048364 "root development" evidence=IMP

TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1255 (446.8 bits), Expect = 7.6e-128, P = 7.6e-128
 Identities = 226/298 (75%), Positives = 261/298 (87%)

Query:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
             M+  +G KF+LGRKIG GSFGE++L  ++QT EE A+KLE  KTKHPQL YE+K+Y +LQ
Sbjct:     5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64

Query:    61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             GG+GIP+L+WFGV+GDYN +VIDLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++H
Sbjct:    65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124

Query:   121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK+YRD  TH+HIPYRENKNLTGTARYA
Sbjct:   125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184

Query:   181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
             S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT            VST IE L
Sbjct:   185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244

Query:   241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
             C+ YP EF SYF YCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWT LK+ QS
Sbjct:   245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=TAS

GO:0005856 "cytoskeleton" evidence=IDA

GO:0055028 "cortical microtubule" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009744 "response to sucrose stimulus" evidence=RCA

GO:0009749 "response to glucose stimulus" evidence=RCA

GO:0009750 "response to fructose stimulus" evidence=RCA

GO:0042732 "D-xylose metabolic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P42158	KC1D_ARATH	2, ., 7, ., 1, 1, ., 1	0.8131	0.9158	0.8222	no	no
Q556Y4	KC1_DICDI	2, ., 7, ., 1, 1, ., 1	0.7074	0.7277	0.6901	yes	no
P48730	KC1D_HUMAN	2, ., 7, ., 1, 1, ., 2, 6	0.7751	0.7376	0.7180	yes	no
Q6QNM1	KC1_TOXGO	2, ., 7, ., 1, 1, ., 1	0.7263	0.7599	0.9475	N/A	no
P35508	KC1D_BOVIN	2, ., 7, ., 1, 1, ., 2, 6	0.7751	0.7376	0.7180	yes	no
Q7T2E3	KC1DA_DANRE	2, ., 7, ., 1, 1, ., 1	0.7796	0.7301	0.7320	yes	no
Q9DC28	KC1D_MOUSE	2, ., 7, ., 1, 1, ., 2, 6	0.7751	0.7376	0.7180	yes	no
Q5RC72	KC1D_PONAB	2, ., 7, ., 1, 1, ., 2, 6	0.7684	0.7376	0.7180	yes	no
P29295	HRR25_YEAST	2, ., 7, ., 1, 1, ., 1	0.6666	0.7425	0.6072	yes	no
P40235	HHP1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6932	0.8143	0.9013	yes	no
Q06486	KC1D_RAT	2, ., 7, ., 1, 1, ., 2, 6	0.7751	0.7376	0.7180	yes	no
O76324	DCO_DROME	2, ., 7, ., 1, 1, ., 1	0.7220	0.7301	0.6704	yes	no
Q8IHZ9	KC1_PLAF7	2, ., 7, ., 1, 1, ., 1	0.6894	0.7252	0.9071	yes	no
Q20471	KIN20_CAEEL	2, ., 7, ., 1, 1, ., 1	0.7389	0.7277	0.5915	yes	no
Q6QNL9	KC1_EIMTE	2, ., 7, ., 1, 1, ., 1	0.7073	0.7698	0.9283	N/A	no
Q4R9A9	KC1G1_MACFA	2, ., 7, ., 1, 1, ., 1	0.5249	0.8242	0.8740	N/A	no
Q5BP74	KC1D_XENLA	2, ., 7, ., 1, 1, ., 1	0.7718	0.7376	0.7180	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034133001 SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (471 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	404
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-35
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-19
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-12
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-12
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-11
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-11
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-07
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
COG2112	201	COG2112, COG2112, Predicted Ser/Thr protein kinase	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-05
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-05
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-04
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-04
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-04
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-04
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.001
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.002
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.002
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.004
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (408), Expect = 7e-47
 Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 23/260 (8%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
           + L RK+GSGSFG +Y   +  T + VA+K+   +++  +       E ++ + L     
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 122
           +  +  F  + D+  LV++       DLF++ SR   LS      +A Q++  +E++HS 
Sbjct: 61  VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             +HRD+KP+N L+        V I DFGLAK+                   GT  Y + 
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167

Query: 183 NTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
              L G     + D+ SLG +L   L G  P+ G     + Q   +I    +        
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227

Query: 242 RGYPTEFASYFHYCRSLRFD 261
            G   E       C  L  D
Sbjct: 228 SGSE-EAKDLIKKC--LNKD 244

Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 96/382 (25%), Positives = 143/382 (37%), Gaps = 28/382 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +R+ RK+G GSFGE+YL  + +    + +A KLE+   +  +   E ++   L     I
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 66  PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
             L  F  +     LV++ + G SLEDL     R   LS    L +  Q+++ +E++HSK
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             +HRDIKP+N L  L R    V +IDFGLAK   D  +   IP   + ++ GT  Y + 
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177

Query: 183 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVSTSIE 238
              LG+     S   D+ SLG  L   L G  P++G K  +   +  + I E    +   
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 239 ALCRGYPTE------------FASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDY 286
            L    P               A       S   D   D     +L            D 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 287 VFDWTILKYQQ----SQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSAD 342
                 L        S +++ A +        S      A     S          S+A 
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357

Query: 343 PSRRRNSGPLGNSANLSKQKSP 364
             R         S+  S   S 
Sbjct: 358 SKRSSLPKISARSSPSSLSSSS 379

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  123 bits (312), Expect = 2e-33
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 71
           +G G FG +YL  + +T ++VAIK    E+  +   +L  E ++ K L     I  L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59

Query: 72  GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
             + ++  LV++   G SL+DL      KLS   +L +  Q++  +E++HS   +HRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-E 189
           P+N L  L     +V + DFGL+K                K + GT  Y +    LG   
Sbjct: 120 PENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 190 QSRRDDLESLGYVLMYFL 207
            S + D+ SLG V++Y L
Sbjct: 171 YSEKSDIWSLG-VILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  106 bits (268), Expect = 1e-26
 Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 29/235 (12%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
           + +  K+G GSFG++YL  + +T + VAIK    + +K    ++  E K+ K L+     
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56

Query: 66  PN----LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           PN       F  + D   LV++   G  L DL      +LS         Q+++ +E++H
Sbjct: 57  PNIVRLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLH 114

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK  +HRD+KP+N L+        V + DFGLA++                   GT  Y 
Sbjct: 115 SKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYM 163

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
           +    LG    +  D+ SLG V++Y  L G  P+ G       + ++KI + K  
Sbjct: 164 APEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.5 bits (225), Expect = 9e-21
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK-HPQLQYEAKLYKILQGGT 63
           +++ G KIG G+FG++Y   N+ T E +A   I++++   K   ++  E K+ ++L+   
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58

Query: 64  GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
             PNL +++GVE     + I +    G +LE+L     R L    + +   Q++  + ++
Sbjct: 59  --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTAR 178
           HS   +HRDIKP N  +        + + DFG A + ++  T       E  ++L GT  
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168

Query: 179 YASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 216
           Y +     G +     R  D+ SLG V++    G  PW  L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGT 63
           ++  G  +G GSFG +YL  +  T E +A+K   +          L+ E ++   LQ   
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58

Query: 64  GIPNL-RWFGVEGDYNVLVIDLL-----GPSLEDLF-NFCSRKLSLKTVLMLADQMINRV 116
             PN+ R++G E D     +++      G SL  L   F   KL    +     Q++  +
Sbjct: 59  --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGL 114

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            ++HS   +HRDIK  N L+          + DFG AKR  D  T +        ++ GT
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRGT 166

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             + +     G E  R  D+ SLG  ++    G  PW
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 6   GNKFRLGRKIGSGSFGEIY---LGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKI- 58
           G ++++ + IG G FG +Y     ++   N +   K+EN++ +      L Y   +Y I 
Sbjct: 11  GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNN-IYDID 69

Query: 59  -LQGGTGIPNLRWFGVEGDYNV------------LVIDLLGPSLEDLFN--FCSRKLSLK 103
            +     I N+   G+   Y              ++++ L  + +++F    C  K  +K
Sbjct: 70  KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK 129

Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
            ++     M+  +E++H     H DIKP+N ++    R    YIID+G+A  +      +
Sbjct: 130 NIMK---DMLTTLEYIHEHGISHGDIKPENIMVDGNNRG---YIIDYGIASHF--IIHGK 181

Query: 164 HIPY-RENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT- 220
           HI Y +E K+L  GT  YA ++ H G   +RR DLESLGY ++ +    LPW+G      
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241

Query: 221 -----KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS-LRFDDKPDYAYLKRLF 273
                K    +++ E K+             +F   F  C + L +++KPDY  L ++F
Sbjct: 242 LIHAAKCDFIKRLHEGKIKIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293

Length = 294

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 67/284 (23%), Positives = 117/284 (41%), Gaps = 40/284 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQG 61
           + F+ G+ IG GSF  + L    +TN+E AIK+ + +      K   ++ E ++   L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 62  GTGIPNLRWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
             GI  L ++  + + N+  V++    G  L+ +  + S  L  K     A +++  +E+
Sbjct: 61  HPGIIKL-YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEY 117

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------RYRDTATHQHI 165
           +HSK  +HRD+KP+N L+    +   + I DFG AK                +  +    
Sbjct: 118 LHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225
             R   +  GTA Y S          +  DL +LG ++   L G  P++G     +   +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SNEYLTF 231

Query: 226 EKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 259
           +KI +                IE L    P +          L+
Sbjct: 232 QKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 21/180 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGI 65
            F +  KIG G FGE+Y   + +T +EVAIK+     K K  ++  E ++ K  +     
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56

Query: 66  PN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
           PN ++++G  ++ D   +V++   G SL+DL    ++ L+   +  +  +++  +E++HS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+       +V +IDFGL+ +  DT        +    + GT  + +
Sbjct: 117 NGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 49/225 (21%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------------QLQY 51
           ++++  +IG G+ G ++   + +T E VA+K   ++                    Q  Y
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 52  EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KL  +   G+G              VLV++ +   L ++     R L    V      
Sbjct: 61  VVKLLDVFPHGSGF-------------VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM 107

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA----THQHIP- 166
           ++  V ++H+   +HRD+KP N L+        + I DFGLA+ + +      +HQ    
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATR 164

Query: 167 -YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
            YR  + L G  +Y       G+      DL ++G +    L GS
Sbjct: 165 WYRAPELLYGARKYDP-----GV------DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 38/165 (23%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT----------------KHPQL 49
           +    K+G G++G +Y   + +T E VA+K   L+N +                 KHP +
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 50  QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
               KL  ++     +              LV +     L+   +     LS   +  + 
Sbjct: 61  ---VKLLDVIHTERKL-------------YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM 104

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            Q++  + + HS   LHRD+KP N L+    R   + + DFGLA+
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 36/177 (20%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLY 56
           ++  G+K+G G++  +Y   + +T   VAIK    K K           +     E KL 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 110
           + L+    I  L  FG + + N LV + +   LE +            VL  AD      
Sbjct: 57  QELKHPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADIKSYML 109

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY---RDTATHQ 163
             +  +E++HS   LHRD+KP+N L+     ++  + + DFGLA+ +       THQ
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMTHQ 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 35/229 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLQYEAKLYKIL 59
             +R G+ +G G+FG +YL  ++ T  E+A+K        P        L+ E +L K L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 60  QGGTGIPNLRWFGVEGDYNVLVI---DLLGPSLED-------LFNFCSRKLSLKTVLMLA 109
           Q    +   +++G   D   L I    + G S++D       L    +RK +        
Sbjct: 62  QHERIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------- 111

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q++  VE++HS   +HRDIK  N L      A  V + DFG +KR +   +        
Sbjct: 112 -QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TG 163

Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
            K++TGT  + S     G    R+ D+ S+G  ++  L    PW   +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 68/255 (26%), Positives = 98/255 (38%), Gaps = 58/255 (22%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLQ------YEAK 54
           + I  G+FG +YL     T +  AIK            + NVK +   +       Y AK
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
           LY   Q               DY  LV++ L G     L       L          +++
Sbjct: 62  LYYSFQ-------------SKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVV 107

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             VE +H +  +HRDIKP+N L+    +   + + DFGL++              ENK  
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKF 153

Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228
            GT  Y +  T LG+   +  D  SLG V+  FL G  P+    A T    ++ I     
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRI 210

Query: 229 ---SEKKVSTSIEAL 240
               E K   S EA+
Sbjct: 211 NWPEEVKEFCSPEAV 225

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 39/166 (23%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVK-----TKHPQL 49
           +++ +++G G+FG +YL  N +T E VAIK              L  VK      +HP +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 50  QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLML 108
               KL ++               E D    V + +  +L  L  +   +  S   +  +
Sbjct: 61  ---VKLKEVF-------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             Q++  +  +H   F HRD+KP+N L+        V I DFGLA+
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 30/154 (19%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTGIPN-LRWF 71
           KIG G+ GE+Y  T+  T +EVAIK   ++ ++ +L   E  + K  +     PN + ++
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----PNIVDYY 81

Query: 72  G--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVH 120
              + GD   +V++ + G SL D+      +++        +  I  V        E++H
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLH 133

Query: 121 SKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153
           S++ +HRDIK DN L+   G     V + DFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 26/176 (14%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKHPQLQY-----EAKLYKILQ 60
            LG+K+G G+FGE+Y G           EVA+K   +K    + Q      EA++ + L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLREARIMRKLD 59

Query: 61  GGTGIPN-LRWFGV-EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
                PN ++  GV   +  + ++        L         KLSL  +L  A Q+   +
Sbjct: 60  H----PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYR 168
           E++ SK+F+HRD+   N L+G       V I DFGL++   D          +P R
Sbjct: 116 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 48/160 (30%), Positives = 68/160 (42%), Gaps = 15/160 (9%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY------EAKLYKILQGGTGIP 66
            KIG G++G +Y   +  T E VAIK   +K +            E KL K L     I 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
            L  F  +GD   LV + +   L  L     R L    +     Q++  + F HS   LH
Sbjct: 63  LLDVFRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121

Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
           RD+KP+N L+        + + DFGLA+ +       TH 
Sbjct: 122 RDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 73/270 (27%), Positives = 111/270 (41%), Gaps = 54/270 (20%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
           R IG G  GE+YL  +   +  VA+K     L        +   EAK+   L     +P 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP- 66

Query: 68  LRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSL----------KTVLMLADQM 112
              + +  D     Y +  I+  G +L+ L     +K SL             L +  ++
Sbjct: 67  --VYSICSDGDPVYYTMPYIE--GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---RYRDTATHQHIPYRE 169
              +E+VHSK  LHRD+KPDN L+GL     +V I+D+G A       +      +  R 
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 170 N--KNLT------GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
               ++T      GT  Y +    LG+  S   D+ +LG +L   L  S P+       +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------R 232

Query: 222 KQKYEKISEKKVSTSIEALCRGYPTEFASY 251
           ++K  KIS + V  S        P E A Y
Sbjct: 233 RKKGRKISYRDVILS--------PIEVAPY 254

Length = 932

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 65.6 bits (161), Expect = 3e-12
 Identities = 65/255 (25%), Positives = 103/255 (40%), Gaps = 79/255 (30%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP---QLQY 51
           +G GSFG++ L     T +  A+K            +E+  T         HP   +L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 52  ----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
               E KLY +L+   GG                            +LF+  S+  + S 
Sbjct: 61  AFQTEEKLYLVLEYAPGG----------------------------ELFSHLSKEGRFSE 92

Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR--YRDTA 160
           +     A +++  +E++HS   ++RD+KP+N L  L    + + + DFGLAK      + 
Sbjct: 93  ERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSR 149

Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG 219
           T+            GT  Y +    LG    +  D  SLG VL+Y  L G  P+    A 
Sbjct: 150 TNT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AE 196

Query: 220 TKKQKYEKISEKKVS 234
            +K+ YEKI +  + 
Sbjct: 197 DRKEIYEKILKDPLR 211

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 65.6 bits (161), Expect = 4e-12
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 26/161 (16%)

Query: 9   FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQG 61
             LG+K+G G+FGE+Y GT       T  +VA+K         + +    EA + K L  
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 62  GTGIPNL-RWFGV--EGDYNVLVIDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
               PN+ R  GV  +G+   +V +    G    DL +F      KL+LK +L +A Q+ 
Sbjct: 61  ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             +E++ SK+F+HRD+   N L+        V I DFGL++
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 22/162 (13%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKILQGGT 63
            ++LG  IG G+FG +Y G N++T + VAIK   LE +K +    +  E  L K L+   
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58

Query: 64  GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDL---FNFCSRKLSLKTVLMLADQMINRV 116
             PN+ ++ G     + L I L      SL  +   F      L    V     Q++  +
Sbjct: 59  --PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQGL 112

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++H +  +HRDIK  N L     +   V + DFG+A +  D
Sbjct: 113 AYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 21/159 (13%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH--PQLQYEAKLYKILQ 60
           ++R G  +GSGSFG +Y G N+   +     EV++  +    +    QL+ E  L   LQ
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 61  GGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
                PN+ ++ G E + + L I L    G SL  L   + S    +  + +   Q++  
Sbjct: 61  H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLG 114

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +E++H ++ +HRDIK  N L+        V + DFG+AK
Sbjct: 115 LEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 11/155 (7%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN- 67
           F +  K+G GS+G +Y   + +T + VAIK+  V+    ++  E  + K        P  
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYI 60

Query: 68  LRWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           ++++G      D  +++      S+ D+    ++ L+ + +  +  Q +  +E++HS   
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +HRDIK  N L+       Q  + DFG++ +  DT
Sbjct: 121 IHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 63.3 bits (155), Expect = 2e-11
 Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 49/188 (26%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQ-LQYEAKLYKILQGG 62
            LG+K+G G+FGE+Y GT          EVA+K   E+   +  +    EA++ + L   
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60

Query: 63  TGIPN-LRWFGV-EGDYNVLVI-------DLL---------GPSLEDLFNFCSRKLSLKT 104
              PN ++  GV   +  ++++       DLL           SL DL +F         
Sbjct: 61  ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA-------- 109

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TA 160
            L +A  M    E++ SK+F+HRD+   N L+G       V I DFGL++   D      
Sbjct: 110 -LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKV 161

Query: 161 THQHIPYR 168
               +P R
Sbjct: 162 KGGKLPIR 169

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 62.5 bits (153), Expect = 4e-11
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGGT 63
           K+ + ++IG GSFG++YL       +   +K   L N+  K       E K+ K L    
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58

Query: 64  GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINRV 116
             PN+ +++    E     +V++   G  L           +    + +L    Q+   +
Sbjct: 59  --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 117 EFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 159
           +++HS+  LHRDIKP N FL         V + DFG++K    T
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSST 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 69/291 (23%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGGTGIPN- 67
            +IG G++G++Y   N +T E VA+K   +EN K   P     E KL + L+     PN 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR----HPNI 60

Query: 68  LRWFGV---EGDYNVLVI------DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
           +R   +   +G  ++ ++      DL G     L +    K +   +     Q++  +++
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP----------YR 168
           +HS   LHRDIK  N L+        + + DFGLA+ Y    T ++            YR
Sbjct: 116 LHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPY----TKRNSADYTNRVITLWYR 168

Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
             + L G  RY        +      D+ S+G +L     G   +QG    T+ ++ EKI
Sbjct: 169 PPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKI 214

Query: 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRLFRDLF 277
            E         LC G PT+    +     L +  + KP   Y KR  R+ F
Sbjct: 215 FE---------LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 61.8 bits (151), Expect = 7e-11
 Identities = 71/246 (28%), Positives = 105/246 (42%), Gaps = 55/246 (22%)

Query: 13  RKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQY-----EAKLYKILQGGTG 64
           +K+G G+FGE+Y G          EVA+K   +K    + +      EA++ K L    G
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----G 54

Query: 65  IPN-LRWFGV--EGDYNVLVI------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQM 112
            PN +R  GV  E +   LV+      DLL     S     +     LSLK +L  A Q+
Sbjct: 55  HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPY 167
              +E++ SK F+HRD+   N L+G       V I DFGL++      Y    T   +P 
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171

Query: 168 R----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTK 221
           R    E           S+   +   +S   D+ S G VL++  F  G+ P+ GL     
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEEV 216

Query: 222 KQKYEK 227
            +   K
Sbjct: 217 LEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQGGTG 64
           + +  K+G G+FGE+Y    I+T   VA+K   + N K   P     E K+ K L+    
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 65  IPNLRWFGVEGD---------YNVL---VIDLLG----PSLEDLFNFCSRKLSLKTVLML 108
           +P +       D         Y V      DL G    PS++        K  +      
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML----- 122

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             Q++  + ++H    LHRDIK  N L+        + I DFGLA+ Y         P  
Sbjct: 123 --QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNP 172

Query: 169 ENKNLTGTARYASM 182
           +     GT +Y ++
Sbjct: 173 KGGGGGGTRKYTNL 186

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 52/281 (18%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           F L RK+GSG FGE++ G   +    VAIK+   +   K    Q E +  K L+    I 
Sbjct: 8   FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI- 65

Query: 67  NLRWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
               F V   G+   ++ +L+  G  L  L +   + L + +++ +A Q+   + ++  +
Sbjct: 66  --SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQHIPYRENKNLTGTARY 179
           + +HRD+   N L+G         + DFGLA+  ++    ++ + IPY+       TA  
Sbjct: 124 NSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
           A+ +       S + D+ S G +L+Y  F  G +P+ G+      + Y++I+        
Sbjct: 175 AASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT-------- 218

Query: 238 EALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 270
                GY        P E       C +   +D+P +  L+
Sbjct: 219 ----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL--QYEAKLYKILQGGT 63
           K+   R +G G+FG ++L       + V IK   V+  TK  +L  Q E ++ K+L    
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I     F  +    +++    G +L +     C+  L   T+L    Q++  +  VH+K
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYA 180
             LHRD+K  N L+   +    V I DFG++K          I   ++K  T  GT  Y 
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGTPCYI 168

Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
           S     G   +++ D+ +LG VL
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 45/169 (26%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHPQLQYE 52
           IG G++G +Y   ++ T   VA+K   V                        +HP +   
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI--- 63

Query: 53  AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-DLFNFCSR----KLSLKTVLM 107
            +L  +  G                  L + L+   ++ DL  + S+     L  +T+  
Sbjct: 64  VRLLDVCHGPR------------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           L  Q++  V+F+HS   +HRD+KP N L+       QV I DFGLA+ Y
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 25/216 (11%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGTG- 64
           F L R IG G+FG++ +     T +  A+K  N K K  +      +     ILQ     
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60

Query: 65  -IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHS 121
            + NL +   + +   LV+DLL     DL    S+K+      V     +++  +E++HS
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-GTARYA 180
           K  +HRDIKPDN L+        V+I DF +A           +        T GT  Y 
Sbjct: 119 KGIIHRDIKPDNILLD---EQGHVHITDFNIAT---------KVTPDTLTTSTSGTPGYM 166

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
           +         S   D  SLG V  Y  LRG  P++G
Sbjct: 167 APEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 29/166 (17%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI----- 65
            G  +G G++G++    +  T + VAIK    K K  ++  +    + L G  GI     
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 66  -----------PN---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
                       N   L    VEGD+  LV+D++   L+ + +   R L+   V  +  Q
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-LTESQVKCILLQ 127

Query: 112 MINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 156
           ++N +  +H   F+HRD+ P N F+   G       I DFGLA+RY
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRY 169

Length = 335

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 33/238 (13%)

Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLR- 69
           G  IGSGSFG +YLG N  + E +A+K   V+        + +   +L      I  L+ 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVK--QVELPSVSASSKDRKRSMLDALAREIALLKE 62

Query: 70  --------WFGVEGDYNVLVIDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVE 117
                   + G   D + L I L    G S+  L N + + + +L  V     Q++  + 
Sbjct: 63  LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKGLN 120

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----DTATHQHIPYRENKNL 173
           ++H++  +HRDIK  N L+        + I DFG++K+       T T+   P     +L
Sbjct: 121 YLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SL 172

Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
            G+  + +         +R+ D+ SLG +++  L G  P+      T+ Q   KI E 
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 38/257 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGG 62
           + F + + IG G+FGE++L  +  T +  A+K+      +K          +        
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             I  L +   + ++  LV++ +     DL N   RK     +T      +++  ++ VH
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVH 118

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT-----------------HQ 163
              F+HRDIKPDN L+        + + DFGL K+                         
Sbjct: 119 KLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 164 HIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 217
                + +        GT  Y +     G       D  SLG V++Y  L G  P     
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FY 231

Query: 218 AGTKKQKYEKISEKKVS 234
           + T ++ Y KI   K S
Sbjct: 232 SDTLQETYNKIINWKES 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 13/150 (8%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAIK  N++    Q + E  + +IL        
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHP 76

Query: 64  GIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I N L  + V  +  V++  L G SL D+       +    +  +  + +  +EF+HS 
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 134

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
             +HRDIK DN L+G+      V + DFG 
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 45/241 (18%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTK-----HPQLQYEAKLYK 57
           I  G++G ++L     T +  AIK            ++ V T+       Q  Y  KLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 58  ILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
             QG     NL +  +E    GD   L ++ +G   ED+                  +++
Sbjct: 61  SFQGKK---NL-YLVMEYLPGGDLASL-LENVGSLDEDVARIYIA------------EIV 103

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKN 172
             +E++HS   +HRD+KPDN L+        + + DFGL+K        + +   +E+K 
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
           + GT  Y +    LG   S+  D  SLG +L  FL G  P+ G    T ++ ++ I   K
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGK 217

Query: 233 V 233
           +
Sbjct: 218 I 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 20/164 (12%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
           PR     +L RK+G+G FGE+++GT N  T  +VA+K     T  P+  LQ EA++ K L
Sbjct: 4   PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ-EAQIMKKL 58

Query: 60  QGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +       L + + V  E +   +V + +  G  L+ L +   +KL L  ++ +A Q+  
Sbjct: 59  RH----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            + ++ S++++HRD+   N L+G         I DFGLA+   D
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 19/181 (10%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
           KIG G++G +Y   +  TNE +A   I+LE      P     E  L K +Q G  I  L+
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQ 67

Query: 70  WFGVEGDYNV-LVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFL 125
              V  +  + LV + L   L+   +     ++   L    +   Q++  + + HS   L
Sbjct: 68  DV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSHRVL 124

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNLTGTARYA 180
           HRD+KP N L  + RR N + + DFGLA+ +     T TH+ +   YR  + L G+  Y+
Sbjct: 125 HRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 S 181
           +
Sbjct: 183 T 183

Length = 294

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 25/277 (9%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
           PR     RL  K+G G FGE+++GT   T + VAIK     T  P+    EA++ K L+ 
Sbjct: 4   PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              +P       E  Y V      G  L+ L     + L L  ++ +A Q+ + + ++  
Sbjct: 61  DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
            +++HRD++  N L+G     N V  I DFGLA+   D        Y   +      ++ 
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWT 170

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
           +    L    + + D+ S G +L   + +G +P+ G+     ++  E     +V      
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYRM 222

Query: 240 LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
            C +G P         C     D++P + Y++    D
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 25/221 (11%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGTGI 65
               + +G GS G +Y   +  T +  A+K  +V        QL  E K    L+     
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK---TLRS-CES 58

Query: 66  PNL-RWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           P + + +G    EG+ + +V++ + G SL DL      K+    +  +A Q++  ++++H
Sbjct: 59  PYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH 116

Query: 121 SKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           +K   +HRDIKP N L+       +V I DFG++K   +T         +     GT  Y
Sbjct: 117 TKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVTY 166

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
            S     G   S   D+ SLG  L+    G  P+      +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 41/230 (17%)

Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKT---KHPQLQY--------EAKLYKIL 59
           G  IG G++G +YL  N+ T E +A+K +E   T   +H   Q         E +  K L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 60  QGGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSR---KLSLKTVLMLADQM 112
                  N+ ++ G E     L I L    G S+      C R   +   + V    +Q+
Sbjct: 66  DH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQV 117

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           +  + ++HSK  LHRD+K DN L+          I DFG++K+  D   +      +N +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMS 169

Query: 173 LTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
           + G+    A     +   G   S + D+ SLG V++    G  PW   +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 8e-09
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 20/162 (12%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKL-YKILQGGTG 64
              F L   IG G++G++Y   + +T + VAIK+ ++       + E K  Y IL+  + 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSN 61

Query: 65  IPNL-RWFGV--------EGDYNVLVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQ 111
            PN+  ++G           D   LV++L  G S+ DL        ++L  + +  +  +
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
            +  + ++H    +HRDIK  N L  L + A +V ++DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 23/200 (11%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNL 68
           R +G G+FGE  L    + +  V  K  N+     + +     E  +  +LQ     PN+
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61

Query: 69  -RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 123
             ++    D N L+I++    G +L D       +L   + VL    Q+++ V ++H   
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            LHRDIK  N  +    +A  + + DFG++K      +         + + GT  Y S  
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPE 171

Query: 184 THLGIEQSRRDDLESLGYVL 203
              G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK---RYRDTATHQHIP 166
            ++   E++H++  ++RD+KP+N L+   G     V ++DFG AK     + T T     
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWT----- 151

Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA------- 218
                   GT  Y +    L        D  SLG +L+Y  L G  P+            
Sbjct: 152 ------FCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYN 204

Query: 219 ----GTKKQKYEKISEKKVSTSIEALCRGYPTE 247
               G  K ++    +K     I+ L R  P E
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.9 bits (134), Expect = 9e-09
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 20/211 (9%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQGGTG 64
           K+    KIG G+ G ++   ++ T +EVAIK  N++ K P+ +    E  + K L+    
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNI 78

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           +  L  F V  +  V++  L G SL D+    C  +  +  V     + +  +EF+H+  
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASM 182
            +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + + 
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 184

Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                     + D+ SLG + +  + G  P+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 48/173 (27%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++ L + IGSG++G +    + +T  +VAIK + NV          AK  +IL+    I 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLID---AK--RILRE---IK 51

Query: 67  NLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------------- 110
            LR    E   N++ ++D+L P   + FN     + + T LM  D               
Sbjct: 52  LLRHLRHE---NIIGLLDILRPPSPEDFN----DVYIVTELMETDLHKVIKSPQPLTDDH 104

Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 154
                 Q++  ++++HS + +HRD+KP N L       N    + I DFGLA+
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 23/222 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
           +RLG+ +G G+FG +YL  +  T  E+A+K      + P+       L+ E +L K L  
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 62  GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
              +   +++G      E   ++ +  + G S++D        L+         Q++  V
Sbjct: 64  ERIV---QYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGV 119

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            ++HS   +HRDIK  N L         V + DFG +KR +       +     K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGT 172

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
             + S     G    R+ D+ S+G  ++  L    PW   +A
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 26/167 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE 52
           +K+    KIG G+FGE++   + +T + VA+K   +EN K   P            L++E
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 53  --AKLYKILQG-GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
               L +I +   T     +     G +  LV +     L  L +  + K +L  +  + 
Sbjct: 72  NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
             ++N + ++H    LHRD+K  N L+    +   + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 72
           +IG GSFGE+Y G + +T E VAIK+ +++    +++   +   +L         R++G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 73  -VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
            ++G    ++++ L G S  DL       L    +  +  +++  ++++HS+  +HRDIK
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
             N L+        V + DFG+A +  DT   ++          GT  + +      I+Q
Sbjct: 129 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175

Query: 191 SRRD---DLESLGYVLMYFLRGSLPWQGL 216
           S  D   D+ SLG   +   +G  P   L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 20/182 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LQYEAKLYKILQGGT 63
           F++ +KIG G F E+Y  T +   + VA+K     E +  K  Q    E  L K L    
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVH 120
            I  L  F  + + N+++       L  +  +  ++  L   +TV     Q+ + VE +H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           S+  +HRDIKP N F+   G     V + D GL + +    T  H       +L GT  Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172

Query: 180 AS 181
            S
Sbjct: 173 MS 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 23/222 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
           +RLG+ +G G+FGE+YL  +  T  E+A+K        +    +   L+ E +L K L+ 
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 62  GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
              +   +++G      E   ++ V  + G S++D        L+         Q++  V
Sbjct: 64  DRIV---QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGV 119

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            ++HS   +HRDIK  N L      A  V + DFG +KR +       +     K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGIKSVTGT 172

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
             + S     G    R+ D+ S+   ++  L    PW   +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 21/156 (13%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI-- 65
            + L ++IGSG++G++Y   +I T E VAIK+  ++            ++I+Q    +  
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--------PGDDFEIIQQEISMLK 55

Query: 66  ----PNL-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
               PN+  +FG     + L I +    G SL+D++      LS   +  +  + +  + 
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
           ++H    +HRDIK  N L+        V + DFG++
Sbjct: 116 YLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 7/158 (4%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQYEAKLYKILQGGTGIPNLRWF 71
           +IG GSFG +Y  TN  TNE VA+K  +   K  + + Q   K  K LQ       + + 
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 72  G--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
           G  ++     LV++    S  DL     + L    +  +    +  + ++HS + +HRDI
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           K  N L+       QV + DFG A +     +    PY
Sbjct: 148 KAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 12/151 (7%)

Query: 13  RKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LQYEAKLYKILQGGTGI 65
           +++G G FG++ L         T E+VA+K  N   +       + E ++ + L     +
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 66  PNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
                    G  ++ +I    P  SL D       +++LK +L+ + Q+   ++++ S+ 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HRD+   N L+      + V I DFGLAK
Sbjct: 130 YIHRDLAARNILV---ESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 38/162 (23%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKT------------KHPQLQYEAK 54
           KIG G++G ++   N +T+E VA+K        E V +            KH  +    +
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI---VR 63

Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           LY +L     +              LV +     L+  F+ C+  +  + V     Q++ 
Sbjct: 64  LYDVLHSDKKL-------------TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            + F HS + LHRD+KP N L+    +  ++ + DFGLA+ +
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 16/162 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
             F L   IG GSFGE+Y   + +TN+ VAIK   LE  + +   +Q E +     +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57

Query: 64  GIPNL-RWFG-VEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
             P + +++G       + +I     G S  DL      KL    +  +  +++  +E++
Sbjct: 58  -SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
           H +  +HRDIK  N L+        V + DFG++ +   T +
Sbjct: 115 HEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMS 153

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 41/191 (21%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
           KIG G++G +Y G N +T + VA   I+LE+ +   P     E  L K LQ     PN+ 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61

Query: 70  WFGVEGDYNVLVIDLL--GPSLEDLFNFCS-------------RKLSLKTVLMLADQMIN 114
                    V + D+L     L  +F F S             + +  + V     Q++ 
Sbjct: 62  ---------VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRE 169
            + F HS+  LHRD+KP N L+        + + DFGLA+ +       TH+ +   YR 
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169

Query: 170 NKNLTGTARYA 180
            + L G+ RY+
Sbjct: 170 PEVLLGSPRYS 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 41/287 (14%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQ 60
           PR     RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+
Sbjct: 4   PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLR 59

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
               +        E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V 
Sbjct: 60  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
             +++HRD++  N L+G     N V  + DFGLA+   D        Y   +      ++
Sbjct: 120 RMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKW 169

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
            +    L    + + D+ S G +L     +G +P+ G+              ++V   +E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE 217

Query: 239 ALCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRLFRDLF 277
              RGY    P E     H     C     +++P + YL+    D F
Sbjct: 218 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 53.6 bits (128), Expect = 5e-08
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77

Query: 64  GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I N     + GD   +V++ L G SL D+       +    +  +  + +  +EF+HS 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 181
             +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + +
Sbjct: 136 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 184

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                      + D+ SLG + +  + G  P+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 23/160 (14%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAK-----------LYKILQGGT 63
           +GSG+FG +Y     + N +  + L+ +   +P    + +              I++   
Sbjct: 8   LGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 64  GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
             PN+ R++   +E D   +V+DL+ G  L + FN    K    + + +  +  QM+  +
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 117 EFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
            ++H  K  +HRD+ P+N ++G     ++V I DFGLAK+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.0 bits (128), Expect = 7e-08
 Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 44/181 (24%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVK-----------TKHPQ- 48
           +++  KIG G+F E+    + +T +  AIK        LE V            + HP  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
           L+    L+    G      L           LV +L+  +L +L     R L  K V   
Sbjct: 61  LRLIEVLFDRKTG-----RL----------ALVFELMDMNLYELIKGRKRPLPEKRVKSY 105

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             Q++  ++ +H     HRDIKP+N L+    + + + + DFG  +       +   PY 
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYT 156

Query: 169 E 169
           E
Sbjct: 157 E 157

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   +I T +EVAIK  N++    Q + E  + +IL        
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNP 76

Query: 64  GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I N     + GD   +V++ L G SL D+       +    +  +  + +  ++F+HS 
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSN 134

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 181
             +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + +
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 183

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                      + D+ SLG + +  + G  P+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.8 bits (126), Expect = 8e-08
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKL-------YKILQGGT 63
           KIG GSFGE++ G + +T + VAIK   LE  + +   +Q E  +       Y     G+
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 64  GIPNLR-WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            + + + W  +E       +DLL P   D       +  + T+L    +++  ++++HS+
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             +HRDIK  N L+       +V + DFG+A +  DT   ++          GT  + + 
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170

Query: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
                I+QS  D   D+ SLG   +   +G  P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.8 bits (126), Expect = 8e-08
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
           +R G+ +G G+FG +YL  ++ T  E+A K      + P+       L+ E +L K LQ 
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLL-----GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
              +   +++G   D     + +      G S++D        L+         Q++  +
Sbjct: 64  ERIV---QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGM 119

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            ++HS   +HRDIK  N L      A  V + DFG +KR +       +     +++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTGT 172

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
             + S     G    R+ D+ SLG  ++  L    PW   +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.2 bits (127), Expect = 8e-08
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 7/159 (4%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
           R+IG GSFG +Y   +++TNE VAIK  +   K    +++   K  K LQ      ++ +
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 71  FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
            G  +      LV++    S  DL     + L    +  +    +  + ++HS + +HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           IK  N L+       QV + DFG A       +    PY
Sbjct: 151 IKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 31/155 (20%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNL-RW 70
           IG G++G +Y G ++ T   VA+K+ N+ T       +Q E  L   L+     PN+ ++
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ-PPNITKY 67

Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR------------VEF 118
           +G           L GP L  +  +     S++T LM A  +  +            +++
Sbjct: 68  YGSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALKY 116

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
           +H    +HRDIK  N L+        V + DFG+A
Sbjct: 117 IHKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 34/198 (17%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +KF +  +IG G++G++Y   +  T E VA+K   L+N K   P     E K+ + L   
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH- 65

Query: 63  TGIPNLRWFGVEGDYNV----------LVI-----DLLGPSLEDLFNFCSRKLSLKTVLM 107
             I NL+    +    +          LV      DL+G     L +F     S   +  
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-----SEDHIKS 120

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQ 163
              Q++  + + H K+FLHRDIK  N L+       Q+ + DFGLA+ Y        T++
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 164 HIP--YRENKNLTGTARY 179
            I   YR  + L G  RY
Sbjct: 178 VITLWYRPPELLLGEERY 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 16/159 (10%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNL 68
             +GSG++G +    + +  ++VA+K  +   +   H +  Y E +L K ++    I  L
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 69  RWF----GVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
             F     +E ++N   LV +L+G  L ++     +KLS + V  L  Q++  ++++HS 
Sbjct: 81  DVFTPATSIE-NFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
             +HRD+KP N  +       ++ I+DFGLA++  D  T
Sbjct: 138 GIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGT 63
              +L RK+G+G FGE++ G  N  T   VA+K     T  P+  L  EA++ K L+   
Sbjct: 6   TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLA-EAQIMKKLRH-- 60

Query: 64  GIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
             P L + + V    +   +V +L+  G  LE L     R L L  ++ +A Q+ + + +
Sbjct: 61  --PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + +++++HRD+   N L+G     N   + DFGLA+
Sbjct: 119 LEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 58/200 (29%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKT------------KHPQL----- 49
           KIG G++G +Y   N  T E VA+K        E V +             HP +     
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 50  --QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVL 106
               E KLY                       LV + L   L+   +      + L  + 
Sbjct: 67  VIHTENKLY-----------------------LVFEFLHQDLKKFMDASPLSGIPLPLIK 103

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQ 163
               Q++  + F HS   LHRD+KP N L+        + + DFGLA+ +     T TH+
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 164 HIP--YRENKNLTGTARYAS 181
            +   YR  + L G   Y++
Sbjct: 161 VVTLWYRAPEILLGCKYYST 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 14/155 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLQYEAKLYKIL 59
           NK+ +   +G G++G +    N  T E VAIK        E+VK        E K+ + L
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57

Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
           +    +     F  +G    LV + +  +L +L       L    V     Q++  + + 
Sbjct: 58  RHENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           HS + +HRDIKP+N L+     +  + + DFG A+
Sbjct: 117 HSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 22/182 (12%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNL- 68
           KIG G++G +Y   +  T E VA   I+LE      P     E  L K L      PN+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61

Query: 69  RWFGV-EGDYNV-LVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFL 125
           R   V   +  + LV + L   L+   +      L    +     Q++  + + HS   L
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP--YRENKNLTGTARY 179
           HRD+KP N L+    R   + + DFGLA+ +    R T TH+ +   YR  + L G+ +Y
Sbjct: 122 HRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQY 177

Query: 180 AS 181
           ++
Sbjct: 178 ST 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 23/206 (11%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 72
           +IG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 73  -VEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
            ++G    ++++ L  G +L+ L      +  + T+L    +++  ++++HS+  +HRDI
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           K  N L+        V + DFG+A +  DT         +     GT  + +      I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174

Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
           QS  D   D+ SLG   +   +G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 15/162 (9%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
           PR     +L +K+G+G FGE+++G     + +VAIK     +  P+    EA L K LQ 
Sbjct: 4   PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 62  GTGIPNL-RWFGVEGDYNVLVID--LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
               P L R + V     + +I   +   SL D        KL++  ++ +A Q+   + 
Sbjct: 61  ----PRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           F+  K+++HRD++  N L+          I DFGLA+   D 
Sbjct: 117 FIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 26/161 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LQYEAKLYKILQGG 62
            K+     +G GS+G +    + +T + VAIK  LE+   K  +     E ++ K L+  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-H 59

Query: 63  TGIPNL--------RWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMI 113
             + NL        R +        LV + +  + L+DL  + +  L    V     Q++
Sbjct: 60  ENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQIL 110

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             +EF HS + +HRDIKP+N L+    ++  V + DFG A+
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 52/168 (30%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
           IG G++G +    N +TNE+VAIK      +N       L+ E KL            LR
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKL------------LR 59

Query: 70  WFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------ 110
               E   NV+ I D++ P   + FN     + +   LM  D                  
Sbjct: 60  HLDHE---NVIAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQY 112

Query: 111 ---QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
              Q++  ++++HS + LHRD+KP N L+     AN  + I DFGLA+
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 30/159 (18%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP-----------QLQYEAKLYKIL 59
           +I  G++G +Y   + +T E VA   +K+E  K   P           +LQ+        
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP------- 64

Query: 60  QGGTGIPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
                I  ++    G   D   +V++ +   L+ L     +      V  L  Q+++ V 
Sbjct: 65  ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            +H    LHRD+K  N L+        + I DFGLA+ Y
Sbjct: 121 HLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREY 156

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 50/237 (21%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI-----PN 67
            KIG G+FG++Y G  ++ N EVA+K    ++  P         K LQ    +     PN
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKR----KFLQEAEILKQYDHPN 53

Query: 68  L-RWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK 122
           + +  GV      + ++  L P    L  F  +K   L++K +L ++      +E++ SK
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR----ENKNL 173
           + +HRD+   N L+G     N + I DFG+++      Y  +   + IP +    E  N 
Sbjct: 113 NCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN- 168

Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 228
               RY S +           D+ S G +L++  F  G  P+ G+   + +Q  E+I
Sbjct: 169 --YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++LG  IG+GSFG +Y    I T+E+VAIK  L++ + K+ +L     L  I      I 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI-----NII 122

Query: 67  NLR-WFGVE----GDYNV---LVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINR 115
            L+ ++  E     + N+   +V++ +  ++       +R    L L  V + + Q+   
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIPYRENK 171
           + ++HSK   HRD+KP N L  +    + + + DFG AK      R  +      YR  +
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240

Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
            + G   Y    TH+        DL SLG ++   + G
Sbjct: 241 LMLGATNYT---THI--------DLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNL- 68
           +IG G++G +Y   +  +   VA+K   V+T    L      E  L K L+     PN+ 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH-PNIV 65

Query: 69  RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVH 120
           R   V      D    V  +     +DL  +  +     L  +T+  L  Q +  ++F+H
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +   +HRD+KP+N L+  G    QV + DFGLA+ Y
Sbjct: 126 ANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 37/283 (13%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
           PR     +L +K+G+G FGE+++GT    N +VA+K     T  P+    EA++ K L+ 
Sbjct: 4   PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              +        E  Y V      G  L+ L +   R L L  ++ +A Q+   + ++  
Sbjct: 61  DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
            +++HRD++  N L+G G       I DFGLA+   D        Y   +      ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
               L    + + D+ S G +L   + +G +P+ G+            + ++V   +E  
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQVE-- 217

Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
            RGY        P         C     +++P + YL+    D
Sbjct: 218 -RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.9 bits (117), Expect = 5e-07
 Identities = 27/149 (18%), Positives = 61/149 (40%), Gaps = 18/149 (12%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG-GTGIPNLRWF 71
           + +  G    +YL      +E+  +K+   + K    + E  + ++L   G  +P +   
Sbjct: 4   KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 72  GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
           G    ++ L+++ + G +L+        ++S +    +A+Q+   +  +H        H 
Sbjct: 62  GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113

Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           D+ P N L+        + IID+  A   
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 22/230 (9%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIP 66
               + +G+G+FG ++L  +  +    A+K+  +    +  Q Q+     ++L+  +   
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            +R F  E D   L + +      +LF++   S + S  T L  A +++  +E++HSK  
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARYASMN 183
           ++RD+KP+N L+    +   + + DFG AK+ RD T T           L GT  Y +  
Sbjct: 123 VYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTPEYLAPE 168

Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
                  ++  D  +LG ++   L G  P+           YEKI   K+
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 15/150 (10%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           LG  IG G FG++ LG      ++VA+K L++  T       EA +   L+     PNL 
Sbjct: 10  LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNLV 63

Query: 69  RWFGV--EGDYNVLVIDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV  +G+   +V + +   SL D      R  ++L   L  A  +   +E++  K+F
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+          + DFGLAK
Sbjct: 124 VHRDLAARNVLVS---EDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 22/219 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           FR+ +KIG G F E+Y  T +     VA+K      L + K +   ++ E  L K L   
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHP 62

Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 119
             I     F  + + N+++       L  +   F    R +  KTV     Q+ + +E +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 120 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           HS+  +HRDIKP N F+   G     V + D GL + +    T  H       +L GT  
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
           Y S         + + D+ SLG +L        P+ G K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 49.9 bits (120), Expect = 7e-07
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 15/158 (9%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
           F   + +G+GSFG + L  +  + +  A+K+ +    VK K  Q+++     +ILQ    
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQS-IR 59

Query: 65  IPNL--RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
            P L   +   + D N+ LV++ + G  L         +         A Q++  +E++H
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH 118

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           S   ++RD+KP+N L+        + I DFG AKR + 
Sbjct: 119 SLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKG 153

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 7/159 (4%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
           R+IG GSFG +Y   +++ +E VAIK  +   K    +++   K  + LQ       +++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 71  FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
            G  +      LV++    S  DL     + L    +  +    +  + ++HS + +HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +K  N L+        V + DFG A            PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 13  RKIGSGSFGEI----YLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGTGI 65
           R +G G FG++    Y   N  T E VA+K    E  +      + E  + K L     +
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
                   +G   + +I    P L  L ++  + KL+L  +L+ A Q+   + ++HS+ +
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+        V I DFGLAK
Sbjct: 129 IHRDLAARNVLL---DNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQGGTGIPNLRWFG 72
           +G G++G +Y   ++ T   +AIK +    +++ Q L  E  L+  L+    +  L    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 73  VEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
             G + + +  + G SL  L    +   K + +T++    Q++  ++++H    +HRDIK
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 131 PDNFLMGLGRRANQVYIIDFGLAKR 155
            DN L  +   +  V I DFG +KR
Sbjct: 136 GDNVL--VNTYSGVVKISDFGTSKR 158

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 27/173 (15%)

Query: 14  KIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ------LQYEAKLYKILQGGTG 64
           K+G GSFG +  G    +  +   VA+K   +K+          L+  A ++ +      
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDH---- 55

Query: 65  IPNL-RWFGVEGDYNV-LVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             NL R +GV   + + +V +L  LG  L+ L         + T+   A Q+ N + ++ 
Sbjct: 56  -ENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
           SK F+HRD+   N L+      ++V I DFGL +       H    Y   ++L
Sbjct: 115 SKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 30/211 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
             F++ +KIG G F  +Y    +     VA+K      + + K +   L+ E  L K L 
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLD 60

Query: 61  GGTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMI 113
                PN +++     + N L I L      DL      F    R +  +T+     Q+ 
Sbjct: 61  H----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           + +E +HSK  +HRDIKP N  +     A   V + D GL + +    T  H       +
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------S 165

Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVL 203
           L GT  Y S         + + D+ SLG +L
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 49/284 (17%)

Query: 14  KIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHPQLQYEA-KLYKILQGGTGIPNLRW 70
           ++GSG+FG +  G     ++ + VA+K+       P L+ E  +   ++Q       +R 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 71  FGV-EGDYNVLVIDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFL 125
            G+ E +  +LV++L  LGP    L  F   ++ ++ K +  L  Q+   ++++   +F+
Sbjct: 62  IGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 126 HRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNLTGTA 177
           HRD+   N L+       Q Y  I DFGL+K       Y    TH   P +         
Sbjct: 118 HRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK--------- 163

Query: 178 RYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
            YA   MN +   + S + D+ S G VLM+  F  G  P++G+K     Q  E    +++
Sbjct: 164 WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GERM 217

Query: 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
                   +  P E       C +   D++P +A ++   R+ +
Sbjct: 218 ECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F L ++IGSG++G++Y   N+ T E  AIK+  ++        + ++  I+       N+
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68

Query: 69  -RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
             +FG     + L I +    G SL+D+++  +  LS   +  ++ + +  + ++HSK  
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +HRDIK  N L+        V + DFG++ +   T
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQITAT 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 35/172 (20%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVK---TKHPQLQYEAK 54
           PR  N    G+ +G+G+FG++   T           +VA+K+       ++   L  E K
Sbjct: 33  PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSL--------EDLFNFCSRK----LSL 102
           +   L     I NL      G          GP L         DL NF  RK    L+L
Sbjct: 91  IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + +L  + Q+   + F+ SK+ +HRD+   N L+  G+      I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 25/182 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
           + + L   IG G+   +Y    +  NE+VAIK   LE  +T   +L+ E +         
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-- 58

Query: 64  GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMIN 114
             PN+ +++   V GD   LV+  L G SL D+      +       + TVL    +++ 
Sbjct: 59  --PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            +E++HS   +HRDIK  N L+G       V I DFG++    D         +  K   
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFV 167

Query: 175 GT 176
           GT
Sbjct: 168 GT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 37/172 (21%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE--A 53
           +L R IG G++G +Y   +  + E VA+K   ++N +   P            L++    
Sbjct: 11  KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 54  KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
           +L +++ G              D   LV++     L  L +      S   V  L  Q++
Sbjct: 70  ELKEVVVGK-----------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 114 NRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATH 162
             ++++H    +HRD+K  N L+   G       + I DFGLA+ Y   A  
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTYGLPAKP 164

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 57/233 (24%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------------------TKH 46
             F++  ++G G +G+++L     T E VA+K                         TK 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 47  PQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSL 102
             L    KL    Q         +  +E    GD+  L+ +L               LS 
Sbjct: 61  EWL---VKLLYAFQD----DEYLYLAMEYVPGGDFRTLLNNL-------------GVLSE 100

Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
                   +M   V+ +H   ++HRD+KP+NFL+     +  + + DFGL+K     A  
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA-- 155

Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                    ++ G+  Y +     G       D  SLG +L  FL G  P+ G
Sbjct: 156 --------NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 12/176 (6%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           K+G G++  ++ G +  T   VA   I+LE+ +        E  L K L+    I  L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN-IVTLHD 71

Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
                    LV + L   L+   + C   +S+  V +   Q++  + + H +  LHRD+K
Sbjct: 72  IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
           P N L+       ++ + DFGLA+ +   T T+ +    + YR    L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 45/281 (16%)

Query: 13  RKIGSGSFGEIYLGTNIQTNE---EVAIKL---ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           +++G G+FG +  G  +  +    EVA+K    E++     +   EA +   L      P
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56

Query: 67  NL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            + R  GV +G+  +LV++L  LGP L+ L     R++ +  +  LA Q+   + ++ SK
Sbjct: 57  CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------RYRDTATHQHIPYRENKNLTGT 176
            F+HRD+   N L  L  R +Q  I DFG+++       Y    T    P +        
Sbjct: 115 HFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
             YA    + G   S + D+ S G V ++  F  G+ P+  +K      +   + E    
Sbjct: 164 -WYAPECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGER 216

Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
                 C   P E  S    C   R +D+P ++ L+  FR 
Sbjct: 217 LPRPEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 30/156 (19%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIPNLR 69
           KIG GS+G ++   N +T + VAIK        P ++     E ++ K L+     PNL 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH----PNL- 62

Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEF 118
                   N++ +      L  +F +C            R +    +  +  Q +  V F
Sbjct: 63  -------VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            H  + +HRD+KP+N L+    +  Q+ + DFG A+
Sbjct: 116 CHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEA-KLYKILQGGTGIP 66
           ++ + +KIG GSFG+IYL      +E   IK  ++ TK P  + EA K   IL      P
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHP 59

Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEF 118
           N+  +F    +   L I +      DL    +R+   + VL   DQ+++        ++ 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKH 116

Query: 119 VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           +H +  LHRDIK  N FL   G  A    + DFG+A++  D+               GT 
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGTP 166

Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y S         + + D+ SLG VL        P++G
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 25/217 (11%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI-LQGGTGIPN 67
           F++ +K+G GS+G +Y    +  N+  A+K  ++ +   Q + E  + +I +      PN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPN 60

Query: 68  LRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEFV 119
           +  +  E   D N L I +      DL    S++   + ++       +  Q++  ++ +
Sbjct: 61  IISYK-EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           H +  LHRD+K  N L      AN +  I D G++K  +             K   GT  
Sbjct: 120 HEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTPH 166

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           Y +     G   S + D+ SLG +L      + P++ 
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 16/158 (10%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIPNL-RW 70
           K+G G +GE+Y G   + +  VA+K   E+       L+ EA + K ++     PNL + 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKH----PNLVQL 67

Query: 71  FGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLH 126
            GV   E  + ++   +   +L D    C+R+ ++   +L +A Q+ + +E++  K+F+H
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-DTATHQ 163
           RD+   N L+G     + V + DFGL++    DT T  
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 4e-06
 Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)

Query: 91  DLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
           DLF+      KLS   V  +  Q++  +  +H  + +H DIK +N L    R  +++Y+ 
Sbjct: 95  DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152

Query: 149 DFGLAKR 155
           D+GL K 
Sbjct: 153 DYGLCKI 159

Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 20/154 (12%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGTGIP 66
             +GSG++G++    + +T  +VAIK      ++    H +  Y E +L K +     I 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78

Query: 67  NLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
            L  F     +E   +V LV  L+G  L ++     +KLS   +  L  Q++  ++++HS
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 122 KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
              +HRD+KP N    +    + ++ I+DFGLA+
Sbjct: 137 AGIIHRDLKPSN----IAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 18/203 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           NKF +   +G G++G +    + +T E VAIK      EN + K   L+ E K+ + L+ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              +     F   G    LV + +  ++ +L       +  + V     Q+I  + + H 
Sbjct: 60  ENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
              +HRDIKP+N L+      N V  + DFG A+   + +   +  Y        T  Y 
Sbjct: 119 NDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYR 168

Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
           S    LG    +  D+ S+G +L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 13/148 (8%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
           R+IG GSFG +Y   +++TNE VAIK  +   K    +++   K  + LQ     PN   
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIE 79

Query: 71  FGVEGDY-----NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
           +  +G Y       LV++    S  D+     + L    +  +    +  + ++HS   +
Sbjct: 80  Y--KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLA 153
           HRDIK  N L+        V + DFG A
Sbjct: 138 HRDIKAGNILL---TEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 57/191 (29%), Positives = 80/191 (41%), Gaps = 47/191 (24%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
           + IG G+FGE+ L   + TN   A+K              +VK +   L     ++  KL
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 56  YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
           Y   Q      NL +F ++    GD   L+I L G   EDL  F   +L+          
Sbjct: 67  YYSFQDKD---NL-YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCA-------- 113

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
               +E VH   F+HRDIKPDN L+    R   + + DFGL   +R   TH    Y++  
Sbjct: 114 ----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG- 163

Query: 172 NLTGTARYASM 182
                 R  SM
Sbjct: 164 ---DHHRQDSM 171

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 14/177 (7%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           K+G G++  ++ G +  T   VA   I+LE+ +        E  L K L+    I  L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-IVTLHD 70

Query: 71  FGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
             +  +  + LV + L   L+   + C   +S+  V +   Q++  + + H +  LHRD+
Sbjct: 71  I-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
           KP N L+       ++ + DFGLA+ +   T T+ +    + YR    L G+  Y++
Sbjct: 130 KPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 37/162 (22%), Positives = 77/162 (47%), Gaps = 19/162 (11%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
            VG++++    IGSG++G +    + ++ ++VAIK      +        L+ E K+ + 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60

Query: 59  LQGGTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
            +    I         G +     +V+DL+   L  +     + L+ + +     Q++  
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRG 119

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAK 154
           ++++HS + +HRD+KP N L+      N+   + I DFG+A+
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKI-LQGGTGIP 66
           G+++G+G+F   Y   +++T   +A+K    + N  ++  ++  EA   +I L      P
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHP 63

Query: 67  NL-RWFGV---EGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 121
           ++ R  G    +  +N+ V  + G S+  L   + + K ++  ++   +Q++  + ++H 
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121

Query: 122 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
              +HRD+K  N L+   G+R   + I DFG A R     T           L GT  + 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +     G +  R  D+ S+G V++       PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRD 158
           Q++N V ++HS   LHRD+KP N  +MG G     V I D GLA+ +  
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 37/229 (16%)

Query: 11  LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGT 63
           L R++G G+FG+++L    N+  T +++ + ++ +K          Q EA+L   LQ   
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 64  GIPNLRWFGV--EGDYNVLVIDLL------------GPSLEDLFNFCSRK----LSLKTV 105
            +   +++GV  +GD  ++V + +            GP    L +   R+    L L  +
Sbjct: 69  IV---KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
           L +A Q+ + + ++ S+ F+HRD+   N L+G       V I DFG++   RD  +  + 
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY- 178

Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
            YR   +     R+    + +  + +   D+ S G +L   F  G  PW
Sbjct: 179 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 12/176 (6%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           K+G G++  +Y G +  T+  VA   I+LE+ +        E  L K L+    +     
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
              E     LV + L   L+   + C   +++  V +   Q++  + + H +  LHRD+K
Sbjct: 73  IHTEKSLT-LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131

Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
           P N L+       ++ + DFGLA+ +   T T+ +    + YR    L G+  Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 17/150 (11%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK-------LYKILQGGTGIP 66
           +GSG++G +    + +T E+VAIK    K   P Q +  AK       L K +Q    I 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 67  NLRWFGVEGDYNVLV-IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L  F      +      L+ P ++ DL       LS   V  L  QM+  ++++HS   
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+KP N  +       ++ I+DFGLA+
Sbjct: 139 IHRDLKPGNLAVN---EDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 58/203 (28%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP----NL 68
           R IG G+FG ++  T+ +  + VA+K               K+  + Q           L
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALK---------------KMPNVFQNLVSCKRVFREL 50

Query: 69  RWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD----------------- 110
           +        NVL  +D+L P   D F     ++ + T LM +D                 
Sbjct: 51  KMLCFFKHDNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106

Query: 111 ----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHI 165
               Q++  ++++HS   LHRDIKP N L+     +N  + I DFGLA R  +    +H+
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLA-RVEEPDESKHM 161

Query: 166 P-------YRENKNLTGTARYAS 181
                   YR  + L G+  Y S
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTS 184

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 11  LGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           LGR IG G FG++Y G  +   NE++A+ ++  K        E    K LQ    +    
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE----KFLQEAYIMRQFD 65

Query: 69  -----RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVH 120
                +  GV  +  V ++  L P L +L ++       L L ++++ + Q+   + ++ 
Sbjct: 66  HPHIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           SK F+HRDI   N L+      + V + DFGL+ RY +
Sbjct: 125 SKRFVHRDIAARNVLVS---SPDCVKLGDFGLS-RYLE 158

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 33/164 (20%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
           + +G G+FGE+ L   + T    A+K            + +VK +   L     ++  +L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
           Y   Q    +  +  +   GD   L+I + G   EDL  F               ++   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIAELTCA 113

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           VE VH   F+HRDIKPDN L+    R   + + DFGL   +R T
Sbjct: 114 VESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIPNLRWF 71
           KIG GS G + +     +  +VA+K+ +++ +  +  L  E  + +  Q    +   + +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 72  GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
            V  +  VL+  L G +L D+ +    +L+ + +  + + ++  + ++HS+  +HRDIK 
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
           D+ L+ L  R   V + DFG   +       + +P R  K+L GT  + +          
Sbjct: 146 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195

Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 38/192 (19%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
           +++  G+   +YLG       EVA+K+    +    L+ EAK+ +IL G    P + ++G
Sbjct: 28  KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG 85

Query: 73  VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRDI 129
            +    + +  + G  L  L     RK  L+ +     L    I   E       +   +
Sbjct: 86  ED---FIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV---L 139

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
             D            VYIIDF       D+AT +  P    +N+T           L  E
Sbjct: 140 VND----------RDVYIIDF-------DSATFKKKP----RNVTQALSL------LFRE 172

Query: 190 QSRRDDLESLGY 201
             R +     GY
Sbjct: 173 GLRIEKTILRGY 184

Length = 201

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 52/245 (21%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           F +G  +G+GSFG + +  +  T E  AIK     E +K K  Q+Q+ A+   IL     
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK--QVQHVAQEKSILM---- 73

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL---SLKTVLMLADQMINRV----- 116
                    E  +  +V  +     E+   F    +    L T L  A +  N V     
Sbjct: 74  ---------ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124

Query: 117 -------EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYR 168
                  E++HSK  ++RD+KP+N L  L  + + V + DFG AK+  D T T       
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT------- 174

Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
               L GT  Y +          +  D  ++G +L  F+ G  P+      T  + YEKI
Sbjct: 175 ----LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKI 227

Query: 229 SEKKV 233
              ++
Sbjct: 228 LAGRL 232

Length = 329

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 9/146 (6%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK--HPQLQYEAKLYKILQGGTGIPNL 68
           + +G G+FG +    +  T + VAIK  ++   T     +   E KL K L+    I   
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75

Query: 69  RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
             F    +    V +LLG  L  L    SR L  + +     Q++  +++VHS   +HRD
Sbjct: 76  DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133

Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
           +KP N L+        + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 43/272 (15%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKILQGGTGIPNL- 68
           +G G+FGE++ GT ++    VA+K    K   PQ        EA++ K        PN+ 
Sbjct: 3   LGKGNFGEVFKGT-LKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55

Query: 69  RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFL 125
           +  GV      + I +      D  +F  +K   L  K ++  A      + ++ SK+ +
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYR-ENKNLTGTARYA 180
           HRD+   N L+G     N + I DFG++++  D    ++  + IP +          RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 181 SMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
           S             D+ S G +L   F  G  P+ G+   T +Q  E++ EK    S   
Sbjct: 173 S-----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSCPQ 217

Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271
            C   P +       C   + +++P ++ L++
Sbjct: 218 KC---PDDVYKVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--------QLQYEAKLY 56
           V +++R  +++GSG++G +    + +T  +VAIK    K   P        +   E +L 
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK----KLYRPFQSELFAKRAYRELRLL 68

Query: 57  KILQGGTGIPNLRWFGVE---GDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
           K ++    I  L  F  +     ++   LV+  +G  L  L      KLS   +  L  Q
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQ 126

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
           M+  ++++H+   +HRD+KP N  +       ++ I+DFGLA++
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 48/251 (19%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGTG 64
           K  LG  IG G FG +  G    T ++VA+K  N+K   T    L+  A + K+      
Sbjct: 7   KLTLGEIIGEGEFGAVLQGE--YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHH---- 58

Query: 65  IPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRV 116
             NL R  GV    G Y  +V++L+  S  +L NF   +    +S+  +L  +  +   +
Sbjct: 59  -KNLVRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           E++ SK  +HRD+   N L+          + DFGLA+       +  +P +       T
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------WT 164

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
           A  A  +       S + D+ S G +L         W+    G  +  Y K+S K+V   
Sbjct: 165 APEALKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKEC 209

Query: 237 IEALCRGYPTE 247
           +E   R  P E
Sbjct: 210 VEKGYRMEPPE 220

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 61/288 (21%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LEN----VKTKHPQLQ 50
           ++  L ++IGSG FG ++LG       +VAIK            +E     +K  HP+L 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL- 61

Query: 51  YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
              +LY +    + I              LV + +    L D       K S +T+L + 
Sbjct: 62  --VQLYGVCTERSPI-------------CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYR 168
             +   + ++ S + +HRD+   N L+G     NQV  + DFG+ +   D        Y 
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQ------YT 156

Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
            +       +++S       + S + D+ S G VLM        W+    G  K  YE  
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG-VLM--------WEVFSEG--KTPYENR 205

Query: 229 SEKKVSTSIEALCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 271
           S  +V  +I A  R Y    AS        +C   R +D+P ++ L  
Sbjct: 206 SNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 42/172 (24%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
           + L +++G G++G +    N +T+EE  VAIK + NV +K    +   +  K+L+   G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------------- 110
            N+            + D     ++ +F     +L L   LM AD               
Sbjct: 62  KNITC----------LYD-----MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106

Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
                 Q++  ++++HS + LHRD+KP N L+       ++ I DFGLA+ +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +A Q+++ + ++H +  +HRDIKP N L+   +    V I DFG+++    T      P 
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225

Query: 168 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
             +    GT  Y S   +NT L       D    D+ SLG  ++ F  G  P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 14/156 (8%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNLRW 70
           +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K ++    I  L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 71  FGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
           F             LV  L+G  L ++     +KL+   V  L  Q++  ++++HS   +
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADII 142

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
           HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 143 HRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 53/281 (18%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
             +++GSG FG ++LG   +   +VAIK+  E   ++   ++ EAK+   L      PNL
Sbjct: 8   FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSH----PNL 61

Query: 69  -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSF 124
            + +GV      + I     +   L N+      KL  + +L +   +   +E++ S  F
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT---ARYAS 181
           +HRD+   N L+G     N V + DFGLA+   D          +  +  GT    ++A 
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDD---------QYTSSQGTKFPVKWAP 169

Query: 182 MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
                    S + D+ S G VLM+  F  G +P            YE+ S  +V   +E+
Sbjct: 170 PEVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV---VES 213

Query: 240 LCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRL 272
           +  GY        PTE  +  + C   + +D+P +  L   
Sbjct: 214 VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 37/161 (22%)

Query: 15  IGSGSFGEI----Y--LGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQG----- 61
           +G G+FG +    Y  L  N  T E VA+K L++   +H +  + E ++ K LQ      
Sbjct: 12  LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 62  ------GTGIPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 113
                   G  NLR          LV++ L P  SL D       +L  + +L+ A Q+ 
Sbjct: 70  YKGVCYSAGRRNLR----------LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             +E++ SK ++HRD+   N L+      N+V I DFGL K
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 14/158 (8%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIP 66
           + L +++GSG++G++Y   N+ T E  A+K+  ++       +Q E  + K  +    + 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 67  NLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
              +FG       L I +    G SL+D+++  +  LS   +  +  + +  + ++HSK 
Sbjct: 71  ---YFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            +HRDIK  N L+        V + DFG+A +   TAT
Sbjct: 127 KMHRDIKGANILL---TDNGDVKLADFGVAAKI--TAT 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 39/170 (22%), Positives = 82/170 (48%), Gaps = 19/170 (11%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG 61
           P   + + +   IG G++G+++   N +   + A+K L+ +     +++ E   Y IL+ 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKA 70

Query: 62  GTGIPNL-RWFG-------VEGDYNVLVIDLL-GPSLEDLFN-FCSR--KLSLKTVLMLA 109
            +  PN+ +++G         GD   LV++L  G S+ DL   F  R  ++    +  + 
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
            + +  ++ +H    +HRD+K +N L+        V ++DFG++ +   T
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 32/144 (22%), Positives = 69/144 (47%), Gaps = 5/144 (3%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNLRWF 71
           ++G G+FG++Y   N +T    A K+   K++     Y  E ++         +  L  F
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 72  GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
             +G   +++    G +++ +     R L+   + ++  QM+  ++++HS   +HRD+K 
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138

Query: 132 DNFLMGLGRRANQVYIIDFGLAKR 155
            N L+ L      + + DFG++ +
Sbjct: 139 GNVLLTLD---GDIKLADFGVSAK 159

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 18/138 (13%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI--PYR 168
           QM+  ++ +HS   +HRD+KP N ++   +    + I+DFGLA+    TA    +  PY 
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR----TACTNFMMTPY- 182

Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
                  T  Y +    LG+      D+ S+G ++   ++GS+ +QG        ++ K+
Sbjct: 183 -----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKV 234

Query: 229 SEKKVSTSIEALCRGYPT 246
            E+  + S E + R  PT
Sbjct: 235 IEQLGTPSAEFMNRLQPT 252

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 36/228 (15%)

Query: 14  KIGSGSFGEIYLG--TNIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++G G+FG+++L    N+   ++   VA+K   E  ++     Q EA+L  +LQ    + 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV- 70

Query: 67  NLRWFGV--EGDYNVLVIDLL------------GPS---LEDLFNFCSRKLSLKTVLMLA 109
             R++GV  EG   ++V + +            GP    L    +    +L+L  +L +A
Sbjct: 71  --RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q+ + + ++ S  F+HRD+   N L+G G     V I DFG++   RD  +  +  YR 
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180

Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
                   R+    + L  + +   D+ S G VL   F  G  PW  L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 39/168 (23%), Positives = 61/168 (36%), Gaps = 53/168 (31%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------ENVKTKHPQ 48
           K+G G++  +Y G N  T E VA+K                          EN+   H  
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVL 106
           +  E KL                       +LV + +   L+     +     L   TV 
Sbjct: 67  IHTENKL-----------------------MLVFEYMDKDLKKYMDTHGVRGALDPNTVK 103

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
               Q++  + F H    LHRD+KP N L+    +  ++ + DFGLA+
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 29/171 (16%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
           ++++   IG GS+G +    +  T E+VAIK      E+V      L+ E KL ++L+  
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59

Query: 63  TGI--------PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
             +        P+ R F    D  V V +L+   L  +    +  L+ +       Q++ 
Sbjct: 60  DIVEIKHIMLPPSRREFK---DIYV-VFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLR 114

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-RYRDTAT 161
            ++++H+ +  HRD+KP N L      AN   ++ I DFGLA+  + DT T
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
           A +++  ++F+HSK  ++RD+K DN ++    R   + I DFG+ K        +++ + 
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCK--------ENV-FG 149

Query: 169 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
           +N+  T  GT  Y +     G++ +   D  S G +L   L G  P+ G     + + +E
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFE 206

Query: 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF-RDLFIREGF--- 282
            I   +V T                 HY R +  + K     L++LF RD   R G    
Sbjct: 207 SI---RVDTP----------------HYPRWITKESKD---ILEKLFERDPTRRLGVVGN 244

Query: 283 ----QFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGR 334
                F    +WT L+          R + P   P    P   +N DR+  +E+ R
Sbjct: 245 IRGHPFFKTINWTALE---------KRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 48/284 (16%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPNL 68
           +L +K+G+G FGE+++G     + +VA+K     T   Q    EA L K LQ    +   
Sbjct: 9   KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV--- 64

Query: 69  RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           R + V    E  Y +      G  L+ L +    K+ L  ++  + Q+   + ++  K++
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+     +    I DFGLA+   D         RE     +  TA  A  
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAIN 177

Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
                I    + D+ S G +L+Y +   G +P+ G+                 S  + AL
Sbjct: 178 FGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDVMSAL 217

Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
            RGY        P E       C   + +++P + YL+ +  D 
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 11/153 (7%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
               + +GSG+FG +Y G  I   E     VAIK+   +T  P+   E      +     
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVD 67

Query: 65  IPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
            P++ R  G+     V +I  L P   L D        +  + +L    Q+   + ++  
Sbjct: 68  HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           K  +HRD+   N L+   +    V I DFGLAK
Sbjct: 128 KRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)

Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------RYRDTATH 162
           +E++H+   +HRD+KPDN L+  +G     + + DFGL+K             + +  T 
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + +    +K + GT  Y +    L     +  D  ++G +L  FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 33/164 (20%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
           + +G G+FGE+ L   + T+   A+K            + +VK +   L     ++  KL
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
           Y   Q    +  +  +   GD   L+I +     E L  F   +L+L             
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLA------------ 113

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +E VH   F+HRDIKPDN L+ L      + + DFGL   +R T
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWT 154

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 10/155 (6%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGT 63
             F +   +G G FGE+ +     T +  A+K+     +  +     +E +   IL    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE-RDILSISN 59

Query: 64  G--IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
              IP L++   + D   LV++   G  L  L N    +           +++  +  VH
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
              ++HRDIKP+N L+    R   + + DFG A R
Sbjct: 120 QMGYVHRDIKPENVLID---RTGHIKLADFGSAAR 151

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 47/168 (27%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------KHPQLQ--YEAKL 55
           +G G+FG++Y   + +T    A K+  +++                 KHP +   YEA  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 56  YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
           Y+          L W  +E    G  + ++++L     E    +  R            Q
Sbjct: 73  YE--------NKL-WILIEFCDGGALDSIMLELERGLTEPQIRYVCR------------Q 111

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           M+  + F+HS   +HRD+K  N L+ L      V + DFG++ + + T
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 31/211 (14%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLQYEAKLYKILQGGTG 64
           ++ L +++G GSFG +YL  + +   E  +K+     V   +P    +A     L     
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 65  IPNLRWFG---VEGDYNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 117
            P +  F    +E D   ++ +   G  L+          + LS   V     Q++  V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIPYRENKNLT 174
           ++H +  LHRD+K  N  +    + N + I DFG+++      D AT            T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166

Query: 175 GTARYASMN--THLGIEQSRRDDLESLGYVL 203
           GT  Y S     H G +   + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 63/288 (21%)

Query: 14  KIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           ++GSG+FG +  G      ++  VAIK+   EN K+   ++  EA++   L      P +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57

Query: 69  -RWFGV-EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
            R  GV E +  +LV+++   GP    L  F S K   +++  V+ L  Q+   ++++  
Sbjct: 58  VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 173
           K+F+HRD+   N L+      NQ Y  I DFGL+K       Y    +    P +     
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163

Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
                YA   +N     + S R D+ S G  +         W+    G K   Y+K+   
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205

Query: 232 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274
           +V + IE   R       P E  +    C   +++D+P++A ++   R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 49/285 (17%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQGGTGI 65
            +L +K+G+G FGE+++ T    N+   + ++ +K     ++    EA + K LQ    +
Sbjct: 8   LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64

Query: 66  PNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
              +   V     + +I      G  L+ L +    K  L  ++  + Q+   + F+  +
Sbjct: 65  ---KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYA 180
           +++HRD++  N L+     +    I DFGLA+   D         RE     +  TA  A
Sbjct: 122 NYIHRDLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEA 174

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
                  I    + D+ S G +LM  +  G +P+ G+                    I A
Sbjct: 175 INFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRA 215

Query: 240 LCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
           L RGY        P E  +    C   R +++P + Y++ +  D 
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 29/170 (17%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHP--------QLQYE 52
           +G+++   R +G GS G ++   +   ++ VA+K     +    KH         +L ++
Sbjct: 3   LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62

Query: 53  --AKLYKILQGGTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLML 108
              K+Y++L G +G       G   + N + I  + +   L ++       LS +   + 
Sbjct: 63  NIVKVYEVL-GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLF 119

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 154
             Q++  ++++HS + LHRD+KP N  +      N     + I DFGLA+
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 24/235 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
           F + + IG G+FGE+ +      ++  A+K+ N    +K        E +   +      
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 65  IPNLRWFGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           I  L  +  + + N+ LV+D  +G  L  L +    +L          +M+  ++ VH  
Sbjct: 63  ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
            ++HRDIKPDN LM +      + + DFG   +  +  T Q      +    GT  Y S 
Sbjct: 122 HYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISP 172

Query: 183 NTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
                +E  +       D  SLG  +   L G  P+    A +  + Y KI   K
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 23/222 (10%)

Query: 2   EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKT-KHPQLQYEA 53
           EP+  NK     F   R +G+GSFG + L T    +   VAIK  E  K  K  Q+ +  
Sbjct: 20  EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79

Query: 54  KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--MLADQ 111
              KIL        +  +G   D + L + L      + F F  R       +    A Q
Sbjct: 80  SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           ++   E++ S + ++RD+KP+N L+    +   + + DFG AK   DT T+         
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAK-VVDTRTY--------- 186

Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            L GT  Y +    L +   +  D  +LG  +   L G  P+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LENVKTKHPQLQY--EAKLYKILQG 61
            L R +G G+FGE+Y G     + +     VA+K L    ++  +  +  EA    ++  
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMS 64

Query: 62  GTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---------SRKLSLKTVLMLADQ 111
                N+ R  GV  +     I L   +  DL +F             L++K +L  A  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKR-YR 157
           +    +++    F+HRDI   N L+   G GR A    I DFG+A+  YR
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 54/190 (28%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY-------- 56
           VG +++    IG G++G +   T+  T  +VAIK        P   +E + +        
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISP---FEHQTFCQRTLREI 54

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVI-DLLGPSLEDLFN----------------FCSRK 99
           KIL         R F  E   N++ I D++ P   + FN                  ++ 
Sbjct: 55  KIL---------RRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH 102

Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRD 158
           LS   +     Q++  ++++HS + LHRD+KP N L+      N  + I DFGLA+    
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLAR---- 154

Query: 159 TATHQHIPYR 168
            A  +H    
Sbjct: 155 IADPEHDHTG 164

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIPNL-RW 70
           KIG GS G + + T+  T  +VA+K  +++ +  +  L  E  + +  Q     PN+   
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81

Query: 71  FG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
           +   + GD   +V++ L G +L D+      +++ + +  +   ++  + F+H++  +HR
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           DIK D+ L+       +V + DFG   +       + +P R  K+L GT  + +      
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISR 189

Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
           +      D+ SLG +++  + G  P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 42/224 (18%)

Query: 12  GRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT---KHPQLQYEAKLYKILQG--- 61
           G  +G G++G +Y G   Q      ++V +   NV     ++ +LQ E  L K L+    
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 62  ----GT----GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
               GT       ++    V G     +++  GP  E +F   ++            Q++
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK------------QIL 112

Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIPYRE 169
           + V ++H+   +HRDIK +N  LM  G     + +IDFG A+R        TH ++    
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML--- 165

Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            K++ GT  + +          R+ D+ S+G  +     G  P 
Sbjct: 166 -KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
            ++G+G+ G +    +  T + +A+K   LE  +    Q+  E     IL      P + 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE---LDILHKCNS-PYIV 62

Query: 69  RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SF 124
            ++G     GD ++ +  + G SL+ +      ++  + +  +A  ++  + ++H K   
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD+KP N L+       Q+ + DFG++ +  ++           K   GT+ Y +   
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170

Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             G + S + D+ SLG  L+    G  P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 16/122 (13%)

Query: 97  SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           S +         A ++I  ++F+H K  ++RD+K DN L+    +   + I DFG+ K  
Sbjct: 90  SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK-- 144

Query: 157 RDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 213
                 +++   E K  T  GT  Y +     G + +   D  S G VL+Y  L G  P+
Sbjct: 145 ------ENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPF 196

Query: 214 QG 215
            G
Sbjct: 197 HG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 16/157 (10%)

Query: 13  RKIGSGSFGEIYL------GTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           R +G G FG++ L      G N  T E+VA+K    ++    +    K  +IL+      
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67

Query: 67  NLRWFGV---EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
            +++ G+   +G   + L+++ L   SL++       K++LK  L  A Q+   ++++ S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           + ++HRD+   N L+      +QV I DFGL K    
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 38/169 (22%), Positives = 77/169 (45%), Gaps = 30/169 (17%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYK---------- 57
           F L   +G+G++G++Y G +++T +  AIK+ +V   +  +++ E  + K          
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 58  -----ILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 110
                I +   G+ +  W         LV++  G  S+ DL  N     L  + +  +  
Sbjct: 68  YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +++  +  +H    +HRDIK  N L+       +V ++DFG++ +   T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 24/188 (12%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLR 69
           KIG G++G++Y   +  T + VA+K   ++       P    E  L ++L     I  +R
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI--VR 65

Query: 70  WFGVE------GDYNV-LVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEF 118
              VE      G  ++ LV + L   L+   +       R L  KT+     Q++  V  
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNL 173
            H    +HRD+KP N L  + ++   + I D GL + +     + TH+ +   YR  + L
Sbjct: 126 CHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183

Query: 174 TGTARYAS 181
            G+  Y++
Sbjct: 184 LGSTHYST 191

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 19/158 (12%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPN-LRWFG 72
           IG G++G++Y  TN +     A+K L+ +     +++ E   Y ILQ     PN ++++G
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE---YNILQSLPNHPNVVKFYG 86

Query: 73  V--EGDYNV-----LVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
           +  + D  V     LV++L  G S+ +L      C ++L    +  +    +  ++ +H+
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
              +HRD+K +N L+        V ++DFG++ +   T
Sbjct: 147 NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 37/165 (22%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQL-----QY 51
           F + + I  G+FG++YLG     ++  A+K+              V+ +   L      +
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 52  EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
              LY  LQ    +  +  + + GD           SL  ++ +   ++++K +     +
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYI----SE 112

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI--IDFGLAK 154
           +   ++++H    +HRD+KPDN L+     +N+ +I   DFGL+K
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 16/162 (9%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGTGIPN 67
           F L   +G+G++G++Y G +++T +  AIK+ +V + +  +++ E  + K       I  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 68  LRWFGV--------EGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 117
             ++G           D   LV++  G  S+ DL  N     L    +  +  +++  + 
Sbjct: 78  --YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
            +H+   +HRDIK  N L+       +V ++DFG++ +   T
Sbjct: 136 HLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
           K+G GS+  +Y G +    + VA+K+    E   T    ++ EA L K L+    I  L 
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHAN-IVLLH 69

Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
                 +   LV + +   L    +     L  + V +   Q++  + ++H +  LHRD+
Sbjct: 70  DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-I 188
           KP N L+       ++ + DFGLA+        + +P     N   T  Y   +  LG  
Sbjct: 130 KPQNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 189 EQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
           E S   D+  +G + +  ++G   + G+K
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 24/217 (11%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GTG----IPN 67
           IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     TG    I  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 68  LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
           + +     D    ++DL+     DL    S+    S   +   A ++I  +E +H++  +
Sbjct: 62  MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY-ASMNT 184
           +RD+KP N L+        V I D GLA  +     H  +         GT  Y A    
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167

Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
             G+      D  SLG +L   LRG  P++  K   K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++ +H   ++HRDIKPDN L+        + + DFGL  
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 10/148 (6%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           + + + IG G+FGE+ L  +  T +  A+KL    E +K       +E +          
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
           +  L +   +  Y  +V++ +     DL N  S   +  K       +++  ++ +HS  
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
           F+HRD+KPDN L+    ++  + + DFG
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 19/215 (8%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
           F + + IG G+FGE+ +     T    A+K+ N    +K        E +   +      
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 65  IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I  L +   + +Y  LV+D  +G  L  L +    +L          +M+  +  +H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           ++HRDIKPDN L+ +      + + DFG   +     T Q      +    GT  Y S  
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173

Query: 184 THLGIEQSRRD-----DLESLGYVLMYFLRGSLPW 213
               +E          D  SLG  +   L G  P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           Q++  ++F+HS   +HRD+KP N L+       Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 41/269 (15%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIPNL- 68
           +IG G+FGE++ G     N  VA+K    +T  P L+     EA++ K        PN+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56

Query: 69  RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
           R  GV  +     +V++L+ G            +L +K ++ + +     +E++ SK  +
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR-ENKNLTGTARY 179
           HRD+   N L+      N + I DFG+++      Y  T   + IP +          RY
Sbjct: 117 HRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
           +S             D+ S G +L   F  G++P+  L   + +Q  E I E+ V     
Sbjct: 174 SS-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPCP 218

Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA 267
            LC   P         C       +P ++
Sbjct: 219 ELC---PDAVYRLMERCWEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)

Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           K +  +A+ ++  + ++HS+  +HRDIKP N L+    R  QV + DFG++    ++   
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160

Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
                      TGT+ Y +     G   S   D+ SLG  L+   +   P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           Q++  V  VHSK  +HRDIK  N L+   GL      V + DFG +K Y  T +      
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200

Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
              +   GT  Y +         S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238

Length = 496

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 33/117 (28%), Positives = 46/117 (39%), Gaps = 19/117 (16%)

Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNLTGTA 177
             + LHRD+KP N FL       N V + DFGLAK     +     ++         GT 
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174

Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
            Y S      +    + D+ SLG ++      S P+    A  + Q   KI E K  
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 44/202 (21%), Positives = 95/202 (47%), Gaps = 14/202 (6%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
           KIG GS G + + T   T ++VA+K  ++ K +  +L +   +         + ++    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 73  VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
           + GD   +V++ L G +L D+      +++ + +  +   ++  + ++H++  +HRDIK 
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
           D+ L+    R   + + DFG   +       + +P R  K+L GT  + +      +   
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196

Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 9/146 (6%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN----LR 69
           ++G G+FG++Y   N +T    A K+ + K++     Y  ++  IL      PN    L 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEI-DIL-ASCDHPNIVKLLD 69

Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
            F  E +  +L+    G +++ +     R L+   + ++  Q +  + ++H    +HRD+
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129

Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKR 155
           K  N L  L      + + DFG++ +
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAK 152

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 10/117 (8%)

Query: 99  KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           K  L      A ++I  ++F+HSK  ++RD+K DN L+        + I DFG+ K    
Sbjct: 92  KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCK---- 144

Query: 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   +     GT  Y +    LG + +   D  S G +L   L G  P+ G
Sbjct: 145 ---ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 28/169 (16%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQY---------EAK-LYKILQGGT 63
           I  G+  EIYLG  +    +  IK    K  +HP+L           EA+ + +  + G 
Sbjct: 4   IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61

Query: 64  GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            +P + +   E    ++V++ + G  L+DL N  S  +    +     +++ ++   HS 
Sbjct: 62  NVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSA 114

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA---KRYRDTATHQHIPYR 168
             +H D+   N ++       ++Y+IDFGLA   K   D A   H+  R
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDLEDRAVDLHVLLR 159

Length = 211

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
           +L  Q++  ++ VHS+  +HRD+K  N FLM  G     + + DFG +K+Y D+     +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223

Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +  GT  Y +         S++ D+ SLG +L   L    P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 64/247 (25%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLENVK-TKHPQLQY--EAKLYKI 58
            K  L R++G GSFG +Y G    +   E    VAIK  N   +   ++++  EA + K 
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 59  LQGGTGIPNL-RWFGV--EGDYNVLVIDLLG-----------------------PSLEDL 92
                   ++ R  GV   G   ++V++L+                        P+L+  
Sbjct: 66  FN----CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121

Query: 93  FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
               +          +AD M     ++ +K F+HRD+   N ++        V I DFG+
Sbjct: 122 IQMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGM 165

Query: 153 AKRYRDTATHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRG 209
               RD     +  YR   K L      A  +   G+  + + D+ S G VL  M  L  
Sbjct: 166 T---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-A 218

Query: 210 SLPWQGL 216
             P+QGL
Sbjct: 219 EQPYQGL 225

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 60/258 (23%), Positives = 97/258 (37%), Gaps = 79/258 (30%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-----------------LENVKT- 44
           +  LG+ +G G+FG++     +  +       VA+K                 +E +K  
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 45  -KHPQL-------QYEAKLYKIL----QGGTGIPNLRWF-----GVEGDYNVLVIDLLGP 87
            KH  +         E  LY ++     G     NLR F           +         
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHG-----NLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 88  SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147
                       L+ K ++  A Q+   +EF+ SK  +HRD+   N L+      + + I
Sbjct: 128 -----------TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKI 173

Query: 148 IDFGLAKR------YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201
            DFGLA+       YR T T+  +P    K +   A +  + TH    QS   D+ S G 
Sbjct: 174 ADFGLARDIHHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG- 221

Query: 202 VLMY--FLRGSLPWQGLK 217
           VL++  F  G  P+ G+ 
Sbjct: 222 VLLWEIFTLGGSPYPGIP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 11/147 (7%)

Query: 15  IGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-R 69
           +GSG+FG +Y G  +   E     VAIK+ N +T  P+   E     ++      P+L R
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFLHR 127
             GV     + ++  L P    L      K ++ + L+L    Q+   + ++  +  +HR
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133

Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
           D+   N L+   +  N V I DFGLA+
Sbjct: 134 DLAARNVLV---KSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGTGIP 66
           + IGSG+ G +    +  T + VAIK      +NV   H +  Y E  L K++     I 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKLVNHKNIIG 79

Query: 67  NLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
            L  F  +          LV++L+  +L  +       L  + +  L  QM+  ++ +HS
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS 136

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
              +HRD+KP N ++   +    + I+DFGLA+
Sbjct: 137 AGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 24/219 (10%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GTG----IPN 67
           IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     TG    I  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 68  LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
           + +     D    ++DL+     DL    S+    S K +   A ++I  +E +H++  +
Sbjct: 62  MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT- 184
           +RD+KP N L+        V I D GLA  +     H  +         GT  Y +    
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167

Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
             G       D  SLG +L   LRG  P++  K   K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)

Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ--YEAKLYKILQGGTGIPNLR 69
           G K+G G++G +Y        +E    L+ ++     +    E  L + L+    I   +
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 70  WFGVEGDYNV-LVIDLLGPSLEDLFNF--CSR------KLSLKTVLMLADQMINRVEFVH 120
            F    D  V L+ D     L  +  F   S+      +L    V  L  Q+++ + ++H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
           +   LHRD+KP N L MG G    +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 24/192 (12%)

Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
           IG G+FGE+ L     T    A+K       LE  +  H + + +     IL     +  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERD-----ILVEADSLWV 63

Query: 68  LRWF-GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKS 123
           ++ F   +   N+ +I    P   D+     +K +L   +T   +A+ ++  ++ +H   
Sbjct: 64  VKMFYSFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLG 121

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLTGTARYASM 182
           F+HRDIKPDN L+        V + DFGL    +    H+   YR  N +L     + +M
Sbjct: 122 FIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK--AHRTEFYRNLNHSLPSDFTFQNM 176

Query: 183 NTHLGIEQSRRD 194
           N+    E  +R+
Sbjct: 177 NSKRKAETWKRN 188

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 38/231 (16%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGT 63
           L R++G G+FG+++L        E    L  VKT              EA+L   LQ   
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 64  GIPNLRWFGV--EGDYNVLVIDLLGPSLEDLFNFCS---------------RKLSLKTVL 106
            +   +++GV  EGD  ++V + +     DL  F                  +L+   +L
Sbjct: 69  IV---KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
            +A Q+   + ++ S+ F+HRD+   N L+G       V I DFG++   RD  +  +  
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY-- 175

Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
           YR   +     R+    + +  + +   D+ SLG VL   F  G  PW  L
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 62/269 (23%), Positives = 96/269 (35%), Gaps = 22/269 (8%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
           F +  KIG GSFG ++           A+K  ++   + + +     EA++   L     
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I     F  +G  N+++       L  L      R L    V     Q++  +  +HSK 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            LHRDIK  N  +      + V I D G+AK   D              + GT  Y S  
Sbjct: 122 ILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFA-------NTIVGTPYYLSPE 171

Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
                  + + D+ +LG VL     G  P+     G    K  +     VS       + 
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------QM 224

Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
           Y  + A     C +  +  +PD   L R 
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 45/164 (27%), Positives = 65/164 (39%), Gaps = 33/164 (20%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLQ---- 50
             F   + IG G+FGE+ L     T +  A+K            L +VK +   L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 51  -YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
            +   LY   Q    +  +  F   GD   ++I     S ED+  F   +  L       
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVTRFYMAECVLA------ 113

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
                 +E VH   F+HRDIKPDN L+    R   + + DFGL+
Sbjct: 114 ------IEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 8/160 (5%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
           F + + IG G+FGE+ +     T +  A+K+ N    +K        E +   +      
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 65  IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I NL +   + +   LV+D  +G  L  L +    +L          +M+  ++ VH   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
           ++HRDIKPDN L+    +   + + DFG   R     T Q
Sbjct: 123 YVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 25/167 (14%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q+I+ +E +H +  ++RD+KP+N L+        V I D GLA   +D  +       + 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154

Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
           K   GT  + +     G E     D  +LG  L   +    P+        + + EK+  
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--------RARGEKVEN 206

Query: 231 KKVSTSIEALCRGYPTEF-ASYFHYCRSLRFDDKPDYAYLKRL-FRD 275
           K++   I      YP +F  +   +C +L     P+    KRL FRD
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFRD 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           Q++  ++++HS + +HRD+KP N L+       +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)

Query: 91  DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
           DL+ +   +   L L  V  +A Q+++ ++++H +  +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293

Length = 461

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 11/149 (7%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           + +GSG+FG +Y G  I   E     VAIK+    T  P+   E      +  G G P +
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYV 71

Query: 69  -RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
            R  G+     V ++  L P   L D       ++  + +L    Q+   + ++     +
Sbjct: 72  CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           HRD+   N L+   +  N V I DFGLA+
Sbjct: 132 HRDLAARNVLV---KSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           ++ +HS   ++RD+KP+N L+        + + DFGL+K   D   H+   Y    +  G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160

Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
           T  Y +         ++  D  S G VLM+  L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 47/243 (19%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIKL--ENVKTKH-PQLQYEAKLY 56
           +K  LG+ +G G FG++ +   +  +++       VA+K+  ++   K    L  E ++ 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLG-------------PSLE---DLFNFCSRKL 100
           K++     I NL     +     ++++                P +E   D+      ++
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----R 155
           + K ++    Q+   +E++ S+  +HRD+   N L+      N + I DFGLA+      
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNID 191

Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPW 213
           Y    T+  +P    K +   A +  + TH       + D+ S G VLM+  F  G  P+
Sbjct: 192 YYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSPY 240

Query: 214 QGL 216
            G+
Sbjct: 241 PGI 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 1/47 (2%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
           Q+++ + ++H+   LHRD+KP N L MG G    +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 169
           ++++ +E++HS+  ++RDIK +N ++    +   + I DFGL K    D AT        
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM------- 152

Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            K   GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 22/159 (13%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL---- 68
           +KIG GSFG+  L  + +  ++  IK  N+    P+ + E++    +      PN+    
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 69  RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEFVHS 121
             F   G+  +++    G  L    N      + + VL   DQ+++        ++ VH 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKIN------AQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 122 KSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 159
           +  LHRDIK  N FL     +   + + DFG+A+    T
Sbjct: 120 RKILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNST 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	404
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.39
KOG3087	229	consensus Serine/threonine protein kinase [General	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.26
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.87
PRK09902	216	hypothetical protein; Provisional	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.05
PLN02876	822	acyl-CoA dehydrogenase	97.95
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.61
PRK05231	319	homoserine kinase; Provisional	97.61
KOG2270	520	consensus Serine/threonine protein kinase involved	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.44
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.41
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.36
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.34
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.27
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.24
PLN02236	344	choline kinase	96.98
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.79
PRK12396	409	5-methylribose kinase; Reviewed	96.77
PRK10593	297	hypothetical protein; Provisional	96.64
PLN02756	418	S-methyl-5-thioribose kinase	96.63
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.32
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.32
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.04
PRK11768	325	serine/threonine protein kinase; Provisional	96.03
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.83
PRK06148	1013	hypothetical protein; Provisional	95.82
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.74
COG2334	331	Putative homoserine kinase type II (protein kinase	95.68
PTZ00384	383	choline kinase; Provisional	95.51
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.48
PTZ00296	442	choline kinase; Provisional	93.45
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.46
PHA03111	444	Ser/Thr kinase; Provisional	91.76

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-56  Score=379.44  Aligned_cols=295  Identities=71%  Similarity=1.242  Sum_probs=287.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+++++|+++++||+|+||.+|+|....+|..||||+...+..++++..|.++++.|++...++.+.+|+.+..+.++||
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            46889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      +++|+||+++++.|++.++..+++.++.|++.-++|+|.+++|||||||+|+|++.+...+.+.|+|||+|+.+.+..+.
T Consensus        91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            99999999999999999999999999999999999999999999999999999999888999999999999999999999


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                      .|+||++.....||.+|++-..+.+.+.+++.|+-|+|++|.++..|.+||++..+.++.+++++|.+++...+++.+|+
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      ++|.++.-.+..|.....++.|++..|.++|+-++...+.+.|..+||+..+.+.
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~  305 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS  305 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence            9999999999999999999999999999999999999999999999999876443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=399.19  Aligned_cols=278  Identities=24%  Similarity=0.354  Sum_probs=234.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.++|.+++.||.|+|++|++|+++.++++||||++.++     ...+-+..|..+|.+|.+|++|..++..+++....|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            456899999999999999999999999999999987653     344558899999999999999999999999999999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +|++|+ +|+|.++|+.. +.|++..+..++.||+.||+|||++|||||||||+||||   +.++++||+|||.|+.+..
T Consensus       151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCCh
Confidence            999999 99999999964 679999999999999999999999999999999999999   7999999999999998876


Q ss_pred             cCCcccc----cccCC--CCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          159 TATHQHI----PYREN--KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       159 ~~~~~~~----~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      ....+.-    .+...  ..++||..|.+||++.....+..+|||+||||||+|+.|++||.+.+...   .+++|....
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~l~  303 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQALD  303 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHHhc
Confidence            5433111    11122  56899999999999999999999999999999999999999999865543   444444433


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccccccCCCC
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPA  304 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  304 (404)
                      .     .++.++|+.+.+||.++|..||.+|++.++|.+.          ++...+||.....++.+...|-
T Consensus       304 y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H----------pFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  304 Y-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH----------PFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             c-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC----------cccccCChhhhhhcCCCcccCC
Confidence            2     4567899999999999999999999998766543          5667788887655554444433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=371.19  Aligned_cols=291  Identities=61%  Similarity=1.044  Sum_probs=282.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|-.|+++++||+|+||++++|++.-+++.||||....+...+++..|.+.++.|.+..+|+.+++|+.++.+.+||||
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            67889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCCeEEEEecCCcccccccCC
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~--~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ++|.||+|+++.|+++|+.++++.++.|++.-++|+|++.+|.|||||+|+||+..  .+.+.+.|+|||+|+.+.+..+
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            99999999999999999999999999999999999999999999999999999742  2456789999999999999999


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                      .+|+||++.+...||.+||+-..+.|.+.+++.|+-|||-+++++|.|.+||+++++.+.+++|++|.+.+...+++.+|
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC  264 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      .++|.++...+......+.++-|+++.+..+|.+++.+.|...|..+||....
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence            99999999999999999999999999999999999999999999999999664

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=377.98  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=218.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+.+.++.||+|..|+||+++++.|++.+|+|++....   ...++.+|+++++..+++.+|..++.|...+....|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            36788899999999999999999999999999885433   345789999999999888777777777666657899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      || +|||+++++.. +++++.....|+.+|++||.|||+ ++||||||||+|||+   +..|.|||||||.++.+.++. 
T Consensus       159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~-  233 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI-  233 (364)
T ss_pred             hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh-
Confidence            99 99999999864 679999999999999999999996 999999999999999   689999999999999887762 


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CCCChHHHHHHHhhhcccccHhH
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                              ..+++||..|||||.+.+..|+.++||||||++++|+.+|+.||...  ......+.+..|.....    +.
T Consensus       234 --------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----P~  301 (364)
T KOG0581|consen  234 --------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----PR  301 (364)
T ss_pred             --------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----CC
Confidence                    35789999999999999999999999999999999999999999773  23456666777666443    34


Q ss_pred             hhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       240 ~~~~-~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      ++.+ +++++++++..||++||.+||++.+   ++++.|.+.
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~q---Ll~Hpfi~~  340 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQ---LLQHPFIKK  340 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHH---HhcCHHHhh
Confidence            5555 8999999999999999999999775   455666553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-52  Score=375.18  Aligned_cols=271  Identities=21%  Similarity=0.268  Sum_probs=224.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.++|++++.||+|+||+||.++.+.|++.||+|+++++.     .......|..||..++||.+|. +.+.+++....|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~-l~ysFQt~~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVK-LIYSFQTEEKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEee-eEEecccCCeEE
Confidence            3578999999999999999999999999999999887653     2345788999999987665554 455556777889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +|++|+ ||.|...+++ .+.+++..+..++.+|+.||.|||++|||||||||+||||   +..|+++|+|||+|+....
T Consensus       102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence            999999 8899999985 6789999999999999999999999999999999999999   7999999999999996655


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       .+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+   .+..+.++++...+...   
T Consensus       178 ~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~---  244 (357)
T KOG0598|consen  178 DGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL---  244 (357)
T ss_pred             CCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC---
Confidence            443       34578999999999999999999999999999999999999999988   45567777777766322   


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV  300 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~  300 (404)
                       .+.-++.+.++++..+|.+||++|....      .+...-...++...++|.........+
T Consensus       245 -~p~~ls~~ardll~~LL~rdp~~RLg~~------~d~~~ik~HpfF~~inW~~l~~k~l~P  299 (357)
T KOG0598|consen  245 -PPGYLSEEARDLLKKLLKRDPRQRLGGP------GDAEEIKRHPFFKGINWEKLLAKKLSP  299 (357)
T ss_pred             -CCccCCHHHHHHHHHHhccCHHHhcCCC------CChHHhhcCcccccCCHHHHHhcCCCC
Confidence             2233789999999999999999996310      111112344677888998776655443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-52  Score=380.95  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=211.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---------chhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      ..+.+.|.+.+.||+|+||.|-+|..++|++.||||+++....         ...+++|+++|++|+||++|....+| .
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-E  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-e
Confidence            3467789999999999999999999999999999999875432         22367999999999988777666555 4


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      ..++.||||||+ ||+|.+.+-. ++.+.+.....++.||+.||.|||++||+||||||+|||++.+.++..+||+|||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            555669999999 9999998874 66799999999999999999999999999999999999998777788999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      |+...+..        ...+++||+.|.|||++.+..   +..++||||+||+||-+++|.+||.+....  ....++|.
T Consensus       326 AK~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~  395 (475)
T KOG0615|consen  326 AKVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQIL  395 (475)
T ss_pred             hhccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHh
Confidence            99877543        356899999999999998765   345889999999999999999999874332  22345555


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+....- +.....++++..+||.+||..||++||++++++
T Consensus       396 ~G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL  435 (475)
T KOG0615|consen  396 KGRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADEAL  435 (475)
T ss_pred             cCccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence            5554332 234467899999999999999999999977543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-51  Score=389.99  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=222.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+|..++.||+|+|+.||++++..+|+.||+|++...     ...+.+.+|++|.+.|+|+|+| .++.++++..+.||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV-~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIV-QFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEE-eeeeEeecCCceEEE
Confidence            6799999999999999999999999999999987653     3456699999999999977655 555666788899999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      .|+| .++|..+++ ..+.+++.+++.++.||+.||.|||+++|||||||..|+||   +++.+|||+|||+|..+....
T Consensus        97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence            9999 899999998 46789999999999999999999999999999999999999   688999999999999888654


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .       ...+.+|||.|.|||++.....+..+||||+|||||-||+|++||+.   .+.++.|.+|......     +
T Consensus       173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~-----~  237 (592)
T KOG0575|consen  173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYS-----M  237 (592)
T ss_pred             c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCcc-----c
Confidence            3       45789999999999999999999999999999999999999999987   4567777777665543     3


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ  283 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  283 (404)
                      +..++.+.++||.++|+.||.+||++++   .|.+-|.+.|+-
T Consensus       238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~---vL~h~Ff~~g~~  277 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLLRPNPSERPSLDE---VLDHPFFKSGFT  277 (592)
T ss_pred             ccccCHHHHHHHHHHhcCCcccCCCHHH---HhcCHhhhCCCc
Confidence            4578899999999999999999999765   456666666653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-51  Score=372.59  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=207.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ...++|.+.+.||.|+||+||+|+++.++..||||.+..+.    ..+.+..|+.+|+.++|+|+| .+..+...+++.+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV-~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIV-RLLDCIEDDDFIY   85 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCccee-eEEEEEecCCeEE
Confidence            45678999999999999999999999999999999887664    334578899999999966655 4556666777999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC---CeEEEEecCCccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAKR  155 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~---~~vkL~DFG~a~~  155 (404)
                      +||||| ||+|.++++. .+.+++.++..++.||+.||++||+++||||||||+||||+.....   -.+||+|||+|+.
T Consensus        86 lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999 8999999995 4579999999999999999999999999999999999999754222   5799999999998


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      +....        ...+.+|++.|||||++..+.|+.|+|+||+|+|||++++|+.||...+.   .+....+...  ..
T Consensus       165 L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~---~eL~~~~~k~--~~  231 (429)
T KOG0595|consen  165 LQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP---KELLLYIKKG--NE  231 (429)
T ss_pred             CCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhcc--cc
Confidence            88654        34578999999999999999999999999999999999999999987544   3433333222  22


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      .++.++..++..+.+|+...+..++.+|-++.
T Consensus       232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~  263 (429)
T KOG0595|consen  232 IVPVLPAELSNPLRELLISLLQRNPKDRISFE  263 (429)
T ss_pred             ccCchhhhccCchhhhhhHHHhcCccccCchH
Confidence            22334445677788999999999999998765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-52  Score=362.32  Aligned_cols=244  Identities=24%  Similarity=0.320  Sum_probs=211.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCcee-EeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLR-WFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~-~~~~~~~~~~lv   81 (404)
                      .+|+|.++||.|+||+||++.+..+|..+|.|.+.-..    ..+.+..|+.+|++|+|+|+|.++. .+..+....+|+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            35999999999999999999999999999999766433    2345889999999999999999987 455556668999


Q ss_pred             Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      |||| +|+|.++++..   .+.+++.++++++.|++.||.++|+  ..  |+||||||.||+|   +.+|.|||+|||++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence            9999 99999998743   4569999999999999999999999  44  9999999999999   69999999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      +.+....+       ...+.+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+.   ...+.-.+|.+...
T Consensus       176 r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  176 RFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY  245 (375)
T ss_pred             hHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence            99988765       445789999999999999999999999999999999999999999994   45566666666654


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      ++...   .-++.++..||..|+..|++.||+.
T Consensus       246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence            43221   3478999999999999999999984

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=369.55  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=213.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcE-EEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ....+.+.||.|+||+||+|.+.  |+. ||||++.....    ...|.+|+.+|.+++|+|+|..++.+.......++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            34566778999999999999974  445 99998775432    347999999999999999998777776665578999


Q ss_pred             Eecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcccccCCCCCC-eEEEEecCCccccc
Q 015592           82 IDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYR  157 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~~  157 (404)
                      |||+ +|+|.+++.. .++.+++..++.|+.||+.||+|||+++ ||||||||+|||+   +... ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeec
Confidence            9999 9999999986 3678999999999999999999999999 9999999999999   5775 99999999998766


Q ss_pred             ccCCcccccccCCCCCccCcCcccccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ....       ..+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.+...   .+....+......+
T Consensus       196 ~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  196 ISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRP  265 (362)
T ss_pred             cccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCC
Confidence            5421       223478999999999999  55899999999999999999999999999765   33333333333332


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                         .++..+++.+..++..||..||+.||++.+|...|+.+....
T Consensus       266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence               334458999999999999999999999999999999887653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=364.55  Aligned_cols=257  Identities=22%  Similarity=0.283  Sum_probs=212.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chh--HHHHHHHHHHHc-CCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQ--LQYEAKLYKILQ-GGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~--~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+-++|.++++||.|+||.||+|+.+.++..||||.++.+-. .++  -.+|++.|++|+ |+|+|.....+.+.....+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456799999999999999999999999999999997765432 233  468999999999 7777766666666665899


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +||||+..+|.++++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||+   .....+||+|||+|+.....
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccccC
Confidence            999999999999999878889999999999999999999999999999999999999   46889999999999977664


Q ss_pred             CCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------  232 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------  232 (404)
                      .     ||   +.++.|..|.|||++.. ..|+.+.||||+|||++|+.+-++.|.|.+..+...++-.+....      
T Consensus       164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            3     33   36788999999999875 458999999999999999999999999966544333333222111      


Q ss_pred             ----------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      ....+..+...++.++.++|.+|+.+||++|||+.+.++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                            122344555667899999999999999999999886544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-49  Score=344.31  Aligned_cols=270  Identities=21%  Similarity=0.295  Sum_probs=228.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      --++|++.+.||.|+||.|.+++++.+|..||+|+++.....     +...+|..+|+.+.| +++..+.+.+.+....+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEE
Confidence            346899999999999999999999999999999998765432     346789999999994 55556666677888999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||. ||.|..+++. .++|++..++.++.||+.||+|||+++|++|||||+||||   |..|.+||+|||+|+....
T Consensus       121 mvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence            999999 9999999986 5679999999999999999999999999999999999999   7999999999999998776


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .          +.+.+|||.|+|||+++...|+.++|+|||||++|||+.|.+||.+.+.   .+.|++|.+.++.    
T Consensus       197 r----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~----  259 (355)
T KOG0616|consen  197 R----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVK----  259 (355)
T ss_pred             c----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCccc----
Confidence            4          3478999999999999999999999999999999999999999988544   7888999888764    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccccccCC
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST  302 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  302 (404)
                       +++-+++++++|+..+|+.|-.+|-  ..+..-.+++   .+.+|...++|.....+....+-
T Consensus       260 -fP~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~dI---k~H~wF~~v~W~~i~~r~ie~P~  317 (355)
T KOG0616|consen  260 -FPSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVEDI---KNHPWFKGVDWEAILQRKIEPPF  317 (355)
T ss_pred             -CCcccCHHHHHHHHHHHhhhhHhhh--cCcCCCcccc---ccCcccccccHHHHhhccccCCC
Confidence             4567899999999999999999992  2222222222   34578888999977666554433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=358.54  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=208.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCC-eEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~lv~e   83 (404)
                      .+|..++.||+|+||.||++.+.++|...|||.......  .+.+.+|+.+|++|+|+++|..++....... .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            458889999999999999999999999999997665421  3458999999999998877777765444444 7899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +|+|.+++...+++|++..+..+..||++||+|||++|||||||||+|||+   +. ++.+||+|||+++.......
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccccccccccc
Confidence            99 999999999766689999999999999999999999999999999999999   56 68999999999987764111


Q ss_pred             cccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .    ........||+.|||||++.++ ...+++|||||||++.||+||+.||.+.  ......+..+....   ..+.+
T Consensus       174 ~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P~i  244 (313)
T KOG0198|consen  174 K----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLPEI  244 (313)
T ss_pred             c----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---CCCCC
Confidence            0    1123467899999999999953 3446999999999999999999999874  12222223333222   23367


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+|++.++++.+|+.+||+.|||+.++   |++.|..
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eL---L~hpf~~  280 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEEL---LEHPFLK  280 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHH---hhChhhh
Confidence            77899999999999999999999998855   4555544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=367.28  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=213.4

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +++++.||+|.||+||+|.+. ....||+|.++..... +.|.+|+++|++|+|.++|..+..+..++ ..+|||||+ .
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEeccc
Confidence            567889999999999999984 4457999988876554 67999999999999988887776665544 889999999 9


Q ss_pred             CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           87 PSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        87 ~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      |+|.++++. .+..+...+.+.++.|||+|++||+++++|||||...|||+   +++..+||+|||+|+...+...    
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y----  358 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEY----  358 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCce----
Confidence            999999986 45679999999999999999999999999999999999999   6888999999999996555443    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                        .......-...|.|||.+....++.|||||||||+||||+| |+.||.+++..+   .++.+..+...    ..+.+|
T Consensus       359 --~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~le~GyRl----p~P~~C  429 (468)
T KOG0197|consen  359 --TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLELLERGYRL----PRPEGC  429 (468)
T ss_pred             --eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHHHhccCcC----CCCCCC
Confidence              22333445778999999999999999999999999999999 999999976544   34444433322    234689


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      |+++.+++..||..+|++||||+.+...|++++..
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            99999999999999999999999999999988754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-48  Score=340.73  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=209.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+.+.++|+|+||+||+++++.||+.||||.+......+    -..+|+++|++|+|+|.|..+..|. .....++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-rkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-RKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-hcceeEEEe
Confidence            57999999999999999999999999999999876544433    3678999999999998887776654 455789999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |||..++.+.+......++.+.+..++.|++.|+.|+|++++|||||||+|||+   ...+.+||||||+|+.+..++. 
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcc-
Confidence            999999988888777789999999999999999999999999999999999999   5899999999999998875432 


Q ss_pred             ccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc--------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------  233 (404)
                            .-+.++.|..|.|||.+.| .+|+..+||||+||++.||++|.+.|.+.++-+....+.+......        
T Consensus       157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence                  1235688999999999998 5699999999999999999999999999766554444333222111        


Q ss_pred             ---------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ---------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ..+++.-.+.++.-+.++++.||..||++|++.+++..
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                           11222222345667899999999999999999887743

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=360.77  Aligned_cols=247  Identities=25%  Similarity=0.332  Sum_probs=208.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ...++|++++.||+|+||.|++|.+..+++.||+|+++.+       ...+.+.+|+.+++.+.+|++|..+..+.....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3567999999999999999999999999999999987664       234457789999999995555555555555555


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC-CeEEEEecCCcc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK  154 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~-~~vkL~DFG~a~  154 (404)
                      ..+++|||+ ||+|.+++.. .+++.+.++..++.|++.|++|||++||+||||||+|||+   +.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence            699999999 7899999997 7889999999999999999999999999999999999999   466 999999999998


Q ss_pred             ccc-ccCCcccccccCCCCCccCcCccccccccCCC-C-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          155 RYR-DTATHQHIPYRENKNLTGTARYASMNTHLGIE-Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       155 ~~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ... ...        ...+.+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||.+.   +....+.++...
T Consensus       170 ~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~  238 (370)
T KOG0583|consen  170 ISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKG  238 (370)
T ss_pred             ccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcC
Confidence            774 221        346789999999999999988 8 48999999999999999999999983   334445555444


Q ss_pred             cccccHhHhhcCC-cHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 KVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 ~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..     .++..+ +++++.|+.+||..||..|+++.+|.
T Consensus       239 ~~-----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 EF-----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             Cc-----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            43     234455 89999999999999999999987776

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-48  Score=358.69  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=217.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCceeEeeee-CCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~   78 (404)
                      +-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+    ...+|+.||++|.|+|+|......... ....
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            44567999999999999999999999999999999877665443    367899999999999999888777666 6689


Q ss_pred             EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      |||+||+..+|.-++....-+|++.++..++.||+.||+|+|++||+|||||.+||||   |.+|.+||+|||+|+.+..
T Consensus       194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccC
Confidence            9999999999999998656689999999999999999999999999999999999999   7999999999999998876


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc-----
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-----  232 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----  232 (404)
                      .....      -++.+-|..|.|||++.|.. |+.++|+||.||||.||++|++.|++.+..+...++.++....     
T Consensus       271 ~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  271 SGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             CCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            54321      24567899999999999865 9999999999999999999999999976655555554443211     


Q ss_pred             ----c------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ----V------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ----~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                          +            ...+.+....+|....+|+..+|..||++|.|+.+.+
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL  398 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL  398 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence                0            1112233456788999999999999999999987553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=359.74  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=216.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....    ..+.+|++|++.|+|+|+|..+.+|.... ..++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-HLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-eEEEEe
Confidence            5799999999999999999999999999999987654332    35899999999999999998888876544 568899


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+-|+|..++.+ .++++++.+..|+.|++.||.|||+++|+|||+||+|||+   +.++.+|+||||+|+.+..... 
T Consensus        81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence            9997799999985 6789999999999999999999999999999999999999   6999999999999998776432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......|||.|||||+..+.+|+..+|+||||||+||+++|++||..   ....+.+..|....+..+     .
T Consensus       156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p-----~  221 (808)
T KOG0597|consen  156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPP-----S  221 (808)
T ss_pred             ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCc-----c
Confidence                  23567899999999999999999999999999999999999999976   556777777776665543     3


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+..+.++++.+|.+||..|.+..++   +.+.|.+
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~L---l~HpF~k  255 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDL---LGHPFWK  255 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHH---hcChHHh
Confidence            678999999999999999999997755   4444444

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=359.16  Aligned_cols=273  Identities=22%  Similarity=0.316  Sum_probs=216.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|+++.+||+|+||+||+|+.+.||..+|+|++++...     ...+..|..+|... ..+.|+.+++.+++.++.||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence            5789999999999999999999999999999999876543     33478899999984 46677777777889999999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ ||++..+|.. .+.|++..+..++.+++.|++.||+.|+|||||||+|+||   |..|++||+|||+|..+...
T Consensus       219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence            99999 9999999985 6689999999999999999999999999999999999999   79999999999999754321


Q ss_pred             CCcc------------------ccc----cc------------------CCCCCccCcCccccccccCCCCCchhHHHHH
Q 015592          160 ATHQ------------------HIP----YR------------------ENKNLTGTARYASMNTHLGIEQSRRDDLESL  199 (404)
Q Consensus       160 ~~~~------------------~~~----~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSl  199 (404)
                      ....                  ..+    .+                  .....+|||.|+|||++.+..|+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence            0000                  000    00                  1133679999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc--ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       200 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      |||+||||.|.+||.+.++   .+.+.+|..-+  +..+.+   ..++++.++||.+|+. ||++|....-+.++     
T Consensus       375 G~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~l~fP~~---~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI-----  442 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETP---QETYRKIVNWRETLKFPEE---VDLSDEAKDLITRLLC-DPENRLGSKGAEEI-----  442 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhhccCCCc---CcccHHHHHHHHHHhc-CHHHhcCcccHHHH-----
Confidence            9999999999999998544   55555555433  111111   2457999999999999 99999762222221     


Q ss_pred             HHcCCCCCceeecccccccc
Q 015592          278 IREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       278 ~~~~~~~~~~~~w~~~~~~~  297 (404)
                        ...++...++|+-.....
T Consensus       443 --K~HPfF~~v~W~~l~~~~  460 (550)
T KOG0605|consen  443 --KKHPFFKGVDWDHLREMP  460 (550)
T ss_pred             --hcCCccccCCcchhhcCC
Confidence              233677788898665444

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-47  Score=367.48  Aligned_cols=269  Identities=22%  Similarity=0.287  Sum_probs=228.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +-.++|+++++||+|+||+|+++..+.+++.||||++++..     ..+....|.+|+.....|+.+..++.+++..+..
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999999999999999987654     3456889999999999999999999999999999


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++||||. ||++..+.+  .+.|++..+..++.+|+.||.|||++|||+||||.+||||   |..|.+||+|||+++...
T Consensus       445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence            9999999 777443333  5689999999999999999999999999999999999999   799999999999998655


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       .+++++||+.|||||++.+..|+..+|+|||||+||||+.|+.||.+.   +..+.++.|....+.   
T Consensus       520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~~~---  586 (694)
T KOG0694|consen  520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDEVR---  586 (694)
T ss_pred             CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCC---
Confidence            3332       467899999999999999999999999999999999999999999984   445566666555443   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCceeecccccccccccCC
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST  302 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~-----~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  302 (404)
                        .+..++.+..+++.++|.++|++|..+     .+|.          ..++...+||+.....+..++-
T Consensus       587 --yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~----------~hpFFr~i~w~~L~~r~i~PPf  644 (694)
T KOG0694|consen  587 --YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK----------KHPFFRSIDWDDLLNRRIKPPF  644 (694)
T ss_pred             --CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhh----------hCCccccCCHHHHhhccCCCCC
Confidence              345789999999999999999999865     2222          1256677889988777665443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-46  Score=355.19  Aligned_cols=261  Identities=18%  Similarity=0.297  Sum_probs=206.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHH-cCCCCCCceeEeeee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKIL-QGGTGIPNLRWFGVE   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~   74 (404)
                      +-.++|++.++||+|+||.||+|.+.     .+++.||||++.....   ...+.+|+.++..+ +|++++..+..+...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34578999999999999999999752     3457899998765332   23588899999999 666666666666656


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcC--------------------------------------------------------
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCS--------------------------------------------------------   97 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~--------------------------------------------------------   97 (404)
                      ....+++|||+ +++|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            66789999999 899999987421                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCC
Q 015592           98 -----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN  172 (404)
Q Consensus        98 -----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~  172 (404)
                           ..+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++........     .....
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~  235 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGS  235 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hcccC
Confidence                 247888999999999999999999999999999999999   57889999999999865432211     12234


Q ss_pred             CccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHH
Q 015592          173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY  251 (404)
Q Consensus       173 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  251 (404)
                      ..++..|+|||++.+..++.++|||||||+||||++ |..||.+.....  .....+.....    ...+..+++++.++
T Consensus       236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~l  309 (338)
T cd05102         236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR----MRAPENATPEIYRI  309 (338)
T ss_pred             CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----CCCCCCCCHHHHHH
Confidence            456788999999999899999999999999999997 999998754321  11222222111    12235678999999


Q ss_pred             HHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          252 FHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       252 i~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +.+||+.||++||++.+|++.|++++.
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=354.43  Aligned_cols=251  Identities=21%  Similarity=0.359  Sum_probs=210.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ..|....+||+|+.|.||.|+...+++.||||.++....  .+-+.+|+.+|+..+|+|+|.++..|... +..++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence            468888999999999999999999999999998776543  34488999999999999999998777666 667899999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + ||+|.+++..  ..+++.++..|+.+++.||+|||.+||+|||||.+|||+   ..++.+||+|||+|..+.....  
T Consensus       352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccccC--
Confidence            9 9999999984  459999999999999999999999999999999999999   5888999999999998877654  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ...+.+||+.|||||+.....|++|+||||||++++||+.|++||-..++   .+.+..|.....+.  -..+..
T Consensus       425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~P~--lk~~~k  494 (550)
T KOG0578|consen  425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTPK--LKNPEK  494 (550)
T ss_pred             -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCCCC--cCCccc
Confidence                 34678999999999999999999999999999999999999999986333   22222222211111  122346


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ++++|++++.+||..|+++|+++.+|   |++-|.
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eL---L~HpFl  526 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKEL---LEHPFL  526 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHH---hcChhh
Confidence            89999999999999999999998765   444444

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-46  Score=329.47  Aligned_cols=254  Identities=19%  Similarity=0.213  Sum_probs=208.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCcee-EeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLR-WFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~-~~~~~~~~~~l   80 (404)
                      .++|+.+.+|++|+||.||+|++++|++.||+|.++.+....    .-.+|+.+|.+++|+|++..-. ..+..-+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467999999999999999999999999999999887766444    3689999999999777665543 34556677999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||||+..+|..+++....+|...++..++.|++.||+|||.+.|+|||||++|+|+   ...|.+||+|||+|+.+.+..
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcCCc
Confidence            99999999999999888899999999999999999999999999999999999999   689999999999999888763


Q ss_pred             CcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc---c-
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---T-  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~-  235 (404)
                      .       .-+..+-|..|.|||++.|.. |+...|+||+|||+.||+++++-|.|....+...++.++....-.   + 
T Consensus       232 k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  232 K-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             c-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            2       234667899999999999866 999999999999999999999999997665544444433221100   0 


Q ss_pred             ---------------cHhHhh---c--CCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          236 ---------------SIEALC---R--GYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       236 ---------------~~~~~~---~--~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                                     +...+.   .  ++++.-.+|++.+|..||.+|.|+.+.
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~  358 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG  358 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence                           000000   1  134778899999999999999998754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=336.63  Aligned_cols=274  Identities=22%  Similarity=0.326  Sum_probs=220.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +.|++++.||+|.-|+||+++...++..+|+|++....     ...+.+.|.+||..++| +.++.++...+..++.|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence            46889999999999999999999999999999987643     33457889999999985 5667777777888899999


Q ss_pred             Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |||| ||+|..+.+.. ++.|++..+..++.+++.||+|||-.|||+|||||+||||   .++|++.|+||.++......
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence            9999 99999998744 4569999999999999999999999999999999999999   79999999999988643211


Q ss_pred             CCcc------------------------------c------------------cc-ccCCCCCccCcCccccccccCCCC
Q 015592          160 ATHQ------------------------------H------------------IP-YRENKNLTGTARYASMNTHLGIEQ  190 (404)
Q Consensus       160 ~~~~------------------------------~------------------~~-~~~~~~~~gt~~y~aPE~~~~~~~  190 (404)
                      .+..                              .                  .+ -.....++||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            0000                              0                  00 012356789999999999999999


Q ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC----H
Q 015592          191 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----Y  266 (404)
Q Consensus       191 ~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~----~  266 (404)
                      +.++|+|+|||+||||++|..||.+.+.   .+.+.+|....+..+-.   ..++..+++||.++|.+||.+|..    +
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA  386 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA  386 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence            9999999999999999999999999544   55666666655443221   256789999999999999999987    4


Q ss_pred             HHHHHHHHHHHHHcCCCCCceeeccccccccccc
Q 015592          267 AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV  300 (404)
Q Consensus       267 ~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~  300 (404)
                      ++|++          .++...++|...+....+.
T Consensus       387 ~eIK~----------HpFF~gVnWaLir~~~PP~  410 (459)
T KOG0610|consen  387 AEIKR----------HPFFEGVNWALIRCARPPE  410 (459)
T ss_pred             HHhhc----------CccccCCChhheeccCCCc
Confidence            54443          3667778898666554443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-45  Score=353.04  Aligned_cols=245  Identities=20%  Similarity=0.303  Sum_probs=212.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+-|++++.||.|+-|.|-+|++..||+.+|||++.....     ...+++|+-+|+.+.|+|++..++.+... .+.|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-QHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-ceEEE
Confidence            4569999999999999999999999999999999876632     23489999999999999888877766544 45666


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +.||. ||.|.+++-. .+++++.++.+++.||+.|+.|+|..+|+||||||+|+||   +..+++||+|||+|..-...
T Consensus        90 vlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCC
Confidence            77776 9999998874 6789999999999999999999999999999999999999   67777999999999765554


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .        ...+.+|++.|+|||++.|.+| +.++||||.|||||.||||++||++   ++....+.++..+.+     
T Consensus       166 k--------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f-----  229 (786)
T KOG0588|consen  166 K--------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVF-----  229 (786)
T ss_pred             c--------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcc-----
Confidence            3        3457799999999999999998 7999999999999999999999986   566777888877765     


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+|.+.++||.+||..||+.|.|.++|.+
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            345789999999999999999999999876643

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.5e-45  Score=346.21  Aligned_cols=239  Identities=20%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|+.+++.++|++++..+..+ ..+...+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~   94 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-QDENRVY   94 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EcCCEEE
Confidence            3478999999999999999999999999999999876432     234588999999999988777766544 5667889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence            999998 8899999875 5679999999999999999999999999999999999999   6888999999999986643


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ..          ....||+.|+|||++.+..++.++|||||||++|||++|..||.+..   ..+.+..+.....     
T Consensus       171 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~-----  232 (329)
T PTZ00263        171 RT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRL-----  232 (329)
T ss_pred             Cc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCc-----
Confidence            22          24578999999999999999999999999999999999999997643   3444455444332     


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      .++..++..+.+|+.+||+.||.+||+.
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~  260 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGT  260 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2334578899999999999999999973

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=333.66  Aligned_cols=258  Identities=19%  Similarity=0.268  Sum_probs=209.7

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .-.+.|++.+.||.|..++||+|+...++..||||+++.+..   .+.+.+|+..++.++|||++.++-. +..+...++
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-Fvv~~~LWv  101 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-FVVDSELWV  101 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-EEecceeEE
Confidence            345789999999999999999999999999999999876543   4568999999999998877766544 455667788


Q ss_pred             EEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           81 VIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ||.|+ +||+.++++.. ...+++..+..|+++++.||.|||.+|.||||||+.||||   +.+|.|||+|||.+-.+.+
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence            99988 99999999743 4459999999999999999999999999999999999999   6999999999999887776


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc--
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--  234 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  234 (404)
                      .+.  ...++. ..++||+.|||||++..  ..|+.|+||||||++..||.+|..||..+.+.  +..+.++......  
T Consensus       179 ~G~--R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  179 SGD--RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTLL  253 (516)
T ss_pred             cCc--eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCcc
Confidence            552  222333 77899999999999654  34999999999999999999999999987652  2223333222210  


Q ss_pred             --ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          235 --TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       235 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                        .......+.++..+++++..||.+||.+|||+++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl  291 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL  291 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence              111223356788999999999999999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-45  Score=317.05  Aligned_cols=253  Identities=20%  Similarity=0.238  Sum_probs=208.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+|...++||+|.||.||+|++.+||+.||||.++.....    ....+|++.|+.++|+++|..+..|. .....-+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-HKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-CCCceEEEE
Confidence            5799999999999999999999999999999988776543    35789999999999888777776665 455678999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+..+|+.+++.....++..++..++.+++.||+|||++.|+||||||.|+|+   +.+|.+||+|||+|+.+......
T Consensus        81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcc
Confidence            999999999999777789999999999999999999999999999999999999   58999999999999988876542


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc--------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------  233 (404)
                      .       ...+-|..|.|||.+.|.. |+..+||||.|||+.||+-|.+-|.|.++-+....+........        
T Consensus       158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            2       2236799999999999865 99999999999999999999999998665443333333221111        


Q ss_pred             ------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 ------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                  ..+...+....+.+..+|+..+|..||.+|.++.+..
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL  279 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL  279 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence                        1111123344567889999999999999999977543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-47  Score=346.92  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=207.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      -...|+..+.||+|+||.||+|.+..+++.||+|++..+...   +.++.|+.++..++++++..++. ....+...+++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yyg-syl~g~~Lwii   89 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYG-SYLKGTKLWII   89 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhh-heeecccHHHH
Confidence            345688899999999999999999999999999998876544   45889999999999855545443 44566678899


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ ||++.++++. +..+++.++..|+.+++.||.|||.++.+|||||+.|||+.   ..+.+||+|||.+-.+....
T Consensus        90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence            9999 9999999983 44569999999999999999999999999999999999995   66999999999998777654


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .       ...+++||+.|||||++.+..|+.|+||||||++.|||++|.+||.+..+....       ........+.+
T Consensus       166 ~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------flIpk~~PP~L  231 (467)
T KOG0201|consen  166 K-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------FLIPKSAPPRL  231 (467)
T ss_pred             h-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------EeccCCCCCcc
Confidence            3       337889999999999999889999999999999999999999999987763222       11112222334


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ...+++.+++++..||++||+.||++.+++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL  261 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELL  261 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence            447899999999999999999999988764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-46  Score=348.36  Aligned_cols=250  Identities=21%  Similarity=0.260  Sum_probs=222.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .++|..++++|+|+||.+++++++..++.|++|.+......    .....|+.++++++||++|.+...|..++.+.+|+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            47899999999999999999999999999999988765432    34788999999999999999999999899889999


Q ss_pred             Eecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+|| ||+|.+.++..+ ..++++.+..|+.|++.|+.|||+++|+|||||+.|||+   ..++.|||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCc
Confidence            9999 999999998654 569999999999999999999999999999999999999   68888999999999988876


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       ...+.+||+.||+||++.+.+|+.|+|||||||++|||++-+.+|..   .+....+.++.....    ..
T Consensus       160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~ki~~~~~----~P  225 (426)
T KOG0589|consen  160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELILKINRGLY----SP  225 (426)
T ss_pred             hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHHHHhhccC----CC
Confidence            42       34678999999999999999999999999999999999999999987   444556666666553    34


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ++..++.+++.+|..||.++|+.||++.+|+..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            567889999999999999999999999988765

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-44  Score=342.40  Aligned_cols=240  Identities=20%  Similarity=0.256  Sum_probs=202.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +|++.+.||+|+||.||+|++..+++.||||++...     ...+.+..|.+++..+.|++++..+..+....+..+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999987643     223457789999999999998888887778888899999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence            999 8999999874 4579999999999999999999999999999999999999   5788999999999874322111


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ..+.+..+.....     .++
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~~  221 (324)
T cd05587         157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYP  221 (324)
T ss_pred             -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence                   1234578999999999999999999999999999999999999998743   3344444443322     234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      ..++.++.+++.+||..||.+|++.
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            5678999999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-44  Score=335.38  Aligned_cols=254  Identities=19%  Similarity=0.248  Sum_probs=200.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.++||.|+||.||+|++..+++.||+|+++...   ....+.+|+.+++.++|++++..+.. .......+++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI-IHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEE-EcCCCeEEEEEe
Confidence            57999999999999999999999999999999876432   23457899999999998777665544 455667899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence            99889999998666678999999999999999999999999999999999999   5788999999999976543221  


Q ss_pred             cccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc---------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------  233 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------  233 (404)
                           ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........         
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence                 1234578999999999876 4589999999999999999999999987543222222211111000         


Q ss_pred             -------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ..........+++++.+++.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                         00011122346788999999999999999999887753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=337.59  Aligned_cols=236  Identities=22%  Similarity=0.342  Sum_probs=198.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|+.+++.++|++++..+ .+..+....+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF-WTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhH-hhhccCCeEEEE
Confidence            47999999999999999999999999999999876432     234578899999999987777665 444566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence            9998 8899999975 5579999999999999999999999999999999999999   578899999999998664321


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                                ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+.....     .+
T Consensus       156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~-----~~  217 (291)
T cd05612         156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKL-----EF  217 (291)
T ss_pred             ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCc-----CC
Confidence                      24578999999999999889999999999999999999999998743   3344444444332     23


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                      +..+++.+.+++.+||+.||.+||+
T Consensus       218 ~~~~~~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         218 PRHLDLYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHccC
Confidence            4467889999999999999999995

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=339.19  Aligned_cols=256  Identities=20%  Similarity=0.259  Sum_probs=206.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------------chhHHHHHHHHHHHcCCCCCCc
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------HPQLQYEAKLYKILQGGTGIPN   67 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~~   67 (404)
                      ...++|++++.||+|.||.|-+|++..+++.||||++.....                .+...+|+.+|++|.|+|+|..
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            456889999999999999999999999999999998765321                1357899999999999888877


Q ss_pred             eeEeee-eCCeEEEEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe
Q 015592           68 LRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        68 ~~~~~~-~~~~~~lv~e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~  144 (404)
                      +..... ..+..|||+||| .|.+...-  .... +++.+++.|+.+++.||+|||.+|||||||||+|+||   +.+|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~  248 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGT  248 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCc
Confidence            766654 457899999999 55543221  2334 9999999999999999999999999999999999999   57899


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT  220 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~  220 (404)
                      |||+|||.+..+.........  ......+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+   ..
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~  323 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DF  323 (576)
T ss_pred             EEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---ch
Confidence            999999999876433211110  1223468999999999988733    36789999999999999999999987   55


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ..+.+.+|....+..+..   +.+.+.+++||.++|.+||+.|.+..+|+..
T Consensus       324 ~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  324 ELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            677788887766544322   2457899999999999999999998777543

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=349.83  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=207.5

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHH
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE   90 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~   90 (404)
                      +||+|.||+||-|+|..|...+|||-+..+..  .+-+..|+.+.+.|+|.|+|.+++.+...+ +.-|.||-. ||||.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcHH
Confidence            68999999999999999999999997765543  345899999999999999999998876666 556666666 99999


Q ss_pred             HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           91 DLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        91 ~~l~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      ++++..-+++  ++.++-.+.+||++||.|||++.|||||||-+|||++  .-.|.+||+|||.++.+..-..       
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP-------  731 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP-------  731 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence            9999777777  8999999999999999999999999999999999997  7789999999999998765433       


Q ss_pred             CCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          169 ENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      .+.++.||..|||||++..++  |+.++|||||||++.||.||++||..+...  ...+.++.--+..+   .++..++.
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP---~iPeelsa  806 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHP---PIPEELSA  806 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCC---CCcHHHHH
Confidence            456889999999999998655  899999999999999999999999876542  22233333323332   34456788


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      +.+.+|.+|+..||.+||++.+   +|.+.|...+
T Consensus       807 eak~FilrcFepd~~~R~sA~~---LL~DpFlq~~  838 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKD---LLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHH---hccCcccccC
Confidence            9999999999999999999875   4566665443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.2e-44  Score=335.76  Aligned_cols=243  Identities=18%  Similarity=0.244  Sum_probs=196.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-ETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-ccCCeEEEEE
Confidence            4889999999999999999999999999999875432     123467899999999887766654444 4566789999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence            998 88998887643 3468999999999999999999999999999999999999   678899999999997654322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+.....    .....+
T Consensus       157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~  224 (285)
T cd05631         157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY  224 (285)
T ss_pred             e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence            1        1245789999999999999999999999999999999999999987554332222222111    112234


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      ...++.++.+|+.+||+.||++||++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGC  250 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCC
Confidence            45688999999999999999999973

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=350.13  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=211.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ..+...++..||+|.||+||+|+|-.   .||||+++.+...    +.|.+|+..+++-+|.|++...+++-..+.  .|
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~--AI  464 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL--AI  464 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce--ee
Confidence            34567889999999999999999854   5999999876544    358999999999998887777666654443  78


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +.-+| |.+|..+++-...+|...+.+.|+.||++|+.|||.++|||||||..||++   .++++|||+|||++..-..-
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeee
Confidence            88888 889999998767789999999999999999999999999999999999999   67799999999999643322


Q ss_pred             CCcccccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ...+     ......|...|||||++..   .+|++.+||||||||+|||+||..||..   ....+.+-.+..+...+.
T Consensus       542 ~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  542 SGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             cccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEecccccCcc
Confidence            1111     1234467889999999874   4589999999999999999999999984   233444445555545555


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .......+|.++++|+..||.+++++||.|.+|+..|+++..
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            566667899999999999999999999999999998888765

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.5e-44  Score=331.88  Aligned_cols=255  Identities=19%  Similarity=0.219  Sum_probs=199.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++....    ..+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCEEEEEE
Confidence            57999999999999999999999999999999876542    234578899999999988877765544 5567889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+.+++.+.+......+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||+++........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence            999666666665445679999999999999999999999999999999999999   57889999999999876433211


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------  233 (404)
                            ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..+.....         
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                  12345789999999999998899999999999999999999999987543222222211110000         


Q ss_pred             ---------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ---------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ..........++.++.+++.+||+.||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                           00001112236788999999999999999999887653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-44  Score=339.49  Aligned_cols=256  Identities=18%  Similarity=0.231  Sum_probs=199.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee----CCeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~~   79 (404)
                      +|++.++||+|+||.||+|++..+++.||||.+....    ....+.+|+++++.++|++++..+..+...    ....+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999999876421    223578899999999998888776655322    23579


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence            9999999999999874 4569999999999999999999999999999999999999   68899999999999865432


Q ss_pred             CCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH---------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI---------  228 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---------  228 (404)
                      ....    .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.........+...         
T Consensus       157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            2111    01134578999999999876  56899999999999999999999999774432111111110         


Q ss_pred             --------------hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 --------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                    ...............+++++.+++.+||+.||++||+++++++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                          0011111122223457888999999999999999999876653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-43  Score=332.74  Aligned_cols=252  Identities=19%  Similarity=0.252  Sum_probs=197.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.++||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++|++++..+.. .......+++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI-IHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEE-EecCCeEEEEE
Confidence            4789999999999999999999999999999998765432   2357789999999998877655544 45567889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||++++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+   +..+.+||+|||+++....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-  158 (303)
T cd07869          83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH-  158 (303)
T ss_pred             ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence            999999999988666679999999999999999999999999999999999999   6788999999999875433221 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc-------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------  234 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-------  234 (404)
                            ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...  ....+..+......       
T Consensus       159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence                  12345689999999998764 589999999999999999999999987533  22222222110000       


Q ss_pred             ------------------ccHhHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          235 ------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       235 ------------------~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                        .......  ..+++.+.+|+.+||+.||++|||+.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l  286 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL  286 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence                              0000000  12457889999999999999999987664

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.3e-44  Score=338.64  Aligned_cols=240  Identities=20%  Similarity=0.257  Sum_probs=201.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +|++.+.||+|+||.||+|++..+++.||||++.....     ...+..|..++..+.+++++..+..+....+..+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999998765321     2246678888888888888888888888888999999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence            999 8899998874 4579999999999999999999999999999999999999   6888999999999975432221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ...+..+.....     .++
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~-----~~p  221 (323)
T cd05616         157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNV-----AYP  221 (323)
T ss_pred             -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCC
Confidence                   12356799999999999999999999999999999999999999987433   344444444332     234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      ..++.++.+++.+||+.||++|++.
T Consensus       222 ~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            5678999999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.1e-44  Score=338.72  Aligned_cols=232  Identities=19%  Similarity=0.240  Sum_probs=190.9

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||+++...     ....+.+|+.+++.++|++++..+. +.......+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~-~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY-SFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEE-EEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999876432     2234678999999999877666544 455667889999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~-----  150 (323)
T cd05571          80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA-----  150 (323)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence            899998874 5679999999999999999999999999999999999999   6788999999999875432221     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+.....     .++..+++
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~~  220 (323)
T cd05571         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLSP  220 (323)
T ss_pred             --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCH
Confidence              2234679999999999999999999999999999999999999997633   2333333333222     23456889


Q ss_pred             HHHHHHHHHHcCCCCCCC
Q 015592          247 EFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP  264 (404)
                      ++.+++.+||+.||++||
T Consensus       221 ~~~~li~~~L~~dP~~R~  238 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             HHHHHHHHHccCCHHHcC
Confidence            999999999999999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=353.51  Aligned_cols=262  Identities=19%  Similarity=0.245  Sum_probs=202.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeE-e-ee----e-CCe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRW-F-GV----E-GDY   77 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~-~-~~----~-~~~   77 (404)
                      .+++|.+.|.+|||+.||+|++...+..||+|.+-..+  ....+.+|+.+|++|++|++|+.+.. . ..    . ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            46889999999999999999998888999999655442  33458899999999996655555433 2 11    1 245


Q ss_pred             EEEEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           78 NVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ++|.|||| |++|-++++. ....|++.++++|+.|+++|+.+||..+  |||||||-+||||   ..++..||||||.+
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSA  193 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCccccc
Confidence            78999999 6899999973 3556999999999999999999999987  9999999999999   58889999999998


Q ss_pred             ccccccC-Cccccc-ccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          154 KRYRDTA-THQHIP-YRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       154 ~~~~~~~-~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ....... ...... ....-....|+.|.|||++.   +...+.|+|||+|||+||.|++...||.+...       ..|
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laI  266 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAI  266 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeE
Confidence            6433221 111110 01112235699999999864   67789999999999999999999999987522       223


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      .......+.  . ..++..+.+||..||+.||++||++-++...+.++..+..
T Consensus       267 lng~Y~~P~--~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  267 LNGNYSFPP--F-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             EeccccCCC--C-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            333322211  1 4678999999999999999999998888888777765544

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=341.05  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...     ....+..|+.++..++|++++..+ .+.......+++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~-~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEE-EEEEcCCEEEEE
Confidence            57999999999999999999999999999999876432     234578899999999977666655 445667789999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..... 
T Consensus        80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~-  154 (333)
T cd05600          80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY-  154 (333)
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence            9999 8999999974 4579999999999999999999999999999999999999   67889999999999765431 


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---ccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---VSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  237 (404)
                               .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....   +.+..+....   ..+..
T Consensus       155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~  222 (333)
T cd05600         155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVY  222 (333)
T ss_pred             ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhccccccCCCC
Confidence                     23567999999999999999999999999999999999999999875432   2233222211   01110


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......+++++.+++.+||..+|++||++.++.+
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            1011256899999999999999999999776644

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=324.68  Aligned_cols=264  Identities=19%  Similarity=0.237  Sum_probs=212.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEec----CCCCchhHHHHHHHHHHHcCCCCCCceeEeee----eCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~   76 (404)
                      +..+|...+.||.|+||.|+.+.++.+|+.||||.+.    .....++..+|+++++.++|.|+|.....+..    ...
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4567777899999999999999999999999999755    23345568899999999999998888877655    345


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ..|+|+|+++.+|.++++. +..|+...+..++.||+.||.|+|+.+|+||||||.|+|+   +.+..+||||||+|+..
T Consensus       100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence            6899999999999999983 4559999999999999999999999999999999999999   68889999999999987


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh------
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------  229 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~------  229 (404)
                      ......     ...+..+-|..|.|||++.. ..|+...||||.||||.||++|++-|.|.+.....+.+..+.      
T Consensus       176 ~~~~~~-----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  176 DKFFED-----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             cccCcc-----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            653111     12356788999999998765 559999999999999999999999998855433222222111      


Q ss_pred             -----------------hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          230 -----------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       230 -----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                                       ......+...+.++.++...+|+.+||..||.+|+|++   +.|++.+...
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~---eAL~hPYl~~  315 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE---EALAHPYLAP  315 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH---HHhcChhhhh
Confidence                             11122233455567789999999999999999999976   4556666543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=341.66  Aligned_cols=207  Identities=25%  Similarity=0.341  Sum_probs=179.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc-----CCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ-----GGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~   78 (404)
                      +..+|.+.+.||+|+||.|-+|.+..|++.||||+++.+. ...+...|+.+|..|+     +..++..+..++......
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            4558999999999999999999999999999999987654 4567888999999998     233566667778888899


Q ss_pred             EEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      |||+|++..+|.++++..+ ..|+...+..|+.||+.||.+||+.||||+||||+||||... ....|||+|||.|....
T Consensus       264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccC
Confidence            9999999999999998643 359999999999999999999999999999999999999654 34489999999998665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK  222 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~  222 (404)
                      ...          ...+.+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.|.+..+..
T Consensus       343 q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl  397 (586)
T KOG0667|consen  343 QRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL  397 (586)
T ss_pred             Ccc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence            533          2567789999999999999999999999999999999999999886554433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=317.99  Aligned_cols=253  Identities=22%  Similarity=0.286  Sum_probs=215.9

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..+.++|++.+.||+|.|+.||++.+..+|+.+|+|+++.+.    ..+.+.+|++|-+.|+||+++.....+. +..+.
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~   85 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFH   85 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-cccee
Confidence            457889999999999999999999999999999999877653    4567999999999999888777665554 55678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      |+++|++ |++|..-+-. ..-+++..+-.++.||+++|.|+|.+||||||+||+|+|+...+...-+||+|||+|..+.
T Consensus        86 ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999998 8787654432 2458999999999999999999999999999999999999877777889999999999887


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ...        ......|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+   .+....|+.|.......+.
T Consensus       165 ~g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  165 DGE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             Ccc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCC
Confidence            332        24578999999999999999999999999999999999999999998   4556677777777665544


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      +. ...++++.++|+.+||..||.+|.|+.|.
T Consensus       234 ~~-w~~is~~Ak~LvrrML~~dP~kRIta~EA  264 (355)
T KOG0033|consen  234 PE-WDTVTPEAKSLIRRMLTVNPKKRITADEA  264 (355)
T ss_pred             cc-cCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence            33 35789999999999999999999997754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-43  Score=347.91  Aligned_cols=254  Identities=20%  Similarity=0.267  Sum_probs=197.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee-------eCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------EGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------~~~~   77 (404)
                      ..++|++++.||+|+||.||+|.+..+++.||||.+...  .....+|+.+++.++|++++.....+..       ...+
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            456899999999999999999999999999999977533  2345679999999999998887655432       1235


Q ss_pred             EEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           78 NVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+++|||++++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++  ...+.+||+|||+++
T Consensus       142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~  219 (440)
T PTZ00036        142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccch
Confidence            679999999899888763   245699999999999999999999999999999999999994  234579999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc-
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-  232 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  232 (404)
                      .+.....        .....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+....+....+....... 
T Consensus       220 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        220 NLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             hccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            6654321        2345789999999998764 58999999999999999999999998754422222221111000 


Q ss_pred             --------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 --------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          .......++...|+++.+||.+||..||.+||++.+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence                                00011123345678999999999999999999988764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-43  Score=333.46  Aligned_cols=262  Identities=18%  Similarity=0.250  Sum_probs=201.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTG   64 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~   64 (404)
                      +..++|++.++||+|+||.||+|.+..                ++..||+|++.....   ...+.+|+.++.+++|+++
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            346789999999999999999998532                345799998865432   2358899999999998877


Q ss_pred             CCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015592           65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFL  125 (404)
Q Consensus        65 i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~------------------~~l~~~~~~~i~~qi~~aL~~LH~~giv  125 (404)
                      +..+..+ ......+++|||+ +++|.+++....                  ..+++..++.++.||+.||.|||++||+
T Consensus        82 v~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          82 IRLLGVC-VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eEEEEEE-ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            7665554 4456789999999 889999986421                  2367889999999999999999999999


Q ss_pred             eccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHH
Q 015592          126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY  205 (404)
Q Consensus       126 HrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~e  205 (404)
                      ||||||+|||+   +.++.+||+|||+++.+.....     +.......++..|+|||++.+..++.++|||||||++||
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            99999999999   5788999999999986543321     112234456789999999998889999999999999999


Q ss_pred             HHc--CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          206 FLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       206 llt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      |++  +..||.+.........................+..+|..+.+++.+||+.||++||++.+|.+.|+
T Consensus       233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            986  678888755433222222211111111111123467899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-43  Score=329.84  Aligned_cols=254  Identities=19%  Similarity=0.256  Sum_probs=198.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcC-CCcEEEEEEecCCCC----chhHHHHHHHHHHHc---CCCCCCceeEeee----e
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----HPQLQYEAKLYKILQ---GGTGIPNLRWFGV----E   74 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~---~~~~i~~~~~~~~----~   74 (404)
                      ++|++.+.||+|+||.||+|++.. +++.||||++.....    ...+.+|+.+++.++   |++++..+..+..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 468899998765332    234677888888774   6666666555432    3


Q ss_pred             CCeEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ....+++||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence            4568999999999999998753 3458999999999999999999999999999999999999   57889999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh---
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---  230 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---  230 (404)
                      +......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.....   
T Consensus       158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            7654321        22355789999999999988999999999999999999999999987544222222211110   


Q ss_pred             ----------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 ----------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      .......+.+...+++.+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                            00111223344567889999999999999999999887763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-43  Score=334.98  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=211.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +|++.+.||+|+||.||+|++..+++.||+|++....     ....+..|..++..+.|++++..+..+....+..+++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4889999999999999999999999999999876432     22346788999999999999988888878888899999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence            999 8899999874 4579999999999999999999999999999999999999   6788999999999875433221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ...+..+.....     ..+
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~-----~~p  221 (323)
T cd05615         157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNV-----SYP  221 (323)
T ss_pred             -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCC
Confidence                   22345789999999999998999999999999999999999999987433   334444443332     233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccc
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY  295 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~  295 (404)
                      ..++.++.+++.+||+++|.+|++..+.  ..+++.   ..++...++|.....
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i~---~h~~f~~~~~~~~~~  270 (323)
T cd05615         222 KSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDIR---EHAFFRRIDWDKLEN  270 (323)
T ss_pred             ccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHHh---cCcccCCCCHHHHhc
Confidence            5678999999999999999999985421  111111   224445567765543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-43  Score=335.55  Aligned_cols=253  Identities=18%  Similarity=0.251  Sum_probs=200.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +|++.+.||+|+||.||++++.   .+++.||+|++....      ..+.+..|+.+++.+++++++..+..+.......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   478999999875321      2235778999999998788887777777788889


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence            9999999 8899999874 4569999999999999999999999999999999999999   578899999999998654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-HHHHHHhhhcccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVST  235 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~  235 (404)
                      .....      ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... .....+....   
T Consensus       157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  227 (332)
T cd05614         157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD---  227 (332)
T ss_pred             ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC---
Confidence            33221      123457999999999998754 789999999999999999999999764333222 2222222211   


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRD  275 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~  275 (404)
                        ..++..+++.+.+++.+||+.||++||++.  .+.+++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              123456789999999999999999999654  34444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-44  Score=326.63  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=205.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeC----CeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e   83 (404)
                      .|+-.+++|.|+||.||+|....+++.||||..-.+..  --.+|..+|+++.|+|+|.....|....    -+..+|||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            58889999999999999999999999999996543333  2357999999999999998887775432    25678999


Q ss_pred             ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        84 ~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |+..+|.++++..   +.+++...+.-+..||++||.|||+.||+||||||+|+|++  .+.+.+||||||.|+.+....
T Consensus       103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCC
Confidence            9999999999853   56799999999999999999999999999999999999996  567999999999999887754


Q ss_pred             CcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH--
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI--  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--  237 (404)
                      .        +.....|..|.|||.+.|.. |+.+.||||.|||+.||+-|++-|.|.+..+....+-++....-...+  
T Consensus       181 p--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  181 P--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             C--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            3        45678899999999999865 999999999999999999999999996655444433333221111111  


Q ss_pred             -------------------hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          238 -------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       238 -------------------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                         .-+....+++..+|+.++|..+|.+|.++.++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l  304 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL  304 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence                               012345689999999999999999999977654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=329.00  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=213.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ...+|++.+.||+|.||.|-+|++...|+.||||.++.+...     -.+.+|++||..|+|+++|.++..| ...+..+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-ENkdKIv  129 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-ENKDKIV  129 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-cCCceEE
Confidence            456899999999999999999999999999999977654432     2378999999999988888776555 4566789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      |||||. +|.|.+++.+ .+.|++.++.+++.||++|+.|+|.++++|||||.+|||+   |.++++||+|||++..+..
T Consensus       130 ivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence            999999 9999999986 4579999999999999999999999999999999999999   7999999999999988776


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..        ...+++|++.|.+||++.|.+| ++.+|-|||||+||-|+.|.+||++   .+.+..+.+|..+....  
T Consensus       206 ~k--------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG---~Dhk~lvrQIs~GaYrE--  272 (668)
T KOG0611|consen  206 KK--------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG---RDHKRLVRQISRGAYRE--  272 (668)
T ss_pred             cc--------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC---chHHHHHHHhhcccccC--
Confidence            54        3457899999999999999998 7899999999999999999999998   45566666666655433  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                          +.-|....-||.+||..||++|-|..+|...
T Consensus       273 ----P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  273 ----PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                3457788999999999999999998887653

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.2e-43  Score=332.50  Aligned_cols=238  Identities=21%  Similarity=0.257  Sum_probs=192.1

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHH---HcCCCCCCceeEeeeeCCeEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKI---LQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~---l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      |++.+.||+|+||.||+|.+..+++.||||+++...     ..+.+..|++++..   ++|++++..+ .+.......++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~-~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLF-ACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhcee-eEEEcCCEEEE
Confidence            789999999999999999999999999999876432     22446677776654   4465555544 45567778999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|..++.  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        80 v~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          80 VMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCC
Confidence            99999 889988876  4579999999999999999999999999999999999999   67889999999998754322


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+...   .+.+..+.....     .
T Consensus       155 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~-----~  219 (324)
T cd05589         155 GD-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEV-----R  219 (324)
T ss_pred             CC-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----C
Confidence            21       22356799999999999999999999999999999999999999987432   333333333222     2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      .+..+++++.+++.+||+.||++||+..
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            3356789999999999999999999643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-44  Score=337.12  Aligned_cols=243  Identities=20%  Similarity=0.277  Sum_probs=199.9

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||+|+||.||+|++..+++.||+|++...     .....+..|+.+++.++|++++..+..+ ......+++|||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-QSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-ecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999987642     1223577899999999988777755544 5667889999999 899


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++.. .+++++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......       
T Consensus        80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-------  148 (312)
T cd05585          80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD-------  148 (312)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence            9999875 5679999999999999999999999999999999999999   6788999999999975433221       


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (404)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ..+.+..+.....     .++..+++++
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~  220 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRDA  220 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHHH
Confidence            1234679999999999999999999999999999999999999998743   3344444433322     2345688999


Q ss_pred             HHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          249 ASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      .+++.+||+.||++||++..+.++|.+.+
T Consensus       221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             HHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence            99999999999999998777777776654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-43  Score=351.54  Aligned_cols=253  Identities=22%  Similarity=0.261  Sum_probs=204.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----   75 (404)
                      ..+++|++.+.||+|+||+||+|++..+++.||||++......    ..+.+|+.++..++|++++.....+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4568999999999999999999999999999999988654332    34678889999888887776654443221    


Q ss_pred             ---CeEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEE
Q 015592           76 ---DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        76 ---~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                         ...+++|||+ +++|.++++..   ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence               2467999999 89999998642   3468999999999999999999999999999999999999   578899999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      |||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+
T Consensus       186 DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~  257 (496)
T PTZ00283        186 DFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT  257 (496)
T ss_pred             ecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence            999998765432111     2235679999999999999999999999999999999999999998643   23333333


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....    ..++..+++++.+++.+||+.||++||++.++++
T Consensus       258 ~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        258 LAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             hcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            33222    2345678999999999999999999999998865

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.1e-43  Score=331.30  Aligned_cols=236  Identities=21%  Similarity=0.271  Sum_probs=191.7

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||+++...     ..+.+..|..++..+.+|++|..+..+...+...+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999876432     22345667777776655666666666666778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~-----  151 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence            999999875 4579999999999999999999999999999999999999   5788999999999975433221     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.   .+.+..+....     ..++..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~-----~~~~~~~~~  221 (316)
T cd05592         152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDR-----PHFPRWISK  221 (316)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-----CCCCCCCCH
Confidence              22356799999999999999999999999999999999999999987443   33333333221     223456789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ++.+++.+||+.||++||++.
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCCh
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=325.74  Aligned_cols=262  Identities=23%  Similarity=0.408  Sum_probs=191.7

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCCchhH----------HHHHH---HHHHHcCCCCC
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQL----------QYEAK---LYKILQGGTGI   65 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~----------~~E~~---~l~~l~~~~~i   65 (404)
                      ..+.+++|++.++||+|+||.||+|.+..+   +..+|+|+..........          ..++.   .+..+.|.+++
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            456778999999999999999999998777   677888865433221100          11122   22233444444


Q ss_pred             CceeEeeeeC---CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           66 PNLRWFGVEG---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        66 ~~~~~~~~~~---~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      ..+.......   .+.+++++++..++.+++.. ....++..+..|+.|++.||+|||+++|+||||||+|||+   +..
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~  162 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN  162 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence            4443322221   24578888888888888874 3346888999999999999999999999999999999999   578


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK  222 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~  222 (404)
                      +.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            89999999999876543221111111223457999999999999999999999999999999999999999886432221


Q ss_pred             H------HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          223 Q------KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       223 ~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .      .+..+...+      .....+|+++.+++..||+.+|++||++++|.+.|
T Consensus       243 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1      111121111      12246789999999999999999999999999876

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-43  Score=336.57  Aligned_cols=237  Identities=21%  Similarity=0.300  Sum_probs=196.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCC-cEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..++|++.+.||+|+||.||+|.+..++ ..||+|++...     .....+.+|+.+++.++|++++..+.. .......
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~-~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS-FKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE-EEeCCEE
Confidence            3467999999999999999999976655 68999987532     223457889999999998777766554 4566788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       107 ~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecC
Confidence            9999999 8899999975 4579999999999999999999999999999999999999   678999999999998654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..          .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..   ....+..+.....    
T Consensus       183 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~----  245 (340)
T PTZ00426        183 TR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGII----  245 (340)
T ss_pred             CC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCC----
Confidence            32          124579999999999999889999999999999999999999998743   3334444443332    


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP  264 (404)
                       .++..+++++.+++.+||+.||++|+
T Consensus       246 -~~p~~~~~~~~~li~~~l~~dp~~R~  271 (340)
T PTZ00426        246 -YFPKFLDNNCKHLMKKLLSHDLTKRY  271 (340)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence             23456789999999999999999996

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.1e-43  Score=331.82  Aligned_cols=232  Identities=19%  Similarity=0.252  Sum_probs=189.7

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||++++..+++.||+|++....     ....+.+|+.+++.++|++++..+.. .......+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~-~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-FQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeE-EecCCEEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346789999999988776665544 45667889999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~-----  150 (323)
T cd05595          80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA-----  150 (323)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence            899888874 5579999999999999999999999999999999999999   6788999999999875332211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ...+..+.....     .++..+++
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~  220 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI-----RFPRTLSP  220 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCH
Confidence              12345799999999999999999999999999999999999999976432   333333332222     23456889


Q ss_pred             HHHHHHHHHHcCCCCCCC
Q 015592          247 EFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP  264 (404)
                      ++.+++.+||+.||++||
T Consensus       221 ~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             HHHHHHHHHccCCHHHhC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=339.07  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=202.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      -+..|+++++||+||.+.||++.. ...+.||+|.+.....    ...+..|+.+|.+|+++..|..+..|...+.+.|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            366799999999999999999996 4445677775443322    23589999999999999989899999999999999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||||-..+|..+|+.....++.-.+..+..||+.++.++|.+||||.||||.|+|+    -.|.+||+|||+|..+....
T Consensus       438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccc
Confidence            99999999999999766656655899999999999999999999999999999999    68999999999999888765


Q ss_pred             CcccccccCCCCCccCcCccccccccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      +..     .....+||+.||+||.+....           .++++||||||||||+|+.|+.||.....  ...++..|.
T Consensus       514 TsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~  586 (677)
T KOG0596|consen  514 TSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAIT  586 (677)
T ss_pred             cce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhc
Confidence            533     234678999999999987443           45789999999999999999999976432  233344444


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ........+.++.  +.++.++++.||.+||++||+..+|+
T Consensus       587 ~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLL  625 (677)
T KOG0596|consen  587 DPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELL  625 (677)
T ss_pred             CCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHh
Confidence            3322222222222  23499999999999999999987664

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-43  Score=341.21  Aligned_cols=257  Identities=20%  Similarity=0.330  Sum_probs=200.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCCCCceeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKIL-QGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~~   76 (404)
                      .++|++.+.||+|+||.||+|++..+     ++.||||++......   ..+.+|+++++.+ +|++++..+ .++....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~-~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLL-GACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEe-eEecCCC
Confidence            35799999999999999999986544     357999988754332   3578899999999 555555544 4555667


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------   97 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~----------------------------------------------------------   97 (404)
                      ..+++|||+ +++|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            789999999 899999885321                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           98 -----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        98 -----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                                 .++++.+++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........    
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~----  268 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY----  268 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce----
Confidence                       247888999999999999999999999999999999999   57889999999999865443211    


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                       .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   .+..........   ..+..+|
T Consensus       269 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~  341 (374)
T cd05106         269 -VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAP  341 (374)
T ss_pred             -eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCC
Confidence             11223345678999999998899999999999999999997 999998754322   122222211111   1223468


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      +++.+++.+||+.||++||++.+|.+.|++++
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=350.51  Aligned_cols=255  Identities=18%  Similarity=0.227  Sum_probs=193.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCC------CCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGT------GIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~------~i~~~~~~~~~~~~~   78 (404)
                      .++|++.++||+|+||+||+|.+..+++.||||+++.. ........|+.+++.+++.+      ++..+.++.......
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            57899999999999999999999999999999998643 22345677999998887654      333334454455678


Q ss_pred             EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCC-------------CCCe
Q 015592           79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR-------------RANQ  144 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~-------------~~~~  144 (404)
                      +++|++++++|.+++.. .+.+++..+..|+.||+.||+|||+ .|||||||||+|||++.++             +...
T Consensus       208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            99999999999998875 4579999999999999999999998 5999999999999995321             1125


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~  224 (404)
                      +||+|||.+.....          ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....+....
T Consensus       287 vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        287 VRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             EEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999998864322          12356899999999999999999999999999999999999999987544322222


Q ss_pred             HHHHhhhccc---------------------------ccHhHhh-------cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          225 YEKISEKKVS---------------------------TSIEALC-------RGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       225 ~~~~~~~~~~---------------------------~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +.+.......                           .....+.       ....+.+.+||.+||.+||++||++++++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            2221110000                           0000000       00135678999999999999999988765


Q ss_pred             H
Q 015592          271 R  271 (404)
Q Consensus       271 ~  271 (404)
                      +
T Consensus       437 ~  437 (467)
T PTZ00284        437 T  437 (467)
T ss_pred             c
Confidence            3

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-43  Score=339.30  Aligned_cols=251  Identities=16%  Similarity=0.186  Sum_probs=196.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .++|++.+.||+|+||.||+|++..+++.||+|...    ...+.+|+++++.|+|++++..+..+ ......+++|+++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTF-TYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEE-EECCeeEEEEecC
Confidence            467999999999999999999999999999999643    34578999999999988877765544 5567789999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|..++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++........   
T Consensus       166 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~---  238 (391)
T PHA03212        166 KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN---  238 (391)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc---
Confidence            9999998874 4579999999999999999999999999999999999999   57889999999999754332111   


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC----hHHHHHHHhhhc---------
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKK---------  232 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~---------  232 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||......+    ....+..+....         
T Consensus       239 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        239 ---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence               1234579999999999999999999999999999999999998875432110    001111111000         


Q ss_pred             -----------------c----cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -----------------V----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -----------------~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                       .    ..+.......+|.++.+||.+||+.||++|||+.++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                             0    00000111235778999999999999999999887653

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.6e-43  Score=323.52  Aligned_cols=254  Identities=13%  Similarity=0.207  Sum_probs=203.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|++.+.||+|+||.||+|.+.   ..+..||+|.++.....   ..+.+|+.+++.++|++++..+. +.......+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEG-VITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEE-EEecCCCcE
Confidence            457999999999999999999865   45678999987765332   35788999999998877666554 445667889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+   +.++.++++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccccc
Confidence            999999 789999998655679999999999999999999999999999999999999   5788999999998765332


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ...      .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+....   .....+......   
T Consensus       160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~---  227 (266)
T cd05064         160 EAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRL---  227 (266)
T ss_pred             cch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCC---
Confidence            211      01123345678999999999999999999999999999775 99999875432   223333322211   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       ..+..+|..+.+++.+||+.+|++||++.+|.+.|+++
T Consensus       228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             23456889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-43  Score=331.37  Aligned_cols=236  Identities=20%  Similarity=0.261  Sum_probs=191.5

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||+|+++..     ........|..++..+.+++++..+..+.......+++|||+ +
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999987643     223446778888877655666666666667778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence            899998875 4579999999999999999999999999999999999999   6788999999999874322111     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   .+.+..+....     ..++..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~-----~~~~~~~~~  221 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDT-----PHYPRWITK  221 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-----CCCCCCCCH
Confidence              12356789999999999999999999999999999999999999987432   33333332221     223345789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ++.+++.+||+.||++||++.
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~  242 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVV  242 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCCh
Confidence            999999999999999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-43  Score=332.53  Aligned_cols=237  Identities=18%  Similarity=0.239  Sum_probs=194.6

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.+|+++..+..+.......+++|||+ +
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999987643     223346778888888766666666666667788899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~-----  151 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK-----  151 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence            899998874 4579999999999999999999999999999999999999   6788999999999875432211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ..+.+..+.....     ..+..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~  221 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEV-----VYPTWLSQ  221 (320)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCCH
Confidence              1234579999999999999899999999999999999999999998743   3344444443322     22345789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~  268 (404)
                      ++.+++.+||+.||++||++.+
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCCCC
Confidence            9999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.1e-43  Score=331.27  Aligned_cols=238  Identities=19%  Similarity=0.248  Sum_probs=192.8

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||++++..+++.||||++....     ....+.+|+.+++.++|++++... .+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceE-EEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999876432     223577899999999887665544 4556677889999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~-----  150 (328)
T cd05593          80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA-----  150 (328)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence            899888874 5579999999999999999999999999999999999999   6788999999999875432211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   .+....+....     ..++..+++
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~-----~~~p~~~~~  220 (328)
T cd05593         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMED-----IKFPRTLSA  220 (328)
T ss_pred             --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCC-----ccCCCCCCH
Confidence              12345799999999999998999999999999999999999999976432   23333332222     133457889


Q ss_pred             HHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015592          247 EFASYFHYCRSLRFDDKP-----DYAYLK  270 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP-----~~~~l~  270 (404)
                      ++.+++.+||..||++|+     ++.++.
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il  249 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIM  249 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence            999999999999999997     555543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=333.45  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=216.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+...|++.+.||.|.||.||+++++.+|+.+|+|++.....     ...+.+|+.+|+.+++|+++..+..........
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            356689999999999999999999999999999998876543     247899999999999666666666666677789


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-~~~vkL~DFG~a~~~  156 (404)
                      +++||++ ||.|.+.+...  .+++.++..++.|++.++.|||+.||+||||||+|+|+...+. .+.+|++|||++...
T Consensus       112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            9999999 89999998754  4999999999999999999999999999999999999975543 458999999999987


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ....        .....+||+.|+|||++....|+..+||||+||++|.|++|..||.+...   .....++........
T Consensus       190 ~~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~f~  258 (382)
T KOG0032|consen  190 KPGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFDFT  258 (382)
T ss_pred             cCCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCCCC
Confidence            7622        34577999999999999999999999999999999999999999998543   444556666665333


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      . .....++..+++++..|+..||..|+++.++++
T Consensus       259 ~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  259 S-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             C-CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            3 333578999999999999999999999887665

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=329.79  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||++++..+++.||||++...     .....+..|+.++..++|++++. +..+...+...+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~-~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITN-LHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCc-eEEEEecCCeEEEE
Confidence            5799999999999999999999999999999987632     12334778999998887665554 54555667788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            9998 999999998656779999999999999999999999999999999999999   678899999999997655432


Q ss_pred             CcccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ..      ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..   ..+.+..+.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~  227 (331)
T cd05597         157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF  227 (331)
T ss_pred             Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence            21      1123468999999999873     347889999999999999999999998643   334444443322212


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCC---CCCHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~---RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      ..+.....+++++.+++.+||.. +.+   |+++.+   ++++       +|....+|....
T Consensus       228 ~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~---~l~h-------p~~~~~~~~~~~  278 (331)
T cd05597         228 QFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQD---FKDH-------PFFEGIDWDNIR  278 (331)
T ss_pred             cCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHH---HhcC-------CCCCCCCHHHHh
Confidence            22222345789999999999875 444   556443   3333       344445666543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-43  Score=318.09  Aligned_cols=254  Identities=19%  Similarity=0.238  Sum_probs=202.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC------e
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD------Y   77 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~------~   77 (404)
                      .|+..++||+|+||+||+|+++.+|+.||+|.+......    ....+|+.+++.|+|.++|..+..+.....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            477888999999999999999999999999988766442    347899999999999995555544444433      7


Q ss_pred             EEEEEeccCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           78 NVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .++++||...+|..+++...   ..++...+..++.||+.||+|||+++|+||||||+|||+   ++.|.+||+|||+|+
T Consensus        92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHH
Confidence            89999999999999999766   358889999999999999999999999999999999999   579999999999999


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc-
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-  232 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  232 (404)
                      .+.-+.       +.-...++|..|.|||++.|. .|+...||||+|||+.||++++.-|.+..+.+....+.++.... 
T Consensus       169 a~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  169 AFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            665332       233466889999999999987 59999999999999999999999999976633333332222111 


Q ss_pred             ---c------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ---V------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ---~------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         +                  ........+...+...+++.+||+.+|.+|.++...++
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~  301 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT  301 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence               0                  00011111222358899999999999999999875543

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-43  Score=334.40  Aligned_cols=260  Identities=19%  Similarity=0.301  Sum_probs=205.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCCCCceeEeeeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKIL-QGGTGIPNLRWFGVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~   75 (404)
                      -.++|++.+.||.|+||.||+|.+..     +++.||+|++......   +.+..|+.++.++ +|++++..+..+...+
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            35689999999999999999997533     4578999987654322   3477899999999 5666677667666677


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC---------------------------------------------------------
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------   97 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------------------------------------------------   97 (404)
                      ...+++|+|+ +++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            7888999999 889999986321                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCc
Q 015592           98 ---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT  174 (404)
Q Consensus        98 ---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (404)
                         ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.++|+|||+++.+......     .......
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~  236 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDAR  236 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCCC
Confidence               257899999999999999999999999999999999999   57889999999999876432211     1223445


Q ss_pred             cCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHH
Q 015592          175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH  253 (404)
Q Consensus       175 gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  253 (404)
                      ++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.  ....+.... .   ...+..+++++.+++.
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~-~---~~~~~~~~~~~~~l~~  310 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGT-R---MRAPEYATPEIYSIML  310 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccC-C---CCCCccCCHHHHHHHH
Confidence            6788999999999999999999999999999998 9999987433221  111111111 1   1123457889999999


Q ss_pred             HHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          254 YCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       254 ~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +||+.+|++||++.+|.+.|++++.
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.4e-43  Score=331.92  Aligned_cols=236  Identities=20%  Similarity=0.245  Sum_probs=194.0

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||++....     ....+..|.+++..+.+|++|..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346778888888766777777777777788899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~-----  151 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV-----  151 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence            899988874 4579999999999999999999999999999999999999   6788999999999875433221     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+......     .+..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~  221 (321)
T cd05591         152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSK  221 (321)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCH
Confidence              2234578999999999999899999999999999999999999998744   33444444433321     2335789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ++.+++.+||+.||++||+..
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~  242 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCV  242 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCC
Confidence            999999999999999999543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-42  Score=333.31  Aligned_cols=269  Identities=19%  Similarity=0.263  Sum_probs=203.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||+||+|++..+++.||||++....     ....+..|+.++..++|++++..+. ...+....+++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~-~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY-SFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEE-EEecCCeEEEE
Confidence            57999999999999999999999999999999886432     2245778999999998777665554 44566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence            9999 8899999975 5679999999999999999999999999999999999999   578899999999998654321


Q ss_pred             Cccc-------c---------------------cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 015592          161 THQH-------I---------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (404)
Q Consensus       161 ~~~~-------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P  212 (404)
                      ....       .                     ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            1000       0                     00011245799999999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCceee
Q 015592          213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRLFRDLFIREGFQFDYVFD  289 (404)
Q Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~---~RP~~~~l~~~l~~~~~~~~~~~~~~~~  289 (404)
                      |.+..   ..+.+.++.........+. ...+++++++++.+++. +|+   .||++++|++          .+|...++
T Consensus       236 f~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~----------hp~f~~~~  300 (363)
T cd05628         236 FCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT----------NPFFEGVD  300 (363)
T ss_pred             CCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC----------CCCCCCCC
Confidence            98743   3344444443221111111 12367899999998664 444   4577666532          25555667


Q ss_pred             cccccc
Q 015592          290 WTILKY  295 (404)
Q Consensus       290 w~~~~~  295 (404)
                      |.....
T Consensus       301 ~~~~~~  306 (363)
T cd05628         301 WEHIRE  306 (363)
T ss_pred             HHHHHh
Confidence            876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.6e-43  Score=332.89  Aligned_cols=239  Identities=18%  Similarity=0.247  Sum_probs=192.6

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||+++...     ....+..|..++..+.+|++|..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999886532     12347789999999966666666666677778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. .+++++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~-----  151 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD-----  151 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence            899988864 5679999999999999999999999999999999999999   6788999999999875322211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------hHHHHHHHhhhcccccHhHh
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  240 (404)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .......+....     ..+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~  224 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-----IRI  224 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-----CCC
Confidence              2235679999999999999999999999999999999999999996432211      111222222222     123


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      +..++.++.+++.+||+.||.+|+++.
T Consensus       225 p~~~~~~~~~li~~~L~~dP~~R~~~~  251 (329)
T cd05588         225 PRSLSVKASSVLKGFLNKDPKERLGCH  251 (329)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            456789999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-42  Score=326.83  Aligned_cols=255  Identities=18%  Similarity=0.245  Sum_probs=201.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.++||+|+||.||+|++..+++.||+|.++...   ....+.+|+.+++.++|++++..+..+ ..+...+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-HTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-eeCCeEEEEE
Confidence            367999999999999999999999999999999876432   233577899999999987777665544 5566789999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++....... 
T Consensus        84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc-
Confidence            999889999988666678999999999999999999999999999999999999   6788999999999975443221 


Q ss_pred             ccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc--------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------  233 (404)
                            ......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+..+....+........        
T Consensus       160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence                  1223467899999999875 4589999999999999999999999987554333222222111000        


Q ss_pred             --------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 --------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                    ..........+++++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                          00011122356889999999999999999999876654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5e-43  Score=332.97  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=206.1

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||+|++.....     ...+..|+.++.++.+++++..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999998875322     2347789999999987777777777777888899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD-----  151 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence            899988874 4579999999999999999999999999999999999999   6788999999999875332211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC----hHHHHHHHhhhcccccHhHhhc
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .......+....     ..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~p~  224 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-----IRIPR  224 (327)
T ss_pred             --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-----CCCCC
Confidence              1234679999999999999999999999999999999999999997533221    112222222221     12345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      .++.++.+++.+||+.||++|+++... ..++++   ...++...++|+.....+
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~h~~f~~~~~~~~~~~~  275 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDI---KSHTFFRSIDWDLLEKKQ  275 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---HcCCCCCCCCHHHHHhCC
Confidence            678999999999999999999986421 111121   133555667787654333

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.6e-43  Score=334.47  Aligned_cols=249  Identities=20%  Similarity=0.250  Sum_probs=198.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...     ....+..|+.+++.++|++++..+ .+.......+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~-~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-YAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCccee-eEEecCCeEEEE
Confidence            47999999999999999999999999999999876532     223477889999888766655544 445566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999 899999998765789999999999999999999999999999999999999   688999999999998665432


Q ss_pred             CcccccccCCCCCccCcCcccccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ..      ......||+.|+|||++.      +..++.++|||||||++|||++|+.||.....   ...+..+......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~  227 (330)
T cd05601         157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF  227 (330)
T ss_pred             ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence            21      122347899999999987      45678999999999999999999999987433   3333443332111


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ...+ ....+++++.+|+..||. +|++||++.++.
T Consensus       228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~  261 (330)
T cd05601         228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLC  261 (330)
T ss_pred             cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence            1111 112478999999999998 999999987653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.8e-43  Score=335.96  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=198.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----   75 (404)
                      .+.++|++.+.||+|+||.||++++..+++.||||++....    ....+.+|+.+++.++|++++..+..+....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35689999999999999999999999999999999876432    2345778999999999998888877664332    


Q ss_pred             -CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ...+++|||++++|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~  171 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  171 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence             3579999999888888775   358999999999999999999999999999999999999   678999999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh-----
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS-----  229 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----  229 (404)
                      ......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....     
T Consensus       172 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         172 TACTNF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccCc--------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            543321        1234578999999999999999999999999999999999999998754321111110000     


Q ss_pred             --------------hhccc---ccHh------------HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 --------------EKKVS---TSIE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 --------------~~~~~---~~~~------------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                    .....   ....            ......++++++|+.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                          00000   0000            011123578899999999999999999886643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.3e-43  Score=338.20  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             CceEEeeeeceeCceeEEEEEE-----cCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ++|++.+.||+|+||.||+|++     ..++..||||+++....   .+.+.+|+.++..+.+|++|..+..++..+...
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     34567899998864332   245788999999995444555555555667788


Q ss_pred             EEEEecc-CCCHHHHHHHcC------------------------------------------------------------
Q 015592           79 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------   97 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~------------------------------------------------------------   97 (404)
                      +++|||+ +|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            9999999 899999886421                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           98 --------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        98 --------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                                    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........ 
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~-  270 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNY-  270 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcccc-
Confidence                          147888999999999999999999999999999999999   57788999999999866543211 


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                          .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  .....+... ...   ..+.
T Consensus       271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~~  340 (375)
T cd05104         271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-YRM---LSPE  340 (375)
T ss_pred             ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-ccC---CCCC
Confidence                11223345678999999999999999999999999999998 999998754322  112222221 111   1223


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..|.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            4678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-42  Score=322.60  Aligned_cols=253  Identities=19%  Similarity=0.245  Sum_probs=197.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHc---CCCCCCceeEeee----eCC
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQ---GGTGIPNLRWFGV----EGD   76 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~---~~~~i~~~~~~~~----~~~   76 (404)
                      +|++.+.||+|+||+||+|++..+++.||+|.++....    .....+|+.+++.++   |++++..+..+..    ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            59999999999999999999999999999998765322    234677888888774   6666666555432    235


Q ss_pred             eEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++||++.++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence            678999999889999987543 358999999999999999999999999999999999999   5788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh----
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----  231 (404)
                      ......        .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......    
T Consensus       158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            643221        23456899999999999988999999999999999999999999765432222222111100    


Q ss_pred             ---------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ........+...++.++.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                           0011122334567889999999999999999999887753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=335.97  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=202.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|+.++..++|++++..+. +..++...+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY-SFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhh-heecCCeEEEE
Confidence            5799999999999999999999999999999987643     22345788999999998777666554 44567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence            9999 88999999853 679999999999999999999999999999999999999   688999999999998665433


Q ss_pred             Ccc----------------------cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 015592          161 THQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (404)
Q Consensus       161 ~~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~  218 (404)
                      ...                      ...........||+.|+|||++.+..++.++|||||||+||||++|+.||.+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            000                      0000122345799999999999999999999999999999999999999987543


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHHH
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKR  271 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~-~~~l~~  271 (404)
                         ...+.++.........+. ...+++++.++|.+||. ||++||+ +.++++
T Consensus       236 ---~~~~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         236 ---QETYNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             ---HHHHHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence               333333333111111111 12368999999999997 9999999 887654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-42  Score=329.75  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=197.5

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||+||+|++..+++.||+|++....     ....+..|.. +++.++|++++.. ..+....+..+++|||+ 
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~-~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL-HFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCce-eEEEEcCCeEEEEEeCCC
Confidence            47999999999999999999999999876432     1123444444 4566776666554 45556677889999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~----  151 (325)
T cd05602          80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG----  151 (325)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence            8899998874 5678999999999999999999999999999999999999   5788999999999975433221    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ..+.+..+.....     .+...++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~  220 (325)
T cd05602         152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPL-----QLKPNIT  220 (325)
T ss_pred             ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCc-----CCCCCCC
Confidence               2235679999999999999999999999999999999999999998743   3344444433322     2234688


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      +++.+++.+||+.||.+||+..+...   ++.   +..+...++|....
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~---~i~---~~~~~~~~~~~~~~  263 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFM---EIK---NHIFFSPINWDDLI  263 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHH---HHh---cCcccCCCCHHHHH
Confidence            99999999999999999999764322   221   22344556786553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-42  Score=329.79  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=203.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.++||+|+||.||++++..+++.||+|++....     ....+..|+.++..++|++++ .+..+.......+++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~-~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWIT-TLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEe-eEEEEEecCCEEEEE
Confidence            57999999999999999999999999999999875321     223367788888888765544 455555667788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            9998 899999998656779999999999999999999999999999999999999   678899999999997654332


Q ss_pred             CcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ..      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...   +..+.+..+.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~  227 (332)
T cd05623         157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERF  227 (332)
T ss_pred             cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCccc
Confidence            21      122457999999999986     345889999999999999999999999874   3344455554433222


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      ..+.....+++++.+++.+|+..++++  |+++.+++   ++       +|...++|+...
T Consensus       228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~---~h-------~~f~~~~~~~~~  278 (332)
T cd05623         228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK---QH-------PFFTGIDWDNIR  278 (332)
T ss_pred             cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh---CC-------CCcCCCCHHHHh
Confidence            223333467899999999999765444  45655443   22       344455676543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-42  Score=329.48  Aligned_cols=253  Identities=18%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ..++|++.+.||+|+||.||++++..++..||+|++.....   ...+.+|+++++.++|++++..+..+ ......+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv   81 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISIC   81 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEEEEE
Confidence            45889999999999999999999999999999998875432   24588999999999988777766554 456678999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+   +.++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            9999 8899999975 45699999999999999999999986 69999999999999   57889999999999765432


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH------------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK------------  227 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------------  227 (404)
                      .         .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..            
T Consensus       158 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             c---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence            2         2345789999999999998999999999999999999999999975432111110000            


Q ss_pred             ---------------------------HhhhcccccHhHh-hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          228 ---------------------------ISEKKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       228 ---------------------------~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                 ..........+.. ...+++++.+||.+||++||++||++.+|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                       0000000000011 1236789999999999999999999887643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-42  Score=329.79  Aligned_cols=270  Identities=19%  Similarity=0.283  Sum_probs=206.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ..++|++.++||+|+||.||++.+..++..+|+|++.....   ...+.+|+++++.++|++++..+..+ ......+++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-EECCEEEEE
Confidence            46889999999999999999999999999999998765432   24588999999999987777666554 556788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+   +.++.+||+|||++..+...
T Consensus        82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence            9999 8899999975 45689999999999999999999985 79999999999999   57788999999999765432


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH-------------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE-------------  226 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------------  226 (404)
                      .         .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.             
T Consensus       158 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             c---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence            1         134578999999999999889999999999999999999999997643321111000             


Q ss_pred             ------------------------HHhhhcccccHhHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          227 ------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       227 ------------------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                                              .+.........+.+. ..++.++.+|+.+||++||++||++.++.   .+.+.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell---~h~~~~~~  305 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM---VHAFIKRS  305 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh---hCHHHhcC
Confidence                                    000000000001111 13578899999999999999999988764   44444433


Q ss_pred             -CCCCceeecc
Q 015592          282 -FQFDYVFDWT  291 (404)
Q Consensus       282 -~~~~~~~~w~  291 (404)
                       .+......|.
T Consensus       306 ~~~~~~~~~~~  316 (333)
T cd06650         306 EAEEVDFAGWL  316 (333)
T ss_pred             ccccccHHHHH
Confidence             2333344554

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-42  Score=328.51  Aligned_cols=235  Identities=21%  Similarity=0.271  Sum_probs=189.0

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||+||+|++..+++.||||++....     ....+..|.. +++.++|++++..+ .........+++|||+ 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~-~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCee-EEEEeCCEEEEEEcCCC
Confidence            47999999999999999999999999876432     1223445544 45667776666554 4445667889999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~----  151 (323)
T cd05575          80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK----  151 (323)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence            8899998874 5679999999999999999999999999999999999999   6788999999999875432211    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..   ..+.+..+.....     .+...++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~  220 (323)
T cd05575         152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPL-----RLKPNIS  220 (323)
T ss_pred             ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCC
Confidence               2235579999999999999999999999999999999999999998743   3444444443322     2334678


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      +++.+++.+||+.||++||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=336.02  Aligned_cols=253  Identities=20%  Similarity=0.264  Sum_probs=194.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.++||+|+||.||++++..+++.||||++....     ....+.+|+++++.++|++++..+ .+..+....+++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~-~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEE-EEEEcCCeeEEE
Confidence            57999999999999999999999999999999875421     224578899999999877766554 445567789999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence            9999 8999999874 4679999999999999999999999999999999999999   578899999999997443211


Q ss_pred             Cccc-------ccc---------------------------------cCCCCCccCcCccccccccCCCCCchhHHHHHH
Q 015592          161 THQH-------IPY---------------------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLG  200 (404)
Q Consensus       161 ~~~~-------~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG  200 (404)
                      ....       ...                                 .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0000       000                                 000135699999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCC---CHHHH
Q 015592          201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL  269 (404)
Q Consensus       201 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---~~~~l  269 (404)
                      |++|||++|..||.+...   ...+..+.........+. ...++.++.++|.+||. +|.+|+   ++.++
T Consensus       236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            999999999999987433   333333332111111000 12467899999999997 777765   65544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-42  Score=330.28  Aligned_cols=267  Identities=21%  Similarity=0.275  Sum_probs=202.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||++++..+++.||+|++....     ....+..|..++..+.|++ |..+..+.......+++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW-ITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999875421     2233677888888877655 45555556677889999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ |++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            9998 999999998656789999999999999999999999999999999999999   578899999999997665432


Q ss_pred             CcccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ..      ......||+.|+|||++.+     ..++.++|||||||+||||++|+.||....   ..+.+..+.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~  227 (331)
T cd05624         157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF  227 (331)
T ss_pred             ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence            21      1223579999999999876     457899999999999999999999998643   334444443322212


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      ..+.....+++++.+++.+||..++ +|+....+.+++++       ++...++|+...
T Consensus       228 ~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h-------~~f~~~~~~~~~  278 (331)
T cd05624         228 QFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKH-------AFFEGIDWENIR  278 (331)
T ss_pred             cCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcC-------CCcCCCCHHHHh
Confidence            2222234578999999999998654 44432223333332       333446676554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-42  Score=329.36  Aligned_cols=264  Identities=19%  Similarity=0.275  Sum_probs=201.2

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||+|+++...     ....+..|+.++..+.+|+++..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999876532     12346788888888755555666666667778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~-----  151 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-----  151 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence            899888864 5679999999999999999999999999999999999999   6788999999999975432221     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------hHHHHHHHhhhcccccHhHh
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  240 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .......+.....     .+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~  224 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RI  224 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CC
Confidence              2234679999999999999999999999999999999999999996422111      1112222222221     24


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      +..++.++.+++.+||+.||++||++.... .+.++.   ..++...++|......
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i~---~hp~f~~~~~~~~~~~  276 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADIQ---GHPFFRNVDWDLMEQK  276 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHHh---cCCCCCCCCHHHHHcC
Confidence            456789999999999999999999853110 011111   2355556778755443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-42  Score=335.18  Aligned_cols=256  Identities=20%  Similarity=0.226  Sum_probs=195.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ..|++++.||+|+||+||+|++..+++.||||++....     ....+..|+.+++.++|++++..+.. ..+....+++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~-~~~~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYS-FQDKDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEE-EecCCEEEEE
Confidence            36999999999999999999999999999999886532     22357889999999987766655544 4567789999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccc
Confidence            9999 8899999875 4569999999999999999999999999999999999999   578899999999986542111


Q ss_pred             Cccc----------------------------------------ccccCCCCCccCcCccccccccCCCCCchhHHHHHH
Q 015592          161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG  200 (404)
Q Consensus       161 ~~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG  200 (404)
                      ....                                        ..........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0000                                        000011245799999999999998899999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHH--cCCCCCCCCHHHHHH
Q 015592          201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLKR  271 (404)
Q Consensus       201 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~~p~~RP~~~~l~~  271 (404)
                      |++|||++|+.||.....   ......+.........+ ....+++++.++|.+|+  ..++..||++.++++
T Consensus       236 ~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999987443   22222222111111111 11247899999999854  455666999877653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-42  Score=326.84  Aligned_cols=235  Identities=20%  Similarity=0.260  Sum_probs=193.1

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..+++.||||++....     ....+..|..++..+.+|+++..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999876432     23346788889988866666666666667778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV-----  151 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence            899988874 4579999999999999999999999999999999999999   6788999999999875322211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+.....     .++..++.
T Consensus       152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~  221 (318)
T cd05570         152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEV-----RYPRWLSK  221 (318)
T ss_pred             --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCC-----CCCCcCCH
Confidence              1234578999999999999999999999999999999999999998643   2333333333222     23356789


Q ss_pred             HHHHHHHHHHcCCCCCCCCH
Q 015592          247 EFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~  266 (404)
                      ++.+++.+||..||++||++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-42  Score=322.07  Aligned_cols=243  Identities=21%  Similarity=0.197  Sum_probs=199.4

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeee---eCCeEEEEEec
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYNVLVIDL   84 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~---~~~~~~lv~e~   84 (404)
                      ..||+|++|.||+|.+  +|+.||||.++....     .+.+.+|+.++++++|++++..+..+..   .....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999996  789999998765432     2456799999999999987777766543   23567899999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++.. ...+++...+.++.|++.||.|||+ .+++||||||+|||+   +.++.+||+|||+++.+....  
T Consensus       104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            9 8899999985 4579999999999999999999998 499999999999999   578899999999998654322  


Q ss_pred             ccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                              ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.   .+.+..+.......   .+
T Consensus       178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~---~~  243 (283)
T PHA02988        178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNNSL---KL  243 (283)
T ss_pred             --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCC---CC
Confidence                    23468899999999976  6799999999999999999999999987543   33344443322222   23


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      +..+|+++.+++.+||+.||++||+++++++.|+.+.
T Consensus       244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            3467899999999999999999999999999998764

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.4e-42  Score=320.80  Aligned_cols=261  Identities=20%  Similarity=0.244  Sum_probs=206.6

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      |+.+..++|++.++||+|+||+||+|++..+++    .||+|+......   ...+.+|+.+++.++|++++..+..+. 
T Consensus         1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-   79 (279)
T cd05109           1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL-   79 (279)
T ss_pred             CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-
Confidence            677888999999999999999999999877766    489998765433   235778999999998877776665543 


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      . ...+++++++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+   ++++.+||+|||+
T Consensus        80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~  155 (279)
T cd05109          80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGL  155 (279)
T ss_pred             C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCc
Confidence            2 3356777777 899999998655679999999999999999999999999999999999999   5778899999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ++.+.......     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+...
T Consensus       156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~  227 (279)
T cd05109         156 ARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKG  227 (279)
T ss_pred             eeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC
Confidence            98765432211     1122345678999999998889999999999999999998 999997644322   22222221


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .. .   .....++.++.+++.+||..||++||++.++.+.|+++..
T Consensus       228 ~~-~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ER-L---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             Cc-C---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11 1   1234678999999999999999999999999998887753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-42  Score=327.60  Aligned_cols=259  Identities=21%  Similarity=0.262  Sum_probs=204.8

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcE----EEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      ..-..+|++.+.||+|+||.||+|++..+++.    ||+|+++....   .+.+..|+.+++.++|++++..++.+.. .
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~   81 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S   81 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-C
Confidence            34567899999999999999999998666654    89998764332   3458889999999999888887765543 3


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ..+++++|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~  157 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK  157 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence             345667766 999999998666679999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+.......     ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....   +. ..+.....
T Consensus       158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~-~~~~~~~~  228 (316)
T cd05108         158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI-SSILEKGE  228 (316)
T ss_pred             cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH-HHHHhCCC
Confidence            765432211     1122334678999999999999999999999999999998 99999874332   22 22222211


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..   ..+..++.++.+++.+||..+|++||++.++...|.++..
T Consensus       229 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            11   1224578899999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-43  Score=336.26  Aligned_cols=260  Identities=19%  Similarity=0.269  Sum_probs=200.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||+||+|++..+++.||||++....     ....+.+|+.+++.++|++++..+ .+.......+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~-~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceE-EEEEcCCeEEEE
Confidence            57999999999999999999999999999999886432     223477899999999876666654 445567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence            9999 8899999875 4579999999999999999999999999999999999999   688999999999997654321


Q ss_pred             Ccccc-----------------cc--------------cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcC
Q 015592          161 THQHI-----------------PY--------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG  209 (404)
Q Consensus       161 ~~~~~-----------------~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg  209 (404)
                      .....                 +.              ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            10000                 00              001134699999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..||.+...   .+.+..+.........+. ...+++++.++|.+|+. +|.+|++...+.++|.+.
T Consensus       236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         236 YPPFCSDNP---QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             CCCCCCCCH---HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            999987443   333333332211111111 12468899999999996 899999854444555443

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-42  Score=335.96  Aligned_cols=253  Identities=22%  Similarity=0.263  Sum_probs=195.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+..+ ..+...+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-QDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-EcCCEEEEE
Confidence            4799999999999999999999999999999987542     2234578899999999987777655444 566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|..+....
T Consensus        80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence            9999 8999999975 4568999999999999999999999999999999999999   688899999999986442110


Q ss_pred             Cccc------------------------------------ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHH
Q 015592          161 THQH------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM  204 (404)
Q Consensus       161 ~~~~------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~  204 (404)
                      ....                                    ..........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0000                                    0000112457999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCC---CHHHH
Q 015592          205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL  269 (404)
Q Consensus       205 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---~~~~l  269 (404)
                      ||++|+.||.+...   ......+......... .....+++++.++|.+|+ .+|.+|+   ++.++
T Consensus       236 ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         236 EMLVGQPPFLADTP---AETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ehhhCCCCCCCCCH---HHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999987543   2222222221111111 112357889999999976 5999999   55544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=335.94  Aligned_cols=238  Identities=19%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCH
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL   89 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL   89 (404)
                      -++.||+|+-|.||+|+.  .++.||||.++     +.-+.+++-|++|+|+|+|.+.+.| .....+||+|||| .|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~-----elkETdIKHLRkLkH~NII~FkGVC-tqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVR-----ELKETDIKHLRKLKHPNIITFKGVC-TQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHh-----hhhhhhHHHHHhccCcceeeEeeee-cCCceeEEeeeccccccH
Confidence            467899999999999984  67899999543     2234578889999998888766555 4555779999999 8999


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccC
Q 015592           90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE  169 (404)
Q Consensus        90 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  169 (404)
                      .++++. ++++.......|..+||.|+.|||.+.|||||||.-||||   ..+..|||+|||.++.+.+..+        
T Consensus       200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~ST--------  267 (904)
T KOG4721|consen  200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKST--------  267 (904)
T ss_pred             HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhh--------
Confidence            999984 6789999999999999999999999999999999999999   4778899999999998877643        


Q ss_pred             CCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHH
Q 015592          170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA  249 (404)
Q Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  249 (404)
                      ...+.||..|||||++.+.+.+.|+|||||||||||||||..||.+.+..   ..+-.+....+.   -..+..+|+.|+
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~---LpvPstcP~Gfk  341 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLH---LPVPSTCPDGFK  341 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCccc---ccCcccCchHHH
Confidence            35789999999999999999999999999999999999999999875432   111111111111   123457899999


Q ss_pred             HHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          250 SYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       250 ~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      -|+++||+..|.+||+|.+|+..|+
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHh
Confidence            9999999999999999999977664

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-42  Score=322.24  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC-----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|++.+.||+|+||.||+|.+...+     +.|++|.+.....   ...+.+|+.++..++|++++..+..+ .....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-TKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-cCCCc
Confidence            467999999999999999999976554     6899998764432   23578899999999988777766554 45567


Q ss_pred             EEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                      .+++|||+ +++|.+++....               ..+++.+++.++.|++.||.|||++||+||||||+||++   ++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence            78999998 889999987532               458899999999999999999999999999999999999   57


Q ss_pred             CCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 015592          142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT  220 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~  220 (404)
                      ++.+||+|||+++.......     +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...  
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--  232 (283)
T ss_pred             CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            88999999999976543221     112234466889999999998889999999999999999998 9999987543  


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                       .+....+.....    ...+..+|+++.+|+.+||+.||++||++.+|.+.|+.
T Consensus       233 -~~~~~~i~~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 -QEVIEMIRSRQL----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCc----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             233333333222    22345789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-43  Score=300.08  Aligned_cols=247  Identities=22%  Similarity=0.298  Sum_probs=210.8

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .-.++|++++.||+|-||.||+|+.++++-.||+|++...     ....++.+|++|...|+|+|++..+.++ .+....
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-hd~~ri   97 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-HDSKRI   97 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-ecccee
Confidence            4457899999999999999999999999999999986543     2345799999999999988877766554 566678


Q ss_pred             EEEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      |+++||. +|+|...+.. ...++++.....++.|++.||.|+|.++||||||||+|+|+   +..+.+||+|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeec
Confidence            9999998 8888888873 24569999999999999999999999999999999999999   58899999999998654


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ...         ...+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||....   ..+.|.+|....... 
T Consensus       175 p~~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~-  241 (281)
T KOG0580|consen  175 PSN---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF-  241 (281)
T ss_pred             CCC---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC-
Confidence            421         3468899999999999999999999999999999999999999998744   566777776655543 


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                          +..++.+.+++|.+|+.++|.+|....++.+
T Consensus       242 ----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 ----PSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                3678999999999999999999998665543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.9e-43  Score=334.45  Aligned_cols=246  Identities=21%  Similarity=0.267  Sum_probs=193.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.++||+|+||.||+|++..+++.||||++.....   ...+.+|+++++.++|++++..+..+ ......+++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCCeEEEEE
Confidence            3578899999999999999999999999999998864432   24588999999999988777666554 5566788999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+.     ...++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus       152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence            999 7777543     235778889999999999999999999999999999999   6788999999999986654321


Q ss_pred             cccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                             ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+.......+....    
T Consensus       224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence                   1234579999999998743     234579999999999999999999998544333333332222111    


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .......++.++.+||.+||+.||++||++.++++
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12233467899999999999999999999887654

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.5e-42  Score=326.54  Aligned_cols=236  Identities=22%  Similarity=0.280  Sum_probs=190.9

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||+||+|++..+++.||||+++..     ........|..++..+.+|+++..+..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999987653     223446678888877645555556666666777899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence            899999875 4579999999999999999999999999999999999999   5788999999999875332211     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   .+.+..+.....     .++..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~  221 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNP-----CYPRWLTR  221 (316)
T ss_pred             --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCCccCCH
Confidence              12345789999999999998999999999999999999999999987433   333333332221     12345788


Q ss_pred             HHHHHHHHHHcCCCCCCCCHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ++.+++.+||..||++||++.
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVK  242 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCCh
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=322.61  Aligned_cols=242  Identities=19%  Similarity=0.228  Sum_probs=194.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +|++.+.||+|+||+||++.+..+++.||||++.....     ...+.+|+.+++.++|++++..+..+ ..+...+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-cCCCeEEEEE
Confidence            58999999999999999999999999999998764321     23467899999999987777655544 4556889999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999 88999888643 3469999999999999999999999999999999999999   578899999999997654322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....|+..|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+.....    ......
T Consensus       157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~  224 (285)
T cd05605         157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----EDQEEY  224 (285)
T ss_pred             c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh----hccccc
Confidence            1        1244789999999999998899999999999999999999999987544322222222111    111223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                      +..+++.+.+++.+||..||++||+
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~  249 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLG  249 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcC
Confidence            3467899999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=332.66  Aligned_cols=253  Identities=21%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----   74 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++++..+..+...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            46689999999999999999999999999999999876432    224577899999999998888777555322     


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|++++++|.++++  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence            24578999999999999886  4579999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc-
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-  232 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  232 (404)
                      ......          ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....... 
T Consensus       167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            654321          24578999999999987 468999999999999999999999997643221111111110000 


Q ss_pred             ----------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                            ..........+.++.+.+|+.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                  000111222356678899999999999999999876653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-43  Score=331.04  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             eeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ++.||+|+||.||++++.   .+++.||+|++....    ....+..|++++++++|++++..+.. .......+++|||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA-FQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEE-EEcCCEEEEEEcC
Confidence            367999999999999863   578999999876432    23346789999999998877765554 4566788999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence            9 8899999874 4579999999999999999999999999999999999999   5788999999999976543321  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ..+.+..+.....     .++..
T Consensus       154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~-----~~p~~  220 (318)
T cd05582         154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKL-----GMPQF  220 (318)
T ss_pred             -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCC-----CCCCC
Confidence                 2234678999999999999889999999999999999999999998743   3334444433322     23356


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHH--HHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRD  275 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~--l~~~l~~  275 (404)
                      +++++.+++.+||+.||++||++.+  +.+++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            7899999999999999999999876  5555543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-42  Score=332.43  Aligned_cols=249  Identities=20%  Similarity=0.248  Sum_probs=197.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee-----C
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~   75 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++++..+..+...     .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            5689999999999999999999999999999999876432    234577899999999999888877655432     2


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|||++++|.+.+.   ..+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence            4579999999989988875   348899999999999999999999999999999999999   6788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......        .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..   ..+.++......+
T Consensus       176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~  244 (364)
T cd07875         176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTP  244 (364)
T ss_pred             cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence            543221        23457899999999999999999999999999999999999999874432   2222221110000


Q ss_pred             c-------------------------Hh------------HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          236 S-------------------------IE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       236 ~-------------------------~~------------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .                         ..            ......+.++.++|.+||..||++|||+.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L  316 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL  316 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            0                         00            00011245789999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-42  Score=315.14  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=204.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.++||+|+||.||+|++..+ ..||+|+.+.... ...+.+|+.+++.++|++++..+..+  .....+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCcEEEEE
Confidence            457899999999999999999998655 4699998875433 35688999999999988777766544  3445789999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||++   +.++.++|+|||.++.+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeecccccc
Confidence            99 78999999743 3458999999999999999999999999999999999999   5788999999999976654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......++..|+|||+..+..++.++|||||||++|||++ |..||.+...   .+.+..+.....    ...
T Consensus       158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~----~~~  224 (262)
T cd05071         158 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR----MPC  224 (262)
T ss_pred             ------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCC----CCC
Confidence                  11123456778999999998889999999999999999999 8999976433   233333322211    112


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...+|..+.+++.+||+.||++||++.++.+.|++.|
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            3457899999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.3e-43  Score=347.47  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=215.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+.++.+.||+|+||+||+|+-..     ....||||.++.+...   .+|++|++++..|+|+|+|..++.+ ..++..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-REGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-ccCCee
Confidence            456788999999999999998542     3467999988766544   5699999999999988877776665 466678


Q ss_pred             EEEEecc-CCCHHHHHHHcCC---------C----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe
Q 015592           79 VLVIDLL-GPSLEDLFNFCSR---------K----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~---------~----l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~  144 (404)
                      ++|+||+ .|+|.++|.....         .    |+..+.+.|+.|||.|++||-++.+|||||-..|+|+   .+...
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceE
Confidence            9999999 9999999975432         2    8899999999999999999999999999999999999   58899


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ  223 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~  223 (404)
                      |||+|||+++..-...+     |+......-..+||+||.++.++||.+||||||||+|||+++ |+.||.+..+.   +
T Consensus       642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---E  713 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---E  713 (774)
T ss_pred             EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---H
Confidence            99999999987655443     333334455789999999999999999999999999999998 99999997764   4


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .++.+....+    -..+.++|.++.+|+..||+.+|.+||+|.+|...|++....
T Consensus       714 VIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 VIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            4444444444    345678999999999999999999999999999999987644

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.9e-42  Score=334.23  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=201.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|+++++||+|+||.||+|++...     +..||||++.....   .+.+.+|+++++++..|++|..+..+......
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            46788999999999999999987433     34799998865433   24588999999999734444445445566778


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-----------------------------------------------------------   97 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (404)
                      .+++|||+ +++|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            89999999 899999886421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           98 ------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        98 ------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                                                          ..+++.+++.++.||+.||+|||+++|+||||||+|||+   +.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence                                                237888899999999999999999999999999999999   57


Q ss_pred             CCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 015592          142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT  220 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~  220 (404)
                      ++.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            889999999999865443211     12234457788999999999889999999999999999997 999998754322


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      .  .+..+.... .   ...+..+|.++.+++.+||+.||++||++.+|.+.|+.++
T Consensus       348 ~--~~~~~~~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 T--FYNKIKSGY-R---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H--HHHHHhcCC-C---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1  122222211 1   1223467899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.9e-42  Score=330.65  Aligned_cols=251  Identities=20%  Similarity=0.228  Sum_probs=198.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----   74 (404)
                      .+.++|++.+.||+|+||.||++.+..+++.||||.+.....    ...+.+|+.+++.++|++++..+..+...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            356899999999999999999999999999999998764322    24577899999999999888887766432     


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||++++|.+.+.   ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccc
Confidence            23579999999888888775   358999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ......        ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.....   .+..+......
T Consensus       168 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~  236 (355)
T cd07874         168 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGT  236 (355)
T ss_pred             cCCCcc--------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence            654332        1234578999999999999999999999999999999999999998743211   11111110000


Q ss_pred             c-------------------------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 T-------------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ~-------------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .                                     .........+.+++++|.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            0                                     000011123567899999999999999999887654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.6e-42  Score=315.55  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=205.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ..+|++.+.||+|+||.||++..  .+..|++|..+.....+.+.+|+.+++.++|++++..+..+...+...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            35799999999999999999985  4788999998766666678999999999999888887776666667789999999


Q ss_pred             -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 -~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                       +++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC---
Confidence             7899999875433 48999999999999999999999999999999999999   578899999999987554322   


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.....   .+....+.....    .....
T Consensus       157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~  222 (256)
T cd05082         157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYK----MDAPD  222 (256)
T ss_pred             -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC----CCCCC
Confidence                   12344668999999998889999999999999999997 9999976432   233333322211    12335


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+|+.+.+++.+||+.+|++||++.++.+.|++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-41  Score=349.64  Aligned_cols=254  Identities=20%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeee-eCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~   77 (404)
                      ....++|+++++||+|+||+||+|++..+++.||+|++.....    ...+..|+.+++.|+|++++.++..+.. ....
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            3456789999999999999999999999999999998765432    2358889999999999998888876643 4567


Q ss_pred             EEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcccccCC-------
Q 015592           78 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG-------  139 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-------givHrDlKp~NILl~~~-------  139 (404)
                      .+|+|||+ +++|.+++...   ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999 78999998743   34699999999999999999999984       49999999999999531       


Q ss_pred             -------CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCC
Q 015592          140 -------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGS  210 (404)
Q Consensus       140 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~  210 (404)
                             +....+||+|||++..+.....        .....||+.|+|||++.+  ..++.++||||||||||||++|+
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                   1234589999999986543321        234579999999999865  34899999999999999999999


Q ss_pred             CCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       211 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .||.....  ..+.+..+.... ..    ....++.++.+||..||..+|++||++.+++.
T Consensus       241 ~PF~~~~~--~~qli~~lk~~p-~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANN--FSQLISELKRGP-DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCc--HHHHHHHHhcCC-CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99976432  222232222211 11    11356899999999999999999999887763

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3e-42  Score=332.89  Aligned_cols=249  Identities=20%  Similarity=0.266  Sum_probs=199.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...     .....+..|+.+++.++|++++..+ .+...+...++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~-~~~~~~~~~~l  120 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYM  120 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE-EEEecCCEEEE
Confidence            46799999999999999999999999999999987542     1223467899999999877766655 44556778999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence            99999 8999999873  468999999999999999999999999999999999999   68899999999999866433


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ...      ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+...   ...+.++.......
T Consensus       196 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~  266 (370)
T cd05596         196 GMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSL  266 (370)
T ss_pred             Ccc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcC
Confidence            210      12345799999999998754    378999999999999999999999987433   34445544322111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK  270 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~l~  270 (404)
                      ..+. ...++.++.++|.+||+.+|++  |++++++.
T Consensus       267 ~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell  302 (370)
T cd05596         267 TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIK  302 (370)
T ss_pred             CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence            1111 1247899999999999999987  99977654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-42  Score=324.74  Aligned_cols=233  Identities=20%  Similarity=0.286  Sum_probs=189.9

Q ss_pred             eeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++.||+|+||.||++++.   .+++.||||++....      ....+..|+.+++.++|++++..+..+ ..+...+++|
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-QTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-ecCCeEEEEE
Confidence            368999999999999864   478899999876421      223467899999999988877766555 4556789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence            998 8899999874 5568999999999999999999999999999999999999   6788999999999875433221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+.....     .++
T Consensus       156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~-----~~~  220 (323)
T cd05584         156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKL-----NLP  220 (323)
T ss_pred             -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence                   1234578999999999999889999999999999999999999998743   2333444433322     234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCC
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP  264 (404)
                      ..+++++.+++.+||+.||++||
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~  243 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRL  243 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcC
Confidence            56789999999999999999999

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-42  Score=319.48  Aligned_cols=247  Identities=18%  Similarity=0.211  Sum_probs=192.2

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||+|+||+||++.+..+++.||+|++.....     .+.+..|+++++.++|++++.. ..+.......+++|||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~-~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeee-eEEEcCCCeEEEEEeCCCCCC
Confidence            7999999999999999999999998754321     2346789999999976665554 44445667789999998 889


Q ss_pred             HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           89 LEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        89 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      |.+++..   .+..+++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++..+.....    
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~----  152 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS----  152 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence            9888753   23469999999999999999999999999999999999999   5788999999999976654322    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-HHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+...     ...++..+
T Consensus       153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  224 (280)
T cd05608         153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----SVTYPDKF  224 (280)
T ss_pred             ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----CCCCcccC
Confidence               123457899999999999999999999999999999999999999864432211 112222111     11233568


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHH--HHHHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLF  277 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~--l~~~l~~~~  277 (404)
                      ++++.+++.+||+.||++||++++  +.+++++.+
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            899999999999999999996542  334444433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.2e-42  Score=341.06  Aligned_cols=249  Identities=18%  Similarity=0.228  Sum_probs=202.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCC-CcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+......  ..+.+|+.+++.++|++++..+..+ ......+++||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-KSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-EECCEEEEEEE
Confidence            4599999999999999999998877 788999976543322  3467899999999988777766654 56678899999


Q ss_pred             cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+ +++|.+++...   ...+++.++..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCc
Confidence            99 89999887632   3468999999999999999999999999999999999999   67889999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ..+.+..+......    .
T Consensus       223 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~  290 (478)
T PTZ00267        223 VSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYD----P  290 (478)
T ss_pred             ccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----C
Confidence            211     12345679999999999999999999999999999999999999997643   33334444333222    2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .+..+++++.++|.+||..||++||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            33467899999999999999999999988753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.5e-42  Score=330.68  Aligned_cols=253  Identities=20%  Similarity=0.234  Sum_probs=197.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC----CeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~~~   79 (404)
                      +|++.+.||+|+||.||+|++..+++.||||.+....    ....+.+|+.+++.++|++++..+..+....    ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4889999999999999999999999999999875432    2245788999999999988888776665433    2679


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccC
Confidence            9999999899988863 5679999999999999999999999999999999999999   67889999999999865432


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh--------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--------  230 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------  230 (404)
                      ...      ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.....        
T Consensus       157 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         157 ESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            211      122346789999999998754 79999999999999999999999987544322222211100        


Q ss_pred             ------------hcc-cccHh---HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          231 ------------KKV-STSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       231 ------------~~~-~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                  ... .....   .+....++++.+||.+||+.||++||++.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  286 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL  286 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence                        000 00000   12234578999999999999999999987653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-42  Score=333.41  Aligned_cols=258  Identities=21%  Similarity=0.237  Sum_probs=196.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+|+++++||+|+||+||+|++..+++.||+|++....     ....+..|+.+++.++|++++..+.. .......+++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~-~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYS-FQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEE-EEeCCEEEEE
Confidence            36999999999999999999999999999999876432     23457889999999988776665544 4567789999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence            9999 8899999875 4568999999999999999999999999999999999999   688999999999986432110


Q ss_pred             Cccc----------------------------------------ccccCCCCCccCcCccccccccCCCCCchhHHHHHH
Q 015592          161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG  200 (404)
Q Consensus       161 ~~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG  200 (404)
                      ....                                        ..........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0000                                        000011235799999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       201 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      |+||||++|+.||.+...   .+....+.........+ ....+++++.++|.+|+ .+|++|++...+.++++
T Consensus       236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999987433   23333332211111111 11356889999998876 59999998333333333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-42  Score=332.11  Aligned_cols=256  Identities=16%  Similarity=0.197  Sum_probs=201.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+..+|++.+.||.|+||.||++...  .+++.|++|.+...   ....+|+++++.++|++++..+..+ ......+++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~~~lv  164 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAY-RWKSTVCMV  164 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeE-eeCCEEEEE
Confidence            35568999999999999999999754  35678999987543   3467899999999988877776555 456678999


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |++++++|.+++. ....+++.+++.|+.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.+.....
T Consensus       165 ~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        165 MPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             ehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcccc
Confidence            9999999999985 35679999999999999999999999999999999999999   6888999999999976654322


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------  235 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------  235 (404)
                      .     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+.......      
T Consensus       241 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        241 T-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             c-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            1     12235679999999999999999999999999999999999999998765543333332222110000      


Q ss_pred             ---------------------cHhHh--hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          236 ---------------------SIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       236 ---------------------~~~~~--~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                                           ..+..  ...++.++.++|.+||..||++||++.+++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                 00000  12456789999999999999999998876543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.7e-42  Score=324.46  Aligned_cols=235  Identities=23%  Similarity=0.265  Sum_probs=188.5

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||.||+|++..+++.||+|++....     ....+..|.. +++.++|++++..+ .+....+..+++|||+ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~-~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH-YSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCcccee-eEEEcCCEEEEEEcCCC
Confidence            47999999999999999999999999876432     1223455554 56777777666654 4456677889999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~----  151 (321)
T cd05603          80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE----  151 (321)
T ss_pred             CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence            8899888864 5579999999999999999999999999999999999999   6788999999999875332211    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+   ..+.+..+.....     .++...+
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~  220 (321)
T cd05603         152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPL-----QLPGGKT  220 (321)
T ss_pred             ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCC
Confidence               2234578999999999999889999999999999999999999998743   3344444443322     2335678


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      .++.+++.+||+.||.+||+..
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            8999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-42  Score=325.70  Aligned_cols=235  Identities=21%  Similarity=0.250  Sum_probs=187.7

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKL-YKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||+||+|++..+++.||+|++....     ....+..|..+ ++.++|++++..+ .........+++|||+ 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~-~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEE-EEEecCCEEEEEEcCCC
Confidence            46999999999999999999999999876432     12234555554 5567776666554 4445677889999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~----  151 (325)
T cd05604          80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD----  151 (325)
T ss_pred             CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence            8899888874 5679999999999999999999999999999999999999   6788999999999875332211    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||...+   ..+.+..+.....     .+...++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~  220 (325)
T cd05604         152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPL-----VLRPGAS  220 (325)
T ss_pred             ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCc-----cCCCCCC
Confidence               1235579999999999999999999999999999999999999998743   3334444433322     2234678


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      .++.+++.+||..+|.+||++.
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCC
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-42  Score=328.36  Aligned_cols=238  Identities=19%  Similarity=0.259  Sum_probs=191.6

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||++++..+++.||+|++....     ....+..|+++++.++|++++.. ..+.......+++|||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~-~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCce-EEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346778899999887765554 44556677889999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      ++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----  151 (325)
T cd05594          80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA----  151 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence            899888874 4579999999999999999999997 799999999999999   6788999999999875432221    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ......+.....     .++..++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~  220 (325)
T cd05594         152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLS  220 (325)
T ss_pred             ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCC
Confidence               12345799999999999999999999999999999999999999977432   233333322221     2345688


Q ss_pred             HHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015592          246 TEFASYFHYCRSLRFDDKP-----DYAYLK  270 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP-----~~~~l~  270 (404)
                      +++.+++.+||+.||++|+     ++.++.
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il  250 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIM  250 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence            9999999999999999997     665554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-42  Score=326.67  Aligned_cols=260  Identities=20%  Similarity=0.287  Sum_probs=203.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEE-----cCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcC-CCCCCceeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQG-GTGIPNLRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~   76 (404)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||+++.....   ..+.+|+.++..+.+ ++++..+..+...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999985     346789999998754332   347789999999965 455555566666677


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------   97 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~----------------------------------------------------------   97 (404)
                      ..+++|||+ +++|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            889999999 899999986421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccC
Q 015592           98 --------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE  169 (404)
Q Consensus        98 --------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  169 (404)
                              ..+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++........     ..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~  237 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VR  237 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcch-----hh
Confidence                    236788899999999999999999999999999999999   57889999999999765432211     11


Q ss_pred             CCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHH
Q 015592          170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (404)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....  .....+.....    ...+..+++++
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~  311 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR----MRAPDYTTPEM  311 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHhccCC----CCCCCCCCHHH
Confidence            223445678999999998889999999999999999997 999997743321  11222211111    11223467899


Q ss_pred             HHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          249 ASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+++..||+.||++||++.+|++.|+.++..
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-41  Score=312.95  Aligned_cols=255  Identities=20%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ..+|++.++||+|+||.||+|.+..+++.||+|+...... ...+.+|+++++.++|++++..+..+ ......+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-cCCCCcEEEEEe
Confidence            4569999999999999999999999999999998765432 34688999999999988777766554 445667899998


Q ss_pred             c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||+   ++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccceee
Confidence            8 88999998753 3458999999999999999999999999999999999999   57889999999999876543211


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                            ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...   .+....+.... .   ...+
T Consensus       161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~  227 (263)
T cd05052         161 ------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGY-R---MERP  227 (263)
T ss_pred             ------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC-C---CCCC
Confidence                  1122344678999999999899999999999999999998 9999987433   22233322211 1   1234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..+|.++.+++.+||+.||++||++.++.+.|+.++
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            568899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-42  Score=315.82  Aligned_cols=256  Identities=18%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .....++|++.+.||+|+||.||+|++..+++.||+|+......  ...+.+|+.+++.++|++++..+..+ ......+
T Consensus         4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-~~~~~~~   82 (267)
T cd06646           4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-LSREKLW   82 (267)
T ss_pred             ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-EeCCEEE
Confidence            44556789999999999999999999999999999998865432  33577899999999988877766554 4567789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence            999999 7899998874 4579999999999999999999999999999999999999   5788899999999986643


Q ss_pred             cCCcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ...       ......|+..|+|||.+.   ...++.++|||||||++|||++|..||........   ...+.......
T Consensus       159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~  228 (267)
T cd06646         159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMSKSNFQP  228 (267)
T ss_pred             ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heeeecCCCCC
Confidence            221       123456889999999985   34478899999999999999999999976433211   11111111111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ........++..+.+++.+||..+|++||++++|++.
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            1111223568899999999999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.1e-41  Score=319.21  Aligned_cols=256  Identities=18%  Similarity=0.221  Sum_probs=194.0

Q ss_pred             eeeeceeCceeEEEEEEc--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEEEEEeccCCC
Q 015592           12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPS   88 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~~~s   88 (404)
                      +++||+|+||+||+|++.  .+++.||+|.+........+.+|+.+++.++|++++..+..+.. .+...+++|||++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            568999999999999965  46789999998766666678999999999999998888776643 455688999999999


Q ss_pred             HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCCeEEEEecCCccccccc
Q 015592           89 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        89 L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~-~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.+...
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence            999886421        248999999999999999999999999999999999999432 35678999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh------HHHHHHHhhhc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK  232 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~~  232 (404)
                      ..    +........||+.|+|||++.+. .++.++|||||||++|||++|+.||........      ...+..+....
T Consensus       166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            21    11123456789999999999874 589999999999999999999999975332110      11111111000


Q ss_pred             c-------------c--------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 V-------------S--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ~-------------~--------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .             .                    ...+......+.++.+||.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0             0                    0000001123457889999999999999999987753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-41  Score=317.74  Aligned_cols=257  Identities=19%  Similarity=0.272  Sum_probs=202.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCc--EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++....   .+.+.+|+.++.++.+|+++..+..+.......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999877664  468887653222   245788999999996555555555555666778999


Q ss_pred             Eecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           82 IDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      |||+ +++|.+++....               ..+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence            9998 889999996422               248899999999999999999999999999999999999   578899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      ||+|||++.......        .......+..|+|||++.+..++.++|||||||++|||++ |..||.+...   ...
T Consensus       159 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~  227 (297)
T cd05089         159 KIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL  227 (297)
T ss_pred             EECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            999999986432211        1112233567999999998889999999999999999997 9999987543   223


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ...+.....    ...+..++.++.+++.+||+.+|.+||+++++.+.|+.++....
T Consensus       228 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         228 YEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            333322211    12234678999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.6e-42  Score=316.63  Aligned_cols=240  Identities=19%  Similarity=0.214  Sum_probs=190.0

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||+|+||.||++++..+++.||+|.+....     ....+..|+++++.++|++++..+. +...+...+++|||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~-~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY-AFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEE-EEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999875422     1234567999999998777665544 445667889999999 889


Q ss_pred             HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccc
Q 015592           89 LEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY  167 (404)
Q Consensus        89 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~  167 (404)
                      |.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++|+|||++........      
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------  150 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------  150 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence            99888643 3358999999999999999999999999999999999999   5788999999999976654321      


Q ss_pred             cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhhcccccHhHhhcCCcH
Q 015592          168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        .....|+..|+|||++.+..++.++|||||||++|||++|+.||.+...... .+..........    ......+++
T Consensus       151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  224 (277)
T cd05607         151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KFEHQNFTE  224 (277)
T ss_pred             --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----ccccccCCH
Confidence              1234689999999999998899999999999999999999999976433211 122222222111    111235789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ++.+++.+||+.||++||++.++.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccch
Confidence            999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.4e-42  Score=330.87  Aligned_cols=271  Identities=19%  Similarity=0.264  Sum_probs=206.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|+.++..++|++++..+.. .......+++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-FQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-EEcCCEEEEE
Confidence            4799999999999999999999999999999987642     223457789999999988776665544 4566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence            9999 8899999874 4579999999999999999999999999999999999999   678999999999987654321


Q ss_pred             Ccccc----------------------------cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 015592          161 THQHI----------------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (404)
Q Consensus       161 ~~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P  212 (404)
                      .....                            ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            10000                            00011245799999999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccc
Q 015592          213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI  292 (404)
Q Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~  292 (404)
                      |.+...   ...+..+.........+. ...++++++++|.+|+ .||.+|++...+.+++.+       +|...++|..
T Consensus       236 f~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h-------p~f~~~~~~~  303 (360)
T cd05627         236 FCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH-------PFFEGVDWGH  303 (360)
T ss_pred             CCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC-------CCCCCCCHHH
Confidence            987443   333344332111111111 1136789999999977 499999975544444433       4455567876


Q ss_pred             cc
Q 015592          293 LK  294 (404)
Q Consensus       293 ~~  294 (404)
                      ..
T Consensus       304 ~~  305 (360)
T cd05627         304 IR  305 (360)
T ss_pred             Hh
Confidence            53

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.8e-42  Score=317.31  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|.+.+.||+|+||.||+|++..     +++.||||+++.....   +.+.+|+++++.++|++++..+..+ .....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-TEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-ecCCC
Confidence            4679999999999999999998743     3578999987654433   4688999999999987766655544 45577


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~  143 (404)
                      .+++|||+ +++|.+++...+             ..+++..+..++.|++.||.|||++|++||||||+||++   +.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence            89999998 899999997532             347899999999999999999999999999999999999   5789


Q ss_pred             eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 015592          144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK  222 (404)
Q Consensus       144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~  222 (404)
                      .+||+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...   .
T Consensus       160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~  231 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E  231 (280)
T ss_pred             eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence            9999999999755332210     11233456788999999999999999999999999999998 9999987543   2


Q ss_pred             HHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      .....+......    .....++.++.+++.+||+.||++||++.++.+.|+
T Consensus       232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 EVIECITQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            333333332222    223467899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.3e-42  Score=330.90  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=197.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||.||++++..+++.||+|++....     ....+..|+.+++.++|++++..+.. ...+...+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-FQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-EEcCCEEE
Confidence            4578999999999999999999999999999999875421     22347789999999988777766544 45677899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence            999999 8999999973  468999999999999999999999999999999999999   6889999999999987643


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ...      .......||+.|+|||++.+..    ++.++|||||||+||||++|+.||.+..   ....+..+......
T Consensus       195 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~~  265 (370)
T cd05621         195 TGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKNS  265 (370)
T ss_pred             CCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Confidence            321      1123567999999999997643    7899999999999999999999998743   34444554432221


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKR  271 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~l~~  271 (404)
                      ...+. ...++..+++++..||..++.+  |+++.++++
T Consensus       266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            11111 1246889999999999855443  777665543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-41  Score=317.73  Aligned_cols=255  Identities=18%  Similarity=0.247  Sum_probs=200.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      -++|++.+.||.|+||.||+|++..+++.||+|.+.....   ...+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-ecCCeEEEEE
Confidence            4679999999999999999999999999999998764332   23577899999999988777666554 4667889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+.++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC-
Confidence            999889999988666679999999999999999999999999999999999999   6788999999999975443221 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------  232 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  232 (404)
                            ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..+....         
T Consensus       160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence                  12234678999999998764 47899999999999999999999998754322211111111000         


Q ss_pred             -------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ...........+++++.+||.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                         000111223457889999999999999999999887654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-41  Score=314.90  Aligned_cols=257  Identities=19%  Similarity=0.219  Sum_probs=200.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      -.++|++.+.||+|+||+||+|.+..+++    .+++|.+.....   ...+..|+.++..+.|++++..+..+.  +..
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GAS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCc
Confidence            34689999999999999999999877776    477777654322   234666777888888888777766543  334


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++++|+ +++|.+++......+++..++.|+.||+.||+|||++|++||||||+|||+   +.++.+||+|||+++..
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            56677776 899999998666779999999999999999999999999999999999999   67889999999999865


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .......     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....    +..+.......
T Consensus       160 ~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~~  230 (279)
T cd05111         160 YPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKGERL  230 (279)
T ss_pred             cCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCCCcC
Confidence            4332111     1223456788999999998889999999999999999998 999998754321    22222211111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                         .....++..+.+++.+||..||++||++.++.+.|..+..
T Consensus       231 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ---AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               1223467889999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-41  Score=312.11  Aligned_cols=248  Identities=20%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             eeceeCceeEEEEEEc--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CC
Q 015592           14 KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP   87 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   87 (404)
                      .||+|+||.||+|.+.  .++..||+|+......   .+.+.+|+.+++.++|++++..+..+.  ....+++|||+ ++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence            4899999999999875  4456799998765433   245889999999999988888776553  34678999998 88


Q ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccc
Q 015592           88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY  167 (404)
Q Consensus        88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~  167 (404)
                      +|.+++......+++..++.++.|++.||.|||++|++||||||+|||+   +.++.+||+|||+++.+.......    
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----  152 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYY----  152 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccce----
Confidence            9999997656679999999999999999999999999999999999999   578899999999998654332110    


Q ss_pred             cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+   ....+.....    ...+..+++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~  225 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQGKR----LDCPAECPP  225 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCCC----CCCCCCCCH
Confidence            11112234678999999998889999999999999999996 999998754422   2222222211    123356789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ++.+++.+||..||++||++.+|.+.|+..+
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=349.20  Aligned_cols=257  Identities=20%  Similarity=0.266  Sum_probs=211.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCC-----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+.++.+.||+|.||+||+|+.....     ..||||.++....   ..+|.+|..+|+.++|+|++..++.+.. ....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCc
Confidence            56788999999999999999875432     3488887665433   3458999999999999999999988877 5666


Q ss_pred             EEEEecc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           79 VLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      +|++||+ ||+|..+|++.      ...++..+.+.++.|||+|++||+++++|||||..+|+||   +....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcccc
Confidence            7888888 99999999976      4569999999999999999999999999999999999999   577999999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      +|+.+-....     |+......-..+|||||.+....++.|+|||||||+|||++| |..||.+..+.+..   ..+.+
T Consensus       848 lArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~---~~~~~  919 (1025)
T KOG1095|consen  848 LARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL---LDVLE  919 (1025)
T ss_pred             hhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH---HHHHh
Confidence            9995444332     333333234578999999999999999999999999999999 99999986653333   22222


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..    .-..+..||..+.++|.+||+.+|++||+|..|++.+..+...
T Consensus       920 gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  920 GG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            22    1223468999999999999999999999999999988887754

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=326.91  Aligned_cols=235  Identities=20%  Similarity=0.245  Sum_probs=186.5

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      ||+|+||+||+|++..+++.||||++....     .......|..++..+.  +++++..+..........+++|||+ +
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999875432     1123445667776654  5666666666667778899999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~-----  151 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK-----  151 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence            899988874 5679999999999999999999999999999999999999   5788999999999875433221     


Q ss_pred             ccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          167 YRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                        ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ..+.+..+.......+    ...++
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~  222 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS  222 (330)
T ss_pred             --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence              223567999999999997654 8999999999999999999999998733   3344444443322211    12468


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      +++.+++.+||+.||++||++.
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCC
Confidence            9999999999999999999643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-41  Score=334.48  Aligned_cols=254  Identities=20%  Similarity=0.233  Sum_probs=197.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..+..|.+.+.||+|+||.||+|.+..+++.||||...    ...+.+|++++++|+|++++..+.. ...+...+++|+
T Consensus       166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~-~~~~~~~~lv~e  240 (461)
T PHA03211        166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDV-RVVGGLTCLVLP  240 (461)
T ss_pred             cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEE-EEECCEEEEEEE
Confidence            34678999999999999999999999999999999532    3356789999999998887776654 455677889999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      ++.++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.+.......
T Consensus       241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccccc
Confidence            99889999987655679999999999999999999999999999999999999   577899999999998664432110


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-----ChHHHHHHHhhhccc----
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVS----  234 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~~~----  234 (404)
                           ......||..|+|||++.+..++.++|||||||+||||++|..|+......     ...+....+......    
T Consensus       318 -----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        318 -----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             -----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence                 123457999999999999999999999999999999999987765432211     011111111111100    


Q ss_pred             -c-------------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 -T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 -~-------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       .                         ....+ ..++.++.+||.+||+.||.+||++.++++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence             0                         00000 134568999999999999999999887754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.5e-42  Score=329.39  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=195.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....     ....+.+|+.+++.++|++++..+.. ...+...+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-FQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEcCCEEE
Confidence            3578999999999999999999999999999999875421     12346788999999887777665544 45677899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       120 lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCc
Confidence            999999 8899999874  468999999999999999999999999999999999999   5788999999999986653


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ...      .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+   ....+.++......
T Consensus       195 ~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~  265 (371)
T cd05622         195 EGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNS  265 (371)
T ss_pred             CCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCc
Confidence            321      1123567999999999997643    7899999999999999999999998743   34445555433211


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCC---CCCHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLK  270 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~---RP~~~~l~  270 (404)
                      ...+ ....++.+++++|..||. +|..   |+++.++.
T Consensus       266 ~~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~  302 (371)
T cd05622         266 LTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK  302 (371)
T ss_pred             ccCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence            1111 123578999999999998 5555   45554443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-41  Score=309.87  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=200.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ++|++.+.||+|+||.||++++. .+..+|+|.+..... ..++.+|+.+++.++|++++..+.. +......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV-CTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEE-EccCCCEEEEEEcC
Confidence            57999999999999999999874 556899998764433 4578899999999998777766554 45566789999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||.++........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT--  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee--
Confidence             899999997555578999999999999999999999999999999999999   57889999999999765432211  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                          ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   .+.+..+......    ..+..
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~  225 (256)
T cd05114         157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRL----YRPKL  225 (256)
T ss_pred             ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCC
Confidence                1123345678999999998889999999999999999999 9999976432   3334444332211    11234


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .+.++.+++.+||..+|++||+++++.+.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            678999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-41  Score=312.55  Aligned_cols=253  Identities=20%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -.++|++.++||+|+||.||+|.+ .++..||+|.+.... ..+.+.+|+.+++.++|++++..+..+ ......+++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-TKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCCcEEEEe
Confidence            357899999999999999999996 466789999876433 345688999999999988777665444 45667899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||++   +.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCce
Confidence            98 88999998743 4568999999999999999999999999999999999999   5788999999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .....+......    ..
T Consensus       159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~----~~  225 (261)
T cd05072         159 T------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGYRM----PR  225 (261)
T ss_pred             e------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCC----CC
Confidence            1      1123345778999999998889999999999999999998 99999774432   223333222111    12


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      ...+|.++.+++.+||+.+|++||+++++.++|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            24578999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.4e-41  Score=312.71  Aligned_cols=253  Identities=18%  Similarity=0.318  Sum_probs=199.7

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCc--EEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee-----CCe
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDY   77 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~~~   77 (404)
                      |.++++||+|+||.||+|.+..++.  .||+|.++...    ....+..|+.+++.++|++++..+..+...     ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999877665  68999876542    234578899999999988888877654321     234


Q ss_pred             EEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           78 NVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      .+++|+|+ +++|.+++...     ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence            68888888 78999887422     2348999999999999999999999999999999999999   578899999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      +++.+......     .......+++.|++||.+.+..++.++|||||||++|||++ |+.||.+...   .+.+..+..
T Consensus       158 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ  229 (272)
T ss_pred             cccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence            99876543211     11223346778999999999899999999999999999999 8999977432   333333333


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ...    ......++..+.+++.+||+.||++||++.+|.+.|+++
T Consensus       230 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            221    122346789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.2e-43  Score=302.94  Aligned_cols=250  Identities=20%  Similarity=0.239  Sum_probs=213.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      -++|.-.+.||.|..++|-++.++.+++++|+|++.....          .+.-..|+.||+++.+|+.|..+..+.+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            3568888999999999999999999999999998765322          123567999999999999998888888888


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...++|+|++ .|.|.|++.. .-.+++++..+|+.|+.+|++|||.++||||||||+|||+   +++.++||+|||+++
T Consensus        96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence            8999999999 8999999984 5579999999999999999999999999999999999999   789999999999999


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      .+....        .....+|||+|+|||.+..      ..|+..+|+||+|||||.|+.|.+||...   .....+..|
T Consensus       172 ~l~~Ge--------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~I  240 (411)
T KOG0599|consen  172 QLEPGE--------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRMI  240 (411)
T ss_pred             ccCCch--------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHHH
Confidence            887654        3457899999999999863      23889999999999999999999999873   234445667


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++++.....++. .+++...++||.+||+.||.+|.|+.+.+.
T Consensus       241 meGkyqF~speW-adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGKYQFRSPEW-ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HhcccccCCcch-hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            777665544443 578899999999999999999999887643

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-41  Score=313.84  Aligned_cols=260  Identities=20%  Similarity=0.303  Sum_probs=209.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcC----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      +-.++|++.+.||+|+||.||+|.+..    ++..|++|.+.....   ...+.+|+.+++.++|++++..+..+...+.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            346789999999999999999999865    368899998764432   2347789999999999888888777666677


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEE
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                      ..+++++++ +++|.+++....       ..+++.+++.++.|++.||+|||+++++||||||+||++   +.++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEEC
Confidence            788999998 789999987532       358999999999999999999999999999999999999   577999999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~  227 (404)
                      |||+++.+.......     ......++..|+|||++.+..++.++|||||||++||+++ |+.||.....   ......
T Consensus       160 d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~  231 (280)
T cd05043         160 DNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY  231 (280)
T ss_pred             CCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH
Confidence            999998665432211     1123345778999999998889999999999999999999 9999987543   222222


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +.... ..   .....+|+++.+++.+||..||++||++.++.+.|+++..
T Consensus       232 ~~~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         232 LKDGY-RL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHcCC-CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22211 11   1123578999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=324.76  Aligned_cols=260  Identities=22%  Similarity=0.303  Sum_probs=202.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|.-...||+|+||.||+|.- .++..||||.+.....  ..+|..|+.++.+++|+|++..+++|...+...+||+|
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            36788889999999999999996 4558999998776655  46699999999999988888777777655546899999


Q ss_pred             cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      |+ +|+|.+.+..... .++|...++|+.++|.||+|||..   .||||||||+||||   |.+..+||+|||+|+....
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence            99 8899999985444 899999999999999999999984   49999999999999   7999999999999965543


Q ss_pred             -cCCcccccccCCCCC-ccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh---HHH-HHHHhhhc
Q 015592          159 -TATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQK-YEKISEKK  232 (404)
Q Consensus       159 -~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~---~~~-~~~~~~~~  232 (404)
                       ...        .... .||..|+|||++..+..+.|+|||||||+|.||+||+.|.+.......   ... ...+....
T Consensus       230 ~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~  301 (361)
T KOG1187|consen  230 GDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK  301 (361)
T ss_pred             cccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence             221        1112 799999999999988999999999999999999999998875432111   111 11111111


Q ss_pred             ccccHhHh-h-cCCc-----HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          233 VSTSIEAL-C-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       233 ~~~~~~~~-~-~~~~-----~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ....++.. . ..++     ..+..+..+|++.+|.+||++.++.+.|+.+.
T Consensus       302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            11111111 1 1233     23667888999999999999999988885543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=314.73  Aligned_cols=255  Identities=20%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      +..++|++.+.||+|+||.||+|.+..     ++..||||++.....   ...+.+|+.+++.++|++++..+.. ...+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV-VSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE-EcCC
Confidence            467899999999999999999998642     356899998754332   2347889999999998877766544 4566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      ...+++|||+ +++|.+++....         ..+++..+..++.|++.||+|||++|++||||||+|||+   +.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence            6789999998 889999987432         235788899999999999999999999999999999999   578899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      +|+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...   ...
T Consensus       159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~  230 (277)
T cd05062         159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV  230 (277)
T ss_pred             EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            99999999765443221     11223355788999999999889999999999999999999 7999987543   222


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ...+.....    ...+..++..+.+++.+||+.||++||++.++.+.|+
T Consensus       231 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            333322222    1233567899999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=312.99  Aligned_cols=253  Identities=18%  Similarity=0.339  Sum_probs=201.4

Q ss_pred             eEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC-----C
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D   76 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----~   76 (404)
                      |++.+.||+|+||.||+|.+..+   +..||+|.++.....    ..+..|+.+++.++|++++..+..+....     .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987643   478999987754332    35788999999999888877765554332     2


Q ss_pred             eEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      ..+++|||+ +++|..++...     ...+++..++.++.|++.||+|||+++|+||||||+||++   ++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence            478999998 88999988532     2358999999999999999999999999999999999999   57889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHh
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      |+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...   .+.+..+.
T Consensus       158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~  229 (273)
T cd05035         158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR  229 (273)
T ss_pred             cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            999866543321     11222345678999999988889999999999999999999 9999977443   23333333


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ....    ...+..++.++.+++.+||+.||++||++.++.+.|+++
T Consensus       230 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HGNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2221    223456889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.5e-41  Score=309.80  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=202.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.++||+|+||.||+|.+..+ ..+|+|....... .+.+.+|+++++.++|+++++.+..+.  ....+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e   80 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTE   80 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEE
Confidence            357899999999999999999997554 4699998765433 356889999999999998887765553  445789999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCcc
Confidence            98 67999999753 3358999999999999999999999999999999999999   6788999999999976543221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   .....+.... .   ...
T Consensus       158 ------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~-~---~~~  224 (260)
T cd05069         158 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVERGY-R---MPC  224 (260)
T ss_pred             ------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC-C---CCC
Confidence                  11223346778999999998889999999999999999999 99999875432   2233332221 1   122


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      +..+|..+.+++.+||.+||++||+++++.+.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.7e-41  Score=309.98  Aligned_cols=246  Identities=20%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             eeceeCceeEEEEEE--cCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           14 KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      .||+|+||.||+|.+  ..+++.+|+|+++.....    +.+..|+.+++.++|++++..+..+  ..+..+++|||+ +
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--EAESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCcEEEEecCCC
Confidence            689999999999965  457889999988654432    3578899999999988877776554  345668899998 7


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.........   
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~---  152 (257)
T cd05116          80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY---  152 (257)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee---
Confidence            899999974 4579999999999999999999999999999999999999   578899999999998765432211   


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+.....    ...+..+|
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~----~~~~~~~~  224 (257)
T cd05116         153 -KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGER----MECPQRCP  224 (257)
T ss_pred             -eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCC----CCCCCCCC
Confidence             11122344678999999988889999999999999999998 9999987443   233333333221    12345689


Q ss_pred             HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      +++.++|.+||+.||++||++++|.+.|++.
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-41  Score=315.18  Aligned_cols=244  Identities=20%  Similarity=0.249  Sum_probs=195.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|+..+.||+|+||+||+|.+..+++.||+|++.....     ...+.+|+++++.++|++++..... ...++..+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYA-YETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEE-EecCCEEEEEE
Confidence            48889999999999999999999999999998764321     2346789999999988777665444 45566889999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++   +..+.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            988 78999888643 3469999999999999999999999999999999999999   577899999999997654322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.......+.   +... ........
T Consensus       157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~-~~~~~~~~  224 (285)
T cd05632         157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRR-VLETEEVY  224 (285)
T ss_pred             c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHh-hhcccccc
Confidence            1        1245789999999999998999999999999999999999999987443222122   2111 11111233


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ...++.++.+|+..||+.||++||++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            456889999999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.8e-41  Score=317.25  Aligned_cols=261  Identities=19%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC-------CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .++|.+.+.||+|+||.||++++..       +...+|+|++......   ..+..|+.+++.+..|+++..+..+....
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999998643       2357999988754322   35778999999995444555555555666


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~  139 (404)
                      ...+++|||+ +++|.+++....               ..+++.+++.++.|++.||+|||++|++||||||+|||+   
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill---  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE---
Confidence            7789999999 789999997532               248899999999999999999999999999999999999   


Q ss_pred             CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 015592          140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~  218 (404)
                      +.++.+||+|||+++.........     ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            577899999999997654322110     1122234578999999999889999999999999999998 8999976432


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                         .+....+.....    ...+..++.++.+++.+||..+|++||++.++.+.|++++...+
T Consensus       249 ---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         249 ---EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             ---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence               222333222221    12334678999999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=311.04  Aligned_cols=255  Identities=15%  Similarity=0.254  Sum_probs=204.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|++.+.||+|+||.||+|++..+   ...||||+++.....   ..+..|+.+++.++|++++..+..+ ......+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-TKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-ecCCceE
Confidence            36799999999999999999998644   457999987654332   3578899999999988776665544 4566789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..++.++.|++.||+|||+++|+||||||+|||+   +.++.++|+|||+++.+..
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence            999998 889999998666689999999999999999999999999999999999999   5788999999999987752


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....     ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .+....+......   
T Consensus       159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---  227 (266)
T cd05033         159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRL---  227 (266)
T ss_pred             cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence            22110     1112345678999999998889999999999999999998 9999976432   2233333322111   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       .....+|..+.+++.+||+.+|++||++.+|.+.|.++
T Consensus       228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             12346789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.6e-41  Score=309.40  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||.+.....     ...+.+|+.+++.++|++++..+..+ ......+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-IEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-EECCeEEEE
Confidence            689999999999999999999999999999997654221     23478899999999988877766554 455678899


Q ss_pred             Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +||+ +++|.+++...   ...+++..+..++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            9999 78999888632   3458999999999999999999999999999999999999   578889999999988665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..... ........+.......  
T Consensus       158 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~--  227 (267)
T cd08228         158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPP--  227 (267)
T ss_pred             chhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCC--
Confidence            4321       11245688999999999988899999999999999999999999976432 2222233332222111  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       .....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus       228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             11234678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-41  Score=314.62  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEc----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+|++.+.||+|+||.||+|.+.    .+++.|++|.+......   ..+.+|+.+++.++|++++..+.. ...+...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGV-VTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEE-EecCCceE
Confidence            57999999999999999999853    35678999987643322   357889999999998877766554 45566789


Q ss_pred             EEEecc-CCCHHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           80 LVIDLL-GPSLEDLFNFCS----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      ++|||+ +++|.+++....                ..+++.+++.++.|++.||+|||++||+||||||+|||+   +.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence            999999 789999985321                247889999999999999999999999999999999999   577


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK  221 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~  221 (404)
                      +.+||+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...   
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---  232 (283)
T cd05090         161 LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---  232 (283)
T ss_pred             CcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            88999999999866433211     11233456778999999998889999999999999999998 9999987543   


Q ss_pred             HHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      ......+.....    ...+..+++++.+++.+||+.||++||++.+|.+.|+.
T Consensus       233 ~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            222222222221    22345688999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-41  Score=313.04  Aligned_cols=257  Identities=19%  Similarity=0.301  Sum_probs=201.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      -.++|++.+.||+|+||.||+|.+..     ++..|++|.......   ...+.+|+.+++.++|++++..+..+ .+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS-FERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCC
Confidence            45789999999999999999999877     778899998764332   23578899999999987766665544 4455


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      ..+++|||+ +++|.+++....      ..+++..++.++.||+.||+|||+++++||||||+|||++.......+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            678999998 899999997543      2489999999999999999999999999999999999996333345799999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHH
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ||+++........     ........+..|+|||++.+..++.++|||||||++|||++ |..||.+....   .....+
T Consensus       163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~  234 (277)
T cd05036         163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV  234 (277)
T ss_pred             CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            9999876432210     01122334568999999999899999999999999999997 99999874432   222222


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      .....    ...+..+|..+.+++.+||+.+|++||++.+|.+.|+
T Consensus       235 ~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22111    1234567899999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-41  Score=310.41  Aligned_cols=253  Identities=21%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.++||+|+||.||+|.+ .+++.||+|.+..... ...+.+|+.+++.++|++++..+..+  .....+++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~   79 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV--TQEPIYIIT   79 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE--ccCCcEEEE
Confidence            4567899999999999999999986 5678899998765443 34688999999999988777766543  345678999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |++ +++|.+++... +..+++.+++.++.|++.||+|||+.|++||||||+||++   +.++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCCC
Confidence            998 88999998643 3468999999999999999999999999999999999999   578899999999997665322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .      .......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....   .....+.....    ..
T Consensus       157 ~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~  223 (260)
T cd05067         157 Y------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGYR----MP  223 (260)
T ss_pred             c------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCCC----CC
Confidence            1      11223456778999999998889999999999999999999 99999875432   22222222211    12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+..+|.++.+++.+||..+|++||+++++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            234578899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.9e-41  Score=307.94  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=202.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....    .+.+..|+++++.++|++++..+..+.......+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            59999999999999999999999999999998765432    23578899999999988888776666555667899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++.+++.++.|++.||++||++||+||||||+||++   +..+.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence            98 78999998753 3458999999999999999999999999999999999999   5788999999999986644322


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......+++.|+|||++.+..++.++|||||||++|+|++|+.||....   .......+.....    ...+
T Consensus       158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~----~~~~  223 (257)
T cd08223         158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKL----PPMP  223 (257)
T ss_pred             -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCC----CCCc
Confidence                   2234568999999999999999999999999999999999999997633   2222223323222    1233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+++++.+++.+||+.||++||++.++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            567899999999999999999999887754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-41  Score=311.42  Aligned_cols=261  Identities=19%  Similarity=0.246  Sum_probs=210.1

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      |.....++|++.+.||+|+||.||+|.+..+++    .+|+|+.......   ..+.+|+.+++.++|++++..+..+..
T Consensus         1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            456678899999999999999999999876664    5899987655432   357889999999998888877766554


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                        ...+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~  155 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL  155 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence              5678889888 899999998666679999999999999999999999999999999999999   5788999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ++.........     ......++..|+|||.+.+..++.++|+|||||++||+++ |+.||.+....+   ....+...
T Consensus       156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~  227 (279)
T cd05057         156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKG  227 (279)
T ss_pred             cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCC
Confidence            98765332211     1112234678999999988889999999999999999998 999998754322   22222222


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..    ...+..++.++.+++.+||..+|++||++.++.+.|+++..
T Consensus       228 ~~----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 ER----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11    11223467899999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.3e-41  Score=308.90  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=201.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +|++.+.||.|+||.||++.+..+++.||+|.++...   ..+.+..|+.+++.++|++++..+. ........+++|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEE-EEEECCEEEEEEee
Confidence            5899999999999999999999999999999875433   2345788999999999877665554 44667788999999


Q ss_pred             c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||.+........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence            9 88999988643 3458999999999999999999999999999999999999   5788999999999976654322 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....   ....+..+.....    ..++.
T Consensus       156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~  222 (255)
T cd08219         156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSY----KPLPS  222 (255)
T ss_pred             ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCC----CCCCc
Confidence                  1234578899999999999889999999999999999999999997633   2333333332222    12334


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+.+++.+||+.||++||++.+|..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            57889999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-41  Score=308.65  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=203.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..++.+|+.++++++|++++..+. +.......+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYA-VCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeE-EEecCCCeeeeee
Confidence            3578999999999999999999974 567899998765433 356889999999999877666554 4556667899999


Q ss_pred             cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCcc
Confidence            99 999999997533 469999999999999999999999999999999999999   5788999999999987753321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .      .......+..|+|||.+.+..++.++||||||+++|||++ |+.||.+...   ...+..+......    ..
T Consensus       159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~  225 (261)
T cd05068         159 E------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYRM----PC  225 (261)
T ss_pred             c------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence            1      1112233468999999999889999999999999999999 9999987543   2223333222111    12


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      ...++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            24578999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-41  Score=313.96  Aligned_cols=243  Identities=21%  Similarity=0.252  Sum_probs=195.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|++.+.||+|+||.||++.+..+++.||||.+.....     ...+..|+.+++.++|++++..+..+ ......+++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-ETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-ecCCEEEEEE
Confidence            48899999999999999999999999999998754321     23467899999999988777665554 4556789999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++   +..+.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            998 88999988643 3359999999999999999999999999999999999999   578889999999987554322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....|+..|+|||++.+..++.++|||||||++|+|++|+.||..................    .....
T Consensus       157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~  224 (285)
T cd05630         157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY  224 (285)
T ss_pred             c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence            1        12347899999999999989999999999999999999999999875432222222222111    11223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      ...+++++.+++.+||+.||++||++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~  250 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGC  250 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCC
Confidence            45688999999999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.8e-41  Score=316.68  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=201.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcE--EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      -++|++.+.||+|+||.||+|++..++..  +++|......   ....+.+|+.++.++.+|+++..+..+.......++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            46899999999999999999998877765  4666554322   223577899999999555556566556667778899


Q ss_pred             EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe
Q 015592           81 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~  144 (404)
                      +|||+ +++|.+++....               ..+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence            99998 889999997432               257899999999999999999999999999999999999   57889


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ  223 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~  223 (404)
                      +||+|||+++......        ......++..|+|||.+.+..++.++|||||||++|||+| |..||.+....   +
T Consensus       163 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~  231 (303)
T cd05088         163 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E  231 (303)
T ss_pred             EEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence            9999999986332111        1112234678999999988889999999999999999998 99999765432   2


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ....+....    ....+..+++++.+++.+||+.+|++||+++++++.|..++....
T Consensus       232 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         232 LYEKLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHHhcCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            222222111    111223578899999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-41  Score=317.63  Aligned_cols=257  Identities=18%  Similarity=0.266  Sum_probs=200.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC----------------cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIP   66 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~   66 (404)
                      -++|++.+.||+|+||.||+|.+..++                ..||+|++.....   .+.+.+|+++++.++|++++.
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876543                5689998765432   345788999999999887776


Q ss_pred             ceeEeeeeCCeEEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        67 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      .+..+ ..+...+++||++ +++|.+++....          ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        84 ~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          84 LLGVC-TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEE-ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            65554 4456788999988 889999987543          26899999999999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW  213 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt--g~~Pf  213 (404)
                      +   +..+.++|+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++  |..||
T Consensus       163 i---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         163 V---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             e---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            9   57799999999999765443211     11234456788999999998889999999999999999998  78888


Q ss_pred             CCCCCCChHHHHHHHhhh---cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          214 QGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ......   +.+..+...   ............+|.++.+++.+||+.||++||++.+|.+.|+
T Consensus       235 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         235 EHLTDQ---QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCcChH---HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            764432   222222211   0111111123457889999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.1e-41  Score=312.96  Aligned_cols=258  Identities=23%  Similarity=0.322  Sum_probs=206.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++|.+.+.||+|+||.||++.+.     .++..+|+|.+.....  ...+.+|+.++++++|++++..+. ++......
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYG-VCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEecCCcc
Confidence            468999999999999999999853     3456799998764432  345889999999999876665554 45566788


Q ss_pred             EEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           79 VLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      +++|||+ +++|.+++....            ..+++..++.++.|++.||+|||++|++||||||+|||+   ++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcE
Confidence            9999998 899999987432            248999999999999999999999999999999999999   678899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      ||+|||+++........     .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....   ...
T Consensus       160 kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV  231 (288)
T ss_pred             EeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            99999999865432211     11223446788999999998889999999999999999998 9999977543   233


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...+......    .....++.++.+++.+||+.||.+||++.++.+.|+++...
T Consensus       232 ~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         232 IECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            3444333221    22346789999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-41  Score=310.48  Aligned_cols=253  Identities=21%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.++||+|+||.||+|.+. .+..+|+|....... .+.+.+|+.++++++|++++..+..+.  ....+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~   79 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVT   79 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEE
Confidence            34578999999999999999999864 667799998765433 356889999999999888877765543  34568999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|+ +++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+||++   ++++.++|+|||++..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccCcc
Confidence            998 78999998753 3458999999999999999999999999999999999999   578899999999998664432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...   ......+.... .   ..
T Consensus       157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~  223 (260)
T cd05070         157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGY-R---MP  223 (260)
T ss_pred             cc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC-C---CC
Confidence            11      1123345678999999998889999999999999999999 9999987543   22233332211 1   12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+..++..+.+++.+||..+|++||+++++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            234678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=319.92  Aligned_cols=250  Identities=19%  Similarity=0.285  Sum_probs=214.8

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      |-.|.+-|.+.+.||+|.|.+|-+|++.-||..||||++++.+..    ..+..|++.|+.++|+|+|..+...... ..
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-TK   91 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-TK   91 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-ce
Confidence            346778899999999999999999999999999999998865433    3589999999999998888777666544 45


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .|++.|+- +|+|.++|-.+...++++.+.+++.||+.|+.|+|+..+|||||||+||.+-  ..-|.|||+|||++..+
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence            68888887 8899999987788899999999999999999999999999999999999885  67899999999999887


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ....        ...+.+|+..|-|||++.|..|+ +++||||||||||-|++|+.||+..++   .+.+..|+..+...
T Consensus       170 ~PG~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtv  238 (864)
T KOG4717|consen  170 QPGK--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTV  238 (864)
T ss_pred             CCcc--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccC
Confidence            7654        34678999999999999999985 789999999999999999999998655   34455555555432


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                           +..++.+.++||..||..||.+|.+.++|.
T Consensus       239 -----PshvS~eCrdLI~sMLvRdPkkRAslEeI~  268 (864)
T KOG4717|consen  239 -----PSHVSKECRDLIQSMLVRDPKKRASLEEIV  268 (864)
T ss_pred             -----chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence                 345689999999999999999999988874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=323.59  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=215.1

Q ss_pred             EEeeeeceeCceeEEEEEEcCC----CcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+.++||.|.||.||+|.+..-    .--||||..+.+.   ..+.|..|.-+|++++|+++|..++.+.+  ...+|+|
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEE
Confidence            3456899999999999987432    2358889776643   34569999999999999999998887753  4579999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |++ -|.|.++++..+..|+......++.||+.||.|||+..+|||||-..|||++   ...+|||+|||+++.+.+...
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccch
Confidence            999 8999999998777899999999999999999999999999999999999994   788999999999998887654


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            ...+...-...|||||.+.-..++.+||||-|||++||++. |..||.+.++.+....+++...       ..+
T Consensus       547 ------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------lP~  613 (974)
T KOG4257|consen  547 ------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------LPC  613 (974)
T ss_pred             ------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-------CCC
Confidence                  22233344678999999999999999999999999999997 9999999887665444443222       235


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF  282 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  282 (404)
                      +++||+.+..|+.+||..+|.+||+|.+|+..|.++++.+..
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~  655 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI  655 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence            578999999999999999999999999999999999985543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.9e-41  Score=313.55  Aligned_cols=258  Identities=22%  Similarity=0.301  Sum_probs=206.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++|.+.+.||+|+||.||+|.+.     .++..+++|.+......  +.+.+|+.+++.++|++++..+. +.......
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~   82 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG-VCGDGDPL   82 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEE-EEccCCce
Confidence            467999999999999999999854     34567999987654432  45889999999999877666555 44566778


Q ss_pred             EEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           79 VLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      +++|||+ +++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||+   +.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence            9999998 899999997432               348999999999999999999999999999999999999   578


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK  221 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~  221 (404)
                      +.++|+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....   
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---  231 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---  231 (291)
T ss_pred             CcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            89999999999765443211     12234456889999999999889999999999999999999 9999977443   


Q ss_pred             HHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...+..+......    .....+|.++.+++.+||+.+|++||++.++.+.|+++...
T Consensus       232 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            2233333332221    22345789999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-41  Score=315.53  Aligned_cols=252  Identities=20%  Similarity=0.244  Sum_probs=201.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||+++.....   ..+..|+.++..++|++++..+..+ ......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-TKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-cCCCce
Confidence            4688999999999999999987543     578999998754432   3578899999999988777666554 444567


Q ss_pred             EEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           79 VLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      +++++|+ +++|.+++...               ...+++..++.++.|++.||+|||++||+||||||+|||+   +++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cCC
Confidence            8889988 78999998521               1348889999999999999999999999999999999999   577


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK  221 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~  221 (404)
                      +.+||+|||+++........     .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...   
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---  232 (283)
T ss_pred             CceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            88999999998865433211     11234456789999999998889999999999999999998 8899987433   


Q ss_pred             HHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      .+.+..+.....    ...+..+|.++.+++.+||+.+|++||++++|...|+
T Consensus       233 ~~~~~~i~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         233 QDVIEMIRNRQV----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            333444443332    2234578999999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-41  Score=313.54  Aligned_cols=259  Identities=21%  Similarity=0.269  Sum_probs=200.7

Q ss_pred             Cce-EEeeeeceeCceeEEEEEE----cCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeee-CCe
Q 015592            7 NKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDY   77 (404)
Q Consensus         7 ~~y-~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~   77 (404)
                      ++| ++.+.||+|+||+||++..    ..+++.||+|++.....   ...+.+|+++++.++|++++..+..+... ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 9999999999999988653    35678999998875432   34578899999999988888777655443 456


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++..  ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccccc
Confidence            78999998 8899999974  469999999999999999999999999999999999999   57789999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-----------HHH
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----------QKY  225 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-----------~~~  225 (404)
                      .......    .......++..|+|||.+.+..++.++|||||||++|||++|..||.........           ...
T Consensus       158 ~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         158 PEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             CCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            5432110    1112334567799999999888999999999999999999999998653321000           000


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ........   ....+..+|.++.+++.+||+.+|++||+++++.+.|+++.
T Consensus       234 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGM---RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCC---CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00000000   01123457899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-41  Score=311.72  Aligned_cols=248  Identities=22%  Similarity=0.384  Sum_probs=195.0

Q ss_pred             EEeeeeceeCceeEEEEEEc----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+.+.||.|.||.||+|.+.    ..+..|+||+++....   .+.+.+|++.+++++|++++..++.+. .....++++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-ccccccccc
Confidence            57899999999999999987    4567899999865433   356899999999998777777665555 555688999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..+..|+.||+.||.|||+++|+|+||+++|||+   +.++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            998 78999999875 4679999999999999999999999999999999999999   578899999999998763322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..     .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+...   .+....+.....    ..
T Consensus       158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~----~~  225 (259)
T PF07714_consen  158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQR----LP  225 (259)
T ss_dssp             SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEE----TT
T ss_pred             cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccc----ce
Confidence            11     12234456789999999998889999999999999999999 7899987533   333444433322    22


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .+..+|..+.+++..||+.||++||++.+|.+.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            3456899999999999999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=298.11  Aligned_cols=266  Identities=18%  Similarity=0.200  Sum_probs=202.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeee----eCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~~~   78 (404)
                      -+++|+|.+.||+|||+-||++++..+++.||+|.+....  ..+...+|++..++++|++++..+.+.-.    .....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3678999999999999999999999999999999765543  34568899999999999888877644322    23457


Q ss_pred             EEEEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           79 VLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      |+++.|. .|||.+.++...   ..+++.+++.|+.+|++||++||+..  +.||||||.|||++   +.+.++|.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccC
Confidence            7888877 899999987542   35999999999999999999999998  99999999999994   689999999999


Q ss_pred             cccccccCCccc--ccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          153 AKRYRDTATHQH--IPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       153 a~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      ++...-.....+  ....+......|..|.|||.+.-   ...+.++|||||||+||.|+.|.-||...-..... ....
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-laLA  254 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LALA  254 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EEEe
Confidence            986543322111  11111223457899999999874   34689999999999999999999999642110000 0000


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      +.......+  . ...+++.+.++|+.||+.||.+||+..++...++++.
T Consensus       255 v~n~q~s~P--~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 VQNAQISIP--N-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eeccccccC--C-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111111111  1 1238899999999999999999999999999887763

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-41  Score=306.82  Aligned_cols=252  Identities=21%  Similarity=0.313  Sum_probs=203.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++....  ....+.+|+.+++.++|++++..+.. .......+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEE-EEeCCEEEEEEe
Confidence            368999999999999999999998899999999876543  34568899999999998887776544 456778899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.....++++.++..++.|++.||.|||++||+|+||||+||++   +.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence            99 779999988655689999999999999999999999999999999999999   5788999999999976654321 


Q ss_pred             ccccccCCCCCccCcCccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                            ......++..|+|||.+.+.   .++.++|+|||||++|+|++|+.||.+...   ......+...........
T Consensus       157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  227 (262)
T cd06613         157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK  227 (262)
T ss_pred             ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence                  12345788899999999877   789999999999999999999999987443   222222222211111111


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....++.++.+++.+||..+|.+||++.+|+.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            22346788999999999999999999988764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-40  Score=317.23  Aligned_cols=261  Identities=18%  Similarity=0.296  Sum_probs=203.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC-------CcEEEEEEecCCCC---chhHHHHHHHHHHH-cCCCCCCceeEeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK---HPQLQYEAKLYKIL-QGGTGIPNLRWFGV   73 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~---~~~~~~E~~~l~~l-~~~~~i~~~~~~~~   73 (404)
                      ...+|++++.||+|+||.||+|++...       ...||+|+++....   ...+.+|+++++++ +|++++. +..++.
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~-~~~~~~   88 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN-LLGACT   88 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee-eeEEEc
Confidence            345799999999999999999986432       23689998765432   24588899999999 4555554 444445


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccccc
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG  137 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~  137 (404)
                      .....+++|||+ +++|.+++....               ..+++.+++.++.|++.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill-  167 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV-  167 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence            566789999998 889999987421               247889999999999999999999999999999999999 


Q ss_pred             CCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 015592          138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL  216 (404)
Q Consensus       138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~  216 (404)
                        +.++.+||+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         168 --TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             --cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence              57789999999999866543211     11122344578999999999899999999999999999998 89999774


Q ss_pred             CCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          217 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ..   ...+..+.....    ...+..++.++.+++.+||+.+|++||++.++++.|+++.....
T Consensus       241 ~~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         241 PV---EELFKLLKEGHR----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             CH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            32   233333322211    12234678899999999999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.3e-41  Score=310.88  Aligned_cols=253  Identities=20%  Similarity=0.232  Sum_probs=197.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||+|++..+++.||||.+.....    ...+.+|+.+++.++|++++..+..+ ..+...+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-MQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-eeCCeEEEEEe
Confidence            58999999999999999999999999999998764322    34578899999999987776666554 45678899999


Q ss_pred             ccCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+.++|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence            99889998886433  569999999999999999999999999999999999999   6788999999999975543211


Q ss_pred             cccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH------------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------  228 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------------  228 (404)
                             ......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.............            
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence                   12234678899999998764 4789999999999999999999999864321111110000            


Q ss_pred             ---------hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 ---------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                               ...............+++++.++|.+||..||++|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     0000011112223457899999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.7e-41  Score=314.48  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=201.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHH-cCCCCCCceeEeeeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKIL-QGGTGIPNLRWFGVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~   75 (404)
                      ..++|.+.+.||+|+||.||++.+.     .++..||||+++....   .+.+.+|+.+++++ +|++++..+. +....
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~-~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG-ACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE-EEecC
Confidence            3468999999999999999999852     3456899998765432   23578899999999 5555555544 45566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ...+++|||+ +++|.+++.... ..+++.++..++.|++.||+|||+++|+|+||||+|||+   +.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence            7789999998 789999997533 238999999999999999999999999999999999999   57889999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      +........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .+.+.....
T Consensus       189 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~  260 (302)
T cd05055         189 RDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEG  260 (302)
T ss_pred             ccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcC
Confidence            866543211     01223456788999999999889999999999999999998 999998754322   121221111


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ...   ..+...++++.+++.+||+.+|++||++.++.+.|+++
T Consensus       261 ~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111   12235688999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.4e-41  Score=307.52  Aligned_cols=246  Identities=20%  Similarity=0.304  Sum_probs=194.8

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      +.||+|+||.||+|++..+++.||+|.......   ...+.+|+++++.++|++++..+..+ ......+++|||+ +++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCeEEEEeeccCCc
Confidence            479999999999999988999999998654322   24588999999999988777665544 4566789999998 889


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++......+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..........     
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~-----  151 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS-----  151 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence            999997555568999999999999999999999999999999999999   577889999999987654321100     


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+... ...   ..+..+|.+
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~~-~~~---~~~~~~~~~  224 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQG-VRL---PCPELCPDA  224 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHcC-CCC---CCcccCCHH
Confidence            0111223467999999998889999999999999999998 99999764432   222222211 111   223457899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +.+++.+||+.+|++||++.++.+.|+
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-41  Score=314.67  Aligned_cols=261  Identities=17%  Similarity=0.300  Sum_probs=204.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc-------CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      +..++|++.+.||+|+||.||+|++.       ..+..||+|+......   ...+.+|+.+++.+.+|+++..+..+..
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34578999999999999999999753       2345799998764322   3458899999999943444444544555


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccccc
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG  137 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~  137 (404)
                      .....+++|||+ +++|.+++....               ..+++.+++.++.||+.||.|||++||+||||||+|||+ 
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-  170 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-  170 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence            667789999999 789999997532               247888999999999999999999999999999999999 


Q ss_pred             CCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 015592          138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL  216 (404)
Q Consensus       138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~  216 (404)
                        +.++.+||+|||+++.........     ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       171 --~~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         171 --TENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             --cCCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence              578899999999998765432211     1223345678999999998889999999999999999998 88999764


Q ss_pred             CCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          217 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..   .+....+......    ..+..++.++.+++.+||..+|++||++.++.+.|++++..
T Consensus       244 ~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         244 PV---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            32   3333333322211    12346789999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.1e-41  Score=326.26  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHc-CCCCCCceeEeeeeCCe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQ-GGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~   77 (404)
                      ++|.++++||+|+||.||+|++.     .+++.||||+++.....   +.+.+|++++..+. |++++.. ..+......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~-~~~~~~~~~  115 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL-LGACTKGGP  115 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE-EEEEccCCC
Confidence            46888999999999999999863     34578999998754332   35788999999998 5555544 444556667


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-----------------------------------------------------------   97 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (404)
                      .+++|||+ +++|.++++...                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            89999999 899999986431                                                           


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015592           98 --------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        98 --------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~  139 (404)
                                                            ..+++..++.++.||+.||+|||+++|+||||||+|||+   
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI---  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---
Confidence                                                  136777889999999999999999999999999999999   


Q ss_pred             CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 015592          140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~  218 (404)
                      +..+.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             eCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            57889999999999865432211     11223457889999999998889999999999999999998 8999976443


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..  .....+... ...   ..+..++.++.+++.+||..+|++||++++|++.|++++
T Consensus       348 ~~--~~~~~~~~~-~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NE--QFYNAIKRG-YRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hH--HHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            21  111222211 111   123457899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.3e-41  Score=312.50  Aligned_cols=251  Identities=20%  Similarity=0.249  Sum_probs=197.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+.....    ...+.+|+.+++.++|++++..+..+ .+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-HSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-ccCCceEEEEe
Confidence            58999999999999999999999999999998764322    24578899999999988777666544 45667899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++.+.....  
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence            99889999887656779999999999999999999999999999999999999   5788999999999986543221  


Q ss_pred             cccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc--------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--------  234 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--------  234 (404)
                           ......++..|+|||++.+.. ++.++|||||||++|+|+||..||.....  ....+..+......        
T Consensus       155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence                 122346788999999987754 79999999999999999999988644222  12222222110000        


Q ss_pred             ----------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 ----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      .........+++++.+++.+||+.||++|||++++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                            0001222457889999999999999999999987754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=306.95  Aligned_cols=266  Identities=19%  Similarity=0.267  Sum_probs=216.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .-++|+.+++||+|.||.|-+++.+.+++.||+|+++++...     ..-..|-++|+..+|+ .+..+.+.++..+..|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HP-FLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHP-FLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCc-HHHHhhhhhccCceEE
Confidence            447899999999999999999999999999999987765322     2245688888888754 4555666677888999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +||||. ||.|.-.+.+ .+.+++..+..+..+|+.||.|||+++||.||||.+|.|+   |.+|++||+|||+++.--.
T Consensus       245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence            999999 8888888774 5579999999999999999999999999999999999999   7999999999999985333


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       ..++++|||.|+|||++....|++.+|+|.+||++|||++|++||...+.   ...++-|....+     
T Consensus       321 ~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~-----  385 (516)
T KOG0690|consen  321 YGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDL-----  385 (516)
T ss_pred             ccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhc-----
Confidence            222       45789999999999999999999999999999999999999999987433   333444433332     


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCC--HHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPD--YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~--~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      .+++.++++.+.|+..+|.+||.+|..  -++.++..++-|       ...++|+..-...
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F-------F~~v~W~~~~~Kk  439 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF-------FASVDWEATYRKK  439 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh-------hccCCHHHHHHhc
Confidence            345688999999999999999999973  456666666544       3457787554333

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.7e-41  Score=312.95  Aligned_cols=256  Identities=17%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +|++.+.||+|+||.||+|++..     ....+++|.+.....   ...+.+|+.+++.++|++++..+..+ ......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-SQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-ecCCCcE
Confidence            58899999999999999998753     235789998765433   23588899999999988877766554 4556678


Q ss_pred             EEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           80 LVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      +++||+ +++|.+++....                       ..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            899998 799999986421                       24789999999999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ  214 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~  214 (404)
                      +   ++++.+||+|||+++.........     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       160 l---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         160 V---AEGRKMKISDFGLSRDVYEEDSYV-----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             E---cCCCcEEeccccccccccCccchh-----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9   578899999999998654332211     1123345678999999998889999999999999999998 999997


Q ss_pred             CCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +....   .....+.. ....   ..+..++.++.+++..||+.+|++||++.++.+.|++++.+
T Consensus       232 ~~~~~---~~~~~~~~-~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         232 GIAPE---RLFNLLKT-GYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CCCHH---HHHHHHhC-CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            74432   22222221 1111   12346789999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-41  Score=307.39  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=200.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+.....       ...+.+|+++++.++|++++..+..+ ......+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-RDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-ccCCeEE
Confidence            579999999999999999999999999999998654321       23578899999999987776655554 4556889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +++|++ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||+++....
T Consensus        81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence            999998 8899999875 4568999999999999999999999999999999999999   5778999999999976543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .....    .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....   ...+.......   ...
T Consensus       157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~---~~~  226 (263)
T cd06625         157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQP---TNP  226 (263)
T ss_pred             ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccC---CCC
Confidence            22100    001234678899999999998899999999999999999999999976432   22222222211   112


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..++.++.+++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            344568899999999999999999999887765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-40  Score=306.43  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=206.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...     ....+.+|+++++.++|++++..+..+ ...+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-IENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-ecCCeEEEE
Confidence            68999999999999999999998899999999775321     234688999999999987776666555 445678999


Q ss_pred             Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      |||+ +++|.+++...   ...+++..++.++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++..+.
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            9999 78999998643   3458999999999999999999999999999999999999   578899999999987654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........+.........
T Consensus       158 ~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~  229 (267)
T cd08224         158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPLP  229 (267)
T ss_pred             CCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCCC
Confidence            4321       12234688899999999988899999999999999999999999976432 222223333322221111


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                         ...++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus       230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence               125778999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.9e-41  Score=305.90  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|.+.+.||+|+||.||+|++..+++.|++|.+....    ....+..|+.+++.++|++++..+..+ ......+++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-LDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-ccCCEEEEEEE
Confidence            5899999999999999999999999999999876432    234578899999999988877766554 45567899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||+++.+.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence            88 88999999754 4579999999999999999999999999999999999999   5778999999999987654322


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....   .......+.....    +.+.
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~  222 (256)
T cd08529         157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVF----PPVS  222 (256)
T ss_pred             -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC----CCCc
Confidence                   1234568899999999999889999999999999999999999997644   2333333333222    2233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++.++.+++.+||+.+|++||++.++.+
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            367899999999999999999999987764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5e-41  Score=308.15  Aligned_cols=250  Identities=17%  Similarity=0.256  Sum_probs=199.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      .++|++.+.||+|+||.||+|.+. .+..+|||.+..... .+.+.+|+.+++.++|++++..+.. .......+++|||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~   80 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV-CTKQRPIYIVTEY   80 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEE-EccCCCcEEEEEc
Confidence            357999999999999999999874 345699998765432 4568899999999997776665554 4556678999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++......+++..++.++.||+.||.|||++|++|+||||+|||+   +.++.+||+|||.++.......  
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~--  155 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY--  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence            8 789999998655579999999999999999999999999999999999999   5788999999999876543321  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                          .......++..|++||.+.+..++.++|||||||++|+|++ |..||.....   ......+......    ....
T Consensus       156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~  224 (256)
T cd05113         156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRL----YRPH  224 (256)
T ss_pred             ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCC----CCCC
Confidence                11123345678999999998889999999999999999998 9999976543   2223333332211    1223


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ..+.++.+++.+||+.+|++||++.+|++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            4688999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=319.73  Aligned_cols=256  Identities=21%  Similarity=0.318  Sum_probs=214.9

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      .....+||-|.||.||.|.|++-.-.||||.++.+.. .++|..|..+|+.++|+|.|..++.|..+.. +||+.||+ .
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-FYIiTEfM~y  347 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-FYIITEFMCY  347 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-eEEEEecccC
Confidence            4567799999999999999999999999998876654 4679999999999999999988888766554 56666665 9


Q ss_pred             CCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           87 PSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        87 ~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      |+|.+++++|++. ++.-..+.++.||..|++||..+++|||||-..|+|+   .++..||++|||+++.+....+.-  
T Consensus       348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTA--  422 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTA--  422 (1157)
T ss_pred             ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceec--
Confidence            9999999988764 6777888999999999999999999999999999999   588999999999999988765432  


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          .....-...|.|||.+.-+.++.|+|||+|||+|||+.| |--||.+.+-......+++....       .-+.+|
T Consensus       423 ----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-------~~PeGC  491 (1157)
T KOG4278|consen  423 ----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-------DGPEGC  491 (1157)
T ss_pred             ----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-------cCCCCC
Confidence                223344678999999999999999999999999999998 99999985543333333332222       234689


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      |+.+.+|+..||+++|.+||+|++|.+.|+.+|....
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            9999999999999999999999999999999986543

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=313.42  Aligned_cols=255  Identities=19%  Similarity=0.298  Sum_probs=215.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      -|.++++||+|+||.||+|.++.+|+.+|||.+..+...+++..|+.|+++++.+..|.+++.|+...+ .++||||| .
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhhcCC
Confidence            478899999999999999999999999999999999999999999999999998888888887776554 58999999 7


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ||..++++..+++|++.++..++...+.||+|||...-||||||..|||+   +.+|..||+|||.|..+.+...     
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA-----  184 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA-----  184 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH-----
Confidence            89999999878899999999999999999999999999999999999999   6899999999999988776554     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ...+..||+.|||||++....|+.++||||||++..||..|++||.+..+....   ..+..+  +++.-.-+...+.
T Consensus       185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMIPT~--PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMIPTK--PPPTFKKPEEWSS  257 (502)
T ss_pred             --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---EeccCC--CCCCCCChHhhhh
Confidence              446789999999999999999999999999999999999999999886653211   111111  1111122234678


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ++.++++.||-++|++|-|+.+   ++++.|.+..
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~---L~~H~FiknA  289 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALR---LCEHTFIKNA  289 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHH---HhhhhhhcCC
Confidence            9999999999999999988654   4455554443

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.9e-41  Score=309.63  Aligned_cols=251  Identities=20%  Similarity=0.339  Sum_probs=197.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHc-CCCCCCceeEeeee-----CCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQ-GGTGIPNLRWFGVE-----GDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~-----~~~   77 (404)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++++. |++++..+..+...     ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            35789999999999999999999999999999998765432 345888999999995 55555555554432     246


Q ss_pred             EEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      .+++|||+ +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||++   +.++.++|+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence            78999999 78999998853 3468999999999999999999999999999999999999   5788999999999976


Q ss_pred             ccccCCcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      ......       ......|+..|+|||++.     +..++.++|||||||++|||++|..||......   .....+..
T Consensus       161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~  230 (272)
T cd06637         161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR  230 (272)
T ss_pred             cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence            543221       223467899999999986     335788999999999999999999999764322   11111111


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..   ........++.++.+++.+||..+|.+||++.++.+
T Consensus       231 ~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NP---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11   111122357889999999999999999999887753

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=314.62  Aligned_cols=260  Identities=19%  Similarity=0.284  Sum_probs=198.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC--------------CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCce
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT--------------NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNL   68 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~   68 (404)
                      .++|++.++||+|+||.||++++..+              ...||+|.+.....   ...+.+|++++++++|++++..+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            36899999999999999999987543              23589998765422   23588899999999988766666


Q ss_pred             eEeeeeCCeEEEEEecc-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccc
Q 015592           69 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM  136 (404)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl  136 (404)
                      ..+ ......+++|||+ +++|.+++....           ..+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus        84 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          84 GVC-VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEE-cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            555 4566789999999 889999986422           136889999999999999999999999999999999999


Q ss_pred             cCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCC
Q 015592          137 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQ  214 (404)
Q Consensus       137 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt--g~~Pf~  214 (404)
                         +.++.+||+|||++..+.....     ........++..|+|||.+.+..++.++|||||||++|+|++  |..||.
T Consensus       163 ---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         163 ---GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             ---cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence               5778899999999976543221     111233455788999999998889999999999999999988  778887


Q ss_pred             CCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ............+................+|+.+.+++.+||+.||++||++++|.+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            754422222221111111111111123457899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-41  Score=307.34  Aligned_cols=249  Identities=21%  Similarity=0.281  Sum_probs=199.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|++..... ...+..|+.+++.++|++++..+. +.......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG-VCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEE-EEcCCCceEEEEecC
Confidence            56899999999999999999875 567899998765433 346888999999999877665544 445666789999998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||+++...+....  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~--  156 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT--  156 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc--
Confidence             889999997655678999999999999999999999999999999999999   57889999999999765432211  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                          ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.....   .+....+.....    ...+..
T Consensus       157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~  225 (256)
T cd05059         157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR----LYRPKL  225 (256)
T ss_pred             ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc----CCCCCC
Confidence                1112234568999999999899999999999999999999 8999986443   223333322211    122345


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      +|.++.+++.+||..+|++||++.++.+.|
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-41  Score=311.04  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=205.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      -..+|++.++||.|+||.||+|.+.. ++.+++|++.....  ...+..|+.+++.++|++++..+.. .......+++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV-CSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeee-EecCCCeEEEE
Confidence            34679999999999999999999866 88999998776543  4568899999999997776665544 45666789999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence            999 78999999743 3468999999999999999999999999999999999999   578899999999998665432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .       ......++..|++||.+.+..++.++||||||+++|+|++ |+.||.+...   .+.+..+.....    ..
T Consensus       159 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~  224 (261)
T cd05148         159 Y-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYR----MP  224 (261)
T ss_pred             c-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCc----CC
Confidence            2       1123446778999999998889999999999999999998 8999977443   333333332211    12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+..+++.+.+++.+||+.||++||++.+|.+.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            235678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.3e-41  Score=307.47  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=198.3

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      |++++.||+|+||+||++++..+++.||+|++........    ..+|+.+++.++|++++ .+..+.......+++|++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIV-QILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBC-HEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccc-cccccccccccccccccc
Confidence            8999999999999999999999999999999887654332    34589999999766655 455555557788899999


Q ss_pred             cCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 LGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      +.+ +|.+++. ....+++..++.++.||+.||.+||++||+|+||||+||++   +.++.++|+|||.+........  
T Consensus        80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~--  153 (260)
T PF00069_consen   80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE--  153 (260)
T ss_dssp             ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred             ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence            955 9999998 35679999999999999999999999999999999999999   6889999999999976422111  


Q ss_pred             cccccCCCCCccCcCcccccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                           ......++..|+|||++. +..++.++||||||+++|+|++|..||......+....+............. ...
T Consensus       154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  227 (260)
T PF00069_consen  154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QSR  227 (260)
T ss_dssp             -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SHT
T ss_pred             -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-ccc
Confidence                 234567899999999998 7789999999999999999999999998753223333333332222111110 011


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+.++.+++.+||+.||++||++.++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22489999999999999999999887753

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=320.36  Aligned_cols=250  Identities=19%  Similarity=0.236  Sum_probs=192.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ..+|++.+.||+|+||.||+|++..+++.||+|+....    ....|+.+++.++|++++..+..+ ......+++|+++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTL-VSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheE-EeCCeeEEEEEcc
Confidence            45799999999999999999999999999999975332    346799999999988877766554 4566789999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      .++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++......     
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~-----  211 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP-----  211 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc-----
Confidence            999999987666789999999999999999999999999999999999999   678899999999997433221     


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-------HHHHHHhhh-c-----
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K-----  232 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~-~-----  232 (404)
                         ......||..|+|||++.+..++.++|||||||++|||+++..|+.........       ..+..+... .     
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence               123457899999999999999999999999999999999855444322221110       001111100 0     


Q ss_pred             cc-----ccHh-----------------Hh-hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 VS-----TSIE-----------------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ~~-----~~~~-----------------~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..     ....                 .+ ...++.++.++|.+||+.||++|||+.++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            00     0000                 00 1245677888999999999999999887653

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.7e-41  Score=311.61  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=200.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.++.....   ..+.+|+.+++.++|++++..+.. .....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGV-VSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE-EcCCC
Confidence            45789999999999999999997642     3558999987644322   246789999999987766655544 45566


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEE
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY  146 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vk  146 (404)
                      ..+++|||+ +++|.+++....         ..++...+..++.|++.||.|||++||+||||||+|||+   +.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcEE
Confidence            789999999 899999997432         235678899999999999999999999999999999999   5788999


Q ss_pred             EEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 015592          147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  225 (404)
                      |+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...   .+..
T Consensus       160 L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~  231 (288)
T cd05061         160 IGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL  231 (288)
T ss_pred             ECcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence            9999999865433211     11223345778999999998889999999999999999998 8999987433   2222


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..+.....    ...+..+++.+.+++.+||+.||++||++.++.+.|++.+
T Consensus       232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGY----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            22222211    1223466899999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.9e-41  Score=312.81  Aligned_cols=256  Identities=20%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCCCCceeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKIL-QGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~~   76 (404)
                      .++|++.+.||+|+||.||++.+...     ...+|+|........   ..+.+|+.+++++ +|++++..+. +.....
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG-VCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE-EEcCCC
Confidence            46899999999999999999997644     378999987654332   3477899999999 5655555444 445566


Q ss_pred             eEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                      ..+++|||+ +++|.+++...               ...+++..++.++.|++.||+|||++||+||||||+|||+   +
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---T  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---c
Confidence            789999998 88999998642               2468999999999999999999999999999999999999   5


Q ss_pred             CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 015592          141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG  219 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~  219 (404)
                      .++.+||+|||+++.+......     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... 
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  240 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-  240 (293)
T ss_pred             CCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence            7889999999999876543211     11222345678999999998889999999999999999997 9999987443 


Q ss_pred             ChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                        .+.+..+.....    ...+..++.++.+++.+||..||++||++.++++.|+++.
T Consensus       241 --~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --EELFKLLKEGYR----MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              222332222211    1223457889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1e-40  Score=307.96  Aligned_cols=256  Identities=16%  Similarity=0.239  Sum_probs=204.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|++.+.||+|+||.||+|++..++   ..+|+|.++....   ...+.+|+.+++.++|++++..+.. ....+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEE-EecCCccE
Confidence            468999999999999999999986544   3799998765332   2458889999999998776665544 45667889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++.+++.++.|++.||.|||++|++||||||+|||+   +.++.++|+|||++..+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence            999999 789999998656678999999999999999999999999999999999999   5788999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....    .......++..|+|||.+.+..++.++|+|||||++||+++ |..||.+....   +....+..... .  
T Consensus       159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-~--  228 (267)
T cd05066         159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYR-L--  228 (267)
T ss_pred             cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCc-C--
Confidence            32211    01112234568999999998889999999999999999886 99999875432   23333332211 1  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       .....+|+.+.+++.+||+.+|++||++.++.+.|+++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             12346789999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.3e-41  Score=307.91  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|++..+++.|+||.+....     ....+.+|+.+++.++|++++..+..+ ..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-IEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-EeCCeEEEE
Confidence            57999999999999999999998999999999765422     123577899999999887777666554 456678899


Q ss_pred             Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++..+.
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            9998 78999988642   3458999999999999999999999999999999999999   578899999999987665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+... +.......+.......  
T Consensus       158 ~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~--  227 (267)
T cd08229         158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPP--  227 (267)
T ss_pred             cCCc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCC--
Confidence            4322       12245688999999999988899999999999999999999999976432 2222222222221111  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                       .....+++++.+++.+||..||++|||+.+|.+.++++.
T Consensus       228 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 -LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             111347889999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-40  Score=341.44  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.++||+|+||.||+|++..+++.||||++.....     .+.+.+|+++++.++|++++..+.. ..+++..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v-~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSI-CSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEE-EeeCCEEEEE
Confidence            689999999999999999999999999999998765322     2358889999999998877766554 4566788999


Q ss_pred             Eecc-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           82 IDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      |||+ |++|.+++...          ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999 89999998642          1235677889999999999999999999999999999999   67889999999


Q ss_pred             CCcccccccCCcc-----------cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 015592          151 GLAKRYRDTATHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG  219 (404)
Q Consensus       151 G~a~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~  219 (404)
                      |+++.........           ...........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998762211100           00111223457999999999999999999999999999999999999999773321


Q ss_pred             ChHHHHHHHhhhcccccHh-HhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHHH
Q 015592          220 TKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR  279 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RP-~~~~l~~~l~~~~~~  279 (404)
                      ...  ...    ....+.. .....+|+.+.+++.+||..||++|| +++++.+.|+..+..
T Consensus       238 ki~--~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KIS--YRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh--hhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            111  111    1111111 11236789999999999999999996 567777878777643

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.2e-41  Score=313.33  Aligned_cols=260  Identities=17%  Similarity=0.256  Sum_probs=198.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIP   66 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~   66 (404)
                      .++|++.++||+|+||.||++.+..                +...||+|++.....   ...+.+|+.+++.++|++++.
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4689999999999999999986432                345799998765432   245889999999998877665


Q ss_pred             ceeEeeeeCCeEEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        67 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      .+. +.......+++|||+ +++|.+++....          ..+++.++..++.|++.||+|||++||+||||||+|||
T Consensus        84 ~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLA-VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             EEE-EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            555 445566789999998 789999987532          23778899999999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW  213 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt--g~~Pf  213 (404)
                      +   +.++.++|+|||+++.+......     .......++..|++||...+..++.++|||||||++|||++  |..||
T Consensus       163 i---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         163 V---GKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             E---cCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9   57889999999999865433211     11223345678999999888889999999999999999998  78999


Q ss_pred             CCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ...........................+..+++.+.+++.+||+.||++||++.+|.+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            7654432222111111111011111123457899999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-41  Score=309.76  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=199.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....  ...+.+|+.+++.++|++++..+..+ ......+++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-LRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCEEEEEEe
Confidence            3689999999999999999999999999999998765432  23577899999999888777776554 45677899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.. .+.+++.+++.++.|++.||.|||++||+|+||||+||++   +..+.++|+|||++........ 
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc-
Confidence            99 7899999874 5579999999999999999999999999999999999999   5788999999999876543221 


Q ss_pred             ccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                            ......|+..|+|||++.   ...++.++|||||||++|+|++|..||........   ...............
T Consensus       162 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~  232 (267)
T cd06645         162 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQPPKLK  232 (267)
T ss_pred             ------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCCCCccc
Confidence                  223457899999999975   44588999999999999999999999976443211   111111111111111


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....++..+.+++.+||+.+|++||++++|++
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11246789999999999999999999887754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-40  Score=307.93  Aligned_cols=258  Identities=15%  Similarity=0.230  Sum_probs=203.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+.|++.+.||+|+||.||+|++..+++   .||||++.....   ...+..|+.+++.++|++++..+.. ...+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~-~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEE-ECCCCceE
Confidence            4579999999999999999999877664   599998765432   2368889999999998877765554 45666789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++....+.+++.+++.++.|++.||+|||++|++||||||+||++   +.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999998 789999998656679999999999999999999999999999999999999   5788999999999876544


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....  .+........+..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+.... ..  
T Consensus       159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~-~~--  230 (269)
T cd05065         159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY-RL--  230 (269)
T ss_pred             Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC-cC--
Confidence            32211  0001111122457999999999899999999999999999886 99999875432   2233332211 11  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       ..+..+|..+.+++.+||+.+|++||++.+|...|+.+
T Consensus       231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 -PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             11246789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-40  Score=313.39  Aligned_cols=260  Identities=19%  Similarity=0.312  Sum_probs=202.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcC-------CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      -.++|.+.++||+|+||.||+|++..       ....+|+|++......   ..+..|+.+++.+.+|++|..+..+...
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34689999999999999999998642       3457999987654332   3477899999999644444445445556


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~  138 (404)
                      ....+++|||+ +++|.+++....               ..+++.++..++.|++.||.|||++||+||||||+|||+  
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--  167 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--  167 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE--
Confidence            67789999998 889999997532               348899999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                       +.++.+||+|||+++.........     ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       168 -~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         168 -TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             -cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence             578899999999998665432111     1122234568999999999889999999999999999999 999997643


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .   ...+..+.....    ...+..++.++.+++.+||+.+|++||++.++.+.|+++...
T Consensus       242 ~---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         242 V---EELFKLLREGHR----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             H---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            3   233333332221    122346788999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-40  Score=305.84  Aligned_cols=253  Identities=19%  Similarity=0.273  Sum_probs=197.9

Q ss_pred             eeeceeCceeEEEEEEcC---CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||.||+|.+..   ....||+|.+.....   ...+.+|+.+++.++|++++..+..+...+...+++|+|+ 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   346799998754322   2457789999999999988888776665666788999998 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+   +.++.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~--  155 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS--  155 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCccee--
Confidence            899999998655567888999999999999999999999999999999999   578899999999997654322110  


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                       ........++..|+|||.+.+..++.++|||||||++|||++ |..||...+.   ......+.....    ......+
T Consensus       156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~  227 (262)
T cd05058         156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRR----LLQPEYC  227 (262)
T ss_pred             -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCcC
Confidence             011223456778999999998889999999999999999999 5667765332   222322222211    1122356


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      |+.+.+++.+||..+|++||++.+|.+.|++++.
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            8899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.2e-41  Score=307.01  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .++|++.+.||+|+||.||++.  .+++.||+|..........+.+|+.+++.++|++++..+..+..  ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECC
Confidence            4679999999999999999997  47889999998766666678999999999999888887766543  3368999998


Q ss_pred             -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 -~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                       +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.......   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccC---
Confidence             789999997543 358999999999999999999999999999999999999   578899999999987543321   


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             .....+..|+|||.+.+..++.++|+|||||++|||++ |+.||.....   ......+......    ....
T Consensus       155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~  220 (254)
T cd05083         155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRM----EPPE  220 (254)
T ss_pred             -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCC----CCCC
Confidence                   12234568999999998889999999999999999997 9999987543   2222222222111    1234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+|.++.+++.+||+.+|++||++++|.+.|++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            678999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-40  Score=315.49  Aligned_cols=256  Identities=18%  Similarity=0.213  Sum_probs=192.2

Q ss_pred             eeeeceeCceeEEEEEEcC--CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEEEEEeccCCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPS   88 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~~~s   88 (404)
                      +.+||+|+||.||+|++..  +++.||+|.+........+.+|+.+++.++|++++..+..+.. .....+++|||++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD   85 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence            4689999999999999653  5689999988766666678899999999999988887766643 456789999999999


Q ss_pred             HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCCeEEEEecCCccccccc
Q 015592           89 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        89 L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~-~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence            998875321        248899999999999999999999999999999999999432 35678999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh------HHHHHHHhhhc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK  232 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~~  232 (404)
                      ...    ........||+.|+|||++.+. .++.++|||||||++|||+||+.||........      ...+..+....
T Consensus       166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            221    1122345789999999999874 489999999999999999999999975332110      00011000000


Q ss_pred             c---------------------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 V---------------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ~---------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .                                 ....+......+..+.+|+.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0                                 00000011123567889999999999999999987753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-40  Score=310.69  Aligned_cols=252  Identities=19%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ...+.|++.++||.|+||.||+|++..+++.|++|++.....  ...+.+|+.+++.++|++++..+..+ ..+...+++
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv   87 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-YWDGKLWIM   87 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-EeCCeEEEE
Confidence            345779999999999999999999999999999998765432  34578899999999988777666554 455678999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|..++......+++..+..++.|++.+|.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence            9999 788888877556679999999999999999999999999999999999999   578899999999987543322


Q ss_pred             CcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .       ......++..|+|||++.     ...++.++|||||||++|||++|..||.....   ...+.++.....  
T Consensus       165 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~--  232 (292)
T cd06644         165 Q-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEP--  232 (292)
T ss_pred             c-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCC--
Confidence            1       123456889999999985     34478899999999999999999999977432   222333222111  


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ........++.++.+++.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111223457789999999999999999999887643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=326.40  Aligned_cols=256  Identities=25%  Similarity=0.340  Sum_probs=206.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCc---E-EEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---E-VAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      .++-.+.++||+|+||+||+|+.+..+.   . ||||..+...     ...++.+|+++|++++|+|++..++ +.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG-Va~~~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG-VAVLEE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE-EEcCCC
Confidence            3455677999999999999998765422   3 8999876522     2345889999999999877665554 556777


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++||+| ||+|.++++.....++..+...++.+.+.||+|||++++|||||-.+|+|+   ..++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccC
Confidence            889999999 999999999766679999999999999999999999999999999999999   4677789999999875


Q ss_pred             ccccCCcccccccCCC-CCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          156 YRDTATHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      -..-.        ... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+.   ..++.....
T Consensus       312 ~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~~~~~  380 (474)
T KOG0194|consen  312 GSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIVKNGY  380 (474)
T ss_pred             Cccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHHhcCc
Confidence            43111        111 1234678999999999999999999999999999999 8999999766433   333322222


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..   ..+...|.++..++.+||..+|++||+|.++.+.|+.+...
T Consensus       381 r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  381 RM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             cC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            22   22236789999999999999999999999999999998754

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.5e-40  Score=308.68  Aligned_cols=252  Identities=20%  Similarity=0.251  Sum_probs=193.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCC-----e
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-----Y   77 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-----~   77 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||.......    ...+.+|+.+++.+.+++++..+..+.....     .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            579999999999999999999999999999998664432    3467889999999987655555544444333     3


Q ss_pred             EEEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           78 NVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      .+++|||+.++|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++  ..++.+||+|||++
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence            79999999889999886432    3589999999999999999999999999999999999994  22789999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      +.+.....       ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.....   .+..+....
T Consensus       159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~  228 (295)
T cd07837         159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLL  228 (295)
T ss_pred             eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHh
Confidence            76543211       1123356889999998875 447999999999999999999999998743322   111111100


Q ss_pred             -----------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 -----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 -----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                             ...........++.++.++|.+||..||++||++.+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil  289 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL  289 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence                                   00111222245789999999999999999999987765

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=304.39  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=197.8

Q ss_pred             eeeceeCceeEEEEEEcCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      ++||+|+||.||+|.+..++   ..||+|.+.....   .+.+..|+.+++.+.|++++..+..+.  ....+++|+|+ 
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            47999999999999876655   7899998775543   345888999999999888777665443  44578999998 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||+   +.++.+||+|||+++........   
T Consensus        79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~---  151 (257)
T cd05060          79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY---  151 (257)
T ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence            7899999985 3479999999999999999999999999999999999999   67889999999999866543321   


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                       +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   .+....+.....    ...+..+
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~  223 (257)
T cd05060         152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGER----LPRPEEC  223 (257)
T ss_pred             -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCc----CCCCCCC
Confidence             111222334578999999998889999999999999999998 9999977543   223333322221    1233567


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      +..+.+++.+||+.+|++||++.+|.+.|+++
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            89999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-40  Score=306.25  Aligned_cols=257  Identities=15%  Similarity=0.221  Sum_probs=203.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..++|+..+.||+|+||.||+|++..+++   .+++|.+.....   .+.+..|+++++.++|++++..+. +.......
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~   81 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEG-VVTKFKPA   81 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEccCCCc
Confidence            35689999999999999999999876554   799998765432   345788999999999887666544 44566678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++.++..++.|++.||+|||++|++||||||+||++   +.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999 789999998656679999999999999999999999999999999999999   578899999999997665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .......    .......+..|+|||++.+..++.++|||||||++|||++ |..||.....   ......+......  
T Consensus       159 ~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~--  229 (268)
T cd05063         159 DDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRL--  229 (268)
T ss_pred             cccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCC--
Confidence            4322110    0112223567999999998889999999999999999997 9999976433   2333333322111  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                        .....++.++.+++.+||+.+|++||++.++.+.|+++
T Consensus       230 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 --PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              11235789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-40  Score=308.83  Aligned_cols=244  Identities=20%  Similarity=0.314  Sum_probs=193.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+|++++++++|++++..+..+. .....+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-VENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-ECCEEEEEEe
Confidence            478999999999999999999999999999998765422   235788999999999887777766554 4567789999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|..+     ..+++..+..++.|++.||.|||++||+|+||||+|||+   +.++.++|+|||++..+....  
T Consensus        80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc--
Confidence            99 7777543     247899999999999999999999999999999999999   578999999999997654322  


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh----HHHHHHHhhhcccccHh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKKVSTSIE  238 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~  238 (404)
                             .....||..|+|||++.+..++.++|||||||++|+|++|+.||........    ......+.......   
T Consensus       150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---  219 (279)
T cd06619         150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV---  219 (279)
T ss_pred             -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---
Confidence                   2345789999999999998999999999999999999999999976432211    11111111111110   


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....+++++.+++.+||+.+|++||+++++.+
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            011346789999999999999999999887654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-40  Score=312.03  Aligned_cols=260  Identities=19%  Similarity=0.253  Sum_probs=205.0

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .+-.++|++.+.||+|+||.||+|.+..++.    .||+|++......   ..+.+|+.+++.++|++++..+..+..  
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--   80 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--   80 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence            4556789999999999999999999877776    4788877654332   257789999999998888887766543  


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...+++++|+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~  157 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLAR  157 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccc
Confidence            2356777877 789999998656678999999999999999999999999999999999999   577889999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+.......     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....    +..+.....
T Consensus       158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~  228 (303)
T cd05110         158 LLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGE  228 (303)
T ss_pred             cccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCC
Confidence            665432110     1223345778999999999899999999999999999997 999997743222    222222111


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..   .....++..+.+++..||..+|++||++.++.+.|+++...
T Consensus       229 ~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         229 RL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11   12245678999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=316.06  Aligned_cols=273  Identities=21%  Similarity=0.247  Sum_probs=217.7

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      .|+-.+.|+.-++||+|+||+||-++-..||+.||+|.+..+     ....-..+|..++.+++.+ .|+.+.+.....+
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd  258 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKD  258 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCC
Confidence            355677899999999999999999999999999999965433     2333477899999999866 5556655566777


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ..++|+..+ ||+|.-.|.+.+ ..|++..++.++.+|+.||++||+.+||.|||||+|||+   |+.|+++|+|+|+|.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV  335 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence            789999998 999988776544 359999999999999999999999999999999999999   799999999999999


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .+.+...        ....+||.+|||||++.+..|+...|+|||||+||||+.|+-||...+.....+.++   . ...
T Consensus       336 ei~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---r-r~~  403 (591)
T KOG0986|consen  336 EIPEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---R-RTL  403 (591)
T ss_pred             ecCCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---H-HHh
Confidence            8877653        234589999999999999999999999999999999999999998765544332222   2 223


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH-HHHHHHHHHHcCCCCCceeeccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL-KRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l-~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      ...++++..++++.++|...+|.+||.+|.....- .+.+      ...++...++|......
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~ev------k~HpfFk~lnw~rleag  460 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEV------KEHPFFKDLNWRRLEAG  460 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchh------hhCcccccCCHhHHhcc
Confidence            33456677899999999999999999999764311 1111      11245556778755443

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=308.87  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|........   ..+.+|+.+++.++|++++..+.. .....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGV-VSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEE-EcCCC
Confidence            457899999999999999999998644     378999987644322   347789999999988776655544 44567


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEE
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY  146 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vk  146 (404)
                      ..+++|||+ +++|.+++....         ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCEE
Confidence            789999998 789999986422         236888999999999999999999999999999999999   6789999


Q ss_pred             EEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 015592          147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  225 (404)
                      |+|||+++.......     +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...   .+..
T Consensus       160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~  231 (277)
T cd05032         160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVL  231 (277)
T ss_pred             ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHH
Confidence            999999986654322     112234456889999999998889999999999999999998 9999976433   2333


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ..+.....    ...+..++.++.+++.+||+.+|++|||+.+|.+.|+
T Consensus       232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            33332211    2234567899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.1e-40  Score=311.28  Aligned_cols=257  Identities=18%  Similarity=0.178  Sum_probs=200.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~   79 (404)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++......    ..+.+|+.++++++|++++..+..+.. .....+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            457899999999999999999999999999999987644322    246689999999999888877666543 335689


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||++++|.+++......+++.++..++.||+.||.|||++|++||||||+||++   +..+.+||+|||++......
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCc
Confidence            999999889999998666779999999999999999999999999999999999999   57889999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc-----
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-----  233 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----  233 (404)
                      ..       ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+........     
T Consensus       162 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         162 AK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             cC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence            21       1123345788999999876 4579999999999999999999999987543322222221110000     


Q ss_pred             -----------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                       ..........+++++.++|.+||..||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                             00001111235788999999999999999999886653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=316.51  Aligned_cols=259  Identities=20%  Similarity=0.210  Sum_probs=199.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeee----CCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~   77 (404)
                      ++++|++.++||+|+||.||+|++..+++.||||+++...   ....+..|+.+++.++|++++..+..+...    ...
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            6789999999999999999999999999999999875422   234577899999999988888776554332    245


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++++|++++|.+++.  ...+++..+..++.|++.||+|||++||+||||||+|||+   +..+.+||+|||+++...
T Consensus        83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence            79999999989998886  4579999999999999999999999999999999999999   688899999999998664


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh-----
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----  231 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  231 (404)
                      .......    ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+...     
T Consensus       158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            4322111    1234578999999998765 45899999999999999999999999764321111111000000     


Q ss_pred             ------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          232 ------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       232 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                                        .............++++.+++.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                              00011112234567889999999999999999998766543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-40  Score=308.37  Aligned_cols=261  Identities=21%  Similarity=0.227  Sum_probs=201.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEE----cCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEee-eeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~   78 (404)
                      .++|++.+.||+|+||.||++..    ..+++.||+|.+.....  ...+.+|+++++.++|++++..+..+. ......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46899999999999999999973    45788999998765432  235889999999999888877765543 344567


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccccc
Confidence            8999999 899999998655679999999999999999999999999999999999999   578899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh------------HHHH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------------KQKY  225 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~------------~~~~  225 (404)
                      ......    .......++..|+|||++.+..++.++|||||||++|||++|..|+......-.            ...+
T Consensus       160 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         160 QDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             CCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            432110    011122344569999999988899999999999999999998877654221100            0000


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ........   .......++.++.+++.+||+.+|++|||+.+|.+.|+++
T Consensus       236 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         236 IELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            01111110   0112245788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-40  Score=310.24  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=202.0

Q ss_pred             CceEEeeeeceeCceeEEEEEE----cCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeee-CCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~   78 (404)
                      ..|++.+.||+|+||.||++++    ..+++.||+|.++....   ...+.+|+.+++.++|++++.....+... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3479999999999999999974    45788999998764432   24588999999999988888776665544 4678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+||++   +.++.++|+|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccccc
Confidence            8999999 899999997555568999999999999999999999999999999999999   577889999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------C-ChHHHH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------G-TKKQKY  225 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~-----------~-~~~~~~  225 (404)
                      ......    .......++..|+|||.+.+..++.++|||||||++|||+++..|+.....           . ......
T Consensus       161 ~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         161 TDKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cCccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            432211    112345677889999999988899999999999999999998776532110           0 000111


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..+.....    ......++.++.+++.+||+.||++||++.++.+.|+++
T Consensus       237 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKR----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCcc----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111    112346789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-40  Score=303.88  Aligned_cols=253  Identities=20%  Similarity=0.343  Sum_probs=203.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.++||+|+||.||++.+ ..+..+++|.+..... ...+.+|+.+++.++|++++..+..+..  ...+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~   79 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIIT   79 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEE
Confidence            4578999999999999999999986 4556799998765432 3568899999999998888777655544  5678999


Q ss_pred             ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++   +..+.+||+|||.+..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCCC
Confidence            999 78999999743 3458899999999999999999999999999999999999   578899999999997664422


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..      ......++..|+|||++.+..++.++|+|||||++|++++ |..||.+.+..   .....+.....    ..
T Consensus       157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~----~~  223 (260)
T cd05073         157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYR----MP  223 (260)
T ss_pred             cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCC----CC
Confidence            11      1223345678999999998889999999999999999999 99999875432   22222222211    11


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .....+.++.+++.+||..+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            234678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=303.52  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=202.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -.++|++.+.||.|+||.||+|.+  .++.||||.+..... .+++.+|+.+++.++|++++..+..+. .....+++||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e   80 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-QGNPLYIVTE   80 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-CCCCeEEEEE
Confidence            357899999999999999999986  488999998876654 457889999999999888776665554 3677899999


Q ss_pred             cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||.++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccccc
Confidence            99 689999997543 268999999999999999999999999999999999999   6788999999999986633221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                                ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+.....    ...
T Consensus       158 ----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~  220 (256)
T cd05039         158 ----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEA  220 (256)
T ss_pred             ----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCC
Confidence                      2334668999999998889999999999999999997 9999976432   222222222211    122


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      +..+|+++.+++.+||..+|++||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            34678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-40  Score=304.76  Aligned_cols=250  Identities=21%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+......+++.+|+++++.++|++++..+..+ ......++++|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY-FKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeee-ecCCcEEEEEecC
Confidence            468999999999999999999998889999999887665567799999999999877777666554 4557788999998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++........   
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~---  154 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA---  154 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc---
Confidence             789999998666789999999999999999999999999999999999999   5788999999999987654331   


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          ......++..|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+....  .........+
T Consensus       155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~~~~~--~~~~~~~~~~  225 (256)
T cd06612         155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMIPNKP--PPTLSDPEKW  225 (256)
T ss_pred             ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhhccCC--CCCCCchhhc
Confidence                1223457889999999999899999999999999999999999998643321   111111111  1111122356


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +.++.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            789999999999999999999987754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-40  Score=309.27  Aligned_cols=251  Identities=20%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCce-eEeee-----eCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNL-RWFGV-----EGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~-~~~~~-----~~~~   77 (404)
                      ..+.|++.+.||.|+||.||+|++..+++.||+|+..... ....+..|+.+++++.+|+++..+ ..+..     ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            3478999999999999999999999999999999876543 334688899999999655555444 33321     3467


Q ss_pred             EEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      .+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++..
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence            89999999 67999998753 3458899999999999999999999999999999999999   5788899999999876


Q ss_pred             ccccCCcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      ......       ......|+..|+|||.+.     +..++.++|||||||++|||++|..||.....   ...+..+..
T Consensus       171 ~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~  240 (282)
T cd06636         171 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPR  240 (282)
T ss_pred             hhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhh
Confidence            543221       123457899999999986     34578899999999999999999999976432   122222222


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..   ........++.++.++|.+||+.||.+||++.+|++
T Consensus       241 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NP---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CC---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11   111122457899999999999999999999987753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.8e-40  Score=309.74  Aligned_cols=248  Identities=21%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..+|++.+.||+|+||.||+|.+..+++.|++|.+.....  ...+.+|+.+++.+.|++++..+..+ ..+...+++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-EeCCEEEEeec
Confidence            4689999999999999999999999999999998765432  34678899999999888777766554 45668899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.  +..+++.++..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc-
Confidence            99 889999987  3468999999999999999999999999999999999999   5788999999999876543221 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  ..+. +.....  .....+.
T Consensus       172 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-~~~~~~--~~~~~~~  240 (296)
T cd06654         172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-IATNGT--PELQNPE  240 (296)
T ss_pred             ------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-HhcCCC--CCCCCcc
Confidence                  1223468899999999998889999999999999999999999997644311  1111 111111  1111234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+.+++.+||..+|++||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            57889999999999999999999887765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=345.68  Aligned_cols=269  Identities=24%  Similarity=0.321  Sum_probs=219.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|+|+++||+|+||+|.+++++.+++.||+|+++...     ...-|..|..+|..-+ ..-|..+.+.++++.+.|+
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence            468999999999999999999999999999999877532     2233666777776544 5667777888899999999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ||||+ ||+|..++.... +++++.+..++..|+.||.-||+.|+|||||||+||||   |..|++||+|||.|-.+...
T Consensus       153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence            99999 999999999766 89999999999999999999999999999999999999   79999999999999888865


Q ss_pred             CCcccccccCCCCCccCcCcccccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      +..      .....+|||-|.|||++.    + +.|++.+|+||+||++|||++|..||..   ...-+.|.+|..-+-.
T Consensus       229 G~V------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~  299 (1317)
T KOG0612|consen  229 GTV------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKES  299 (1317)
T ss_pred             CcE------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhh
Confidence            542      345679999999999986    3 4689999999999999999999999987   5556777777765332


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCceeeccccccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV  300 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~---~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~  300 (404)
                      -..+.. ..+|.+.++||...+. +|+.|..   ++++..          .+|....+|...+...+|.
T Consensus       300 l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----------HpFF~g~~W~~iR~~~pP~  356 (1317)
T KOG0612|consen  300 LSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----------HPFFEGIDWDNIRESVPPV  356 (1317)
T ss_pred             cCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----------CccccCCChhhhhhcCCCC
Confidence            222211 2488999999999887 4888877   544432          3667778897666554443

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-40  Score=304.77  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=205.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|.+.+.||+|+||.||+|.+...   ...|+||.......   .+.+.+|+.+++.++|++++..+..+..  ...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcE
Confidence            46799999999999999999987544   35689998765432   3458889999999998888777765543  4467


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..++.++.|++.||+|||++|++||||||+|||+   +..+.+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeeccc
Confidence            899998 889999998655579999999999999999999999999999999999999   5788999999999986654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   +....+......   
T Consensus       160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~---  227 (270)
T cd05056         160 ESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERL---  227 (270)
T ss_pred             ccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcC---
Confidence            3211      1122334568999999988889999999999999999986 99999875432   222333222211   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                       ..+..+|.++.+++.+||..+|++||++.++.+.|+++...
T Consensus       228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             23356789999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.3e-40  Score=304.92  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=196.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....    ..+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-RRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-eeCCEEEEEE
Confidence            57999999999999999999999899999999865432    224578899999999987766665544 5667789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|..++. ....+++..++.++.|++.||+|||++||+||||||+||++   +.++.++|+|||++........
T Consensus        80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          80 EYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             eccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            999 555555544 35579999999999999999999999999999999999999   5778999999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc--------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------  232 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------  232 (404)
                             ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+............        
T Consensus       156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence                   1123467889999999876 457899999999999999999999998755432222211111000        


Q ss_pred             ---------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ...........++..+.+++.+||+.+|++||++.++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                           001112223467889999999999999999999987753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.2e-40  Score=306.16  Aligned_cols=249  Identities=18%  Similarity=0.335  Sum_probs=191.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||.++....   ..++..|..++.+..+++++..+..+.......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            579999999999999999999999999999998765432   23455666664444444444444444456677899999


Q ss_pred             ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+.++|.+++...   +..+++..++.++.||+.||+|||++ +++||||||+|||+   +.++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence            9999999888642   34689999999999999999999997 99999999999999   67889999999999865432


Q ss_pred             CCcccccccCCCCCccCcCccccccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ..        .....|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.....  ..+.+..+.......
T Consensus       158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~  227 (283)
T cd06617         158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQ  227 (283)
T ss_pred             cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCC
Confidence            21        123467889999999865    4468999999999999999999999975322  122222222211111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       .  ....+|.++.+++.+||..+|++||++.++.+
T Consensus       228 -~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 -L--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -C--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0  11247899999999999999999999987754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.9e-40  Score=306.36  Aligned_cols=247  Identities=22%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..+|++.+.||.|+||.||+|.+..+++.|+||.+....  ..+.+.+|+.+++.++|++++..+..+ ......++++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e   96 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-LVGDELFVVME   96 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-ecCceEEEEEE
Confidence            357999999999999999999999999999999876543  234578899999999988877766554 45667899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.  ...+++.++..++.|++.||+|||++|++||||||+||++   +.++.+||+|||++........ 
T Consensus        97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          97 YLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             ecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc-
Confidence            99 889999887  3468999999999999999999999999999999999999   5788999999999876544321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.+...   ......+.....  .....+.
T Consensus       171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~~~~~~--~~~~~~~  239 (296)
T cd06655         171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGT--PELQNPE  239 (296)
T ss_pred             ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC--cccCCcc
Confidence                  12245688999999999988899999999999999999999999977433   222222221111  1112234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+++.+.+++.+||..||++||++.+|.
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il  267 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELL  267 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            6789999999999999999999988665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=306.27  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=201.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||.|+||.||+|++..+++.||+|+......   ...+.+|+.+++.++|++++..+.. ...+...++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS-FLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEE-EEECCeEEEEEE
Confidence            579999999999999999999999999999998765432   2357889999999998877766654 455678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ++ +++|.+++..  .++++..+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||+++.+..... 
T Consensus        80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence            98 8899999984  379999999999999999999999999999999999999   5788999999999987765422 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....   ......+......    .+..
T Consensus       154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~----~~~~  220 (274)
T cd06609         154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPP----SLEG  220 (274)
T ss_pred             ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCC----CCcc
Confidence                  22345788899999999998899999999999999999999999976442   2222222222111    1122


Q ss_pred             C-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 G-YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~-~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      . ++.++.+++.+||..+|++||+++++.+
T Consensus       221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2 7899999999999999999999887744

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-40  Score=302.60  Aligned_cols=245  Identities=27%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             eeeceeCceeEEEEEEcCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.||+|+||.||+|.+...   +..|++|++.....   ...+..|+++++.++|++++..+..+. .....+++|||+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-EEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-CCCceEEEEEecc
Confidence            4799999999999998765   89999998876544   356889999999999766666555444 477889999999 


Q ss_pred             CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           86 GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        86 ~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|.+++...        ...+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence            99999999865        3679999999999999999999999999999999999999   577999999999998766


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ....     +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   .+....+....    
T Consensus       157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~----  224 (262)
T cd00192         157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGY----  224 (262)
T ss_pred             cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC----
Confidence            5432     112344567889999999998889999999999999999999 6999988633   33333333221    


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ....+..+|.++.+++.+||..+|++||++.++.+.|
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1123456789999999999999999999999998876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-40  Score=305.73  Aligned_cols=254  Identities=19%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHc-CCCCCCceeEee----eeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQ-GGTGIPNLRWFG----VEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-~~~~i~~~~~~~----~~~~~   77 (404)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|+...... ...+..|+.+++.+. |++++..+..+.    ..+..
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            356799999999999999999999999999999998764332 356888999999995 666666655443    24567


Q ss_pred             EEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           78 NVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      .+++|||+ +++|.+++..   ....+++..+..++.|++.||.|||+++|+||||||+||++   +..+.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~  171 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVS  171 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCce
Confidence            89999999 8899998753   23468999999999999999999999999999999999999   57788999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      +.......       ......|+..|+|||++..     ..++.++|||||||++|||++|+.||......   ..+..+
T Consensus       172 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~  241 (286)
T cd06638         172 AQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI  241 (286)
T ss_pred             eecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence            76643221       1234468999999999853     44789999999999999999999999875432   112221


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ....  ......+..++.++.+++.+||+.||++||++.++++.
T Consensus       242 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 PRNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1111  11111223467899999999999999999999887653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-40  Score=303.49  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=200.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+......           +.+.+|+.+++.++|++++..+.. .....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS-SLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE-EEeCC
Confidence            588899999999999999999889999999977543221           347789999999998776665554 45667


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||++   ++++.++|+|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~  155 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK  155 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence            888999998 8899999975 4578999999999999999999999999999999999999   6888999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .......... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+...   ...+..+...    
T Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----  227 (267)
T cd06628         156 LEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGEN----  227 (267)
T ss_pred             cccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhcc----
Confidence            7532211100 0112235688999999999988899999999999999999999999987432   2222222221    


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....++..++.++.+++.+||+.||++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            112334567899999999999999999999887764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-40  Score=306.90  Aligned_cols=247  Identities=19%  Similarity=0.306  Sum_probs=197.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .|++.+.||+|+||.||+|.+..++..+++|.+.....  ...+.+|+++++.++|++++..+..+ ......++++||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-eeCCEEEEEEEec
Confidence            47889999999999999999999999999998765432  34577899999999988877766554 4566789999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|..++......+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++........   
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~---  158 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ---  158 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence             788888877556679999999999999999999999999999999999999   5788999999999876543221   


Q ss_pred             ccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          165 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                          ......++..|+|||++.     +..++.++|||||||++|||++|+.||.....   .+.+..+.......  ..
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~  229 (282)
T cd06643         159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--LA  229 (282)
T ss_pred             ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--CC
Confidence                123456899999999984     44578899999999999999999999987442   22233332221111  12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+..++.++.+++.+||+.||++||++.+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  260 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLL  260 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            2345789999999999999999999987664

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-40  Score=307.47  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..+|++.++||+|+||.||++...     .++..+++|.+.....  ...+.+|+++++.++|++++..+. +.......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYG-VCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEE-EEecCCce
Confidence            467899999999999999999743     3467899997654332  346889999999999877666554 45566778


Q ss_pred             EEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC
Q 015592           79 VLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~  143 (404)
                      +++|||+ +++|.+++....              ..+++..++.++.|++.||+|||++||+||||||+|||+   ++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cCCC
Confidence            9999998 889999987532              248899999999999999999999999999999999999   5788


Q ss_pred             eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 015592          144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK  222 (404)
Q Consensus       144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~  222 (404)
                      .+||+|||+++.......     +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   .
T Consensus       160 ~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~  231 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---T  231 (280)
T ss_pred             CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---H
Confidence            999999999975543221     112233445788999999999899999999999999999998 9999976433   2


Q ss_pred             HHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ..+..+.....    ......+|+.+.+++.+||+.||++||++.+|.+.|+
T Consensus       232 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 EAIECITQGRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHHcCcc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            22333322211    1223467899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=293.40  Aligned_cols=248  Identities=18%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.+++..||.|+-|.||+++.+.+|...|||.+......+   ++.+.+.++.+....+.|+.-..|+..+....+.||+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3456778999999999999999999999999887655443   4566666666666577777777777777778899999


Q ss_pred             cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      +..-++.+++...+++++.-+-++...++.||.||.+ +||||||+||+|||+   |..|++||||||++-.+.++..  
T Consensus       173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA--  247 (391)
T KOG0983|consen  173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA--  247 (391)
T ss_pred             HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc--
Confidence            9888999998888899999999999999999999997 589999999999999   7999999999999988877654  


Q ss_pred             cccccCCCCCccCcCccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .+...|.+.|||||.+.-.   .|+.++||||||++|+||.||+.||.+.+  ...+.+.++..... +.++. 
T Consensus       248 ------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~eP-P~L~~-  317 (391)
T KOG0983|consen  248 ------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEP-PLLPG-  317 (391)
T ss_pred             ------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCC-CCCCc-
Confidence                  3456799999999998743   48999999999999999999999999854  34555666665332 22222 


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..++++.+++++..||.+|+.+||.+.+|+
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll  347 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLL  347 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence            235899999999999999999999998654

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.5e-40  Score=306.94  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=197.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-------hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +|++.+.||+|+||.||+|.+..+++.|+||.+......       ..+..|+.+++.++|++++..+..+.. ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            589999999999999999999889999999987654332       346789999999998887776665544 678899


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+++......+++..++.++.||++||.|||++||+|+||||+|||+   +.++.++|+|||+++......
T Consensus        80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence            99999999999997533379999999999999999999999999999999999999   578899999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc-------
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------  232 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------  232 (404)
                      .       ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+......   +.++....       
T Consensus       157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~  226 (298)
T cd07841         157 R-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEEN  226 (298)
T ss_pred             c-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhh
Confidence            1       1123356788999999865 4578999999999999999999888876443222   22221110       


Q ss_pred             ----------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      ............+.++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                            011112223455788999999999999999999877654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=304.81  Aligned_cols=247  Identities=20%  Similarity=0.272  Sum_probs=192.6

Q ss_pred             eeeceeCceeEEEEEEcCCCc--EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|++..++.  .+++|..+...   ..+.+..|++++.++.+|+++..+..++......+++|||+ +
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999887775  46888765322   22457889999999965555555555556667789999998 8


Q ss_pred             CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           87 PSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        87 ~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      ++|.+++....               ..+++.+++.++.|++.||+|||++|++||||||+|||+   +.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence            89999987422               247899999999999999999999999999999999999   678899999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      ++.......        .......+..|+|||++.+..++.++|||||||++|||++ |..||.+...   ...+..+..
T Consensus       158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~  226 (270)
T cd05047         158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ  226 (270)
T ss_pred             Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence            986322111        1112234567999999988889999999999999999997 9999976433   222333322


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...    ......++.++.+++.+||..||.+||++.++...|+.++
T Consensus       227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 GYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC----CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111    1123357789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=321.79  Aligned_cols=241  Identities=22%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|.=++.||.|+||.||-|++..+.+.||||.+....     .+.++..|+.+|+.+.|||.|.+ ..|...+...++||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieY-kgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEY-KGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccc-cceeeccchHHHHH
Confidence            3666788999999999999999999999999876432     34568999999999998887755 45555666789999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |||-||-.|++.-..+++.+.++..|+.+.+.||.|||+.+.||||||..|||+   .+.|.|||+|||.|......   
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCch---
Confidence            999999999998778899999999999999999999999999999999999999   58999999999999766543   


Q ss_pred             ccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                              .+++|||.|||||++.   .+.|+-|+||||||++..||...++|+.++++......+   .....+..   
T Consensus       180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtL---  245 (948)
T KOG0577|consen  180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTL---  245 (948)
T ss_pred             --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCC---
Confidence                    4689999999999986   456999999999999999999999999987764433322   22221111   


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      .....+..|+.++..||.+-|.+|||.+++
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~l  275 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEEL  275 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence            123478899999999999999999998865

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=301.88  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.++||+|+||.||+|.+. .++.||||.+..... ...+..|+.+++.++|++++..+.. .......+++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV-CSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeee-eecCCceEEEE
Confidence            45789999999999999999999974 567899998775433 4568999999999998776665544 44556789999


Q ss_pred             ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |++ +++|.+++.... ..+++.++..++.|++.||.|||++||+|+||||+||++   +.++.+||+|||+++.+....
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence            998 889999997533 469999999999999999999999999999999999999   578999999999998765421


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .      .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+...   ...+..+.....    ..
T Consensus       158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~----~~  224 (261)
T cd05034         158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR----MP  224 (261)
T ss_pred             h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CC
Confidence            1      11123345678999999998889999999999999999998 9999976433   333333332211    11


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .+..+|.++.+++.+||..+|++||+++++.+.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            224568999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-39  Score=303.08  Aligned_cols=250  Identities=20%  Similarity=0.233  Sum_probs=192.2

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHc-CCCCCCceeEeeeeC--CeEEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQ-GGTGIPNLRWFGVEG--DYNVLVI   82 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~--~~~~lv~   82 (404)
                      |++.++||+|+||.||+|.+..+++.||+|.++....   .....+|+.++.++. |++++..+..+ .+.  ...+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL-FDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEE-ecCCCCcEEEEE
Confidence            7889999999999999999999999999998765322   223457888888887 55555544444 444  6789999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+.++|.+.+......+++.+++.++.|++.||+|||++||+||||||+||++   +. +.+||+|||+++....... 
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCCC-
Confidence            999889999887655679999999999999999999999999999999999999   45 9999999999986644321 


Q ss_pred             ccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh----------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------  231 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------  231 (404)
                             .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+...........          
T Consensus       155 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         155 -------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             -------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence                   123467899999997654 45789999999999999999999999874432211111111000          


Q ss_pred             -----------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                 .....+..+...++.++.+++.+||+.+|++||++.++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                       0001122233467899999999999999999999887754

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.4e-40  Score=301.69  Aligned_cols=247  Identities=23%  Similarity=0.309  Sum_probs=198.0

Q ss_pred             eeeceeCceeEEEEEEcC-CC--cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      ++||+|++|.||+|.+.. .+  ..||||.+.....   .+.+.+|+.++++++|++++..+..+..  ...+++|||+ 
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999999865 33  3699998876544   3468899999999999888877766554  7789999998 


Q ss_pred             CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 ~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++   +.++.+||+|||+++.+......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~--  153 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH--  153 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc--
Confidence            899999997544 468999999999999999999999999999999999999   57799999999999876543221  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                        +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....+.....   ....+..
T Consensus       154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~---~~~~~~~  225 (257)
T cd05040         154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGE---RLERPEA  225 (257)
T ss_pred             --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCC---cCCCCcc
Confidence              112223457789999999998889999999999999999998 9999976443   222333222111   1122345


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +|..+.+++.+||+.+|++||++.++.+.|.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            7899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.3e-40  Score=302.03  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCceeEeee-eCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~   78 (404)
                      .+|++.+.||+|+||.||+|.+..+++.|++|.+.....       ...+.+|+.+++.++|++++..+..+.. .....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            479999999999999999999999999999998754321       1347789999999998888777765544 34678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++++||+ +++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+||++   +.++.+||+|||+++.+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence            8999998 7899999874 4568999999999999999999999999999999999999   578899999999997654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ......    .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....   .+.........   ..
T Consensus       158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~---~~  227 (266)
T cd06651         158 TICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQP---TN  227 (266)
T ss_pred             cccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCC---CC
Confidence            321100    011234588999999999998899999999999999999999999986432   22222222111   11


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++..+++.+.+++ .||..+|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            233345678889998 688899999999887753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-39  Score=303.13  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=200.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||+|.+..+++.|++|++.....    ...+.+|+.+++.++|++++..+..+ ..+...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-PHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-ecCCeeEEEec
Confidence            58999999999999999999998999999998765432    34688999999999977766655544 45778899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |++++|.+++......+++.+++.++.||+.||+|||++||+|+||||+||++   +..+.++|+|||++........  
T Consensus        80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~--  154 (286)
T cd07832          80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP--  154 (286)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence            99999999998666779999999999999999999999999999999999999   5788999999999986654321  


Q ss_pred             cccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc----------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------  232 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------  232 (404)
                          +......|+..|+|||++.+.. ++.++|||||||++|||++|..||.+....   ..+..+....          
T Consensus       155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhh
Confidence                1123456899999999987654 689999999999999999998888764332   1121111100          


Q ss_pred             ---------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ............+.++.+++.+||..+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                           000122333456789999999999999999999887654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=305.04  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=196.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+.....   ...+.+|+++++.++|++++..+. +.......+++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD-IIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEE-EEecCCeEEEEE
Confidence            4789999999999999999999988999999998764332   234678999999999877665554 455677899999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+.++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc-
Confidence            999889999988666679999999999999999999999999999999999999   6788999999999875432211 


Q ss_pred             ccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------  232 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  232 (404)
                            ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+...  ..+....+....         
T Consensus       159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhh
Confidence                  1122356889999999876 4589999999999999999999999976432  111111111000         


Q ss_pred             ----------------ccccHhHhhcCCc--HHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ----------------~~~~~~~~~~~~~--~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      ...........++  .++.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                            0011111112334  78899999999999999999887653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-39  Score=306.99  Aligned_cols=251  Identities=18%  Similarity=0.284  Sum_probs=196.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.....   ..++.+|+++++.++|++++..+..+ ..+...+++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-YSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCEEEEEee
Confidence            479999999999999999999999999999998765432   23578899999999988777666554 55678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.++++. ...+++..+..++.|++.||.|||+ .+|+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence            98 7899999985 4679999999999999999999998 699999999999999   578889999999987554322 


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH-------------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-------------  228 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------  228 (404)
                              .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+...             
T Consensus       155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                    23457899999999999888999999999999999999999999753321111111000             


Q ss_pred             ----------------hhhcccccHhHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 ----------------SEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ----------------~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      .........+.++ ..++.++.+++.+||..+|++||++.++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  286 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK  286 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            0000000000111 136788999999999999999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.8e-40  Score=306.81  Aligned_cols=253  Identities=22%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++.....   ...+.+|+.+++.+.|++++..+. +...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~-~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLG-VCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEE-EEcCCCc
Confidence            468999999999999999999874     3678999998765432   245888999999999877666555 4455667


Q ss_pred             EEEEEecc-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      .+++|||+ +++|.+++....                     ..+++.+++.++.|++.||+|||++|++||||||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            89999998 789999987421                     24788899999999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ  214 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~  214 (404)
                      +   +.++.++|+|||++........     +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       163 ~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         163 V---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             e---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9   5788999999999875543221     111223345678999999998899999999999999999997 889997


Q ss_pred             CCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +...   .+....+......    ..+..++.++.+++.+||+.+|++||++.++.+.|+
T Consensus       235 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         235 GMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            6443   2333333322221    223467899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.9e-40  Score=308.02  Aligned_cols=261  Identities=18%  Similarity=0.254  Sum_probs=204.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+.....     ...+.+|+++++.++|++++..+ .....+...+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~-~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeE-EEEecCCEEEEE
Confidence            479999999999999999999999999999998765432     23577899999999887766655 444566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ |++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++   +..+.+||+|||+++......
T Consensus        80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence            9999 8899999975 4579999999999999999999999999999999999999   578899999999987422111


Q ss_pred             Ccc--------cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          161 THQ--------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       161 ~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      ...        ...........++..|+|||.+.+..++.++|+|||||++|||++|..||.+...   .+.+..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~  232 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD  232 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence            000        0000011234678899999999988899999999999999999999999986432   33333333222


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...+  .....+|.++.+++.+||+.||++||++..+.++|++.+
T Consensus       233 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         233 IEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             cCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            1111  111257899999999999999999999888888877654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-39  Score=297.71  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....    ....+.+|+.++++++|++++..+..+ .+....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-MDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-ecCCeEEEEEE
Confidence            6999999999999999999999999999999866443    234588999999999877766655554 45678899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+||++   +.++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence            99 88999999754 3468999999999999999999999999999999999999   5788999999999986654332


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......|++.|+|||++.+..++.++||||||+++|||++|..||...   +..+....+.......    ..
T Consensus       157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~~  222 (256)
T cd08221         157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTP----VV  222 (256)
T ss_pred             -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCC----Cc
Confidence                   123456899999999999888999999999999999999999999763   3334444444333322    22


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ..++.++.+++.+||..+|++||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            5678999999999999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.7e-40  Score=305.95  Aligned_cols=248  Identities=18%  Similarity=0.283  Sum_probs=198.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....   ...+.+|+.++++++|++++..+..+ ......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-FIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-ecCCeEEEEEe
Confidence            479999999999999999999988999999998765422   24688899999999887777766544 45678899999


Q ss_pred             cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+ +++|.+++...  ...+++..+..++.|++.||.|||+ .||+||||||+||++   +.++.+||+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence            99 88999888743  2369999999999999999999997 599999999999999   56889999999999765432


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .         .....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||...........+..+.....
T Consensus       157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd06622         157 L---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP  227 (286)
T ss_pred             c---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence            2         12346788999999986543      58899999999999999999999976443332222333322221


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                          ..++..++.++.+++.+||..+|++||++.++.+
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                2234457899999999999999999999887765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.8e-40  Score=312.55  Aligned_cols=254  Identities=17%  Similarity=0.211  Sum_probs=190.5

Q ss_pred             Eeeeecee--CceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592           11 LGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus        11 i~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ++++||+|  +|++||++++..+++.||+|.++....    ...+.+|+.+++.++|++++..+.. ...+...+++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~-~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRAT-FIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEE-EEECCEEEEEEec
Confidence            57889999  789999999999999999998875432    2347789999999998777776554 4566778999999


Q ss_pred             c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+   +.++.++++||+.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence            9 88999999743 3459999999999999999999999999999999999999   57789999999876544322111


Q ss_pred             ccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc-----
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-----  235 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-----  235 (404)
                      ............++..|+|||++.+  ..++.++|||||||++|||++|+.||........   ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence            1000001123356788999999976  4589999999999999999999999986443211   11111100000     


Q ss_pred             ------------------------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 ------------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ------------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                          ........+++++.+++.+||+.||++|||++++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                                000112235678999999999999999999987754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-39  Score=300.38  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCceeEeeee-CCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~   78 (404)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+.....       ...+.+|+.+++.+.|++++..+..+... ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999998753221       13477899999999988887776655433 4567


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+||++   +.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            8999999 7899999875 3568999999999999999999999999999999999999   578899999999998654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ......    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+...   ...+..+.....   .
T Consensus       158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~---~  227 (265)
T cd06652         158 TICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT---N  227 (265)
T ss_pred             cccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCC---C
Confidence            321110    012235688999999999988899999999999999999999999986422   222222222111   1


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+..++..+.+++.+||. +|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            22334567889999999995 8999999887754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.7e-40  Score=315.32  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----   74 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||.+....    ....+.+|+.+++.++|++++..+..+...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45788999999999999999999999999999999875432    223577899999999998888877665432     


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||+.++|.+.+..   .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence            235799999999899998863   28999999999999999999999999999999999999   678899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .......        .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.   ...+..+......
T Consensus       167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~  235 (353)
T cd07850         167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGT  235 (353)
T ss_pred             eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence            6544221        2244678999999999999999999999999999999999999976432   1112211110000


Q ss_pred             c-------------------------cHhHh-------------hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 T-------------------------SIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ~-------------------------~~~~~-------------~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +                         ....+             ....++++.++|.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0                         00000             1134667899999999999999999876653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-39  Score=302.84  Aligned_cols=253  Identities=20%  Similarity=0.238  Sum_probs=198.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||.|+||.||+|++..+++.||||.+.....    ...+.+|++++++++|++++..+..+ ......+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-ccCCcEEEEee
Confidence            58999999999999999999999999999998765432    24588999999999988877766654 46678899999


Q ss_pred             ccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+.++|.+++... ...+++..+..++.|++.||+|||++|++||||+|+||++   +.++.+||+|||++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence            9988999988743 3568999999999999999999999999999999999999   6788999999999876543221 


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh----------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------  231 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------  231 (404)
                            ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||.+....+...........          
T Consensus       156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence                  112335688999999987655 689999999999999999999999764332111111110000          


Q ss_pred             -----------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                 ............+++++.++|.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                       0011122233457889999999999999999999887753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-39  Score=307.58  Aligned_cols=263  Identities=22%  Similarity=0.235  Sum_probs=201.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeee-------
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-------   73 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------   73 (404)
                      ..++|++.++||+|+||.||+|++..+++.||||++.....    ...+.+|+++++.++|++++..+..+..       
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            35799999999999999999999999999999998754322    2357889999999999888887655433       


Q ss_pred             eCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           74 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      .....+++|+|++++|.+.+......+++..+..++.|+++||.|||++||+||||||+|||+   +.++.++|+|||++
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~  162 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA  162 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence            234579999999889988887555679999999999999999999999999999999999999   68899999999999


Q ss_pred             ccccccCCcccc----cccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          154 KRYRDTATHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       154 ~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      +...........    .........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.......+.+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            866543221110    00112344678899999988764 4799999999999999999999999875443222222211


Q ss_pred             hhh----------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          229 SEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       229 ~~~----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ...                      ............+++.+.+++.+||+.||++||++.+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            110                      001111112234557899999999999999999987765

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=321.93  Aligned_cols=248  Identities=19%  Similarity=0.325  Sum_probs=204.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|.|+..||.|+||.||+|.++.++-..|.|++..+.  ..+.+.-|+.||..+.|+.++..+..|..++.. +|+.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL-wiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL-WILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce-EEEEee
Confidence            45778889999999999999999898888999876554  345688899999999988888888777666655 555666


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      | ||-...++-..++.|.+.++..+++|++.||.|||+++|||||||..|||+   .-+|.++|+|||.+........  
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~q--  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQ--  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhHHh--
Confidence            7 888888888888999999999999999999999999999999999999999   5889999999999875544332  


Q ss_pred             cccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                           ....+.|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++...   +.++.....+.  -
T Consensus       186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV---llKiaKSePPT--L  255 (1187)
T KOG0579|consen  186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSEPPT--L  255 (1187)
T ss_pred             -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH---HHHHhhcCCCc--c
Confidence                 345789999999999865     56799999999999999999999999988766332   33333332222  2


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..+..++..|.+++.+||.+||+.||++++|+
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll  287 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL  287 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence            22345788999999999999999999998874

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-40  Score=305.82  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=204.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee-eCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~   77 (404)
                      .+.|++.+.||+|+||.||+|++.    .+++.||||++.....   ...+.+|+++++.++|++++..+..+.. ....
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            357889999999999999999864    3478999998876554   4568999999999998877776654433 3557


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+|+||||+||++   +.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccccc
Confidence            89999999 889999998655569999999999999999999999999999999999999   57799999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-----------HHHH
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQKY  225 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-----------~~~~  225 (404)
                      ......    +.......++..|++||.+.+..++.++|||||||++|||++|..||........           ....
T Consensus       160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            532211    1111223456679999999988899999999999999999999999876432210           1111


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      .........   ......+|.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       236 ~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111111   111245688999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=305.79  Aligned_cols=250  Identities=19%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.||.|+||.||+|.+..+++.||+|+......  .+.+..|+.+++.++|++++..+..+ ......+++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-FYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-ecCCeEEEEee
Confidence            4679999999999999999999988999999998765432  24578899999999977666655554 45678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence            99 889999998666779999999999999999999999999999999999999   5789999999999876543221 


Q ss_pred             ccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                            ......+++.|+|||.+.     +..++.++|||||||++|+|++|+.||.....   ...+..+......  .
T Consensus       159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~--~  227 (280)
T cd06611         159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPP--T  227 (280)
T ss_pred             ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCC--C
Confidence                  123456899999999975     34478899999999999999999999987533   2223333222111  1


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+..++.++.+++.+||..+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1123457889999999999999999999887643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-39  Score=299.23  Aligned_cols=247  Identities=22%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~   82 (404)
                      +|++.+.||.|+||.||++.+..+++.||+|++.....    .+.+..|+.+++.++|++++..+..+.. .+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999998764432    2347789999999999888877655543 456678999


Q ss_pred             ecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        83 e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH-----~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ||+ +++|.+++...   ..++++..++.++.||+.||.|||     +.+|+|+||||+||++   +.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence            998 88999998754   457999999999999999999999     8999999999999999   57899999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      ........       ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....   .......+.....
T Consensus       158 ~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~  227 (265)
T cd08217         158 KILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKF  227 (265)
T ss_pred             ccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCC
Confidence            87654332       1234568999999999999889999999999999999999999998743   2233333333222


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                          ..++..++.++.+++.+||+.+|++||++.+|++
T Consensus       228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                2344567899999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.2e-40  Score=311.91  Aligned_cols=257  Identities=21%  Similarity=0.217  Sum_probs=200.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC----C
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----D   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~   76 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||.+...    .....+.+|+.+++.++|++++..+..+....    .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            678999999999999999999999999999999987542    12345778999999999888887776543322    3


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ..++++||++++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||+|||+++..
T Consensus        83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTT  158 (337)
T ss_pred             cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccccc
Confidence            5799999999999999874 4679999999999999999999999999999999999999   57889999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh-----
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-----  230 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-----  230 (404)
                      .....       ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...............     
T Consensus       159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         159 SEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             CCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            54321       1234567889999999875 4589999999999999999999999976432111111111000     


Q ss_pred             ------------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          231 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       231 ------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                                        .............+++++.+++.+||+.+|++||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                              000111222335678999999999999999999998766543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.4e-39  Score=302.52  Aligned_cols=252  Identities=20%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHH-cCCCCCCceeEeeee----CCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKIL-QGGTGIPNLRWFGVE----GDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~----~~~~   78 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ....+..|+.+++++ +|++++..+..+...    ....
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            4578999999999999999999999999999999876543 235678899999999 556555555544332    2467


Q ss_pred             EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           79 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +++|||+ +++|.++++.   ...++++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||++.
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~  176 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSA  176 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccch
Confidence            9999999 8899998863   24578999999999999999999999999999999999999   578889999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      .......       ......|+..|+|||.+....     ++.++|||||||++|||++|+.||.....   ...+..+.
T Consensus       177 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~  246 (291)
T cd06639         177 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP  246 (291)
T ss_pred             hcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence            6554321       112346889999999986433     68999999999999999999999987433   22233332


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......  ...+..++..+.+++.+||+.+|++||++.++.+
T Consensus       247 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         247 RNPPPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cCCCCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            221111  0112346678999999999999999999887764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-39  Score=297.39  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=200.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||++.+..+++.+|||.+.....    ...+..|+.+++.++|++++..+.. .......+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-FLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-EecCCEEEEEEe
Confidence            69999999999999999999999999999998765432    3358889999999998777766554 446677899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..+..++.|++.+|+|||++||+|+||||+||+++  +.++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence            99 88999999754 34589999999999999999999999999999999999995  3456789999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+.....    ..++
T Consensus       158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~  222 (256)
T cd08220         158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTF----APIS  222 (256)
T ss_pred             --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCC----CCCC
Confidence                    2245688999999999988899999999999999999999999977433   223333322221    2234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++.++.+++.+||+.+|++||++.++.+
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            467899999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-40  Score=306.02  Aligned_cols=253  Identities=17%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.+.||+|+||+||++.+..+++.||+|+......   ...+.+|+++++.++|++++..+..+ ......+++|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-LNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-ecCCEEEEEE
Confidence            4679999999999999999999999999999998764432   34688999999999877777666554 4557889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ ++|+||||||+||++   +.++.++|+|||++.......
T Consensus        83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence            999 8899998875 4569999999999999999999997 699999999999999   578899999999987553322


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC----hHHHHHHHhhhccccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKKVSTS  236 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~  236 (404)
                               .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......    ....+...........
T Consensus       159 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         159 ---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             ---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence                     124578999999999988889999999999999999999999998654321    0000111111111111


Q ss_pred             HhHhhc-CCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          237 IEALCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       237 ~~~~~~-~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ...+.. .++.++.+++.+||+.||++||++.++.+.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111112 378899999999999999999999877654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-40  Score=304.39  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=200.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ...|+..+.||.|+||.||+|.+..+++.||||++.....   ...+.+|+.+++.+.|++++..+.. ...+...+++|
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS-YLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEE-EEECCEEEEEE
Confidence            4568899999999999999999988999999998765432   2357889999999987766666554 45677899999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.  ..++++..+..++.|++.||+|||+++++|+||+|+||++   +.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence            999 889999987  4579999999999999999999999999999999999999   5788899999999976644321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......++..|+|||.+.+..++.++|+|||||++|||++|..||......   .....+....    .+.+.
T Consensus       157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~----~~~~~  222 (277)
T cd06640         157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNN----PPTLT  222 (277)
T ss_pred             -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCC----CCCCc
Confidence                   123346788999999999888999999999999999999999999875432   1122221111    12233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ..++..+.+++.+||+.+|++||++.++.+.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            4568899999999999999999999888543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-40  Score=306.60  Aligned_cols=251  Identities=16%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHc-CCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQ-GGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.....   ...+.+|+.++.++. |++++..+. +...+...+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~-~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG-ALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeee-EEecCCcEEEEE
Confidence            467788999999999999999999999999998765432   235788999999997 555555444 444566788999


Q ss_pred             eccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           83 DLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        83 e~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ||++.+|.++...    ....+++..+..++.|++.||+|||+. +|+||||||+|||+   +..+.+||+|||+++.+.
T Consensus        83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhc
Confidence            9998888776542    235699999999999999999999974 99999999999999   578899999999997654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ....        .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....  ...+...++......
T Consensus       160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~  229 (288)
T cd06616         160 DSIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP  229 (288)
T ss_pred             cCCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC
Confidence            4321        1234678999999999876   58999999999999999999999997643  122222222221111


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .........++.++.+|+.+||+.+|++||++++|.+
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111122347899999999999999999999987754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-39  Score=302.26  Aligned_cols=252  Identities=20%  Similarity=0.246  Sum_probs=195.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++......   ..+.+|+.+++.++|++++... .+...+...+++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~-~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH-DIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEE-EEEecCCeEEEEE
Confidence            46899999999999999999999999999999987654322   3577899999999987766544 4455677889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||++++|.+.+......+++..+..++.|++.||.|||++||+|+||||+|||+   +.++.+||+|||+++....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC-
Confidence            999888888876545568899999999999999999999999999999999999   5788999999999975443221 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------  232 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  232 (404)
                            ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+...  ..+.+.++....         
T Consensus       159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence                  12234578999999998764 478999999999999999999999986432  122222211100         


Q ss_pred             ----------------ccccHhHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ----------------VSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ----------------~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                      ..........  ..+.++.+++.+|+..||.+|||+.++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l  286 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL  286 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence                            0000111111  1357899999999999999999988764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.4e-40  Score=306.36  Aligned_cols=248  Identities=22%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....  .+.+..|+.+++.++|++++..+..+ ..+...+++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCEEEEeec
Confidence            4789999999999999999999989999999998765432  34578899999999888777666554 45667899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.  ...+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc-
Confidence            99 889999987  3568999999999999999999999999999999999999   5788999999999976544321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+......   ...+....  ......+.
T Consensus       171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~--~~~~~~~~  239 (297)
T cd06656         171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNG--TPELQNPE  239 (297)
T ss_pred             ------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCC--CCCCCCcc
Confidence                  12244688999999999998899999999999999999999999976433111   11111111  11111234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+.+++.+||..+|++||++.++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            57889999999999999999999886654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.5e-39  Score=302.36  Aligned_cols=235  Identities=22%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....     ..+.+.+|+++++.++|++++..+. +...+...+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG-SFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceee-EEEcCCeEEEE
Confidence            57999999999999999999999999999999875432     2345788999999999776665554 44566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+|+||+|+|||+   +.++.+||+|||+++..... 
T Consensus        80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence            9999 9999999975 4679999999999999999999999999999999999999   57889999999999876543 


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                               .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......+.....     .+
T Consensus       155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~  217 (290)
T cd05580         155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RF  217 (290)
T ss_pred             ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cC
Confidence                     124568999999999998889999999999999999999999997644   2333333332221     23


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP  264 (404)
                      +..++..+.+++.+||..||++|+
T Consensus       218 ~~~~~~~l~~li~~~l~~~p~~R~  241 (290)
T cd05580         218 PSFFSPDAKDLIRNLLQVDLTKRL  241 (290)
T ss_pred             CccCCHHHHHHHHHHccCCHHHcc
Confidence            456789999999999999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-39  Score=310.90  Aligned_cols=260  Identities=18%  Similarity=0.243  Sum_probs=202.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeee---eCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~---~~~~   77 (404)
                      ++++|++.+.||.|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.++|++++..+..+..   ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            5689999999999999999999999999999999876532    23457789999999998887776655432   3457


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++|||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        83 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          83 VYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceeec
Confidence            899999998899999874 4569999999999999999999999999999999999999   688999999999997665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH--------
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------  228 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------  228 (404)
                      .......   .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+...        
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         159 SSPTEHK---YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ccCcCCC---cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            4322110   11234578899999999876 45899999999999999999999999774332111111110        


Q ss_pred             ---------------hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 ---------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ...........+.+..+.++.++|.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                           0011111122334567899999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.2e-40  Score=306.38  Aligned_cols=257  Identities=19%  Similarity=0.189  Sum_probs=199.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~   79 (404)
                      ..++|++.+.||.|+||.||+|.+..+++.+++|.++.....    ..+.+|+.++++++|++++.....+... ....+
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            346899999999999999999999989999999987654332    2457899999999987776665544332 37899


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||++++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||+   +.++.+||+|||++..+...
T Consensus        83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCC
Confidence            999999889999998655579999999999999999999999999999999999999   57889999999999876553


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------  232 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------  232 (404)
                      ..       ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.......      
T Consensus       160 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         160 LK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             cc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            21       122345788999999987654 6899999999999999999999998754322222111110000      


Q ss_pred             -----------------ccccHhHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -----------------VSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -----------------~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                       .......++.. +++.+.++|.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                             00000111112 4788999999999999999999887754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-39  Score=296.23  Aligned_cols=244  Identities=19%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ++||+|+||.||+|.. .+++.||+|++.....   ...+.+|+++++.++|++++..+..+ ......+++|||+ +++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-TQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-ecCCccEEEEECCCCCc
Confidence            4789999999999985 5788999998765432   23478899999999888777766554 4556789999998 899


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++......+++..++.++.|++.+|.|||++|++||||||+||++   +.++.+||+|||++.........      
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------  149 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------  149 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence            999987555678999999999999999999999999999999999999   57889999999998754432210      


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||.+....   .....+.....    ...+..++..
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~  222 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYR----MSCPQKCPDD  222 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCC----CCCCCCCCHH
Confidence            1122344678999999998889999999999999999998 99999875332   22222222111    1223467899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +.+++.+||+.+|++||++.++.+.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=304.79  Aligned_cols=250  Identities=20%  Similarity=0.254  Sum_probs=197.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+......     ..+..|+++++.++|++++..+.. .......+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYAS-FQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheee-eecCCEEEEE
Confidence            4799999999999999999999889999999987654322     357889999999997776666544 4566788999


Q ss_pred             Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |||+ +++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence            9998 88999998743 3569999999999999999999999999999999999999   57889999999998765432


Q ss_pred             CCcccc----------------------cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 015592          160 ATHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (404)
Q Consensus       160 ~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~  217 (404)
                      ......                      .........||..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            211000                      0001224578999999999999889999999999999999999999998744


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      .   ...+..+........   ....++.++.+++.+||..||++||+.
T Consensus       237 ~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         237 R---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             h---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCCc
Confidence            3   233333332222111   112268999999999999999999993

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-39  Score=310.40  Aligned_cols=259  Identities=19%  Similarity=0.228  Sum_probs=199.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeee--------
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVE--------   74 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--------   74 (404)
                      ++++|++.+.||.|+||.||+|++..+++.||+|.+.....  ...+.+|+.+++.++|++++..+..+...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            57899999999999999999999999999999998765433  34588899999999998888776544332        


Q ss_pred             -----CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           75 -----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        75 -----~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                           ....+++|||++++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+||+++  ..++.+||+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d  158 (342)
T cd07854          83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD  158 (342)
T ss_pred             ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence                 23578999999889998886  45699999999999999999999999999999999999995  3566899999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ||+++.+.......    .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus       159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99997654322111    01123467889999998764 45889999999999999999999999764432111111000


Q ss_pred             ----------------------hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 ----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                            .......+...+...++.++.+++.+||..||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                                  0001111222334467889999999999999999999887653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-39  Score=298.79  Aligned_cols=252  Identities=20%  Similarity=0.326  Sum_probs=198.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+.....        ...+.+|+.+++.++|++++..+..+ .+....+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-LDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-ecCCeEE
Confidence            588999999999999999986 5788999998764432        13478899999999987766655544 4567889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +++||+ +++|.+++.. ..++++..+..++.|++.||+|||+.||+|+||||+||++   +.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence            999999 8899999975 4568999999999999999999999999999999999999   6788999999999986543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||......   .....+...  ....+
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~  228 (265)
T cd06631         155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAH--RGLMP  228 (265)
T ss_pred             ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhc--cCCCC
Confidence            2111000 01123456899999999999988999999999999999999999999764321   111111111  11223


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..++.++.+++.+||+.+|++||++.++.+
T Consensus       229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            345678899999999999999999999887653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.6e-39  Score=307.54  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=201.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++++|++.+.||.|+||.||+|.+..+++.||||.+...    ...+.+..|+.+++.++|++++.....+.......+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3678999999999999999999999999999999976432    223567889999999999888887777666667789


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||++++|.++++  ...+++..+..++.|++.||.|||++||+||||||+|||+   +..+.++|+|||++......
T Consensus        87 lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             EEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC
Confidence            999999999999887  4568999999999999999999999999999999999999   57889999999998754321


Q ss_pred             CCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh---------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---------  229 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------  229 (404)
                                .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............+..         
T Consensus       162 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         162 ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence                      123467889999998876 568999999999999999999999997643211111111100         


Q ss_pred             --------------hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          230 --------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       230 --------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                    ......+.......+++++.++|.+||+.+|++||++.+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell  286 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL  286 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence                          00011122233346788999999999999999999987664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-39  Score=304.78  Aligned_cols=260  Identities=19%  Similarity=0.218  Sum_probs=198.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-------
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-------   74 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-------   74 (404)
                      .++|++.++||+|+||.||+|++..+++.||||.+.....    ...+.+|+++++.++|++++..+..+...       
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4679999999999999999999999999999998754322    22456899999999999888877665432       


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||++++|.+++......+++.+++.++.|++.||+|||++|++|+||||+||++   +.++.+||+|||++.
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcc
Confidence            24569999999999999987655579999999999999999999999999999999999999   678899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+........   .......++..|+|||.+.+.. ++.++||||||+++|||++|..||.+.........+..+.....
T Consensus       168 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         168 AFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             cccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            6654322110   0122446788999999987654 78999999999999999999999987543222222222111000


Q ss_pred             c------------------cc-----HhHh-hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 S------------------TS-----IEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~------------------~~-----~~~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .                  ..     ...+ ....++.+.++|.+||..||++||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0                  00     0000 0112467889999999999999999887753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-39  Score=301.50  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=195.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.++||+|+||.||+|.+..+++.||+|+......    .+.+.+|+++++.++|++++..+..+ ..+...++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCCeEEEEE
Confidence            579999999999999999999988999999997654322    34578899999999988777665554 5677889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.++.. ....+++..++.++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++........
T Consensus        80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          80 EFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             ecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            999 556666655 34569999999999999999999999999999999999999   5788999999999986544321


Q ss_pred             cccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------  231 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------  231 (404)
                             ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+....+......         
T Consensus       156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence                   12235678999999998764 4788999999999999999999999764321111111110000         


Q ss_pred             --------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                    ..........++++..+.+++.+||..+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                          0001112223467899999999999999999999987754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.6e-39  Score=301.08  Aligned_cols=255  Identities=20%  Similarity=0.241  Sum_probs=195.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.+.||+|++|.||+|++..+++.||+|.+.....    ...+.+|+++++.++|++++..+.. .......+++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV-VHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEE-EecCCeEEEEE
Confidence            579999999999999999999998999999998754322    2457889999999988776665554 45667899999


Q ss_pred             eccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++  ..++.+||+|||++........
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence            9998899888864332 368889999999999999999999999999999999994  3456899999999976543211


Q ss_pred             cccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc--------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------  232 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------  232 (404)
                             ......+++.|+|||.+.+. .++.++|||||||++|+|+||..||......+............        
T Consensus       159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence                   11234678899999998764 47899999999999999999999997643321111111100000        


Q ss_pred             -------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ...........+++++.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                         011111223457889999999999999999999887764

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=300.48  Aligned_cols=255  Identities=20%  Similarity=0.265  Sum_probs=198.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.+.||+|+||.||+|.+..+++.|+||+++...    ..+.+.+|+++++.++|++++..+..+ ..++..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-RRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-EECCEEEEEE
Confidence            57999999999999999999999999999999865432    335688999999999987776666554 4577889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||+++++.+.+......+++.++..++.||+.||.|||++||+|+||+|+||++   +.++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence            999666666555445669999999999999999999999999999999999999   57899999999999876554321


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh----------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------  231 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------  231 (404)
                            ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+...........          
T Consensus       157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence                  12345678899999999988 7899999999999999999999999864332111111110000          


Q ss_pred             --------c-----ccccHh-HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 --------K-----VSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 --------~-----~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                              .     ...... .....++.++.+++.+||..+|++||+++++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                    0     000001 122235889999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-39  Score=298.63  Aligned_cols=236  Identities=18%  Similarity=0.222  Sum_probs=187.7

Q ss_pred             eeeceeCceeEEEEEEcCCC----------cEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592           13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +.||+|+||.||+|.+..++          ..+++|+...... ...+.+|+.+++.++|++++..+..+..  ...+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEE
Confidence            47899999999999997766          4588887655433 5678899999999998888777766544  567899


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC-------eEEEEecCCc
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-------QVYIIDFGLA  153 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~-------~vkL~DFG~a  153 (404)
                      |||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   ..+       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence            9999 8899999986554799999999999999999999999999999999999995   444       7999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhh
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      ......           ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...........+.   .
T Consensus       156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~  221 (259)
T cd05037         156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D  221 (259)
T ss_pred             cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence            765431           133567789999999877  68999999999999999999 688887754322222221   1


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ...      .+......+.+++.+||..+|++||++.++.+.|
T Consensus       222 ~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         222 QHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            110      1111237899999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-39  Score=300.24  Aligned_cols=254  Identities=21%  Similarity=0.311  Sum_probs=200.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +|+..+.||+|+||.||++.+..+++.||+|++....        ....+..|+++++.++|++++..+..+. +....+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCeEE
Confidence            5889999999999999999999999999999876433        1345888999999999888877776654 555678


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++++|+ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++  .....+||+|||.+..+..
T Consensus        80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence            888888 8899999975 45799999999999999999999999999999999999994  2334699999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .......   ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..............+....   ...
T Consensus       157 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  230 (268)
T cd06630         157 KGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---TAP  230 (268)
T ss_pred             ccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC---CCC
Confidence            3221110   1234568899999999998889999999999999999999999997644333222222222111   112


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+..+++++.+++.+||..+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            333457889999999999999999999887753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-39  Score=299.48  Aligned_cols=253  Identities=19%  Similarity=0.250  Sum_probs=199.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~   82 (404)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+.....   ...+.+|+++++.++|++++..+..+.. .....+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999999999999998765433   3458899999999998888887766543 445789999


Q ss_pred             ecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        83 e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ||+ +++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||++   +..+.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccc
Confidence            999 8899988753   24568999999999999999999999999999999999999   5778899999999875543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--CChHHHHHHHhhhccccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~  236 (404)
                      ..         .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....  ....+....+........
T Consensus       158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            22         1234578899999999998999999999999999999999999986532  122222222222111110


Q ss_pred             HhHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....  ..+++.+.+++.+||..+|++||++.++.+
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00000  134678999999999999999999886654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-41  Score=319.76  Aligned_cols=248  Identities=19%  Similarity=0.330  Sum_probs=208.5

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEE---E---ecCCCCchhHHHHHHHHHHHcCCCCCCceeE-eeeeCCeEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---L---ENVKTKHPQLQYEAKLYKILQGGTGIPNLRW-FGVEGDYNVLV   81 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK---~---~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~-~~~~~~~~~lv   81 (404)
                      .++..+||+|+|-+||+|.|..+|.+||--   +   .+.....+.|..|+.+|+.|+|+|+|..+.. .........++
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            356779999999999999999999998843   2   2222334678999999999999999999854 45556677889


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      .|++ .|+|..++++. ++++.+.+..|++||+.||.|||++  .|||||||.+||+|+  ...|.|||+|+|+|+....
T Consensus       122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence            9988 99999999864 5699999999999999999999997  599999999999997  7789999999999998877


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      +..         ...+|||.|||||+.. ..|+..+||||||++|.||+|+.+||....  ...+.|.++..+..+..+.
T Consensus       199 s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  199 SHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             ccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhh
Confidence            543         3479999999999998 579999999999999999999999999874  4678888888777665444


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..   -.++++++|.+||.. ..+||++.+|   |.+.|.
T Consensus       267 kV---~dPevr~fIekCl~~-~~~R~sa~eL---L~d~Ff  299 (632)
T KOG0584|consen  267 KV---KDPEVREFIEKCLAT-KSERLSAKEL---LKDPFF  299 (632)
T ss_pred             cc---CCHHHHHHHHHHhcC-chhccCHHHH---hhChhh
Confidence            33   368999999999999 9999997655   444443

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.7e-39  Score=295.37  Aligned_cols=249  Identities=20%  Similarity=0.271  Sum_probs=199.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .+|++.+.||.|+||.||++.+. .+..+|+|.+..... ...+..|+++++.++|++++..+.. .......+++|+|+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV-CTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEE-EccCCceEEEEEcC
Confidence            57999999999999999999874 467899998765433 3568999999999998876665544 44556778999998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..+..++.|++.+|+|||++|++||||||+||++   +.++.++|+|||++........   
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~---  155 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY---  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc---
Confidence             889999998655678999999999999999999999999999999999999   5788999999999876543221   


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                         .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+......    ..+..
T Consensus       156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~  225 (256)
T cd05112         156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRL  225 (256)
T ss_pred             ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCC
Confidence               11123345678999999998889999999999999999998 9999976432   2233333221111    11234


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .+..+.+++.+||+.+|++||++.++.+.|
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            689999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=298.63  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=197.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHc-CCCCCCceeEeee-----eCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQ-GGTGIPNLRWFGV-----EGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-~~~~i~~~~~~~~-----~~~~   77 (404)
                      -.++|++.+.||+|+||.||+|.+..+++.+++|++..... .+.+.+|+.+++++. |++++..+..+..     .+..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            46899999999999999999999988999999998775443 356889999999995 5555555554432     2446


Q ss_pred             EEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           78 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      .+++|||+ +++|.+++...   +..+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccc
Confidence            79999999 77999988743   3579999999999999999999999999999999999999   57889999999998


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ........       ......|+..|+|||++..     ..++.++|||||||+||+|++|..||.....   ......+
T Consensus       161 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~  230 (275)
T cd06608         161 AQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKI  230 (275)
T ss_pred             eecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHh
Confidence            76544322       1234568999999998764     2367899999999999999999999976432   2222222


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ........  .....++.++.+++.+||..||++||++.++++
T Consensus       231 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            22211111  111246789999999999999999999988764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=302.60  Aligned_cols=260  Identities=21%  Similarity=0.238  Sum_probs=198.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEcC--CCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~   79 (404)
                      +|++.++||+|+||.||+|.+..  +++.||||++..     ....+.+.+|+.+++.++|++++..+..+... ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  899999998776     33345688899999999988888777665443 36789


Q ss_pred             EEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCCeEEEEecCCcc
Q 015592           80 LVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK  154 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~-~~~~~~vkL~DFG~a~  154 (404)
                      ++|||++++|.+++....    ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||+++
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            999999889988876432    26899999999999999999999999999999999999942 1128899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh------HHHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEK  227 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~  227 (404)
                      ........    ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+......      ...+..
T Consensus       161 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         161 LFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            76543221    1123345788999999988764 479999999999999999999999987544320      001111


Q ss_pred             Hhhh----------------------------ccc-ccH-hHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          228 ISEK----------------------------KVS-TSI-EALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       228 ~~~~----------------------------~~~-~~~-~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +...                            ... ... ....  ...+.++.+++.+||+.||++||++.++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1000                            000 000 0011  146678999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-40  Score=304.48  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=199.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-LKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-ccCCceEEEE
Confidence            3568888999999999999999988999999998764432   23578899999999987777666554 4566789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.  ...+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence            999 789998886  4579999999999999999999999999999999999999   5788999999999976654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........   ..+....    ...+.
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~----~~~~~  222 (277)
T cd06642         157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNS----PPTLE  222 (277)
T ss_pred             -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcCC----CCCCC
Confidence                   122346789999999999988999999999999999999999999765432221   1111111    11233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++.++.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            457889999999999999999999998876

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.4e-40  Score=301.88  Aligned_cols=247  Identities=19%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||.|+||.||++.+..+++.|++|.+.....   ..++.+|+++++.++|++++..+..+ ......++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-YNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-ecCCEEEEEEE
Confidence            478999999999999999999999999999998765432   24578899999999977766655554 44578899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ++ +++|.+++......+++..+..++.|++.||+|||+ .|++|+||||+||++   +.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence            99 689999998655789999999999999999999999 999999999999999   5788999999999876643321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--CChHHHHHHHhhhcccccHhH
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (404)
                               ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  .........+.....    ..
T Consensus       157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~  223 (265)
T cd06605         157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----PR  223 (265)
T ss_pred             ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----CC
Confidence                     125688999999999998999999999999999999999999976421  112222222222211    11


Q ss_pred             hhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       240 ~~~~-~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ++.. ++.++.++|.+||..||++||++.++.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  255 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL  255 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence            2222 788999999999999999999988765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-39  Score=309.37  Aligned_cols=264  Identities=18%  Similarity=0.247  Sum_probs=204.5

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHH-cCCCCCCceeEeee-e
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKIL-QGGTGIPNLRWFGV-E   74 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~-~   74 (404)
                      .+..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+...    .....+.+|+.+++.+ +|++++..+..+.. .
T Consensus         1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            3678899999999999999999999999889999999976432    2234577899999999 77777777665543 3


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||+.++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~  155 (337)
T cd07852          81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLAR  155 (337)
T ss_pred             CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchh
Confidence            456899999998899998873  378999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh---
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---  230 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---  230 (404)
                      .+........  ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.....   
T Consensus       156 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         156 SLSELEENPE--NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccc--CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            6654332110  012234568999999998865 4478999999999999999999999976443222111111100   


Q ss_pred             --------------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 --------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                          ...........+.++.++.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                                00111122333457899999999999999999999887765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-39  Score=297.58  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=202.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||.|+||+||+|.+..++..+++|++....   ....+.+|+.+++.++|++++..+.. .......+++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS-FVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEE-EeeCCEEEEEEe
Confidence            57999999999999999999998899999999886543   23468899999999998776665544 456678899999


Q ss_pred             cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        84 ~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ++ +++|.+++...  ...+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence            99 88999999753  2468999999999999999999999999999999999999   577899999999998776543


Q ss_pred             CcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ....   .......|+..|+|||++... .++.++|+|||||++|+|++|+.||......   +.+.+....... ....
T Consensus       157 ~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~~  229 (267)
T cd06610         157 DRTR---KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPP-SLET  229 (267)
T ss_pred             cccc---cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCC-CcCC
Confidence            3210   122345689999999998877 6899999999999999999999999875432   222222222111 1111


Q ss_pred             h--hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 L--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~--~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .  ...+++++.+++.+||..||++||++.+|++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1  1357899999999999999999999887764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.6e-39  Score=297.50  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +|++.++||.|++|.||+|++..+++.||||+++...   ....+.+|+.+++.++|++++..+. +.......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD-VIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeee-eEeeCCcEEEEEec
Confidence            5899999999999999999999999999999876543   2345778999999998766655554 44556778999999


Q ss_pred             cCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 LGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      +.++|.+++....  ..+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||++........ 
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence            9889999887543  458999999999999999999999999999999999999   5788999999999976543221 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc--------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------  233 (404)
                            ......++..|++||++.+. .++.++|||||||++|+|++|+.||.+..................        
T Consensus       156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence                  12234578899999998764 478999999999999999999999987543222221111110000        


Q ss_pred             -------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ......+...++.++.+++.+||+.||++||++.++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                         00111222356788999999999999999999887753

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.9e-39  Score=296.12  Aligned_cols=246  Identities=20%  Similarity=0.236  Sum_probs=201.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||++++..+++.|++|.+....    ....+.+|+.+++.++|++++..+. +.......++++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE-SFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEe-eecCCCeEEEEEe
Confidence            5999999999999999999999999999999876432    2346888999999999877665544 4456678899999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++.+++.++.|++.||.|||++|++|+||+|+|||+   +.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence            98 88999998753 3368999999999999999999999999999999999999   5788999999999986654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...   +....+..+.....    ...+
T Consensus       157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~----~~~~  222 (256)
T cd08218         157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSY----PPVS  222 (256)
T ss_pred             -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCC----CCCc
Confidence                   112346788999999999888999999999999999999999999753   33334444433322    2234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++.++.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            567899999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=294.66  Aligned_cols=245  Identities=21%  Similarity=0.312  Sum_probs=194.4

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ++||.|+||.||++.+.. ++.|++|.......   ...+.+|+++++.++|++++..+ .+.......+++|||+ +++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI-GVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEE-EEEecCCCeEEEEEcCCCCc
Confidence            479999999999999877 99999998765443   24688899999999977665544 4455666789999998 889


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++......+++..++.++.|++.||.|||+++++||||||+|||+   +.++.+||+|||++..........     
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~-----  150 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV-----  150 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence            999997655678999999999999999999999999999999999999   678899999999997654322110     


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.........   ..+... ..   ...+..+|.+
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~~~~-~~---~~~~~~~~~~  223 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERIESG-YR---MPAPQLCPEE  223 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHHhcC-CC---CCCCccCCHH
Confidence            1112234667999999998889999999999999999999 89999775432222   222111 11   1123467899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +.+++.+||..+|++||++.++.+.|+
T Consensus       224 ~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         224 IYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.1e-39  Score=304.23  Aligned_cols=246  Identities=22%  Similarity=0.327  Sum_probs=197.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..+.|++.+.||+|+||.||+|++..+++.||+|++.....     ...+.+|+.+++.++|++++..+..+ ......+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-~~~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-LREHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-EeCCeEE
Confidence            44679999999999999999999988999999998754322     13477899999999987766655544 4667789


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +++||+.++|.+++......+++..+..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||++......
T Consensus        92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCCC
Confidence            999999999999887666779999999999999999999999999999999999999   57889999999998654322


Q ss_pred             CCcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                                 ....++..|+|||++.   ...++.++||||||+++|||++|+.||.+...   ......+....... 
T Consensus       169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~-  233 (307)
T cd06607         169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPT-  233 (307)
T ss_pred             -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCC-
Confidence                       2346788999999885   35588999999999999999999999976432   22122222111111 


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                        .....++.++.+++.+||+.+|++||++.+|+.
T Consensus       234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              111246789999999999999999999888764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-39  Score=297.69  Aligned_cols=250  Identities=21%  Similarity=0.291  Sum_probs=189.0

Q ss_pred             eeeceeCceeEEEEEEc--CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|.+.  .++..+|+|.++.....   ..+.+|+.+++.++|++++..+..+ .+....+++|||+ +
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-TEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCCcEEEEECCCC
Confidence            46899999999999864  35578999987654332   3578899999999988877766544 4556678999999 7


Q ss_pred             CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        87 ~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ++|.+++....    ..+++..+..++.|++.||+|||++|++||||||+||++   +..+.+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~-  155 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY-  155 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence            89999987432    246778888999999999999999999999999999999   5788999999999875433221 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                          +.......++..|+|||++.+.       .++.++|||||||++|||++ |+.||.........  ...+......
T Consensus       156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~  229 (269)
T cd05087         156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQLK  229 (269)
T ss_pred             ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccCC
Confidence                1122345678899999998643       35789999999999999996 99999775432211  1112222222


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ...+.+...+++.+.+++.+|| .+|++||++++|...|.
T Consensus       230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2223333457889999999999 58999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-39  Score=295.80  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=198.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+....       ..+.+.+|+.+++.++|++++..+. +...+...++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheee-eEecCCeEEE
Confidence            5888999999999999999998899999999876543       2345888999999998877666554 4456677899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.+||+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence            99999 7899999975 3468999999999999999999999999999999999999   57889999999998765443


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .        ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||.....   ......+...   ....
T Consensus       156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~---~~~~  221 (258)
T cd06632         156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRS---KELP  221 (258)
T ss_pred             c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhc---ccCC
Confidence            2        123456889999999998776 89999999999999999999999977442   2222222211   1122


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+++++.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            334567899999999999999999999887754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.2e-39  Score=294.91  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=205.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|++|.||+|++..+++.|+||++.....   ...+.+|+..+..++|++++..+.. .......+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA-FYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEE-EccCCeEEEEEE
Confidence            479999999999999999999999999999998876543   4568899999999997766555444 455578899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++.. ...+++..++.++.|++.||+|||+ +|++||||+|+||++   +.++.++|+|||++........
T Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            99 6999999985 3679999999999999999999999 999999999999999   6789999999999986654332


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........+....+.....    ..+.
T Consensus       156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  224 (264)
T cd06623         156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP  224 (264)
T ss_pred             -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence                   11244678999999999998899999999999999999999999987653333444444432222    2233


Q ss_pred             cC-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~-~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .. ++..+.+++.+||..+|++||++.++.+
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            44 7899999999999999999999887765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=296.24  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCceeEeeee-CCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~   78 (404)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+....       ....+.+|+++++.++|++++..+..+... ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999864321       123578899999999988888777655433 4567


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++++||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            8899998 8899999874 3468999999999999999999999999999999999999   578899999999998654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ......    .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+...   .....++.   .....
T Consensus       158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~---~~~~~  227 (264)
T cd06653         158 TICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIA---TQPTK  227 (264)
T ss_pred             cccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHH---cCCCC
Confidence            321100    011245689999999999998899999999999999999999999986432   22222222   12222


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +.++..+++++.+++.+||. +++.||+..++..
T Consensus       228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            34556788999999999999 5799999886643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-39  Score=305.88  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||||.......    ...+.+|+.+++.++|++++..+..+....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            67899999999999999999999999999999998754322    235778999999999988887776664432     


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|++++++|.+++.  ...+++..++.++.|++.||+|||++||+||||||+||++   +..+.++|+|||++..
T Consensus        93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccccc
Confidence            2468999999999999887  4579999999999999999999999999999999999999   5788999999999976


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---  231 (404)
                      .....          ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+..+...   
T Consensus       168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            54321          23467889999999876 35889999999999999999999999864432111111110000   


Q ss_pred             --------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          ........+...+++++.+++.+||..||++||++.+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence                                000111223346788899999999999999999988765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=290.16  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=212.9

Q ss_pred             eEE-eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            9 FRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         9 y~i-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      |++ .+.||+|+|+.|--+....++++||||++.+...  +.++.+|++++...++|.+|..+..|++++..+|+|||-+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            444 4689999999999999999999999999887644  4568999999999999999988888888899999999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       ||+|...|.+ ...|++.++.++..+|+.||.|||.+||.||||||+|||....+.-.-||||||.+..-+.....-..
T Consensus       159 ~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  159 RGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             cCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence             9999998885 45699999999999999999999999999999999999996555555689999998865443222111


Q ss_pred             ccccCCCCCccCcCcccccccc---CC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------------hHHHHHH
Q 015592          165 IPYRENKNLTGTARYASMNTHL---GI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYEK  227 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~---~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------------~~~~~~~  227 (404)
                      ...-...+.+|+..|||||+..   +.  .|+.++|+||||||||-|+.|.+||.+....+            ....++.
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence            1111334568999999999853   32  38999999999999999999999998765432            2456777


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      |++++...+.... ..++.+.++++..+|..|+.+|.++..+.+
T Consensus       318 IQEGkYeFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKYEFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCCcCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            8888776654443 578999999999999999999988765543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.6e-39  Score=296.06  Aligned_cols=249  Identities=18%  Similarity=0.260  Sum_probs=187.4

Q ss_pred             eeeceeCceeEEEEEEcC--CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|....  ....+++|.+.....   ...+.+|+.+++.++|++++..+..+ ......+++|||+ +
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-IESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCceEEEEEeCCC
Confidence            468999999999997533  345788887654332   23477899999999988877766554 4556789999999 8


Q ss_pred             CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           87 PSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        87 ~sL~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ++|.+++.....    .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence            899999975332    25678889999999999999999999999999999999   67889999999998654322110


Q ss_pred             ccccccCCCCCccCcCccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHH-Hhhhcc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKKV  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~-~~~~~~  233 (404)
                           .......++..|+|||++..       ..++.++|||||||++|||++ |..||......   +.... +.....
T Consensus       157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~  228 (269)
T cd05042         157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDI  228 (269)
T ss_pred             -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCc
Confidence                 11223456778999998743       346889999999999999999 88999765332   22222 222222


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ....+.+...+++.+.+++..|| .||++||++++|.++|.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22223445568899999999999 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-39  Score=297.75  Aligned_cols=252  Identities=19%  Similarity=0.233  Sum_probs=196.7

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      |++.+.||.|++|.||+|.+..+++.||+|++.....    ...+.+|+.+++.++|++++..+..+ ..+...+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-HSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-ccCCeEEEEEec
Confidence            6788999999999999999999999999998765432    24578899999999988777766554 456788999999


Q ss_pred             cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      ++++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+||++   +.++.++|+|||++........  
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc--
Confidence            9889999987533 368999999999999999999999999999999999999   5688999999999975543211  


Q ss_pred             cccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh-------------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS-------------  229 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------  229 (404)
                           ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....             
T Consensus       155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence                 11233568899999988764 47899999999999999999999997643321111110000             


Q ss_pred             --------hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 --------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                              ..............++.++.+++.+||+.||++||++.++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    000011122334567889999999999999999999887753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-39  Score=297.46  Aligned_cols=242  Identities=25%  Similarity=0.295  Sum_probs=199.3

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....     ....+.+|++++++++|++++..+..+ ..+...++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCeEEEEE
Confidence            5999999999999999999998899999999876532     234688899999999987766655444 5667889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++... ..+++..+..++.|+++||.|||++|++|+||||+||++   +.++.++|+|||++........
T Consensus        80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence            999 88999999753 579999999999999999999999999999999999999   6788999999999986654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.................     .....+
T Consensus       156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~  222 (258)
T cd05578         156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP  222 (258)
T ss_pred             --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence                    2245688899999999988899999999999999999999999987654322222222111     222344


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYA  267 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~  267 (404)
                      ..+|.++.+++.+||..||++||++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~  248 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDN  248 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCcc
Confidence            56789999999999999999999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-39  Score=296.23  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.++....            .+.+..|+.+++.++|++++..+. +....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG-FETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE-EeccC
Confidence            68999999999999999999988999999997653211            124678999999999877666554 45566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...+++|||+ +++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~  156 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK  156 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence            7889999998 89999999854 579999999999999999999999999999999999999   578999999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      .........     ......|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||.....   ...+..+....
T Consensus       157 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~  228 (272)
T cd06629         157 KSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR  228 (272)
T ss_pred             ccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence            654322111     123456889999999988755  78999999999999999999999965322   22222222111


Q ss_pred             -ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ...........++.++.+++.+||..+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             111122333467899999999999999999999887754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-39  Score=294.80  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=199.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||+|.+..++..||+|.+...    ...+.+.+|+.+++.++|++++..+..+ ......++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeEEEEEe
Confidence            589999999999999999999999999999987653    2344688999999999988777766544 55677899999


Q ss_pred             cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++  +....+||+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence            99 889999987533 3589999999999999999999999999999999999994  2335679999999987654322


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......|++.|+|||.+.+..++.++|+|||||++|||++|..||....   ..+....+.....    ....
T Consensus       158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~  223 (257)
T cd08225         158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQGYF----APIS  223 (257)
T ss_pred             -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhcccC----CCCC
Confidence                   1123468899999999998889999999999999999999999997633   2333333332222    2233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++.++.+++.+||..+|++||++.++.+
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            467889999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-39  Score=299.65  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=193.1

Q ss_pred             eeeceeCceeEEEEEEcCCC------cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +.||+|+||.||+|++....      +.++||.+....   ....+.+|+.+++.++|++++..+..+ ......+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-LLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-cCCCCeEEEEe
Confidence            46899999999999976543      689999765433   344688999999999988877766554 45567899999


Q ss_pred             cc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCCeEEEEecCCcc
Q 015592           84 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAK  154 (404)
Q Consensus        84 ~~-~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~--~~~~vkL~DFG~a~  154 (404)
                      |+ +++|.+++...      ...+++.+++.++.|++.||+|||+++++|+||||+||+++.++  ....++|+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            98 88999998642      13478999999999999999999999999999999999995221  12389999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      ........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....+.....
T Consensus       160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~  231 (269)
T cd05044         160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGR  231 (269)
T ss_pred             cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCc
Confidence            65433211     11223456788999999999899999999999999999998 9999976433   222222222111


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                          ......+|..+.+++.+||..+|++||+++++.+.|+
T Consensus       232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         232 ----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                1223467899999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.1e-39  Score=297.33  Aligned_cols=234  Identities=23%  Similarity=0.300  Sum_probs=181.1

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHc--CCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      .||+|+||.||++.+..+++.||+|++......     ....+|..+++.+.  +++++..+..+...++..+++|||+ 
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999987643221     22345555555443  3445555555556667889999998 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++|+|||++.......     
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-----  151 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-----  151 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-----
Confidence            8899988874 4569999999999999999999999999999999999999   678899999999987554322     


Q ss_pred             cccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ......    .....++..+
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----~~~~~~~~~~  222 (279)
T cd05633         152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----TVNVELPDSF  222 (279)
T ss_pred             ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----cCCcCCcccc
Confidence                123468999999999874 558999999999999999999999998754433222 111111    1112334568


Q ss_pred             cHHHHHHHHHHHcCCCCCCCC
Q 015592          245 PTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~  265 (404)
                      ++++.+++.+||..||++||+
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcC
Confidence            899999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=297.96  Aligned_cols=244  Identities=20%  Similarity=0.331  Sum_probs=195.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHc---CCCCCCceeEeeeeCCeEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~---~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++....   ...+.+|+.+++.++   |++++..+. +...+...+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~-~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYG-SYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEee-eeeeCCEEEEE
Confidence            58899999999999999999999999999998765422   345888999999997   555555544 44567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++..  ..+++..++.++.|++.||.|||+.||+|+||+|+||++   +..+.++|+|||++..+....
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999 8899999873  479999999999999999999999999999999999999   578899999999998765543


Q ss_pred             CcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .       ......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+...   ......+....    ...
T Consensus       156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~----~~~  221 (277)
T cd06917         156 S-------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKSK----PPR  221 (277)
T ss_pred             c-------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccCC----CCC
Confidence            2       12345689999999998754 478999999999999999999999986433   11121111111    111


Q ss_pred             hhc-CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~-~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +.. .++.++.+++.+||+.||++||++.++.+
T Consensus       222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            222 37889999999999999999999887754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.3e-39  Score=302.31  Aligned_cols=259  Identities=20%  Similarity=0.242  Sum_probs=201.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----   74 (404)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|+++....    ...+.+|+.+++.++|++++..+..+...     
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            356789999999999999999999998999999998765432    23567899999999988888776555432     


Q ss_pred             ----CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           75 ----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        75 ----~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                          ....++++||++++|.+++......+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+||
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~df  160 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADF  160 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcc
Confidence                23789999999888988887545579999999999999999999999999999999999999   68889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      |++..+......      ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+....
T Consensus       161 g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~  234 (302)
T cd07864         161 GLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC  234 (302)
T ss_pred             cccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            999866543320      11233567889999988754 47899999999999999999999997643322222222221


Q ss_pred             hhccc----------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 EKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 ~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....                      .........+|..+.+++.+||..||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11100                      0111122357899999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=291.13  Aligned_cols=254  Identities=16%  Similarity=0.205  Sum_probs=206.4

Q ss_pred             ccCCceEEe-eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCce-eEee---eeCCeE
Q 015592            4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-RWFG---VEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~-~~~~---~~~~~~   78 (404)
                      -|.++|++. ++||-|-.|.|-.+.++.|++.+|+|++.   ..+...+|+++.-....|++|+.+ ..|.   ......
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            467788885 58999999999999999999999999875   456678999998888766666555 4442   234567


Q ss_pred             EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+|||++ ||.|.+.+...+ ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|......+..+||+|||+|+.-
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            8999999 999999998543 35999999999999999999999999999999999999987777889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~  235 (404)
                      .....        ..+-+-|+.|.|||++....|+..+|+||+||++|-|++|.+||........ .....+|.......
T Consensus       215 ~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  215 QEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             CCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            54332        3455779999999999999999999999999999999999999986554322 22334444444444


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      +-++ ...+++..+++|..+|..+|.+|.|+.++
T Consensus       287 P~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~  319 (400)
T KOG0604|consen  287 PEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEV  319 (400)
T ss_pred             CChh-HhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence            3333 35678999999999999999999996644

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-39  Score=304.14  Aligned_cols=247  Identities=18%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|.....||+|+||.||++.+..+++.||||.+....  ..+.+.+|+.+++.++|++++..+..+ ..++..+++|||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-LVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-ecCCeEEEEEeC
Confidence            45666788999999999999998899999999875432  234578899999999988777766554 456778999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++.  ...+++.++..++.||+.||+|||++||+||||||+||++   +.++.++|+|||++........  
T Consensus       101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence            9 789998886  3468999999999999999999999999999999999999   5778999999999875543221  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+...   ...+..+... ..... .....
T Consensus       174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~-~~~~~  243 (292)
T cd06658         174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDN-LPPRV-KDSHK  243 (292)
T ss_pred             -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCCcc-ccccc
Confidence                 12345689999999999988899999999999999999999999986433   2222222111 11111 11234


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++..+.+++.+||..||.+||++.++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            6789999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-40  Score=300.95  Aligned_cols=240  Identities=19%  Similarity=0.237  Sum_probs=184.3

Q ss_pred             eeeceeCceeEEEEEEcCCCc-------EEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +.||+|+||.||+|.+..++.       .|++|.......  .+.+..|+.+++.++|++++..+..+ ..+...+++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVC-VCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEE-EeCCCcEEEEe
Confidence            479999999999999865543       488887654322  24578899999999988777666554 44566789999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-----CCeEEEEecCCccccc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKRYR  157 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-----~~~vkL~DFG~a~~~~  157 (404)
                      |+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.     .+.++++|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99 88999999865557899999999999999999999999999999999999953211     1247999999986543


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ..           ....++..|+|||++.+. .++.++|||||||++|||++| ..||........   . ......   
T Consensus       160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~-~~~~~~---  221 (258)
T cd05078         160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L-QFYEDR---  221 (258)
T ss_pred             Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-HHHHcc---
Confidence            22           234678899999999874 479999999999999999998 466655332111   1 111111   


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                        ..++...+.++.+++.+||+.||++||++++|++.|
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              123334568899999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-39  Score=306.27  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=196.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----   74 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.++|++++..+..+...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            356899999999999999999999999999999998764321    24577899999999998888777655432     


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....++++++++++|.++++  ...+++..+..++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~  168 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  168 (345)
T ss_pred             cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence            23478899999999999887  3469999999999999999999999999999999999999   578899999999987


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh--
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--  231 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--  231 (404)
                      .....          .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+......  
T Consensus       169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         169 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            54332          124567899999999876 45899999999999999999999999764332111111110000  


Q ss_pred             ---------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 ---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                           .............++++.++|.+||+.||++||++.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l  298 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  298 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence                                 000001111224578899999999999999999977554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.4e-39  Score=298.17  Aligned_cols=252  Identities=18%  Similarity=0.312  Sum_probs=200.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ++|++.+.||.|+||.||+|+++.     +.+.|++|........   ..+.+|++++++++|++++..+. +.......
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG-LCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEE-EECCCCcc
Confidence            679999999999999999999754     3467999987654433   46889999999998877665554 44556778


Q ss_pred             EEEEecc-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           79 VLVIDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      +++|||+ +++|.+++....        ..+++..+..++.|++.||+|||++||+||||||+|||+   +..+.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEcc
Confidence            9999999 789999997433        158999999999999999999999999999999999999   5788999999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHH
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ||+++.......      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...   ...+..+
T Consensus       161 ~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~  231 (275)
T cd05046         161 LSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL  231 (275)
T ss_pred             cccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH
Confidence            999875433211      12234466788999999988889999999999999999998 8999976433   2233333


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      .......   .....+|..+.+++.+||+.+|++||++.++.+.|.
T Consensus       232 ~~~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLEL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            3222211   123467899999999999999999999999988774

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.6e-39  Score=294.84  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=193.6

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.....||+|+||.||+|++..++..|++|.......  .+.+.+|+.+++.++|++++..+.. ...+...++++||+ 
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e~~~   88 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS-DSENGFFKIFMEQVP   88 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeee-eccCCEEEEEEecCC
Confidence            4445689999999999999988999999998765432  3458899999999998887766554 45567889999998 


Q ss_pred             CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      +++|.+++......+  ++..+..++.||+.||+|||++||+||||||+||+++  ...+.++|+|||++........  
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~--  164 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP--  164 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence            889999997544455  8889999999999999999999999999999999994  3367899999999876543221  


Q ss_pred             cccccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                           ......|+..|+|||.+.+..  ++.++||||||+++|+|++|..||........ . .....   .......++
T Consensus       165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~-~~~~~---~~~~~~~~~  234 (268)
T cd06624         165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-A-MFKVG---MFKIHPEIP  234 (268)
T ss_pred             -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-h-Hhhhh---hhccCCCCC
Confidence                 122346789999999987644  78999999999999999999999976432111 1 11111   111112334


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+++++.+++.+||+.+|++||++.++..
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            567899999999999999999999987754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.5e-39  Score=292.83  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=198.5

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCC----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +++.+.||.|+||.||++.+...+    ..||+|+......   ...+..|+.+++.++|++++..+..+ ......+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-TEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-cCCCeeEEE
Confidence            467899999999999999998766    8999998866543   34688999999999766665555444 445778899


Q ss_pred             Eecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           82 IDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+++ +++|.+++...... +++..+..++.|++.||+|||++|++|+||||+||++   +.++.++|+|||+++.....
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence            9998 88999999754433 9999999999999999999999999999999999999   57889999999999876654


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ....      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   ...+..+......    
T Consensus       157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----  223 (258)
T smart00219      157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRL----  223 (258)
T ss_pred             cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCC----
Confidence            2211      112336789999999988889999999999999999998 8899876332   3333333333222    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .....++.++.+++.+||..||++||++.++.+.|
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22345789999999999999999999999887653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-39  Score=323.00  Aligned_cols=257  Identities=19%  Similarity=0.208  Sum_probs=184.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCC-cEEEEE------------------Eec-CCCCchhHHHHHHHHHHHcCCCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LEN-VKTKHPQLQYEAKLYKILQGGTG   64 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK------------------~~~-~~~~~~~~~~E~~~l~~l~~~~~   64 (404)
                      +.++|+++++||+|+||+||+|..+... ..+++|                  ... .......+.+|+.+++.++|+++
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998764322 112222                  111 11122357899999999998877


Q ss_pred             CCceeEeeeeCCeEEEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        65 i~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                      +..+.. .......++++++++++|.+++...    ........+..|+.||+.||+|||++|||||||||+|||+   +
T Consensus       226 v~l~~~-~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---~  301 (501)
T PHA03210        226 LKIEEI-LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---N  301 (501)
T ss_pred             CcEeEE-EEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---C
Confidence            766554 4566678899999988888877532    1224467788999999999999999999999999999999   5


Q ss_pred             CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCCCC
Q 015592          141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAG  219 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P-f~~~~~~  219 (404)
                      .++.+||+|||+++.+......      ......||..|+|||++.+..++.++|||||||+||||++|..+ |.+....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            7889999999999876543221      12346799999999999999999999999999999999998764 4432222


Q ss_pred             ChHHHHHHHhhh-----ccc-------------------ccHhHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          220 TKKQKYEKISEK-----KVS-------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       220 ~~~~~~~~~~~~-----~~~-------------------~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+....+...     ...                   .....+.  ..++..+.+++.+||+.||++||++.++++
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            222221111100     000                   0011111  135678889999999999999999887753

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-39  Score=304.92  Aligned_cols=253  Identities=20%  Similarity=0.247  Sum_probs=201.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC----CeEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV   79 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~~~   79 (404)
                      +|++.+.||.|+||.||+|++..+++.|+||.+....    ..+.+.+|+.+++.++|++++..+..+....    ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999998889999999876532    3456889999999999888777666554433    4679


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|+|++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.++|+|||++......
T Consensus        81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeeccc
Confidence            9999998899999874 4489999999999999999999999999999999999999   57799999999999876654


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------  232 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------  232 (404)
                      ....    .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.....   .+..+....      
T Consensus       157 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  229 (330)
T cd07834         157 EDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE  229 (330)
T ss_pred             cccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence            3110    112345678999999999988 78999999999999999999999998754322   122211110      


Q ss_pred             --------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 --------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                          ...........++.++.+++.+||+++|++||++.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                                011112233457889999999999999999999887654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=294.93  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||+|.+..+++.||||++.....     ...+..|..++....+++++..+..+...+...++++||+ +
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999988999999998764321     1224445555444434445555555556677889999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++   +.++.++|+|||+++....        
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~--------  149 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE--------  149 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence            899999975 4579999999999999999999999999999999999999   5788999999999875433        


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                         .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....   ...+..+....... .......+++
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~  222 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSP  222 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCH
Confidence               1234688899999999988899999999999999999999999976433   33333333322211 1122336789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ++.+++.+||+.||++||++.++.+++.+.+.+
T Consensus       223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~  255 (260)
T cd05611         223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK  255 (260)
T ss_pred             HHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence            999999999999999999988888888776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5e-39  Score=301.47  Aligned_cols=247  Identities=17%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ..|+....||.|+||.||++.+..+++.||+|++....  ..+.+.+|+.+++.+.|++++..+..+ ..+...++++||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-LVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-eeCCeEEEEEec
Confidence            44666778999999999999998899999999876432  334588899999999987766665544 456778999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++.  ...+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..+.....  
T Consensus       100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc--
Confidence            8 789998876  3568999999999999999999999999999999999999   6889999999999875543321  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....   .+.+..+......  .......
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~  242 (297)
T cd06659         173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPP--KLKNAHK  242 (297)
T ss_pred             -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCC--CccccCC
Confidence                 12345689999999999988899999999999999999999999976432   2223332221111  1122345


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            7889999999999999999999887765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=301.94  Aligned_cols=273  Identities=21%  Similarity=0.247  Sum_probs=226.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -..+|.++.+||+|+||.|.++..+.+.+.||||+++.+..     .+--..|.++|.....++.+..+..+++.-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34578899999999999999999999999999998776532     2224568888888888999999999999999999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +||||+ ||+|--.+++ -+++.+..+..++.+|+-||-+||++|||.||||.+|||+   +..|++||+|||+++.-.-
T Consensus       427 FVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccccc
Confidence            999999 9999988886 4579999999999999999999999999999999999999   7999999999999985433


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       .+.+++||+.|+|||++.-++|+..+|+||+||+||||+.|+.||.+.   +..+.+..|.+..+.    
T Consensus       503 ~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvs----  568 (683)
T KOG0696|consen  503 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVS----  568 (683)
T ss_pred             CCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCc----
Confidence            222       356889999999999999999999999999999999999999999994   456666777766653    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH-HHHHHHHHHHcCCCCCceeecccccccccccCC
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL-KRLFRDLFIREGFQFDYVFDWTILKYQQSQVST  302 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l-~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  302 (404)
                       .++.++.+..++++..|.+.|.+|.....- .+.++      ...+...+||......+.+++-
T Consensus       569 -yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~------~H~FFR~iDWek~E~~eiqPPf  626 (683)
T KOG0696|consen  569 -YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIR------EHPFFRRIDWEKLERREIQPPF  626 (683)
T ss_pred             -CcccccHHHHHHHHHHhhcCCccccCCCCccccchh------hCcchhhccHHHHhhccCCCCC
Confidence             456789999999999999999999743211 11111      1245566899988777766544

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-39  Score=300.79  Aligned_cols=253  Identities=19%  Similarity=0.323  Sum_probs=198.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      -.++|++.+.||+|+||.||+|.+..+++.||||.++....   ...+..|+.++.++..++++..+..+.......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            45789999999999999999999988899999998865432   234566777777776455555555556677789999


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||++++|.+++......+++..+..++.|++.||.|||+ +||+||||+|+||++   +.++.+||+|||++..+....
T Consensus        93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence            9999989999887666789999999999999999999997 699999999999999   578899999999997664432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .        .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.....  ..+.+..+....... 
T Consensus       170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~-  238 (296)
T cd06618         170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS-  238 (296)
T ss_pred             c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC-
Confidence            2        12335788999999997654    78999999999999999999999975322  122233332222111 


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      . .....++.++.+++.+||..||++||++.++.+.
T Consensus       239 ~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1 1112478899999999999999999998877543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8e-39  Score=305.18  Aligned_cols=263  Identities=20%  Similarity=0.285  Sum_probs=202.0

Q ss_pred             CCcccCCceEE-eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----------------hhHHHHHHHHHHHcCCC
Q 015592            1 MEPRVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------PQLQYEAKLYKILQGGT   63 (404)
Q Consensus         1 m~~~~~~~y~i-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------~~~~~E~~~l~~l~~~~   63 (404)
                      |..-+.++|.. .+.||.|+||+||+|.+..+++.||||++......                ..+.+|+.+++.++|++
T Consensus         2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            66778899975 57799999999999999999999999987543222                14678999999999887


Q ss_pred             CCCceeEeeeeCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~  143 (404)
                      ++..+..+ ..+...+++|||+.++|.+++.. ...+++..+..++.|++.||+|||++||+|+||||+||++   +.++
T Consensus        82 iv~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~  156 (335)
T PTZ00024         82 IMGLVDVY-VEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG  156 (335)
T ss_pred             eeeeeEEE-ecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence            77766544 56678899999998899999874 5569999999999999999999999999999999999999   5788


Q ss_pred             eEEEEecCCcccccccCCcccc-------cccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 015592          144 QVYIIDFGLAKRYRDTATHQHI-------PYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG  215 (404)
Q Consensus       144 ~vkL~DFG~a~~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~  215 (404)
                      .++|+|||++............       .........++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999866522111000       000112335688899999988654 69999999999999999999999987


Q ss_pred             CCCCChHHHHHHHhhhc-----------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          216 LKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       216 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....   .+..+....                       ...........++.++.+++.+||+.+|++||++++++.
T Consensus       237 ~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        237 ENEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            54322   222221110                       011112223456788999999999999999999876653

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.5e-39  Score=296.76  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +-|++.+.||.|+||.||+|.+..+++.||||+......   ...+.+|+.+++.++|++++..+..+ ..+...+++||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-LKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-EeCCeEEEEEE
Confidence            348889999999999999999988999999998764332   24578899999999987766665554 55677899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.  +..+++..+..++.|++.+|.|||++|++|+||||+||++   +.++.++|+|||++..+..... 
T Consensus        83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh-
Confidence            99 789999887  4569999999999999999999999999999999999999   5778999999999876544221 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....   ......+....    .+.+..
T Consensus       157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~  223 (277)
T cd06641         157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNN----PPTLEG  223 (277)
T ss_pred             ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCC----CCCCCc
Confidence                  12234678899999999988899999999999999999999999976443   22222222211    122334


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++.++.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            67899999999999999999999998876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-38  Score=302.23  Aligned_cols=256  Identities=18%  Similarity=0.203  Sum_probs=194.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCC--CcEEEEEEecCCC----CchhHHHHHHHHHHHc-CCCCCCceeEee---eeCCe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT----KHPQLQYEAKLYKILQ-GGTGIPNLRWFG---VEGDY   77 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-~~~~i~~~~~~~---~~~~~   77 (404)
                      +|++.+.||+|+||.||++++..+  +..||+|.+....    ..+.+.+|+.+++++. |++++..+....   .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  8999999876432    2345788999999996 555554443321   22356


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++|++++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence            789999999999999874 5679999999999999999999999999999999999999   578899999999998665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH----------
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----------  226 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~----------  226 (404)
                      ......   ........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...........          
T Consensus       157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            432211   011234578999999998776 458999999999999999999999997643211111111          


Q ss_pred             --HHhh-----------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          227 --KISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       227 --~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                        .+..           .............++..+.+++.+||+.||++||++.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence              0000           0001112233345678999999999999999999988663

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=317.10  Aligned_cols=269  Identities=22%  Similarity=0.293  Sum_probs=205.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC---CCCchhHHHHHHHHHHHcCCCCCCceeEeee-----eCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV---KTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~   76 (404)
                      ....|...+.||+|+||.||+++++.+|+.||||.++.   ....+...+|++++++|+|+|+|..+..-..     ...
T Consensus        11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            34567788999999999999999999999999998776   3345668899999999998887776644322     245


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGL  152 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~  152 (404)
                      ..+++|||| ||||..+++...  ..|++.+++.++..++.||.|||++||+||||||.||++-.+. .....||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            678999999 999999998432  3499999999999999999999999999999999999985433 223469999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-ChHHHHHHHhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISE  230 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~  230 (404)
                      |+.+.+...        ...+.||..|++||++.. ..|+..+|.|||||++|+.+||..||-..... ..++..-.+..
T Consensus       171 Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  171 ARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            998887653        357899999999999995 77999999999999999999999999543222 11222222211


Q ss_pred             hcccc-----------------c---HhHhhcCCcHHHHHHHHHHHcCCCCCCC--CHHHHHHHHHHHHHHcC
Q 015592          231 KKVST-----------------S---IEALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREG  281 (404)
Q Consensus       231 ~~~~~-----------------~---~~~~~~~~~~~l~~li~~cl~~~p~~RP--~~~~l~~~l~~~~~~~~  281 (404)
                      ++...                 .   ...+.++.-..+..++..+|..+|.+|-  .+.+....+.+++...-
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v  315 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV  315 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence            11110                 0   0011111223456677888899999998  77888888888876644

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-38  Score=304.52  Aligned_cols=249  Identities=21%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----   75 (404)
                      .+.++|.+.+.||+|+||.||+|++..+++.||||.+....    ....+.+|+.+++.++|++++..+..+....    
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            35689999999999999999999998899999999876432    2245788999999999988887776654322    


Q ss_pred             -CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ...+++++|+..+|.+++   ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~  165 (342)
T cd07879          92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR  165 (342)
T ss_pred             CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence             346899999988887765   3468999999999999999999999999999999999999   578999999999987


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh--
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--  231 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--  231 (404)
                      .....          .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....   ..+..+...  
T Consensus       166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~  232 (342)
T cd07879         166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG  232 (342)
T ss_pred             CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence            54322          124467889999999876 45899999999999999999999999874321   111111110  


Q ss_pred             ------------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                              .............++++.+++.+||+.||++||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                                    0001111222356788999999999999999999887753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-39  Score=306.85  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=198.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.+.|++++..+..+....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            6789999999999999999999999999999999875432    2245778999999999888877665443332     


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++++|++++|.+++.  ..++++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        93 ~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccccc
Confidence            3489999999999999997  3579999999999999999999999999999999999999   5788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc-
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-  233 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-  233 (404)
                      ....          .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+...   ...+..+..... 
T Consensus       168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~  234 (343)
T cd07851         168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGT  234 (343)
T ss_pred             cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Confidence            5432          1234678899999998753 578999999999999999999999976433   222222211100 


Q ss_pred             -------------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 -------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                               ..........+++++.+++.+||+.||++|||+.+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell  296 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL  296 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence                                     0111222345688999999999999999999988764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.1e-39  Score=295.41  Aligned_cols=240  Identities=15%  Similarity=0.179  Sum_probs=182.0

Q ss_pred             eeeceeCceeEEEEEEcC------------CCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592           13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +.||+|+||.||+|+...            ....|++|++.....  ...+..|+.+++.++|++++..+..+ ......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVC-VRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCCC
Confidence            468999999999998532            233588998654332  23577888999999987777666544 455667


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC----CCCeEEEEecCCc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLA  153 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~----~~~~vkL~DFG~a  153 (404)
                      +++|||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.+.    ....++++|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            8999999 7888888875556799999999999999999999999999999999999995211    1123899999998


Q ss_pred             ccccccCCcccccccCCCCCccCcCcccccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCCChHHHHHHHhhh
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~il~ell-tg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ......           ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.........    .....
T Consensus       160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~  224 (262)
T cd05077         160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG  224 (262)
T ss_pred             ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence            654321           2346788999999987 456899999999999999998 589998764322211    11111


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ..     ......++++.+++.+||+.||++||++.+|.+.|
T Consensus       225 ~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11     11123467899999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-39  Score=295.70  Aligned_cols=253  Identities=18%  Similarity=0.291  Sum_probs=195.9

Q ss_pred             eEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeC-----C
Q 015592            9 FRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D   76 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----~   76 (404)
                      |++.+.||+|+||.||+|.+.   .+++.||||++..+..    .+++.+|+++++.++|++++..+..+....     .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   3578999998765432    235778999999999888777765543321     2


Q ss_pred             eEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      ..+++++|+ +++|.+++...     ...+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcc
Confidence            346777877 88998887422     1247899999999999999999999999999999999999   57889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHh
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      |+++.......     +.......+++.|++||.+.+..++.++|||||||++|+|++ |+.||.+...   ...+..+.
T Consensus       158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~  229 (273)
T cd05074         158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI  229 (273)
T ss_pred             cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence            99986543221     111223345678999999998889999999999999999999 9999976433   22222222


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ....    ......++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       230 ~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KGNR----LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2111    112235788999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=294.23  Aligned_cols=251  Identities=22%  Similarity=0.260  Sum_probs=193.1

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHc---CCCCCCceeEeeeeCC----e
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQ---GGTGIPNLRWFGVEGD----Y   77 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~---~~~~i~~~~~~~~~~~----~   77 (404)
                      |++.+.||+|+||.||+|++..+++.||+|++......    ..+.+|+.++++++   |++++..+..+.....    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999888999999988644322    34667888888775   5666555554433222    3


Q ss_pred             EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++||++.++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||++   +.++.+||+|||++..+
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence            89999999889999887543 369999999999999999999999999999999999999   57799999999999776


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh------
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------  230 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------  230 (404)
                      .....        .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+.....      
T Consensus       158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence            44321        1234578899999999998899999999999999999999999987543322222111100      


Q ss_pred             -------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          231 -------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       231 -------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                   .............+++.+.+++.+||+.||++||++.++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il  282 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL  282 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence                         0001111222234568889999999999999999988775

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=296.48  Aligned_cols=252  Identities=22%  Similarity=0.249  Sum_probs=199.0

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.....    ...+..|+.+++.++|++++..+..+ ..+...++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-RHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-ccCCCEEEEEec
Confidence            6788999999999999999988999999998765433    24578899999999977666655444 455788999999


Q ss_pred             cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      +.++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||.+........   
T Consensus        80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~---  153 (283)
T cd05118          80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR---  153 (283)
T ss_pred             cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence            9889999988656689999999999999999999999999999999999999   5788999999999977655431   


Q ss_pred             ccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh------------
Q 015592          165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------  231 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------  231 (404)
                          ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+...........            
T Consensus       154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence                11234678899999999877 6899999999999999999999999764432211111110000            


Q ss_pred             ----------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 ----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                ........+...++.++.++|.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0011112333457889999999999999999999987754

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-38  Score=293.53  Aligned_cols=243  Identities=19%  Similarity=0.267  Sum_probs=188.0

Q ss_pred             CCceEEeeee--ceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.+  |+|+||.||++++..+++.+|+|+........   .|+.....+.+++++..+...+......+++||
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            3567777776  99999999999999999999999876543221   233344444445555555555566678999999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC-eEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.++++.. ..+++.+++.++.|++.||.|||+.|++||||||+||++.   .++ .++|+|||++......  
T Consensus        90 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         90 YIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC--
Confidence            98 89999999853 4899999999999999999999999999999999999994   555 8999999998765432  


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                               ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  ........ . ......
T Consensus       164 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~-~~~~~~  230 (267)
T PHA03390        164 ---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ-Q-KKLPFI  230 (267)
T ss_pred             ---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh-c-ccCCcc
Confidence                     2346789999999999988999999999999999999999999864332211  11111111 1 111233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCC-HHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPD-YAYLK  270 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~-~~~l~  270 (404)
                      +.+++.+.++|.+||+.+|++||+ +++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence            468899999999999999999995 56654

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=295.85  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=198.7

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEEEEEe
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNVLVID   83 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e   83 (404)
                      |++.+.||.|+||.||+|++..+++.+|+|.+....    ....+.+|+.+++.++|++++..+..+... ....+++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999998899999999887543    233578899999999988887777666544 378899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |+.++|.+++......+++..++.++.||+.||+|||++|++|+||||+||++   ++++.+||+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~-  156 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA-  156 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc-
Confidence            99889999987544679999999999999999999999999999999999999   57899999999999876554320 


Q ss_pred             cccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh-----------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----------  231 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----------  231 (404)
                           ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+......           
T Consensus       157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         157 -----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             -----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence                 11234568889999987754 5799999999999999999999999875432211111111000           


Q ss_pred             -----------cccccHhHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 -----------KVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 -----------~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                 ............ ++.++.+++.+||..+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       000001111223 3889999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=315.24  Aligned_cols=250  Identities=20%  Similarity=0.237  Sum_probs=205.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ++.++.++||+|.||.|++|.|...+   ..||||++.....   ..+|.+|+.+|.+|+|++.|..++.+-.  ....+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhH
Confidence            45678899999999999999997532   4699998876543   4679999999999999988877766543  66789


Q ss_pred             EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           81 VIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      |||++ .|||.+.++. ....|-......++.||+.|+.||.++++|||||-..|+|+   -....|||||||+.+.+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceeccCC
Confidence            99999 9999999986 34568899999999999999999999999999999999999   4688999999999998876


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....    |.......-...|+|||.+....++.+||||+|||+||||+| |+.||.+....   +.++++..+...   
T Consensus       265 ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD~~erL---  334 (1039)
T KOG0199|consen  265 NEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNIDAGERL---  334 (1039)
T ss_pred             CCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhccccccC---
Confidence            5431    122223334678999999999999999999999999999999 99999997653   444444432221   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                       .-++.||+.+++++..||..+|++||+|..|++.
T Consensus       335 -pRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  335 -PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             2245789999999999999999999999999743

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-38  Score=290.79  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=203.1

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||.|+||.||++.+..+++.|++|++....    ....+..|+++++.++|++++..+..+. .....++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-EKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-cCCEEEEEEE
Confidence            5899999999999999999999899999999887543    2345888999999999777776665544 4478889999


Q ss_pred             cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++ +++|.+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence            98 78999999864   3679999999999999999999999999999999999999   57889999999999876554


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....   ............    ...
T Consensus       157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~  222 (258)
T cd08215         157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YPP  222 (258)
T ss_pred             cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CCC
Confidence            31       1234578899999999998889999999999999999999999997643   233333332222    223


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++..++.++.+++.+||..+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            44578899999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.6e-38  Score=292.82  Aligned_cols=239  Identities=22%  Similarity=0.261  Sum_probs=184.7

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHc--CCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      .||+|+||.||+|++..+++.||+|++..+...     .....|..+++.++  +++++..+..+....+..+++|||+ 
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999899999999987653221     12344555544443  3455555556666777889999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      |++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||++   +.++.+||+|||++..+....     
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-----  151 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-----  151 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence            8899988874 4579999999999999999999999999999999999999   578899999999987554321     


Q ss_pred             cccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+................     ...++..+
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  222 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELPDSF  222 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-----CCCCCCcC
Confidence                1245789999999999754 5899999999999999999999999875433322222111111     12234457


Q ss_pred             cHHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKP-----DYAYLK  270 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP-----~~~~l~  270 (404)
                      +.++.+++.+||..+|.+||     ++.++.
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll  253 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  253 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence            89999999999999999999     766664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4e-38  Score=289.61  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=198.8

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|+||.||+|.+..+++.|++|++.....    ...+..|+.+++.++|++++..+. +.......++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~-~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG-VEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheee-eEecCCEEEEEEe
Confidence            69999999999999999999988999999998776543    345889999999999877665554 4456678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||++   +..+.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            98 8999999974 4468999999999999999999999999999999999999   57889999999999876554321


Q ss_pred             ccccccCCCCCccCcCccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ...   ......++..|+|||++.+..   ++.++||||||+++|+|++|+.||......  ......+.... ....+.
T Consensus       156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~-~~~~~~  229 (264)
T cd06626         156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGAGH-KPPIPD  229 (264)
T ss_pred             ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhcCC-CCCCCc
Confidence            100   012356789999999998766   889999999999999999999999764321  11121222111 111111


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ...+++.+.+++.+||+.+|++||++.++..
T Consensus       230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 -SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             1234889999999999999999999887753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-38  Score=296.03  Aligned_cols=256  Identities=18%  Similarity=0.265  Sum_probs=202.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +|++.+.||+|+||.||++++.   .+++.||||++....      ..+.+..|+.++..+++++++..+......+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   467889999875422      2245778999999998777666666666777788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..+..++.|++.+|.|||+.|++||||||+||++   +.++.++|+|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence            9999999 7899998874 4568999999999999999999999999999999999999   577899999999987654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhhccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~  234 (404)
                      ....      .......|+..|+|||.+.+..  .+.++||||||+++|||++|..||........ ......+....  
T Consensus       157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  228 (288)
T cd05583         157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--  228 (288)
T ss_pred             cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--
Confidence            4321      1123456889999999987765  78899999999999999999999965332211 11112211111  


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                         ...+..++..+.+++.+||+.||++|||+.++.++|++.+.
T Consensus       229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence               12334578999999999999999999999999888877653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3e-38  Score=291.56  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=195.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcC-CCcEEEEEEecCCC------------CchhHHHHHHHHHH-HcCCCCCCceeEeee
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT------------KHPQLQYEAKLYKI-LQGGTGIPNLRWFGV   73 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~------------~~~~~~~E~~~l~~-l~~~~~i~~~~~~~~   73 (404)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....            ...++..|+.++.+ ++|++++..+. +..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~-~~~   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK-TFL   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe-eEc
Confidence            48899999999999999999877 68899999765321            11235667777765 55555555444 445


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEE
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                      .+...+++|||+ +++|.+++..   ....+++..++.++.|++.||.|||+ .||+|+||||+|||+   +..+.+||+
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~  156 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTIT  156 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEe
Confidence            667889999998 7899998753   24468999999999999999999996 789999999999999   578899999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      |||.+.......        ......|+..|++||.+.+..++.++||||||+++|+|++|+.||.....   ......+
T Consensus       157 dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~  225 (269)
T cd08528         157 DFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKI  225 (269)
T ss_pred             cccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHH
Confidence            999997654432        12345688999999999998899999999999999999999999976432   2223333


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      ......+.   ....+++++.+++.+||+.||++||++.++...++
T Consensus       226 ~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            32222211   11257899999999999999999999999988775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=293.41  Aligned_cols=290  Identities=43%  Similarity=0.693  Sum_probs=240.2

Q ss_pred             ccCC-ceEEeeeeceeCceeEEEEEEcCCC-cEEEEEEecCCCCc--hhHHHHHHHHHHHc---CCCCCCceeEee-eeC
Q 015592            4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTKH--PQLQYEAKLYKILQ---GGTGIPNLRWFG-VEG   75 (404)
Q Consensus         4 ~~~~-~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~--~~~~~E~~~l~~l~---~~~~i~~~~~~~-~~~   75 (404)
                      .... +|++.++||+|+||.||+|.+..++ ..+|+|+.......  ..+..|..++..+.   +..+++.+...+ ..+
T Consensus        14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            3445 8999999999999999999987764 68999987764332  27999999999998   456888888888 588


Q ss_pred             CeEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCCeEEEEecCC
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGL  152 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~--~~~~vkL~DFG~  152 (404)
                      .+.++||.++|.+|.++..... ++++..+++.|+.|++.+|++||+.|++||||||+|++++...  ....++|.|||+
T Consensus        94 ~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   94 DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            8999999999999999997554 7899999999999999999999999999999999999997543  125799999999


Q ss_pred             cc--cccccCCcccccccC-CCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          153 AK--RYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       153 a~--~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      ++  .+.........+.+. ...+.||.+|++++++.+.+.+++.|+||+++++.|++.|..||.+.........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  443333221233333 345679999999999999999999999999999999999999998877665555555555


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      .......   .....|.++.++...+-+.+..++|++..+...|++.+.+.+.....++||......
T Consensus       254 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~~  317 (322)
T KOG1164|consen  254 RKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLRL  317 (322)
T ss_pred             hhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccccc
Confidence            4443332   334567899999999999999999999999999999999999999999999876543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=295.65  Aligned_cols=239  Identities=17%  Similarity=0.205  Sum_probs=182.3

Q ss_pred             eeceeCceeEEEEEEcCC------------------------CcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCc
Q 015592           14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPN   67 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~   67 (404)
                      .||+|+||.||+|....+                        ...|++|++.....  ...+..|+.+++.++|++++..
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999975321                        23588887754322  2357788889999998776665


Q ss_pred             eeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC----CCC
Q 015592           68 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRA  142 (404)
Q Consensus        68 ~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~----~~~  142 (404)
                      +. ++......+++|||+ +++|..++......+++..+..++.||+.||+|||++||+||||||+|||++..    ...
T Consensus        82 ~~-~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          82 HG-VCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EE-EEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            55 455667889999999 889999887656679999999999999999999999999999999999999521    122


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCCC
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT  220 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~ell-tg~~Pf~~~~~~~  220 (404)
                      ..+|++|||++......           ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus       161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            35899999988643321           12356788999998876 45899999999999999995 6999998754432


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ....+    ....     ..+...++++.+++.+||+.+|++||++.+|++.|
T Consensus       230 ~~~~~----~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KERFY----EKKH-----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHH----Hhcc-----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22211    1111     11223457899999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-39  Score=307.90  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=208.4

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..-.+.|.+.+.||+|.|+.|.+|++..++..||||+++.....    ..+.+|+++|+.|+|+|+|..+... ......
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-ETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-eeccee
Confidence            34567899999999999999999999999999999998765432    3478999999999988877766555 445678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      |+||||+ ++.+.+++... +++.+.++..++.|++.|++|||+++|||||||.+||||   +.+..+||+|||++..+.
T Consensus       131 ylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence            9999999 99999999864 457779999999999999999999999999999999999   688889999999999887


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ...        ...+.+|++.|+|||++.+..| ++++|+||+|++||-|+.|.+||.+..   .+..-.++...+..  
T Consensus       207 ~~~--------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---lk~Lr~rvl~gk~r--  273 (596)
T KOG0586|consen  207 YGL--------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---LKELRPRVLRGKYR--  273 (596)
T ss_pred             ccc--------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---cccccchheeeeec--
Confidence            544        2457899999999999999887 789999999999999999999999833   33333444444432  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                         ++..++.+..++|.++|.++|.+|++.+++.
T Consensus       274 ---Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim  304 (596)
T KOG0586|consen  274 ---IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM  304 (596)
T ss_pred             ---ccceeechhHHHHHHhhccCccccCCHHHhh
Confidence               2334678999999999999999999988873

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-38  Score=294.01  Aligned_cols=246  Identities=20%  Similarity=0.301  Sum_probs=197.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .|...+.||+|++|.||++.+..+++.+++|.+....  ..+.+.+|+.+++.+.|++++..+..+ ......+++++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-LVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-EcCCeEEEEEecc
Confidence            5667789999999999999998899999999875433  234578899999999887776666544 4567789999998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++..  .++++.++..++.|++.||+|||++||+||||||+||++   +.++.++|+|||.+........   
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~---  170 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP---  170 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc---
Confidence             8899999874  579999999999999999999999999999999999999   5788999999998875543221   


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....   ...+..+.......  ......+
T Consensus       171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~~~  241 (285)
T cd06648         171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPK--LKNLHKV  241 (285)
T ss_pred             ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCC--CcccccC
Confidence                12345689999999999988899999999999999999999999976332   33333333221111  1112347


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +..+.+++.+||..+|++||++.++.+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            889999999999999999999876653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=308.53  Aligned_cols=242  Identities=21%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEeccCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP   87 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~   87 (404)
                      .+.||+|.||+||-|+++++|+.||||++++-    +...++.+|+.||+.+. |+.|+.+...++..+..++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhcc
Confidence            47899999999999999999999999998753    33467999999999997 56677777778888899999999977


Q ss_pred             CHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           88 SLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        88 sL~~~l-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      +..+++ ....++|++.....++.||+.||.|||.++|+|+||||+|||+...+.-.++||||||+|+.+.+...     
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-----  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-----  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence            766655 44467899999999999999999999999999999999999998777778999999999999887653     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                         ....+||+.|+|||++.+..|++.-|+||.|||+|--+.|..||....  +..   ++|+...+-.+... .+.+++
T Consensus       723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIn---dQIQNAaFMyPp~P-W~eis~  793 (888)
T KOG4236|consen  723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DIN---DQIQNAAFMYPPNP-WSEISP  793 (888)
T ss_pred             ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chh---HHhhccccccCCCc-hhhcCH
Confidence               357899999999999999999999999999999999999999997632  222   33333332222222 246789


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~  268 (404)
                      +..+||+.+|+..-.+|-+.+.
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHh
Confidence            9999999999999999988654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.8e-38  Score=294.62  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..+.|++.+.||+|+||.||+|.+..+++.|++|++..... .+.+..|+.+++.++|++++..+. +.......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEE-EEEECCEEEEEEe
Confidence            45679999999999999999999988899999998876543 456889999999998876655544 4455678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++......+++..+..++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence            99 699999998644479999999999999999999999999999999999999   6788999999999875543321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......++..|++||.+.+..++.++|+|||||++|+|++|+.||.....   ......+....... .. ...
T Consensus       172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~-~~~  240 (286)
T cd06614         172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPP-LK-NPE  240 (286)
T ss_pred             ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC-Cc-chh
Confidence                  11234578899999999988899999999999999999999999976433   22222222222111 11 123


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++.++.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            47899999999999999999999887743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4e-38  Score=298.04  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=197.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.|+..+.||+|+||.||+|++..++..||+|++.....     ...+..|+++++.++|++++..+.. ...+...++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~l  102 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC-YLREHTAWL  102 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEE-EeeCCeEEE
Confidence            3458899999999999999999988999999998764322     2357789999999998776665544 455667899


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||+.++|.+++.....++++.++..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||++...... 
T Consensus       103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc-
Confidence            99999889998887666779999999999999999999999999999999999999   57889999999998654322 


Q ss_pred             CcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                                ....|+..|+|||.+.   +..++.++|||||||++|||++|..||.....   ......+.......  
T Consensus       179 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--  243 (317)
T cd06635         179 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPT--  243 (317)
T ss_pred             ----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCC--
Confidence                      2446888999999974   45689999999999999999999999977432   22222222222111  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                       .....+++.+.+++.+||+.+|.+||++.++.+.
T Consensus       244 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         244 -LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             -CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence             1123567899999999999999999999887654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.7e-38  Score=295.95  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=197.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.+.||+|+||.||++.+..+++.|++|.+....  ..+.+.+|+.+++.++|++++..+.. .......++++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-YLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhe-eeeCCcEEEEEe
Confidence            468999999999999999999998899999999875432  23457889999999997776665544 445667899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.  ...+++.++..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             cCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc-
Confidence            99 889999987  3468999999999999999999999999999999999999   5778999999999876554322 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......|++.|++||.+.+..++.++|+|||||++|++++|+.||.......   ....+....  ........
T Consensus       171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~~~~--~~~~~~~~  239 (293)
T cd06647         171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNG--TPELQNPE  239 (293)
T ss_pred             ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehhcCC--CCCCCCcc
Confidence                  1234468899999999998889999999999999999999999997643311   111111111  11111123


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+.+++.+||..+|++||++.++..
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            46788999999999999999999886653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8e-38  Score=295.46  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.|...++||+|+||.||+|++..+++.|++|++.....     ...+..|+.+++.++|++++..+. +..+....++
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~~l   98 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG-CYLKEHTAWL   98 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEE-EEEeCCEEEE
Confidence            3457778899999999999999999999999998764322     134778999999999777666554 4456678899


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||+.++|.+++......+++.+++.++.||+.+|.|||++||+|+||||+||++   +.++.+||+|||++.....  
T Consensus        99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633          99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC--
Confidence            99999889999887666779999999999999999999999999999999999999   5778999999999864321  


Q ss_pred             CcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                               .....|+..|+|||++.   +..++.++|||||||++|+|++|..||......   .....+......   
T Consensus       174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~---  238 (313)
T cd06633         174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSP---  238 (313)
T ss_pred             ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCC---
Confidence                     23457889999999984   356889999999999999999999999775332   222222221111   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......++..+.+++.+||+.+|++||++.++..
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112356788999999999999999999887653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.8e-38  Score=289.76  Aligned_cols=234  Identities=18%  Similarity=0.241  Sum_probs=190.3

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||.|+||.||+|++..+++.|++|++....     ..+.+.+|+.+++.++|++++..+.. ...+...++++||+ +++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT-FKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeee-EEcCCccEEEEecCCCCc
Confidence            699999999999998899999999876432     22458889999999998777776654 45667789999997 899


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||++   +.++.++|+|||++........       
T Consensus        80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~-------  148 (262)
T cd05572          80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK-------  148 (262)
T ss_pred             HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence            9999975 4568999999999999999999999999999999999999   5788999999999987654321       


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (404)
                       .....|+..|++||.+.+..++.++|+||||+++|+|++|..||..... +....+..+......   ...+...++++
T Consensus       149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~  223 (262)
T cd05572         149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGK---LEFPNYIDKAA  223 (262)
T ss_pred             -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCC---CCCCcccCHHH
Confidence             1234678999999999888899999999999999999999999987543 223333333321111   12233457899


Q ss_pred             HHHHHHHHcCCCCCCCC
Q 015592          249 ASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~  265 (404)
                      .+++.+||..+|++||+
T Consensus       224 ~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         224 KDLIKQLLRRNPEERLG  240 (262)
T ss_pred             HHHHHHHccCChhhCcC
Confidence            99999999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-38  Score=291.00  Aligned_cols=238  Identities=21%  Similarity=0.241  Sum_probs=188.3

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||+|+||+||+|.+..+++.||+|++....     ....+..|+++++.++|++++..+..+ ......+++|||+ +++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-ETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-ecCCeEEEEEecCCCCc
Confidence            689999999999999999999999875432     223467899999999876666655444 4556789999999 789


Q ss_pred             HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccc
Q 015592           89 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY  167 (404)
Q Consensus        89 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~  167 (404)
                      |.+++.... ..+++.+++.++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+.......       
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~-------  149 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK-------  149 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC-------
Confidence            999987533 369999999999999999999999999999999999999   578899999999987654321       


Q ss_pred             cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                       ......++..|++||.+.+..++.++|||||||++|+|++|+.||...........+..   ... ......+..++++
T Consensus       150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~  224 (277)
T cd05577         150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTL-EMAVEYPDKFSPE  224 (277)
T ss_pred             -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccc-cccccCCccCCHH
Confidence             12345678899999999988899999999999999999999999977544222222211   111 1112234567899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~  268 (404)
                      +.++|.+||+.||++||++.+
T Consensus       225 ~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         225 AKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHccCChhHccCCCc
Confidence            999999999999999995544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.8e-38  Score=285.73  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~   82 (404)
                      +|++.+.||+|++|.||+|.+..+++.|++|+......    .+.+.+|+.++++++|++++..+..+... ....++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58899999999999999999988999999998776543    45688999999999987777766555433 26788999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |++ +++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||++   +.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEecccccc
Confidence            999 899999998543 89999999999999999999999999999999999999   5688999999999987765432


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                      ..     ......++..|++||.+.+..++.++||||||+++|+|++|..||....  ........+..   ......++
T Consensus       157 ~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~---~~~~~~~~  226 (260)
T cd06606         157 GE-----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGS---SGEPPEIP  226 (260)
T ss_pred             cc-----cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccc---cCCCcCCC
Confidence            10     1234568899999999998889999999999999999999999998754  22222222221   11222344


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..++..+.+++.+||+.||++||++.++.+
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            566899999999999999999999887754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7e-38  Score=285.20  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=199.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .|++.+.||+|++|.||++.+..+++.+++|+.....  ....+.+|+.+++.++|++++..+. +.......+++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEE-EEecCCeEEEEEecC
Confidence            4889999999999999999998899999999887655  4567899999999999766665554 445557788999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..+..++.|++.+|.|||++|++|+||+|+||++   +.++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence             699999998654679999999999999999999999999999999999999   5788999999999976654321   


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                           .....++..|++||.+.+..++.++||||||+++|+|++|+.||......   ..............  .....+
T Consensus       154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~--~~~~~~  223 (253)
T cd05122         154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGPPGL--RNPEKW  223 (253)
T ss_pred             -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCCCCc--Cccccc
Confidence                 23456889999999999888999999999999999999999999874322   22222211111110  011124


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +.++.+++.+||+.||++||++.++.+
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            789999999999999999999987754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-37  Score=291.10  Aligned_cols=243  Identities=17%  Similarity=0.282  Sum_probs=193.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +|++.+.||.|+||.||+|++.   .+|+.||+|++....      ..+.+..|+++++.+.++++|..+..+...+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999874   478999999876432      2345788999999998777787777777777888


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence            9999999 7899999875 4568999999999999999999999999999999999999   578899999999998654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-HHHHHHhhhccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVS  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~  234 (404)
                      .....      ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......... .....+....  
T Consensus       157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--  228 (290)
T cd05613         157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--  228 (290)
T ss_pred             ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--
Confidence            43211      12245688999999998753  3688999999999999999999999753322221 2222221111  


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                         ...+..+++.+.+++.+||+.||++||+
T Consensus       229 ---~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         229 ---PPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             ---CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence               1223457899999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4e-38  Score=296.83  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=196.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.|+..+.||+|+||.||+|++..+++.+++|.+.....     ..++.+|+++++.++|++++.....+ ......++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l   92 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREHTAWL   92 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-EcCCeeEE
Confidence            4568888999999999999999999999999998753211     23467899999999988777766544 45677899


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||+.++|.+++......+++.++..++.|++.||.|||+++++||||||+|||+   +.++.++|+|||++...... 
T Consensus        93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc-
Confidence            99999889988887656679999999999999999999999999999999999999   57789999999998755432 


Q ss_pred             CcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                                ....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......   ....+.......  
T Consensus       169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~--  233 (308)
T cd06634         169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPA--  233 (308)
T ss_pred             ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcCCCC--
Confidence                      2346788999999985   3457889999999999999999999997754321   122222211111  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                       .....++..+.++|.+||..+|++||++.++.+.
T Consensus       234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             1123578899999999999999999998877644

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=285.67  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||+|++|.||++++..+++.|++|.......    .+.+.+|++++++++|++++..+.. .......+++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEE-EEeCCEEEEEEe
Confidence            58999999999999999999988999999998765542    3458899999999988776655444 455678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ++ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          80 YAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             cCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCcc-
Confidence            99 7799999985 3679999999999999999999999999999999999999   5678999999999987665332 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ...........    ...++.
T Consensus       155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~  221 (254)
T cd06627         155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDD----HPPLPE  221 (254)
T ss_pred             ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccC----CCCCCC
Confidence                  12345688999999999888889999999999999999999999986442   22222222111    123345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++..+.+++.+||..+|++||++.++..
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            67899999999999999999999887753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.4e-38  Score=288.39  Aligned_cols=248  Identities=18%  Similarity=0.262  Sum_probs=185.3

Q ss_pred             eeeceeCceeEEEEEEcCC--CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +.||+|+||.||++.....  ...+++|.......   .+.+.+|+.+++.++|++++..+..+. .....+++|||+ +
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEEecCCC
Confidence            3699999999999975433  34566776554332   346888999999999888877776554 456789999999 7


Q ss_pred             CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           87 PSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        87 ~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      ++|.+++....   ..+++..++.++.||+.||+|||+++|+||||||+|||+   +.++.++|+|||++........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~--  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY--  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence            89999987532   346777889999999999999999999999999999999   5788999999999864322111  


Q ss_pred             cccccCCCCCccCcCccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhh-ccc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVS  234 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~-~~~  234 (404)
                         ........++..|+|||++..       ..++.++|||||||++|||++ |..||.....   .+.+..+... ...
T Consensus       155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~  228 (268)
T cd05086         155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK  228 (268)
T ss_pred             ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence               012234567899999999753       235789999999999999997 6778876433   2333332222 111


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      ...+.+...+++.+.+++..|| .+|++||++++|.+.|
T Consensus       229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            1223334457889999999999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=295.14  Aligned_cols=257  Identities=19%  Similarity=0.252  Sum_probs=205.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCC-----CCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~   77 (404)
                      .+.++|.+.+.+|+|.||.|-.+.+..++..||||+++.- ...+...-|++++.++.+.     +-+..+..++.....
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            4678999999999999999999999999999999987653 4456678899999999532     233444555667778


Q ss_pred             EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC----------------
Q 015592           78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----------------  140 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~----------------  140 (404)
                      .|||+|.+|.|+.+++...+ .+++..++..|+.|++++++|||+.+++|-||||+|||+...+                
T Consensus       166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            89999999999999998532 3699999999999999999999999999999999999995311                


Q ss_pred             -CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 015592          141 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG  219 (404)
Q Consensus       141 -~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~  219 (404)
                       ....|+|+|||.|+.-.+..          ...+.|..|.|||++.+-.++..+||||+||||+||.||...|+...+.
T Consensus       246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence             23468999999998655432          4678899999999999999999999999999999999999999987766


Q ss_pred             ChHHHHHHHhhhcccccHhHh----------------------------h-------cCC---cHHHHHHHHHHHcCCCC
Q 015592          220 TKKQKYEKISEKKVSTSIEAL----------------------------C-------RGY---PTEFASYFHYCRSLRFD  261 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~----------------------------~-------~~~---~~~l~~li~~cl~~~p~  261 (404)
                      +....++.+........+...                            +       ..-   -.+|.+|+.+||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            655566665542222221111                            0       000   13689999999999999


Q ss_pred             CCCCHHHHH
Q 015592          262 DKPDYAYLK  270 (404)
Q Consensus       262 ~RP~~~~l~  270 (404)
                      +|+|+.|++
T Consensus       396 ~RiTl~EAL  404 (415)
T KOG0671|consen  396 RRITLREAL  404 (415)
T ss_pred             ccccHHHHh
Confidence            999976543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.1e-38  Score=291.31  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHc-CCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ-GGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ++|.+.+.||+|+||.||+|++..+++.|++|+.....     ....+..|..++++++ |++++. +..+.......++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~-~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK-LYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchh-HHHHhcCCceEEE
Confidence            57999999999999999999999999999999876532     2345788999999998 555554 4444556678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +||++ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          80 VLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCc
Confidence            99999 9999999985 4479999999999999999999999999999999999999   57889999999999876553


Q ss_pred             CCcccc-------------cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 015592          160 ATHQHI-------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       160 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  226 (404)
                      ......             .........++..|+|||.+.+..++.++||||||+++|++++|+.||.....   ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH
Confidence            321100             01233455688999999999988899999999999999999999999987542   23333


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY  266 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~  266 (404)
                      .+....     ..++..+++.+.+++.+||+.+|++||++
T Consensus       233 ~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         233 KILKLE-----YSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             HHHhcC-----CCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            332221     12334678999999999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=288.34  Aligned_cols=274  Identities=20%  Similarity=0.279  Sum_probs=223.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|+++++||+|+|.+|.+++.++|.+.||+|+++++     ...+..+.|..+...-.+++.++-+..+++.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999999999999999999987654     2334578899999999989999889999999999999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |.||. ||+|--.+++ .++++++.+..+..+|+.||.|||++|||.||||.+|+|+   +..|++||+|+|+++.--.+
T Consensus       329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence            99999 8898777764 6789999999999999999999999999999999999999   79999999999999865444


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CCChHHHHHHHhhhccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEKKVS  234 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~~~~~  234 (404)
                      ..       .+++++|||.|.|||++.|..|+..+|+|+|||+++||+.|+.||.-..     .++....+..|.++.. 
T Consensus       405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-  476 (593)
T KOG0695|consen  405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-  476 (593)
T ss_pred             Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-
Confidence            33       4578999999999999999999999999999999999999999996321     1223334445555543 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ  299 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~  299 (404)
                          .+++.++-....+++.-|++||.+|....- .--|.++   .+.++...+||+.....+..
T Consensus       477 ----riprslsvkas~vlkgflnkdp~erlgc~~-~~g~~di---k~h~ffr~idwd~leqk~v~  533 (593)
T KOG0695|consen  477 ----RIPRSLSVKASHVLKGFLNKDPKERLGCRP-QTGFSDI---KSHAFFRSIDWDLLEQKQVL  533 (593)
T ss_pred             ----cccceeehhhHHHHHHhhcCCcHHhcCCCc-ccchhhh---hcchhhhhCCHHHHhhcccC
Confidence                345677888899999999999999964320 1122222   23455667899988766543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-38  Score=290.26  Aligned_cols=252  Identities=21%  Similarity=0.231  Sum_probs=197.4

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      |++.+.||+|+||.||+|++..+++.|++|++....    ..+.+..|+.+++.++|++++..+..+. .....++++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceEEEecC
Confidence            678899999999999999999999999999877543    2345788999999999777766555443 45788999999


Q ss_pred             cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      ++++|.+++......+++..+..++.|++.||.|||++||+||||+|+||++   ++++.++|+|||+++.......   
T Consensus        80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~---  153 (282)
T cd07829          80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR---  153 (282)
T ss_pred             cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence            9889999998654579999999999999999999999999999999999999   5789999999999986654321   


Q ss_pred             ccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh-------------
Q 015592          165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-------------  230 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------------  230 (404)
                          ......++..|+|||.+.+. .++.++|||||||++|||++|..||.+.........+.....             
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence                11234567889999999876 789999999999999999999999977443221111111100             


Q ss_pred             --------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 --------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 --------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                              ...........+.++..+.+++.+||..||++||++.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                    00001111222345789999999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=306.00  Aligned_cols=272  Identities=19%  Similarity=0.277  Sum_probs=218.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+++++..||-|+||.|-++........+|+|++++...     .+.+..|.+||..+..+.++ .++-.+.+.++.|++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIv-rLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIV-RLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHH-HHHHHhccchhhhhh
Confidence            457788899999999999999766655689998776432     23477899999999855444 444445677888999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||-| ||.|..++.. .+.|+..++..++..+++|++|||++|||.|||||+|.|+   +.+|-+||.|||+|+.+....
T Consensus       499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence            9988 9999999985 6689999999999999999999999999999999999999   799999999999999988764


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                              .+-+++||+.|.|||++.+...+.++|.||||+++|||++|++||.+.++   ...|..|....   ..-.+
T Consensus       575 --------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGi---d~i~~  640 (732)
T KOG0614|consen  575 --------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGI---DKIEF  640 (732)
T ss_pred             --------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhh---hhhhc
Confidence                    35688999999999999999999999999999999999999999999555   44444444432   11245


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccccccCC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST  302 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  302 (404)
                      ++.++....+||.++...+|.+|..+.  ..-+.++   ....|...|||.-.+.++.+++-
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~--~~gI~DI---kkH~Wf~gfdweglr~~~L~pPi  697 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLGYQ--KGGINDI---KKHRWFEGFDWEGLRSRTLPPPI  697 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhccc--cCChHHH---HhhhhhhcCChhhhhhccCCCCc
Confidence            567889999999999999999997621  1122222   12356778999988877665443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=299.89  Aligned_cols=263  Identities=21%  Similarity=0.315  Sum_probs=212.6

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---------chhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      +.+.++|-++..||+|+|++||+|.|....+.||||+-.....         .+...+|.+|.+.|.|+.+|..+.++..
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            4577899999999999999999999999999999998544332         2346789999999999999999999999


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcccccCCCCCCeEEEEec
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      +.+.+|-|+||| |.+|.-+++. .+-++++++..|+.||+.||.||...  .|||-||||.|||+..+...|.+||+||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            999999999999 7889888885 45699999999999999999999985  6999999999999988888999999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  226 (404)
                      |+++.+.+...........++...||..|++||.+.-.    ..+.|+||||+|||+|..++|+.||.........-.+.
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            99999988766543334456678899999999998643    26889999999999999999999997643221111111


Q ss_pred             HHhhh-cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          227 KISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       227 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      .|... .+..   ...+.++.+.+.+|.+||.+.-++|.+..+|
T Consensus       698 TIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  698 TILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             chhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            11111 1111   0113467899999999999999999775443

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9e-38  Score=285.83  Aligned_cols=244  Identities=18%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +|++.+.||.|+||.||++++..+++.+++|.+....    ....+..|+.+++.++|++++..... .......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA-FLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhh-hccCCEEEEEeh
Confidence            5899999999999999999999999999999876432    22357789999999997766655444 445578899999


Q ss_pred             cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+ +++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||++   +..+.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC
Confidence            98 88999988642   3468999999999999999999999999999999999999   46788999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .         .....++..|++||.+.+..++.++|+||||+++|+|++|+.||.....   ......+.....    ..
T Consensus       157 ~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~  220 (256)
T cd08530         157 M---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKY----PP  220 (256)
T ss_pred             C---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC----CC
Confidence            1         1234678899999999998899999999999999999999999987443   222223322222    22


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +...++.++.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            33467899999999999999999999988764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=289.17  Aligned_cols=251  Identities=22%  Similarity=0.264  Sum_probs=193.5

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHc-CCCCCCceeEeeeeCCeEEEEEec
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQ-GGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      |++.+.||+|+||+||+|++..+++.|+||.+.....   .....+|+..+++++ |++++..+.. ...+...+++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~-~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV-FRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHH-hhcCCcEEEEEec
Confidence            7889999999999999999988999999998765432   123557889999998 6665555544 4457788999999


Q ss_pred             cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      ++++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||||+||++   +..+.++|+|||+++.......  
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC--
Confidence            9999999887543 468999999999999999999999999999999999999   6789999999999986654321  


Q ss_pred             cccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc----------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------  232 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------  232 (404)
                            .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||......+............          
T Consensus       155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence                  123567889999998864 447999999999999999999999997754322221111110000          


Q ss_pred             ------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                  ............+..+.+++.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                        001111222234688999999999999999999887753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-38  Score=280.81  Aligned_cols=269  Identities=20%  Similarity=0.247  Sum_probs=208.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC----cEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ...|++...||+|.||.||+|...+++    +.+|||.++.+.    ......+|+.+++.++|+|+|..+..+-..+..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356999999999999999999765553    379999877663    345689999999999999999998888777889


Q ss_pred             EEEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCCeEEEEecCC
Q 015592           78 NVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL  152 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~-~~~~~~vkL~DFG~  152 (404)
                      .++++||...+|.++|+...    +.++...+..|+.||+.|+.|||++=|+||||||.|||+-- ..+.|.|||+|||+
T Consensus       103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999999999999998653    34899999999999999999999999999999999999931 23459999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------hHHHH
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY  225 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------~~~~~  225 (404)
                      ++.+.+.-.    |.......+-|..|.|||++.|.. ||.+.||||.|||+.||+|-++-|.+.....      ....+
T Consensus       183 aR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  183 ARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             HHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            998887542    333456678899999999999866 9999999999999999999998887632211      11122


Q ss_pred             HHHhhhcc------cccHhHh----------h----------------cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          226 EKISEKKV------STSIEAL----------C----------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       226 ~~~~~~~~------~~~~~~~----------~----------------~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .+|.+...      .+.+..+          .                ..-++...+|+.++|..||-+|.|+.   +.|
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~---qAl  335 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE---QAL  335 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH---HHh
Confidence            22221110      0000000          0                11244578999999999999999976   455


Q ss_pred             HHHHHHcC
Q 015592          274 RDLFIREG  281 (404)
Q Consensus       274 ~~~~~~~~  281 (404)
                      ++.+..+.
T Consensus       336 eh~yF~~d  343 (438)
T KOG0666|consen  336 EHPYFTED  343 (438)
T ss_pred             cccccccC
Confidence            66665544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-37  Score=295.72  Aligned_cols=252  Identities=15%  Similarity=0.217  Sum_probs=185.8

Q ss_pred             eeecee--CceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      ..||.|  +||+||++++..+++.||+|+......    .+.+.+|+.+++.++|++++..+..+ ..+...+++|+|+ 
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-TTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-ecCCceEEEEeccc
Confidence            456666  999999999999999999998765432    24578899999889987766655544 5566789999998 


Q ss_pred             CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 ~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++++||+.+...........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCcccc
Confidence            78999998753 3458999999999999999999999999999999999999   5778999999986644332221111


Q ss_pred             ccccCCCCCccCcCccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc--------
Q 015592          165 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--------  234 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--------  234 (404)
                      ..+.......++..|+|||++.+.  .++.++|||||||++|||++|+.||.+....   +.+.........        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCcccccc
Confidence            111111223456779999999764  4789999999999999999999999874321   111111100000        


Q ss_pred             ----------------------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 ----------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ----------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                        .........+++.+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                              0000112245778999999999999999999887743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=334.99  Aligned_cols=252  Identities=22%  Similarity=0.343  Sum_probs=205.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.-++.-+..||.|.||.||-|.+..+|...|+|.++..    +..+.+.+|..++..|+|+|+|.++ .+..+.+..+|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~Yy-GVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYY-GVEVHREKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccC-ceeecHHHHHH
Confidence            345677888999999999999999999999999965543    2345688999999999987766554 45567777899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      .|||| +|+|.+++. .++..++.....+..|++.||.|||++|||||||||+||+|   +.+|.+|++|||.|..+...
T Consensus      1312 FMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence            99999 999999998 46667888888899999999999999999999999999999   68889999999999988765


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .  +.++ .+.....||+.|||||++.+..   -..++||||||||+.||+||+.||..++..  .+.+-++..+..+  
T Consensus      1388 ~--~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~P-- 1460 (1509)
T KOG4645|consen 1388 A--QTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKP-- 1460 (1509)
T ss_pred             h--hcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCC--
Confidence            3  1122 2345678999999999998754   467899999999999999999999987553  3334444433332  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                        .++..++.+-+++|.+||..||+.|.++.+|+
T Consensus      1461 --q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1461 --QIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred             --CCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence              33445789999999999999999998866443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=313.81  Aligned_cols=258  Identities=15%  Similarity=0.226  Sum_probs=213.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ....|.++||.|.||+||+|+.+..+   ..||||.++....   +.+|..|+.||-+++|||+|..- .+....+..+|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLE-GVVTks~PvMI  707 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLE-GVVTKSKPVMI  707 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEE-EEEecCceeEE
Confidence            34578999999999999999987555   5799998886543   44599999999999988877554 44456677888


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +.||+ +|+|..+|+...+.|+.-+...+++.|+.|++||-+.++|||||...|||+   +.+-.+|++|||+++.+.+.
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence            99998 999999999888889999999999999999999999999999999999999   68889999999999988765


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...   .| .+....-..+|.|||.+....++.+|||||||++|||.+. |..||.++++.+....+   .+.-..++  
T Consensus       785 ~~~---~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI---e~gyRLPp--  855 (996)
T KOG0196|consen  785 PEA---AY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI---EQGYRLPP--  855 (996)
T ss_pred             CCc---cc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH---HhccCCCC--
Confidence            421   11 1122223578999999999999999999999999999887 99999998775443333   33222221  


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                        +.+||..|.+|+..||++|-.+||.|.+|+..|.+++.+
T Consensus       856 --PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  856 --PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence              347999999999999999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=304.60  Aligned_cols=242  Identities=19%  Similarity=0.235  Sum_probs=203.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ..+.|.+...+|.|+|+.|-.+.+..+++..++|++...  ..+..+|+.++....+|+++..+.....++...++|||+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            467899999999999999999999999999999998765  445678888888888888888888888899999999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + |+-|.+.+.. . +....++..|+.||+.|+.|||++|||||||||+|||+.  +..++++|+|||.++......   
T Consensus       398 l~g~ell~ri~~-~-~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~---  470 (612)
T KOG0603|consen  398 LDGGELLRRIRS-K-PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC---  470 (612)
T ss_pred             ccccHHHHHHHh-c-chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh---
Confidence            9 6666555542 2 333378889999999999999999999999999999994  478899999999998776541   


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                             .+-+-|..|.|||++....|+.++||||||++||+|++|+.||.....+  .+.+.++...+..       ..
T Consensus       471 -------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~  534 (612)
T KOG0603|consen  471 -------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------EC  534 (612)
T ss_pred             -------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------cc
Confidence                   1335588999999999999999999999999999999999999875544  4445555444332       46


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++.+.++|+.+||+.||.+||++.++..
T Consensus       535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  535 VSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            8999999999999999999999987643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.6e-38  Score=287.09  Aligned_cols=245  Identities=23%  Similarity=0.292  Sum_probs=193.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +|.+.+.||+|+||.||++++..++..+++|+.+...       ...++..|+.+++.++|++++..+..+ ......++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-LERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-hcCCceEE
Confidence            6999999999999999999998877777777654311       222466789999999988777766554 44556789


Q ss_pred             EEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           81 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ++||+ +++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++    .+.++|+|||+++..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            99998 88999888642   35699999999999999999999999999999999999993    356999999999766


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .....       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....   .......+....    
T Consensus       156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~----  221 (260)
T cd08222         156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGP----  221 (260)
T ss_pred             CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCC----
Confidence            44322       1234567889999999988889999999999999999999999996532   233333332222    


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .......++.++.+++.+||..+|++||++.++.+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            12234567899999999999999999999887754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-37  Score=285.45  Aligned_cols=252  Identities=22%  Similarity=0.303  Sum_probs=197.4

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||.|+||.||++++..+++.|++|++....     ....+.+|+++++.++|++++..+. ....+...++++|++ +++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY-SFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHH-heecCcEEEEEEecCCCCc
Confidence            689999999999998889999999876543     2345888999999999777666554 445677889999999 789


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc-cccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-HIPY  167 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~-~~~~  167 (404)
                      |.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++.......... ....
T Consensus        80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence            99999853 479999999999999999999999999999999999999   678899999999987544321100 0000


Q ss_pred             cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .......++..|++||.+.+..++.++||||||+++|+|++|..||.....   .+.+..+........  .. ..++..
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~-~~~~~~  229 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNILNGKIEWP--ED-VEVSDE  229 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCcCCC--cc-ccCCHH
Confidence            012345678899999999988899999999999999999999999976442   333333333222111  11 124899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      +.+++.+||+.+|++||++..+.++|++.+
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~  259 (265)
T cd05579         230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPF  259 (265)
T ss_pred             HHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence            999999999999999999988888777554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=300.35  Aligned_cols=261  Identities=16%  Similarity=0.250  Sum_probs=216.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+...+.++||+|-||+|.+++- ..+..||||.++...   ...+|.+|+++|.+|+|||++..++.|. .++..++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-QDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-cCCchHHHH
Confidence            35678899999999999999984 456999999887643   3356999999999999888777766664 455678888


Q ss_pred             ecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ .|+|.+++..+..+ +..+....|+.||+.|++||.+.++|||||.+.|+|+   +.++++||+|||+++.+-...
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCC
Confidence            888 99999999865433 4667788899999999999999999999999999999   799999999999999665544


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .     |+.....+-..+|||+|.+.-++++.+||+|+||+++||+++  ...||..++++...+....+..........
T Consensus       692 y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  692 Y-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             c-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            3     334455666889999999999999999999999999999876  889999887765555555555544444455


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..+.-||.++.+++.+||..+-.+||+|++|...|.+.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            56677999999999999999999999999999888764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=283.32  Aligned_cols=253  Identities=18%  Similarity=0.280  Sum_probs=200.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++.+-+..||.|+||+|++-.++.+|+..|||.+.....   ..++..|.+...+-...+.|+.++...-.+...+|.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            344556789999999999999999999999998776544   44588888877776666555555443334445689999


Q ss_pred             ccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           84 LLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        84 ~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++..||..+.+..    +..+++.-+-.|....+.||.||-. ..|||||+||+|||+   +..|.+||||||++-.+.+
T Consensus       144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence            9999998876532    4569999999999999999999997 589999999999999   7999999999999987776


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      +..        .+.-.|...|||||.+...  .|+.+||+||||++|||+.||+.||.+...  ..+.+..+..+..+..
T Consensus       221 SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  221 SIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence            543        2345789999999998743  489999999999999999999999987433  4555555555443332


Q ss_pred             HhH-hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          237 IEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       237 ~~~-~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ... -+-.++..+..+|..||.+|-.+||.+.+|++.
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            211 123478999999999999999999999988654

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-37  Score=288.67  Aligned_cols=244  Identities=18%  Similarity=0.281  Sum_probs=193.5

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      +...+||+|+||.||++.+..+++.||||.+....  ....+.+|+.+++.++|++++..+.. ....+..+++|||+ +
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-YLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeE-EEeCCEEEEEEecCCC
Confidence            33467999999999999999999999999875433  23457889999999998766666554 45667889999999 7


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      ++|.+++.  ..++++..+..++.|++.||+|||++|++|+||||+||++   +.++.++|+|||++........     
T Consensus       102 ~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~-----  171 (292)
T cd06657         102 GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-----  171 (292)
T ss_pred             CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc-----
Confidence            89998876  4568999999999999999999999999999999999999   5778999999999875543221     


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcH
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT  246 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                        ......|+..|++||.+.+..++.++|+|||||++|+|++|..||.+...   ......+... ...... ....+++
T Consensus       172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~  244 (292)
T cd06657         172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSP  244 (292)
T ss_pred             --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCH
Confidence              12345688999999999888899999999999999999999999986432   2222222211 111111 1235788


Q ss_pred             HHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          247 EFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       247 ~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .+.+++.+||..+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            9999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-36  Score=313.91  Aligned_cols=144  Identities=22%  Similarity=0.404  Sum_probs=125.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++.++||+|+||.||+|++..+++.||||++.....     ...+..|+.++..++|++++..+ .+.......++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~-~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEE-EEEEECCEEEE
Confidence            3789999999999999999999999999999998865432     24578899999999887766655 44566778999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +|||+ +++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            99999 8999999975 4568999999999999999999999999999999999999   577899999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.3e-38  Score=319.14  Aligned_cols=257  Identities=20%  Similarity=0.229  Sum_probs=189.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEee---------
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFG---------   72 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~---------   72 (404)
                      ...+|+.++.||+||||.||+++++-+|+.||||.+....   ....+.+|+.++.+|+|+|+|.++..+.         
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467889999999999999999999999999999877653   2234888999999999999887652221         


Q ss_pred             -----------------------------------------------e---------------------e----------
Q 015592           73 -----------------------------------------------V---------------------E----------   74 (404)
Q Consensus        73 -----------------------------------------------~---------------------~----------   74 (404)
                                                                     .                     +          
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0                     0          


Q ss_pred             -----------------------C--------CeEEEEEeccCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 015592           75 -----------------------G--------DYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSK  122 (404)
Q Consensus        75 -----------------------~--------~~~~lv~e~~~~sL~~~l~~~~~~l-~~~~~~~i~~qi~~aL~~LH~~  122 (404)
                                             .        .+.||-||||..+|...+...+... .....++++.||++||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                   0        2458999999665555444333323 4788999999999999999999


Q ss_pred             CceeccCCCCcccccCCCCCCeEEEEecCCcccccc---c-------CCcc-cccccCCCCCccCcCccccccccCCC--
Q 015592          123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---T-------ATHQ-HIPYRENKNLTGTARYASMNTHLGIE--  189 (404)
Q Consensus       123 givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~---~-------~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~--  189 (404)
                      |||||||||.||++   +..+.|||+|||+|+....   .       .... .......+..+||.-|+|||++.+..  
T Consensus       717 giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             ceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999   6899999999999987220   0       0000 01111345678999999999998765  


Q ss_pred             -CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015592          190 -QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       190 -~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  268 (404)
                       |+.|+|||||||||+||+.   ||..  ..+....+..+.....+.+ ..+...--+.-.++|.++++.||.+|||+.+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence             9999999999999999985   5653  2222233333333333222 1112222245678999999999999999988


Q ss_pred             HH
Q 015592          269 LK  270 (404)
Q Consensus       269 l~  270 (404)
                      |+
T Consensus       868 LL  869 (1351)
T KOG1035|consen  868 LL  869 (1351)
T ss_pred             Hh
Confidence            74

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.4e-37  Score=288.86  Aligned_cols=247  Identities=19%  Similarity=0.265  Sum_probs=182.3

Q ss_pred             CceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHH
Q 015592           19 SFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLF   93 (404)
Q Consensus        19 ~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l   93 (404)
                      ++|.||.+++..+++.||||+++...    ....+..|+.+++.++|++++..+..+ ......+++|||+ +++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-ecCCeEEEEEeccCCCCHHHHH
Confidence            44556666666799999999876542    224688999999999988877766544 5566789999999 78999999


Q ss_pred             HHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCC
Q 015592           94 NFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN  172 (404)
Q Consensus        94 ~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~  172 (404)
                      ... ...+++..+..++.|++.||+|||+++|+||||||+||++   +.++.+||+|||.+...................
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccccccccccccc
Confidence            753 3468999999999999999999999999999999999999   577899999999987664432211111112234


Q ss_pred             CccCcCccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------------c--
Q 015592          173 LTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------V--  233 (404)
Q Consensus       173 ~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------~--  233 (404)
                      ..++..|+|||++.+.  .++.++|||||||++|||++|+.||......  .....++....               .  
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCcCc
Confidence            5678899999998763  4889999999999999999999999864321  11111111000               0  


Q ss_pred             -----------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -----------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                 ..........++.++.+++.+||..||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                       00001111234578999999999999999999876654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=252.38  Aligned_cols=252  Identities=20%  Similarity=0.261  Sum_probs=203.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+|...++||+|.||+||+|++..+++.||+|....+...    ....+|+-+++.++|.|++..+... ..++...+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-hsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-ccCceeEEeH
Confidence            4678889999999999999999999999999987665443    3588999999999988877665544 4556678999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+|..+|..++..+++.++.+.+..++.|++.||.++|+++++||||||+|.|+   +.+|.+||.|||+++.+.-+.  
T Consensus        81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce--
Confidence            999999999999999999999999999999999999999999999999999999   699999999999999776543  


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc---cccH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV---STSI  237 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~  237 (404)
                           +.-+..+-|..|.+|.++.|.. |+...|+||.|||+.|+.. |++.|.+.+..+....+.+......   .+.+
T Consensus       156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence                 2334556799999999999876 8999999999999999997 8888988655444444433322111   1111


Q ss_pred             h------------------HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          238 E------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       238 ~------------------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      .                  .+.+.+...=+++++.+|.-+|..|.+++..
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa  280 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA  280 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence            1                  1112233455789999999999999997744

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=300.26  Aligned_cols=250  Identities=20%  Similarity=0.360  Sum_probs=208.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeee-----eCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~~   78 (404)
                      -.+.|+|.+.||.|.+|.||+++++.+++.+|+|++.... ..++++.|.++++.+.+|++++.++.++.     .++..
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            3567999999999999999999999999999999987654 45568999999999999999888866543     35678


Q ss_pred             EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      +|||||| |||.-|+++.. +.++.|..+..|+..++.||.+||.+.++|||||-.|||+   +..+.|||+|||.+..+
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL  173 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeee
Confidence            9999999 89999999854 5579999999999999999999999999999999999999   68999999999999877


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      .....       ...+.+||+.|||||++...+     |+.++|+||||++..||..|.+|+.++.+...   +..|...
T Consensus       174 dsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRN  243 (953)
T KOG0587|consen  174 DSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRN  243 (953)
T ss_pred             ecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCC
Confidence            76543       456789999999999997543     67899999999999999999999998766211   1111111


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      .  ++-..-+...+.+|.++|..||.+|.++||+..++
T Consensus       244 P--PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l  279 (953)
T KOG0587|consen  244 P--PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL  279 (953)
T ss_pred             C--CccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence            1  11112234567899999999999999999997654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-38  Score=273.55  Aligned_cols=260  Identities=20%  Similarity=0.242  Sum_probs=202.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeee-------
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------   73 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------   73 (404)
                      .++.|+...+||+|.||+||+|+.+++++.||+|++-.+    .......+|+++|..|+|.+.+..+..+..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            356788889999999999999999999999999953221    223457899999999999998887755532       


Q ss_pred             eCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           74 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      +....|+|+++|..+|..++.....+++..++..++.++.+||.|+|+..|+|||+||+|+||   +.++.+||+|||++
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla  171 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA  171 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence            223479999999999999998666789999999999999999999999999999999999999   68899999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      +.+..........|   .+.+-|..|.+||.+.|.. |+++.|||..|||+.||.||.+-|++.+.......+..+....
T Consensus       172 r~fs~~~n~~kpry---tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRY---TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             cceecccccCCCCc---ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            88776544332222   2456699999999999755 9999999999999999999999998855543333333322111


Q ss_pred             ---ccccH-----------hHhhc-------------CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ---VSTSI-----------EALCR-------------GYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ---~~~~~-----------~~~~~-------------~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                         +.+..           +.++.             .-.++..+|+.+++..||.+|++++++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al  313 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL  313 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence               11100           00110             1135788999999999999999988654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=272.40  Aligned_cols=234  Identities=22%  Similarity=0.263  Sum_probs=192.1

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ||.|+||.||++.+..+++.|++|++.....     ...+..|+.+++.++|++++..+.. ...+...+++|+++ +++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-FQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-eecCCeeEEEEecCCCCc
Confidence            6999999999999988899999998765432     2358889999999997776665544 45677889999999 999


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                      |.+++.. ...+++..+..++.|++.||.|||+++++|+||||+||++   +..+.++|+|||++........       
T Consensus        80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------  148 (250)
T cd05123          80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS-------  148 (250)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence            9999985 4469999999999999999999999999999999999999   5778999999999976654321       


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (404)
                      ......++..|++||.+.+...+.++|+||||+++|+|++|..||.....   .+....+....     ..++..++.++
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~l  220 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDP-----LRFPEFLSPEA  220 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCC-----CCCCCCCCHHH
Confidence            12345688899999999988899999999999999999999999976332   33333333321     23345568999


Q ss_pred             HHHHHHHHcCCCCCCCCHHH
Q 015592          249 ASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~~~~  268 (404)
                      .+++.+||..||++||++.+
T Consensus       221 ~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         221 RDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHhcCCHhhCCCccc
Confidence            99999999999999999855

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=274.87  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=208.3

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCceeEeeeeC---Ce
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEG---DY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~~~~~---~~   77 (404)
                      .-|.++..+.+.||+|.||+||+|.|  .|+.||||++... ..+.+.+|.+|++.  |+|.|++.++..=..+.   ..
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34678899999999999999999997  5889999998754 34567788888764  67888777663322222   24


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcccccCCCCCCeEEEE
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                      .+|+.+|. .|||.|+++.  ..++.+..++++..++.||++||.        ..|.|||||..|||+   ..++.+.|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEe
Confidence            68888888 9999999984  679999999999999999999995        259999999999999   799999999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccCCC----C--CchhHHHHHHHHHHHHHcC----------CCC
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----Q--SRRDDLESLGYVLMYFLRG----------SLP  212 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDiwSlG~il~elltg----------~~P  212 (404)
                      |+|+|-...+......+   .....+||.+|||||++...-    +  -..+||||||.|+||++.+          ++|
T Consensus       359 DLGLAv~h~~~t~~idi---~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDI---PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             eceeeEEecccCCcccC---CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999877665433332   345679999999999987532    1  2468999999999999853          689


Q ss_pred             CCCCCCCCh--HHHHHHHhhhcccccHhHhhcCCc--HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          213 WQGLKAGTK--KQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       213 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      |.+..+.+.  .+..+-+...+..+.++......|  ..+.++++.||..||.-|-|+-.|++.|.++..
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            988666543  333333445555565555555544  468899999999999999999999999998863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.5e-36  Score=302.22  Aligned_cols=253  Identities=17%  Similarity=0.165  Sum_probs=167.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC----CcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeE----e-eeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW----F-GVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~----~-~~~~   75 (404)
                      -.++|++.++||+|+||.||+|++..+    +..||||.+......+....| . ++...+..+...+..    . ...+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-R-VRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-H-HHhhchhhHHHHHHhhhcccccccC
Confidence            346899999999999999999999888    899999986543222211111 1 111111111111111    1 2455


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRK-------------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      ...+++++|+ +++|.+++......                   .....+..++.||+.||+|||++||+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            6789999999 78999998743211                   123446789999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCC----------------------CCch
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----------------------QSRR  193 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~  193 (404)
                      ++  +..+.+||+|||+|+.+......      ......+++.|+|||.+....                      ++.+
T Consensus       288 l~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        288 FS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             Ee--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            94  34678999999999866543221      234567899999999764322                      3456


Q ss_pred             hHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc-------------cccHh---HhhcCCcHHHHHHHHHHHc
Q 015592          194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------------STSIE---ALCRGYPTEFASYFHYCRS  257 (404)
Q Consensus       194 sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~---~~~~~~~~~l~~li~~cl~  257 (404)
                      +|||||||+||||+++..|+...    ..+....+.....             .....   .+.........+||.+||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            79999999999999987765431    1111111111000             00000   0001112345689999999


Q ss_pred             CCCCCCCCHHHHHH
Q 015592          258 LRFDDKPDYAYLKR  271 (404)
Q Consensus       258 ~~p~~RP~~~~l~~  271 (404)
                      +||++|||+.++++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999876654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.2e-36  Score=270.42  Aligned_cols=220  Identities=16%  Similarity=0.146  Sum_probs=173.6

Q ss_pred             eCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHc
Q 015592           18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC   96 (404)
Q Consensus        18 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~   96 (404)
                      |.+|.||++++..+++.||+|.+....   ....|...+....|++++. +..+.......+++|||+ +++|.+++.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVC-LHKYIVSEDSVFLVLQHAEGGKLWSHISK-   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceee-hhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence            899999999999999999999886543   2344555444445555554 444455667889999999 7899999875 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccC
Q 015592           97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT  176 (404)
Q Consensus        97 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt  176 (404)
                      ...+++..+..++.|++.||+|||++||+||||||+||++   +.++.++|+|||.+.......          ....++
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~  145 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVE  145 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcC
Confidence            3469999999999999999999999999999999999999   578889999999886554322          123457


Q ss_pred             cCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHH
Q 015592          177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR  256 (404)
Q Consensus       177 ~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  256 (404)
                      ..|+|||.+.+..++.++|+|||||++|||++|+.||......        +.. .   ....++..+++.+++++.+||
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~-~---~~~~~~~~~~~~~~~li~~~l  213 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INT-H---TTLNIPEWVSEEARSLLQQLL  213 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccc-c---cccCCcccCCHHHHHHHHHHc
Confidence            7899999998888999999999999999999999988643211        000 0   001233457899999999999


Q ss_pred             cCCCCCCCCHH
Q 015592          257 SLRFDDKPDYA  267 (404)
Q Consensus       257 ~~~p~~RP~~~  267 (404)
                      +.||++||++.
T Consensus       214 ~~dp~~R~~~~  224 (237)
T cd05576         214 QFNPTERLGAG  224 (237)
T ss_pred             cCCHHHhcCCC
Confidence            99999999863

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=299.49  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEc---C----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNI---Q----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~---~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +..+.+.||+|.||.|++|.-.   .    ....||||..+....   .+.+..|+++|+.+.+|+++..+..+......
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            4467779999999999999732   1    246799998765443   35689999999999866666665554445778


Q ss_pred             EEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                      .++++||+ .|+|.++++...               ..++..+.+.++.||+.|++||++.++|||||-..|||+   ..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---TK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cC
Confidence            88899998 999999998655               238999999999999999999999999999999999999   57


Q ss_pred             CCeEEEEecCCcccccccCCcccccccCCCCCc--cCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 015592          142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~  218 (404)
                      +..+||+|||+|+.......     |+ .....  -...|||||.+....|+.++||||||++|||+++ |..||.+...
T Consensus       454 ~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             CCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            78999999999986554332     11 11122  2446999999999999999999999999999999 9999988432


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .  ...++.+..+..    ...+..+++++.+++..||+.+|++||+|.++.+.|...+..
T Consensus       528 ~--~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  528 T--EELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             H--HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            1  222333333222    233456799999999999999999999999999999997653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=292.44  Aligned_cols=253  Identities=21%  Similarity=0.262  Sum_probs=212.5

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+..++||+|+||+||+|.+...|+    +||||++.....   ..++..|+-+|.+|.|++++..+..+-...  ..|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence            4567899999999999999876554    688887665443   457899999999999999998887775444  5677


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      .+|+ .|+|.++++..+.++..+..+.|..||++|+.|||.+++|||||-..|||+   .....+||.|||+++.+....
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence            7777 999999999888899999999999999999999999999999999999999   789999999999999887765


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..-+.     ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+....+++-.+       -.
T Consensus       853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------Ls  920 (1177)
T KOG1025|consen  853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------LS  920 (1177)
T ss_pred             ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------CC
Confidence            43222     22233678999999999999999999999999999999 9999999877665555544322       12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .++.++.++.-++.+||..|++.||+|+++...|.++..
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            345688999999999999999999999999999988764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-36  Score=285.32  Aligned_cols=278  Identities=21%  Similarity=0.247  Sum_probs=209.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      -|..++.||-|+||+|.+++...|...||.|.+.+.+..     ..+..|..||..-. .+-|+.+++.+++.+..|+||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEE
Confidence            488899999999999999999999999999976554322     23667888888776 455666777778888999999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      +|. ||++-.+|-+ -+-|.+..+..++.++.+|+++.|..|+|||||||+||||   |.+|++||+|||+|+-++....
T Consensus       709 dYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             eccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence            999 9999999875 4579999999999999999999999999999999999999   7999999999999986653211


Q ss_pred             --------ccccc-------c--------------------cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHH
Q 015592          162 --------HQHIP-------Y--------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF  206 (404)
Q Consensus       162 --------~~~~~-------~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~el  206 (404)
                              +....       +                    ...-.++||+.|+|||++....|+..+|+||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                    10000       0                    012346799999999999999999999999999999999


Q ss_pred             HcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCc
Q 015592          207 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDY  286 (404)
Q Consensus       207 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~  286 (404)
                      +.|+.||..........++......  ..  -..+.+++++..++|.++.. ++++|..-. ..+      .-...+|..
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~--l~--~~~~~~ls~e~~~li~kLc~-sad~RLGkn-g~d------~vKaHpfFk  932 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNF--LH--IPYQGNLSKEALDLIQKLCC-SADSRLGKN-GAD------QVKAHPFFK  932 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhc--cc--cccccccCHHHHHHHHHHhc-Chhhhhccc-chh------hhhcCcccc
Confidence            9999999887665443332221111  00  12234678888888877544 477885411 111      123347788


Q ss_pred             eeecccccccccccCC
Q 015592          287 VFDWTILKYQQSQVST  302 (404)
Q Consensus       287 ~~~w~~~~~~~~~~~~  302 (404)
                      .+||...+.+.++..+
T Consensus       933 gIDfsslRkq~ApYIP  948 (1034)
T KOG0608|consen  933 GIDFSSLRKQRAPYIP  948 (1034)
T ss_pred             ccchHhhhhccCCcCc
Confidence            8899887666655444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=266.88  Aligned_cols=134  Identities=26%  Similarity=0.476  Sum_probs=114.3

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCC--------CCCceeEe--
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGT--------GIPNLRWF--   71 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~--------~i~~~~~~--   71 (404)
                      ...+++|.+.++||.|.|++||+|.|..+.+.||+|+.+... ..+....|+++|+++....        +|..+.+|  
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            445599999999999999999999999999999999987654 3456889999999987433        33334444  


Q ss_pred             -eeeCCeEEEEEeccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccc
Q 015592           72 -GVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLM  136 (404)
Q Consensus        72 -~~~~~~~~lv~e~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl  136 (404)
                       +..+...|+|+|++|.+|..+|.+++. .++...+..|+.||+.||.|||. .||||-||||+|||+
T Consensus       154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             456778999999999999999987653 49999999999999999999998 599999999999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=313.25  Aligned_cols=249  Identities=14%  Similarity=0.165  Sum_probs=187.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-C
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G   86 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   86 (404)
                      .|...+.||+|+||.||+|++..+++.||||.++....  ....|++++++++|++++..++.+ ......+++|||+ +
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~-~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLC-RSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEE-EcCCCCEEEEeCCCC
Confidence            46667899999999999999988999999998764332  234678899999988877766655 4556789999999 8


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      ++|.++++    .+++..+..|+.|++.||+|||   +.+|+||||||+||++   +.++..++. ||.......     
T Consensus       768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc-----
Confidence            99999996    3899999999999999999999   6799999999999999   466666664 665543221     


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC--hHHHHHHHhhh-c----cccc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEKISEK-K----VSTS  236 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~-~----~~~~  236 (404)
                            .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......  ..+........ .    ..+.
T Consensus       835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence                  123367899999999999999999999999999999999999995432211  11111100000 0    0000


Q ss_pred             Hh---HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          237 IE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       237 ~~---~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..   ........++.+++.+||+.||++||++.++.+.|+++..
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            00   0001123467889999999999999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=269.28  Aligned_cols=257  Identities=21%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCceeEe---eeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWF---GVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~---~~~~~~~~lv~   82 (404)
                      ..++.++||+|.||.||+|..  +++.||||++... ..+.++.|.+|++.  ++|.|++.++..-   ......+.||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            456788999999999999984  6799999998644 35568889888876  5666666555321   11234667888


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      +|. .|||.++++  ...++|....+|+..|+.||+|||+         ..|+|||||.+|||+   ..+.+..|+|||+
T Consensus       288 ~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccce
Confidence            887 999999998  4579999999999999999999996         269999999999999   7899999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCC-CC-----chhHHHHHHHHHHHHHcCCC------------CCC
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRGSL------------PWQ  214 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDiwSlG~il~elltg~~------------Pf~  214 (404)
                      |..+......     ...-+.+||.+|||||++.|.- +.     .+.||||+|.|||||+++-.            ||.
T Consensus       363 Al~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  363 ALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9988754321     2334579999999999998753 22     36899999999999997533            333


Q ss_pred             CC--CCCChHHHHHHHhhhcccccHhHhhcC--CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          215 GL--KAGTKKQKYEKISEKKVSTSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       215 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..  ...+..+....+..++..+.++.....  ...-+++.+..||..|++.|.|+..+.+.+.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            10  011223334444455555444433322  3467899999999999999999999999988775

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.4e-35  Score=275.48  Aligned_cols=211  Identities=22%  Similarity=0.276  Sum_probs=177.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCC-----CCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~   77 (404)
                      .+.++|.+....|+|-|++|.+|.+...|+.||||++... ..++.=+.|++||++|+..     .++..+.-.+.....
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            5678999999999999999999999999999999998754 3556678899999999742     233333333456678


Q ss_pred             EEEEEeccCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      .|||+|.+.-+|.++++..+..  |....+..++.|+..||..|-..||+|.||||+|||+.  .....+||||||.|..
T Consensus       509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASF  586 (752)
T ss_pred             eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccc
Confidence            8999999999999999977654  78899999999999999999999999999999999996  5667889999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~  225 (404)
                      ..+...         ..+.-+..|.|||++.|.+|+...|+||.||+||||.||+..|.|.+++.....+
T Consensus       587 ~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  587 ASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             cccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            665432         2334567899999999999999999999999999999999999997765544433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=261.28  Aligned_cols=259  Identities=18%  Similarity=0.248  Sum_probs=207.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ..++++...+-+|.||.||.|.+...     .+.|.+|..+.....-   .+..|.-.+..+.|+|..........+...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            35678888999999999999977543     2455666544333222   256677777778888888888887777777


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      .++++.+. -++|..++..|+       +.++..+...++.|++.|++|||++||||.||...|.+|   ++.-+|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence            78888887 789999998554       247788899999999999999999999999999999999   6789999999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHH
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  228 (404)
                      =.+++.+.....+.     -..+......||+||.+.+..|+..+|+|||||+||||+| |+.|+...++.+.   ...+
T Consensus       440 saLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---~~yl  511 (563)
T KOG1024|consen  440 SALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---EHYL  511 (563)
T ss_pred             chhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH---HHHH
Confidence            99999887765543     2233345778999999999999999999999999999999 9999988665333   3322


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+..    -..+-+||+++..++..||...|++||++++++..|.+....
T Consensus       512 kdGyR----laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  512 KDGYR----LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             hccce----ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            22221    123458999999999999999999999999999999987654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=242.55  Aligned_cols=211  Identities=21%  Similarity=0.277  Sum_probs=170.9

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ..-+..||+|++|.|-+.++..+|+..|+|.+......   .++.+|+.+..+...++.++.++..--.....++.||.+
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            44567899999999999999999999999987654432   346777777776666666665544334555678999999


Q ss_pred             CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           86 GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        86 ~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ..||..+.++   .++.+++.-+-+|+..++.||.|||++ .+||||+||+|||+   +..|+||+||||++-.+.++..
T Consensus       128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhH
Confidence            9999887653   356799999999999999999999986 89999999999999   7999999999999988777643


Q ss_pred             cccccccCCCCCccCcCccccccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                              .+...|...|||||.+..    ..|+.||||||||+++.||.++++||..-  .+..+.+.++.+..
T Consensus       205 --------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  205 --------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEP  269 (282)
T ss_pred             --------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCC
Confidence                    223578899999998863    25899999999999999999999999753  45666666665543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=288.22  Aligned_cols=245  Identities=20%  Similarity=0.224  Sum_probs=190.3

Q ss_pred             eeeeceeCce-eEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEeccCCCHH
Q 015592           12 GRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE   90 (404)
Q Consensus        12 ~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~sL~   90 (404)
                      .+.+|.|+.| .||+|..  .++.||||.+-. ....-..+|+..++.-+.|++|..++....+....||..|+|..+|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~  590 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ  590 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhh-HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence            4578899888 5799984  788999995422 23445789999999999888888877777888899999999999999


Q ss_pred             HHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCCeEEEEecCCcccccccCCcccc
Q 015592           91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        91 ~~l~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~--~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      ++++.....   ......+.++.|++.||++||+.+||||||||+||||+..+  ...+++|+|||+++++......   
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS---  667 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS---  667 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch---
Confidence            999853111   12245678899999999999999999999999999997542  3357899999999988765432   


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                       ++...+..||-+|+|||++.....+..+|||||||++|+.++ |.+||.+....     -.+|......-  ..+....
T Consensus       668 -~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~~~~~L--~~L~~~~  739 (903)
T KOG1027|consen  668 -FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILTGNYTL--VHLEPLP  739 (903)
T ss_pred             -hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhcCccce--eeeccCc
Confidence             234678899999999999999888999999999999999999 59999764322     22222222111  1111111


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..+..+||.+|++.+|..||++.+|+
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            12889999999999999999998774

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.3e-33  Score=251.82  Aligned_cols=236  Identities=25%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             CceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHH
Q 015592           19 SFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN   94 (404)
Q Consensus        19 ~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~   94 (404)
                      +||.||+|.+..+++.+++|+......   .+.+..|++.+++++|++++..+..+ ......++++|+. +++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVF-EDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhe-eeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999988899999999876554   46789999999999776666555444 4457789999999 559999997


Q ss_pred             HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCc
Q 015592           95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT  174 (404)
Q Consensus        95 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (404)
                      .. ..+++..++.++.+++.+|.|||+.+|+|+||+|+||++   +.++.++|+|||.+.......        ......
T Consensus        80 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~  147 (244)
T smart00220       80 KR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFV  147 (244)
T ss_pred             hc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------cccccc
Confidence            53 338999999999999999999999999999999999999   567899999999998766542        123456


Q ss_pred             cCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHH
Q 015592          175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY  254 (404)
Q Consensus       175 gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  254 (404)
                      ++..|++||.+.+..++.++||||||+++|+|++|..||.....  .......+.......  ......++.++.+++.+
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~  223 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRK  223 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHH
Confidence            78899999999988899999999999999999999999976322  122222222221111  11111178899999999


Q ss_pred             HHcCCCCCCCCHHHHHH
Q 015592          255 CRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       255 cl~~~p~~RP~~~~l~~  271 (404)
                      ||..+|++||++.++.+
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999988765

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=250.81  Aligned_cols=263  Identities=20%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCC-CCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGT-GIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~-~i~~~~~~~~~~~~~~lv~   82 (404)
                      +.+.|.|.+.||+|-||.+-+++++.++..+++|.+... ....+|.+|..---.|.+|. +|..+...++..+++++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            567899999999999999999999999999999976543 34456888887766676554 4445566667777999999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ .|+|.+-+.  ...+.+.....++.|+++||.|||++++||||||.+||||-.. +..+|||||||..+.......
T Consensus       102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCceeh
Confidence            999 889988776  3458899999999999999999999999999999999999533 455999999999976554321


Q ss_pred             cccccccCCCCCccCcCccccccccCC---C--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhhcccc
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGI---E--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST  235 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~  235 (404)
                                ...-+..|.+||.....   .  ..+.+|+|.||+++|.++||.+||+.....+. ...+.+....+.. 
T Consensus       179 ----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-  247 (378)
T KOG1345|consen  179 ----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-  247 (378)
T ss_pred             ----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-
Confidence                      12335678999976532   2  47889999999999999999999985433332 2334444444433 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ..+...+-+++.+.+++++-|..++++|-...+..+.-...+.+..
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            3344456688999999999999999999666666666666555443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=259.21  Aligned_cols=251  Identities=19%  Similarity=0.258  Sum_probs=190.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC----Ce
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~   77 (404)
                      ..+.+-.+.||.|+||.||.++|.++|+.||+|.+..-    ...+.+.+|++++..++|.|.+..++......    ..
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            34556678999999999999999999999999964321    23456889999999999988877665443221    23


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .|++.|++..+|..++-. ...++.+.+.-+++||+.||+|||+.+|+||||||.|.|+   +.+..+||||||+++..+
T Consensus       132 iYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence            577888888889888863 5679999999999999999999999999999999999999   688899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .... .     .....+-|..|.|||+++|.. |+...||||.|||+.||+.++..|+...+....+.+..+..   .+.
T Consensus       208 ~d~~-~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG---TPs  278 (449)
T KOG0664|consen  208 QRDR-L-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG---TPS  278 (449)
T ss_pred             hhhh-h-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC---CCc
Confidence            5432 1     112335688999999999865 99999999999999999999999987655444333333222   111


Q ss_pred             HhHhh---c--------------------------CCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          237 IEALC---R--------------------------GYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       237 ~~~~~---~--------------------------~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      .+.+.   .                          .-.-+...++..++..||++|.+..+.
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A  340 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA  340 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence            11111   0                          012356678888899999999875544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.3e-33  Score=271.92  Aligned_cols=255  Identities=20%  Similarity=0.212  Sum_probs=176.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc----------------CCCcEEEEEEecCCCC----------------chhHHH
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLENVKTK----------------HPQLQY   51 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~----------------~~~~~~   51 (404)
                      +-.++|++.++||+|+||.||+|.+.                ..++.||||.+.....                .+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34678999999999999999999752                2346799998754321                112344


Q ss_pred             HHHHHHHHcCCCCCC-----ceeEeee-------eCCeEEEEEecc-CCCHHHHHHHcC---------------------
Q 015592           52 EAKLYKILQGGTGIP-----NLRWFGV-------EGDYNVLVIDLL-GPSLEDLFNFCS---------------------   97 (404)
Q Consensus        52 E~~~l~~l~~~~~i~-----~~~~~~~-------~~~~~~lv~e~~-~~sL~~~l~~~~---------------------   97 (404)
                      |+.++.+++|++++.     .+.++..       .....++|+||+ +++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            677777787766422     2222221       234578999999 889999886321                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCcc
Q 015592           98 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG  175 (404)
Q Consensus        98 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~g  175 (404)
                        ..+++..+..++.|++.+|.|||+++|+||||||+|||+   +.++.+||+|||++.........      ......+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~~  372 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGML  372 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccCC
Confidence              124677889999999999999999999999999999999   57789999999999755432210      1112345


Q ss_pred             CcCccccccccCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCCCCCCChH--------HH
Q 015592          176 TARYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKK--------QK  224 (404)
Q Consensus       176 t~~y~aPE~~~~~~~----------------------~~~sDiwSlG~il~elltg~~-Pf~~~~~~~~~--------~~  224 (404)
                      |+.|+|||.+.....                      ..+.||||+||++|+|++|.. ||.+.......        ..
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~  452 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR  452 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence            889999999864321                      134799999999999999886 77653221110        11


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCC---CCCCCHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLK  270 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RP~~~~l~  270 (404)
                      +..+......  . ......++..++|+.+||.++|   .+|+++++++
T Consensus       453 ~r~~~~~~~~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL  498 (507)
T PLN03224        453 WRMYKGQKYD--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL  498 (507)
T ss_pred             HHhhcccCCC--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence            1111111111  1 1234567899999999999876   6899987664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.1e-33  Score=234.90  Aligned_cols=250  Identities=19%  Similarity=0.319  Sum_probs=188.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCC-CceeEe-eeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI-PNLRWF-GVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i-~~~~~~-~~~~~~~~lv~e   83 (404)
                      .++|++.+++|+|-|++||.|.+..+++.++||+++.- ..+.+.+|+.||+.|.++++| ..+... ........+++|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            46799999999999999999999999999999998753 345689999999999955544 444443 334455678888


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      +. ..+...+..    .|+..++..++.|++.||.|+|++||+|||+||.|++++  .....++|+|+|+|..+..... 
T Consensus       116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e-  188 (338)
T KOG0668|consen  116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE-  188 (338)
T ss_pred             hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence            88 556555543    588899999999999999999999999999999999996  5667899999999987765432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC-CCCCChHHHHHHHhh----------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG-LKAGTKKQKYEKISE----------  230 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~----------  230 (404)
                             -.-.+.+..|--||++..-+ |+..-|+|||||+|..|+..+.||.. .++.+...++.++..          
T Consensus       189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence                   12345677788999988644 89999999999999999999988854 333222222222211          


Q ss_pred             --hcccccHhH------------hh-----cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          231 --KKVSTSIEA------------LC-----RGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       231 --~~~~~~~~~------------~~-----~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                        ..+.+....            +-     .-.+++..+++..+|..|-.+|+|+.|..
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence              011111111            10     11368999999999999999999988654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=7.1e-33  Score=262.01  Aligned_cols=194  Identities=22%  Similarity=0.345  Sum_probs=167.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHc---CCCCCCceeEeeee
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQ---GGTGIPNLRWFGVE   74 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~---~~~~i~~~~~~~~~   74 (404)
                      .|..++.+|.|+||.|++|.++.+...|+||.+.++..          .-.+-.|+.||..|+   |+|+++. ..++++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl-LdfFEd  640 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL-LDFFED  640 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh-hheeec
Confidence            49999999999999999999999999999998765432          123667999999998   5555544 455667


Q ss_pred             CCeEEEEEecc--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           75 GDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        75 ~~~~~lv~e~~--~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      ++++||+||--  |-+|.+++.. ...+++.++..|+.|++.|+++||++||||||||-+|+.+   +.+|.+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccc
Confidence            78889999987  5688888884 6679999999999999999999999999999999999999   7999999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG  215 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~  215 (404)
                      +.......         ...++||..|+|||++.|..| +..-|||+||++||.+++...||.+
T Consensus       717 aa~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            97655432         246899999999999999987 6778999999999999999999865

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=242.39  Aligned_cols=254  Identities=22%  Similarity=0.256  Sum_probs=197.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCceeEeeee-----C
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~   75 (404)
                      +..+|.-++.+|.|.- .|..+.|.-+++.||+|....    ....++..+|..++..++|.|+|..+..+...     .
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3457888889999988 888999999999999996433    23445688999999999999999988777543     2


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...|++||++..+|.+.+.   -.++-+++..|+.|++.|++|||+.||+||||||+||++   ..+..+||+|||+|+.
T Consensus        94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART  167 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence            3579999999999999987   347889999999999999999999999999999999999   7899999999999985


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .....        ..+..+.|..|.|||++.+..|...+||||+||++.||++|..-|.+..-   ...+.++.+....+
T Consensus       168 e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~---idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  168 EDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH---IDQWNKIIEQLGTP  236 (369)
T ss_pred             cCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH---HHHHHHHHHHhcCC
Confidence            44331        23566889999999999999999999999999999999999999987332   22222221111000


Q ss_pred             -------------------------cHhHhhc------------CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          236 -------------------------SIEALCR------------GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       236 -------------------------~~~~~~~------------~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                                               ...+..+            .-..-+++++.+||..||++|.++++   .|++.+.
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d---aL~HPY~  313 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD---ALRHPYI  313 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH---HhcCCee
Confidence                                     0000000            01245789999999999999999664   4555544


Q ss_pred             H
Q 015592          279 R  279 (404)
Q Consensus       279 ~  279 (404)
                      +
T Consensus       314 ~  314 (369)
T KOG0665|consen  314 K  314 (369)
T ss_pred             e
Confidence            3

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=7e-33  Score=265.96  Aligned_cols=249  Identities=17%  Similarity=0.267  Sum_probs=204.5

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|+++.++|+|.||.||+++++.+++..|+|+++...  ...-++.|+-+++..+|+|++.+++.|-... ..+++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEE
Confidence            467999999999999999999999999999999887653  4456889999999999999999988775444 5689999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      || ||+|.+..+ ..+++++.++...+++.+.||+|||++|-+|||||-.|||+   .+.+.+|+.|||.+-.+..... 
T Consensus        93 ycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqitati~-  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATIA-  167 (829)
T ss_pred             ecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhhhhh-
Confidence            99 789988876 46789999999999999999999999999999999999999   5889999999999977665443 


Q ss_pred             ccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                            ..+.+.||+.|||||+..   ...|..++|||++|++..|+-.-+.|..+.........   .......++..+
T Consensus       168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L---mTkS~~qpp~lk  238 (829)
T KOG0576|consen  168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL---MTKSGFQPPTLK  238 (829)
T ss_pred             ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH---hhccCCCCCccc
Confidence                  456789999999999864   45599999999999999999988888766544222211   112222222222


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      -....++.|.++++.||.++|++||+++.+
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaekl  268 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKL  268 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence            223467889999999999999999998875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=6.7e-32  Score=247.78  Aligned_cols=262  Identities=25%  Similarity=0.374  Sum_probs=200.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcC---CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +.+.+.|.++++||.|+|++||++++..   .++.||+|.+........+..|+++|..+.+..+|..+..+...++..+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3466789999999999999999999877   7889999998888888889999999999999999999988888899999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++++|. .....+++.    .++..++..++..++.||.++|.+|||||||||+|+|.+  ...+.-.|+|||+|.....
T Consensus       112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHh
Confidence            999999 556666665    478999999999999999999999999999999999997  5667778999999972211


Q ss_pred             cC------C----cc---------------------------cccccCCCCCccCcCccccccccCCC-CCchhHHHHHH
Q 015592          159 TA------T----HQ---------------------------HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLG  200 (404)
Q Consensus       159 ~~------~----~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG  200 (404)
                      ..      .    +.                           ...........||++|.|||++...+ .+.++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            00      0    00                           00001123457999999999998765 79999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCh--HHH--------HHHH--hhhc--cc----------------cc-HhH----------
Q 015592          201 YVLMYFLRGSLPWQGLKAGTK--KQK--------YEKI--SEKK--VS----------------TS-IEA----------  239 (404)
Q Consensus       201 ~il~elltg~~Pf~~~~~~~~--~~~--------~~~~--~~~~--~~----------------~~-~~~----------  239 (404)
                      ||+.-++++++||....++..  .+.        +.+.  ..+.  ..                .. .+.          
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999965333210  000        0000  0000  00                00 011          


Q ss_pred             ---hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       240 ---~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                         ....+|..+.+++.+|++.||.+|.++++.+
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL  379 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDAL  379 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence               1112456889999999999999999988653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.1e-30  Score=227.54  Aligned_cols=208  Identities=28%  Similarity=0.424  Sum_probs=176.8

Q ss_pred             eceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHH
Q 015592           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE   90 (404)
Q Consensus        15 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~   90 (404)
                      ||+|++|.||++.+..+++.+++|+.......   +.+.+|++.++.+++.+ +..+..+.......+++++++ +++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPN-IVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCC-eeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            68999999999999878999999998876653   67999999999999854 444444445557889999999 59999


Q ss_pred             HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CCeEEEEecCCcccccccCCcccccccC
Q 015592           91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTATHQHIPYRE  169 (404)
Q Consensus        91 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~  169 (404)
                      +++......+++..+..++.+++.+|.+||++|++|+||+|.||++   +. .+.++|+|||.+........       .
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~-------~  149 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKS-------L  149 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcc-------h
Confidence            9998543578999999999999999999999999999999999999   45 78999999999986655421       1


Q ss_pred             CCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHH
Q 015592          170 NKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       170 ~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (404)
                      .....+...|++||.+... .++.++|+|+||+++|+|                                       ..+
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~  190 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL  190 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence            2235678899999999887 789999999999999999                                       578


Q ss_pred             HHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          249 ASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      .+++..|++.+|++||++.++.+.
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhC
Confidence            899999999999999999887653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=9.8e-30  Score=219.68  Aligned_cols=167  Identities=17%  Similarity=0.183  Sum_probs=129.6

Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      |+|.++++..+..+++.+++.|+.|++.||.|||+++      ||+|||+   +.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence            6899999865667999999999999999999999998      9999999   67888998  9998765432       


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh--HhhcCC
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY  244 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  244 (404)
                           ...||+.|+|||++.+..++.++|||||||++|||+||+.||......  ...+..+..........  .....+
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  135 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV  135 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence                 125889999999999999999999999999999999999999764321  12222222111111000  011123


Q ss_pred             cH--HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          245 PT--EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       245 ~~--~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +.  ++.+++.+||..+|++||++.++.+.+.....
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            33  69999999999999999999999888766653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.9e-30  Score=272.20  Aligned_cols=188  Identities=14%  Similarity=0.163  Sum_probs=134.4

Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----------------
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----------------  138 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~----------------  138 (404)
                      ....++++|+++++|.++++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.                
T Consensus        52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            3457888899999999999855567999999999999999999999999999999999999942                


Q ss_pred             CCCCCeEEEEecCCcccccccCC--------cccccc-cCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTAT--------HQHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG  209 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~--------~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg  209 (404)
                      .+..+.+||+|||+++.......        ....++ .......||+.|||||++.+..|+.++|||||||+||||++|
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence            02344566667776654321100        000000 001124689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..|+....     ..+..+.....+.   ... ...++...++.+||..+|.+||++.++++
T Consensus       212 ~~~~~~~~-----~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        212 VSSREEKS-----RTMSSLRHRVLPP---QIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCchhhHH-----HHHHHHHHhhcCh---hhh-hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            98875421     1122222111111   111 12345678999999999999999998853

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.9e-28  Score=219.22  Aligned_cols=197  Identities=29%  Similarity=0.440  Sum_probs=164.8

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      |++.+.||.|++|.||++.+..+++.+++|......   ..+.+.+|++.++.++|++++..+..+ ......+++++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-EDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-ecCCceEEEEecc
Confidence            678899999999999999998889999999887654   345688899999999877666655544 4556778899998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..+..++.+++.+|.+||+++++|+||+|.||++   +..+.++|+|||.+.........  
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~--  154 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA--  154 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc--
Confidence             559999998533228999999999999999999999999999999999999   56789999999999876654210  


Q ss_pred             ccccCCCCCccCcCccccccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 015592          165 IPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG  215 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlG~il~elltg~~Pf~~  215 (404)
                          ......++..|++||.+ ....++.++|+||||+++|+|++|+.||..
T Consensus       155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                12345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.4e-27  Score=223.30  Aligned_cols=172  Identities=19%  Similarity=0.210  Sum_probs=133.2

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcC-CCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      +.+.++|++.+.||+|+||+||+|++.. +++.||||++....       ....+.+|+++++.++|+++++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4577899999999999999999999876 67888999764321       123588999999999999988766543   


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcccccCCCCCCeEEEEecCC
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl-Kp~NILl~~~~~~~~vkL~DFG~  152 (404)
                       ...+++|||+ |++|.. +.    ...   ...++.|++++|.|||++||+|||| ||+|||+   +.++.+||+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence             3469999999 777862 21    111   1467899999999999999999999 9999999   5678899999999


Q ss_pred             cccccccCCcccc-cccCCCCCccCcCccccccccCCC
Q 015592          153 AKRYRDTATHQHI-PYRENKNLTGTARYASMNTHLGIE  189 (404)
Q Consensus       153 a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~  189 (404)
                      |+.+........+ .+..-.+..+++.|+|||.+...+
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            9987765433222 112224677899999999987543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.5e-24  Score=202.50  Aligned_cols=257  Identities=30%  Similarity=0.404  Sum_probs=191.4

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....     ...+.+|+.++..+.+++.+..+..+.......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999976   7889998765443     34588999999999988644444444455555788999


Q ss_pred             cc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC-eEEEEecCCccccccc
Q 015592           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT  159 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~~~~  159 (404)
                      ++ ++++.+++....  ..++...+..++.|++.++.|+|+.+++||||||+||++   +..+ .++++|||.++.+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence            88 888887776433  269999999999999999999999999999999999999   4555 7999999999865544


Q ss_pred             CCcccccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-ChHHHHHHHhhhcccc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVST  235 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~  235 (404)
                      ....... .......||..|++||.+.+   ..++...|+||+|++++++++|..||...... ........+.......
T Consensus       156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            3211000 12356789999999999998   57899999999999999999999998765431 1122222222222110


Q ss_pred             cHhHhhcCC----cHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          236 SIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       236 ~~~~~~~~~----~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      .........    ...+.+++..|+..+|..|.+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111111111    2578999999999999999987665543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.3e-25  Score=226.09  Aligned_cols=253  Identities=19%  Similarity=0.232  Sum_probs=187.8

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEecC----CCCch----hHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHP----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ...+.+|.|++|.|+.+......+.++.|....    .....    .+..|.-+-..|.|++++..+..+......... 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~-  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS-  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh-
Confidence            457789999999888888776666666664331    11111    134455556667788776666444443333333 


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||||..+|..++.. ...+...++..++.|++.|++|||+.||.||||||+|+++   ...+.+||+|||.+..+.-...
T Consensus       400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence            99995599999873 3479999999999999999999999999999999999999   6888999999999987765433


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCCChHH-HHHHHhhhcccccHhH
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVSTSIEA  239 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDiwSlG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (404)
                      ...   ......+|+..|+|||.+.+.+|.+ ..||||.|++++.|.+|+.||......+... ................
T Consensus       476 ~~~---~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  476 KNI---HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR  552 (601)
T ss_pred             hhh---hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence            210   1346789999999999999999864 5899999999999999999997655433321 1111222233333455


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +...+|.+.+.+|-++|+.||.+|.|+++|.
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~  583 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQIL  583 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence            5667899999999999999999999977554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=5.3e-24  Score=193.44  Aligned_cols=231  Identities=23%  Similarity=0.291  Sum_probs=148.5

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcC----------CCCCCceeEee
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQG----------GTGIPNLRWFG   72 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~----------~~~i~~~~~~~   72 (404)
                      .+..++.||.|+++.||.+++..|++.+|||+......     .+++.+|.-....+.+          -..+.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778899999999999999999999999997654332     1234444433322211          01111111111


Q ss_pred             --------eeC---C-----eEEEEEeccCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015592           73 --------VEG---D-----YNVLVIDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK  130 (404)
Q Consensus        73 --------~~~---~-----~~~lv~e~~~~sL~~~l~~~---~~~---l~~~~~~~i~~qi~~aL~~LH~~givHrDlK  130 (404)
                              ...   .     ..+++|+-+.++|.+++...   ...   +.....+.+..|++..+++||+.||+|+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                    111   1     23667777889999887532   221   2334446667999999999999999999999


Q ss_pred             CCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC--------CCCCchhHHHHHHHH
Q 015592          131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV  202 (404)
Q Consensus       131 p~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlG~i  202 (404)
                      |+|+++   +.+|.++|+||+..........          ....+..|.+||....        ..++.+.|.|+||++
T Consensus       173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            999999   6899999999988765544321          0233577999997643        247899999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCC
Q 015592          203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK  263 (404)
Q Consensus       203 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  263 (404)
                      +|.|.+|..||...........           ... .|.++|+.++.||..+|+.||++|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~-----------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW-----------DFS-RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG-----------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc-----------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999987544221110           122 344889999999999999999988

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=189.50  Aligned_cols=244  Identities=12%  Similarity=0.150  Sum_probs=187.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ...+.-+|.+...|+.|+|++.  |..+++|+++....    ...|..|.-.++.+.|+|+++.+..+........|...
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3456678899999999999984  44677787765433    34588899999999999999999998887766666665


Q ss_pred             ccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEE--ecCCcccccc
Q 015592           84 LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYII--DFGLAKRYRD  158 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~--DFG~a~~~~~  158 (404)
                      +..+||..+++.... -.+..++.+++.+++.|++|||+..  |.---|....+++   |++.+.+|+  |--++..   
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq---  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee---
Confidence            569999999985322 3688899999999999999999953  4444688888999   566665553  4332211   


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                                 .....-.+.||+||.++..+-   -+.+|+|||.++||||.|...||.+..+.+.-      .+..+..
T Consensus       343 -----------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialeg  405 (448)
T KOG0195|consen  343 -----------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEG  405 (448)
T ss_pred             -----------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhcc
Confidence                       112344789999999987663   36799999999999999999999997774322      2222333


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ....++++++..+.+|+.-|++.||.+||.|+.|+-+|+++
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            34566789999999999999999999999999999999876

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.7e-24  Score=186.27  Aligned_cols=171  Identities=13%  Similarity=0.192  Sum_probs=127.3

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCCCCceeE
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LQYEAKLYKILQGGTGIPNLRW   70 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~E~~~l~~l~~~~~i~~~~~   70 (404)
                      +.++.++|++.+.||.|+||.||++.+  ++..+|||++.......+           +.+|++.+.++.|+.+......
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            457889999999999999999999764  577899998865432221           5789999999986655544433


Q ss_pred             eeee-------CCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           71 FGVE-------GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        71 ~~~~-------~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      +...       ....+++|||+ |.+|.++..     +++    ....+++.+|..+|+.|++|||+||+||++   +.+
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~  171 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKN  171 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCC
Confidence            2322       23578999999 678887743     333    245699999999999999999999999999   456


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHH
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF  206 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~el  206 (404)
                      + ++|+|||..+...+...                   .-..+....|+.++|+||||+++..+
T Consensus       172 g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             C-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHH
Confidence            6 99999998875533211                   01134455577899999999998654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=6.6e-23  Score=210.64  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=184.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCC---ceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP---NLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~---~~~~~~~~~~~~~lv   81 (404)
                      -++.|.|.+.||+|+||.||+|.+.+ ++.||||+.+.....+ |.--.+++.+|+ +..++   .+.......+.-+++
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLK-PQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhc-hhhhcchHHHHHHHccCCcceee
Confidence            36789999999999999999999866 9999999987665543 222234444444 22222   222333345556889


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----CCCCCeEEEEecCCcccc
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~----~~~~~~vkL~DFG~a~~~  156 (404)
                      ++|. .|+|.++++ ..+.+++..++.++.|++.-+++||..+|||+||||+|+||..    +.+...++|+|||.+-.+
T Consensus       773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9988 999999998 5677999999999999999999999999999999999999953    223457899999999655


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .--....     .....++|-.+-.+|+..|.+++...|.|.|..+++-||.|++-=              .........
T Consensus       852 ~lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~~~  912 (974)
T KOG1166|consen  852 KLFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSWMV  912 (974)
T ss_pred             eEcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcceec
Confidence            4322211     234567889999999999999999999999999999999997531              110000000


Q ss_pred             HhHhhcCCc-HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          237 IEALCRGYP-TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       237 ~~~~~~~~~-~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...+.+..- +-..+++..+|+.|-+.=|...+|+..|++.+..
T Consensus       913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            011111111 2345788888887777778889999888888765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.8e-23  Score=180.98  Aligned_cols=137  Identities=22%  Similarity=0.219  Sum_probs=103.8

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----------chh-----------------HHHHHHHHHHHcCCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQ-----------------LQYEAKLYKILQGGT   63 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~-----------------~~~E~~~l~~l~~~~   63 (404)
                      ...||+|+||.||+|.+. +|+.||||+++....           ...                 ...|++++..+.+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 899999998765321           111                 234999999998654


Q ss_pred             CCCceeEeeeeCCeEEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcccccCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givHrDlKp~NILl~~~~~  141 (404)
                      + .....+...  ..+|+|||+++ ++...... ...++..++..++.|++.+|.|+ |+.||+||||||+|||++    
T Consensus        81 v-~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----  152 (190)
T cd05147          81 I-PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----  152 (190)
T ss_pred             C-CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence            3 222222222  23899999954 45443322 45799999999999999999999 799999999999999993    


Q ss_pred             CCeEEEEecCCccccc
Q 015592          142 ANQVYIIDFGLAKRYR  157 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~  157 (404)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.3e-23  Score=187.81  Aligned_cols=193  Identities=18%  Similarity=0.216  Sum_probs=144.3

Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CCeEEEEecCCc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLA  153 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-~~~vkL~DFG~a  153 (404)
                      +...|++|.-+..+|.+++.  .+..+......|+.|+++|+.|||++||.|||+|.+|||+..+++ ...+.|+|||++
T Consensus       315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence            34569999999999999997  556888899999999999999999999999999999999976533 346789999988


Q ss_pred             ccccccCCcccccccCC-CCCccCcCccccccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 015592          154 KRYRDTATHQHIPYREN-KNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  226 (404)
                      -.-+.  .....||... -..-|+..-||||+....+      --.|+|.|+.|.+.||+++...||.+.......  ..
T Consensus       393 LAd~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r  468 (598)
T KOG4158|consen  393 LADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TR  468 (598)
T ss_pred             eeccc--cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hh
Confidence            53322  2223344322 2446788899999987543      125899999999999999999999873221111  01


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...+    ..++.++..+|+.+++++..+|+.||.+|++..-..+.|.-.+
T Consensus       469 ~Yqe----~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsL  515 (598)
T KOG4158|consen  469 TYQE----SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSL  515 (598)
T ss_pred             hhhh----hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHH
Confidence            1111    2334566789999999999999999999998765555554333

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1e-22  Score=176.03  Aligned_cols=193  Identities=17%  Similarity=0.112  Sum_probs=139.3

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch------hHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +.+...|++|+||+||++..  .+..++.+-+.......      .+.+|+++|++|.+++.++.+..+    ...+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999998874  67788877555443322      378899999999988878877554    3358999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl-Kp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|+ |.+|.+.+..        ....++.|++.+|+++|++||+|||| ||+|||+   +.++.++|+|||++.......
T Consensus        78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcc
Confidence            998 7777654321        12457889999999999999999999 7999999   567889999999998554432


Q ss_pred             Cccc-cccc-----CCCCCccCcCccccccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCCCC
Q 015592          161 THQH-IPYR-----ENKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLKA  218 (404)
Q Consensus       161 ~~~~-~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~-~~sDiwSlG~il~elltg~~Pf~~~~~  218 (404)
                      .... ..++     .......++.|++|+...-. ..+ ...++++.|+-+|.++|+..|+.+...
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            1000 0000     00112357788888765432 233 567899999999999999999876443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-24  Score=207.63  Aligned_cols=250  Identities=19%  Similarity=0.271  Sum_probs=192.4

Q ss_pred             eeceeCceeEEEEEE---cCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           14 KIGSGSFGEIYLGTN---IQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      .+|+|+||.|++++-   ...+.-+|+|+.+.....    .....|..++..++.++.+..+.+..+.....++++++. 
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998763   245677888876654321    134568888888887777777777777777788888888 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      |+.|...+.. ...+.+.....+...++.+++++|+.+|+|||+|++||++   +..|++++.|||+++.......    
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence            7788777663 4568888999999999999999999999999999999999   7999999999999987665432    


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                             .+||..|||||++.  .....+|+||||++++||+||..||.+       +....|...+..     .+..+.
T Consensus       153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~-----~p~~l~  211 (612)
T KOG0603|consen  153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELE-----MPRELS  211 (612)
T ss_pred             -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccC-----Cchhhh
Confidence                   28999999999998  467789999999999999999999987       233444443322     234567


Q ss_pred             HHHHHHHHHHHcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCceeecccccccccc
Q 015592          246 TEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ  299 (404)
Q Consensus       246 ~~l~~li~~cl~~~p~~RP~~--~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~  299 (404)
                      ...++++.+++.++|.+|-..  ..+.+..++       .+....+|+....++..
T Consensus       212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h-------~f~~~i~~~~l~~r~~~  260 (612)
T KOG0603|consen  212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQH-------EFFQSIDWNELEARSRP  260 (612)
T ss_pred             HHHHHHHHHHHhhCHHHHhccCcchhHHHhcc-------chheeeeHhhHhhcCCC
Confidence            889999999999999999754  233333333       34566788855555443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.2e-23  Score=210.54  Aligned_cols=217  Identities=22%  Similarity=0.337  Sum_probs=154.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ...+|..++.|..|+||.||+++++.+.+.+|+|+-+.+...   .+   ++.....                .++|   
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lil---Rn---ilt~a~n----------------pfvv---  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLIL---RN---ILTFAGN----------------PFVV---  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccchhh---hc---cccccCC----------------ccee---
Confidence            356799999999999999999999999999999643221111   00   1111111                1111   


Q ss_pred             cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                        |+-..+++. -++++..        ++.+++|||+.||+|||+||+|.||   ..-|++|++|||+++..........
T Consensus       136 --gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 --GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             --chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchh
Confidence              444555552 2344433        2789999999999999999999999   6899999999999875433211110


Q ss_pred             ----c----cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          165 ----I----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       165 ----~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                          +    -.-..+..+||+.|.|||++....|+..+|+|++|+|+||++-|..||.+.++.+   .+..+.......+
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~i~wp  278 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDIEWP  278 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhhcccc
Confidence                0    0012356799999999999999999999999999999999999999999965533   3333332222111


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                       +. -..++++.++++.++|..+|..|-.
T Consensus       279 -E~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  279 -EE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -cc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence             11 2357899999999999999999964

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.7e-22  Score=174.45  Aligned_cols=138  Identities=20%  Similarity=0.231  Sum_probs=106.2

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----------------------------hhHHHHHHHHHHHcCC
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------PQLQYEAKLYKILQGG   62 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~E~~~l~~l~~~   62 (404)
                      +.+.||+|+||.||+|++. +|+.||||+++.....                            ..+..|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999986 8999999987754210                            1135788999999876


Q ss_pred             CCCCceeEeeeeCCeEEEEEeccCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCC
Q 015592           63 TGIPNLRWFGVEGDYNVLVIDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        63 ~~i~~~~~~~~~~~~~~lv~e~~~~-sL~-~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~  139 (404)
                      .+. ....+...  ..+++|||+++ ++. ..+.  ...++..++..++.|++.+|.++|+ +||+||||||+|||+   
T Consensus        80 ~i~-~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---  151 (190)
T cd05145          80 GVP-VPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---  151 (190)
T ss_pred             CCC-CceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---
Confidence            542 22222222  24899999944 343 3343  3568889999999999999999999 999999999999999   


Q ss_pred             CCCCeEEEEecCCcccccc
Q 015592          140 RRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~~  158 (404)
                      + ++.++|+|||+++....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            4 68899999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=205.71  Aligned_cols=249  Identities=16%  Similarity=0.131  Sum_probs=172.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---ch---hHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +|...+.||++.|=+|.+|++ ..|. |+||++-....   ..   +...|++ ...++++|.+++..+ .+..+..|++
T Consensus        24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHH
Confidence            688899999999999999997 3454 89998654432   22   2333444 444556666655444 4566677888


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      =.|...+|.|.+.- ..-+...+.+.|+.|++.||..+|..||+|+|||.+|||+   ..-+-+.|+||..-+..--+..
T Consensus       100 RqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence            88889999999872 3347888999999999999999999999999999999999   5777889999987654321111


Q ss_pred             ccc-ccccCCCCCccCcCccccccccCC----------C-CCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHH
Q 015592          162 HQH-IPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       162 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ... ..|. ..+...-..|.|||.+...          . .+++-||||+||++.||++ |++||.-.    ..-.|...
T Consensus       176 NPadf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~  250 (1431)
T KOG1240|consen  176 NPADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSG  250 (1431)
T ss_pred             CcccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhcc
Confidence            100 0010 1111223469999987541          1 5678999999999999998 89998531    01111111


Q ss_pred             hhhcccccHhHhhcCC-cHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      .    ....+.....+ ...++.++..|++.||.+|.++++.++.-
T Consensus       251 ~----~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  251 N----ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             C----ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            1    11222222222 35789999999999999999999876653

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.5e-20  Score=167.96  Aligned_cols=142  Identities=20%  Similarity=0.230  Sum_probs=109.0

Q ss_pred             ceEEeeeeceeCceeEEEEE-EcCCCcEEEEEEecCCCC--------------------------chhHHHHHHHHHHHc
Q 015592            8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTK--------------------------HPQLQYEAKLYKILQ   60 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~--------------------------~~~~~~E~~~l~~l~   60 (404)
                      -|++.+.||+|+||.||+|. +..+|+.||||++.....                          ...+..|..++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 668999999998764321                          012568999999998


Q ss_pred             CCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcccccC
Q 015592           61 GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGL  138 (404)
Q Consensus        61 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlKp~NILl~~  138 (404)
                      + .++.....+...  ..+++|||+ |.+|...... ...+...++..++.|++.+|.+||++| |+||||||+||++  
T Consensus       109 ~-~~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli--  182 (237)
T smart00090      109 E-AGVPVPKPIAWR--RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV--  182 (237)
T ss_pred             h-cCCCCCeeeEec--CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE--
Confidence            5 333333323222  247999999 4466554421 345667778899999999999999999 9999999999999  


Q ss_pred             CCCCCeEEEEecCCccccc
Q 015592          139 GRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~  157 (404)
                       + .+.++|+|||.+....
T Consensus       183 -~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 -H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -E-CCCEEEEEChhhhccC
Confidence             4 6789999999986443

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1e-19  Score=160.11  Aligned_cols=137  Identities=14%  Similarity=0.170  Sum_probs=102.4

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHc-----CCCCCCceeEeeeeC--Ce-EEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQ-----GGTGIPNLRWFGVEG--DY-NVL   80 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~--~~-~~l   80 (404)
                      -.+.||+|+||.||.  +..++.. +||++....  ..+.+.+|+.+++.+.     |++++..++.+..+.  .+ ..+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999995  6667666 699876532  3456899999999994     466666556555543  23 347


Q ss_pred             EEeccC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCCcc
Q 015592           81 VIDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK  154 (404)
Q Consensus        81 v~e~~~---~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~a~  154 (404)
                      ++||+|   ++|.++++.  ..+++.  ..++.|++.++ +|||+++|+||||||+|||+...+ ....++|+||+.+.
T Consensus        83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            899965   899999974  346665  46688888888 999999999999999999996332 34489999955443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=5.4e-21  Score=181.30  Aligned_cols=173  Identities=25%  Similarity=0.352  Sum_probs=131.1

Q ss_pred             CeEEEEEecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      .+.+|.|++| ..+|.+++...  ....+....+.++.|++.|++|   +|.+|||+||.||++   ..+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence            3678999999 88999999632  3347788999999999999999   999999999999999   4666899999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ........+. .-++.......||..||+||.+.+..|+.|+||||||+||+||+. -..+|....      ....+...
T Consensus       403 ~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t~~d~r~g  475 (516)
T KOG1033|consen  403 VTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------TLTDIRDG  475 (516)
T ss_pred             eeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------hhhhhhcC
Confidence            9877665411 111223456789999999999999999999999999999999998 444443221      12223332


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                      .++   +.+..++| +-..|+.+++...|.+||+
T Consensus       476 ~ip---~~~~~d~p-~e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  476 IIP---PEFLQDYP-EEYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             CCC---hHHhhcCc-HHHHHHHHhcCCCcccCch
Confidence            222   12223343 4468999999999999994

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-19  Score=174.92  Aligned_cols=213  Identities=16%  Similarity=0.214  Sum_probs=158.0

Q ss_pred             HHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCcc
Q 015592           57 KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNF  134 (404)
Q Consensus        57 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi-vHrDlKp~NI  134 (404)
                      +.+.|.|+.+.++.+ .++...+++.+|| .|+|.+.+.....++++--...++++|+.||+|||+-.| .|+.|+..|+
T Consensus         2 ~~l~h~n~~~f~g~~-~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGAS-VDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccchhhhhhheeeE-ecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            345655555555444 4447778888898 899999998766678888899999999999999998765 9999999999


Q ss_pred             cccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCC-------CCchhHHHHHHHHHHHHH
Q 015592          135 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFL  207 (404)
Q Consensus       135 Ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwSlG~il~ell  207 (404)
                      ++   +....+||+|||+..........     .......-..-|.|||.+.+..       .+.+.||||||+++||++
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            99   79999999999998776531100     0111222356799999998742       366799999999999999


Q ss_pred             cCCCCCCCCCCCCh-HHHHHHHhh---hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          208 RGSLPWQGLKAGTK-KQKYEKISE---KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       208 tg~~Pf~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +.+.||........ .+.+..+..   ....+.+.... .+++++..++..||..+|++||+++.+...++.+...
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99999987433222 233333333   11223333222 5677899999999999999999999999888877654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.2e-18  Score=154.82  Aligned_cols=131  Identities=26%  Similarity=0.391  Sum_probs=104.4

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +.||+|++|.||+|.+  .+..+++|+......          ...+.+|+.++..+.++++... ..+.......+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-AVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-eEEEEeCCCCEEEE
Confidence            6799999999999986  677899997654322          1246789999999986654333 33333455678999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ||+ |++|.+++....    . ....++.+++.+|.+||+.|++|||++|.|||+   + .+.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence            998 889999987422    2 888999999999999999999999999999999   3 67899999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.8e-18  Score=150.31  Aligned_cols=127  Identities=25%  Similarity=0.390  Sum_probs=99.7

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .||+|+||.||+|.+  ++..|++|+......          ..++.+|++++..+.+++ +.....+.......+++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence            489999999999984  678899997543221          134668999999998764 3333334445556689999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      |+ |++|.+++....  .      .++.|++.+|.+||+.|++|+|++|.||++   + ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence            98 889998876321  1      889999999999999999999999999999   4 68899999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.1e-18  Score=151.84  Aligned_cols=137  Identities=20%  Similarity=0.282  Sum_probs=104.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC------------------------chhHHHHHHHHHHHcCCC
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------HPQLQYEAKLYKILQGGT   63 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~E~~~l~~l~~~~   63 (404)
                      .|.+.+.||+|+||.||++.+ .+|+.||||++.....                        ......|..++..+.+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            488999999999999999987 4899999998654320                        012567888888887653


Q ss_pred             CCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      + .....+.  ....+++|||+ |++|.++..       ......++.+++.++.++|+.||+||||||+||++   +.+
T Consensus        95 i-~v~~~~~--~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~  161 (198)
T cd05144          95 F-PVPKPID--WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD  161 (198)
T ss_pred             C-CCCceee--cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence            2 2222221  23458999999 777765532       13456788999999999999999999999999999   568


Q ss_pred             CeEEEEecCCcccccc
Q 015592          143 NQVYIIDFGLAKRYRD  158 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~  158 (404)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            8999999999975554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.2e-17  Score=168.65  Aligned_cols=133  Identities=23%  Similarity=0.376  Sum_probs=102.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..|...+.||+|+||+||+|.+..  ..+++|+...+.          ..+.+.+|+++++.+++++++. ...+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~-p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT-PVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe-eEEEEEeCC
Confidence            445678899999999999998643  344555322111          1134778999999999776544 334444555


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ |++|.+++.         ....++.|++.+|.+||++||+||||||+|||+    .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence            678999999 889998875         356789999999999999999999999999999    456899999999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.1e-16  Score=139.55  Aligned_cols=136  Identities=24%  Similarity=0.331  Sum_probs=95.6

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hh----------------------HHHHHHHHHHHcCCC-
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQ----------------------LQYEAKLYKILQGGT-   63 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~----------------------~~~E~~~l~~l~~~~-   63 (404)
                      +.+.||+|+||.||+|.+. +++.||||++......    ..                      ...|...+..+.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999975 8999999987643211    01                      135666666665432 


Q ss_pred             CCCceeEeeeeCCeEEEEEeccCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~~~-sL~-~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~  140 (404)
                      .++....+    ...+++|||+.+ ++. ..+....  .. ..+..++.+++.++.++|+ +||+||||||+||++   +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~  149 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D  149 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E
Confidence            22222222    235899999944 221 1222111  11 6788999999999999999 999999999999999   4


Q ss_pred             CCCeEEEEecCCcccccc
Q 015592          141 RANQVYIIDFGLAKRYRD  158 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~  158 (404)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             78899999999975544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=6.5e-16  Score=139.52  Aligned_cols=132  Identities=17%  Similarity=0.208  Sum_probs=96.9

Q ss_pred             eeec-eeCceeEEEEEEcCCCcEEEEEEecCC---------------CCchhHHHHHHHHHHHcCCCC-CCceeEe-eee
Q 015592           13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLENVK---------------TKHPQLQYEAKLYKILQGGTG-IPNLRWF-GVE   74 (404)
Q Consensus        13 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~~~~~-i~~~~~~-~~~   74 (404)
                      ..|| .|+.|+||.+..  .+..++||.....               .....+.+|++++..|.+..+ ++....+ ...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 899999999985  4778999966421               112357889999999987654 2333222 222


Q ss_pred             CCe---EEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           75 GDY---NVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        75 ~~~---~~lv~e~~-~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      ...   .+++|+++ | .+|.+++..  ..++...    +.||+.+|.+||++||+||||||+|||+   +.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence            222   35899988 4 589998863  4566543    5789999999999999999999999999   4567899999


Q ss_pred             cCCccc
Q 015592          150 FGLAKR  155 (404)
Q Consensus       150 FG~a~~  155 (404)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998863

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=7.3e-16  Score=128.73  Aligned_cols=131  Identities=20%  Similarity=0.340  Sum_probs=105.2

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      +.+.||.|.++.||++...  +..+++|..........+..|..+++.++++ ..++.+..+.......+++|+|+ +..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4678999999999999964  3789999876544445789999999999876 45555555555556789999998 445


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +..+        +......++.+++.+|++||..   +++|+||+|+||++   +..+.++++|||.+.
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~  137 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAG  137 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEeccccc
Confidence            5433        5566778899999999999984   79999999999999   457899999999886

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=4.8e-18  Score=171.38  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=187.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC-CCcEEEEEEecCCC-C---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-K---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ...|.+.+.||+|+|+.|-+..... ....+|+|.+.... .   ......|..+-+.+..|.++..+..........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4568999999999999999988633 34456666544432 1   22344577777777756666666666667778888


Q ss_pred             EEecc-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcccccCCCCCC-eEEEEecCCcccc
Q 015592           81 VIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY  156 (404)
Q Consensus        81 v~e~~-~~sL~~~l-~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~  156 (404)
                      .++|. |+++.+.+ +......+...+-.++.|+..+|.|+| ..++.||||||+|.++   +..+ .+++.|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence            88988 88888877 422225777888999999999999999 9999999999999999   5666 8999999999988


Q ss_pred             cc-cCCcccccccCCCCCcc-CcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          157 RD-TATHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       157 ~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .. .+...     .....+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||.......  ..+........
T Consensus       176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~  248 (601)
T KOG0590|consen  176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG  248 (601)
T ss_pred             cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence            77 33322     2234567 99999999999854 5788999999999999999999997644332  22222222211


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      . ........++....+++..++..+|+.|.+..++.
T Consensus       249 ~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 R-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c-cccCccccCChhhhhcccccccCCchhcccccccc
Confidence            1 01223356778899999999999999999866553

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=3.4e-16  Score=151.48  Aligned_cols=254  Identities=17%  Similarity=0.166  Sum_probs=190.5

Q ss_pred             cCCceEEeeeece--eCceeEEEEEE--cCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      +.+.|-+...+|.  |.+|.||.+..  ..++..+|+|.-+...    ....-.+|..-.+++..|.............+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3456778889999  99999999998  7889999999633221    22233456666666665555555445556778


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcccccCCCCC-CeEEEEecC
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFG  151 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~givHrDlKp~NILl~~~~~~-~~vkL~DFG  151 (404)
                      ..++.+|+++.+|.++......-++...++.++.+...    ||.++|+.+++|-|+||+||++.   .+ ...+++|||
T Consensus       192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~  268 (524)
T KOG0601|consen  192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFG  268 (524)
T ss_pred             cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcc
Confidence            89999999999999998865555888899999999999    99999999999999999999994   55 789999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      +...+.+.......  .......|...|++||...+ -++..+||||||.++.+..++..++.........    .+.. 
T Consensus       269 ~v~~i~~~~~~~~~--~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----~~r~-  340 (524)
T KOG0601|consen  269 LVSKISDGNFSSVF--KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----QLRQ-  340 (524)
T ss_pred             eeEEccCCccccce--eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----cccc-
Confidence            99988776532211  11233367889999999876 5888999999999999999988777554221111    1111 


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                        .....+++.+.+.++...+.++++.++-.|++.+.+..
T Consensus       341 --~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 --GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              11224556677788888999999999999999877644

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=1.6e-14  Score=141.53  Aligned_cols=139  Identities=20%  Similarity=0.313  Sum_probs=98.7

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc------------------------------------------hhHH
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------------PQLQ   50 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------------------------------~~~~   50 (404)
                      +.||+|++|.||+|+. .+|+.||||+.......                                          -++.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999996 58999999986543100                                          0134


Q ss_pred             HHHHHHHHHc----CCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 015592           51 YEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKSF  124 (404)
Q Consensus        51 ~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~gi  124 (404)
                      +|.+.+.++.    +.+.+.....+.......+++|||+ |.+|.++.......++   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            4555555553    3444444444444445579999999 8888887653222232   3456666665 4788999999


Q ss_pred             eeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592          125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus       125 vHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +|+|+||.||++   +.++.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999   5778999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.1e-12  Score=130.17  Aligned_cols=140  Identities=19%  Similarity=0.277  Sum_probs=94.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC------------------------------------ch----
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------------------HP----   47 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------------------------~~----   47 (404)
                      .|+. +.||+|++|.||+|+.+.+|+.||||+......                                    ..    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999877799999998764310                                    00    


Q ss_pred             --hHHHHHHHHHHHc----CCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 015592           48 --QLQYEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINR  115 (404)
Q Consensus        48 --~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~-----l~~~~~~~i~~qi~~a  115 (404)
                        ++.+|...+.++.    +.+.+.....|..-....+++|||+ |+.+.++-.-....     +....+..++.|    
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q----  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ----  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence              1344555555554    3333433344444455679999999 77887753211122     333334444444    


Q ss_pred             HHHHHhCCceeccCCCCcccccCCCCCC----eEEEEecCCcccccc
Q 015592          116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKRYRD  158 (404)
Q Consensus       116 L~~LH~~givHrDlKp~NILl~~~~~~~----~vkL~DFG~a~~~~~  158 (404)
                         ++..|++|+|+||.||++.   .++    .++++|||++..+..
T Consensus       276 ---if~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ---VFRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---HHhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence               4469999999999999994   455    999999999976644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=2.1e-13  Score=116.75  Aligned_cols=126  Identities=20%  Similarity=0.290  Sum_probs=96.0

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCH
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL   89 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL   89 (404)
                      .+.|+.|.++.||+++.  .++.|++|+..... ....+..|..+++.+.+...++.+..+..  ...+++||++ |.++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            46789999999999985  47889999865543 23457899999999987766666655543  2347899998 5555


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        90 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi-----vHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+. .        .....++.+++.+|..||+.++     +|+|++|.||++   + ++.++++|||.+.
T Consensus        79 ~~~-~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE-D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E-CCeEEEEeccccc
Confidence            432 0        1123457899999999999885     999999999999   3 5679999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=5.7e-13  Score=115.37  Aligned_cols=137  Identities=18%  Similarity=0.210  Sum_probs=97.8

Q ss_pred             eeeeceeCceeEEEEEEcC------CCcEEEEEEecCCC-----------------------C-chh----HHHHHHHHH
Q 015592           12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT-----------------------K-HPQ----LQYEAKLYK   57 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~-----------------------~-~~~----~~~E~~~l~   57 (404)
                      ...||.|--+.||.|....      .+..+|||+.+...                       . ...    .++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998543      35799999743210                       0 011    237999999


Q ss_pred             HHcCCC-CCCceeEeeeeCCeEEEEEeccCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCc
Q 015592           58 ILQGGT-GIPNLRWFGVEGDYNVLVIDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN  133 (404)
Q Consensus        58 ~l~~~~-~i~~~~~~~~~~~~~~lv~e~~~~s-L-~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givHrDlKp~N  133 (404)
                      ++.... .+|....+    ...+|+|||.+++ + ...++  ...++..+...+..|++.+|..| |+.||||+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            987542 33333332    4578999999653 2 12233  22456667788899999999998 89999999999999


Q ss_pred             ccccCCCCCCeEEEEecCCcccccc
Q 015592          134 FLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus       134 ILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ||+    .++.++|+|||.+.....
T Consensus       156 IL~----~~~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLW----HDGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEE----ECCcEEEEECCCceeCCC
Confidence            999    356799999998875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.39  E-value=1.8e-13  Score=139.61  Aligned_cols=274  Identities=19%  Similarity=0.167  Sum_probs=188.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCcee---EeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLR---WFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~---~~~~~~~~   77 (404)
                      -+.+.+.+-+-+|+++.++.+.-..++...++|+......     .+....+-.++    .++..+.+.   .-......
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~----i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL----ITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc----ccCCCCceecccCCCCCCCC
Confidence            4567788889999999999998777776666665332211     11111221111    111112221   11335567


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++++|. +++|...++. .+..+.+-+......+..+++|||+..++|||++|.|+|.   ...+..++.|||.....
T Consensus       879 ~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             cchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence            78999998 7888888874 3457777778888899999999999999999999999999   68899999999844322


Q ss_pred             ccc---CC---------------------cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 015592          157 RDT---AT---------------------HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (404)
Q Consensus       157 ~~~---~~---------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P  212 (404)
                      ...   ..                     .....-+......||+.|.+||...+......+|+|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110   00                     000011234557899999999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccc
Q 015592          213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI  292 (404)
Q Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~  292 (404)
                      |.....   .+.++.+.......+  .-+...+.+.++++...+..++.+|-.+.--       -...+..+....+|..
T Consensus      1035 ~na~tp---q~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1035 FNAETP---QQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CCCcch---hhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCccc
Confidence            987444   444455544443332  1223457899999999999999999775411       1234556778889987


Q ss_pred             ccccccc
Q 015592          293 LKYQQSQ  299 (404)
Q Consensus       293 ~~~~~~~  299 (404)
                      ...+...
T Consensus      1103 l~~q~~~ 1109 (1205)
T KOG0606|consen 1103 LALQKAE 1109 (1205)
T ss_pred             cccccCc
Confidence            7655433

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.38  E-value=4.3e-12  Score=105.84  Aligned_cols=142  Identities=19%  Similarity=0.239  Sum_probs=107.8

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-C---------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-K---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+..|.+|+-+.|+++.+  .|+.+.||.--.+. .         ..+..+|++++.++.-- .|..-..+..+.....|
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence            677889999999999985  78889999532222 2         22356799999888743 55555666667777789


Q ss_pred             EEeccCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           81 VIDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        81 v~e~~~~--sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      +||+..|  ++.+++...-.. ........++.+|-+.+.-||.++|||+||..+||++..++....+.++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999966  888888643333 33333378889999999999999999999999999997555555669999999853

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=6.5e-12  Score=105.25  Aligned_cols=127  Identities=24%  Similarity=0.386  Sum_probs=97.4

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC-Cc---------hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KH---------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~---------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ..+++|+-+.||.+.+  -|..+++|.-..+. ..         ..-.+|.+++.++.. ..|+.-..+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence            4678999999999976  35558888533222 22         235679999998874 47777777788888889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ||. |..|.+.+...        ...++..+-.-+.-||..||||+||.++||++    .++.+.++|||++.
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~  139 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGE  139 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCccc
Confidence            999 55677788742        25566777777888999999999999999999    34559999999986

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=3.7e-12  Score=123.71  Aligned_cols=241  Identities=19%  Similarity=0.121  Sum_probs=162.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-CCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ..+|-++..||.|.|+.|+.+... .++..|++|-.......    ..-..|+-+...+.-+.++..+..........++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456889999999999999998754 67888999954332211    1134466666666544444442222223333458


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      -.||| ++++...+ .....+++...+++..|++.++.++|+..++|+|+||+||++.  ...+..++.|||+++.+.-.
T Consensus       344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhcccccccccccee
Confidence            88899 66665554 3455689999999999999999999999999999999999995  22277889999998753221


Q ss_pred             CCcccccccCCCCCccCcCcc--ccccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCCCCChHHHHHHHhhhccccc
Q 015592          160 ATHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDiwSlG~il~elltg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .          ......-++.  +++......+..+.|++|||..+++.+++.. ++.+..       ...+.....   
T Consensus       421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~i~~~~~---  480 (524)
T KOG0601|consen  421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLTIRSGDT---  480 (524)
T ss_pred             c----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------ceeeecccc---
Confidence            1          1222333333  5555666678999999999999999999864 332211       111111111   


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       + ...+...++..+.+.+...++..||.+.++..
T Consensus       481 -p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  481 -P-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             -c-CCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence             1 11344477888899999999999998766543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=9.5e-11  Score=115.24  Aligned_cols=181  Identities=17%  Similarity=0.167  Sum_probs=131.5

Q ss_pred             eEEeeeeceeCceeEE-EEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            9 FRLGRKIGSGSFGEIY-LGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy-~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      |++ ...+-++.+ +| .|..+.++.+|.|...+....  .....+-++-++.++|++++.++..+..++ ..|++.|-+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV   91 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERV   91 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecc
Confidence            444 333334443 44 466678899999998776665  445778888999999999998887776655 778999877


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      -+ |..++++    +....+...+.||+.||.||| +.+++|++|.-+.|++   +..|..||++|.++.........  
T Consensus        92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~--  161 (690)
T KOG1243|consen   92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP--  161 (690)
T ss_pred             cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc--
Confidence            43 5666664    346777888999999999998 5789999999999999   69999999999988655443210  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG  209 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg  209 (404)
                           .....--..|..|+.+....  -..|.|-|||+++|++.|
T Consensus       162 -----~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  162 -----AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -----cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence                 01111223355666544322  356999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=4.6e-11  Score=107.83  Aligned_cols=195  Identities=11%  Similarity=0.143  Sum_probs=126.5

Q ss_pred             HHHcCCCCCCceeEeee----eCCeEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 015592           57 KILQGGTGIPNLRWFGV----EGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK--SFLH  126 (404)
Q Consensus        57 ~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--givH  126 (404)
                      ..+.|.+++....++..    +....+++.+|+ .++|.++|++.   ...+....-.+|+.||+.||.|||+.  -|+|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            34456665555444432    223467778888 89999998743   44588899999999999999999985  6999


Q ss_pred             ccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHH
Q 015592          127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF  206 (404)
Q Consensus       127 rDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~el  206 (404)
                      +++..+-|++   ..++.+|+.--.-. ......  ......+.....+.++|.+||.=.....+..+|||+||++..+|
T Consensus       202 gnlTc~tifi---q~ngLIkig~~ap~-s~h~s~--~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  202 GNLTCDTIFI---QHNGLIKIGSVAPD-STHPSV--NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCcchhheee---cCCceEEecccCcc-ccchhh--hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            9999999999   57776776321110 000000  00000122334567899999987766778899999999999999


Q ss_pred             HcCCCCCCC-CCCCChHHHHHHHhhhcccccHhHhhcCCc-HHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          207 LRGSLPWQG-LKAGTKKQKYEKISEKKVSTSIEALCRGYP-TEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       207 ltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      ..+..--.. .......+   .+.....         +.. .--+.++..|++-.|..||++..+
T Consensus       276 ailEiq~tnseS~~~~ee---~ia~~i~---------~len~lqr~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEE---NIANVII---------GLENGLQRGSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             HHheeccCCCcceeehhh---hhhhhee---------eccCccccCcCcccccCCCCCCcchhhh
Confidence            887653222 11111111   1111100         111 223568899999999999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1.9e-10  Score=102.68  Aligned_cols=136  Identities=20%  Similarity=0.276  Sum_probs=99.2

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCC-CCceeEeeeeC---CeEEEEEecc
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVLVIDLL   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~---~~~~lv~e~~   85 (404)
                      +.|+.|.++.||+++.. +|+.+++|+.....   ....+..|.++++.+.+..+ ++.+..+....   ...+++|+++
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999863 36889999876543   24578999999999987433 45444444432   2567999998


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------  121 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------------------------------------------  121 (404)
                       |.++.+.+.  ...++......++.+++..|..||+                                           
T Consensus        83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence             666655442  1346677777777777777777773                                           


Q ss_pred             -------------CCceeccCCCCcccccCCCC--CCeEEEEecCCcc
Q 015592          122 -------------KSFLHRDIKPDNFLMGLGRR--ANQVYIIDFGLAK  154 (404)
Q Consensus       122 -------------~givHrDlKp~NILl~~~~~--~~~vkL~DFG~a~  154 (404)
                                   ..++|+|++|.|||++   .  .+.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence                         2469999999999994   4  4668999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=8.8e-10  Score=102.96  Aligned_cols=256  Identities=12%  Similarity=0.192  Sum_probs=159.2

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCc-eeE-----eee-eCCeEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN-LRW-----FGV-EGDYNVL   80 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~-~~~-----~~~-~~~~~~l   80 (404)
                      -...++.||+|+-+.+|-.-..   ...+-|+.....-..+ ..-+..|...-.++.+.+ +.|     ++. .+....+
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             ccCCCccccCCccceeeecchh---hchhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3446788999999999976421   2234576544332211 111222222222333333 211     222 3334677


Q ss_pred             EEeccCC--CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           81 VIDLLGP--SLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        81 v~e~~~~--sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      +|....+  ....+++-..     ..+.|.-.++.+..++.+.+-||..|.+-+|+.++|+|++   +++.|.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccce
Confidence            7877732  3333432111     1378999999999999999999999999999999999994   7888998874433


Q ss_pred             ccccccCCcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCC----hHH
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT----KKQ  223 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg-~~Pf~~~~~~~----~~~  223 (404)
                      ....+...        --.-+|...|.+||.-.     +-.-+...|.|.||+++++++.| ++||.+.....    ..+
T Consensus       165 qi~~ng~~--------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         165 QINANGTL--------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             eeccCCce--------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            22222211        12457899999999754     34457789999999999999985 99998743321    111


Q ss_pred             -HHH--------HHhhhcccccHhHhhcCCcHHHHHHHHHHHcC--CCCCCCCHHHHHHHHHHHHH
Q 015592          224 -KYE--------KISEKKVSTSIEALCRGYPTEFASYFHYCRSL--RFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       224 -~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RP~~~~l~~~l~~~~~  278 (404)
                       .+.        +-.....+.+...-...+|+.+..++.+|+..  ++.-||+++.-...|..+-.
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence             000        00011111122212234689999999999985  36689999887777666543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=2.2e-09  Score=98.16  Aligned_cols=133  Identities=18%  Similarity=0.097  Sum_probs=93.2

Q ss_pred             ceeEEEEEEcCCCcEEEEEEecCCCC-----------c--hhHHHHHHHHHHHcCCCC-CCceeEeeee-----CCeEEE
Q 015592           20 FGEIYLGTNIQTNEEVAIKLENVKTK-----------H--PQLQYEAKLYKILQGGTG-IPNLRWFGVE-----GDYNVL   80 (404)
Q Consensus        20 ~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~--~~~~~E~~~l~~l~~~~~-i~~~~~~~~~-----~~~~~l   80 (404)
                      ...|.++.  -.|+.|.||.......           .  ..+.+|...+.+|....+ ++....++..     ....++
T Consensus        35 ~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         35 GRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            33466665  3577899996533221           1  137789999988863322 1222223322     234689


Q ss_pred             EEeccCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----CCCCCeEEEEecCCc
Q 015592           81 VIDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLA  153 (404)
Q Consensus        81 v~e~~~~--sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~----~~~~~~vkL~DFG~a  153 (404)
                      ++|++++  +|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||+..    .+....+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            9998855  799998632 344667788899999999999999999999999999999952    123578999999988


Q ss_pred             c
Q 015592          154 K  154 (404)
Q Consensus       154 ~  154 (404)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            5

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=9.3e-11  Score=115.71  Aligned_cols=154  Identities=13%  Similarity=0.207  Sum_probs=107.6

Q ss_pred             HHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCC--CCccCcCccccccc
Q 015592          109 ADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK--NLTGTARYASMNTH  185 (404)
Q Consensus       109 ~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~--~~~gt~~y~aPE~~  185 (404)
                      +.+++.||.|+|. .++||++|.|++|.+   +..+..||+.|+++.............|...-  ...-...|.|||++
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455599999997 599999999999999   68999999999998765553321111111111  12335679999999


Q ss_pred             cCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015592          186 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP  264 (404)
Q Consensus       186 ~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  264 (404)
                      .+...+.++|+|||||++|.+.. |+.-+.... ........   ..............+|.++.+-+.+++..+...||
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~~~~~~---~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLLSYSFS---RNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccC-Ccchhhhh---hcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence            99888999999999999999984 555444322 12111111   11111122223357899999999999999999999


Q ss_pred             CHHHH
Q 015592          265 DYAYL  269 (404)
Q Consensus       265 ~~~~l  269 (404)
                      ++..+
T Consensus       258 ~~~~l  262 (700)
T KOG2137|consen  258 TLDLL  262 (700)
T ss_pred             chhhh
Confidence            76655

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=9.4e-10  Score=94.96  Aligned_cols=125  Identities=24%  Similarity=0.346  Sum_probs=79.4

Q ss_pred             eEEEEEEcCCCcEEEEEEecCCC--------------C---------c-----hhHHHHHHHHHHHcCCC-CCCceeEee
Q 015592           22 EIYLGTNIQTNEEVAIKLENVKT--------------K---------H-----PQLQYEAKLYKILQGGT-GIPNLRWFG   72 (404)
Q Consensus        22 ~Vy~~~~~~~~~~vavK~~~~~~--------------~---------~-----~~~~~E~~~l~~l~~~~-~i~~~~~~~   72 (404)
                      .||.|.. ..+..+|||+.....              .         .     ....+|.+.|.++.... .+|....+ 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            4899986 577899999743210              0         0     12567999999998653 35554433 


Q ss_pred             eeCCeEEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           73 VEGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        73 ~~~~~~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                       .  ..+|+|||.+  |.....+...  .++......++.+++..+.. +|+.||+|+||.+.|||++    .+.+.|+|
T Consensus        79 -~--~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID  149 (188)
T PF01163_consen   79 -N--RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID  149 (188)
T ss_dssp             -E--TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred             -e--CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence             2  3589999997  5433333321  12245567788888886655 5799999999999999993    34899999


Q ss_pred             cCCccccc
Q 015592          150 FGLAKRYR  157 (404)
Q Consensus       150 FG~a~~~~  157 (404)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99886443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.87  E-value=3e-07  Score=88.48  Aligned_cols=213  Identities=17%  Similarity=0.195  Sum_probs=148.9

Q ss_pred             CceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEee---eeCCeEEEEEecc--CCCHHH
Q 015592           19 SFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG---VEGDYNVLVIDLL--GPSLED   91 (404)
Q Consensus        19 ~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~---~~~~~~~lv~e~~--~~sL~~   91 (404)
                      ...+.|++....+|..|++|.+.....  .-....-++.++++.|.|+|+.-..+.   -.+...++|++|.  .++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            445789999999999999998743221  112445688999999999888765443   2345678899988  567877


Q ss_pred             HHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           92 LFNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        92 ~l~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +.-..              +.++++..+|.++.|+..||.++|+.|+.-+-|.|.+||+   ..+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeec
Confidence            64211              1247889999999999999999999999999999999999   566689998888765544


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....                     |.+.+   -.+-|.=.||.++..|.||..--..   .+..+..          ..
T Consensus       445 ~d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~~~s----------~~  487 (655)
T KOG3741|consen  445 EDPT---------------------EPLES---QQQNDLRDLGLLLLALATGTENSNR---TDSTQSS----------HL  487 (655)
T ss_pred             CCCC---------------------cchhH---HhhhhHHHHHHHHHHHhhccccccc---ccchHHH----------HH
Confidence            3220                     11111   2356999999999999999643111   1111111          01


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ..+...++.++++++......++++ -+..++...
T Consensus       488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            2344567889999999999998886 356655443

>PRK09902 hypothetical protein; Provisional

Probab=98.84  E-value=1.2e-07  Score=82.46  Aligned_cols=136  Identities=11%  Similarity=0.075  Sum_probs=98.2

Q ss_pred             ceeCceeEEEEEEcCCCcEEEEEEecC--------CCCchhHHHHHHHHHHHcCCCC-CCceeEeeee----CCeEEEEE
Q 015592           16 GSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVE----GDYNVLVI   82 (404)
Q Consensus        16 g~G~~g~Vy~~~~~~~~~~vavK~~~~--------~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~----~~~~~lv~   82 (404)
                      |.||.+-|+....  .|+.+-+|....        ....+.+.+|...+..|....+ ++...++...    ....+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            5689999999874  444688885431        2245679999999999985332 3333333222    22357888


Q ss_pred             eccC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           83 DLLG--PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        83 e~~~--~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +-++  .+|.+++.... .+.+......++.+++..+.-||+.|+.|+|+.+.|||+..+ ....++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence            8775  69999886322 246778888999999999999999999999999999999421 12349999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=9.7e-08  Score=84.35  Aligned_cols=109  Identities=19%  Similarity=0.277  Sum_probs=80.2

Q ss_pred             chhHHHHHHHHHHHcCCCC-CCceeEeeee----CCeEEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 015592           46 HPQLQYEAKLYKILQGGTG-IPNLRWFGVE----GDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF  118 (404)
Q Consensus        46 ~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~----~~~~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~  118 (404)
                      .....+|...+..|....+ ++....++..    ....+++++++.  .+|.+++.... ..+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence            3457889998888874222 2222333332    124578888883  37999988532 26777889999999999999


Q ss_pred             HHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592          119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus       119 LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ||++||+|+|+++.|||+..++....+.|+||+.++.
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999995433344899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=6.2e-08  Score=84.60  Aligned_cols=138  Identities=18%  Similarity=0.257  Sum_probs=92.2

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcC--CCCCCce
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LQYEAKLYKILQG--GTGIPNL   68 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~E~~~l~~l~~--~~~i~~~   68 (404)
                      +.++.++|.+.+.+-......|.+..  -.|+.+++|.........+           ..+++..+..++.  ......+
T Consensus        26 ~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   26 EKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            35678899999999998888888887  5678999997655432211           2233443444432  1121111


Q ss_pred             eEeee-----eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           69 RWFGV-----EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        69 ~~~~~-----~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      .....     .....+++|||+ |..|.++..     +++    .+...+.+++.-||+.|+.|+|..|.|+++    .+
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~  170 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SN  170 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----EC
Confidence            11111     223457899999 667766543     232    245667788999999999999999999999    35


Q ss_pred             CeEEEEecCCcc
Q 015592          143 NQVYIIDFGLAK  154 (404)
Q Consensus       143 ~~vkL~DFG~a~  154 (404)
                      +.++++||+..+
T Consensus       171 ~~i~iID~~~k~  182 (229)
T PF06176_consen  171 NGIRIIDTQGKR  182 (229)
T ss_pred             CcEEEEECcccc
Confidence            569999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.76  E-value=7.4e-08  Score=80.47  Aligned_cols=128  Identities=26%  Similarity=0.428  Sum_probs=97.9

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      +..+.|++|.+|.||+|.+  .|..+|+|+-..+.....++.|++++..++...+-+.++.|+.+.    +.|||. |..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcc
Confidence            3467899999999999996  566999999999989999999999999999999888888886544    349999 668


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC--CcccccCCCCCCeEEEEecCCccc
Q 015592           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP--DNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp--~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      |.++....    +-+++.    .+++.---|-..||-|..|.-  .||++    .++.+.|+||..|+.
T Consensus        99 L~~~~~~~----~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG----DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc----cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            88776521    223333    344444445567999998864  46666    455899999999873

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=5.7e-08  Score=86.60  Aligned_cols=132  Identities=19%  Similarity=0.324  Sum_probs=95.3

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----------------C-------CchhHHHHHHHHHHHcCC-C
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----------------T-------KHPQLQYEAKLYKILQGG-T   63 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------------~-------~~~~~~~E~~~l~~l~~~-~   63 (404)
                      +.++.+||-|--+.||.|.+ ..|.++|||.-...                 .       .....++|.++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45788999999999999997 47889999952210                 0       011357899999999744 2


Q ss_pred             CCCceeEeeeeCCeEEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      .|+...    ..+...++||+..| .|..+      +++....-.++..|++-+.-+-..||||+|+.+=|||+   +++
T Consensus       172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d  238 (304)
T COG0478         172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED  238 (304)
T ss_pred             CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence            333322    33567899999955 33221      23455566667777777777778999999999999999   688


Q ss_pred             CeEEEEecCCcc
Q 015592          143 NQVYIIDFGLAK  154 (404)
Q Consensus       143 ~~vkL~DFG~a~  154 (404)
                      |.++++||=-+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            899999997664

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=4.6e-07  Score=81.12  Aligned_cols=71  Identities=18%  Similarity=0.130  Sum_probs=55.7

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEeeeeCCeEEEEEeccCC
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLGP   87 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lv~e~~~~   87 (404)
                      ..||+|..+.||+.    .+..+++|+...........+|.++++.+....+ ++....++.......++|+++.|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999984    2456889987765556678999999999986555 67777777777777889999944

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=1.9e-07  Score=92.60  Aligned_cols=141  Identities=20%  Similarity=0.312  Sum_probs=94.6

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc------------------------------------h------hHH
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------P------QLQ   50 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------------------------~------~~~   50 (404)
                      .-|+.++-|.||+|+. .+|+.||||+.......                                    +      ++.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5688999999999996 56999999985432100                                    0      134


Q ss_pred             HHHHHHHHHc----CCCCCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015592           51 YEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL  125 (404)
Q Consensus        51 ~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv  125 (404)
                      +|...+.++.    +.+.+..-..|..-....+++|||. |-.+.++.......++.+.+.....++.  +..+-..|+.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            4555555543    3444444455555556679999999 6677777432234466444433333322  3444458999


Q ss_pred             eccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592          126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus       126 HrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |.|..|.||++   +.++.+.+.|||+...+.+.
T Consensus       288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            99999999999   67899999999998766543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=1.5e-06  Score=76.83  Aligned_cols=135  Identities=21%  Similarity=0.253  Sum_probs=91.2

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCC---------------------ch-----hHHHHHHHHHHHcCCCCCCc
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------------HP-----QLQYEAKLYKILQGGTGIPN   67 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------------~~-----~~~~E~~~l~~l~~~~~i~~   67 (404)
                      .|++|--+.||+|.. .++..+|||+......                     ..     ...+|..-|+++..- +|+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA-GVrv  132 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA-GVRV  132 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc-CCCC
Confidence            566777779999984 6788999998654221                     00     134577777776532 1222


Q ss_pred             eeEeeeeCCeEEEEEeccCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCe
Q 015592           68 LRWFGVEGDYNVLVIDLLGPSL--EDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        68 ~~~~~~~~~~~~lv~e~~~~sL--~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~  144 (404)
                      -.-+  .....+++||+.|...  .-.|+  .-.+...++..+..++++.+.-|-. .++||+||..=|||+    .++.
T Consensus       133 P~Pi--~~~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~~~  204 (268)
T COG1718         133 PEPI--AFRNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HDGE  204 (268)
T ss_pred             CCce--eecCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----ECCe
Confidence            1111  1234689999996541  01111  1123444788889999999998887 899999999999999    3788


Q ss_pred             EEEEecCCcccccc
Q 015592          145 VYIIDFGLAKRYRD  158 (404)
Q Consensus       145 vkL~DFG~a~~~~~  158 (404)
                      +.|+|||.|....+
T Consensus       205 p~iID~~QaV~~~h  218 (268)
T COG1718         205 PYIIDVSQAVTIDH  218 (268)
T ss_pred             EEEEECccccccCC
Confidence            99999999875543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.42  E-value=4.2e-06  Score=75.95  Aligned_cols=75  Identities=17%  Similarity=0.274  Sum_probs=52.7

Q ss_pred             eeceeCc-eeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHH
Q 015592           14 KIGSGSF-GEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLED   91 (404)
Q Consensus        14 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~   91 (404)
                      .|..|.+ ..||+...  .+..+.||+..... ...+.+|+++++.+...-.++.+..+.......+++|++. |.+|.+
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3445555 78999974  34678899865543 4568899999999986655666666665556678899988 556653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=3.6e-06  Score=75.46  Aligned_cols=78  Identities=19%  Similarity=0.272  Sum_probs=55.0

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEee---eeCCeEEEEEecc-C
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFG---VEGDYNVLVIDLL-G   86 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~---~~~~~~~lv~e~~-~   86 (404)
                      ++.|+.|..+.||++....  ..+++|+.........+..|..+++.|....+ ++.+..+.   ......+++|+++ |
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4678999999999999643  58999987654344568899999999986644 55554432   2334578899988 5


Q ss_pred             CCHHH
Q 015592           87 PSLED   91 (404)
Q Consensus        87 ~sL~~   91 (404)
                      ..+..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            55555

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=6.2e-08  Score=95.21  Aligned_cols=186  Identities=12%  Similarity=0.040  Sum_probs=135.3

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEeccCCC
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPS   88 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~s   88 (404)
                      |.....+++|+++.+++.+...+...+ .|++...   ....-++++|.+++|++-......-...+.+..+.++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            445566789999999999876554444 6655433   456678899999999883333333334566788999999432


Q ss_pred             --HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           89 --LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        89 --L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                        .........-.+...+...+...-+.+|+++|+--=+|||    ||+.    ..+..+..||+....+....      
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------  385 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------  385 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc------
Confidence              2222221122355556677778888999999998778999    8887    45788999999987776543      


Q ss_pred             ccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 015592          167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ  214 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~  214 (404)
                        ......+|+.++|||+..+..+..+.|.|++|+--.++.-|.+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              2356789999999999999999999999999987777777777654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=5.9e-06  Score=81.86  Aligned_cols=144  Identities=19%  Similarity=0.257  Sum_probs=92.3

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---------------------------------h------hHHHHH
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------------------P------QLQYEA   53 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------------------~------~~~~E~   53 (404)
                      +.||.-+.|.||+|+- .+|+.||||+.+..-..                                 +      +|..|.
T Consensus       167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            5789999999999996 45999999984432110                                 0      133444


Q ss_pred             HHHHH----HcCCCCCC---ceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015592           54 KLYKI----LQGGTGIP---NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL  125 (404)
Q Consensus        54 ~~l~~----l~~~~~i~---~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv  125 (404)
                      +-..+    +.+-+...   .-..|.......+++|||+ |..+.++-.-....++...+..-+.++.  ++.|-..|++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~Gff  323 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFF  323 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCc
Confidence            44333    33333111   2233334445679999999 6555555432345577776555544443  2344457899


Q ss_pred             eccCCCCcccccCC-CCCCeEEEEecCCccccccc
Q 015592          126 HRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus       126 HrDlKp~NILl~~~-~~~~~vkL~DFG~a~~~~~~  159 (404)
                      |+|=.|.||++..+ ..+..+.+.|||+...+...
T Consensus       324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             cCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            99999999999522 24778999999999766543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=4.1e-05  Score=66.33  Aligned_cols=124  Identities=19%  Similarity=0.305  Sum_probs=84.2

Q ss_pred             CceEEeeeeceeCc-eeEEEEEEcCCCcEEEEEEecC---C--------------------CCchhHHHHHHHHHHHcCC
Q 015592            7 NKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLENV---K--------------------TKHPQLQYEAKLYKILQGG   62 (404)
Q Consensus         7 ~~y~i~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~--------------------~~~~~~~~E~~~l~~l~~~   62 (404)
                      .+++.++.||.|.- |.||+++  -.|+.||||+...   .                    .....|..|.+..-+|++.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 9999998  4788999998221   0                    1112477899999888854


Q ss_pred             CC-----CCceeEeeee-----------------CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015592           63 TG-----IPNLRWFGVE-----------------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH  120 (404)
Q Consensus        63 ~~-----i~~~~~~~~~-----------------~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH  120 (404)
                      ..     +..+++....                 .....||.||....-         .++..    -+.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence            43     3333333221                 112345655542211         12333    3456777789999


Q ss_pred             hCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592          121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus       121 ~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ..||+-+|+|+.|..=+        ||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRGG--------KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccCC--------EEEecccC
Confidence            99999999999998732        79999865

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.06  E-value=2.7e-05  Score=70.30  Aligned_cols=72  Identities=17%  Similarity=0.206  Sum_probs=44.8

Q ss_pred             eeeceeCce-eEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCceeEeeeeC---CeEEEEEecc-
Q 015592           13 RKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIPNLRWFGVEG---DYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~~~---~~~~lv~e~~-   85 (404)
                      +.|+.|+.. .||+..     ..+++|+.........+.+|.+++..|...-  -++.+...+...   ...+++|+++ 
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457767666 599762     3578897655444557999999999997532  233333333321   2347788887 


Q ss_pred             CCCH
Q 015592           86 GPSL   89 (404)
Q Consensus        86 ~~sL   89 (404)
                      |.++
T Consensus        78 G~~l   81 (235)
T cd05155          78 GETA   81 (235)
T ss_pred             CCCC
Confidence            5444

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.05  E-value=0.00015  Score=63.25  Aligned_cols=129  Identities=22%  Similarity=0.309  Sum_probs=87.7

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCC------------------CchhHHHHHHHHHHHc-C----CCCCCce
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------------KHPQLQYEAKLYKILQ-G----GTGIPNL   68 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~~~E~~~l~~l~-~----~~~i~~~   68 (404)
                      ...||+|+.-.||.--   .+....||+.....                  ...+..+|+..+..+. .    ..+++.+
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4578999999999653   44556889876654                  2456778888887777 3    2234444


Q ss_pred             eEeeeeCCeEEEEEecc-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           69 RWFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-------~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                      +.+...+....+++|..       ..+|.+++.  ...++. .....+.   +-.+||-+++|+.+||+|.||++...++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            44445555556777754       347888886  344665 3333333   3456788999999999999999976655


Q ss_pred             CC-eEEEEe
Q 015592          142 AN-QVYIID  149 (404)
Q Consensus       142 ~~-~vkL~D  149 (404)
                      .. .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence            55 788888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.95  E-value=0.00011  Score=78.28  Aligned_cols=77  Identities=10%  Similarity=0.163  Sum_probs=51.3

Q ss_pred             EeeeeceeCceeEEEEEEcCCC--cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCC--CceeEeeeeC---CeEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGI--PNLRWFGVEG---DYNVL   80 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i--~~~~~~~~~~---~~~~l   80 (404)
                      -.+.|+.|.+..+|+......+  ..+++|+.....   ....+.+|.++++.+..+..+  +.+..++.+.   ...++
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3577899999999998764332  467888754332   224688999999999743333  4444443332   35689


Q ss_pred             EEeccCC
Q 015592           81 VIDLLGP   87 (404)
Q Consensus        81 v~e~~~~   87 (404)
                      +||++.|
T Consensus       122 VME~v~G  128 (822)
T PLN02876        122 IMEYLEG  128 (822)
T ss_pred             EEEecCC
Confidence            9999844

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.81  E-value=0.0028  Score=60.16  Aligned_cols=70  Identities=14%  Similarity=0.231  Sum_probs=47.2

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEe----cC-----CCCchhHHHHHHHHHHHcC--CCCCCceeEeeeeCCeEEEEE
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLE----NV-----KTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~----~~-----~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .||.|....||++.+...++.|+||.-    ..     ....++...|...|+....  |..++.++.+  +....+++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997544468999941    11     2223456778888877654  3345555554  455567888


Q ss_pred             ecc
Q 015592           83 DLL   85 (404)
Q Consensus        83 e~~   85 (404)
                      |++
T Consensus        80 EdL   82 (370)
T TIGR01767        80 EDL   82 (370)
T ss_pred             hhC
Confidence            887

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.75  E-value=0.00045  Score=62.20  Aligned_cols=74  Identities=19%  Similarity=0.213  Sum_probs=49.3

Q ss_pred             eeeeceeCceeEEEEEEcC-CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      .+.|..|-...+|++.... .++.|++|+....... -...+|..+++.+....+.+.+.....    ..++|||+ |.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            4567888888999997532 3578999976543221 234689999999976666666644332    24788887 444


Q ss_pred             H
Q 015592           89 L   89 (404)
Q Consensus        89 L   89 (404)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            3

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00083  Score=64.97  Aligned_cols=73  Identities=19%  Similarity=0.293  Sum_probs=51.3

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecC---------CCCchhHHHHHHHHHHHcC--CCCCCceeEeeeeCCeEEE
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV---------KTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---------~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.||.|.+..||++.+...++.|+||.-..         ....++...|.+.|+.+..  +..++.+..++.  ...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            4678999999999999754446899996321         1123457788888888753  345666666644  55789


Q ss_pred             EEeccC
Q 015592           81 VIDLLG   86 (404)
Q Consensus        81 v~e~~~   86 (404)
                      +||++.
T Consensus       109 VME~L~  114 (401)
T PRK09550        109 VMEDLS  114 (401)
T ss_pred             EEecCC
Confidence            999873

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.61  E-value=0.00065  Score=72.00  Aligned_cols=198  Identities=13%  Similarity=0.032  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHcCCCCCCceeEeeeeCCeE---EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015592           49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYN---VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF  124 (404)
Q Consensus        49 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~---~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  124 (404)
                      .+.|...+.++.|.+...++.+-......-   .+.-+++ ..++...+.. -..++..+.+.+..++.+||.|+|+...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            556777788888777666654433322111   2233455 6677777763 4568999999999999999999999866


Q ss_pred             eeccCCCCcccccCCCCCCeEEEE--ecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCc--hhHHHHHH
Q 015592          125 LHRDIKPDNFLMGLGRRANQVYII--DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR--RDDLESLG  200 (404)
Q Consensus       125 vHrDlKp~NILl~~~~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDiwSlG  200 (404)
                      .|.-|...-..-...+..+.+.++  ||+.++.+.+....        .....+..+.++|......+..  ..|+|.+|
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHHHHHH
Confidence            666555552222222456666666  99988876654321        1223456678888887766544  47999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       201 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      ..+..+..|..+-....      ....           -++.....+.......|+..+.++|+...++...
T Consensus       380 ll~~~~~~~~~i~~~~~------~~~~-----------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSA------VPVS-----------LLDVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHhhhhhcCccccccc------chhh-----------hhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999988765422100      0000           1111222367888899999999999997766443

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0015  Score=61.83  Aligned_cols=73  Identities=15%  Similarity=0.145  Sum_probs=44.9

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeE------eeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~------~~~~~~~~~lv~e~   84 (404)
                      .+.|+.|....+|+... . +..+++|+.. ......+..|..++..|....+ ++.+..      +.......++++++
T Consensus        27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEe-C-CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            35566777789999874 2 3368999876 3344567778888888864322 222211      12234456788888


Q ss_pred             cCC
Q 015592           85 LGP   87 (404)
Q Consensus        85 ~~~   87 (404)
                      ..|
T Consensus       104 l~G  106 (319)
T PRK05231        104 LEG  106 (319)
T ss_pred             cCC
Confidence            733

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.60  E-value=0.00089  Score=62.79  Aligned_cols=137  Identities=23%  Similarity=0.270  Sum_probs=96.1

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----------------------Cch------hHHHHHHHHHHHcCC
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHP------QLQYEAKLYKILQGG   62 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~------~~~~E~~~l~~l~~~   62 (404)
                      |-..|..|--+.||.|+. .+|..+|||+.+...                      ..+      ..+.|++-|++|...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            445678899999999984 678889999754210                      000      145688888888743


Q ss_pred             CCCCceeEeeeeCCeEEEEEeccCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCC
Q 015592           63 TGIPNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        63 ~~i~~~~~~~~~~~~~~lv~e~~~~sL~--~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~  139 (404)
                      - |+.-.-..  -...+|||+++|.+=.  -.|+  ...++...+..+-.|++.-+.-|.+ .++||.||.-=|+|+   
T Consensus       227 G-IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---  298 (520)
T KOG2270|consen  227 G-IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---  298 (520)
T ss_pred             C-CCCCCcee--eecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE---
Confidence            2 33322111  1235899999965422  1222  3457888888888888888877765 699999999999999   


Q ss_pred             CCCCeEEEEecCCccccc
Q 015592          140 RRANQVYIIDFGLAKRYR  157 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~  157 (404)
                       .+|.++|+|.+-+....
T Consensus       299 -hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             -ECCEEEEEEccccccCC
Confidence             78999999998775443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.00076  Score=63.46  Aligned_cols=139  Identities=17%  Similarity=0.251  Sum_probs=79.2

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeE------eeeeCCeEEEEEe
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVID   83 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~------~~~~~~~~~lv~e   83 (404)
                      ..+.++.|....+|++.. . +..+++|+.........+..|.+++..|..... ++.+..      +....+..+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            356677787789999874 3 446888987554344567788888888864322 222211      1122345678888


Q ss_pred             ccCC-CH-----H------HHH---HHcCCCCC-----------HHHHH------------HHHHHHHHHHHHHHh----
Q 015592           84 LLGP-SL-----E------DLF---NFCSRKLS-----------LKTVL------------MLADQMINRVEFVHS----  121 (404)
Q Consensus        84 ~~~~-sL-----~------~~l---~~~~~~l~-----------~~~~~------------~i~~qi~~aL~~LH~----  121 (404)
                      +..| .+     .      ..+   +.....++           +....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            8733 21     1      111   11111110           00000            011123334555542    


Q ss_pred             ---CCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       122 ---~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                         .+++|+|+.+.||++   +.++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEE---ECCceEEEeeccccc
Confidence               689999999999999   455556899999773

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.50  E-value=0.0023  Score=58.48  Aligned_cols=131  Identities=18%  Similarity=0.183  Sum_probs=77.2

Q ss_pred             eeceeCceeEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHH
Q 015592           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE   90 (404)
Q Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~   90 (404)
                      .+..|-.+.+|+..  .+++.+++|+.......  -....|..+++.+......+.+.....    .+++|+++ |..+.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            35668888999987  45778999975443222  246889999999987656666554432    36788887 43332


Q ss_pred             --------------HHHHHc-C-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCCCC
Q 015592           91 --------------DLFNFC-S-----RKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKPD  132 (404)
Q Consensus        91 --------------~~l~~~-~-----~~l~~~-~~~~i~~qi---------~~aL~~LH~--------~givHrDlKp~  132 (404)
                                    +.+... .     .+++.. .+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence                          111110 1     112221 112221111         111222211        25899999999


Q ss_pred             cccccCCCCCCeEEEEecCCcc
Q 015592          133 NFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       133 NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ||+++   +++ +.|+||..+.
T Consensus       157 Nil~~---~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVT---PQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEe---CCC-CEEEeccccC
Confidence            99994   444 7899998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.48  E-value=8.4e-05  Score=68.32  Aligned_cols=132  Identities=20%  Similarity=0.354  Sum_probs=90.2

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC--------CCC----------------chhHHHHHHHHHHHcCCC-
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTK----------------HPQLQYEAKLYKILQGGT-   63 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--------~~~----------------~~~~~~E~~~l~~l~~~~-   63 (404)
                      +.++++||-|--+.||.+-+ ..|++.++|+-..        +..                .-...+|...|+.|..+- 
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56889999999999999987 5788899995111        000                012467899999987532 


Q ss_pred             CCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      -|+..    .+....+++|++. |-.|.++-+    -.+.   ..+...+..-+.-|-.+|+||+|..-=||++   +++
T Consensus       173 pVPkp----iD~~RH~Vvmelv~g~Pl~~v~~----v~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd  238 (465)
T KOG2268|consen  173 PVPKP----IDHNRHCVVMELVDGYPLRQVRH----VEDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD  238 (465)
T ss_pred             CCCCc----ccccceeeHHHhhcccceeeeee----cCCh---HHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence            22222    1345678999988 556654432    1222   2334444445566778999999999999999   578


Q ss_pred             CeEEEEecCCccc
Q 015592          143 NQVYIIDFGLAKR  155 (404)
Q Consensus       143 ~~vkL~DFG~a~~  155 (404)
                      +.++++||--...
T Consensus       239 ~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  239 DKIVVIDFPQMVS  251 (465)
T ss_pred             CCEEEeechHhhc
Confidence            8999999976543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.44  E-value=0.0015  Score=61.07  Aligned_cols=137  Identities=15%  Similarity=0.177  Sum_probs=79.2

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeE------eeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~------~~~~~~~~~lv~e~   84 (404)
                      .+.|..|....+|+...  .+..+++|+... .....+..|++++..|.+..+ ++.+..      +...++..++++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            55677788889999873  345789998765 344568889999999865432 222211      11223455788888


Q ss_pred             c-CCCHH-----------HHH---HHcCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------C
Q 015592           85 L-GPSLE-----------DLF---NFCSRKL----------SLKTV----------LMLADQMINRVEFVHS-------K  122 (404)
Q Consensus        85 ~-~~sL~-----------~~l---~~~~~~l----------~~~~~----------~~i~~qi~~aL~~LH~-------~  122 (404)
                      . |..+.           ..+   +.....+          .+...          ......+..++.++.+       .
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            7 43321           111   1110000          11000          0011122333444443       4


Q ss_pred             CceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       123 givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +++|+|+.|.|||+   +.++.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLF---DGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence            79999999999999   455556899998773

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.41  E-value=0.00062  Score=59.02  Aligned_cols=97  Identities=25%  Similarity=0.313  Sum_probs=71.5

Q ss_pred             HHHHHHHHHHcCCCCCCce-eEeeeeCCeEEEEEeccC-CCHHH----HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--
Q 015592           50 QYEAKLYKILQGGTGIPNL-RWFGVEGDYNVLVIDLLG-PSLED----LFNFCSRKLSLKTVLMLADQMINRVEFVHS--  121 (404)
Q Consensus        50 ~~E~~~l~~l~~~~~i~~~-~~~~~~~~~~~lv~e~~~-~sL~~----~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~--  121 (404)
                      ..|.-+++.+++..+++.+ +.++     .+++.|+.+ +++..    +.+  -..-+|..+.+|+.++++.+++|+.  
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            3588889999986555554 3442     256777774 44432    111  1236899999999999999999998  


Q ss_pred             -CCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592          122 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus       122 -~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                       ..+.-.|++++|+-+   ++++.+|++|...+...
T Consensus        80 ~~~~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCcEEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence             457889999999999   57789999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.36  E-value=3.8e-05  Score=82.80  Aligned_cols=154  Identities=12%  Similarity=-0.056  Sum_probs=110.8

Q ss_pred             HHHHHHHHHcCCCCCCce-eEeeeeCCeEEEEEecc-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---
Q 015592           51 YEAKLYKILQGGTGIPNL-RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---  122 (404)
Q Consensus        51 ~E~~~l~~l~~~~~i~~~-~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---  122 (404)
                      .|...++...|....... +.-.......+..++++ +|.+.+.+-+...   .+...-+.....+.+.+..-+|+.   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            344445555665555444 22333455667888888 8888888864322   244444444455557778887764   


Q ss_pred             --CceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHH
Q 015592          123 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG  200 (404)
Q Consensus       123 --givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG  200 (404)
                        -.+|++||+-|.+|   ..+..+|+.++|+.+.......       ..+...+++.|+++++.....++.++|+|..|
T Consensus      1358 g~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRS 1427 (2724)
T ss_pred             Cccchhhhhhhhccce---ecCCcccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHH
Confidence              37999999999999   6888899999999983333222       23456788999999999988899999999999


Q ss_pred             HHHHHHHcCCCCCC
Q 015592          201 YVLMYFLRGSLPWQ  214 (404)
Q Consensus       201 ~il~elltg~~Pf~  214 (404)
                      +-+|++..|..+|-
T Consensus      1428 ~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHhcccHHHH
Confidence            99999998888773

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.34  E-value=0.0031  Score=59.08  Aligned_cols=70  Identities=13%  Similarity=0.068  Sum_probs=47.3

Q ss_pred             eeeeceeCceeEEEEEEcC------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ++.|..|-...||++....      .++.|++|+...... .....+|.++++.+....+.+.+..+...    .+++++
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            3556677777999997532      257899998665432 24578899999999876666666555432    246676


Q ss_pred             c
Q 015592           85 L   85 (404)
Q Consensus        85 ~   85 (404)
                      +
T Consensus        79 i   79 (302)
T cd05156          79 I   79 (302)
T ss_pred             e
Confidence            5

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.27  E-value=0.0007  Score=66.00  Aligned_cols=163  Identities=18%  Similarity=0.153  Sum_probs=97.4

Q ss_pred             CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015592           45 KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF  124 (404)
Q Consensus        45 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  124 (404)
                      ...++.-....++.++|.+...++..........++|||+++.||++++....  +-.....              .+++
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~   88 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGV   88 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------cccc
Confidence            34456667788888998887777766665666689999999999999997432  2111111              2333


Q ss_pred             eeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHH
Q 015592          125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM  204 (404)
Q Consensus       125 vHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~  204 (404)
                      .|     .|++.          ++| -++..                       |  |-     ...+|+||||+|.++.
T Consensus        89 ~~-----~~~~~----------~td-~~~t~-----------------------~--~~-----~~~pKsdVwsl~~i~~  122 (725)
T KOG1093|consen   89 LH-----LNIIY----------ITD-HFLTK-----------------------Y--PS-----PIGPKSDVWSLGFIIL  122 (725)
T ss_pred             ce-----ehhhh----------ccc-ccccc-----------------------C--CC-----CCCcchhhhhHHHHHH
Confidence            33     23332          333 11100                       0  00     1124999999999999


Q ss_pred             HHHcCCCCCCCCCCCChHHHHHHHhhhcccc---cH-hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015592          205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVST---SI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL  269 (404)
Q Consensus       205 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l  269 (404)
                      |+.-|..-|......+....+.+........   .. ..+...++..+..+...|+-..|..||...++
T Consensus       123 el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  123 ELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            9999988776544322222222211111000   00 01223467888999999999999999876654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.24  E-value=0.0018  Score=59.91  Aligned_cols=50  Identities=4%  Similarity=0.137  Sum_probs=32.6

Q ss_pred             eeeeceeCce---eEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 015592           12 GRKIGSGSFG---EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG   62 (404)
Q Consensus        12 ~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~   62 (404)
                      .+.++.|+.|   .|+.+.+ ..|+.+++|.-........+.+|.++++.|...
T Consensus        13 ~~~~~~~~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~   65 (276)
T cd05152          13 PETLSLNESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH   65 (276)
T ss_pred             CCcceecCCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence            3444444444   4555432 357889999765434455689999999999854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.98  E-value=0.022  Score=54.52  Aligned_cols=137  Identities=12%  Similarity=0.156  Sum_probs=79.4

Q ss_pred             eeeeceeCceeEEEEEEcC----CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           12 GRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      ...|..|-...+|++....    .++.|++|+...... .-....|..+++.+....+-+.+..++..+    .+++|+ 
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            4455558888999987432    347899998654321 123477999999998777777765554333    356665 


Q ss_pred             CCCHHH-----------H---HHH-cCCC------C-CHHHHHHHHHHH-----------------HHHHHHH----H--
Q 015592           86 GPSLED-----------L---FNF-CSRK------L-SLKTVLMLADQM-----------------INRVEFV----H--  120 (404)
Q Consensus        86 ~~sL~~-----------~---l~~-~~~~------l-~~~~~~~i~~qi-----------------~~aL~~L----H--  120 (404)
                      +.+|..           +   +.+ +...      . .+.++..+..++                 ...+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            434321           1   110 0101      1 123333333221                 1111122    1  


Q ss_pred             --hCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       121 --~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                        ...++|+|+++.|||++  +.++.++|+||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence              23689999999999994  234689999998774

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.79  E-value=0.018  Score=54.72  Aligned_cols=70  Identities=14%  Similarity=0.063  Sum_probs=44.1

Q ss_pred             eeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592           12 GRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .+.|..|=...+|++.....   +..|++|+...... .-.-.+|..+++.+....+-+.+..+...+    ++.+|.
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi   92 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI   92 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence            34444477778999874332   34799998654332 123468999999998777766665554322    356665

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.77  E-value=0.012  Score=56.74  Aligned_cols=72  Identities=18%  Similarity=0.314  Sum_probs=49.2

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEE----ecCC----CCchhHHHHHHHHHHHcC--CCCCCceeEeeeeCCeEEEE
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVK----TKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~----~~~~----~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+.||.|.-..||++.+...++.|+||.    ++..    ...++...|.++|+.+..  |..++.++.+  +....+++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5688999999999999744456799994    2221    123456778888887753  4456666665  44455677


Q ss_pred             Eecc
Q 015592           82 IDLL   85 (404)
Q Consensus        82 ~e~~   85 (404)
                      ||++
T Consensus       112 MEdL  115 (409)
T PRK12396        112 MEDL  115 (409)
T ss_pred             HHhC
Confidence            7776

>PRK10593 hypothetical protein; Provisional

Probab=96.64  E-value=0.02  Score=53.48  Aligned_cols=107  Identities=16%  Similarity=0.113  Sum_probs=73.0

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCceeEeee---eCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIPNLRWFGV---EGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~---~~~~~~lv~   82 (404)
                      .-.-.+.||.|..+.||+... .++ .+.+|+.+.......+..|...++.|....  .++.+..++.   .....+++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hhheeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            334467899999999999974 223 577787543234457999999999998653  3444543332   245689999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK  122 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  122 (404)
                      |+. |.++.+.      ..+......+..+++.+|.-||+.
T Consensus        93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            998 5556541      123445566778888999999974

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.63  E-value=0.044  Score=53.06  Aligned_cols=73  Identities=15%  Similarity=0.289  Sum_probs=48.5

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEec-----CCC----CchhHHHHHHHHHHHcC--CCCCCceeEeeeeCCeEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKT----KHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-----~~~----~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~   79 (404)
                      ..+.||.|....||+..+  .+..|+||.-.     ...    ...+-..|.+.|+.+..  +..++.+..++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            467889999999999986  34569999633     111    23445666777776653  345666666655  4567


Q ss_pred             EEEeccCC
Q 015592           80 LVIDLLGP   87 (404)
Q Consensus        80 lv~e~~~~   87 (404)
                      ++||++.+
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88998844

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.32  E-value=0.075  Score=49.85  Aligned_cols=29  Identities=38%  Similarity=0.729  Sum_probs=24.3

Q ss_pred             CCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       122 ~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+++|+|+.+.||+++   . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            5799999999999993   3 568899998663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.32  E-value=0.014  Score=55.04  Aligned_cols=74  Identities=24%  Similarity=0.292  Sum_probs=60.2

Q ss_pred             eeCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           73 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        73 ~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      .+..|.|++|++-|++|.-.-     ...+++++.|+.+.+.-+.-+..+ .+=|||+.-.||||   + .|+|.|+||-
T Consensus       296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk  366 (488)
T COG5072         296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK  366 (488)
T ss_pred             CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence            456788899999888875332     246788999999888877777765 68999999999999   4 8999999999


Q ss_pred             Cccc
Q 015592          152 LAKR  155 (404)
Q Consensus       152 ~a~~  155 (404)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9983

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.04  E-value=0.045  Score=50.74  Aligned_cols=73  Identities=18%  Similarity=0.249  Sum_probs=51.5

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCceeEeeeeCCeEEEEEecc
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      +-.+.|+.|....+|+..  .+++.+.||+-. ......+..|..-|+.|.  .+-.++.+..++......+++||+.
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678889999999988  778899999876 445567999999999994  4556777777777777779999997

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.03  E-value=0.25  Score=46.80  Aligned_cols=68  Identities=12%  Similarity=0.090  Sum_probs=40.4

Q ss_pred             eCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCC--CCce----eEeeeeCCeEEEEEeccC
Q 015592           18 GSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTG--IPNL----RWFGVEGDYNVLVIDLLG   86 (404)
Q Consensus        18 G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~--i~~~----~~~~~~~~~~~lv~e~~~   86 (404)
                      +.-..||+... .++..+++|+..... ...++..|.+.+..|....+  +..+    ..+...+...+.++++.+
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            34457898874 456789999876443 34567889999988864221  1111    111222445666777763

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.83  E-value=0.064  Score=50.27  Aligned_cols=140  Identities=14%  Similarity=0.201  Sum_probs=76.0

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-C---CCchhHHHHHHHHHHHcCCCCCCce--eEeeeeCC--eEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-K---TKHPQLQYEAKLYKILQGGTGIPNL--RWFGVEGD--YNVL   80 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~---~~~~~~~~E~~~l~~l~~~~~i~~~--~~~~~~~~--~~~l   80 (404)
                      ..+.+.+..|-.-.+|...+  +++.+++. ... .   .......+|..+++.+... .++.-  ..++.++.  ..+.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~-~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV-DVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC-CCCCcccccccccCCCCCceE
Confidence            44556665565556666664  37888888 331 1   2233466777788777643 33332  22232322  4588


Q ss_pred             EEeccCC-------------------CHHHHHHHcC------C-------CCCHHHHHHHHHHH--------------HH
Q 015592           81 VIDLLGP-------------------SLEDLFNFCS------R-------KLSLKTVLMLADQM--------------IN  114 (404)
Q Consensus        81 v~e~~~~-------------------sL~~~l~~~~------~-------~l~~~~~~~i~~qi--------------~~  114 (404)
                      +|++..|                   +|.++|....      .       .....++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            8888744                   2222221110      0       01111222222222              12


Q ss_pred             HHHHHHhC--------CceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592          115 RVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus       115 aL~~LH~~--------givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      -..+|+.+        .++|+|+.+.||++.   ..+-+=|.||+++..
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l  228 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence            23455542        589999999999994   555588999999864

>PRK06148 hypothetical protein; Provisional

Probab=95.82  E-value=0.17  Score=55.48  Aligned_cols=47  Identities=11%  Similarity=0.143  Sum_probs=33.8

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG   61 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~   61 (404)
                      +.|+ |..-.+|+... .+++.+++|+.+.......+..|.+++..|..
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~   77 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA   77 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence            4554 45577898874 56778999998876555567778888887754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.74  E-value=0.034  Score=53.23  Aligned_cols=59  Identities=24%  Similarity=0.280  Sum_probs=44.2

Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCccccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMG  137 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlKp~NILl~  137 (404)
                      ..+++.+|. |-++..+++.  ...+++-...++.-.+.||-.+- -.+++|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            457777888 7788888873  34566667777776777765444 46899999999999995

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.68  E-value=0.084  Score=49.93  Aligned_cols=131  Identities=16%  Similarity=0.197  Sum_probs=75.5

Q ss_pred             CceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCcee-------EeeeeCC--eEEEEEecc-CCC
Q 015592           19 SFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLR-------WFGVEGD--YNVLVIDLL-GPS   88 (404)
Q Consensus        19 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~-------~~~~~~~--~~~lv~e~~-~~s   88 (404)
                      .-..||+... ..| .+++|+........++..|...+..|....+.+..-       ....-..  +.+-+.+++ |..
T Consensus        37 ~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            4557898884 333 449999887756667889999999887544322211       1111122  556666666 555


Q ss_pred             HHH-----H----------HHHcCC-----------CCCHH----H---------HHHHHHHHHHHHHHHHh--------
Q 015592           89 LED-----L----------FNFCSR-----------KLSLK----T---------VLMLADQMINRVEFVHS--------  121 (404)
Q Consensus        89 L~~-----~----------l~~~~~-----------~l~~~----~---------~~~i~~qi~~aL~~LH~--------  121 (404)
                      +..     .          ++...+           ...|.    .         -.....++...+..+.+        
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            541     1          111111           11222    0         01123344455555554        


Q ss_pred             CC--ceeccCCCCcccccCCCCCC-eEEEEecCCcc
Q 015592          122 KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK  154 (404)
Q Consensus       122 ~g--ivHrDlKp~NILl~~~~~~~-~vkL~DFG~a~  154 (404)
                      -+  +||+|+.|.||++   +.+. .+.++||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeE---cCCCCeeeEEEccccc
Confidence            23  9999999999999   3444 47899999774

>PTZ00384 choline kinase; Provisional

Probab=95.51  E-value=0.31  Score=47.24  Aligned_cols=71  Identities=14%  Similarity=0.117  Sum_probs=43.7

Q ss_pred             EeeeeceeCceeEEEEEEcCC-Cc-----EEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           11 LGRKIGSGSFGEIYLGTNIQT-NE-----EVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~-~~-----~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..+.|..|-...+|++..... +.     .|.+++..... ..-.-.+|.++++.+....+-+.+...+..    +++.+
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            344565688889999975332 12     24444421111 112346799999999988888887666542    47777


Q ss_pred             cc
Q 015592           84 LL   85 (404)
Q Consensus        84 ~~   85 (404)
                      |.
T Consensus       130 fI  131 (383)
T PTZ00384        130 WV  131 (383)
T ss_pred             Ee
Confidence            76

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.48  E-value=0.24  Score=46.54  Aligned_cols=29  Identities=24%  Similarity=0.457  Sum_probs=25.6

Q ss_pred             CceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       123 givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +++|+|+.+.|||+   +.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence            79999999999999   567788999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00296 choline kinase; Provisional

Probab=93.45  E-value=1.3  Score=43.90  Aligned_cols=71  Identities=14%  Similarity=0.025  Sum_probs=45.2

Q ss_pred             EeeeeceeCceeEEEEEEcC--------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      -.+.|..|=.-.+|++....        .++.|.+++...... .-.-..|..+++.+....+-+.+.....    .+.+
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            45566667777899987532        156899998654332 2245679999999987766666654332    2345


Q ss_pred             Eecc
Q 015592           82 IDLL   85 (404)
Q Consensus        82 ~e~~   85 (404)
                      .+|.
T Consensus       185 ~efi  188 (442)
T PTZ00296        185 EEWL  188 (442)
T ss_pred             EEee
Confidence            6666

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.46  E-value=0.92  Score=40.35  Aligned_cols=71  Identities=17%  Similarity=0.301  Sum_probs=49.2

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCceeEeeeeCCeEEEEEecc
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .+.+.-|..-+.|...+  ...++-||+-. ......+..|+.-|+.|...+  .|+.+...+......|+||+|+
T Consensus        21 r~~v~gG~inea~~v~d--g~~~~FvK~n~-~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          21 REEVSGGDINEAWRLRD--GTDPFFVKCNQ-REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             ccccCCccccceeEeec--CCcceEEEecc-hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            34455555555666653  44678888632 233456888999888887665  4566777788889999999998

>PHA03111 Ser/Thr kinase; Provisional

Probab=91.76  E-value=0.24  Score=46.23  Aligned_cols=62  Identities=23%  Similarity=0.201  Sum_probs=37.8

Q ss_pred             eEEEEEeccCCCHHHHH----HHcCCCCCHHHHHHHHHHHHHHHHHHHh----CCceeccCCCCcccccC
Q 015592           77 YNVLVIDLLGPSLEDLF----NFCSRKLSLKTVLMLADQMINRVEFVHS----KSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l----~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~givHrDlKp~NILl~~  138 (404)
                      ..++++.+.-++-..+-    .+.+-.--.+-+..+..||+.-.-.+-.    ..++|-||||+|||+-.
T Consensus       249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            35677777644332221    1112112234577788898776544533    36999999999999953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	404
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		0.0
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-136
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-136
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-136
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		2e-96
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		1e-95
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		4e-95
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		4e-95
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		3e-94
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		4e-94
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-93
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-26
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		6e-26
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		6e-26
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		7e-26
2jii_A	352	Structure Of Vaccinia Related Kinase 3 Length = 352		4e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-06
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		7e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-05
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-04

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score =  639 bits (1648), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 304/379 (80%), Positives = 328/379 (86%), Gaps = 2/379 (0%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT            V+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 STXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 360
           ++                      DRQSG +EGR +GWSS D  RRR   P+ +   L+K
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAK 358
Query: 361 QKSPMANDPAFSKDAMVST 379
           QK+P+ ND +FSK+ ++S 
Sbjct: 359 QKAPVGNDASFSKEPVISA 377

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score =  482 bits (1241), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 221/298 (74%), Positives = 259/298 (86%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA T            +ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score =  481 bits (1238), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 220/294 (74%), Positives = 257/294 (87%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 3   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA T            +ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score =  480 bits (1235), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 219/294 (74%), Positives = 257/294 (87%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL  E+K YK++Q
Sbjct: 3   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 62
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA T            +ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294
           C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score =  349 bits (895), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 165/289 (57%), Positives = 211/289 (73%), Gaps = 2/289 (0%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           +G  FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L    G
Sbjct: 2   MGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLSATEG 61
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           +P + +FG  G YN +V++LLGPSLEDLF+ C R  +LKTVLM+A Q+I R+E+VH+KS 
Sbjct: 62  VPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHTKSL 121
Query: 125 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RD+KP+NFL+G    +R + ++IIDFGLAK Y D  T +HIPYRE+K+LTGTARY S+
Sbjct: 122 IYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSI 181
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T             +T IE LC 
Sbjct: 182 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 241
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 291
            +P E A+Y  Y R L F +KPDY YL++LF DLF R GF FDY +DW 
Sbjct: 242 NFPEEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRSGFVFDYEYDWA 290

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score =  346 bits (888), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 170/288 (59%), Positives = 214/288 (74%), Gaps = 3/288 (1%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L  G G
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IP + +FG  G YN +V++LLGPSLEDLF+ C R  SLKTVLM+A Q+I+R+E+VHSK+ 
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 125 LHRDIKPDNFLMGL-GRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RD+KP+NFL+G  G +  QV +IIDFGLAK Y D  T +HIPYRE+K+LTGTARY S+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T             +T IE LC 
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 246
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 290
            +P E A+Y  Y R L F +KPDY YL++LF DLF R+G+ FDY +DW
Sbjct: 247 NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score =  344 bits (883), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 169/288 (58%), Positives = 213/288 (73%), Gaps = 3/288 (1%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L  G G
Sbjct: 28  VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG 87
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IP + +FG  G YN +V++LLGPSLEDLF+ C R  SLKTVLM+A Q+I+R+E+VHSK+ 
Sbjct: 88  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 147
Query: 125 LHRDIKPDNFLMGL-GRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RD+KP+NFL+G  G +  QV +IIDF LAK Y D  T +HIPYRE+K+LTGTARY S+
Sbjct: 148 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 207
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T             +T IE LC 
Sbjct: 208 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 267
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 290
            +P E A+Y  Y R L F +KPDY YL++LF DLF R+G+ FDY +DW
Sbjct: 268 NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 314

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score =  344 bits (883), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 169/288 (58%), Positives = 213/288 (73%), Gaps = 3/288 (1%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L  G G
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IP + +FG  G YN +V++LLGPSLEDLF+ C R  SLKTVLM+A Q+I+R+E+VHSK+ 
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 125 LHRDIKPDNFLMGL-GRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RD+KP+NFL+G  G +  QV +IIDF LAK Y D  T +HIPYRE+K+LTGTARY S+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T             +T IE LC 
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 246
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 290
            +P E A+Y  Y R L F +KPDY YL++LF DLF R+G+ FDY +DW
Sbjct: 247 NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score =  342 bits (876), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 166/291 (57%), Positives = 205/291 (70%), Gaps = 2/291 (0%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  +++GR+IG GSFG I+ GTN+  N++VAIK E  ++  PQL+ E + YK+L G TG
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS 
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 125 LHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RDIKPDNFL+G    + AN +Y++DFG+ K YRD  T QHIPYRE KNL+GTARY S+
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T             ST +  LC 
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
           G+P EF  Y HY R+L FD  PDY YL+ LF  +  R     D  FDW +L
Sbjct: 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score =  341 bits (875), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 166/291 (57%), Positives = 205/291 (70%), Gaps = 2/291 (0%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  +++GR+IG GSFG I+ GTN+  N++VAIK E  ++  PQL+ E + YK+L G TG
Sbjct: 7   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 66
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS 
Sbjct: 67  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 126
Query: 125 LHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RDIKPDNFL+G    + AN +Y++DFG+ K YRD  T QHIPYRE KNL+GTARY S+
Sbjct: 127 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 186
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T             ST +  LC 
Sbjct: 187 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 246
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
           G+P EF  Y HY R+L FD  PDY YL+ LF  +  R     D  FDW +L
Sbjct: 247 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 297

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score =  340 bits (871), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 161/286 (56%), Positives = 211/286 (73%), Gaps = 3/286 (1%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL-QGGTGIPN 67
            R+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L   G G+P 
Sbjct: 2   MRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQ 61
Query: 68  LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
           + +FG  G YN +V++LLGPSLEDLF+ C R  +LKTVLM+A Q+++R+E+VHSK+ ++R
Sbjct: 62  VYYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNLIYR 121
Query: 128 DIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           D+KP+NFL+G    ++ + ++IIDFGLAK Y D  T +HIPYRE+K+LTGTARY S+NTH
Sbjct: 122 DVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTH 181
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGYP 245
           LG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T             +T IEALC  +P
Sbjct: 182 LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRNTPIEALCENFP 241
Query: 246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 291
            E A+Y  Y R L F +KPDY YL+ LF DLF ++G+ FDY +DW 
Sbjct: 242 EEMATYLRYVRRLDFFEKPDYEYLRTLFTDLFEKKGYTFDYAYDWV 287

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 140/292 (47%), Gaps = 28/292 (9%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGT- 63
           GN++ LG+KIGSG FG IYL       E+ A  +  V+  ++  L  E K Y+ +     
Sbjct: 36  GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 64  -------------GIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 106
                        GIP     G+       Y  +V++ LG  L+ + +  +      TVL
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI-SGQNGTFKKSTVL 154
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
            L  +M++ +E++H   ++H DIK  N L+G  +  +QVY+ D+GL+ RY     H+   
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQ-- 211
Query: 167 YREN--KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW-QGLKAGTXXX 223
           Y+EN  K   GT  + S++ H G+  SRR D+E LGY ++ +L G LPW Q LK      
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271
Query: 224 XXXXXXXXXVSTSI--EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273
                    +  S+   A       E A +     SL +D+KP+Y  LK++ 
Sbjct: 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 146/314 (46%), Gaps = 29/314 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK----- 57
            ++++G  IG G FG IYL  ++ ++E V      V    P     L  E K Y+     
Sbjct: 35  KEWKVGLPIGQGGFGCIYL-ADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93
Query: 58  -ILQGGTGIPNLRWFGVEG------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
             +Q       L++ GV               Y  +++D  G  L+ ++   +++ S KT
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
           VL L+ ++++ +E++H   ++H DIK  N L+   +  +QVY++D+GLA RY     H+ 
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKE 212
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ-GLKAGTXXX 223
                 +   GT  + S++ H G+  SRR DLE LGY ++ +L G LPW+  LK      
Sbjct: 213 YKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272
Query: 224 XXXXXXXXXVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280
                    +++ ++  C   +  P E A Y    + L + +KP Y  L+ +        
Sbjct: 273 DSKIRYRENIASLMDK-CFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331
Query: 281 GFQFDYVFDWTILK 294
           G + D   D ++++
Sbjct: 332 GSKDDGKLDLSVVE 345

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 146/313 (46%), Gaps = 29/313 (9%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK------ 57
           ++++G  IG G FG IYL  ++ ++E V      V    P     L  E K Y+      
Sbjct: 36  EWKVGLPIGQGGFGCIYL-ADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 58  ILQGGTGIPNLRWFGVEG------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV 105
            +Q       L++ GV               Y  +++D  G  L+ ++   +++ S KTV
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
           L L+ ++++ +E++H   ++H DIK  N L+   +  +QVY++D+GLA RY     H+  
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKEY 213
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ-GLKAGTXXXX 224
                +   GT  + S++ H G+  SRR DLE LGY ++ +L G LPW+  LK       
Sbjct: 214 KEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273
Query: 225 XXXXXXXXVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281
                   +++ ++  C   +  P E A Y    + L + +KP Y  L+ +        G
Sbjct: 274 SKIRYRENIASLMDK-CFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332
Query: 282 FQFDYVFDWTILK 294
            + D   D ++++
Sbjct: 333 SKDDGKLDLSVVE 345

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 143/311 (45%), Gaps = 27/311 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK------I 58
           +++G  IG G FG IYL  ++ ++E V      V    P     L  E K Y+       
Sbjct: 37  WKVGLPIGQGGFGCIYL-ADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 59  LQGGTGIPNLRWFGVEG------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 106
           +Q       L++ GV               Y  +++D  G  L+ ++   +++ S KTVL
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
            L+ ++++ +E++H   ++H DIK  N L+   +  +QVY++D+GLA RY     H+   
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ-GLKAGTXXXXX 225
               +   GT  + S++ H G+  SRR DLE LGY ++ +L G LPW+  LK        
Sbjct: 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274
Query: 226 XXXXXXXVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283
                  +++ ++        P E A Y    + L + +KP Y  L+ +        G +
Sbjct: 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334
Query: 284 FDYVFDWTILK 294
            D   D ++++
Sbjct: 335 DDGKLDLSVVE 345

>pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 14/226 (6%)
Query: 64  GIPNLRWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHS 121
            IP    FGV  D Y  LV+  LG SL+   +   +  LS ++VL +A ++++ +EF+H 
Sbjct: 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARY 179
             ++H ++  +N  +      +QV +  +G A RY    + +H+ Y E       G   +
Sbjct: 178 NEYVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRY--CPSGKHVAYVEGSRSPHEGDLEF 234
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 239
            SM+ H G   SRR DL+SLGY ++ +L G LPW      T                   
Sbjct: 235 ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG 294
Query: 240 LCRGY--PTE-FASYFHYCRSLRFDDKPDYAYLKR----LFRDLFI 278
            C  +  P+E    Y     +L +++KP YA L+     L +DL +
Sbjct: 295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGT 63
           + + F   RK+GSG+FG+++L     +  E  IK  N  +++ P  Q EA++ ++L+   
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI-EVLKSLD 78
Query: 64  GIPNLRWFGVEGDYNVLVIDLL----GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVE 117
               ++ F V  DY+ + I +     G  LE + +  +R   LS   V  L  QM+N + 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HS+  +H+D+KP+N L       + + IIDFGLA+ ++   + +H     + N  GTA
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEH-----STNAAGTA 190
Query: 178 RYASMNTHLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQG 215
            Y      +  E  +RD     D+ S G V+ + L G LP+ G
Sbjct: 191 LY------MAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 128 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 175
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 128 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTDLCGTL 175
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 93
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 94  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 148
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 149 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRDDLCGTL 196
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTDLCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 123
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L+GT 
Sbjct: 124 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------CHAPSSRRTTLSGTL 171
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 123
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 124 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTDLCGTL 171
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTDLCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRDDLCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTELCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 93
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 94  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 148
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 149 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 196
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 128 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 175
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 123
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 124 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRDTLCGTL 171
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 84
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 85  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 139
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 140 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 187
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 126
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 127 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 174
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 69
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 70  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 124
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 125 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRXXLCGTL 172
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 66
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 67  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 121
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 122 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 169
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRAALCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++    Q  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEI----QSH 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRXXLCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTXLCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRAALCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++    Q  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEI----QSH 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRXXLCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q    +A+K      LE    +H QL+ E ++   L+  
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 64
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 65  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 119
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 120 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 167
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 69
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 70  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 124
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I +FG +          H P      L GT 
Sbjct: 125 YCHSKRVIHRDIKPENLLLG---SAGELKIANFGWS---------VHAPSSRRTTLCGTL 172
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 25  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +K ++ +A Q    ++++H+KS 
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLA-KRYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +      N V I DFGLA ++ R + +HQ       + L+G+  + +  
Sbjct: 142 IHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQF------EQLSGSILWMAPE 192
Query: 184 THLGIEQSR----RDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 239
             + ++ S     + D+ + G VL   + G LP+  +                +S  +  
Sbjct: 193 V-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIEMVGRGSLSPDLSK 249
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 276
           +    P         C   + D++P +    A ++ L R+L
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L     G   ++L      K   +       ++ N + 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALS 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 128 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTL 175
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I +FG +          H P      L GT 
Sbjct: 126 YCHSKRVIHRDIKPENLLLG---SAGELKIANFGWS---------VHAPSSRRTTLCGTL 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L     G   ++L      K   +       ++ N + 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALS 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 128 YCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRXXLXGTL 175
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL     +   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L      K   +       ++ N + 
Sbjct: 68  ---PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALS 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT 
Sbjct: 123 YCHSKKVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRAALCGTL 170
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 27/281 (9%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 13  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 69
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +K ++ +A Q    ++++H+KS 
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +      N V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 130 IHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 180
Query: 184 THLGIEQSR----RDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 239
             + ++ S     + D+ + G VL   + G LP+  +                +S  +  
Sbjct: 181 V-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIEMVGRGSLSPDLSK 237
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 276
           +    P         C   + D++P +    A ++ L R+L
Sbjct: 238 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLEN-VKTKHP-QLQYEAKLYKIL 59
           P++ N F++  KIG G+F  +YL T  +Q   E  I L++ + T HP ++  E +   + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
            G   +  +++   + D+ V+ +  L   S  D+ N     LS + V      +   ++ 
Sbjct: 77  GGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKR 132
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +H    +HRD+KP NFL    RR  +  ++DFGLA+   DT
Sbjct: 133 IHQFGIVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTHDT 171

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 25  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +K ++ +A Q    ++++H+KS 
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLA-KRYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +      N V I DFGLA ++ R + +HQ       + L+G+  + +  
Sbjct: 142 IHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQF------EQLSGSILWMAPE 192
Query: 184 THLGIEQSR----RDDLESLGYVLMYFLRGSLPWQGL 216
             + ++ S     + D+ + G VL   + G LP+  +
Sbjct: 193 V-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L    SR    +T   + + + N + 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITE-LANALS 126
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G      ++ I DFG +          H P      L GT 
Sbjct: 127 YCHSKRVIHRDIKPENLLLG---SNGELKIADFGWS---------VHAPSSRRDTLCGTL 174
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+  
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  TGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              PN LR +G   D    Y +L    LG    +L    SR    +T   + + + N + 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYITE-LANALS 126
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + HSK  +HRDIKP+N L+G      ++ I DFG +          H P      L GT 
Sbjct: 127 YCHSKRVIHRDIKPENLLLG---SNGELKIADFGWS---------VHAPSSRRTTLCGTL 174
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y       G     + DL SLG +   FL G  P++ 
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 20/277 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQ-YEAKLYKILQ- 60
           +  ++++  K+G G    +YL  +   N +VAIK   +  + K   L+ +E +++   Q 
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
               I ++     E D   LV++ + GP+L +        LS+ T +   +Q+++ ++  
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHA 127
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H    +HRDIKP N L+   +    + I DFG+AK   +T+  Q        ++ GT +Y
Sbjct: 128 HDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQ------TNHVLGTVQY 178
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 239
            S     G       D+ S+G VL   L G  P+ G  A +            V+T +  
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR- 237
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
             +  P   ++     R+   D    Y  ++ +  DL
Sbjct: 238 --KDIPQSLSNVI--LRATEKDKANRYKTIQEMKDDL 270

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT- 44
           + +++ LG  +G G   E++L  +++ + +VA+K+                   +N    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
            HP +     +Y   +  T    L +  +E       +D  G +L D+ +        + 
Sbjct: 70  NHPAI---VAVYDTGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRA 118
Query: 105 VLMLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + ++AD  Q +N   F H    +HRD+KP N L+      N V ++DFG+A+   D+   
Sbjct: 119 IEVIADACQALN---FSHQNGIIHRDVKPANILISA---TNAVKVVDFGIARAIADSGNS 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 173 ----VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           ++++  R +G GSFGE+ L  +  T +E A+K+        KT    L  E +L K L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
              +    +F  +G + ++     G  L D     SRK  S      +  Q+++ + ++H
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYMH 149
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    +   + IIDFGL+  +  +        ++ K+  GTA Y 
Sbjct: 150 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDKIGTAYYI 201
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +     G     + D+ S G +L   L G  P+ G
Sbjct: 202 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 235

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           ++++  R +G GSFGE+ L  +  T +E A+K+        KT    L  E +L K L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
              +    +F  +G + ++     G  L D     SRK  S      +  Q+++ + ++H
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYMH 166
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    +   + IIDFGL+  +  +        ++ K+  GTA Y 
Sbjct: 167 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDKIGTAYYI 218
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +     G     + D+ S G +L   L G  P+ G
Sbjct: 219 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 252

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT- 44
           + +++ LG  +G G   E++L  +++ + +VA+K+                   +N    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
            HP +     +Y   +  T    L +  +E       +D  G +L D+ +        + 
Sbjct: 70  NHPAI---VAVYDTGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRA 118
Query: 105 VLMLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + ++AD  Q +N   F H    +HRD+KP N ++      N V ++DFG+A+   D+   
Sbjct: 119 IEVIADACQALN---FSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNS 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 173 ----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           ++++  R +G GSFGE+ L  +  T +E A+K+        KT    L  E +L K L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
              +    +F  +G + ++     G  L D     SRK  S      +  Q+++ + ++H
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYMH 167
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    +   + IIDFGL+  +  +        ++ K+  GTA Y 
Sbjct: 168 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDKIGTAYYI 219
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +     G     + D+ S G +L   L G  P+ G
Sbjct: 220 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 253

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT- 44
           + +++ LG  +G G   E++L  +++ + +VA+K+                   +N    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
            HP +     +Y   +  T    L +  +E       +D  G +L D+ +        + 
Sbjct: 70  NHPAI---VAVYDTGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRA 118
Query: 105 VLMLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + ++AD  Q +N   F H    +HRD+KP N ++      N V ++DFG+A+   D+   
Sbjct: 119 IEVIADACQALN---FSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNS 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 173 ----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           ++++  R +G GSFGE+ L  +  T +E A+K+        KT    L  E +L K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
              +    +F  +G + ++     G  L D     SRK  S      +  Q+++ + ++H
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    +   + IIDFGL+  +  +        ++ K+  GTA Y 
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDKIGTAYYI 195
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +     G     + D+ S G +L   L G  P+ G
Sbjct: 196 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
           ++++  R +G GSFGE+ L  +  T +E A+K+        KT    L  E +L K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 62  GTGIPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFV 119
              I  L  F  +  Y  LV ++  G  L D     SRK  S      +  Q+++ + + 
Sbjct: 86  -PNIXKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYX 142
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H    +HRD+KP+N L+    +   + IIDFGL+  +  +        ++ K+  GTA Y
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKXKDKIGTAYY 194
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            +     G     + D+ S G +L   L G  P+ G
Sbjct: 195 IAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT- 44
           + +++ LG  +G G   E++L  +++ + +VA+K+                   +N    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
            HP +     +Y   +  T    L +  +E       +D  G +L D+ +        + 
Sbjct: 70  NHPAI---VAVYATGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRA 118
Query: 105 VLMLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + ++AD  Q +N   F H    +HRD+KP N ++      N V ++DFG+A+   D+   
Sbjct: 119 IEVIADACQALN---FSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNS 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 173 ----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT- 44
           + +++ LG  +G G   E++L  +++ + +VA+K+                   +N    
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
            HP +     +Y   +  T    L +  +E       +D  G +L D+ +        + 
Sbjct: 70  NHPAI---VAVYDTGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRA 118
Query: 105 VLMLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + ++AD  Q +N   F H    +HRD+KP N ++      N V ++DFG+A+   D+   
Sbjct: 119 IEVIADACQALN---FSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNS 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                 +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 173 ----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 43/231 (18%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT-KH 46
           +++ LG  +G G   E++L  +++ + +VA+K+                   +N     H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 47  PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 106
           P +     +Y   +  T    L +  +E       +D  G +L D+ +        + + 
Sbjct: 89  PAI---VAVYDTGEAETPAGPLPYIVME------YVD--GVTLRDIVHTEGPMTPKRAIE 137
Query: 107 MLAD--QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
           ++AD  Q +N   F H    +HRD+KP N ++      N V ++DFG+A+   D+     
Sbjct: 138 VIADACQALN---FSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNS-- 189
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
               +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 190 --VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 29  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 85
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLA-KRYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA ++ R + +HQ       + L+G+  + +  
Sbjct: 146 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQF------EQLSGSILWMAPE 196
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 197 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 9   QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLA-KRYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA ++ R + +HQ       + L+G+  + +  
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQF------EQLSGSILWMAPE 176
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 37  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLA-KRYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA ++ R + +HQ       + L+G+  + +  
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQF------EQLSGSILWMAPE 204
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 14  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 181
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 11  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 67
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 128 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 178
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 14  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 181
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 9   QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 176
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++ + P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 68  VSSGFSGVIRLLDWFE-RPDSFVLILERMEP-VQDLFDFITERGALQEELARSFFWQVLE 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 169

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 37  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 204
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T  EVAIK+ +    +P    +L  E ++ K
Sbjct: 8   QPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 66
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMIN 114
           IL      PN+ + F V      L + +   S  ++F++     ++  K       Q+++
Sbjct: 67  ILNH----PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            V++ H K  +HRD+K +N L+        + I DFG +  +                  
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDADM---NIKIADFGFSNEFTVGGKLD--------TFC 171
Query: 175 GTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
           G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 36  QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 92
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 153 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 203
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 204 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIP 66
           +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ LQ       +L+    + 
Sbjct: 9   QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L + G      + ++     G SL    +    K  +  ++ +A Q    ++++H+KS 
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQHIPYRENKNLTGTARYASMN 183
           +HRD+K +N  +        V I DFGLA  + R + +HQ       + L+G+  + +  
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQF------EQLSGSILWMAPE 176
Query: 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGL 216
                ++   S + D+ + G VL   + G LP+  +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
           +P +GN +RL + IG G+F ++ L  ++ T  EVA+K+ +    +P    +L  E ++ K
Sbjct: 11  QPHIGN-YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           IL      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 70  ILNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            V++ H K  +HRD+K +N L+        + I DFG +  +  T  ++           
Sbjct: 126 AVQYCHQKYIVHRDLKAENLLLD---GDMNIKIADFGFSNEF--TVGNKL------DTFC 174
Query: 175 GTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
           G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T  EVAIK+ +    +P    +L  E ++ K
Sbjct: 11  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMIN 114
           IL      PN+ + F V      L + +   S  ++F++     ++  K       Q+++
Sbjct: 70  ILNH----PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            V++ H K  +HRD+K +N L+        + I DFG +  +                  
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADM---NIKIADFGFSNEFTVGGKLD--------AFC 174
Query: 175 GTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
           G   YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQGGT 63
           F++G  +G GSF  +Y   +I T  EVAIK+ + K  +      ++Q E K++  L+  +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 64  GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            +    +F  + +Y  LV+++     +        +  S         Q+I  + ++HS 
Sbjct: 73  ILELYNYFE-DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             LHRD+   N L+    R   + I DFGLA + +       +P+ ++  L GT  Y S 
Sbjct: 132 GILHRDLTLSNLLL---TRNMNIKIADFGLATQLK-------MPHEKHYTLCGTPNYISP 181
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                       D+ SLG +    L G  P+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 83  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 184

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 84  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 185

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 97  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 198

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 83  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 184

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 84  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 185

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 97  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 198

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 103 VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 160
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 204

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 69  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 170

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 64  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 165

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 111 VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 168
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 212

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 96  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 197

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 97  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 198

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 96  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 197

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 96  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 197

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 97  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 198

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 84  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 185

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 111 VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 168
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 212

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 69  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 170

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 68  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 169

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 96  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 197

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 116 VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 173
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 69  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 170

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAIK+         + +   P L  + E ++ 
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 126
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 178
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAIK+         + +   P L  + E ++ 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 127
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 179
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAIK+         + +   P L  + E ++ 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 127
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 179
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 64  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 165

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 64  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 165

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 59  LQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G    I  L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 67  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 168

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAIK+         + +   P L  + E ++ 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 127
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 179
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAIK+         + +   P L  + E ++ 
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 133
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 185
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 17/188 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +++R   K+G G++GE+Y   +  TNE VAIK   LE+ +   P     E  L K LQ  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
               N+        +N  +  +   +  DL  +  +   +S++ +     Q+IN V F H
Sbjct: 94  ----NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTA---THQHIP--YRENKNL 173
           S+  LHRD+KP N L+ +   +    + I DFGLA+ +       TH+ I   YR  + L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 174 TGTARYAS 181
            G+  Y++
Sbjct: 210 LGSRHYST 217

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH-------PQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK +E  +           ++  E  L K 
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 59  LQGG-TGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMIN 114
           +  G +G+   L WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q++ 
Sbjct: 91  VSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 148
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 192

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+K ++  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-----DTATHQHIPYRE 169
            V++ H K  +HRD+K +N L+        + I DFG +  +      DT          
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEFTFGNKLDT---------- 171
Query: 170 NKNLTGTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
                G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 172 ---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+K ++  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-----DTATHQHIPYRE 169
            V++ H K  +HRD+K +N L+        + I DFG +  +      DT          
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEFTFGNKLDT---------- 171
Query: 170 NKNLTGTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
                G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 172 ---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAI++         + +   P L  + E ++ 
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 266
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 267 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 318
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQL--QYEAKLY 56
           +++ + + +GSG+ GE+ L    +T ++VAI++         + +   P L  + E ++ 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K L     I    +F  E  Y VL +   G   + +    +++L   T  +   QM+  V
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAV 252
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +++H    +HRD+KP+N L+        + I DFG +K   +T+          + L GT
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RTLCGT 304
Query: 177 ARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPW 213
             Y +    + +  +   R  D  SLG +L   L G  P+
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTK-HPQLQYEAKLYKILQGGTGIPNL 68
           +K+GSG++GE+ L  +  T+ E AIK+    +V T  + +L  E  + K+L     +   
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 69  RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHSKSFLH 126
            +F  + +Y +++    G    +LF+    ++    V   ++  Q+++ V ++H  + +H
Sbjct: 103 DFFEDKRNYYLVMECYKGG---ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD+KP+N L+    +   + I+DFGL+  + +         ++ K   GTA Y +    L
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--------KKMKERLGTAYYIAPEV-L 210
Query: 187 GIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
             +   + D+ S+G +L   L G  P+ G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+K ++  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            V++ H K  +HRD+K +N L+        + I DFG +  +  T  ++   +       
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEF--TFGNKLDAF------C 173
Query: 175 GTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
           G   YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+++ +  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-----DTATHQHIPYRE 169
            V++ H K  +HRD+K +N L+        + I DFG +  +      DT          
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEFTFGNKLDT---------- 171
Query: 170 NKNLTGTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
                G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 172 ---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+++ +  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L + +   S  ++F++      +K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK--N 172
            V++ H K  +HRD+K +N L+        + I DFG +  +             NK   
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEFTFG----------NKLDE 171
Query: 173 LTGTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
             G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L +++G+G FGE+++GT    N +VAIK     T  P+    EA++ K L+    +  
Sbjct: 11  LQLIKRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQL 69
Query: 68  LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
                 E  Y V      G  L+ L +   R L L  ++ +A Q+   + ++   +++HR
Sbjct: 70  YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASMNTH 185
           D++  N L+G G       I DFGLA+   D         R+     +  TA  A++   
Sbjct: 130 DLRSANILVGNGLICK---IADFGLARLIEDNEXTA----RQGAKFPIKWTAPEAALYGR 182
Query: 186 LGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
             I    + D+ S G +L   + +G +P+ G+                    +E + RGY
Sbjct: 183 FTI----KSDVWSFGILLTELVTKGRVPYPGMNN---------------REVLEQVERGY 223
Query: 245 --------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 284
                   P        +C     +++P + YL+    D F     Q+
Sbjct: 224 RMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQY 271

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 45/291 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 24  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 80
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 81  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 140 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 192
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 193 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 233
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 284
           RGY        P E       C   R +D+P + YL+ +  D F     QF
Sbjct: 234 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQF 284

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 94  FVKLYFTFQDDEKL----YFGLSYAKNGCLLKYIR-KIGSFDETCTR--------FYTAE 140
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 192
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +  GTA+Y S         S+  DL +LG ++   + G  P++ 
Sbjct: 193 SFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 67  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 124 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 175
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGG 62
           ++++L  ++G G+F  +     I T +E A K+ N K      H +L+ EA++ ++L+  
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH- 62
Query: 63  TGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             I  L     E  ++ LV DL+  G   ED+        S         Q++  V   H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIQQILESVNHCH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
               +HRD+KP+N L+    +   V + DFGLA
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MXGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQY---EAKLYK 57
           +P +GN +RL + IG G+F ++ L  +I T +EVA+K ++  +     LQ    E ++ K
Sbjct: 10  QPHIGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXK 68
Query: 58  ILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMIN 114
           +L      PN+ + F V      L +     S  ++F++       K     A   Q+++
Sbjct: 69  VLNH----PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            V++ H K  +HRD+K +N L+        + I DFG +  +  T  ++   +       
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDAD---XNIKIADFGFSNEF--TFGNKLDAF------C 173
Query: 175 GTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
           G   YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGG 62
           ++++L  ++G G+F  +     I T +E A K+ N K      H +L+ EA++ ++L+  
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH- 62
Query: 63  TGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             I  L     E  ++ LV DL+  G   ED+        S         Q++  V   H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIQQILESVNHCH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
               +HRD+KP+N L+    +   V + DFGLA
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 23  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 79
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 80  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 139 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 191
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 192 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 232
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 233 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---------------ENVKTKH 46
           E ++G  +   RK+GSG++GE+ L      + E AIK+               +N++  H
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 47  PQLQYEAKLYKILQGGTGIPNL-RWFGVEGD--YNVLVIDLL--GPSLEDLFNFCSRKLS 101
            ++  E  L K L      PN+ + F V  D  Y  LV +    G   E + N    K  
Sbjct: 91  EEIYNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFD 144
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY-RDTA 160
                 +  Q+++ + ++H  + +HRDIKP+N L+        + I+DFGL+  + +D  
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
               +         GTA Y +    L  + + + D+ S G ++   L G  P+ G
Sbjct: 205 LRDRL---------GTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
           + F +GR +G G FG +YL    Q    +A+K      LE    +H QL+ E ++    Q
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEI----Q 69
Query: 61  GGTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVE 117
                PN LR +    D   + + L      +L+    +  +   +      +++ + + 
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 129
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + H +  +HRDIKP+N LMG      ++ I DFG +          H P    + + GT 
Sbjct: 130 YCHERKVIHRDIKPENLLMGY---KGELKIADFGWS---------VHAPSLRRRXMCGTL 177
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            Y       G     + DL   G +   FL G  P+
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V+     G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 138 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 188
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 233
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 21  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 77
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 78  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 137 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 189
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 190 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 230
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 231 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V+     G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 138 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 188
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 233
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 71
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 72  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 131 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 183
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 184 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 224
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 71
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 72  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 131 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 183
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 184 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 224
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 17  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 73
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 74  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 133 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 185
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 186 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 226
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 227 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 16  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 72
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 73  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 132 IHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTA----REGAKFPIKWTAPEAIN 184
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 185 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 225
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 226 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 25  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 81
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 82  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 141 IHRDLRAANILVS---DTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAIN 193
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 194 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 234
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 235 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 278

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 21  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 77
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 78  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 137 IHRDLRAANILVS---DTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAIN 189
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 190 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 230
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 231 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           RD++  N L+G     N V  + DFGLA+   D        Y   +      ++ +    
Sbjct: 138 RDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAA 187
Query: 186 LGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
           L    + + D+ S G +L     +G +P+ G+                V   +E   RGY
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGY 232
Query: 245 ----PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
               P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKIL 59
           + ++++  +K+GSG++GE+ L  +  T  E AIK+         +    L  E  + K L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
                +    +F  + +Y +++    G  L D      +K S     ++  Q+++   ++
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H  + +HRD+KP+N L+    R   + I+DFGL+  +            + K   GTA Y
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKERLGTAYY 189
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            +    L  +   + D+ S G +L   L G  P+ G
Sbjct: 190 IAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 43/290 (14%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V+     G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASMN 183
           RD++  N L+G     N V  + DFGLA+   D         R+     +  TA  A++ 
Sbjct: 138 RDLRAANILVG----ENLVCKVADFGLARLIEDNEXTA----RQGAKFPIKWTAPEAALY 189
Query: 184 THLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
               I    + D+ S G +L     +G +P+ G+                V   +E   R
Sbjct: 190 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---R 230
Query: 243 GY----PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
           GY    P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 10  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 66
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 67  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 126 IHRDLRAANILVS---DTLSCKIADFGLARLIED----NEYTAREGAKFPIKWTAPEAIN 178
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 179 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 219
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 220 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 263

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 20  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 76
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 77  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 136 IHRDLRAANILVS---DTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAIN 188
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 189 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 229
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 230 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 273

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           +  + + +  ++G G+F  +    +  T  E A K+ N K        +L+ EA++ + L
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRV 116
           Q    I  L     E  ++ LV DL+  G   ED+    +R+  S         Q++  +
Sbjct: 62  QH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESI 117
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            + HS   +HR++KP+N L+    +   V + DFGLA    D+               GT
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAGT 169
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             Y S         S+  D+ + G +L   L G  P+
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           +  + + +  ++G G+F  +    +  T  E A K+ N K        +L+ EA++ + L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRV 116
           Q    I  L     E  ++ LV DL+  G   ED+    +R+  S         Q++  +
Sbjct: 63  QH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESI 118
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            + HS   +HR++KP+N L+    +   V + DFGLA    D+               GT
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAGT 170
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             Y S         S+  D+ + G +L   L G  P+
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 54/232 (23%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------------- 44
           +GN +++ + +G GSFG++ L  +  T ++VA+K+ N K                     
Sbjct: 12  IGN-YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 70
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
           +HP +    KLY +++    I             ++VI+  G    +LF++  +  K+S 
Sbjct: 71  RHPHI---IKLYDVIKSKDEI-------------IMVIEYAG---NELFDYIVQRDKMSE 111
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +       Q+I+ VE+ H    +HRD+KP+N L  L    N V I DFGL+    D    
Sbjct: 112 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLL--LDEHLN-VKIADFGLSNIMTDGNFL 168
Query: 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
                   K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 169 --------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 9   LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 66
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 67  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 127 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 177
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 222
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 223 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G+ GE+ L  N  T E VA+K+ ++K     P+ ++ E  + K+L     +
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 125 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 19/216 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           +  + + +  ++G G+F  +    +  T  E A K+ N K        +L+ EA++ + L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRV 116
           Q    I  L     E  ++ LV DL+  G   ED+    +R+  S         Q++  +
Sbjct: 63  QH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESI 118
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            + HS   +HR++KP+N L+    +   V + DFGLA    D+               GT
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAGT 170
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
             Y S         S+  D+ + G +L   L G  P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 54/232 (23%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------------- 44
           +GN +++ + +G GSFG++ L  +  T ++VA+K+ N K                     
Sbjct: 7   IGN-YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 65
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
           +HP +    KLY +++    I             ++VI+  G    +LF++  +  K+S 
Sbjct: 66  RHPHI---IKLYDVIKSKDEI-------------IMVIEYAG---NELFDYIVQRDKMSE 106
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +       Q+I+ VE+ H    +HRD+KP+N L  L    N V I DFGL+    D    
Sbjct: 107 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLL--LDEHLN-VKIADFGLSNIMTDGNFL 163
Query: 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
                   K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 164 --------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77
Query: 64  GIPNLRWFGVEGDYNVLVID-LLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
            I N     + GD   +V++ L G SL D+    C  +  +  V     + +  +EF+HS
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYA 180
              +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + 
Sbjct: 135 NQVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWM 183
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +           + D+ SLG + +  + G  P+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 54/232 (23%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------------- 44
           +GN +++ + +G GSFG++ L  +  T ++VA+K+ N K                     
Sbjct: 13  IGN-YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 71
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
           +HP +    KLY +++    I             ++VI+  G    +LF++  +  K+S 
Sbjct: 72  RHPHI---IKLYDVIKSKDEI-------------IMVIEYAG---NELFDYIVQRDKMSE 112
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +       Q+I+ VE+ H    +HRD+KP+N L  L    N V I DFGL+    D    
Sbjct: 113 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLL--LDEHLN-VKIADFGLSNIMTDGNFL 169
Query: 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
                   K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 170 --------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 54/232 (23%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------------- 44
           +GN +++ + +G GSFG++ L  +  T ++VA+K+ N K                     
Sbjct: 3   IGN-YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 45  KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
           +HP +    KLY +++    I             ++VI+  G    +LF++  +  K+S 
Sbjct: 62  RHPHI---IKLYDVIKSKDEI-------------IMVIEYAG---NELFDYIVQRDKMSE 102
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +       Q+I+ VE+ H    +HRD+KP+N L  L    N V I DFGL+    D    
Sbjct: 103 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLL--LDEHLN-VKIADFGLSNIMTDGNFL 159
Query: 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
                   K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 160 --------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 11  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 68
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 69  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 129 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 179
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 224
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 225 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 271

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77
Query: 64  GIPNLRWFGVEGDYNVLVID-LLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
            I N     + GD   +V++ L G SL D+    C  +  +  V     + +  +EF+HS
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYA 180
              +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + 
Sbjct: 135 NQVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSEMVGTPYWM 183
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +           + D+ SLG + +  + G  P+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77
Query: 64  GIPNLRWFGVEGDYNVLVID-LLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
            I N     + GD   +V++ L G SL D+    C  +  +  V     + +  +EF+HS
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYA 180
              +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + 
Sbjct: 135 NQVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSXMVGTPYWM 183
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +           + D+ SLG + +  + G  P+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGG 62
           ++++L   IG G+F  +     + T  E A K+ N K      H +L+ EA++ ++L+  
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH- 62
Query: 63  TGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           + I  L     E  ++ LV DL+  G   ED+        S         Q++  V   H
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
               +HRD+KP+N L+    +   V + DFGLA
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 71
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 72  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 131 IHRDLRAANILVS---DTLSCKIADFGLARLIED----NEYTAREGAKFPIKWTAPEAIN 183
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 184 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 224
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + ++L RK+G G + E++   NI  NE+V +K+     K  +++ E K+ + L+GG  I 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKNKIKREIKILENLRGGPNII 95
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------QMINRVEF 118
            L       D   +V D +  +   +F   +     +    L D        +++  +++
Sbjct: 96  TL------AD---IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            HS   +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQ-LQYEAKLYKILQGGTGI 65
           + L + +G G++GE+ L  N  T E VA+K+ ++K     P+ ++ E  +  +L     +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFVHSKS 123
              +++G   + N+  + L   S  +LF+     + +          Q++  V ++H   
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L  L  R N + I DFGLA  +R     + +    NK + GT  Y +  
Sbjct: 126 ITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----NK-MCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPW 213
                E  +   D+ S G VL   L G LPW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGGTGIPN-LR 69
           +G GSFGE+    +  T +E A+K+ N  +   +    +  E +L K L      PN ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH----PNIMK 85
Query: 70  WFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 127
            F + E   +  ++  L    E       RK  S      +  Q+ + + ++H  + +HR
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+KP+N L+    +   + IIDFGL+  ++           + K+  GTA Y +     G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG 197
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                + D+ S G +L   L G+ P+ G
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 138 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 188
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 233
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 78
Query: 64  GIPNLRWFGVEGDYNVLVID-LLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
            I N     + GD   +V++ L G SL D+    C  +  +  V     + +  +EF+HS
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYA 180
              +HRDIK DN L+G+      V + DFG           Q  P +  ++ + GT  + 
Sbjct: 136 NQVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSXMVGTPYWM 184
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +           + D+ SLG + +  + G  P+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGGTGIPN-LR 69
           +G GSFGE+    +  T +E A+K+ N  +   +    +  E +L K L      PN ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH----PNIMK 85
Query: 70  WFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 127
            F + E   +  ++  L    E       RK  S      +  Q+ + + ++H  + +HR
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+KP+N L+    +   + IIDFGL+  ++           + K+  GTA Y +     G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG 197
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                + D+ S G +L   L G+ P+ G
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 95  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 141
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 142 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 193
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +  GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 194 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQY---EAKLYKILQ 60
           +GN +RL + IG G+F ++ L  +I T +EVA+K ++  +     LQ    E ++ K+L 
Sbjct: 6   IGN-YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 61  GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--QMINRVE 117
                PN+ + F V      L + +   S  ++F++      +K     A   Q+++ V+
Sbjct: 65  H----PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-----DTATHQHIPYRENKN 172
           + H K  +HRD+K +N L+        + I DFG +  +      DT             
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADM---NIKIADFGFSNEFTFGNKLDT------------- 164
Query: 173 LTGTARYASMNTHLGIEQSRRD-DLESLGYVLMYFLRGSLPWQG 215
             G+  YA+     G +    + D+ SLG +L   + GSLP+ G
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           RD++  N L+G     N V  + DFGLA+   D        Y   +      ++ +    
Sbjct: 138 RDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAA 187
Query: 186 LGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
           L    + + D+ S G +L     +G +P+ G+                V   +E   RGY
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGY 232
Query: 245 ----PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
               P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           R  + ++L  ++G G+F  +         +E A K+ N K      H +L+ EA++ ++L
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +    I  L     E  ++ LV DL+  G   ED+        S         Q++  V 
Sbjct: 88  KH-PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIHQILESVN 144
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H    +HRD+KP+N L+    +   V + DFGLA   +           E +   G  
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG----------EQQAWFG-- 192
Query: 178 RYASMNTHLGIEQSRRD------DLESLGYVLMYFLRGSLP---------WQGLKAGT 220
            +A    +L  E  R+D      D+ + G +L   L G  P         +Q +KAG 
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGA 249

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 72  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 118
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 119 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 170
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 171 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGGT 63
           K+    KIG G++G ++   N +T+E VA+K   L++     P     E  L K L+   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-K 61
Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            I  L           LV +     L+  F+ C+  L  + V     Q++  + F HS++
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            LHRD+KP N L+    R  ++ + DFGLA+ +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLADFGLARAF 151

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNLRWFG 72
           +G G+   +    N+ T++E A+K+   +  H + +   E ++    QG   +  L  F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 73  VEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
            E D   LV + +  G  L  +     R  +     ++   + + ++F+H+K   HRD+K
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
           P+N L     + + V I DFGL    +       I   E     G+A Y +        +
Sbjct: 139 PENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 191 S-----RRDDLESLGYVLMYFLRGSLPWQG 215
                 +R DL SLG +L   L G  P+ G
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 69  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 115
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 116 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 167
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 168 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K ++    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKIRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 138 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 188
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 233
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKIL 59
           + ++++  +K+GSG++GE+ L  +  T  E AIK+         +    L  E  + K L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
                +    +F  + +Y +++    G  L D      +K S     ++  Q+++   ++
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H  + +HRD+KP+N L+    R   + I+DFGL+  +            + K   GTA Y
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKERLGTAYY 172
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            +    L  +   + D+ S G +L   L G  P+ G
Sbjct: 173 IAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 77
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD+   N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 138 RDLAAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 188
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 233
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R D  ++P + YL+    D F     Q+
Sbjct: 234 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQY 280

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 13  RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
            KIG G++G +Y   N   +T     I+LE      P     E  + K L+  + I  L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLY 66
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
                    VLV + L   L+ L + C   L   T      Q++N + + H +  LHRD+
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           KP N L+    R  ++ I DFGLA+ +        IP R+  +   T  Y + +  +G +
Sbjct: 127 KPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 190 Q-SRRDDLESLGYVLMYFLRGSLPWQGL 216
           + S   D+ S+G +    + G+  + G+
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------EN------------VKTKHPQ 48
           F+ G+ +G GSF  + L   + T+ E AIK+        EN             +  HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP- 89
Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
             +  KLY   Q    +    +FG+    N  ++  +   +      C+R          
Sbjct: 90  --FFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FY 134
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             ++++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----R 187
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            N +  GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 188 AN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 13  RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
            KIG G++G +Y   N   +T     I+LE      P     E  + K L+  + I  L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLY 66
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
                    VLV + L   L+ L + C   L   T      Q++N + + H +  LHRD+
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           KP N L+    R  ++ I DFGLA+ +        IP R+  +   T  Y + +  +G +
Sbjct: 127 KPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 190 Q-SRRDDLESLGYVLMYFLRGSLPWQGL 216
           + S   D+ S+G +    + G+  + G+
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGV 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 71  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 117
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 118 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 169
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 170 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 99  FVKLYFCFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 145
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 146 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 197
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 198 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 92  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 138
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 190
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 92  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 138
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 190
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 97  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 143
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 144 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 195
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 196 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           +  + + +  ++G G+F  +    +  T  E A K+ N K        +L+ EA++ + L
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRV 116
           Q    I  L     E  ++ LV DL+  G   ED+    +R+  S         Q++  +
Sbjct: 86  QH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESI 141
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            + HS   +HR++KP+N L+    +   V + DFGLA    D+               GT
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAGT 193
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             Y S         S+  D+ + G +L   L G  P+
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + IG+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P   D+F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPG-GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 243
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 304 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 354
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 399
Query: 245 ---PTEFASYFH--YCRSLRF--DDKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R   +++P + YL+    D F     Q+
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 94  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 140
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 192
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------EN------------VKTKHPQ 48
           F+ G+ +G GSF  + L   + T+ E AIK+        EN             +  HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP- 92
Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
             +  KLY   Q    +    +FG+    N  ++  +   +      C+R          
Sbjct: 93  --FFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FY 137
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             ++++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----R 190
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            N    GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 191 AN-XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 95  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 141
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 142 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 193
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 194 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 38/228 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 94  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 140
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 192
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
              GTA+Y S          +  DL +LG ++   + G  P++    G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + IG+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P   D+F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPG-GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 70  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 116
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 168
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 92  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 138
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RANA 191
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 192 -FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 13  RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
            KIG G++G +Y   N   +T     I+LE      P     E  + K L+  + I  L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLY 66
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
                    VLV + L   L+ L + C   L   T      Q++N + + H +  LHRD+
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           KP N L+    R  ++ I DFGLA+ +        IP R+  +   T  Y + +  +G +
Sbjct: 127 KPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 190 Q-SRRDDLESLGYVLMYFLRGSLPWQGL 216
           + S   D+ S+G +    + G+  + G+
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 94  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 140
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 192
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 326
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 327 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 127 RDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           RD++  N L+G     N V  + DFGLA+   D        Y   +      ++ +    
Sbjct: 387 RDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAA 436
Query: 186 LGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
           L    + + D+ S G +L     +G +P+ G+                V   +E   RGY
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGY 481
Query: 245 ----PTEFASYFH--YCRSLR--FDDKPDYAYLKRLFRDLF 277
               P E     H   C+  R   +++P + YL+    D F
Sbjct: 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------EN------------VKTKHPQ 48
           F+ G+ +G GSF  + L   + T+ E AIK+        EN             +  HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP- 74
Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
             +  KLY   Q    +    +FG+    N  ++  +   +      C+R          
Sbjct: 75  --FFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FY 119
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             ++++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----R 172
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            N    GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 173 AN-XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 38/228 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF  + L   + T+ E AIK+   +      K P +  E           
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 94  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 140
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 192
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
              GTA+Y S          +  DL +LG ++   + G  P++    G
Sbjct: 193 XFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 243
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 304 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 354
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 399
Query: 245 ---PTEFASYFH--YCRSLRF--DDKPDYAYLKRLFRDLF 277
              P E     H   C+  R   +++P + YL+    D F
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-----QLQYEAKLYKIL 59
           ++RLG  +G G FG ++ G  +    +VAIK+     V    P         E  L   +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 60  QGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMI 113
             G G P     L WF  +  + +LV++   P+ +DLF++ + K  L          Q++
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
             ++  HS+  +HRDIK +N L+ L R   +  +IDFG      D
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAK--LIDFGSGALLHD 192

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 13  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 70
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 71  LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 130
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 131 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 181
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 226
Query: 245 ---PTEFASYFH--YCRSLR--FDDKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R   +++P + YL+    D F     Q+
Sbjct: 227 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 273

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------EN------------VKTKHPQ 48
           F+ G+ +G GSF  + L   + T+ E AIK+        EN             +  HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP- 89
Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
             +  KLY   Q    +    +FG+    N  ++  +   +      C+R          
Sbjct: 90  --FFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FY 134
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
             ++++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----R 187
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            N    GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 188 AN-XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 11  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 67
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 68  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HR+++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 127 IHRNLRAANILVS---DTLSCKIADFGLARLIED----NEYTAREGAKFPIKWTAPEAIN 179
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 180 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 220
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 221 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 264

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNL-RWF 71
           +G G++ ++    ++Q  +E A+K+   +  H + +   E +     QG   I  L  +F
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 72  GVEGDYNVLVIDLLGPSL----EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
             +  + ++   L G S+    +   +F  R+ S      +   +   ++F+H+K   HR
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREAS-----RVVRDVAAALDFLHTKGIAHR 135
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY-ASMNTHL 186
           D+KP+N L     + + V I DF L    +   +   I   E     G+A Y A     +
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 187 GIEQS----RRDDLESLGYVLMYFLRGSLPWQG 215
             +Q+    +R DL SLG VL   L G  P+ G
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 11/211 (5%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAKLYKILQGGTG 64
            ++  L  +IGSGSFG +Y G   + + +VA+K+  V    P Q Q       +L+    
Sbjct: 35  ASEVMLSTRIGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 65  IPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           +  L + G     N+ ++     G SL    +    K  +  ++ +A Q    ++++H+K
Sbjct: 92  VNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           + +HRD+K +N  +  G     V I DFGLA      +  Q +       L        M
Sbjct: 152 NIIHRDMKSNNIFLHEGL---TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             +     S + D+ S G VL   + G LP+
Sbjct: 209 QDNNPF--SFQSDVYSYGIVLYELMTGELPY 237

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQ-LQYEAKLYKILQGGTGIPN-LR 69
           +G GSFGE+    +  T +E A+K+ N    K K    +  E +L K L      PN ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH----PNIMK 85
Query: 70  WFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 127
            F + E   +  ++  L    E       RK  S      +  Q+ + + ++H  + +HR
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+KP+N L+    +   + IIDFGL+  ++           + K+  GTA Y +     G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG 197
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                + D+ S G +L   L G+ P+ G
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + IG+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 114/284 (40%), Gaps = 45/284 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L  ++G+G  GE+++G     + +VA+K     +  P     EA L K LQ    +  
Sbjct: 15  LKLVERLGAGQAGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV-- 71
Query: 68  LRWFGVEGDYNVLVID--LLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
            R + V     + +I   +   SL D     S  KL++  +L +A Q+   + F+  +++
Sbjct: 72  -RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
           +HRD++  N L+          I DFGLA+   D         RE     +  TA  A  
Sbjct: 131 IHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTA----REGAKFPIKWTAPEAIN 183
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALC 241
                I    + D+ S G +L   +  G +P+ G+                    I+ L 
Sbjct: 184 YGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNLE 224
Query: 242 RGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           RGY        P E       C   R +D+P + YL+ +  D F
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
           + F + R +G G FG +YL    Q    +A+K      LE    +H QL+ E ++    Q
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEI----Q 68
Query: 61  GGTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVE 117
                PN LR +    D   + + L      +L+    +  +   +      +++ + + 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           + H +  +HRDIKP+N LMG      ++ I DFG +          H P    + + GT 
Sbjct: 129 YCHERKVIHRDIKPENLLMGY---KGELKIADFGWS---------VHAPSLRRRXMCGTL 176
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            Y       G     + DL   G +   FL G  P+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  ++++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFGLAKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLMID---QQGYIQVTDFGLAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLMID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
           K+    KIG G+ G +Y   ++ T +EVAI+  N++    Q + E  + +IL        
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 78
Query: 64  GIPNLRWFGVEGDYNVLVID-LLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
            I N     + GD   +V++ L G SL D+    C  +  +  V     + +  +EF+HS
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
              +HR+IK DN L+G+      V + DFG   +     + +         + GT  + +
Sbjct: 136 NQVIHRNIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMA 185
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                      + D+ SLG + +  + G  P+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  ++++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFGLAKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLMID---QQGYIKVTDFGLAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 72
           +IG GSFGE+Y G +  T E VAIK+ +++    +++   +   +L         R+FG 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 73  -VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
            ++     ++++ L G S  DL       L    +  +  +++  ++++HS+  +HRDIK
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
             N L+        V + DFG+A +  DT   ++          GT  + +      I+Q
Sbjct: 144 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMAPEV---IKQ 190
Query: 191 SRRD---DLESLGYVLMYFLRGSLP 212
           S  D   D+ SLG   +   +G  P
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPP 215

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 85
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 145 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------TLCGTPEYL 191
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 192 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 222

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYE----------- 52
           F+ G+ +G GSF    L   + T+ E AIK+   +      K P +  E           
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
             KLY   Q    +    +FG+    N  ++  +   +      C+R            +
Sbjct: 92  FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIR-KIGSFDETCTR--------FYTAE 138
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ +E++H K  +HRD+KP+N L+        + I DFG AK     +       R N 
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA----RAN- 190
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              GTA+Y S          +  DL +LG ++   + G  P++ 
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------TLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
           +G GSFG++ L T+ +T ++VA+K     L      H +++ E    K+L+    I    
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
                 D  V+VI+  G  L D +    ++++         Q+I  +E+ H    +HRD+
Sbjct: 77  VITTPTDI-VMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-I 188
           KP+N L+        V I DFGL+    D            K   G+  YA+     G +
Sbjct: 135 KPENLLLDDNL---NVKIADFGLSNIMTDGNFL--------KTSCGSPNYAAPEVINGKL 183
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
                 D+ S G VL   L G LP+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------TKHPQLQYEAKLY 56
           V + + +G ++GSG F  +       T +E A K    +            +++ E  + 
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMIN 114
           + ++    I     F  + D  VL+++L+     +LF+F + K SL          Q+++
Sbjct: 70  REIRHPNIITLHDIFENKTDV-VLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILD 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
            V ++HSK   H D+KP+N ++      N ++ +IDFG+A        H+     E KN+
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNI 178
Query: 174 TGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 243
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 244 LYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 304 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 354
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 399
Query: 245 ---PTEFASYFH--YCRSLRF--DDKPDYAYLKRLFRDLF 277
              P E     H   C+  R   +++P + YL+    D F
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGGT 63
           K+    KIG G++G ++   N +T+E VA+K   L++     P     E  L K L+   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-K 61
Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            I  L           LV +     L+  F+ C+  L  + V     Q++  + F HS++
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            LHRD+KP N L+    R  ++ + +FGLA+ +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAF 151

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------TKHPQLQYEAKLY 56
           V + + +G ++GSG F  +       T +E A K    +            +++ E  + 
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMIN 114
           + ++    I     F  + D  VL+++L+     +LF+F + K SL          Q+++
Sbjct: 63  REIRHPNIITLHDIFENKTDV-VLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILD 119
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
            V ++HSK   H D+KP+N ++      N ++ +IDFG+A        H+     E KN+
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNI 171
Query: 174 TGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------TKHPQLQYEAKLY 56
           V + + +G ++GSG F  +       T +E A K    +            +++ E  + 
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMIN 114
           + ++    I     F  + D  VL+++L+     +LF+F + K SL          Q+++
Sbjct: 84  REIRHPNIITLHDIFENKTDV-VLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILD 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
            V ++HSK   H D+KP+N ++      N ++ +IDFG+A        H+     E KN+
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNI 192
Query: 174 TGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 34/170 (20%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           +V + + +   IG GS+G +YL  +   N+ VAIK  N        +      +IL+  T
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-----RMFEDLIDCKRILREIT 79
Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL-----------KTVLMLADQM 112
            +  L+      DY + + DL+ P  EDL  F    + L           KT + L +Q 
Sbjct: 80  ILNRLK-----SDYIIRLHDLIIP--EDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQH 132
Query: 113 INRV--------EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +  +        +F+H    +HRD+KP N L+    +   V I DFGLA+
Sbjct: 133 VKTILYNLLLGEKFIHESGIIHRDLKPANCLLN---QDCSVKICDFGLAR 179

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
           + F +GR +G G FG +YL    +++  VA+K      +E    +H QL+ E ++    Q
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH-QLRREIEI----Q 77
Query: 61  GGTGIPN-LRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
                PN LR +    D    Y +L     G   ++L   C+        +M  +++ + 
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM--EELADA 135
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           + + H K  +HRDIKP+N L+G      ++ I DFG +          H P    K + G
Sbjct: 136 LMYCHGKKVIHRDIKPENLLLG---LKGELKIADFGWS---------VHAPSLRRKTMCG 183
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           T  Y       G   + + DL  +G +    L G+ P++ 
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
           + +G GSF       + ++N+  A+K+ + K      Q E    K+ +G   I  L    
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 73  VEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
            +  +  LV++LL     +LF    +K   S      +  ++++ V  +H    +HRD+K
Sbjct: 76  HDQLHTFLVMELLNGG--ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG---TARYAS--MNTH 185
           P+N L        ++ IIDFG A+          +   +N+ L     T  YA+  +   
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFAR----------LKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            G ++S   DL SLG +L   L G +P+Q 
Sbjct: 184 NGYDESC--DLWSLGVILYTMLSGQVPFQS 211

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           F L + +G GSFG+++L    +TN+  AIK   ++V      ++      ++L      P
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 67  NLRW----FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            L      F  + +   ++  L G  L      C  K  L      A ++I  ++F+HSK
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK 138
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR--DTATHQHIPYRENKNLTGTARYA 180
             ++RD+K DN L+    +   + I DFG+ K     D  T++           GT  Y 
Sbjct: 139 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNE---------FCGTPDYI 186
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +    LG + +   D  S G +L   L G  P+ G
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 74
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ ++ Q+ + + +V   +++H
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGLA+   D        Y   +      ++ +    L
Sbjct: 135 RDLRAANILVGENLVCK---VADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 185
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 230
Query: 245 ---PTEFASYFH--YCRSLR--FDDKPDYAYLKRLFRDLFIREGFQF 284
              P E     H   C+  R   +++P + YL+    D F     Q+
Sbjct: 231 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 277

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 37/233 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTG 64
           ++L  ++G G+F  +     +   +E A K+ N K      H +L+ EA++ ++L+    
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH-PN 82
Query: 65  IPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           I  L     E  ++ L+ DL+  G   ED+        S         Q++  V   H  
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQM 140
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             +HRD+KP+N L+    +   V + DFGLA               E +   G   +A  
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFG---FAGT 187
Query: 183 NTHLGIEQSRRD------DLESLGYVLMYFLRGSLP---------WQGLKAGT 220
             +L  E  R+D      DL + G +L   L G  P         +Q +KAG 
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 43/283 (15%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGTGI 65
            +L +K+G+G FGE+++ T    N+   + ++ +K     ++    EA + K LQ    +
Sbjct: 190 LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
                   E  Y +      G  L+ L +    K  L  ++  + Q+   + F+  ++++
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASMN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 307 HRDLRAANILVSASLVCK---IADFGLARVIEDN----EYTAREGAKFPIKWTAPEAINF 359
Query: 184 THLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 242
               I    + D+ S G +LM  +  G +P+ G+                    I AL R
Sbjct: 360 GSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRALER 400
Query: 243 GY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           GY        P E  +    C   R +++P + Y++ +  D +
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 49/293 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 10  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLV- 66
Query: 67  NLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
             + + V  +  + ++      G  L+ L     + L L  ++ +A Q+ + + +V   +
Sbjct: 67  --QLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 124 FLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYA 180
           ++HRD++  N L+G     N V  + DFGLA+   D         R+     +  TA  A
Sbjct: 125 YVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEXTA----RQGAKFPIKWTAPEA 176
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 239
           ++     I    + D+ S G +L     +G +P+ G+                V   +E 
Sbjct: 177 ALYGRFTI----KSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE- 219
Query: 240 LCRGY----PTEFASYFH--YCRSLR--FDDKPDYAYLKRLFRDLFIREGFQF 284
             RGY    P E     H   C+  R   +++P + YL+    D F     Q+
Sbjct: 220 --RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 270

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKL-YKILQGGTGI 65
           ++F   R +G+GSFG + L  + +T    A+K+ + +      Q E  L  K +Q     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 66  PNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS 121
           P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++HS
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
              ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y +
Sbjct: 161 LDLIYRDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYLA 207
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
               L    ++  D  +LG VL+Y +    P
Sbjct: 208 PEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 11/210 (5%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNLRWFG 72
           +G G+   +    N+ T++E A+K+   +  H + +   E ++    QG   +  L  F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 73  VEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
            E D   LV + +  G  L  +     R  +     ++   + + ++F+H+K   HRD+K
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
           P+N L     + + V I DF L    +       I   E     G+A Y +        +
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 191 S-----RRDDLESLGYVLMYFLRGSLPWQG 215
                 +R DL SLG +L   L G  P+ G
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
            +IG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 73  --VEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
             ++G    ++++ L  G +L+ L      +  + T+L    +++  ++++HS+  +HRD
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRD 145
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 188
           IK  N L+        V + DFG+A +  DT   ++          GT  + +      I
Sbjct: 146 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---I 192
Query: 189 EQSRRD---DLESLGYVLMYFLRGSLP 212
           +QS  D   D+ SLG   +   +G  P
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + F + R IG GSFG++ +     T +  A+K  N K K  +      ++K LQ   G+ 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLE 73
Query: 67  -----NLRWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEF 118
                NL W+  + + ++ +V+DLL     DL     + +  K  TV +   +++  +++
Sbjct: 74  HPFLVNL-WYSFQDEEDMFMVVDLLLGG--DLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY-RDTATHQHIPYRENKNLTGTA 177
           + ++  +HRD+KPDN L+        V+I DF +A    R+T             + GT 
Sbjct: 131 LQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQI---------TTMAGTK 178
Query: 178 RYAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
            Y +    ++  G   S   D  SLG      LRG  P+ 
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK        P+  LQ EA++ K L+    + 
Sbjct: 187 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQ-EAQVMKKLRHEKLVQ 244
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ +A Q+ + + +V   +++H
Sbjct: 245 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD++  N L+G         + DFGL +   D        Y   +      ++ +    L
Sbjct: 305 RDLRAANILVGENLVCK---VADFGLGRLIEDNE------YTARQGAKFPIKWTAPEAAL 355
Query: 187 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY- 244
               + + D+ S G +L     +G +P+ G+                V   +E   RGY 
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RGYR 400
Query: 245 ---PTEFASYFH--YCRSLRFD--DKPDYAYLKRLFRDLF 277
              P E     H   C+  R D  ++P + YL+    D F
Sbjct: 401 MPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYF 440

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRW 70
           +G G FG+++      T  ++A K+  +KT+      +++ E  +   L     I     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 71  FGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
           F  + D  VLV++ + G  L D     S  L+    ++   Q+   +  +H    LH D+
Sbjct: 155 FESKNDI-VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYR 157
           KP+N L  + R A Q+ IIDFGLA+RY+
Sbjct: 214 KPENILC-VNRDAKQIKIIDFGLARRYK 240

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 76/146 (52%), Gaps = 5/146 (3%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
           +  K+G G +GE+Y+G   + +  VA+K L+    +  +   EA + K ++    +  L 
Sbjct: 36  MKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSFLHRD 128
              +E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F+HRD
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRD 155
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
           +   N L+G     + V + DFGL++
Sbjct: 156 LAARNCLVG---ENHVVKVADFGLSR 178

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQ 60
           V + + +  ++G+G+FG ++  T   T    A K   V T H      ++ E +   +L+
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVLR 212
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 117
             T + NL     + +  V++ + +  S  +LF   +    K+S    +    Q+   + 
Sbjct: 213 HPTLV-NLHDAFEDDNEMVMIYEFM--SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H  +++H D+KP+N +M   +R+N++ +IDFGL        T    P +  K  TGTA
Sbjct: 270 HMHENNYVHLDLKPEN-IMFTTKRSNELKLIDFGL--------TAHLDPKQSVKVTTGTA 320
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            +A+     G       D+ S+G +    L G  P+ G
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 68  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 125 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 175
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 17/216 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQ 60
           V + + +  ++G+G+FG ++  T   T    A K   V T H      ++ E +   +L+
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVLR 106
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
             T + NL     + +  V++ + + G  L +       K+S    +    Q+   +  +
Sbjct: 107 HPTLV-NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H  +++H D+KP+N +M   +R+N++ +IDFGL        T    P +  K  TGTA +
Sbjct: 166 HENNYVHLDLKPEN-IMFTTKRSNELKLIDFGL--------TAHLDPKQSVKVTTGTAEF 216
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           A+     G       D+ S+G +    L G  P+ G
Sbjct: 217 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 252

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++ RLGR    GSFGE++   + QT  + A+K   ++       + A+      G T   
Sbjct: 78  HQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPR 127
Query: 67  NLRWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            +  +G   EG +  + ++LL G SL  L       L     L    Q +  +E++HS+ 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY------RDTATHQHIPYRENKNLTGTA 177
            LH D+K DN L  L    +   + DFG A         +D  T  +IP        GT 
Sbjct: 187 ILHGDVKADNVL--LSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP--------GTE 236
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            + +    LG     + D+ S   ++++ L G  PW
Sbjct: 237 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 68  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 124
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 125 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 175
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 15  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 70
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + +++  +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 131 IHRDLAARNCLVG---ENHLVKVADFGLSR 157

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G FGE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 15  MKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 70
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 131 IHRDLAARNCLVG---ENHLVKVADFGLSR 157

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
            KIG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 73  V---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
               +    +++  L G S  DL       L    +  +  +++  ++++HS+  +HRDI
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           K  N L+       +V + DFG+A +  DT   ++          GT  + +      I+
Sbjct: 131 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IK 177
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
           QS  D   D+ SLG   +   RG  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + +++  +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNL 68
           R +GSG++G +    + +  ++VA+K  +   +   H +  Y E +L K L+    I  L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 69  RWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
             F     +E    V LV  L+G  L ++    S+ LS + V  L  Q++  ++++HS  
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK--SQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            +HRD+KP N  +      +++ I+DFGLA++  +  T
Sbjct: 152 IIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMT 186

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 79  VLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF-L 135
           VL+++L+     +LF+F ++K SL  +       Q+++ V ++H+K   H D+KP+N  L
Sbjct: 91  VLILELVSGG--ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
Query: 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT----HLGIEQS 191
           +        + +IDFGLA    D          E KN+ GT  + +        LG+E  
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA- 199
Query: 192 RRDDLESLGYVLMYFLRGSLPWQG 215
              D+ S+G +    L G+ P+ G
Sbjct: 200 ---DMWSIGVITYILLSGASPFLG 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + +++  +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K   P     E K+ ++L+  
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 63  TGIPNLRWFGVEGD-YN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
             +  +     +   YN       LV D     L  L +    K +L  +  +   ++N 
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           + ++H    LHRD+K  N L+    R   + + DFGLA+ +
Sbjct: 138 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIP 66
            RL  K+G G FGE+++GT   T   VAIK     T  P+  LQ EA++ K L+    + 
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQ 74
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
                  E  Y V      G  L+ L     + L L  ++ ++ Q+ + + +V   +++H
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT--ATHQHIPYRENKNLTGTARYASMNT 184
           RD++  N L+G         + DFGLA+   D      Q   +     +  TA  A++  
Sbjct: 135 RDLRAANILVGENLVCK---VADFGLARLIEDNEWTARQGAKF----PIKWTAPEAALYG 187
Query: 185 HLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 243
              I    + D+ S G +L     +G +P+ G+                V   +E   RG
Sbjct: 188 RFTI----KSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE---RG 228
Query: 244 Y----PTEFASYFH--YCRSLR--FDDKPDYAYLKRLFRDLFIREGFQF 284
           Y    P E     H   C+  R   +++P + YL+    D F     Q+
Sbjct: 229 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 277

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K   P     E K+ ++L+  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 63  TGIPNLRWFGVEGD-YN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
             +  +     +   YN       LV D     L  L +    K +L  +  +   ++N 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           + ++H    LHRD+K  N L+    R   + + DFGLA+ +
Sbjct: 137 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 174

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 120
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 180 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 226
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 227 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 257

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 92
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 152 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 198
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 199 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 229

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++ L + IGSG+FG   L  + Q+NE VA+K +E  +     ++ E   ++ L+    
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRH--- 73
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +LF   C+  + S         Q+I+ V + H+
Sbjct: 74  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y +
Sbjct: 133 MQVCHRDLKLENTLLD-GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 183
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++ L + IGSG+FG   L  + Q+NE VA+K +E  +     ++ E   ++ L+    
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRH--- 74
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +LF   C+  + S         Q+I+ V + H+
Sbjct: 75  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y +
Sbjct: 134 MQVCHRDLKLENTLLD-GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 184
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+D  +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP+N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 125 LHRDLKPENLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 174
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 175 LLGCKYYSTAVDIWSLGCI 193

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
            KIG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 73  V---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
               +    +++  L G S  DL       L    +  +  +++  ++++HS+  +HRDI
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           K  N L+       +V + DFG+A +  DT   ++          GT  + +      I+
Sbjct: 146 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMAPEV---IK 192
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
           QS  D   D+ SLG   +   RG  P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
            KIG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 73  V---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
               +    +++  L G S  DL       L    +  +  +++  ++++HS+  +HRDI
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDI 150
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           K  N L+       +V + DFG+A +  DT   ++          GT  + +      I+
Sbjct: 151 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IK 197
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
           QS  D   D+ SLG   +   RG  P
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPP 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
            KIG GSFGE++ G + +T + VAIK+ +++    +++   +   +L         +++G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 73  V---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
               +    +++  L G S  DL       L    +  +  +++  ++++HS+  +HRDI
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
           K  N L+       +V + DFG+A +  DT   ++          GT  + +      I+
Sbjct: 131 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMAPEV---IK 177
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
           QS  D   D+ SLG   +   RG  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 160 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 206
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 207 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K   P     E K+ ++L+  
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 63  TGIPNLRWFGVEGD-YN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
             +  +     +   YN       LV D     L  L +    K +L  +  +   ++N 
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           + ++H    LHRD+K  N L+    R   + + DFGLA+ +
Sbjct: 138 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K   P     E K+ ++L+  
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 63  TGIPNLRWFGVEGD-YN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
             +  +     +   YN       LV D     L  L +    K +L  +  +   ++N 
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           + ++H    LHRD+K  N L+    R   + + DFGLA+ +
Sbjct: 138 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG- 64
           +++ +   IG GSFG++    +    E VAIK ++N K    Q Q E +L +++      
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 65  ----IPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFV 119
               I +L+   +  ++  LV ++L  +L DL  N   R +SL      A QM   + F+
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 120 HSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
            +   S +H D+KP+N L+   +R+  + I+DFG
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFG 187

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 39/280 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGTGI 65
            +L +K+G+G FGE+++ T    N+   + ++ +K     ++    EA + K LQ    +
Sbjct: 17  LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
                   E  Y +      G  L+ L +    K  L  ++  + Q+   + F+  ++++
Sbjct: 74  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD++  N L+          I DFGLA+   D        Y   +      ++ +    
Sbjct: 134 HRDLRAANILVSASLVCK---IADFGLARVIEDNE------YTAREGAKFPIKWTAPEAI 184
Query: 186 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
                + + D+ S G +LM  +  G +P+ G+                    I AL RGY
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRALERGY 229
Query: 245 --------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
                   P E  +    C   R +++P + Y++ +  D 
Sbjct: 230 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+++L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N ++ L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG- 64
           +++ +   IG GSFG++    +    E VAIK ++N K    Q Q E +L +++      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 65  ----IPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFV 119
               I +L+   +  ++  LV ++L  +L DL  N   R +SL      A QM   + F+
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 120 HSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
            +   S +H D+KP+N L+   +R+  + I+DFG
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFG 206

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  +++T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+D  +  +   + L  +     Q++  + F HS   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 127 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 176
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 177 LLGCKYYSTAVDIWSLGCI 195

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+D  +  +   + L  +     Q++  + F HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 177
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 178 LLGCKYYSTAVDIWSLGCI 196

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 12/188 (6%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 6   PEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNL 173
            HS   LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L
Sbjct: 126 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 174 TGTARYAS 181
            G   Y++
Sbjct: 183 LGCKYYST 190

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 77
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 138 IHRDLAARNCLVG---ENHLVKVADFGLSR 164

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           F L + +G GSFG+++L    +TN+  AIK   ++V      ++      ++L      P
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 67  NLRW----FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            L      F  + +   ++  L G  L      C  K  L      A ++I  ++F+HSK
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK 137
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR--DTATHQHIPYRENKNLTGTARYA 180
             ++RD+K DN L+    +   + I DFG+ K     D  T+            GT  Y 
Sbjct: 138 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNX---------FCGTPDYI 185
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +    LG + +   D  S G +L   L G  P+ G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LEN---VKTKHPQLQYEAKLYKILQ 60
           VG+++ +   IG+G++G +       T ++VAIK + N   V T   +   E K+ K  +
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 111
Query: 61  GGTGI-------PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
               I       P + +   +  Y  +V+DL+   L  + +  S+ L+L+ V     Q++
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVY--VVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLL 168
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             ++++HS   +HRD+KP N L+       ++ I DFG+A+
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMAR 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 53/233 (22%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------ENVKT 44
           ++G+ + LG  +G G+FG++ +G +  T  +VA+K+                   +N+K 
Sbjct: 14  KIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 45  -KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLS 101
            +HP +    KLY+++   + I              +V++ +  S  +LF++  +  +L 
Sbjct: 73  FRHPHI---IKLYQVISTPSDI-------------FMVMEYV--SGGELFDYICKNGRLD 114
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            K    L  Q+++ V++ H    +HRD+KP+N L+     A    I DFGL+    D   
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEF 171
Query: 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
                    +   G+  YA+     G +      D+ S G +L   L G+LP+
Sbjct: 172 --------LRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 18/172 (10%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LEN---VKTKHPQLQYEAKLYKILQ 60
           VG+++ +   IG+G++G +       T ++VAIK + N   V T   +   E K+ K  +
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 112
Query: 61  GGTGI-------PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
               I       P + +   +  Y  +V+DL+   L  + +  S+ L+L+ V     Q++
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVY--VVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLL 169
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY-RDTATHQH 164
             ++++HS   +HRD+KP N L+       ++ I DFG+A+      A HQ+
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMARGLCTSPAEHQY 218

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 12/188 (6%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 6   PEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNL 173
            HS   LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L
Sbjct: 126 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 174 TGTARYAS 181
            G   Y++
Sbjct: 183 LGXKYYST 190

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 15  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 70
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 131 IHRDLAARNCLVG---ENHLVKVADFGLSR 157

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++G+ + LG  +G G+FG++ +G +  T  +VA+K+ N + K   L    K+ + +Q   
Sbjct: 9   KIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQ--- 63
Query: 64  GIPNLRWF---GVEGDYNV--------LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLAD 110
              NL+ F    +   Y V        +V++ +  S  +LF++  +  ++       L  
Sbjct: 64  ---NLKLFRHPHIIKLYQVISTPTDFFMVMEYV--SGGELFDYICKHGRVEEMEARRLFQ 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q+++ V++ H    +HRD+KP+N L+     A    I DFGL+    D            
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEF--------L 167
Query: 171 KNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
           ++  G+  YA+     G +      D+ S G +L   L G+LP+
Sbjct: 168 RDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG- 64
           +++ +   IG GSFG++    +    E VAIK ++N K    Q Q E +L +++      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 65  ----IPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFV 119
               I +L+   +  ++  LV ++L  +L DL  N   R +SL      A QM   + F+
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 120 HSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
            +   S +H D+KP+N L+   +R   + I+DFG
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRX-AIKIVDFG 206

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    +  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    +  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    +  + + N+ ++    P  E +F+   R  + S       A Q++   E++H
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 205
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 85
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 146 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 177

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRWF- 71
           IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRYFF 116
Query: 72  ---GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS 123
              G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS  
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
             HRDIKP N L  L      + + DFG AK+
Sbjct: 177 ICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 77
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + +++  +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 138 IHRDLAARNCLVG---ENHLVKVADFGLSR 164

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKIL 59
           R   +++L  ++G G+F  +     +   +E A  + N K      H +L+ EA++ ++L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +    I  L     E  ++ L+ DL+  G   ED+        S         Q++  V 
Sbjct: 68  KH-PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCIQQILEAVL 124
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
             H    +HR++KP+N L+    +   V + DFGLA               E +   G  
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFG-- 172
Query: 178 RYASMNTHLGIEQSRRD------DLESLGYVLMYFLRGSLP---------WQGLKAGT 220
            +A    +L  E  R+D      DL + G +L   L G  P         +Q +KAG 
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 93
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 154 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 185

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 108
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 169 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 200

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 118
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 179 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 210

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIPNLRWF 71
           KIG GS G + L     +  +VA+K+ +++ +  +  L  E  + +  Q    +   + +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 72  GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
            V  +  VL+  L G +L D+ +    +L+ + +  + + ++  + ++H++  +HRDIK 
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
           D+ L+ L  R   V + DFG   +       + +P R  K L GT  + +         +
Sbjct: 170 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KXLVGTPYWMAPEVISRSLYA 219
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPY 241

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 116
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 177 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 208

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNL 68
           R +GSG++G +    + +  ++VA+K  +   +   H +  Y E +L K L+    I  L
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 69  RWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
             F     +E    V LV  L+G  L ++   C + LS + V  L  Q++  ++++HS  
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-C-QALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            +HRD+KP N  +      +++ I+DFGLA++  +  T
Sbjct: 152 IIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMT 186

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRWF- 71
           IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRYFF 116
Query: 72  ---GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS 123
              G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS  
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
             HRDIKP N L  L      + + DFG AK+
Sbjct: 177 ICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 206

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 73
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + +++  +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 134 IHRDLAARNCLVG---ENHLVKVADFGLSR 160

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 99
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 160 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 191

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 92
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 153 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 184

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 159
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 220 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 251

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 81
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 142 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 173

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++G+ + LG  +G G+FG++ +G +  T  +VA+K+ N + K   L    K+ + +Q   
Sbjct: 9   KIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQ--- 63
Query: 64  GIPNLRWF---GVEGDYNV--------LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLAD 110
              NL+ F    +   Y V        +V++ +  S  +LF++  +  ++       L  
Sbjct: 64  ---NLKLFRHPHIIKLYQVISTPTDFFMVMEYV--SGGELFDYICKHGRVEEMEARRLFQ 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q+++ V++ H    +HRD+KP+N L+     A    I DFGL+    D            
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEF--------L 167
Query: 171 KNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 213
           +   G+  YA+     G +      D+ S G +L   L G+LP+
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 92
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 153 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 184

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 88
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 149 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 180

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQGGTGIPNLRWFG 72
           +G G++G +Y G ++     +AIK +    +++ Q L  E  L+K L+    +  L  F 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 73  VEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
             G   + +  + G SL  L    +   K + +T+     Q++  ++++H    +HRDIK
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
            DN L  +   +  + I DFG +KR          P  E    TGT +Y +      I++
Sbjct: 150 GDNVL--INTYSGVLKISDFGTSKRLAGIN-----PCTE--TFTGTLQYMAPEI---IDK 197
Query: 191 SRRD-----DLESLGYVLMYFLRGSLPW 213
             R      D+ SLG  ++    G  P+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++ RLGR    GSFGE++   + QT  + A+K   ++       + A+      G T   
Sbjct: 97  HQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPR 146
Query: 67  NLRWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            +  +G   EG +  + ++LL G SL  L       L     L    Q +  +E++HS+ 
Sbjct: 147 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            LH D+K DN L  L    +   + DFG A   +     + +       + GT  + +  
Sbjct: 206 ILHGDVKADNVL--LSSDGSHAALCDFGHAVCLQPDGLGKSL--LTGDYIPGTETHMAPE 261
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             LG     + D+ S   ++++ L G  PW
Sbjct: 262 VVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L++ + K+ +LQ   KL         I  LR+
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY 84
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 145 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 176

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQGGTGIPNLRWFG 72
           +G G++G +Y G ++     +AIK +    +++ Q L  E  L+K L+    +  L  F 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 73  VEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
             G   + +  + G SL  L    +   K + +T+     Q++  ++++H    +HRDIK
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
            DN L  +   +  + I DFG +KR          P  E    TGT +Y +      I++
Sbjct: 136 GDNVL--INTYSGVLKISDFGTSKRLAGIN-----PCTE--TFTGTLQYMAPEI---IDK 183
Query: 191 SRRD-----DLESLGYVLMYFLRGSLPW 213
             R      D+ SLG  ++    G  P+
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 15/215 (6%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           V + + +  ++GSG+FG ++      T      K  N  T +P  +Y  K    +     
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLH 106
Query: 65  IPNLRWF--GVEGDYN-VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
            P L       E  Y  VL+++ L G  L D       K+S   V+    Q    ++ +H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             S +H DIKP+N +M   ++A+ V IIDFGLA +          P    K  T TA +A
Sbjct: 167 EHSIVHLDIKPEN-IMCETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFA 217
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +             D+ ++G +    L G  P+ G
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 22/219 (10%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
           FR+ +KIG G F E+Y    +     VA+K      L + K +   ++ E  L K L   
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHP 92
Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 119
             I     F  + + N+++       L  +   F    R +  +TV     Q+ + +E +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 120 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           HS+  +HRDIKP N F+   G     V + D GL + +    T  H       +L GT  
Sbjct: 153 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 201
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
           Y S         + + D+ SLG +L        P+ G K
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 142
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 186

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++F L + +G GSFG+++L   I  ++     A+K+    T   + +   K+ + +    
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 64  GIP---NLRW-FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVE 117
             P    L + F  EG    L++D L     DLF   S+++    + V     ++   ++
Sbjct: 84  NHPFIVKLHYAFQTEGKL-YLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +HS   ++RD+KP+N L+        + + DFGL+K   D   H+   Y    +  GT 
Sbjct: 141 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCGTV 190
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y +         ++  D  S G ++   L G+LP+QG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 9   FRLGRKIGSGSFGEIYLG---TNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
           F L + +G GSFG+++L    T   +    A+K+    T   + +   K+ + +      
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 66  P---NLRW-FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFV 119
           P    L + F  EG    L++D L     DLF   S+++    + V     ++   ++ +
Sbjct: 90  PFVVKLHYAFQTEGKL-YLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+        + + DFGL+K   D   H+   Y    +  GT  Y
Sbjct: 147 HSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKEAID---HEKKAY----SFCGTVEY 196
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            +         S   D  S G ++   L GSLP+QG
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQG 232

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 49/281 (17%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGTGI 65
            +L +K+G+G FGE+++ T    N+   + ++ +K     ++    EA + K LQ    +
Sbjct: 184 LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
                   E  Y +      G  L+ L +    K  L  ++  + Q+   + F+  ++++
Sbjct: 241 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD++  N L+          I DFGLA+           P   N        + S    
Sbjct: 301 HRDLRAANILVSASLVCK---IADFGLARVGAKFPIKWTAPEAIN--------FGSFTI- 348
Query: 186 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRGY 244
                  + D+ S G +LM  +  G +P+ G+                    I AL RGY
Sbjct: 349 -------KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRALERGY 386
Query: 245 --------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
                   P E  +    C   R +++P + Y++ +  D +
Sbjct: 387 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 427

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV 73
           ++G G+FG++Y   N +T    A K+   K++     Y  ++ +IL        ++  G 
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIVKLLGA 84
Query: 74  ---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
              +G   +++    G +++ +     R L+   + ++  QM+  + F+HSK  +HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKR 155
             N LM L      + + DFG++ +
Sbjct: 145 AGNVLMTL---EGDIRLADFGVSAK 166

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + +T    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 92
Query: 65  IPNL--RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 120
            P L    F  + + N+ ++    P  E +F+   R  +         A Q++   E++H
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           S   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y 
Sbjct: 152 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYL 198
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +    L    ++  D  +LG VL+Y +    P
Sbjct: 199 APEIILSKGYNKAVDWWALG-VLIYEMAAGYP 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++   C+ KL+   V  L  Q++ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CA-KLTDDHVQFLIYQILR 132
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 176

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 156
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 200

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 155
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 199

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 AS 181
           ++
Sbjct: 182 ST 183

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    ++++  ++A+K  +   +   H +  Y E +L K +
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 165
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++F L + +G GSFG+++L   I  ++     A+K+    T   + +   K+ + +    
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 64  GIP---NLRW-FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVE 117
             P    L + F  EG    L++D L     DLF   S+++    + V     ++   ++
Sbjct: 84  NHPFIVKLHYAFQTEGKL-YLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +HS   ++RD+KP+N L+        + + DFGL+K   ++  H+   Y    +  GT 
Sbjct: 141 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSK---ESIDHEKKAY----SFCGTV 190
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y +         ++  D  S G ++   L G+LP+QG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++F L + +G GSFG+++L   I  ++     A+K+    T   + +   K+ + +    
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 64  GIP---NLRW-FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVE 117
             P    L + F  EG    L++D L     DLF   S+++    + V     ++   ++
Sbjct: 85  NHPFIVKLHYAFQTEGKL-YLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +HS   ++RD+KP+N L+        + + DFGL+K   ++  H+   Y    +  GT 
Sbjct: 142 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSK---ESIDHEKKAY----SFCGTV 191
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            Y +         ++  D  S G ++   L G+LP+QG
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 229

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-------LQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K ++  +TK  +       ++ E  + 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMIN 114
           K +Q    I     +  + D  +L+ +L+     +LF+F + K SL  +       Q++N
Sbjct: 69  KEIQHPNVITLHEVYENKTDV-ILIGELVAGG--ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKN 172
            V ++HS    H D+KP+N +M L R   +  + IIDFGLA        H+     E KN
Sbjct: 126 GVYYLHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLA--------HKIDFGNEFKN 176
Query: 173 LTGTARYASMNT----HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           + GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV 73
           ++G G+FG++Y   N +T    A K+   K++     Y  ++ +IL        ++  G 
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIVKLLGA 76
Query: 74  ---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
              +G   +++    G +++ +     R L+   + ++  QM+  + F+HSK  +HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKR 155
             N LM L      + + DFG++ +
Sbjct: 137 AGNVLMTL---EGDIRLADFGVSAK 158

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 180 AS 181
           ++
Sbjct: 181 ST 182

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 14/177 (7%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           K+G G++  +Y G +  T+  VA+K   LE+ +        E  L K L+    +     
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
              E     LV + L   L+   + C   +++  V +   Q++  + + H +  LHRD+K
Sbjct: 69  IHTEKSLT-LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           P N L+       ++ + DFGLA+        + IP +   N   T  Y   +  LG
Sbjct: 128 PQNLLIN---ERGELKLADFGLARA-------KSIPTKTYDNEVVTLWYRPPDILLG 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 AS 181
           ++
Sbjct: 182 ST 183

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 146
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 190

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 14/158 (8%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNL 68
           R +GSG++G +    + +  ++VA+K  +   +   H +  Y E +L K L+    I  L
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 69  RWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
             F     +E    V LV  L+G  L ++     + LS + V  L  Q++  ++++HS  
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            +HRD+KP N  +       ++ I+DFGLA++  +  T
Sbjct: 144 IIHRDLKPSNVAVN---EDCELRILDFGLARQADEEMT 178

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 180 AS 181
           ++
Sbjct: 183 ST 184

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 132
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 176

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 57/128 (44%), Gaps = 13/128 (10%)
Query: 90  EDLFNFCSRKLSLK-----TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144
           E+L ++ +R+ SL+       L +  Q+   VEF+HSK  +HRD+KP N    +    + 
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DV 202
Query: 145 VYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 199
           V + DFGL          Q +      Y  +    GT  Y S     G   S + D+ SL
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 200 GYVLMYFL 207
           G +L   L
Sbjct: 263 GLILFELL 270

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++   C +KL+   V  L  Q++ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILR 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +      +++ I+DFGLA+   D  T
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEMT 182

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 13  RKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQLQYEAKLYK-ILQGGTGIPN-LR 69
           R IG G FG +Y G  I Q    +   ++++       Q EA L + +L  G   PN L 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 70  WFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
             G+    EG  +VL+  +    L        R  ++K ++    Q+   +E++  + F+
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD+   N ++     +  V + DFGLA   RD    ++   +++++     ++ ++ + 
Sbjct: 147 HRDLAARNCMLD---ESFTVKVADFGLA---RDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 186 LGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 216
                + + D+ S G +L   L RG+ P++ +
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 77
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 138 IHRDLAARNCLVG---ENHLVKVADFGLSR 164

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++   C +KL+   V  L  Q++ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILR 142
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +      +++ I+DFGLA+   D  T
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEMT 186

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGG-TGIP 66
           G K+G G FG +Y G     N  VA+K    + ++ T+  + Q++ ++  + +     + 
Sbjct: 30  GNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 67  NLRWFGVEGDYNVLV-IDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS 123
            L  F  +GD   LV + +   SL D  +    +  LS      +A    N + F+H   
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 147
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            +HRDIK  N L+     A    I DFGLA+     A+ +         + GT  Y +  
Sbjct: 148 HIHRDIKSANILLD---EAFTAKISDFGLAR-----ASEKFAQXVMXXRIVGTTAYMAPE 199
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
              G E + + D+ S G VL+  + G LP
Sbjct: 200 ALRG-EITPKSDIYSFGVVLLEIITG-LP 226

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 76
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 137 IHRDLAARNCLVG---ENHLVKVADFGLSR 163

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 77
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 138 IHRDLAARNCLVG---ENHLVKVADFGLSR 164

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 AS 181
           ++
Sbjct: 182 ST 183

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 180 AS 181
           ++
Sbjct: 181 ST 182

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 74
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 135 IHRDLAARNCLVG---ENHLVKVADFGLSR 161

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 77
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 138 IHRDLAARNCLVG---ENHLVKVADFGLSR 164

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 74
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 135 IHRDLAARNCLVG---ENHLVKVADFGLSR 161

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP+N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 126 LHRDLKPENLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 175
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 176 LLGCKYYSTAVDIWSLGCI 194

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++    S+KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--SQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +      +++ I+DFGL +   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLCRHTDDEMT 180

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 74
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 135 IHRDLAARNCLVG---ENHLVKVADFGLSR 161

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 129 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 180 AS 181
           ++
Sbjct: 186 ST 187

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP+N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 128 LHRDLKPENLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 177
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 178 LLGCKYYSTAVDIWSLGCI 196

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 72
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ ++   +L +A Q+ + +E++  K+F
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 133 IHRDLAARNCLVG---ENHLVKVADFGLSR 159

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 73
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 134 IHRDLAARNCLVG---ENHLVKVADFGLSR 160

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 279
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+ +S   +L +A Q+ + +E++  K+F
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HR++   N L+G     + V + DFGL++
Sbjct: 340 IHRNLAARNCLVG---ENHLVKVADFGLSR 366

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 12/182 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 180 AS 181
           ++
Sbjct: 182 ST 183

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    IGSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT 185

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 31/185 (16%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LQYEAKLYKILQGGTGIPNL-- 68
           +G GS+G +    N  T   VAIK  LE+   K  +     E KL K L+    +  L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 69  -----RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
                RW+        LV + +  ++ D        L  + V     Q+IN + F HS +
Sbjct: 93  CKKKKRWY--------LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-------YRDTATHQHIPYRENKNLTGT 176
            +HRDIKP+N L+    ++  V + DFG A+        Y D    +   YR  + L G 
Sbjct: 145 IIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRW--YRAPELLVGD 199
Query: 177 ARYAS 181
            +Y  
Sbjct: 200 VKYGK 204

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 27/172 (15%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 36  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK------------LSL 102
           +   L     I NL      G   +++ +       DL NF  RK            L L
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DFGLA+
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDFGLAR 200

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++ L + IG+G+FG   L  + Q NE VA+K +E  +     ++ E   ++ L+    
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRH--- 74
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +LF   C+  + S         Q+I+ V + H+
Sbjct: 75  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y +
Sbjct: 134 MQVAHRDLKLENTLLD-GSPAPRLKIADFGYSK--------ASVLHSQPKSAVGTPAYIA 184
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 30  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 85
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+   N L+G     + V + DFGL++
Sbjct: 146 IHRDLAARNCLVG---ENHLVKVADFGLSR 172

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 27/172 (15%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 44  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK------------LSL 102
           +   L     I NL      G   +++ +       DL NF  RK            L L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DFGLA+
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDFGLAR 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F +  K+G GS+G +Y   + +T + VAIK   V++    LQ   K   I+Q       +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVV 87
Query: 69  RWFG--VEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
           +++G   +     +V++  G  S+ D+    ++ L+   +  +    +  +E++H    +
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRDIK  N L+     A    + DFG+A +  D    ++        + GT  + +    
Sbjct: 148 HRDIKAGNILLNTEGHAK---LADFGVAGQLTDXMAKRN-------XVIGTPFWMAPEVI 197
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             I  +   D+ SLG   +    G  P+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGG-TGIP 66
           G K+G G FG +Y G     N  VA+K    + ++ T+  + Q++ ++  + +     + 
Sbjct: 36  GNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 67  NLRWFGVEGDYNVLV-IDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS 123
            L  F  +GD   LV + +   SL D  +    +  LS      +A    N + F+H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            +HRDIK  N L+     A    I DFGLA+     A+ +         + GT  Y +  
Sbjct: 154 HIHRDIKSANILLD---EAFTAKISDFGLAR-----ASEKFAQTVMXSRIVGTTAYMAPE 205
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
              G E + + D+ S G VL+  + G LP
Sbjct: 206 ALRG-EITPKSDIYSFGVVLLEIITG-LP 232

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++ L + IGSG+FG   L  + Q+NE VA+K +E  +     ++ E   ++ L+    
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRH--- 74
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +LF   C+  + S         Q+I+ V + H+
Sbjct: 75  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I  FG +K          + + + K+  GT  Y +
Sbjct: 134 MQVCHRDLKLENTLLD-GSPAPRLKICAFGYSK--------SSVLHSQPKDTVGTPAYIA 184
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGG-TGIP 66
           G K+G G FG +Y G     N  VA+K    + ++ T+  + Q++ ++  + +     + 
Sbjct: 36  GNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 67  NLRWFGVEGDYNVLV-IDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS 123
            L  F  +GD   LV + +   SL D  +    +  LS      +A    N + F+H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            +HRDIK  N L+     A    I DFGLA+     A+ +         + GT  Y +  
Sbjct: 154 HIHRDIKSANILLD---EAFTAKISDFGLAR-----ASEKFAQTVMXXRIVGTTAYMAPE 205
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
              G E + + D+ S G VL+  + G LP
Sbjct: 206 ALRG-EITPKSDIYSFGVVLLEIITG-LP 232

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTG 64
           F+   KIG G++G +Y   N  T E VA   I+L+      P     E  L K L     
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS 123
           +  L     E     LV + L   L+   +  +   + L  +     Q++  + F HS  
Sbjct: 65  VKLLDVIHTENKL-YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTAR 178
            LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   
Sbjct: 124 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 179 YAS 181
           Y++
Sbjct: 181 YST 183

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTG 64
           F+   KIG G++G +Y   N  T E VA   I+L+      P     E  L K L     
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS 123
           +  L     E     LV + L   L+   +  +   + L  +     Q++  + F HS  
Sbjct: 64  VKLLDVIHTENKL-YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTAR 178
            LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 179 YAS 181
           Y++
Sbjct: 180 YST 182

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L+    K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 1   PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            HS   LHRD+KP+N L+        + + DFGLA+ +        +P R   +   T  
Sbjct: 121 CHSHRVLHRDLKPENLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLW 170
Query: 179 YASMNTHLGIE-QSRRDDLESLGYV 202
           Y +    LG +  S   D+ SLG +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCI 195

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 142
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 186

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 38/235 (16%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ--G 61
           + N F + RK+G G+FG + L  +I   +  A+K + N+K      + EA + K +Q   
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 62  GTGIPNLRWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
                 +++ G  +  D+  L+ + LGPSL ++    +     ++ + +   +++  + +
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 119 VHSKSFLHRDIKPDNFLMG---------LGRRAN-----QVY--------IIDFGLAKRY 156
           +   S  H D+KP+N L+            RR       Q+Y        +IDFG A   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211
            D           + ++  T +Y +    L +      D+ S G VL     GSL
Sbjct: 213 SDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP+N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 126 LHRDLKPENLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 175
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 176 LLGCKYYSTAVDIWSLGCI 194

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 148
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 192

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++   C +KL+   V  L  Q++ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILR 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT 185

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE-AKLYKILQGGTGIPNLRW 70
           +G+G+F E+ L  + +T + VAIK    E ++ K   ++ E A L+KI      I  L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKH--PNIVALDD 83
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRD 128
               G +  L++ L+  S  +LF+    K   + +    L  Q+++ V+++H    +HRD
Sbjct: 84  IYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 141
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 188
           +KP+N L       +++ I DFGL+K           P        GT  Y +       
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLSK--------MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
             S+  D  S+G +    L G  P+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L+    K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE-AKLYKILQGGTGIPNLRW 70
           +G+G+F E+ L  + +T + VAIK    E ++ K   ++ E A L+KI      I  L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKH--PNIVALDD 83
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRD 128
               G +  L++ L+  S  +LF+    K   + +    L  Q+++ V+++H    +HRD
Sbjct: 84  IYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 141
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 188
           +KP+N L       +++ I DFGL+K           P        GT  Y +       
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLSK--------MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
             S+  D  S+G +    L G  P+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 143
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT 187

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG +Y      + E VAIK  L+    K+ +LQ   KL         I  LR+
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY 80
Query: 71  F----GVEGD--YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
           F    G + D  Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               HRDIKP N L  L      + + DFG AK+
Sbjct: 141 FGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++ L + IGSG+FG   L  + Q+NE VA+K +E  +     ++ E   ++ L+    
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRH--- 74
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +LF   C+  + S         Q+I+ V + H+
Sbjct: 75  -PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I  FG +K          + + + K+  GT  Y +
Sbjct: 134 MQVCHRDLKLENTLLD-GSPAPRLKICAFGYSK--------SSVLHSQPKSTVGTPAYIA 184
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 143
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT 187

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 182

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
           K+ L +K+G G++G ++   + +T E VA+K      +N  T   +   E  +   L G 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGH 68
Query: 63  TGIPNL-RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
             I NL      + D +V LV D +   L  +      +   K  ++   Q+I  ++++H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY--QLIKVIKYLH 126
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT-ATHQHIPYRENKN 172
           S   LHRD+KP N L+        V + DFGL++ + +      +IP   N+N
Sbjct: 127 SGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE-AKLYKILQGGTGIPNLRW 70
           +G+G+F E+ L  + +T + VAIK    E ++ K   ++ E A L+KI      I  L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKH--PNIVALDD 83
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRD 128
               G +  L++ L+  S  +LF+    K   + +    L  Q+++ V+++H    +HRD
Sbjct: 84  IYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 141
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 188
           +KP+N L       +++ I DFGL+K           P        GT  Y +       
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLSK--------MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
             S+  D  S+G +    L G  P+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 134
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 178

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 120
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 179 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGATW----------TLCGTPEY 225
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 226 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 257

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 143
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT 187

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 185

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 142
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 186

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 132
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 176

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 147
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT 191

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 143
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 187

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 155
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 199

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 182

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--XQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT 180

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 182

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 185

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 135
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 179

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 159
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 203

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 156
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 200

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 133
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 177

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 148
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 192

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 148
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 192

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 177

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 30/224 (13%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAK-LYKIL 59
           ++ R G  F+    IGSG FG+++   +    +   IK   VK  + + + E K L K+ 
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--RVKYNNEKAEREVKALAKLD 62
Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF---NFCSR-------------KLSLK 103
                  N  W G + D      +      + LF    FC +             KL   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
             L L +Q+   V+++HSK  ++RD+KP N  +       QV I DFGL    ++     
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
                      GT RY S       +  +  DL +LG +L   L
Sbjct: 180 RSK--------GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 20/221 (9%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQ---LQYEAKL 55
           ++PR   ++  GR +G G F + Y  T++ T E  A K+  +++  K  Q   +  E  +
Sbjct: 20  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMI 113
           +K L     +     F  + D+  +V+++       L     R+ ++          Q I
Sbjct: 80  HKSLDNPHVV-GFHGFFEDDDFVYVVLEIC--RRRSLLELHKRRKAVTEPEARYFMRQTI 136
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             V+++H+   +HRD+K  N  +        V I DFGLA +       +       K+L
Sbjct: 137 QGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERK-------KDL 186
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
            GT  Y +         S   D+ SLG +L   L G  P++
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 156
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 197

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ- 60
           EP    ++ L RK+G G F  ++L  ++  N  VA+K+  V+      +      K+LQ 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQR 71
Query: 61  ------------GGTGIPNL----RWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLK 103
                       G   I  L       G  G + V+V ++LG +L  L   +  R + L 
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 104 TVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAKRYRDT 159
            V  ++ Q++  ++++H +   +H DIKP+N LM +        Q+ I D G A  Y + 
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 160 ATH--QHIPYRENKNLTGT 176
            T+  Q   YR  + L G 
Sbjct: 192 YTNSIQTREYRSPEVLLGA 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 177

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 132
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 133
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 19/215 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLQYEAKLYKILQGGTGI 65
           F + + IG G+FGE+ +      ++  A+K+ N   +  +     +  +   ++ G +  
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 66  PNLRWFGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
                +  + D N+ LV+D  +G  L  L +    +L  +       +M+  ++ VH   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           ++HRDIKPDN LM +      + + DFG   +  +  T Q      +    GT  Y S  
Sbjct: 196 YVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPE 246
Query: 184 THLGIEQSR-----RDDLESLGYVLMYFLRGSLPW 213
               +E  +       D  SLG  +   L G  P+
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQL---QYEAKLY 56
            K+     +GSG+FG ++   + + N+EV +K       LE+   + P+L     E  + 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM--LADQMIN 114
             ++    I  L  F  +G +  LV++  G  L DLF F  R   L   L   +  Q+++
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQ-LVMEKHGSGL-DLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
            V ++  K  +HRDIK +N ++        + +IDFG A
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSA 177

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ- 60
           EP    ++ L RK+G G F  ++L  ++  N  VA+K+  V+      +      K+LQ 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQR 71
Query: 61  ------------GGTGIPNL----RWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLK 103
                       G   I  L       G  G + V+V ++LG +L  L   +  R + L 
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 104 TVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAKRYRDT 159
            V  ++ Q++  ++++H +   +H DIKP+N LM +        Q+ I D G A  Y + 
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 160 ATH--QHIPYRENKNLTGT 176
            T+  Q   YR  + L G 
Sbjct: 192 YTNSIQTREYRSPEVLLGA 210

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 147
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 191

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 20/221 (9%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQ---LQYEAKL 55
           ++PR   ++  GR +G G F + Y  T++ T E  A K+  +++  K  Q   +  E  +
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMI 113
           +K L     +     F  + D+  +V+++       L     R+ ++          Q I
Sbjct: 96  HKSLDNPHVV-GFHGFFEDDDFVYVVLEIC--RRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             V+++H+   +HRD+K  N  +        V I DFGLA +       +       K+L
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERK-------KDL 202
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
            GT  Y +         S   D+ SLG +L   L G  P++
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--XQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 180

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 174
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 175 LLGCKYYSTAVDIWSLGCI 193

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 3   PRVGNK--FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           P  GN+  ++L RK+G G + E++   NI  NE V +K+     K    +    L + L+
Sbjct: 32  PSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKIL-ENLR 90
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------QM 112
           GGT I  L            V D +  +   +F + +     +   +L D        ++
Sbjct: 91  GGTNIIKLI---------DTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYEL 141
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +  +++ HSK  +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 142 LKALDYCHSKGIMHRDVKPHNVM--IDHQQKKLRLIDWGLAEFY 183

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 21/221 (9%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHP-----QLQYEAKLYKILQG 61
           + L   IG G+F  +    N +T ++ A+K+ +V   T  P      L+ EA +  +L+ 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-----LSLKTVLMLADQMINRV 116
              +  L  +  +G   ++   + G  L   F    R       S         Q++  +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            + H  + +HRD+KP+N L+     +  V + DFG+A +  ++               GT
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL-------VAGGRVGT 196
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
             + +          +  D+   G +L   L G LP+ G K
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 175
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 176 LLGCKYYSTAVDIWSLGCI 194

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFG-------VPVRTYXHEVVTLWYRAPEI 173
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 174 LLGCKYYSTAVDIWSLGCI 192

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 174
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 175 LLGCKYYSTAVDIWSLGCI 193

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 177
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 178 LLGCKYYSTAVDIWSLGCI 196

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFG-------VPVRTYXHEVVTLWYRAPEI 174
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 175 LLGCKYYSTAVDIWSLGCI 193

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 174
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 175 LLGCKYYSTAVDIWSLGCI 193

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 1   PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            HS   LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  
Sbjct: 121 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLW 170
Query: 179 YASMNTHLGIE-QSRRDDLESLGYV 202
           Y +    LG +  S   D+ SLG +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCI 195

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 173
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 174 LLGCKYYSTAVDIWSLGCI 192

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 1   PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            HS   LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  
Sbjct: 121 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLW 170
Query: 179 YASMNTHLGIE-QSRRDDLESLGYV 202
           Y +    LG +  S   D+ SLG +
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCI 195

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 177
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 178 LLGCKYYSTAVDIWSLGCI 196

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 129 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 178
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 179 LLGCKYYSTAVDIWSLGCI 197

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 77/184 (41%), Gaps = 38/184 (20%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 29  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVID------------------LLGPSL------E 90
           +   L     I NL      G   VLVI                   +LGPSL      E
Sbjct: 87  IMSHLGQHENIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE 145
Query: 91  DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
            L     R L L+ +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DF
Sbjct: 146 GLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDF 202
Query: 151 GLAK 154
           GLA+
Sbjct: 203 GLAR 206

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
           P     F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L   
Sbjct: 2   PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 63  TGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
              PN+ +   V    N   LV + L   L+   +  +   + L  +     Q++  + F
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            HS   LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  
Sbjct: 122 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLW 171
Query: 179 YASMNTHLGIE-QSRRDDLESLGYV 202
           Y +    LG +  S   D+ SLG +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCI 196

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + L   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAFG-------VPVRTYXHEVVTLWYRAPEI 175
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 176 LLGCKYYSTAVDIWSLGCI 194

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
           +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     PNL 
Sbjct: 263 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLV 318
Query: 69  RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM-LADQMINRVEFVHSKSF 124
           +  GV   E  + ++   +   +L D    C+R+     VL+ +A Q+ + +E++  K+F
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HR++   N L+G     + V + DFGL++
Sbjct: 379 IHRNLAARNCLVG---ENHLVKVADFGLSR 405

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLAGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAK-LYKILQGGTGIPNLRW 70
           +G G FG ++   N   +   AIK   L N +    ++  E K L K+   G     +R+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI----VRY 68
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK-------------------TVLMLADQ 111
           F    + N    + L PS   ++ +   +L  K                     L +  Q
Sbjct: 69  FNAWLEKNT--TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----P 166
           +   VEF+HSK  +HRD+KP N    +    + V + DFGL          Q +      
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
           Y  +    GT  Y S     G   S + D+ SLG +L   L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 3   PRVGNK--FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           P  GN+  ++L RK+G G + E++   NI  NE V +K+     K    +    L + L+
Sbjct: 37  PSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKIL-ENLR 95
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------QM 112
           GGT I  L            V D +  +   +F + +     +   +L D        ++
Sbjct: 96  GGTNIIKLI---------DTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYEL 146
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +  +++ HSK  +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 147 LKALDYCHSKGIMHRDVKPHNVM--IDHQQKKLRLIDWGLAEFY 188

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 60/261 (22%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------------ENVKTK-------- 45
           K+ L   IG GS+G + +    QT    AIK+              E +KT+        
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 46  HPQL----------QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSL------ 89
           HP +          QY   + ++  GG  +  L  F ++       +D++   +      
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF-IDDSTGKCAMDVVKTQICPCPEC 145
Query: 90  -EDLFN-----------FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
            E+  N           F  R+   K +  +  Q+ + + ++H++   HRDIKP+NFL  
Sbjct: 146 NEEAINGSIHGFRESLDFVQRE---KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDD 195
              ++ ++ ++DFGL+K +      +   Y       GT  + +        +S   + D
Sbjct: 203 TN-KSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 196 LESLGYVLMYFLRGSLPWQGL 216
             S G +L   L G++P+ G+
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGV 279

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQY--EAKLYKILQGGTGI 65
           G K G G FG +Y G     N  VA+K    + ++ T+  + Q+  E K+    Q    +
Sbjct: 27  GNKXGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQH-ENL 83
Query: 66  PNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 121
             L  F  +GD ++ ++ +  P  SL D  +    +  LS      +A    N + F+H 
Sbjct: 84  VELLGFSSDGD-DLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHE 142
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+     A    I DFGLA+     A+ +         + GT  Y +
Sbjct: 143 NHHIHRDIKSANILLD---EAFTAKISDFGLAR-----ASEKFAQXVXXSRIVGTTAYXA 194
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
                G E + + D+ S G VL+  + G LP
Sbjct: 195 PEALRG-EITPKSDIYSFGVVLLEIITG-LP 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           F++ R +G+GSFG ++L  +       A+K+  + +  +  Q+++      +L   T   
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSF 124
            +R +G   D   + + +      +LF+    S++         A ++   +E++HSK  
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           ++RD+KP+N L+    +   + I DFG AK   D              L GT  Y +   
Sbjct: 128 IYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------XLCGTPDYIAPEV 174
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                 ++  D  S G ++   L G  P+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 20/221 (9%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQ---LQYEAKL 55
           ++PR   ++  GR +G G F + Y  T++ T E  A K+  +++  K  Q   +  E  +
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMI 113
           +K L     +     F  + D+  +V+++       L     R+ ++          Q I
Sbjct: 96  HKSLDNPHVV-GFHGFFEDDDFVYVVLEIC--RRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             V+++H+   +HRD+K  N  +        V I DFGLA +       +       K L
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERK-------KTL 202
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
            GT  Y +         S   D+ SLG +L   L G  P++
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYQMAAGYP 236

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 34/169 (20%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           V + + +   IG GS+G +YL  +  T + VAIK  N        +      +IL+  T 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-----MFEDLIDCKRILREITI 78
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL-----------KTVLMLADQMI 113
           +  L+      DY + + DL+ P  +DL  F    + L           KT + L ++ I
Sbjct: 79  LNRLK-----SDYIIRLYDLIIP--DDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHI 131
Query: 114 NRV--------EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             +         F+H    +HRD+KP N L+    +   V + DFGLA+
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFGLAR 177

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLXGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLR---W 70
           ++G GSFGE++   + QT  + A+K         +++ E    + L    G+ + R    
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVK---------KVRLEVFRVEELVACAGLSSPRIVPL 115
Query: 71  FGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
           +G   EG +  + ++LL G SL  L       L     L    Q +  +E++H++  LH 
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+K DN L  L    ++  + DFG A   +     + +       + GT  + +    +G
Sbjct: 175 DVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGDYIPGTETHMAPEVVMG 230
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
                + D+ S   ++++ L G  PW
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 100
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 159 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 205
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 206 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 237

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 7/109 (6%)
Query: 55  LYKILQGGTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQ 111
           L K+  G +G+  L  WF    D  VL+++   P ++DLF+F + + +L+  L  +   Q
Sbjct: 108 LKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQ 165
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
           ++  V   H+   LHRDIK +N L+ L R   ++ +IDFG     +DT 
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTV 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 31/176 (17%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 44  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--------------- 99
           +   L     I NL      G   +++ +       DL NF  RK               
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            LS + +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DFGLA+
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDFGLAR 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE-AKLYKILQGGTGIPNLRW 70
           +G+G+F E+ L  + +T + VAIK    + ++ K   ++ E A L+KI      I  L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH--PNIVALDD 83
Query: 71  FGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRD 128
               G +  L++ L+  S  +LF+    K   + +    L  Q+++ V+++H    +HRD
Sbjct: 84  IYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 141
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 188
           +KP+N L       +++ I DFGL+K           P        GT  Y +       
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLSK--------MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
             S+  D  S+G +    L G  P+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 20/221 (9%)
Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQ---LQYEAKL 55
           ++PR   ++  GR +G G F + Y  T++ T E  A K+  +++  K  Q   +  E  +
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 56  YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMI 113
           +K L     +     F  + D+  +V+++       L     R+ ++          Q I
Sbjct: 96  HKSLDNPHVV-GFHGFFEDDDFVYVVLEIC--RRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             V+++H+   +HRD+K  N  +        V I DFGLA +       +       K L
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKIEFDGERK-------KXL 202
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
            GT  Y +         S   D+ SLG +L   L G  P++
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQY-------EAKLYKILQGGTG 64
           IG G    +    +  T  E A+K+  V  +     QL+        E  + + + G   
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSK 122
           I  L        +  LV DL+     +LF++ + K++L  K    +   ++  V F+H+ 
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKG--ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY--- 179
           + +HRD+KP+N L+       Q+ + DFG +            P  + + L GT  Y   
Sbjct: 220 NIVHRDLKPENILLDDNM---QIRLSDFGFSCHLE--------PGEKLRELCGTPGYLAP 268
Query: 180 ----ASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                SM+ TH G    +  DL + G +L   L GS P+
Sbjct: 269 EILKCSMDETHPGY--GKEVDLWACGVILFTLLAGSPPF 305

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+D+GLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDYGLARHTDDEMT 180

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---------EAKLYKILQGGTGI 65
           +G G F  +Y   +  TN+ VAIK   +K  H              E KL + L     I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIK--KIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
             L  FG + + + LV D +   LE +    S  L+   +       +  +E++H    L
Sbjct: 76  GLLDAFGHKSNIS-LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           HRD+KP+N L+        + + DFGLAK +
Sbjct: 135 HRDLKPNNLLLD---ENGVLKLADFGLAKSF 162

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV 73
           ++G GSFGE++   + QT  + A+K         +++ E    + L    G+ + R   +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVK---------KVRLEVFRVEELVACAGLSSPRIVPL 131
Query: 74  -----EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
                EG +  + ++LL G SL  L       L     L    Q +  +E++H++  LH 
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+K DN L  L    ++  + DFG A   +     + +       + GT  + +    +G
Sbjct: 191 DVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGDYIPGTETHMAPEVVMG 246
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
                + D+ S   ++++ L G  PW
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 86
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+        + + DFG AKR +               L GT  Y
Sbjct: 145 HSLDLIYRDLKPENLLID---EQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 191
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 192 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 223

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 159
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD 200

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPAIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 19/215 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           F + + IG G+FGE+ +     T    A+K+    E +K        E +   +      
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 65  IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I  L +   + ++  LV+D  +G  L  L +    KL          +M+  ++ +H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           ++HRDIKPDN L+ +      + + DFG   +  D  T Q      +    GT  Y S  
Sbjct: 212 YVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQ------SSVAVGTPDYISPE 262
Query: 184 THLGIEQSR-----RDDLESLGYVLMYFLRGSLPW 213
               +E          D  SLG  +   L G  P+
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 19/215 (8%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           F + + IG G+FGE+ +     T    A+K+    E +K        E +   +      
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 65  IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I  L +   + ++  LV+D  +G  L  L +    KL          +M+  ++ +H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           ++HRDIKPDN L+ +      + + DFG   +  D  T Q      +    GT  Y S  
Sbjct: 196 YVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQ------SSVAVGTPDYISPE 246
Query: 184 THLGIEQSR-----RDDLESLGYVLMYFLRGSLPW 213
               +E          D  SLG  +   L G  P+
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69  -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKS 123
            +   V    N L + +     +DL  F        + L  +     Q++  + F HS  
Sbjct: 64  VKLLDVIHTENKLYL-VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTAR 178
            LHRD+KP N L+        + + DFGLA+ +     T TH+ +   YR  + L G   
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 179 YAS 181
           Y++
Sbjct: 180 YST 182

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGT 63
           ++F+   K+G+G++  +Y G N  T   VA   +KL++ +        E  L K L+   
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 64  GIPNLRWFGVEGDYN--VLVIDLLGPSLEDLFNF-----CSRKLSLKTVLMLADQMINRV 116
            +   R + V    N   LV + +   L+   +        R L L  V     Q++  +
Sbjct: 65  IV---RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            F H    LHRD+KP N L+    +  Q+ + DFGLA+ +
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAF 158

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNL 173
           ++F+HS +  HRD+KP+N L     +   + + DFG AK     A  T  + PY     +
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            G  +Y            +  D+ SLG V+MY L    P
Sbjct: 201 LGPEKY-----------DKSCDMWSLG-VIMYILLCGFP 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLR---W 70
           ++G GSFGE++   + QT  + A+K         +++ E    + L    G+ + R    
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVK---------KVRLEVFRVEELVACAGLSSPRIVPL 129
Query: 71  FGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
           +G   EG +  + ++LL G SL  L       L     L    Q +  +E++H++  LH 
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
           D+K DN L  L    ++  + DFG A   +     + +       + GT  + +    +G
Sbjct: 189 DVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGDYIPGTETHMAPEVVMG 244
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
                + D+ S   ++++ L G  PW
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNL 173
           ++F+HS +  HRD+KP+N L     +   + + DFG AK     A  T  + PY     +
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 181
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            G  +Y            +  D+ SLG V+MY L    P
Sbjct: 182 LGPEKY-----------DKSCDMWSLG-VIMYILLCGFP 208

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + ++L RK+G G + E++   NI  NE+VA+K+     K    +    L + L+GG  I 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKIL-ENLRGGPNII 95
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------QMINRVEF 118
            L       D   +V D +  +   +F   +     +    L D        +++  +++
Sbjct: 96  TL------AD---IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            HS   +HRD+KP N L+    R  ++ +ID+GLA+ Y
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHR--KLRLIDWGLAEFY 182

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGTGI 65
           F     +G+G+F E+ L     T +  A+K    + +K K   ++ E  + + ++    I
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH-ENI 82
Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 123
             L       ++  LV+ L+  S  +LF+    K   + K    L  Q+++ V ++H   
Sbjct: 83  VALEDIYESPNHLYLVMQLV--SGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +HRD+KP+N L       +++ I DFGL+K
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSK 171

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + +       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFAEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 47/109 (43%), Gaps = 11/109 (10%)
Query: 99  KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           KL     L L +Q+   V+++HSK  +HRD+KP N  +       QV I DFGL    ++
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL---VDTKQVKIGDFGLVTSLKN 188
Query: 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
                           GT RY S       +  +  DL +LG +L   L
Sbjct: 189 DGKRTRSK--------GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIP 66
           + +   IG GS+       +  TN E A+K+ +   + P  + E     +L+ G    I 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNII 79
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
            L+    +G Y  +V +L+  G  L+ +     F  R+ S   VL     +   VE++H+
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--AVLF---TITKTVEYLHA 134
Query: 122 KSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           +  +HRD+KP N L +        + I DFG AK+ R           EN  L      A
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTA 184
Query: 181 SMNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPW 213
           +      +E+   D   D+ SLG +L   L G  P+
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTM 65
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
            ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 125 AYLESKRFVHRDIAARNVLVS---ATDCVKLGDFGLS-RYMEDSTY 166

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+DF LA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFYLARHTDDEMT 180

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 1   MEPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYK 57
           M+P+V  N F   + +G G+FG++ L     T    A+K+  + V     ++ +     +
Sbjct: 3   MDPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 58  ILQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMI 113
           +LQ      +  L++     D    V++       +LF   SR+   + +       +++
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIV 120
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKN 172
           + +E++HS+  ++RDIK +N ++    +   + I DFGL K    D AT         K 
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KX 169
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
             GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 7/145 (4%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
           R+IG GSFG +Y   +++ +E VAIK  +   K    +++   K  + LQ       +++
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 71  FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
            G  +      LV++    S  DL     + L    +  +    +  + ++HS + +HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLA 153
           +K  N L+        V + DFG A
Sbjct: 180 VKAGNILLS---EPGLVKLGDFGSA 201

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 8/103 (7%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q++  V ++H    +HRD+KP+N L         + I DFGL+K       HQ +     
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK----IVEHQVL----M 207
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           K + GT  Y +     G       D+ S+G +    L G  P+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 44  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVI-------DLLG-------PSLEDLFNFC---S 97
           +   L     I NL      G   VLVI       DLL        P LE  +N      
Sbjct: 102 IMSHLGQHENIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPE 160
Query: 98  RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +LS + +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DFGLA+
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDFGLAR 214

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN----LR 69
           ++G G+FG++Y   N +T+   A K+ + K++     Y  ++  IL      PN    L 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DIL-ASCDHPNIVKLLD 101
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
            F  E +  +L+    G +++ +     R L+   + ++  Q ++ + ++H    +HRD+
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKR 155
           K  N L  L      + + DFG++ +
Sbjct: 162 KAGNILFTLD---GDIKLADFGVSAK 184

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNLR--WFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N ++    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLIID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    +    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIIISKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           F+   KIG G++G +Y   N  T E VA+K   + T+   +   A     L      PN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 69  -RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
            +   V    N   LV + +   L+   +  +   + L  +     Q++  + F HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+KP N L+        + + DFGLA+ +        +P R   +   T  Y +   
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAF-------GVPVRTYXHEVVTLWYRAPEI 177
Query: 185 HLGIE-QSRRDDLESLGYV 202
            LG +  S   D+ SLG +
Sbjct: 178 LLGCKYYSTAVDIWSLGCI 196

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK----NCTSDSVREKFLQEALTM 93
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 94  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 152
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
            ++ SK F+HRDI   N L+      + V + DFGL++   D+  ++
Sbjct: 153 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYK 196

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN----LR 69
           ++G G+FG++Y   N +T+   A K+ + K++     Y  ++  IL      PN    L 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DIL-ASCDHPNIVKLLD 101
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
            F  E +  +L+    G +++ +     R L+   + ++  Q ++ + ++H    +HRD+
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKR 155
           K  N L  L      + + DFG++ +
Sbjct: 162 KAGNILFTLD---GDIKLADFGVSAK 184

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTM 67
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 68  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 126
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
            ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 127 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-RYMEDSTY 168

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN----LR 69
           ++G G+FG++Y   N +T+   A K+ + K++     Y  ++  IL      PN    L 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DIL-ASCDHPNIVKLLD 101
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
            F  E +  +L+    G +++ +     R L+   + ++  Q ++ + ++H    +HRD+
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKR 155
           K  N L  L      + + DFG++ +
Sbjct: 162 KAGNILFTLD---GDIKLADFGVSAK 184

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  +         A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTM 68
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 69  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 127
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
            ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 128 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-RYMEDSTY 169

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 7/145 (4%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
           R+IG GSFG +Y   +++ +E VAIK  +   K    +++   K  + LQ       +++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 71  FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
            G  +      LV++    S  DL     + L    +  +    +  + ++HS + +HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLA 153
           +K  N L+        V + DFG A
Sbjct: 141 VKAGNILLS---EPGLVKLGDFGSA 162

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTM 65
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 124
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
            ++ SK F+HRDI   N L+      + V + DFGL++   D+  ++
Sbjct: 125 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYK 168

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTG 64
            +++   + IGSG+FG   L  +  T E VA+K +E        +Q E   ++ L+    
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH--- 75
Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
            PN+ R+  V      L I +   S  +L+   C+  + S         Q+++ V + HS
Sbjct: 76  -PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
               HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y +
Sbjct: 135 MQICHRDLKLENTLLD-GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 185
Query: 182 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
               L  E   +  D+ S G  L   L G+ P++
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTM 70
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
            ++ SK F+HRDI   N L+      + V + DFGL++   D+  ++
Sbjct: 130 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYK 173

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIP 66
           LG +IG G+FGE++ G     N  VA+K    +T  P L+     EA++ K        P
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 122
           N+ R  GV      + I +      D   F      +L +KT+L +       +E++ SK
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
             +HRD+   N L+      N + I DFG+++   D
Sbjct: 233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEAD 265

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTM 65
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 124
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
            ++ SK F+HRDI   N L+      + V + DFGL++   D+  ++
Sbjct: 125 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYK 168

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIP 66
           LG +IG G+FGE++ G     N  VA+K    +T  P L+     EA++ K        P
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 122
           N+ R  GV      + I +      D   F      +L +KT+L +       +E++ SK
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
             +HRD+   N L+      N + I DFG+++   D
Sbjct: 233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEAD 265

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 120
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  +         A Q++   E++
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 178
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 179 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 225
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 226 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 257

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  +         A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 94
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  +         A Q++   E++
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 152
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 153 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 199
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 200 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 231

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTM 62
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 63  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
            ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 122 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-RYMEDSTY 163

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQYEAKLYKILQGGT- 63
           + F + + IG G+F E+ +    QT +  A+K+ N     K  ++    +   +L  G  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 64  -GIPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
             I  L +   + +Y  LV++  +G  L  L +    ++  +       +++  ++ VH 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
             ++HRDIKPDN L+    R   + + DFG   + R   T
Sbjct: 181 LGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGT 217

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK-------LYKILQGGTGIP 66
           +GSG++G +    + ++ E+VAIK    K   P Q +  AK       L K +Q    I 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 67  NLRWFGVEGDY-NVLVIDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L  F       N     L+ P ++ DL      K S + +  L  QM+  ++++HS   
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+KP N  +       ++ I+DFGLA+
Sbjct: 148 VHRDLKPGNLAVN---EDCELKILDFGLAR 174

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTM 445
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
            ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 505 AYLESKRFVHRDIAARNVLVSA---TDCVKLGDFGLS-RYMEDSTY 546

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  +         A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           HS   ++RD+KP+N L+    +   + + DFG AKR +               L GT  Y
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEY 204
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
            +    L    ++  D  +LG VL+Y +    P
Sbjct: 205 LAPEIILSKGYNKAVDWWALG-VLIYEMAAGYP 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQL------QYEAKLYKILQGGT 63
           L R++G G+FG+++L      +      L  VK  K P L      Q EA+L   LQ   
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 64  GIPNLRWFGVEGDYNVLVI--------DL------LGPSLEDLFNFCSRK----LSLKTV 105
            +   +++GV GD + L++        DL       GP    L +   R+    L L  +
Sbjct: 79  IV---KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQH 164
           L +A Q+ + + ++ S+ F+HRD+   N L+G    AN  V I DFG++   RD  +  +
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDFGMS---RDVYSTDY 188
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
             YR   +     R+    + +  + +   D+ S G +L   F  G  PW
Sbjct: 189 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           + + + IG G+FGE+ L  +  T +  A+KL    E +K       +E +          
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
           +  L +   +  Y  +V++ +     DL N  S   +  K       +++  ++ +HS  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
           F+HRD+KPDN L+    ++  + + DFG
Sbjct: 194 FIHRDVKPDNMLLD---KSGHLKLADFG 218

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYK-ILQGGTGI 65
           ++ + RK+G G F  ++L  +IQ  + VA+K+      + +    E +L K +       
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 66  PN----------LRWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMIN 114
           PN           +  GV G +  +V ++LG   L+ +     + L L  V  +  Q++ 
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 141
Query: 115 RVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYI 147
            ++++H+K   +H DIKP+N L+ +    N+ YI
Sbjct: 142 GLDYLHTKCRIIHTDIKPENILLSV----NEQYI 171

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------LENVKT-KHP 47
           +   + L   IG GS+GE+ +     T    A K                +E +K+  HP
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +    +LY+  +  T I           Y V+ +   G   E + +   R         
Sbjct: 67  NI---IRLYETFEDNTDI-----------YLVMELCTGGELFERVVH--KRVFRESDAAR 110
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +   +++ V + H  +  HRD+KP+NFL       + + +IDFGLA R++        P 
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--------PG 162
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +  +   GT  Y S     G+     D+  S G V+MY L    P
Sbjct: 163 KMMRTKVGTPYYVSPQVLEGLYGPECDEW-SAG-VMMYVLLCGYP 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNLR 69
           +IG G++G +Y   +  +   VA+K   V      L      E  L + L+       +R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 70  WFGV----EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHS 121
              V      D  + V  +     +DL  +  +     L  +T+  L  Q +  ++F+H+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
              +HRD+KP+N L+  G     V + DFGLA+ Y
Sbjct: 131 NCIVHRDLKPENILVTSG---GTVKLADFGLARIY 162

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           + + + IG G+FGE+ L  +  T +  A+KL    E +K       +E +          
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
           +  L +   +  Y  +V++ +     DL N  S   +  K       +++  ++ +HS  
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
           F+HRD+KPDN L+    ++  + + DFG
Sbjct: 189 FIHRDVKPDNMLLD---KSGHLKLADFG 213

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG--TGIP 66
           + +   IG GS+       +  TN E A+K+ +   + P  + E     +L+ G    I 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNII 79
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
            L+    +G Y  +V +L   G  L+ +     F  R+ S   VL     +   VE++H+
Sbjct: 80  TLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREAS--AVLF---TITKTVEYLHA 134
Query: 122 KSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           +  +HRD+KP N L +        + I DFG AK+ R           EN  L      A
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLXTPCYTA 184
Query: 181 SMNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPW 213
           +      +E+   D   D+ SLG +L   L G  P+
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
            +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    +
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTM 65
Query: 66  -----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
                P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   +
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            ++ SK F+HRDI   N L+      + V + DFGL++   D+ 
Sbjct: 125 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 165

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNLR 69
           +IG G++G +Y   +  +   VA+K   V      L      E  L + L+       +R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 70  WFGV----EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHS 121
              V      D  + V  +     +DL  +  +     L  +T+  L  Q +  ++F+H+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
              +HRD+KP+N L+  G     V + DFGLA+ Y
Sbjct: 131 NCIVHRDLKPENILVTSG---GTVKLADFGLARIY 162

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           F     +GSG+F E++L     T +  A+K   ++   +   L+ E  + K ++    I 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIV 69
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSF 124
            L        +  LV+ L+     +LF+    +   + K   ++  Q+++ V+++H    
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGG--ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD+KP+N L       +++ I DFGL+K  ++                GT  Y +   
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---------STACGTPGYVAPEV 178
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
                 S+  D  S+G +    L G  P+
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYK-ILQGGTGI 65
           ++ + RK+G G F  ++L  +IQ  + VA+K+      + +    E +L K +       
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 66  PN----------LRWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMIN 114
           PN           +  GV G +  +V ++LG   L+ +     + L L  V  +  Q++ 
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 115 RVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYI 147
            ++++H+K   +H DIKP+N L+ +    N+ YI
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSV----NEQYI 187

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNLR 69
           +IG G++G +Y   +  +   VA+K   V      L      E  L + L+       +R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 70  WFGV----EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHS 121
              V      D  + V  +     +DL  +  +     L  +T+  L  Q +  ++F+H+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
              +HRD+KP+N L+  G     V + DFGLA+ Y
Sbjct: 131 NCIVHRDLKPENILVTSG---GTVKLADFGLARIY 162

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
           + + + IG G+FGE+ L  +  T +  A+KL    E +K       +E +          
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
           +  L +   +  Y  +V++ +     DL N  S   +  K       +++  ++ +HS  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
           F+HRD+KPDN L+    ++  + + DFG
Sbjct: 194 FIHRDVKPDNMLLD---KSGHLKLADFG 218

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTG-- 64
           ++ + RK+G G F  ++L  ++Q    VA+K+      + +    E KL K ++      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 65  ---------IPNLRWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMIN 114
                    I + +  G+ G +  +V ++LG   L+ +     + L ++ V  +  Q++ 
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQ 151
Query: 115 RVEFVHSKS-FLHRDIKPDNFLM 136
            ++++HSK   +H DIKP+N LM
Sbjct: 152 GLDYLHSKCKIIHTDIKPENILM 174

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+ FGLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILGFGLARHTDDEMT 180

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 31/176 (17%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQ----LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E A+    VK    T H      L  E K
Sbjct: 44  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--------------- 99
           +   L     I NL      G   +++ +       DL NF  RK               
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYC--CYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             S + +L  + Q+   + F+ SK+ +HRD+   N L+  G  A    I DFGLA+
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK---IGDFGLAR 212

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------LENVKT-KHP 47
           +   + L   IG GS+GE+ +     T    A K                +E +K+  HP
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 83
Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +    +LY+  +  T I           Y V+ +   G   E + +   R         
Sbjct: 84  NI---IRLYETFEDNTDI-----------YLVMELCTGGELFERVVH--KRVFRESDAAR 127
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +   +++ V + H  +  HRD+KP+NFL       + + +IDFGLA R++        P 
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--------PG 179
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           +  +   GT  Y S     G+     D+  S G V+MY L    P
Sbjct: 180 KMMRTKVGTPYYVSPQVLEGLYGPECDEW-SAG-VMMYVLLCGYP 222

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+D GLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDAGLARHTDDEMT 180

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLQYEAKLYKILQGGT 63
           V  ++ + + IG GSFG++    + + ++ VA+K+  N K  H Q   E ++ + L+   
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 64  GIPNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
               +    +  ++       +  +LL  +L +L      +  SL  V   A  ++  ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H    +H D+KP+N L+    R+  + +IDFG +  Y     +  I  R         
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFG-SSCYEHQRVYTXIQSR--------- 263
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
            Y +    LG       D+ SLG +L   L G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++   + IG G++G +    +      VAIK  +        Q   +  +IL     
Sbjct: 41  VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRH 100
Query: 60  QGGTGIPN-LRWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI + LR   +E   +V ++ DL+   L  L    S++LS   +     Q++  ++
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK--SQQLSNDHICYFLYQILRGLK 158
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 159 YIHSANVLHRDLKPSNLLIN---TTCDLKICDFGLAR 192

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+ + +   K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 65  IPNL--RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
            P L    F  + + N+ +V++ +     ++F+   R  + S       A Q++   E++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
           HS   ++RD+KP+N L+    +   + + DFG AKR +
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI- 65
           +  LGR IG G FG+++ G  +   N  +A+ ++  K        ++   K LQ    + 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMR 446
Query: 66  ----PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVE 117
               P++ +  GV  +  V +I  L  +L +L +F   +   L L ++++ A Q+   + 
Sbjct: 447 QFDHPHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           ++ SK F+HRDI   N L+      + V + DFGL+ RY + +T+
Sbjct: 506 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-RYMEDSTY 546

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLQYEAKLYKILQGGT 63
           V  ++ + + IG GSFG++    + + ++ VA+K+  N K  H Q   E ++ + L+   
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 64  GIPNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
               +    +  ++       +  +LL  +L +L      +  SL  V   A  ++  ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H    +H D+KP+N L+    R+  + +IDFG +  Y     +  I  R         
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFG-SSCYEHQRVYTXIQSR--------- 263
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
            Y +    LG       D+ SLG +L   L G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
           KIG GS G + + T   T ++VA+K  ++ K +  +L +   +         + ++    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 73  VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
           + GD   +V++ L G +L D+      +++ + +  +   ++  + ++H++  +HRDIK 
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
           D+ L+    R   + + DFG   +       + +P R  K L GT  + +      +   
Sbjct: 170 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KXLVGTPYWMAPEVISRLPYG 219
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPY 241

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 22/222 (9%)
Query: 1   MEPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYK 57
           M+PRV  N+F   + +G G+FG++ L     T    A+K+  + V     ++ +     +
Sbjct: 3   MDPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 58  ILQGGTG--IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMI 113
           +LQ      +  L++     D    V++       +LF   SR+   S         +++
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIV 120
Query: 114 NRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENK 171
           + ++++HS K+ ++RD+K +N ++    +   + I DFGL K   +D AT         K
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATM--------K 169
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
              GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+D GLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDRGLARHTDDEMT 180

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 101/247 (40%), Gaps = 49/247 (19%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVK-----TKHPQLQYEAK 54
           PR  N+   G+ +G+G+FG++   T    I+++  + + ++ +K     T+   L  E K
Sbjct: 44  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKT--VLM- 107
           +   L     I NL      G   +++ +       DL NF  RK    +  KT   +M 
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIME 159
Query: 108 -------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                         + Q+   + F+ SK+ +HRD+   N L+  GR      I DFGLA+
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLAR 216
Query: 155 RYRDTATHQHIPYRENKNLTGTAR----YASMNTHLGIEQSRRDDLESLGYVLM-YFLRG 209
                    HI    N  + G AR    + +  +      +   D+ S G  L   F  G
Sbjct: 217 ---------HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 267
Query: 210 SLPWQGL 216
           S P+ G+
Sbjct: 268 SSPYPGM 274

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG--TGIP 66
           + +   IG GS+ E     +  TN E A+K+ +   + P  + E     +L+ G    I 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI----LLRYGQHPNII 84
Query: 67  NLRWFGVEGDYNVLVIDLL--GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
            L+    +G +  LV +L+  G  L+ +     F  R+ S      +   +   VE++HS
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHS 139
Query: 122 KSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           +  +HRD+KP N L +        + I DFG AK+ R           EN  L      A
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTA 189
Query: 181 SMNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPW 213
           +      +++   D   D+ SLG +L   L G  P+
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GT 63
           N F + R IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 64  G----IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 117
           G    I  + +     D    ++DL+     DL    S+    S   +   A ++I  +E
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H++  ++RD+KP N L+        V I D GLA  +     H  +         GT 
Sbjct: 307 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTH 354
Query: 178 RYASMNT-HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
            Y +      G+      D  SLG +L   LRG  P++  K 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 75/163 (46%), Gaps = 30/163 (18%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYK---------- 57
           F L   +G+G++G++Y G +++T +  AIK+ +V   +  +++ E  + K          
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 58  -----ILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 110
                I +   G+ +  W         LV++  G  S+ DL  N     L  + +  +  
Sbjct: 86  YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
           +++  +  +H    +HRDIK  N L+       +V ++DFG++
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVS 176

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 87
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 148 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 177

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 33  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 88
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 148
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 149 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 178

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG--TGIPNLRWFG 72
           IG GS+ E     +  TN E A+K+ +   + P  + E     +L+ G    I  L+   
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI----LLRYGQHPNIITLKDVY 90
Query: 73  VEGDYNVLVIDLL--GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
            +G +  LV +L+  G  L+ +     F  R+ S      +   +   VE++HS+  +HR
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQGVVHR 145
Query: 128 DIKPDNFL-MGLGRRANQVYIIDFGLAKRYR 157
           D+KP N L +        + I DFG AK+ R
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLR 176

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKIL 59
            V  +++    +GSG++G +    + +T   VA+K  +   +   H +  Y E +L K +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 60  QGGTGIPNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
           +    I  L  F     +E   +V LV  L+G  L ++     +KL+   V  L  Q++ 
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 136
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++++HS   +HRD+KP N  +       ++ I+D GLA+   D  T
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVN---EDCELKILDGGLARHTDDEMT 180

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GT 63
           N F + R IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     T
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 64  G----IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 117
           G    I  + +     D    ++DL+     DL    S+    S   +   A ++I  +E
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H++  ++RD+KP N L+        V I D GLA  +     H  +         GT 
Sbjct: 306 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTH 353
Query: 178 RYASMNT-HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
            Y +      G+      D  SLG +L   LRG  P++  K 
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK-------LYKILQGGTGIP 66
           +GSG++G +    + ++ E+VAIK    K   P Q +  AK       L K +Q    I 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 67  NLRWFGVEGDY-NVLVIDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            L  F       N     L+ P ++ DL      + S + +  L  QM+  ++++HS   
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +HRD+KP N  +       ++ I+DFGLA+
Sbjct: 166 VHRDLKPGNLAVN---EDCELKILDFGLAR 192

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVK-----TKHPQLQYEAK 54
           PR  N+   G+ +G+G+FG++   T    I+++  + + ++ +K     T+   L  E K
Sbjct: 21  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKT--VLM- 107
           +   L     I NL      G   +++ +       DL NF  RK    +  KT   +M 
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 108 -------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                         + Q+   + F+ SK+ +HRD+   N L+  GR      I DFGLA 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLA- 192
Query: 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
             RD     +   + N  L    ++ +  +      +   D+ S G  L   F  GS P+
Sbjct: 193 --RDIKNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 214 QGL 216
            G+
Sbjct: 249 PGM 251

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GT 63
           N F + R IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 64  G----IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 117
           G    I  + +     D    ++DL+     DL    S+    S   +   A ++I  +E
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H++  ++RD+KP N L+        V I D GLA  +     H  +         GT 
Sbjct: 307 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTH 354
Query: 178 RYASMNT-HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
            Y +      G+      D  SLG +L   LRG  P++  K 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GT 63
           N F + R IG G FGE+Y      T +  A+K L+  + K  Q +  A   +I+     T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 64  G----IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 117
           G    I  + +     D    ++DL+     DL    S+    S   +   A ++I  +E
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H++  ++RD+KP N L+        V I D GLA  +     H  +         GT 
Sbjct: 307 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTH 354
Query: 178 RYASMNT-HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
            Y +      G+      D  SLG +L   LRG  P++  K 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 11/165 (6%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGG 62
            + R  + +GSG+FG +Y G  I   E     VAIK+    T  P+   E      +  G
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAG 75
Query: 63  TGIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
            G P + R  G+     V ++  L P   L D       +L  + +L    Q+   + ++
Sbjct: 76  VGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
                +HRD+   N L+   +  N V I DFGLA+      T  H
Sbjct: 136 EDVRLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYH 177

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 100
Query: 60  QGGTGIPNL-RWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V LV  L+G  L  L    ++ LS   +     Q++  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLK 158
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 159 YIHSANVLHRDLKPSNLLLN---TTXDLKICDFGLAR 192

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 67/136 (49%), Gaps = 14/136 (10%)
Query: 80  LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
           LV++L+  +L  + +    +L  + +  L  QM+  ++ +HS   +HRD+KP N ++   
Sbjct: 104 LVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 157
Query: 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 199
           +    + I+DFGLA+    +      PY        T  Y +    LG+      D+ S+
Sbjct: 158 KSDCTLKILDFGLAR--TASTNFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSV 209
Query: 200 GYVLMYFLRGSLPWQG 215
           G ++   ++GS+ +QG
Sbjct: 210 GCIMGELVKGSVIFQG 225

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 87
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 147
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 148 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 177

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 52  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 107
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 167
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 168 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 197

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
           + IG+GSFG ++    +++ +EVAIK  L++ + K+ +LQ    + +I++    +    +
Sbjct: 46  KVIGNGSFGVVFQAKLVES-DEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVDLKAF 100
Query: 71  FGVEGDY-NVLVIDLLGPSLEDLFNFCSR---KLSLKTVLMLAD----QMINRVEFVHSK 122
           F   GD  + + ++L+   + +     SR   KL     ++L      Q++  + ++HS 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
              HRDIKP N L  L   +  + +IDFG AK
Sbjct: 161 GICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 50/224 (22%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNLR 69
           KIG GS+G ++   N  T + VAIK        P ++     E ++ K L+     PNL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH----PNL- 64
Query: 70  WFGVEGDYNVLVIDLLGPSLEDLFNFC-----------SRKLSLKTVLMLADQMINRVEF 118
                   N+L +      L  +F +C            R +    V  +  Q +  V F
Sbjct: 65  -------VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------RYRDTATHQHIPYRENK 171
            H  + +HRD+KP+N L+    + + + + DFG A+        Y D    +   YR  +
Sbjct: 118 CHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRW--YRSPE 172
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
            L G  +Y               D+ ++G V    L G   W G
Sbjct: 173 LLVGDTQYGPPV-----------DVWAIGCVFAELLSGVPLWPG 205

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLMGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 46/285 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L +K+G+G FGE+++G     + +VA+K     T   Q    EA L K LQ    +  
Sbjct: 14  IKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV-- 70
Query: 68  LRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            R + V    E  Y +      G  L+ L +    K+ L  ++  + Q+   + ++  K+
Sbjct: 71  -RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYAS 181
           ++HRD++  N L+     +    I DFGLA+   D         RE     +  TA  A 
Sbjct: 130 YIHRDLRAANVLVS---ESLMCKIADFGLARVIEDN----EYTAREGAKFPIKWTAPEAI 182
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
                 I    + ++ S G +L   +  G +P+ G                  +  + AL
Sbjct: 183 NFGCFTI----KSNVWSFGILLYEIVTYGKIPYPG---------------RTNADVMSAL 223
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            +GY        P E       C   + +++P + YL+ +  D +
Sbjct: 224 SQGYRMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFY 268

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + + + RK+G G + E++ G N+  NE    K      K  + +   +  KILQ   G P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 67  NL-RWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           N+ +   +  D +     L+   + +  F      L+   +     +++  +++ HS+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 146
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 176

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 46/285 (16%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPN 67
            +L +++G+G FGE+++G     + +VA+K     T   Q    EA L K LQ    +  
Sbjct: 15  IKLVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV-- 71
Query: 68  LRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            R + V    E  Y +      G  L+ L +    K+ L  ++  + Q+   + ++  K+
Sbjct: 72  -RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYAS 181
           ++HRD++  N L+     +    I DFGLA+   D         RE     +  TA  A 
Sbjct: 131 YIHRDLRAANVLVS---ESLMCKIADFGLARVIEDN----EYTAREGAKFPIKWTAPEAI 183
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
                 I    + D+ S G +L   +  G +P+ G                  +  + AL
Sbjct: 184 NFGCFTI----KSDVWSFGILLYEIVTYGKIPYPG---------------RTNADVMTAL 224
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            +GY        P E       C   + +++P + YL+ +  D +
Sbjct: 225 SQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFY 269

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVK-----TKHPQLQYEAK 54
           PR  N+   G+ +G+G+FG++   T    I+++  + + ++ +K     T+   L  E K
Sbjct: 39  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKT--VLM- 107
           +   L     I NL      G   +++ +       DL NF  RK    +  KT   +M 
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIME 154
Query: 108 -------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                         + Q+   + F+ SK+ +HRD+   N L+  GR      I DFGLA+
Sbjct: 155 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLAR 211
Query: 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
             ++ +      Y    N     ++ +  +      +   D+ S G  L   F  GS P+
Sbjct: 212 DIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266
Query: 214 QGL 216
            G+
Sbjct: 267 PGM 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVK-----TKHPQLQYEAK 54
           PR  N+   G+ +G+G+FG++   T    I+++  + + ++ +K     T+   L  E K
Sbjct: 37  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKT--VLM- 107
           +   L     I NL      G   +++ +       DL NF  RK    +  KT   +M 
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIME 152
Query: 108 -------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                         + Q+   + F+ SK+ +HRD+   N L+  GR      I DFGLA+
Sbjct: 153 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLAR 209
Query: 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
             ++ +      Y    N     ++ +  +      +   D+ S G  L   F  GS P+
Sbjct: 210 DIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264
Query: 214 QGL 216
            G+
Sbjct: 265 PGM 267

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVK-----TKHPQLQYEAK 54
           PR  N+   G+ +G+G+FG++   T    I+++  + + ++ +K     T+   L  E K
Sbjct: 44  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKT--VLM- 107
           +   L     I NL      G   +++ +       DL NF  RK    +  KT   +M 
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIME 159
Query: 108 -------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                         + Q+   + F+ SK+ +HRD+   N L+  GR      I DFGLA+
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLAR 216
Query: 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
             ++ +      Y    N     ++ +  +      +   D+ S G  L   F  GS P+
Sbjct: 217 DIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271
Query: 214 QGL 216
            G+
Sbjct: 272 PGM 274

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           + G  +Y            +  D+ SLG ++   L G  P+
Sbjct: 204 VLGPEKY-----------DKSCDMWSLGVIMYILLCGYPPF 233

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           + G  +Y            +  D+ SLG ++   L G  P+
Sbjct: 196 VLGPEKY-----------DKSCDMWSLGVIMYILLCGYPPF 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 126 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KTFCGTPEY 174
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 189 VLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 194 VLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 188 VLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KTFCGTPEY 171
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 190 VLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
           + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 195 VLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 222

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KTFCGTPEY 171
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRH 82
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 140
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+      + + I DFGLA+
Sbjct: 141 YIHSANVLHRDLKPSNLLLN---TTSDLKICDFGLAR 174

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KXFCGTPEY 171
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 13  RKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           + +GSG+FG +Y G  +   E     VAIK+ N +T  P+   E     ++      P+L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 102
Query: 69  -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFL 125
            R  GV     + ++  L P    L      K ++ + L+L    Q+   + ++  +  +
Sbjct: 103 VRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 162
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           HRD+   N L+   +  N V I DFGLA+
Sbjct: 163 HRDLAARNVLV---KSPNHVKITDFGLAR 188

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           + G  +Y            +  D+ SLG ++   L G  P+
Sbjct: 240 VLGPEKY-----------DKSCDMWSLGVIMYILLCGYPPF 269

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           + G  +Y            +  D+ SLG ++   L G  P+
Sbjct: 234 VLGPEKY-----------DKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 49/105 (46%), Gaps = 13/105 (12%)
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +I  +E++H +  +HRDIKP N L+G       + I DFG++  ++ +            
Sbjct: 146 LIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKGSDALL-------S 195
Query: 172 NLTGTARY---ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           N  GT  +    S++    I   +  D+ ++G  L  F+ G  P+
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--------QLQYEAKLYKILQ 60
           +R  + +GSG++G +    + +T  +VAIK    K   P        +   E +L K ++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 61  GGTGIPNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
               I  L  F  +   +      LV+  +G  L  L      KL    +  L  QM+  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKG 140
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
           + ++H+   +HRD+KP N  +       ++ I+DFGLA++
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 177

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KXFCGTPEY 171
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR---YRDTATHQHIPYRENKN 172
           ++++HS +  HRD+KP+N L    R    + + DFG AK    +    T  + PY     
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           + G  +Y            +  D+ SLG ++   L G  P+
Sbjct: 190 VLGPEKY-----------DKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLQYEAKLYKILQGGT 63
           V  ++ + + IG G FG++    + + ++ VA+K+  N K  H Q   E ++ + L+   
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 64  GIPNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
               +    +  ++       +  +LL  +L +L      +  SL  V   A  ++  ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
            +H    +H D+KP+N L+    R+  + +IDFG +  Y     +  I  R         
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFG-SSCYEHQRVYXXIQSR--------- 263
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
            Y +    LG       D+ SLG +L   L G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           N F   + +G G+FG++ L     T    A+K+  + V     ++ +     ++LQ    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 65  --IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
             +  L++     D    V++       +LF   SR+   + +       ++++ +E++H
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKNLTGTARY 179
           S+  ++RDIK +N ++    +   + I DFGL K    D AT         K   GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KXFCGTPEY 171
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +       +  R  D   LG V+   + G LP+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 14  KIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++G G+FG+++L    N+   ++   VA+K   E  ++     Q EA+L  +LQ    + 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV- 77
Query: 67  NLRWFGV--EGDYNVLVIDLL------------GPSLEDLF---NFCSRKLSLKTVLMLA 109
             R+FGV  EG   ++V + +            GP  + L    +     L L  +L +A
Sbjct: 78  --RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q+   + ++    F+HRD+   N L+G G     V I DFG++   RD  +  +  YR 
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 187
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
                   R+    + L  + +   D+ S G VL   F  G  PW
Sbjct: 188 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 14  KIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++G G+FG+++L    N+   ++   VA+K   E  ++     Q EA+L  +LQ    + 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV- 106
Query: 67  NLRWFGV--EGDYNVLVIDLL------------GPSLEDLF---NFCSRKLSLKTVLMLA 109
             R+FGV  EG   ++V + +            GP  + L    +     L L  +L +A
Sbjct: 107 --RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q+   + ++    F+HRD+   N L+G G     V I DFG+++    T       YR 
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDY-----YRV 216
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
                   R+    + L  + +   D+ S G VL   F  G  PW
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 13  RKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           + +GSG+FG +Y G  +   E     VAIK+ N +T  P+   E     ++      P+L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 79
Query: 69  -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFL 125
            R  GV     + ++  L P    L      K ++ + L+L    Q+   + ++  +  +
Sbjct: 80  VRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 139
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           HRD+   N L+   +  N V I DFGLA+
Sbjct: 140 HRDLAARNVLV---KSPNHVKITDFGLAR 165

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 21/103 (20%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ------HIPYRE 169
           ++++HS +  HRD+KP+N L    R    + + DFG AK   +T +H       + PY  
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYV 184
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
              + G  +Y            +  D+ SLG V+MY L    P
Sbjct: 185 APEVLGPEKY-----------DKSCDMWSLG-VIMYILLCGYP 215

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/209 (21%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTGI 65
            K+ +   +G G FG ++      + +    K   VK T    ++ E  +  I +    I
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNI 63
Query: 66  PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            +L       +  V++ + + G  + +  N  + +L+ + ++    Q+   ++F+HS + 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
            H DI+P+N +    RR++ + II+FG A++ +        P    + L     Y +   
Sbjct: 124 GHFDIRPENIIYQ-TRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEYYAPEV 174
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           H     S   D+ SLG ++   L G  P+
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 221
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY----EAKLYKILQGGTGIP 66
           +IG G++G +Y   +  +   VA+K   + N       L      E  L + L+      
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 67  NLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
            +R   V      D  + V  +     +DL  +  +     L  +T+  L  Q +  ++F
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           +H+   +HRD+KP+N L+  G     V + DFGLA+ Y
Sbjct: 136 LHANCIVHRDLKPENILVTSG---GTVKLADFGLARIY 170

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 14  KIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
           ++G G+FG+++L    N+   ++   VA+K   E  ++     Q EA+L  +LQ    + 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV- 83
Query: 67  NLRWFGV--EGDYNVLVIDLL------------GPSLEDLF---NFCSRKLSLKTVLMLA 109
             R+FGV  EG   ++V + +            GP  + L    +     L L  +L +A
Sbjct: 84  --RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q+   + ++    F+HRD+   N L+G G     V I DFG++   RD  +  +  YR 
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 193
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
                   R+    + L  + +   D+ S G VL   F  G  PW
Sbjct: 194 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 238

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 16/137 (11%)
Query: 80  LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
           LV++L+  +L  + +    +L  + +  L  QM+  ++ +HS   +HRD+KP N ++   
Sbjct: 106 LVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 159
Query: 140 RRANQVYIIDFGLAKRYRDTATH-QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 198
           +    + I+DFGLA   R   T+    PY        T  Y +    LG+  +   D+ S
Sbjct: 160 KSDCTLKILDFGLA---RTACTNFMMTPY------VVTRYYRAPEVILGMGYAANVDIWS 210
Query: 199 LGYVLMYFLRGSLPWQG 215
           +G ++   ++G + +QG
Sbjct: 211 VGCIMGELVKGCVIFQG 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 25/201 (12%)
Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
           +KIG GSFG+  L  + +   +  IK  N+     + + E++    +      PN+  + 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 73  VEGDYN---VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEFVHSK 122
              + N    +V+D       DLF    R  + K VL   DQ+++        ++ VH +
Sbjct: 90  ESFEENGSLYIVMDYCEGG--DLFK---RINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             LHRDIK  N  +    +   V + DFG+A+    T           +   GT  Y S 
Sbjct: 145 KILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELA-------RACIGTPYYLSP 194
Query: 183 NTHLGIEQSRRDDLESLGYVL 203
                   + + D+ +LG VL
Sbjct: 195 EICENKPYNNKSDIWALGCVL 215

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 139 YIHSANVLHRDLKPSNLLLN---TTXDLKICDFGLAR 172

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 142
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 143 YIHSANVLHRDLKPSNLLLN---TTXDLKICDFGLAR 176

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
           + + L   IGSG+   +         E+VAIK   LE  +T   +L  E +         
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-------LSLKTVLMLADQMINRV 116
            +     F V+ +  +++  L G S+ D+      K       L   T+  +  +++  +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY-RENKNLTG 175
           E++H    +HRD+K  N L+G       V I DFG++      AT   I   +  K   G
Sbjct: 130 EYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 183
Query: 176 TARYASMNTHLGIEQSR----RDDLESLGYVLMYFLRGSLPWQ 214
           T  + +      +EQ R    + D+ S G   +    G+ P+ 
Sbjct: 184 TPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYH 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 100
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 158
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 159 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 192

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRH 82
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 140
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 141 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 174

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 82
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 140
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 141 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 174

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 139 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 172

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 29  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 88
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 146
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 147 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 180

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 139 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 172

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 139 YIHSANVLHRDLKPSNLLLN---TTXDLKICDFGLAR 172

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 85
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 143
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 144 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 177

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/212 (17%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPN 67
            +++G G F  +    +  T +E A K    + +      ++ +E  + ++ +    + N
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 68  LRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS 123
           L          +L+++       ++F+ C    +  +S   V+ L  Q++  V ++H  +
Sbjct: 94  LHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            +H D+KP N L+        + I+DFG++++             E + + GT  Y +  
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--------ELREIMGTPEYLAPE 203
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                  +   D+ ++G +    L  + P+ G
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 27  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 86
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 144
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 145 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 178

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 18  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 77
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 135
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 136 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 169

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 142
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 143 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 176

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 142
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 143 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 176

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 85
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 143
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 144 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 177

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 78
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 136
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 137 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 170

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 105/282 (37%), Gaps = 26/282 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
           + + L   IGSG+   +         E+VAIK   LE  +T   +L  E +         
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-------LSLKTVLMLADQMINRV 116
            +     F V+ +  +++  L G S+ D+      K       L   T+  +  +++  +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLTG 175
           E++H    +HRD+K  N L+G       V I DFG++      AT   I   +  K   G
Sbjct: 135 EYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 188
Query: 176 TARYASMNTHLGIEQSR----RDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXX 231
           T  + +      +EQ R    + D+ S G   +    G+ P+                  
Sbjct: 189 TPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 232 XVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271
            + T ++   + + Y   F      C     + +P  A L R
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 78
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 136
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 137 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 170

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 193
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGI 65
           K+ LG+ +G+GSFG +    +I++ +  A+K  L++ + K+ +L     + K+L     I
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVNII 63
Query: 66  PNLRWFGVEGD-------------------------------------YNVLVIDLLGPS 88
             + +F   GD                                     Y  ++++ +  +
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 89  LEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145
           L  +   F    R + +  + +   Q+   V F+HS    HRDIKP N L  +  + N +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTL 181
Query: 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLM 204
            + DFG AK+         IP   +     +  Y +    LG  E +   DL S+G V  
Sbjct: 182 KLCDFGSAKKL--------IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 205 YFLRGSLPWQG 215
             + G   + G
Sbjct: 234 ELILGKPLFSG 244

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 221
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRH 84
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 142
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 143 YIHSANVLHRDLKPSNLLLN---TTXDLKICDFGLAR 176

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 124 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 174
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 69
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 70  HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 127 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 177
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTG 64
           ++F++ R  G G+FG + LG    T   VAIK  +++ + ++ +LQ    L  +L     
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL-AVLHHPNI 81
Query: 65  IPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL-------MLADQMINR 115
           +    +F   G  D   + ++++   + D  + C R    + V        +   Q+I  
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 116 VEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
           +  +H  S +  HRDIKP N L  +      + + DFG AK+
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKK 181

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD+KP+N L+     A   Y++DFG+A    D    Q        N  GT  Y +    
Sbjct: 157 HRDVKPENILVSADDFA---YLVDFGIASATTDEKLTQL------GNTVGTLYYXAPERF 207
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                + R D+ +L  VL   L GS P+QG
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L    ++ LS   +     Q++  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLK 138
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 139 YIHSANVLHRDLKPSNLLLN---TTXDLKIXDFGLAR 172

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----- 59
           VG ++     IG G++G +    +      VAIK  +        Q   +  KIL     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 60  QGGTGIPNL-RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
           +   GI ++ R   +E   +V ++ DL+   L  L     + LS   +     Q++  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--CQHLSNDHICYFLYQILRGLK 142
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 143 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLAR 176

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 23/163 (14%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVA-IKLEN---VKTKHPQLQYEAKLYKILQG 61
           G   +   +IG GSF  +Y G + +T  EVA  +L++    K++  + + EA+  K LQ 
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQH 84
Query: 62  GTGIPNLRWF------GVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMI 113
               PN+  F       V+G   ++++  L  S   L  +  R     +K +     Q++
Sbjct: 85  ----PNIVRFYDSWESTVKGKKCIVLVTELXTS-GTLKTYLKRFKVXKIKVLRSWCRQIL 139
Query: 114 NRVEFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLA 153
             ++F+H+++   +HRD+K DN F+ G       V I D GLA
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLA 179

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----QYEAKLYKILQ 60
           G  + + ++IGSG   +++   N +  +  AIK  N++    Q         A L K+ Q
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 65
Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA--DQMINRVEF 118
               I  L  + +   Y  +V++       DL ++  +K S+      +    M+  V  
Sbjct: 66  HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +  GT  
Sbjct: 123 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 173
Query: 179 YASMNTHLGIEQSRRD-----------DLESLGYVLMYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           + + F+L   +G G++G +   T+  T E VAIK      K        +  KIL+    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 65  IPNLRWFGVE-----GDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              +  F ++      ++N + I  +L+   L  + +  ++ LS   +     Q +  V+
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVK 126
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--- 174
            +H  + +HRD+KP N L+        + + DFGLA+   ++A     P  +   +T   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 175 GTARYASMNTHL-GIEQSRRDDLESLGYVLM-YFLR 208
            T  Y +    L   + SR  D+ S G +L   FLR
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + ++L RK+G G + E++   NI  NE+V +K+     K    +    L + L+GG  I 
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNII 95
Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------QMINRVEF 118
            L       D   +V D +  +   +F   +     +    L D        +++  +++
Sbjct: 96  TL------AD---IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
            HS   +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFY 182

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           + + F+L   +G G++G +   T+  T E VAIK      K        +  KIL+    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 65  IPNLRWFGVE-----GDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
              +  F ++      ++N + I  +L+   L  + +  ++ LS   +     Q +  V+
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVK 126
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--- 174
            +H  + +HRD+KP N L+        + + DFGLA+   ++A     P  +   +T   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 175 GTARYASMNTHL-GIEQSRRDDLESLGYVLM-YFLR 208
            T  Y +    L   + SR  D+ S G +L   FLR
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 10/97 (10%)
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H K  ++RD+KP+N ++        V + DFGL K      T  H          GT  
Sbjct: 137 LHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTH-------TFCGTIE 186
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           Y +    +    +R  D  SLG ++   L G+ P+ G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTKHPQLQY----EAKLYKI 58
           R   ++    +IG G++G+++   +++     VA+K   V+T    +      E  + + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 59  LQGGTGIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLAD 110
           L+       +R F V      D    +  +     +DL  +  +     +  +T+  +  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           Q++  ++F+HS   +HRD+KP N L+     + Q+ + DFGLA+ Y
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 170

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTKHPQLQY----EAKLYKI 58
           R   ++    +IG G++G+++   +++     VA+K   V+T    +      E  + + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 59  LQGGTGIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLAD 110
           L+       +R F V      D    +  +     +DL  +  +     +  +T+  +  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
           Q++  ++F+HS   +HRD+KP N L+     + Q+ + DFGLA+ Y
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 170

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	404
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	0.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	0.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	0.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	0.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	0.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-177
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-173
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-20
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-19
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-18
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-17
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-17
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-16
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-16
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-16
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-16
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-16
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-15
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-15
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-15
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-15
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-15
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-15
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-14
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-12
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-12
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-12
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-11
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-11
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-05
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-10
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-09
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-09
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-08
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-08
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-08
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-08
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-08
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-08
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-07
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-07
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-07
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-07
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-07
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-07
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-07
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-07
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-07
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-07
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-07
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-07
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-06
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-05
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-04

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score =  613 bits (1581), Expect = 0.0
 Identities = 330/380 (86%), Positives = 353/380 (92%), Gaps = 4/380 (1%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
           CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
            S P RA+G GAGPS   PPA  N DRQSG +EGR +GWSS D  RRR   P+ +   L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357

Query: 360 KQKSPMANDPAFSKDAMVST 379
           KQK+P+ ND +FSK+ ++S 
Sbjct: 358 KQKAPVGNDASFSKEPVISA 377

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score =  571 bits (1474), Expect = 0.0
 Identities = 172/326 (52%), Positives = 224/326 (68%), Gaps = 3/326 (0%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT 63
            VG  FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL  E + YK L  G 
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           GIP + +FG  G YN +V++LLGPSLEDLF+ C R  SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 124 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
            ++RD+KP+NFL+G    +    ++IIDF LAK Y D  T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
           +NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245

Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 301
             +P E A+Y  Y R L F +KPDY YL++LF DLF R+G+ FDY +DW   +      +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304

Query: 302 TPARAIGPGAGPSSGMPPAAANVDRQ 327
                       +            Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score =  567 bits (1464), Expect = 0.0
 Identities = 230/294 (78%), Positives = 269/294 (91%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 3   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score =  563 bits (1452), Expect = 0.0
 Identities = 175/295 (59%), Positives = 215/295 (72%), Gaps = 2/295 (0%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
               VG  +++GR+IG GSFG I+ GTN+  N++VAIK E  ++  PQL+ E + YK+L 
Sbjct: 4   QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           G TGIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 121 SKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            KS ++RDIKPDNFL+G    + AN +Y++DFG+ K YRD  T QHIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
           Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + 
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
            LC G+P EF  Y HY R+L FD  PDY YL+ LF  +  R     D  FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score =  518 bits (1337), Expect = 0.0
 Identities = 83/331 (25%), Positives = 148/331 (44%), Gaps = 29/331 (8%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKL 55
           +       +++G  IG G FG IYL       ++ ++    +K+E   + +  L  E K 
Sbjct: 29  ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86

Query: 56  YKILQ--------------GGTGIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCS 97
           Y+                    G+P     G+       Y  +++D  G  L+ ++   +
Sbjct: 87  YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146

Query: 98  RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
           ++ S KTVL L+ ++++ +E++H   ++H DIK  N L+      +QVY++D+GLA RY 
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYC 205

Query: 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
               H+       +   GT  + S++ H G+  SRR DLE LGY ++ +L G LPW+   
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265

Query: 218 AGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274
              K  +  KI  ++   S+   C      P E A Y    + L + +KP Y  L+ +  
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325

Query: 275 DLFIREGFQFDYVFDWTILKYQQSQVSTPAR 305
                 G + D   D ++++    +  T  +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITK 356

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score =  496 bits (1278), Expect = e-177
 Identities = 92/322 (28%), Positives = 144/322 (44%), Gaps = 30/322 (9%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKIL 59
           ++   GN++ LG+KIGSG FG IYL       E+ A  +  V+  ++  L  E K Y+ +
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90

Query: 60  QGGT--------------GIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLS 101
                             GIP     G+       Y  +V++ LG  L+ +    +    
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149

Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
             TVL L  +M++ +E++H   ++H DIK  N L+G     +QVY+ D+GL+ RY     
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGN 208

Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 218
           H+       K   GT  + S++ H G+  SRR D+E LGY ++ +L G LPW+       
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268

Query: 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278
             +  K   + E   S    A       E A +     SL +D+KP+Y  LK++     I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328

Query: 279 REGFQFDYVFDWTILKYQQSQV 300
             G       D++  K Q   V
Sbjct: 329 PLGP-----LDFST-KGQSINV 344

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score =  486 bits (1252), Expect = e-173
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 33/316 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKT------------ 44
            G +++L       + G +Y      T         ++ ++KL+                
Sbjct: 40  SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99

Query: 45  -KHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LS 101
            K  Q+    KLY        IP    FGV +  Y  LV+  LG SL+   +   +  LS
Sbjct: 100 AKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157

Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
            ++VL +A ++++ +EF+H   ++H ++  +N  +    + +QV +  +G A RY  +  
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS-- 214

Query: 162 HQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
            +H+ Y E       G   + SM+ H G   SRR DL+SLGY ++ +L G LPW      
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274

Query: 220 TKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
           T+    +K             C  +         Y     +L +++KP YA L+     L
Sbjct: 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334

Query: 277 FIREGFQFDYVFDWTI 292
                          +
Sbjct: 335 LQDLRVSPYDPIGLPM 350

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (268), Expect = 3e-26
 Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 51/259 (19%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
           G  + + ++IGSG   +++   N +  +  AIK   LE    +     + E      LQ 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 62  GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
                +   +R +  E     + +      +E    DL ++  +K  +           M
Sbjct: 67  ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 117

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           +  V  +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 168

Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKA 218
             GT  Y              N     + S + D+ SLG   Y + Y   G  P+Q +  
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII- 224

Query: 219 GTKKQKYEKISEKKVSTSI 237
             +  K   I +       
Sbjct: 225 -NQISKLHAIIDPNHEIEF 242

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  105 bits (264), Expect = 8e-26
 Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 47/257 (18%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
           G  + + ++IGSG   +++   N +  +  AIK   LE    +     + E      LQ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 62  GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
                +   +R +  E     + +      +E    DL ++  +K  +           M
Sbjct: 86  ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           +  V  +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 187

Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
             GT  Y              N     + S + D+ SLG  ++Y    G  P+Q +    
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--N 244

Query: 221 KKQKYEKISEKKVSTSI 237
           +  K   I +       
Sbjct: 245 QISKLHAIIDPNHEIEF 261

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (266), Expect = 1e-25
 Identities = 52/256 (20%), Positives = 92/256 (35%), Gaps = 45/256 (17%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
           G  + + ++IGSG   +++   N +  +  AIK   LE    +     + E      LQ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 62  GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
                +   +R +  E     + +      +E    DL ++  +K  +           M
Sbjct: 114 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 164

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           +  V  +H    +H D+KP NFL+  G     + +IDFG+A + +   T          +
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 215

Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
             G   Y              N     + S + D+ SLG +L Y   G  P+Q +    +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQ 273

Query: 222 KQKYEKISEKKVSTSI 237
             K   I +       
Sbjct: 274 ISKLHAIIDPNHEIEF 289

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (262), Expect = 3e-25
 Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 53/247 (21%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQG- 61
           K +L   +  G    ++L  +++  E+ A+K+  +  ++      +L         L G 
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 62  -------------------GTGIPN-LRWFGVEGDYNV----LVIDLLGPSLEDLFNFCS 97
                                  P   +    + DY V    L++      LE LF+   
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 98  R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
                     +  + +L  Q+I     + SK  +H    PDN  +       ++ + D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239

Query: 152 LAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 208
              +                  +    YA            +   +   LG + +Y    
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288

Query: 209 GSLPWQG 215
             LP+  
Sbjct: 289 LFLPFGL 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (258), Expect = 8e-25
 Identities = 46/276 (16%), Positives = 79/276 (28%), Gaps = 47/276 (17%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQGG 62
               G  +G          T+ +T E   + +             Q++ E    ++L+G 
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 63  ---------------------TGIPNL-RWFGVEGDYNVLVIDLLGPS--------LEDL 92
                                     + R    E D  VL    L P          E L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 93  FNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
            +  S  + L     L L  Q+I  +  +H    +H  ++P + ++    +   V++  F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250

Query: 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
               R             E   L       S +       +   D  +LG +++Y     
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309

Query: 210 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
            LP             E I  S K +   + AL  G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  101 bits (253), Expect = 2e-24
 Identities = 61/315 (19%), Positives = 108/315 (34%), Gaps = 55/315 (17%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGT 63
           + + L   +G G+   ++ G + +T +  AIK+    +          E ++ K L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66

Query: 64  GIPN-LRWFGVEGDYN----VLVIDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
              N ++ F +E +      VL+++    G     L+           L     L++   
Sbjct: 67  --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYREN 170
           ++  +  +     +HR+IKP N +  +G     VY + DFG A+   D            
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172

Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
            +L GT  Y          +      +     DL S+G V  Y    GSLP++  +    
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231

Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL---F 277
            K+   KI   K S +I  + +                   D P    L R  + L    
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282

Query: 278 IREGFQFDYVFDWTI 292
           +    + D    W  
Sbjct: 283 LANILEADQEKCWGF 297

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  101 bits (254), Expect = 4e-24
 Identities = 59/325 (18%), Positives = 104/325 (32%), Gaps = 75/325 (23%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE----------- 52
           + + L   +G G+   ++ G + +T +  AIK+    +          E           
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 53  -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRK-----LSLKT 104
             KL+ I +  T             + VL+++    G     L+           L    
Sbjct: 69  IVKLFAIEEETT-----------TRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESE 113

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQ 163
            L++   ++  +  +     +HR+IKP N +  +G     VY + DFG A+   D     
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----- 168

Query: 164 HIPYRENKNLT---GTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
                 ++      GT  Y          +      +     DL S+G V  Y    GSL
Sbjct: 169 ------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSL 221

Query: 212 PWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270
           P++  +     K+   KI   K S +I  + +                   D P    L 
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLS 272

Query: 271 RLFRDL---FIREGFQFDYVFDWTI 292
           R  + L    +    + D    W  
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGF 297

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKT-----KHPQLQYEA 53
           E      +RLG  +G G FG ++ G  +    +VAIK+     V              E 
Sbjct: 27  EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85

Query: 54  KLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--M 107
            L   +  G G P     L WF  +  + +LV++   P+ +DLF++ + K  L       
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRC 143

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
              Q++  ++  HS+  +HRDIK +N L  +  R     +IDFG      D         
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT----- 196

Query: 168 RENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
                    GT  Y+     S + +  +       + SLG   Y ++    G +P++ 
Sbjct: 197 ------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.0 bits (246), Expect = 5e-23
 Identities = 42/281 (14%), Positives = 77/281 (27%), Gaps = 60/281 (21%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG-- 61
              G  +G          T+ +T E   + +             Q++ E    ++L+G  
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 62  -------------------GTGIPNL-RWFGVEGDYNVLVIDLLGP----SLEDLFNFCS 97
                                    + R    E D  VL    L P    +L+       
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 98  RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
                   L     L L  Q+I  +  +H    +H  ++P + ++    +   V++  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256

Query: 152 LAKRY-RDTATHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 205
              R      +     +             +        H     +   D  +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308

Query: 206 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
           +     LP             E I  S K +   + AL  G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 45/232 (19%), Positives = 86/232 (37%), Gaps = 38/232 (16%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEA--------- 53
           R  + F     +G G+FG++    N   +   AIK + + + K   +  E          
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62

Query: 54  ---KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
              + Y                 +     + ++     +L DL +  +          L 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP--- 166
            Q++  + ++HS+  +HRD+KP N  +     +  V I DFGLAK    +     +    
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 167 -YRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 205
               + NLT   GTA Y +  +     ++ +   + +    SLG   + ++Y
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.8 bits (243), Expect = 3e-22
 Identities = 52/333 (15%), Positives = 107/333 (32%), Gaps = 73/333 (21%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE----- 52
           +  +    + +  ++G+G FG +    +  T E+VAIK    E       +   E     
Sbjct: 8   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67

Query: 53  -------AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-----L 100
                      ++  G   +          D  +L ++       DL  + ++      L
Sbjct: 68  KLNHPNVVSAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENCCGL 118

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
               +  L   + + + ++H    +HRD+KP+N ++  G +     IID G AK      
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-- 176

Query: 161 THQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-RGSL 211
                     +  T   GT +Y +  +     +EQ +     D  S G  L +    G  
Sbjct: 177 ---------GELCTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECITGFR 221

Query: 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYAYLK 270
           P+       +  ++     +K +  I             Y     +++F    P   +L 
Sbjct: 222 PFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLS 267

Query: 271 RLFRDL---FIREGFQFDYVFDWTILKYQQSQV 300
            +       +++    +      T  +      
Sbjct: 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 51/239 (21%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLQYE 52
           EP     +++G  +GSG FG +Y G  +  N  VAIK    K +           ++  E
Sbjct: 39  EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPME 96

Query: 53  AKLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVL 106
             L K +   +G       L WF     + VL+++   P  +DLF+F + +  L  +   
Sbjct: 97  VVLLKKVS--SGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELAR 152

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
               Q++  V   H+   LHRDIK +N L  +     ++ +IDFG     +DT       
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---- 206

Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
                     GT  Y+       + + G        + SLG   Y ++    G +P++ 
Sbjct: 207 -------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 37/239 (15%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
           E  + N     + +G GS G +           VA+K             E K   +L  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML-IDFCDIALMEIK---LLTE 64

Query: 62  GTGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQM 112
               PN +R++  E       + ++L   +L+DL       +   +       + L  Q+
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 113 INRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKRYRDTATH 162
            + V  +HS   +HRD+KP N L             G    ++ I DFGL K+       
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--- 181

Query: 163 QHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLP 212
           Q        N +GT+ +        S N       +R  D+ S+G  + Y++  +G  P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 28/222 (12%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGT 63
              +   +K+G G F  + L   +      A+K      +    + Q EA ++++     
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85

Query: 64  GIPN----LRWFGVEGDYNVLVIDLL----GPSLEDLFNFCSRK---LSLKTVLMLADQM 112
             PN    + +   E         LL      +L +       K   L+   +L L   +
Sbjct: 86  --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT--HQHIPYREN 170
              +E +H+K + HRD+KP N L+G      Q  ++D G   +         Q +  ++ 
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
                T  Y +    +         R D+ SLG   Y +M+ 
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 21/223 (9%)

Query: 4   RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
            VG   F     +G G+ G I     +  N +VA+K             E +   +L+  
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-PECFSFADREVQ---LLRES 74

Query: 63  TGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
              PN +R+F  E D     + I+L   +L++              + L  Q  + +  +
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 120 HSKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
           HS + +HRD+KP N L  M       +  I DFGL K+           +     + GT 
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTE 190

Query: 178 RYAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 215
            + +   ++       +   D+ S G  + Y++   GS P+  
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 53/249 (21%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
             F +GR +G G FG +YL    Q+   +A+K      LE    +H QL+ E ++   L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLR 67

Query: 61  GGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQ 111
                PN LR +G       V +I      LE      ++    +  K   +       +
Sbjct: 68  H----PNILRLYGYFHDATRVYLI------LEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           + N + + HSK  +HRDIKP+N L+G    A ++ I DFG +          H P     
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRT 165

Query: 172 NLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 225
           +L GT  Y    M     IE    D   DL SLG VL Y FL G  P++   A T ++ Y
Sbjct: 166 DLCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETY 216

Query: 226 EKISEKKVS 234
           ++IS  + +
Sbjct: 217 KRISRVEFT 225

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 55/252 (21%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
           +PR   ++  GR +G G F + +  ++  T E  A K      L     +  ++  E  +
Sbjct: 10  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68

Query: 56  YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 106
           ++ L       + + + G  E +  V V+      LE      L     R+  L+     
Sbjct: 69  HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 118

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
               Q++   +++H    +HRD+K  N  +       +V I DFGLA +         + 
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK---------VE 166

Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 218
           Y   +     GT  Y      S   H     S   D+ S+G  +MY  L G  P++    
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 217

Query: 219 GTKKQKYEKISE 230
              K+ Y +I +
Sbjct: 218 SCLKETYLRIKK 229

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 59/236 (25%), Positives = 90/236 (38%), Gaps = 34/236 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
             F++G  +G GSF  +Y   +I T  EVAIK      +        ++Q E K++  L+
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69

Query: 61  GGTGIPN-LRWFGV-EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
                P+ L  +   E    V LV+++     +        +  S         Q+I  +
Sbjct: 70  H----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-- 174
            ++HS   LHRD+   N L+    R   + I DFGLA           +     K+ T  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHEKHYTLC 173

Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
           GT  Y S             D+ SLG  + Y  L G  P+      T K    K+ 
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 56/252 (22%), Positives = 94/252 (37%), Gaps = 55/252 (21%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
           +PR   ++  GR +G G F + +  ++  T E  A K      L     +  ++  E  +
Sbjct: 36  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94

Query: 56  YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVL 106
           ++ L       + + + G  E +  V V+      LE      L     R   L+     
Sbjct: 95  HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 144

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
               Q++   +++H    +HRD+K  N    L      V I DFGLA +         + 
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VE 192

Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 218
           Y   +     GT  Y      S   H     S   D+ S+G  +MY  L G  P++    
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 243

Query: 219 GTKKQKYEKISE 230
              K+ Y +I +
Sbjct: 244 SCLKETYLRIKK 255

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 50/202 (24%), Positives = 76/202 (37%), Gaps = 38/202 (18%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ++ R G  F+    IGSG FG+++   +    +   IK   VK  + + + E K    L 
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--VKYNNEKAEREVKALAKLD 62

Query: 61  GGTGIPNL-----RWFGVEGDYNVLVIDLLGPSLEDLF---NFCS-------------RK 99
                 N+      W G + D      +      + LF    FC               K
Sbjct: 63  H----VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           L     L L +Q+   V+++HSK  ++RD+KP N  +       QV I DFGL    ++ 
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKND 175

Query: 160 ATHQHIPYRENKNLTGTARYAS 181
                          GT RY S
Sbjct: 176 GKRTRS--------KGTLRYMS 189

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 37/171 (21%), Positives = 61/171 (35%), Gaps = 15/171 (8%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
            E      F+   ++G GS+GE++   + +     A+K         K +  +L      
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110

Query: 56  YKILQGGTGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
            K+ Q     P   R      EG    L  +L GPSL+         L    V       
Sbjct: 111 EKVGQH----PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
           +  +  +HS+  +H D+KP N  +G      +  + DFGL          +
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 51/244 (20%), Positives = 92/244 (37%), Gaps = 57/244 (23%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQ 50
                  +     +GSG+FG ++   + + N+EV +K    K K             ++ 
Sbjct: 20  GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVT 77

Query: 51  YEAKLYKILQGGTGIPN-LRWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKT 104
            E  +   ++      N ++   +   +G +  LV++  G  L+ LF F  R   L    
Sbjct: 78  LEIAILSRVEH----ANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEPL 131

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
              +  Q+++ V ++  K  +HRDIK +N +  +      + +IDFG A           
Sbjct: 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER------ 182

Query: 165 IPYRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPW 213
                 K      GT  Y        N + G E     ++ SLG   Y L++      P+
Sbjct: 183 -----GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPF 230

Query: 214 QGLK 217
             L+
Sbjct: 231 CELE 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 87.7 bits (217), Expect = 3e-19
 Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 21/172 (12%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
                +   +G G+F ++Y  T     + +  ++  +K++       +     +L + L+
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLK 122

Query: 61  GGT--GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMI 113
                         +  + +VLV +L    +L +  N       + +    V+  A +M+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKRYR 157
             +E VH    +H DIKPDNF++G G             + +ID G +   +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 34/187 (18%), Positives = 75/187 (40%), Gaps = 26/187 (13%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG 62
            +  K+ +   +G G FG ++      + +    K   VK      ++ E  +  I +  
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60

Query: 63  TGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMIN 114
               N+       E    + ++ + +       D+F   +     L+ + ++    Q+  
Sbjct: 61  ---RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCE 113

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            ++F+HS +  H DI+P+N +    RR++ + II+FG A++ +        P    + L 
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLF 164

Query: 175 GTARYAS 181
               Y +
Sbjct: 165 TAPEYYA 171

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 61/248 (24%), Positives = 115/248 (46%), Gaps = 43/248 (17%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKIL 59
            +   ++  +K+GSG++GE+ L  +  T+ E AIK     +V T  + +L  E  + K+L
Sbjct: 34  HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 60  QGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
                 PN ++ +   E   N  LV++    G    +LF+    R   +     ++  Q+
Sbjct: 94  DH----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQV 145

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           ++ V ++H  + +HRD+KP+N L+    +   + I+DFGL+  + +            K 
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KE 197

Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
             GTA Y +       E  R+      D+ S+G V+++  L G  P+ G    T ++   
Sbjct: 198 RLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILR 247

Query: 227 KISEKKVS 234
           K+ + K +
Sbjct: 248 KVEKGKYT 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 44/250 (17%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK--HPQLQYEAKLYK 57
               ++++  R +G GSFGE+ L  +  T +E A+K      VK K     L  E +L K
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 58  ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
            L      PN ++ +   E      LV ++   G    +LF+   SRK  S      +  
Sbjct: 82  QLDH----PNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIR 133

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q+++ + ++H    +HRD+KP+N L+    +   + IIDFGL+  +  +           
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------- 185

Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
           K+  GTA Y +       E          D+ S G V++Y  L G  P+ G     +   
Sbjct: 186 KDKIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDI 235

Query: 225 YEKISEKKVS 234
            +K+ + K +
Sbjct: 236 LKKVEKGKYT 245

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 29/229 (12%)

Query: 4   RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQ 60
            +G  + R+ R +  G F  +Y   ++ +  E A+K      +     +  E    K L 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83

Query: 61  GGTGI-------PNLRWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRK--LSLKTVLMLAD 110
           G   I          +     G    L++ +L    L +       +  LS  TVL +  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 111 QMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-----TATHQ 163
           Q    V+ +H +    +HRD+K +N L+        + + DFG A           +  +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 164 HIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
                E      T  Y +   ++ +       + D+ +LG   Y+L + 
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 85.3 bits (212), Expect = 6e-19
 Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 53/249 (21%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
           + F +GR +G G FG +YL    Q    +A+K      LE    +H QL+ E ++   L+
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 72

Query: 61  GGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQ 111
                PN LR +        + ++      LE     +L+    +  +   +      ++
Sbjct: 73  H----PNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           + + + + H +  +HRDIKP+N LMG      ++ I DFG +          H P    +
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRR 170

Query: 172 NLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 225
            + GT  Y    M     IE    D   DL   G VL Y FL G  P+    + +  + +
Sbjct: 171 TMCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETH 221

Query: 226 EKISEKKVS 234
            +I    + 
Sbjct: 222 RRIVNVDLK 230

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.0 bits (211), Expect = 7e-19
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 42/248 (16%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQG 61
           + + F   RK+GSG+FG+++L     +  E  IK    +  +    Q++ E ++ K L  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79

Query: 62  GTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLF------NFCSRKLSLKTVLMLAD 110
               PN+ + F V E  +N+ +V++    G    +L           + LS   V  L  
Sbjct: 80  ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           QM+N + + HS+  +H+D+KP+N L       + + IIDFGLA+ ++             
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183

Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
            N  GTA Y +       +  +     D+ S G V+MYF L G LP+ G    + ++  +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235

Query: 227 KISEKKVS 234
           K + K+ +
Sbjct: 236 KATYKEPN 243

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 43/250 (17%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYK 57
           +     ++ +   +G GSFGE+    +  T +E A+K     + K K    +  E +L K
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 58  ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
            L      PN ++ F + E   +  +V +L   G    +LF+    RK  S      +  
Sbjct: 77  KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q+ + + ++H  + +HRD+KP+N L+    +   + IIDFGL+  ++             
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180

Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
           K+  GTA Y +       E  R       D+ S G V++Y  L G+ P+ G     +   
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230

Query: 225 YEKISEKKVS 234
            +++   K +
Sbjct: 231 LKRVETGKYA 240

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 87.2 bits (216), Expect = 9e-19
 Identities = 40/188 (21%), Positives = 82/188 (43%), Gaps = 27/188 (14%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQG 61
            V + + +  ++G+G+FG ++  T   T    A K      +     ++ E +   +L+ 
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 62  GTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMI 113
               P L       E D  + ++ + +  G    +LF   + +   +S    +    Q+ 
Sbjct: 214 ----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             +  +H  +++H D+KP+N +    +R+N++ +IDFGL             P +  K  
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVT 316

Query: 174 TGTARYAS 181
           TGTA +A+
Sbjct: 317 TGTAEFAA 324

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 63/281 (22%), Positives = 117/281 (41%), Gaps = 29/281 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQGG 62
            +  +G++IGSGSFG +Y G     + +VA+K+ NV    PQ     + E  + +  +  
Sbjct: 24  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79

Query: 63  TGIPNLRWF-GV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
               N+  F G         +V     G SL    +    K  +K ++ +A Q    +++
Sbjct: 80  ---VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H+KS +HRD+K +N  +      N V I DFGLA         +     + + L+G+  
Sbjct: 136 LHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSIL 187

Query: 179 YAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
           + +   +        S + D+ + G VL   + G LP+  +    + Q  E +    +S 
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245

Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
            +  +    P         C   + D++P +  +     +L
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 21/173 (12%)

Query: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNL- 68
              +G G++G +Y G ++     +AIK    +       L  E  L+K L+      N+ 
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82

Query: 69  RWFGVEGDYNVLVIDL---LGPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           ++ G   +   + I +    G SL  L    +   K + +T+     Q++  ++++H   
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
            +HRDIK DN L  +   +  + I DFG +KR               +  TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEAK 54
           +  ++++  K+G G    +YL  +   N +VAIK                     + E  
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFEREVH 63

Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
               L     I ++     E D   LV++ + GP+L +        LS+ T +   +Q++
Sbjct: 64  NSSQLSH-QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQIL 121

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
           + ++  H    +HRDIKP N L+        + I DFG+AK   +T+  Q        ++
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHV 172

Query: 174 TGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
            GT +Y S       EQ++        D+ S+G +++Y  L G  P+ G
Sbjct: 173 LGTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 16/174 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           +      ++G GSFGE++   + QT  + A+K   ++        E      L      P
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSS----P 110

Query: 67  NL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            +   +G   +   + I +    G SL  L       L     L    Q +  +E++H++
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR 169

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
             LH D+K DN L  L    ++  + DFG A   +     + +       + GT
Sbjct: 170 RILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 45/247 (18%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH---PQLQYEAKLY 56
            +P +GN +RL + IG G+F ++ L  +I T  EVAIK ++  +       +L  E ++ 
Sbjct: 10  EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68

Query: 57  KILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLM 107
           KIL      PN ++ F V E +  + +I      +E     ++F++     ++  K    
Sbjct: 69  KILNH----PNIVKLFEVIETEKTLYLI------MEYASGGEVFDYLVAHGRMKEKEARS 118

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
              Q+++ V++ H K  +HRD+K +N L  L    N + I DFG +  +           
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV--------- 166

Query: 168 RENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
                L    G   YA+     G +      D+ SLG +L   + GSLP+ G      K+
Sbjct: 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKE 221

Query: 224 KYEKISE 230
             E++  
Sbjct: 222 LRERVLR 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 46/247 (18%), Positives = 99/247 (40%), Gaps = 44/247 (17%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYK 57
            +G K+ +G  +G GS+G++    + +T    A+K      L  +      ++ E +L +
Sbjct: 3   LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 58  ILQGGTGIPN-LR----WFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQ 111
            L+      N ++     +  E     +V++     ++++ +    ++  +        Q
Sbjct: 62  RLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +I+ +E++HS+  +H+DIKP N L  L      + I   G+A+           P+  + 
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAADD 166

Query: 172 NLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
                 G+  +        ++T  G +     D+ S G  L     G  P++G       
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG---DNIY 219

Query: 223 QKYEKIS 229
           + +E I 
Sbjct: 220 KLFENIG 226

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 40/220 (18%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKIL 59
            V + + +  ++GSG+FG ++      T      K   + T +P     ++ E  +   L
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL 105

Query: 60  QGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQ 111
                 P L        +    VL+++ L  G    +LF+  + +   +S   V+    Q
Sbjct: 106 HH----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
               ++ +H  S +H DIKP+N +    ++A+ V IIDFGLA +          P    K
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVK 208

Query: 172 NLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 207
             T TA +A+        +G       D+ ++G VL Y L
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 42/234 (17%)

Query: 2   EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--------- 49
           E R G +F   RL R +G G  G++Y   +      VA+KL         L         
Sbjct: 26  ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTR 80

Query: 50  -QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLM 107
            Q EA+    LQ    +  +  FG       + + L+ G  L  +       L+    + 
Sbjct: 81  MQREARTAGRLQE-PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVA 138

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +  Q+ + ++  H+    HRD+KP+N L+      +  Y++DFG+A    D    Q    
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ---- 191

Query: 168 RENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMYFLRGSLPWQG 215
               N  GT  Y +       E+        R D+ +L  VL   L GS P+QG
Sbjct: 192 --LGNTVGTLYYMAP------ERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 63/251 (25%), Positives = 99/251 (39%), Gaps = 42/251 (16%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
            P V   + L + +G G++GE+ L  N  T E VA+K+ +   +       ++ E  + K
Sbjct: 3   VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60

Query: 58  ILQGGTGIPN-LRWFGVEGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLMLA 109
           +L       N ++++G   + N+  +      LE     +LF+       +         
Sbjct: 61  MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q++  V ++H     HRDIKP+N L  L  R N + I DFGLA  +R     + +    
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL---- 164

Query: 170 NKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
              + GT  Y                    D+ S G VL   L G LPW         Q+
Sbjct: 165 -NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQE 217

Query: 225 YEKISEKKVST 235
           Y    EKK   
Sbjct: 218 YSDWKEKKTYL 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 29/177 (16%)

Query: 4   RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYK 57
             G  ++  R     K+G G F  ++L  ++  N  VA+K +   K      + E KL +
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70

Query: 58  IL-------QGGTGIPN----LRWF---GVEGDYNVLVIDLLGPSLEDL---FNFCSRKL 100
            +       +   G  +    L  F   G  G + V+V ++LG +L  L   +    R +
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128

Query: 101 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLA 153
            L  V  ++ Q++  ++++H +   +H DIKP+N LM +        Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 44/200 (22%), Positives = 64/200 (32%), Gaps = 25/200 (12%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQ 60
           R    F   + +G G FG ++   N   +   AIK   L N +    ++  E K    L+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 61  ---------GGTGIPNLRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL--KTVL 106
                                       L I +      +L+D  N             L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
            +  Q+   VEF+HSK  +HRD+KP N         + V + DFGL          Q + 
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 167 YRENKNLT-----GTARYAS 181
                        GT  Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 32/188 (17%), Positives = 73/188 (38%), Gaps = 29/188 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---------EAKLYK 57
           N+    ++IG G FG ++ G  ++    VAIK   +     + +          E  +  
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 58  ILQGGTGIPN-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
            L      PN ++ +G+  +   +V++ +    L       +  +     L L   +   
Sbjct: 79  NLNH----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRDTATHQHIPYRENK 171
           +E++ +++   +HRD++  N  +        V   + DFGL+++   + +          
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---------- 184

Query: 172 NLTGTARY 179
            L G  ++
Sbjct: 185 GLLGNFQW 192

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 36/181 (19%), Positives = 75/181 (41%), Gaps = 26/181 (14%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGTGIPN 67
             +++G G F  +    +  T +E A K   +K +       A++     +L+     P 
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 68  L-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
           +     V       +L+++    G    ++F+ C  +    +S   V+ L  Q++  V +
Sbjct: 91  VINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H  + +H D+KP N L+        + I+DFG++++             E + + GT  
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIMGTPE 198

Query: 179 Y 179
           Y
Sbjct: 199 Y 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 38/167 (22%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           + +++ + + +GSG+ GE+ L    +T ++VAI++ + +        EA     ++    
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192

Query: 65  I------PN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
           I      P  ++        +  +V++L+  G    +LF+      +L   T  +   QM
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 248

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +  V+++H    +HRD+KP+N L+        + I DFG +K   +T
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 42/227 (18%), Positives = 86/227 (37%), Gaps = 30/227 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQGG 62
            +  +G  IG G FG++Y G     + EVAI+L +++  +       + E   Y+  +  
Sbjct: 33  EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88

Query: 63  TGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
               N+  + G      +  ++  L  G +L  +       L +     +A +++  + +
Sbjct: 89  ---ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +H+K  LH+D+K  N     G+    V I DFGL          +     + +   G   
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR--EDKLRIQNGWLC 199

Query: 179 Y---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
           +         +       +  S+  D+ +LG +         P++  
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 19/169 (11%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYK 57
           +     ++ +   +G GSFGE+    +  T +E A+K+    + K K    +  E +L K
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 58  ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSR-KLSLKTVLMLAD 110
            L      PN ++ F + E   +  +V +L   G    +LF+    R + S      +  
Sbjct: 77  KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           Q+ + + ++H  + +HRD+KP+N L+    +   + IIDFGL+  ++  
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 47/180 (26%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------- 45
           +  +G  + +   +G GSFG++ L T+ +T ++VA+K  + +                  
Sbjct: 5   KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISY 62

Query: 46  -----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK- 99
                HP +    KLY ++   T I             V+VI+  G    +LF++   K 
Sbjct: 63  LKLLRHPHI---IKLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKK 103

Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            ++         Q+I  +E+ H    +HRD+KP+N L+        V I DFGL+    D
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTD 160

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 65/253 (25%), Positives = 99/253 (39%), Gaps = 46/253 (18%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
            P V   + L + +G G++GE+ L  N  T E VA+K+ +   +       ++ E  + K
Sbjct: 3   VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60

Query: 58  ILQGGTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLM 107
           +L       N ++++G   EG+   L        LE     +LF+       +       
Sbjct: 61  MLNH----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQR 109

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
              Q++  V ++H     HRDIKP+N L  L  R N + I DFGLA  +R     + +  
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL-- 164

Query: 168 RENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
                + GT  Y                    D+ S G VL   L G LPW         
Sbjct: 165 ---NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSC 215

Query: 223 QKYEKISEKKVST 235
           Q+Y    EKK   
Sbjct: 216 QEYSDWKEKKTYL 228

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 38/200 (19%)

Query: 1   MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQ 48
           MEP    +V + + +G ++GSG F  +       T  E A K                 +
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61

Query: 49  LQYEAKLYKILQGGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL- 102
           ++ E  + + +       N+     V E   +V L+++L+  G    +LF+F ++K SL 
Sbjct: 62  IEREVSILRQVLH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLS 113

Query: 103 -KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDT 159
            +       Q+++ V ++H+K   H D+KP+N ++ L +      + +IDFGLA    D 
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 160 ATHQHIPYRENKNLTGTARY 179
                      KN+ GT  +
Sbjct: 173 VEF--------KNIFGTPEF 184

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 39/167 (23%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           + +++ + + +GSG+ GE+ L    +T ++VAIK+ + +        EA     ++    
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 65  I------PN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
           I      P  ++        +  +V++L+  G    +LF+      +L   T  +   QM
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 123

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +  V+++H    +HRD+KP+N L+        + I DFG +K   +T
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 28/174 (16%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQY 51
                 +     +G G    +    +  T +E A+K            E V+        
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 52  EAKLYKILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKT 104
           E     IL+  +G PN ++     E +    LV DL+  G    +LF++   +  LS K 
Sbjct: 73  EV---DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKE 125

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
              +   ++  +  +H  + +HRD+KP+N L  L    N + + DFG + +   
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 52/280 (18%), Positives = 98/280 (35%), Gaps = 57/280 (20%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVKT----- 44
            +  K+ L   IG GS+G + +    QT    AIK              +E +KT     
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82

Query: 45  ---KHPQL--QYEA-----KLYKIL---QGG--------------TGIPNLRWFGVEGDY 77
               HP +   YE       +  ++    GG                             
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 78  NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
                + +  S+             K +  +  Q+ + + ++H++   HRDIKP+NFL  
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201

Query: 138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 195
              ++ ++ ++DFGL+K +      ++          GT  + +  +          + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 196 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 234
             S G VL++  L G++P+ G           ++  KK+ 
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------------LENVKTKH 46
           E ++G  +   RK+GSG++GE+ L      + E AIK                +N++  H
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 47  PQLQYEAKLYKILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK- 99
            ++  E  L K L      PN ++ F V E      LV +    G    +LF    +R  
Sbjct: 91  EEIYNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHK 142

Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
                   +  Q+++ + ++H  + +HRDIKP+N L+        + I+DFGL+  +   
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPW 213
                      ++  GTA Y +       E  ++      D+ S G V+MY  L G  P+
Sbjct: 203 YKL--------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPF 247

Query: 214 QGLKAGTKKQKYEKISEKKVS 234
            G      +   +K+ + K  
Sbjct: 248 GG---QNDQDIIKKVEKGKYY 265

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 39/178 (21%), Positives = 69/178 (38%), Gaps = 48/178 (26%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHP 47
               ++   + IGSG+FG   L  +  T E VA+K         ENV+         +HP
Sbjct: 18  DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNF-CSR-KL 100
            +    +  +++   T +             ++         E     +L+   C+  + 
Sbjct: 77  NI---VRFKEVILTPTHL-----------AIIM---------EYASGGELYERICNAGRF 113

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           S         Q+++ V + HS    HRD+K +N L+  G  A ++ I DFG +K    
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 19/167 (11%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYKI 58
            +  + + +  ++G G+F  +    +  T  E A K+   + +  +  Q L+ EA++ + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 59  LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
           LQ     PN +R     + +    LV DL+  G    +LF    +R   S         Q
Sbjct: 62  LQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQ 113

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           ++  + + HS   +HR++KP+N L+    +   V + DFGLA    D
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 39/180 (21%), Positives = 71/180 (39%), Gaps = 25/180 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
            +  +   +G G+FG +         ++VAIK    +++      E +    +      P
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----P 61

Query: 67  N-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS- 121
           N ++ +G   +   LV++   G SL ++ +        +    +    Q    V ++HS 
Sbjct: 62  NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
             K+ +HRD+KP N L  L      + I DFG A   +   T          N  G+A +
Sbjct: 122 QPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAAW 169

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 45/247 (18%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKI 58
           +   + L   IG GS+GE+ +     T    A K      +E+V     + + E ++ K 
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKS 62

Query: 59  LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQ 111
           L      PN +R +   E + ++ LV++L   G    +LF     K          +   
Sbjct: 63  LDH----PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKD 114

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
           +++ V + H  +  HRD+KP+NFL       + + +IDFGLA R++             +
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------R 166

Query: 172 NLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 227
              GT  Y S   +    G E     D  S G V+MY  L G  P+      T  +   K
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLK 218

Query: 228 ISEKKVS 234
           I E   +
Sbjct: 219 IREGTFT 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 28/189 (14%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           V + + +G ++GSG F  +       T +E A K   +K +           + ++    
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60

Query: 65  I------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
           I      PN+     + E   +V L+++L+  G    +LF+F + K SL          Q
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQ 116

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           +++ V ++HSK   H D+KP+N ++        ++ +IDFG+A +               
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------- 168

Query: 171 KNLTGTARY 179
           KN+ GT  +
Sbjct: 169 KNIFGTPEF 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 43/209 (20%), Positives = 69/209 (33%), Gaps = 43/209 (20%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
           M+ R   +F    KIGSG FG ++           AIK     L     +   L+     
Sbjct: 5   MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64

Query: 56  YKILQGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSL---KTVLML 108
             + Q      + +R+F    E D+ ++  +   G SL D  +   R +S      +  L
Sbjct: 65  AVLGQ----HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGL 152
             Q+   + ++HS S +H DIKP N F+                            D G 
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 153 AKRYRDTATHQHIPYRENKNLTGTARYAS 181
             R                   G +R+ +
Sbjct: 181 VTRISSPQV-----------EEGDSRFLA 198

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 40/172 (23%), Positives = 82/172 (47%), Gaps = 30/172 (17%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKL 55
             ++G+ + LG  +G G+FG++ +G +  T  +VA+K+ N + K        +++ E + 
Sbjct: 7   RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQN 64

Query: 56  YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 106
            K+ +     P+ ++ + V     +  ++      +E     +LF++  +   +      
Sbjct: 65  LKLFRH----PHIIKLYQVISTPTDFFMV------MEYVSGGELFDYICKHGRVEEMEAR 114

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            L  Q+++ V++ H    +HRD+KP+N L  L    N   I DFGL+    D
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 30/167 (17%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
           V  ++ + + IG GSFG++    + + ++ VA+K + N K  H Q   E +   IL+   
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---ILE--- 148

Query: 64  GIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDLF---NFCSRKLSLKTVL 106
              +LR    +   NV              +  +LL  +L +L     F  +  SL  V 
Sbjct: 149 ---HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVR 203

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
             A  ++  ++ +H    +H D+KP+N L+    R + + +IDFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 49/237 (20%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEA 53
            + +++ LG  +G G   E++L  +++ + +VA+K+         L          + EA
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREA 63

Query: 54  KLYKILQGGTGIPNL-------RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTV 105
           +    L      P +             G    +V++ + G +L D+ +     ++ K  
Sbjct: 64  QNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRA 118

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
           + +       + F H    +HRD+KP N ++      N V ++DFG+A+   D+      
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN---- 171

Query: 166 PYRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
              +   + GTA+Y S       EQ+R      R D+ SLG  ++Y  L G  P+ G
Sbjct: 172 SVTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 50/260 (19%), Positives = 90/260 (34%), Gaps = 46/260 (17%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           N++ L  +IG GS+G + L  N   N   A+K+ + K    Q  +  +            
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 67  NLRWFGVEGDY-------------NVL----VIDLLGPS-----LE-----DLFNFCSR- 98
            ++  G                  NV+    V+D           E      +    +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 99  KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            LS          +I  +E++H +  +HRDIKP N L+G       + I DFG++  ++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189

Query: 159 TATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
           +            N  GT  + +      T       +  D+ ++G  L  F+ G  P+ 
Sbjct: 190 SDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFM 241

Query: 215 GLKAGTKKQKYEKISEKKVS 234
                     + KI  + + 
Sbjct: 242 D---ERIMCLHSKIKSQALE 258

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 32/192 (16%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKL 55
           +V + + +G ++GSG F  +       T  E A K                 +++ E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 56  YKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSL--KTVLML 108
            + +      PN+     V       VL+++L+  G    +LF+F ++K SL  +     
Sbjct: 69  LRQVLH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSF 120

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
             Q+++ V ++H+K   H D+KP+N ++         + +IDFGLA    D         
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----- 175

Query: 168 RENKNLTGTARY 179
              KN+ GT  +
Sbjct: 176 ---KNIFGTPEF 184

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 21/169 (12%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY-------K 57
              K+     IG G    +    +  T  E A+K+  V  +    +   ++         
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151

Query: 58  ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
           IL+   G P+ +      E    + LV DL+  G    +LF++   +  LS K    +  
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
            ++  V F+H+ + +HRD+KP+N L  L      + + DFG +      
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPG 253

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 40/227 (17%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIK-LENVKTKHPQ--LQYEAKLYKIL 59
            V  ++ +   I  G  G IYL  +   N   V +K L +      Q     E +    +
Sbjct: 77  IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136

Query: 60  QGGTGIPNLRWFGVEGDYNV-----LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
                I  +  F    D +      +V++ + G SL+       +KL +   +    +++
Sbjct: 137 VH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEIL 192

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             + ++HS   ++ D+KP+N ++       Q+ +ID G   R                 L
Sbjct: 193 PALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGY-----------L 237

Query: 174 TGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQG 215
            GT  + +       E  R       D+ ++G  L           G
Sbjct: 238 YGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYK 57
             +  + + +  ++G G+F  +    +  T  E A K+ N K        +L+ EA++ +
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 58  ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
            LQ     PN +R     + +    LV DL+  G    +LF    +R   S         
Sbjct: 84  KLQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 135

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           Q++  + + HS   +HR++KP+N L+    +   V + DFGLA    D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 33/209 (15%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
             + +G GSF       + ++N+  A+K+ + K      Q E    K+ +G   I  L  
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 71  FGVEGDYNVLVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVEFVHS 121
              +  +  LV++LL  G    +LF       +F   + S      +  ++++ V  +H 
Sbjct: 74  VFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVSHMHD 124

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT---GTAR 178
              +HRD+KP+N L        ++ IIDFG A+              +N+ L     T  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLH 174

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFL 207
           YA+             DL SLG V++Y +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLG-VILYTM 202

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 77.0 bits (190), Expect = 5e-16
 Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 23/170 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
             FR+ +KIG G F E+Y    +     VA+K      L + K +      E  L K L 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90

Query: 61  GGTGIPN-LRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL---KTVLMLADQMI 113
                PN ++++    + N L I L       L  +     ++  L   +TV     Q+ 
Sbjct: 91  H----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           + +E +HS+  +HRDIKP N F+         V + D GL + +    T 
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 28/189 (14%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           V + +  G ++GSG F  +       T  + A K   +K +  +        + ++    
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66

Query: 65  I------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
           I      PN+     V E   +V L+++L+  G    +LF+F + K SL  +       Q
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQ 122

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           ++N V ++HS    H D+KP+N ++        ++ IIDFGLA +               
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------- 174

Query: 171 KNLTGTARY 179
           KN+ GT  +
Sbjct: 175 KNIFGTPEF 183

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 18/186 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ--LQYEAKLYKILQGGT 63
           +    G  +G G FG+    T+ +T E + +K L     +  +  L+ E K+ + L+   
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEH-- 66

Query: 64  GIPN-LRWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
             PN L++ GV   +   N  + + + G +L  +      +      +  A  + + + +
Sbjct: 67  --PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +HS + +HRD+   N L+        V + DFGLA R       Q    R  K      R
Sbjct: 124 LHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 179 YASMNT 184
           Y  +  
Sbjct: 180 YTVVGN 185

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 26/168 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGG 62
            K+   +KIG GSFG+  L  + +   +  IK   +  + +K   + + E  +   ++  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82

Query: 63  TGIPN-LRWFGVEGDYNVLVIDLLGPSLE-----DLFNFCSRK----LSLKTVLMLADQM 112
              PN +++     +   L I      ++     DLF   + +         +L    Q+
Sbjct: 83  ---PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
              ++ VH +  LHRDIK  N  +    +   V + DFG+A+    T 
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 8/162 (4%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
             + ++L RK+G G + E++   NI  NE+V +K L+ VK K  +++ E K+ + L+GG 
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGP 91

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I  L    +  D       L+   + +  F    + L+   +     +++  +++ HS 
Sbjct: 92  NIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
             +HRD+KP N +  +     ++ +ID+GLA+ Y     +  
Sbjct: 150 GIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNV 189

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 49/251 (19%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQ 60
            + L   IG G F  +    N +T ++ A+K+ +V             L+ EA +  +L+
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 61  GGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLAD----- 110
                P++         D  + +V + +       DL     ++     V   A      
Sbjct: 85  H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136

Query: 111 -QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q++  + + H  + +HRD+KP   L+     +  V +  FG+A +  +           
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189

Query: 170 NKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQ 223
                GT  + +         G       D+   G V+++  L G LP +     GTK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKER 239

Query: 224 KYEKISEKKVS 234
            +E I + K  
Sbjct: 240 LFEGIIKGKYK 250

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 29/185 (15%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN-LR 69
           L   IG G FGE++ G      EEVA+K+ + + +    + EA++Y+ +       N L 
Sbjct: 46  LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRH--ENILG 100

Query: 70  WFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           +   +   N     L          SL D  N     ++++ ++ LA    + +  +H +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158

Query: 123 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
                   +  HRD+K  N L+   ++     I D GLA R+        I      +  
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRV 212

Query: 175 GTARY 179
           GT RY
Sbjct: 213 GTKRY 217

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 54/267 (20%), Positives = 96/267 (35%), Gaps = 41/267 (15%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLY 56
           M  R    + +   IG+GS+G           + +  K     ++       L  E  L 
Sbjct: 1   MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59

Query: 57  KILQGGTGIPNL-----RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLM 107
           + L+     PN+     R          +V++   G  L  +    +++   L  + VL 
Sbjct: 60  RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 108 LADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +  Q+   ++  H +S      LHRD+KP N  +        V + DFGLA+      + 
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172

Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG-----L 216
                   K   GT  Y S      +  + + D+ SLG  L+Y L     P+       L
Sbjct: 173 -------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKEL 224

Query: 217 KAGTKKQKYEKISEKKVSTSIEALCRG 243
               ++ K+ +I   + S  +  +   
Sbjct: 225 AGKIREGKFRRIPY-RYSDELNEIITR 250

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 17/165 (10%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQ 60
             +   F     +GSG+F E++L     T +  A+K   ++   +   L+ E  + K ++
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64

Query: 61  GGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMI 113
                 N +    + E   +  LV+ L+  G    +LF+    R   + K   ++  Q++
Sbjct: 65  H----ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVL 116

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           + V+++H    +HRD+KP+N L       +++ I DFGL+K  ++
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 19/167 (11%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKI 58
            R   +++L  ++G G+F  +     +   +E A  + N K      H +L+ EA++ ++
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 59  LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
           L+     PN +R       + +  L+ DL+  G    +LF    +R   S         Q
Sbjct: 67  LKH----PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQ 118

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           ++  V   H    +HR++KP+N L+    +   V + DFGLA     
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 45/193 (23%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
           + ++IG G +GE+++G      E+VA+K+     +    + E ++Y+        IL   
Sbjct: 41  MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFI 97

Query: 61  -----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
                G      L +         L+ D     SL D     S  L  K++L LA   ++
Sbjct: 98  AADIKGTGSWTQL-Y---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVS 145

Query: 115 RVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
            +  +H++ F         HRD+K  N L+   ++     I D GLA ++        IP
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 167 YRENKNLTGTARY 179
                   GT RY
Sbjct: 203 ---PNTRVGTKRY 212

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 27/222 (12%)

Query: 3   PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
            R  + ++L    +G G+   +    N+ T++E A+K+   +  H +  +  E ++    
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67

Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLAD 110
           QG   +  L  F  E D   LV + +  G     +        +F   + S     ++  
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS-----VVVQ 118

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
            + + ++F+H+K   HRD+KP+N L     + + V I DF L    +       I   E 
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 207
               G+A Y +        +         DL SLG V++Y L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 43/192 (22%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
           L   +G G +GE++ G+     E VA+K+ + + +    + E +LY         IL   
Sbjct: 12  LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFI 68

Query: 61  ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
                        W         L+       SL D        L   + L +   + + 
Sbjct: 69  ASDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASG 117

Query: 116 VEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +  +H + F         HRD+K  N L+   ++  Q  I D GLA  +  +     +  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG- 173

Query: 168 RENKNLTGTARY 179
             N    GT RY
Sbjct: 174 --NNPRVGTKRY 183

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 33/190 (17%)

Query: 4   RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK 57
            V + + + +   +G G FG+++      T  ++A K+  +KT+  +    ++ E  +  
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMN 141

Query: 58  ILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLA 109
            L       NL + +      +  VLV++ +  G    +LF+    +   L+    ++  
Sbjct: 142 QLDH----ANLIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILFM 193

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            Q+   +  +H    LH D+KP+N L  + R A Q+ IIDFGLA+RY+        P  +
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREK 244

Query: 170 NKNLTGTARY 179
            K   GT  +
Sbjct: 245 LKVNFGTPEF 254

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 54/184 (29%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
             ++G+ + LG  +G G+FG++ +G +  T  +VA+K            +  ++      
Sbjct: 12  RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70

Query: 45  ---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNFC 96
              +HP +    KLY+++   + I              +V       +E     +LF++ 
Sbjct: 71  KLFRHPHI---IKLYQVISTPSDI-------------FMV-------MEYVSGGELFDYI 107

Query: 97  SRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +   L  K    L  Q+++ V++ H    +HRD+KP+N L  L    N   I DFGL+ 
Sbjct: 108 CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSN 164

Query: 155 RYRD 158
              D
Sbjct: 165 MMSD 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 40/229 (17%), Positives = 77/229 (33%), Gaps = 48/229 (20%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
           +  +L   IG G +G +Y G+       VA+K+ +   +      E  +Y+        I
Sbjct: 13  DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNI 69

Query: 59  LQ------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 111
            +        T    + +         LV++     SL    +         +   LA  
Sbjct: 70  ARFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHS 119

Query: 112 MINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +   + ++H+          +  HRD+   N L+   +      I DFGL+ R       
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLV 176

Query: 163 QHIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 203
           +         +  GT RY        ++N        ++ D+ +LG + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 40/248 (16%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
            +  + + +   IG GS+       +  TN E A+K+ + K+K    +    L +  Q  
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQH- 75

Query: 63  TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMINR 115
              PN +    V +    V +V +L+  G    +L +     +  S +    +   +   
Sbjct: 76  ---PNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKT 128

Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
           VE++H++  +HRD+KP N L          + I DFG AK+ R           EN  L 
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLM 178

Query: 175 ---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
               TA + +                 D+ SLG VL+Y  L G  P+      T ++   
Sbjct: 179 TPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEILA 233

Query: 227 KISEKKVS 234
           +I   K S
Sbjct: 234 RIGSGKFS 241

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 37/192 (19%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL------ENVKTKHPQLQYEAKLYKIL 59
            +  L   IG G FG++Y         +EVA+K       E++      ++ EAKL+ +L
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 60  QGGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
           +     PN+    GV  +     LV++   G  L  + +   +++    ++  A Q+   
Sbjct: 64  KH----PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117

Query: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKRYRDTATHQHIPY 167
           + ++H +     +HRD+K  N L+        +      I DFGLA+ +  T        
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169

Query: 168 RENKNLTGTARY 179
               +  G   +
Sbjct: 170 -TKMSAAGAYAW 180

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 43/259 (16%), Positives = 89/259 (34%), Gaps = 49/259 (18%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
           N +R+ R +  G F +I L      N+  A+K  E    +  +   ++   KI       
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 66  --------------PN-LRWFGVEGD----YNVL-------VIDLLGPSLEDLFNFCSRK 99
                            L   G+  +    Y +        ++         L    +  
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCF 147

Query: 100 LSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           + ++ +  +   ++N   ++H+ K+  HRD+KP N LM    +  +V + DFG ++   D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVD 204

Query: 159 TATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
                           GT  +      ++       + D+ SLG + +Y      +P+  
Sbjct: 205 KKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL 254

Query: 216 LKAGTKKQKYEKISEKKVS 234
               +  + +  I  K + 
Sbjct: 255 --KISLVELFNNIRTKNIE 271

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 19/160 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKILQGG 62
            F   R+IG GSFG +Y   +++ +E VAIK  +   K        +  E +  + L+  
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113

Query: 63  TGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
              PN  ++ G  +      LV++    S  DL     + L    +  +    +  + ++
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKR 155
           HS + +HRD+K  N L+        V + DFG    +A  
Sbjct: 171 HSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAPA 207

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 41/179 (22%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
            K+    KIG GS+G ++   N  T + VAIK                  ++     KHP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            L     L ++ +    +              LV +    ++    +   R +    V  
Sbjct: 63  NL---VNLLEVFRRKRRL-------------HLVFEYCDHTVLHELDRYQRGVPEHLVKS 106

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
           +  Q +  V F H  + +HRD+KP+N L+    + + + + DFG A+      D    +
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 21/180 (11%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKIL 59
               + + L   IGSG+   +         E+VAIK   LE  +T   +L  E +     
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 60  QGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--I 113
                 PN + ++   V  D   LV+ LL G S+ D+      K   K+ ++    +  I
Sbjct: 71  HH----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 114 NR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
            R     +E++H    +HRD+K  N L+G       V I DFG++              R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 23/169 (13%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGGTG 64
            +   +IG GSF  +Y G + +T  EVA       +  K++  + + EA++ K LQ    
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84

Query: 65  IPNL-----RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
            PN+      W         +V+        +L+       + + +K +     Q++  +
Sbjct: 85  -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGL 142

Query: 117 EFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 162
           +F+H+++   +HRD+K DN F+ G       V I D GLA   R +   
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 50/239 (20%), Positives = 80/239 (33%), Gaps = 52/239 (21%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
              +L      G FG ++       NE VA+K+  ++ K    Q E ++Y         I
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENI 80

Query: 59  LQ------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 111
           LQ       GT +    W         L+       SL D     +  +S   +  +A+ 
Sbjct: 81  LQFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129

Query: 112 MINRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
           M   + ++H               HRDIK  N L+   +      I DFGLA ++    +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKS 186

Query: 162 HQHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                  +     GT RY          +   +   R D+ ++G VL           G
Sbjct: 187 AG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 31/150 (20%), Positives = 64/150 (42%), Gaps = 9/150 (6%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
             + +G G  G++    N +T E+ A+K   +    P+ + E +L+        I  +  
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 71  F---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
                  G   + +V++ L  G     + +   +  + +    +   +   ++++HS + 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            HRD+KP+N L    R    + + DFG AK
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 22/164 (13%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
             +++ +   IG GSFG++    +    E VAIK ++N K    Q Q E +L +++    
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111

Query: 64  G------IPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 111
                  +   R F     +     LV ++L  +L DL    NF  R +SL      A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165

Query: 112 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
           M   + F+ +   S +H D+KP+N L+   +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 35/156 (22%), Positives = 73/156 (46%), Gaps = 11/156 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
            F +  K+G GS+G +Y   + +T + VAIK   V++   ++  E  + +        P+
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85

Query: 68  L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           + +++G   +     +V++     S+ D+    ++ L+   +  +    +  +E++H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
            +HRDIK  N L+          + DFG+A +  DT
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 5e-14
 Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 41/179 (22%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
            K+    KIG G++G ++   N +T+E VA+K   L++       +           KH 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +    +L+ +L     +              LV +     L+  F+ C+  L  + V  
Sbjct: 62  NI---VRLHDVLHSDKKL-------------TLVFEFCDQDLKKYFDSCNGDLDPEIVKS 105

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
              Q++  + F HS++ LHRD+KP N L+    R  ++ + +FGLA+ +       + +
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 41/179 (22%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
            K+     +G GS+G +    N  T   VAIK     +            +K     +H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            L     L ++ +                   LV + +  ++ D        L  + V  
Sbjct: 85  NL---VNLLEVCKKKKRW-------------YLVFEFVDHTILDDLELFPNGLDYQVVQK 128

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
              Q+IN + F HS + +HRDIKP+N L+    ++  V + DFG A+      +    +
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 40/186 (21%), Positives = 80/186 (43%), Gaps = 30/186 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQG 61
               +  KIG+GSFG ++    +     +VA+K+   +  H +       E  + K L+ 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 62  GTGIPN-LRWFGV--EGDYNVLVIDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINR 115
               PN + + G   +     +V + L   SL  L   +    +L  +  L +A  +   
Sbjct: 94  ----PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
           + ++H+++   +HR++K  N L+    +   V + DFGL++    T       +  +K+ 
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSA 199

Query: 174 TGTARY 179
            GT  +
Sbjct: 200 AGTPEW 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 15/164 (9%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
             + + F +  ++G G+   +Y      T +  A+K+         ++ E  +   L   
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107

Query: 63  TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINR 115
              PN ++   + E    + LV++L+  G    +LF+    +   S +       Q++  
Sbjct: 108 ---PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEA 160

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           V ++H    +HRD+KP+N L         + I DFGL+K     
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 31/154 (20%), Positives = 64/154 (41%), Gaps = 9/154 (5%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
             + +G G  G++    N +T E+ A+K   +    P+ + E +L+        I  +  
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 122

Query: 71  F---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
                  G   + +V++ L  G     + +   +  + +    +   +   ++++HS + 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            HRD+KP+N L    R    + + DFG AK    
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 39/206 (18%), Positives = 81/206 (39%), Gaps = 14/206 (6%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ----- 60
            ++ + RK+G G F  ++L  +IQ  + VA+K +++ +        E +L K ++     
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 61  --GGTGIPNLR-WF---GVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 113
                 +  L   F   GV G +  +V ++LG  L         + L L  V  +  Q++
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 114 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
             ++++H+K   +H DIKP+N L+ +  +  +    +    +R                 
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 173 LTGTARYASMNTHLGIEQSRRDDLES 198
                       +    + +  DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 40/178 (22%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
             +    K+G G++  +Y G +  T+  VA   I+LE+           V      KH  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
           +     L+ I+     +              LV + L   L+   + C   +++  V + 
Sbjct: 62  I---VTLHDIIHTEKSL-------------TLVFEYLDKDLKQYLDDCGNIINMHNVKLF 105

Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
             Q++  + + H +  LHRD+KP N L+       ++ + DFGLA+       T  ++
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 9/150 (6%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
            + +  ++G G+FG++Y   N +T    A K+   K++  +L+      +IL      P 
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDH-PY 77

Query: 68  L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           + +  G         ++I+   G +++ +     R L+   + ++  QM+  + F+HSK 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
            +HRD+K  N LM        + + DFG++
Sbjct: 138 IIHRDLKAGNVLMT---LEGDIRLADFGVS 164

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 43/188 (22%), Positives = 65/188 (34%), Gaps = 48/188 (25%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------- 44
                ++     +G G F  +Y   +  TN+ VAIK   L +                  
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 45  ----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL 100
                HP       L       + I              LV D +   LE +    S  L
Sbjct: 66  LQELSHP---NIIGLLDAFGHKSNI-------------SLVFDFMETDLEVIIKDNSLVL 109

Query: 101 SLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           +   +   ML    +  +E++H    LHRD+KP+N L+        + + DFGLAK +  
Sbjct: 110 TPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGS 164

Query: 159 ---TATHQ 163
                THQ
Sbjct: 165 PNRAYTHQ 172

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 35/166 (21%), Positives = 75/166 (45%), Gaps = 18/166 (10%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTG 64
              F L   +G+G++G++Y G +++T +  AIK+ +V     + ++ E     +L+  + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSH 79

Query: 65  IPN--------LRWFGVEGDYNV-LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMI 113
             N        ++      D  + LV++     S+ DL        L  + +  +  +++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
             +  +H    +HRDIK  N L+       +V ++DFG++ +   T
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 30/162 (18%), Positives = 69/162 (42%), Gaps = 10/162 (6%)

Query: 4   RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
            V + ++L ++ +G G  G++    + +T ++ A+K   +    P+ + E   +    GG
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGG 81

Query: 63  TGIPNLRWF---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
             I  +         G   + ++++ +  G     +     +  + +    +   +   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           +F+HS +  HRD+KP+N L     +   + + DFG AK    
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 32/174 (18%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKI 58
           +      +   + IG+GSFG +Y      + E VAIK    K    + ++   E ++ + 
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDK-RFKNRELQIMRK 103

Query: 59  LQGGTGIPN---LRWF------GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
           L       N   LR+F        +  Y  LV+D +    E ++         K  L + 
Sbjct: 104 LDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVI 156

Query: 110 D------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
                  Q+   + ++HS    HRDIKP N L  L      + + DFG AK+  
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
           F    KIG GSFGE++ G + +T + VAIK   LE  + +   +Q E  +          
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79

Query: 66  PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
           P + +++G  ++     ++++ L G S  DL       L    +  +  +++  ++++HS
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS 137

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +  +HRDIK  N L+       +V + DFG+A +  DT
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 41/181 (22%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
           +++R   K+G G++GE+Y   +  TNE VAIK   LE+            V      +H 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +    +L  ++     +              L+ +     L+   +     +S++ +  
Sbjct: 94  NI---IELKSVIHHNHRL-------------HLIFEYAENDLKKYMDKN-PDVSMRVIKS 136

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRD---TATH 162
              Q+IN V F HS+  LHRD+KP N L+ +   +    + I DFGLA+ +       TH
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196

Query: 163 Q 163
           +
Sbjct: 197 E 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 30/173 (17%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKIL 59
             +  ++F++ R  G G+FG + LG    T   VAIK  +++ + ++ +LQ   +   +L
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVL 76

Query: 60  QGGTGIPN---LRWF----GVEGD---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
                 PN   L+ +    G       Y  +V++ +    + L   C      +      
Sbjct: 77  HH----PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129

Query: 110 D------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                  Q+I  +  +H  S    HRDIKP N L  +      + + DFG AK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAK 180

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 30/180 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHP 47
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K                 KH 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +     L +I +      N     +   Y  LV D     L  L +    K +L  +  
Sbjct: 77  NV---VNLIEICRTKASPYNRCKGSI---Y--LVFDFCEHDLAGLLSNVLVKFTLSEIKR 128

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
           +   ++N + ++H    LHRD+K  N L+    R   + + DFGLA+ +      Q   Y
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 185

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 74/262 (28%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KH 46
           + F + R IG GSFG++ +     T +  A+K            + NV          +H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 47  P---QLQY----EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCS 97
           P    L Y    E  ++                       +V+DLL  G    DL     
Sbjct: 75  PFLVNLWYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQ 107

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
           +      +TV +   +++  ++++ ++  +HRD+KPDN L+        V+I DF +A  
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAM 164

Query: 156 YRDTATHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
                            + GT  Y +    ++  G   S   D  SLG V  Y  LRG  
Sbjct: 165 LPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRR 215

Query: 212 PWQGLKAGTKKQKYEKISEKKV 233
           P+    + + K+         V
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVV 237

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 42/180 (23%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
             F+   KIG G++G +Y   N  T E VA+K   L+        T            HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVL 106
            +    KL  ++     +              LV + L   L+   +  +   + L  + 
Sbjct: 63  NI---VKLLDVIHTENKL-------------YLVFEFLHQDLKKFMDASALTGIPLPLIK 106

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
               Q++  + F HS   LHRD+KP N L+        + + DFGLA+ +     T TH+
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 163

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 40/181 (22%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ--- 60
           + N F + RK+G G+FG + L  +I   +  A+K + N+K      + EA + K +Q   
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92

Query: 61  -GGTGIPNLR-WFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQM 112
                I      F     Y     L+ + LGPSL ++    N+      ++ + +   ++
Sbjct: 93  INNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146

Query: 113 INRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYIIDF 150
           +  + ++   S  H D+KP+N L+                          ++  + +IDF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 151 G 151
           G
Sbjct: 207 G 207

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 36/175 (20%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP--------------QLQYEA--- 53
           +IG G++G +Y   +  +   VA   +++ N                    +L+      
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 54  --KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLAD 110
             +L  +         ++          LV + +   L    +      L  +T+  L  
Sbjct: 76  VVRLMDVCATSRTDREIKVT--------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 163
           Q +  ++F+H+   +HRD+KP+N L+        V + DFGLA+ Y      T  
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.0 bits (162), Expect = 3e-12
 Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 42/179 (23%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
            K+    KIG G++G +Y   N    E  A+K   LE        T           KH 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
                 KLY ++     +             VLV + L   L+ L + C   L   T   
Sbjct: 61  ---NIVKLYDVIHTKKRL-------------VLVFEHLDQDLKKLLDVCEGGLESVTAKS 104

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
              Q++N + + H +  LHRD+KP N L+    R  ++ I DFGLA+ +       TH+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 73/258 (28%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
           F+ G+ +G GSF  + L   + T+ E AIK            +  V           HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 48  --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
             +L +    + KLY  L   + G                            +L  +  +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNG----------------------------ELLKYIRK 123

Query: 99  --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
                         ++++ +E++H K  +HRD+KP+N L+        + I DFG AK  
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVL 180

Query: 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
              +           +  GTA+Y S          +  DL +LG  ++Y  + G  P+  
Sbjct: 181 SPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF-- 232

Query: 216 LKAGTKKQKYEKISEKKV 233
            +AG +   ++KI + + 
Sbjct: 233 -RAGNEYLIFQKIIKLEY 249

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 36/179 (20%), Positives = 66/179 (36%), Gaps = 42/179 (23%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVK-----T-----------KHP 47
            K++   K+G G++G +Y   +      VA   I+L+        T            HP
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 48  QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
            +     L  ++     +              LV + +   L+ + +     L    + +
Sbjct: 80  NI---VSLIDVIHSERCL-------------TLVFEFMEKDLKKVLDENKTGLQDSQIKI 123

Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
              Q++  V   H    LHRD+KP N L+        + + DFGLA+ +     + TH+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 11/150 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
           K+    KIG G+ G +Y   ++ T +EVAI+  N++ + P+ +       +++     PN
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKN-PN 78

Query: 68  L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           +  +    + GD   +V++ L G SL D+       +    +  +  + +  +EF+HS  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
            +HRDIK DN L+G       V + DFG  
Sbjct: 137 VIHRDIKSDNILLG---MDGSVKLTDFGFC 163

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 41/183 (22%), Positives = 73/183 (39%), Gaps = 45/183 (24%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
           ++F+   K+G+G++  +Y G N  T   VA   +KL++           +      KH  
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64

Query: 49  LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL-----FNFCSRKLSLK 103
           +    +LY ++     +              LV + +   L+            R L L 
Sbjct: 65  I---VRLYDVIHTENKL-------------TLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108

Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TA 160
            V     Q++  + F H    LHRD+KP N L+    +  Q+ + DFGLA+ +     T 
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTF 165

Query: 161 THQ 163
           + +
Sbjct: 166 SSE 168

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 21/187 (11%), Positives = 50/187 (26%), Gaps = 36/187 (19%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQG 61
            +     K+     GE++ G        ++ +K+  V+    +       E    +I   
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 62  GTGIPN-LRWFGV----EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 114
               PN L   G        +  L+   +   SL + L    +  +     +  A  M  
Sbjct: 67  ----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122

Query: 115 RVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
            + F+H+         +   + ++          I    +   ++               
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR----------- 168

Query: 173 LTGTARY 179
                 +
Sbjct: 169 -MYAPAW 174

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 35/170 (20%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQ 60
           +    +   + IG+GSFG ++    ++++E VAIK    K    + ++   E ++ +I++
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK----KVLQDK-RFKNRELQIMRIVK 90

Query: 61  GGTGIPN---LRWF-------GVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKT 104
                PN   L+ F         E   N LV++ +    E +      +    + + +  
Sbjct: 91  H----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPMLL 142

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + +   Q++  + ++HS    HRDIKP N L  L   +  + +IDFG AK
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 19/174 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
               LG +IG G+FGE++ G     N  VA+K                EA++ K      
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171

Query: 64  GIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
             PN+ R  GV  +     +V++L+ G            +L +KT+L +       +E++
Sbjct: 172 --PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-----IPYR 168
            SK  +HRD+   N L+      N + I DFG+++   D           +P +
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 35/182 (19%), Positives = 65/182 (35%), Gaps = 46/182 (25%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKTKHPQLQYEAKLYKILQGG 62
           +  ++ +   +G G+FG++    + +     VA+K ++NV       + E +   +L+  
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VLE-- 66

Query: 63  TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 105
               +L        +                +V +LLG S  D      F      L  +
Sbjct: 67  ----HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHI 120

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
             +A Q+   V F+HS    H D+KP+N L                         + ++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 150 FG 151
           FG
Sbjct: 181 FG 182

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 31/150 (20%), Positives = 72/150 (48%), Gaps = 11/150 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
                 KIG GS G + L     +  +VA+K+ +++ K  + +       I++      N
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH-FN 103

Query: 68  L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           +   +   + G+   ++++ L G +L D+ +    +L+ + +  + + ++  + ++H++ 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG 161

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
            +HRDIK D+ L+       +V + DFG  
Sbjct: 162 VIHRDIKSDSILLT---LDGRVKLSDFGFC 188

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 32/182 (17%), Positives = 66/182 (36%), Gaps = 46/182 (25%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGG 62
           +  ++ +   +G G+FG++     + +   +VA+K + NV       + E     +L+  
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK-- 71

Query: 63  TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 105
                ++    E  +                +  +LLG +  +     NF  +   L  V
Sbjct: 72  ----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHV 125

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
             +A Q+ + + F+H     H D+KP+N L                     +   + + D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 150 FG 151
           FG
Sbjct: 186 FG 187

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 46/194 (23%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-------------- 45
                 K+ LG+ +G+GSFG +    +I++ +  A+K  L++ + K              
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61

Query: 46  --------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV-----------LVIDLLG 86
                   +     E K  +       +            +V           ++++ + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 87  PSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140
              + L      F    R + +  + +   Q+   V F+HS    HRDIKP N L  +  
Sbjct: 122 ---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNS 176

Query: 141 RANQVYIIDFGLAK 154
           + N + + DFG AK
Sbjct: 177 KDNTLKLCDFGSAK 190

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 29/181 (16%), Positives = 62/181 (34%), Gaps = 18/181 (9%)

Query: 7   NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYKILQ 60
             + L   IG G      + L     T E V ++   LE    +    LQ E  + K+  
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 61  GGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
                PN + +    +  +   +V   +   S +DL        ++   +  +   ++  
Sbjct: 85  H----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           ++++H   ++HR +K  + L+       +VY+               Q + +   K    
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 176 T 176
            
Sbjct: 198 V 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 21/171 (12%)

Query: 3   PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
            RV + F   G K+G G++G +Y       + +++ A+K             E  L + L
Sbjct: 16  ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75

Query: 60  QGGTGIPN----LRWFGVEGDYNV-LVID--------LLGPSLEDLFNFCSRKLSLKTVL 106
           +     PN     + F    D  V L+ D        ++        N    +L    V 
Sbjct: 76  KH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
            L  Q+++ + ++H+   LHRD+KP N L MG G    +V I D G A+ +
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.8 bits (151), Expect = 7e-11
 Identities = 32/173 (18%), Positives = 70/173 (40%), Gaps = 34/173 (19%)

Query: 14  KIGSGSFGEIYLGTNIQ-TNEEVA---IKLENVKTKHP-----------QLQYEA----- 53
           +IG G++G+++   +++     VA   ++++  +   P            L+        
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 54  KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQM 112
           +L+ +          +          LV + +   L    +      +  +T+  +  Q+
Sbjct: 78  RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 163
           +  ++F+HS   +HRD+KP N L+     + Q+ + DFGLA+ Y      T  
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV 179

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 7   NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
              +  R +G G FG++ L     TN  T E VA+K    +   +H    + E  + + L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 60  QGGTGIPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMIN 114
                  ++ ++ G     G  ++ ++    P L  L ++     + L  +L+ A Q+  
Sbjct: 91  YH----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQICE 145

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            + ++H++ ++HRD+   N L+        V I DFGLAK
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 48/196 (24%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
           + + F+L   +G G++G +   T+  T E VAIK      K         E K+      
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI------ 62

Query: 62  GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
                 L+ F  E   N++ + ++  P   + FN    ++ +   LM  D          
Sbjct: 63  ------LKHFKHE---NIITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQML 109

Query: 111 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT 159
                     Q +  V+ +H  + +HRD+KP N L+     +N  + + DFGLA+   ++
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDES 165

Query: 160 ATHQHIPYRENKNLTG 175
           A     P  +   +  
Sbjct: 166 AADNSEPTGQQSGMVE 181

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 55/298 (18%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
               +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++     
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275

Query: 66  PNL-RWFGV--EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
           PNL +  GV        ++ + +  G +L D L     +++S   +L +A Q+ + +E++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTG 175
             K+F+HR++   N L+G     + V + DFGL++               P +       
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------ 385

Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
           TA  +          S + D+ + G VL++     G  P            Y  I   +V
Sbjct: 386 TAPESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQV 428

Query: 234 STSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283
               E L + Y        P +       C      D+P +A + + F  +F      
Sbjct: 429 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 57/262 (21%), Positives = 91/262 (34%), Gaps = 77/262 (29%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
           + + + IG G+FGE+ L  +  T +  A+KL +                         P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 48  --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
             QL Y    +  LY +++   GG                            DL N  S 
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG----------------------------DLVNLMSN 162

Query: 99  -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
             +  K       +++  ++ +HS  F+HRD+KPDN L+    ++  + + DFG   +  
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 219

Query: 158 DTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 212
                +           GT  Y S     +        R  D  S+G V +Y  L G  P
Sbjct: 220 KEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTP 272

Query: 213 WQGLKAGTKKQKYEKISEKKVS 234
           +    A +    Y KI   K S
Sbjct: 273 F---YADSLVGTYSKIMNHKNS 291

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 10/85 (11%)

Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTAT 161
              L +  Q+   VEF+HSK  +HRD+KP N F        + V + DFGL         
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 219

Query: 162 HQHIPYRENKNLT-----GTARYAS 181
            Q +        T     GT  Y S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMS 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 12/56 (21%), Positives = 21/56 (37%)

Query: 4  RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
          R    F   + +G G FG ++   N   +   AIK   +  +    +   +  K L
Sbjct: 3  RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
              +  R +G G FG++ L         T E+VA+K         H   L+ E ++ + L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 60  QGGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 113
                  N+ ++ G+   +G   + +I    P  SL++       K++LK  L  A Q+ 
Sbjct: 81  YH----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             ++++ S+ ++HRD+   N L+      +QV I DFGL K
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 19/160 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQ 60
              +   ++G G+FG + L         T   VA+K L++      +  Q E ++ K L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 61  GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
                  + ++ GV    G  ++ ++    P   L D       +L    +L+ + Q+  
Sbjct: 83  S----DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +E++ S+  +HRD+   N L+        V I DFGLAK
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 49/179 (27%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQ 60
           +G+++   + +G G  G ++   +   ++ VAIK   L + +    +    E K+     
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKI----- 61

Query: 61  GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTV-----LMLAD---- 110
                  +R    +   N++ V ++LGPS   L +       L +V      M  D    
Sbjct: 62  -------IRRLDHD---NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111

Query: 111 ----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
                           Q++  ++++HS + LHRD+KP N    +      + I DFGLA
Sbjct: 112 LEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
           +   +     +GSG++G +    + ++ E+VAIK L          +  Y E  L K +Q
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 61  -------GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
                       P          Y  LV+  +     DL      K S + +  L  QM+
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQML 136

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
             ++++HS   +HRD+KP N  +      + ++ I+DFGLA+      T
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 31/161 (19%), Positives = 69/161 (42%), Gaps = 15/161 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
           N      ++GSG+ G+++     +T   +A+K       K ++ ++  +     ++    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSH 81

Query: 64  GIPNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
             P + + FG      D   + ++L+G   E L       +  + +  +   ++  + ++
Sbjct: 82  DCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
             K   +HRD+KP N L+       Q+ + DFG++ R  D 
Sbjct: 141 KEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 39/178 (21%), Positives = 69/178 (38%), Gaps = 54/178 (30%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
           + +++ +   IG+GS+G +    +      VAIK +  V       +    E  +     
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI----- 105

Query: 61  GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 110
                  L     +   +V+ V+D++ P   + F+    +L +   +  +D         
Sbjct: 106 -------LNRLNHD---HVVKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTPV 151

Query: 111 ------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
                        ++  V++VHS   LHRD+KP N L       NQ   V + DFGLA
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGI 65
               +  K+G G +GE+Y G   + +  VA+K     T   +    EA + K ++     
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68

Query: 66  PNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           PNL +  GV        ++ + +  G  L+ L     +++S   +L +A Q+ + +E++ 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            K+F+HRD+   N L+G     + V + DFGL++    
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
              +  +++G G+FG + +         T E VA+K    + +      + E ++ K LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 61  GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
                 N+ ++ GV    G  N+ +I    P  SL D       ++    +L    Q+  
Sbjct: 101 H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +E++ +K ++HRD+   N L+      N+V I DFGL K
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 53/290 (18%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
              RL  K+G G FGE+++GT       VAIK L+           EA++ K L+     
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238

Query: 66  PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
             L + + V  +  + ++       SL D L     + L L  ++ +A Q+ + + +V  
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 177
            +++HRD++  N L+G         + DFGLA+   D           P +       TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349

Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
             A++        + + D+ S G +L+     +G +P            Y  +  ++V  
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 390

Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            ++ + RGY        P         C     +++P + YL+    D F
Sbjct: 391 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 59/265 (22%), Positives = 90/265 (33%), Gaps = 80/265 (30%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
           F + + IG G+FGE+ +      ++  A+K+ N                    V      
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 48  --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
              L Y    +  LY ++    GG                            DL    S+
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG----------------------------DLLTLLSK 167

Query: 99  ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
              +L  +       +M+  ++ VH   ++HRDIKPDN LM        + + DFG   +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLK 224

Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLRG 209
             +  T Q      +    GT  Y S      +E  +       D  SLG V MY  L G
Sbjct: 225 LMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYG 277

Query: 210 SLPWQGLKAGTKKQKYEKISEKKVS 234
             P+    A +  + Y KI   K  
Sbjct: 278 ETPFY---AESLVETYGKIMNHKER 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
              +  +++G G+FG + +         T E VA+K    + +      + E ++ K LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 61  GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
                 N+ ++ GV    G  N+ +I    P  SL D       ++    +L    Q+  
Sbjct: 70  H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            +E++ +K ++HRD+   N L+      N+V I DFGL K
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 53/290 (18%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
              RL  K+G G FGE+++GT       VAIK L+           EA++ K L+     
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321

Query: 66  PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
             L + + V  +  + ++       SL D L     + L L  ++ +A Q+ + + +V  
Sbjct: 322 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 177
            +++HRD++  N L+G         + DFGLA+   D           P +       TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432

Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
             A++        + + D+ S G +L+     +G +P            Y  +  ++V  
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 473

Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            ++ + RGY        P         C     +++P + YL+    D F
Sbjct: 474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 19/156 (12%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTG 64
                 +++G+G FG +  G   +   +VAIK+    +      ++ EAK+   L     
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSH--- 78

Query: 65  IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 118
              L + +GV  +     ++ + +  +   L N+      +   + +L +   +   +E+
Sbjct: 79  -EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + SK FLHRD+   N L+        V + DFGL++
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 34/155 (21%), Positives = 66/155 (42%), Gaps = 17/155 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGI 65
           ++    ++IGSG FG ++LG      ++VAIK         +    EA++   L      
Sbjct: 8   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62

Query: 66  PNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
           P L + +GV  E     LV + +      L ++        + +T+L +   +   + ++
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                +HRD+   N L+G       + + DFG+ +
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTR 152

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 55/267 (20%), Positives = 88/267 (32%), Gaps = 82/267 (30%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
           F + + IG G+F E+ +    QT +  A+K+ N                    V      
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 48  --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
             QL +    E  LY +++   GG                            DL    S+
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG----------------------------DLLTLLSK 154

Query: 99  ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
              ++  +       +++  ++ VH   ++HRDIKPDN L+    R   + + DFG   +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLK 211

Query: 156 YRDTATHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
            R   T +      +    GT  Y       A              D  +LG V  Y   
Sbjct: 212 LRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMF 264

Query: 208 RGSLPWQGLKAGTKKQKYEKISEKKVS 234
            G  P+    A +  + Y KI   K  
Sbjct: 265 YGQTPFY---ADSTAETYGKIVHYKEH 288

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 64/280 (22%), Positives = 91/280 (32%), Gaps = 84/280 (30%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
           N F + R IG G FGE+Y      T +  A+K                      L  V T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 45  -KHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 93
              P    + Y      KL  IL    GG                            DL 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG----------------------------DLH 280

Query: 94  NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
              S+    S   +   A ++I  +E +H++  ++RD+KP N L+        V I D G
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG 337

Query: 152 LAKRYRDTATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
           LA  +     H            GT  Y A      G+      D  SLG  +++  LRG
Sbjct: 338 LACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRG 387

Query: 210 SLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
             P++  K   K +         V      S  + +L  G
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 19/161 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTG 64
            +  L +++GSG FG + LG   +   +VA+K+    +       Q EA+    L     
Sbjct: 8   EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSH--- 62

Query: 65  IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 118
            P L +++GV  +     +V + +  S   L N+     + L    +L +   +   + F
Sbjct: 63  -PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           + S  F+HRD+   N L+    R   V + DFG+ +   D 
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
           V  +++  + IGSG+ G +    +      VAIK L        H +  Y E  L K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 61  GGTGIPNLRWFGVEGDYNV-----LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
               I  L  F  +          +V++L+     +L      +L  + +  L  QM+  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCG 139

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
           ++ +HS   +HRD+KP N ++    +++  + I+DFGLA
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
           V  +++  + IGSG+ G +    +   +  VAIK L        H +  Y E  L K   
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 58  ------ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
                 +L   T    L  F  +  Y  LV++L+     +L      +L  + +  L  Q
Sbjct: 120 HKNIISLLNVFTPQKTLEEF--QDVY--LVMELMD---ANLCQVIQMELDHERMSYLLYQ 172

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
           M+  ++ +HS   +HRD+KP N ++    +++  + I+DFGLA
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 211

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 24/171 (14%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
           V   +R  + +GSG++G +    + +T  +VAIK L          +  Y E +L K   
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 58  ------ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
                 +L   T    L  F     Y  LV+  +G  L  L      KL    +  L  Q
Sbjct: 83  HENVIGLLDVFTPDETLDDF--TDFY--LVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQ 136

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
           M+  + ++H+   +HRD+KP N  +      + ++ I+DFGLA++     T
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 55/211 (26%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
           V + + +   IG GS+G +YL  +  T + VAIK +  +       +    E  +     
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI----- 78

Query: 61  GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 110
                  L     +    ++ + DL+ P     F+    +L +   +  +D         
Sbjct: 79  -------LNRLKSD---YIIRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKTPI 124

Query: 111 ------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAKR 155
                        ++    F+H    +HRD+KP N L       NQ   V + DFGLA R
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA-R 177

Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHL 186
             ++    +I     +N        ++   L
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 48/174 (27%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
           VG ++     IG G++G +    +      VAIK  +      + Q    E K+      
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI------ 78

Query: 62  GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
                 L  F  E   N++ + D++     +        + +   LM  D          
Sbjct: 79  ------LLRFRHE---NIIGINDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHL 125

Query: 111 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
                     Q++  ++++HS + LHRD+KP N L+         + I DFGLA
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 27/174 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
            + +L + IG G FG++ LG       +VA+K             EA +   L+      
Sbjct: 21  KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 74

Query: 67  NL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF----CSRKLSLKTVLMLADQMIN 114
           NL +  GV  E    + ++       E      L ++        L    +L  +  +  
Sbjct: 75  NLVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
            +E++   +F+HRD+   N L+      N   + DFGL K    T     +P +
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK 57
           +  V  K+ L +K+G G++G ++   + +T E VA+K + +    +   Q  + E  +  
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63

Query: 58  ILQGGTGIPNLR-WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
            L G   I NL      + D +V LV D +   L  +    +  L       +  Q+I  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKV 121

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
           ++++HS   LHRD+KP N L+     A   V + DFGL+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 38/178 (21%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK--------- 54
           V  +++    +GSG++G +    + +T   VA+K    K   P Q    AK         
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLL 82

Query: 55  ----------LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
                     L  +       P          Y  LV  L+G  L ++     +KL+   
Sbjct: 83  KHMKHENVIGLLDVF-----TPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDH 133

Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
           V  L  Q++  ++++HS   +HRD+KP N  +      + ++ I+DFGLA+   D  T
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 22/217 (10%), Positives = 50/217 (23%), Gaps = 47/217 (21%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKIL 59
              ++RL    G     + +   +   + +VA+   + +   P                +
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
               G+  +          ++V + + G SL+++        S    +     +    + 
Sbjct: 89  DK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADA 144

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
            H          P    +        V +            A                  
Sbjct: 145 AHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDANP---------------- 181

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
                         +DD+  +G  L   L    P   
Sbjct: 182 --------------QDDIRGIGASLYALLVNRWPLPE 204

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 17/160 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGI 65
              +L  ++G+G FGE+++G     + +VA+K     +  P     EA L K LQ     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67

Query: 66  PNL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
             L R + V   E  Y  ++ + +   SL D L      KL++  +L +A Q+   + F+
Sbjct: 68  QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
             ++++HRD++  N L+          I DFGLA+   D 
Sbjct: 126 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDN 162

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 35/162 (21%), Positives = 68/162 (41%), Gaps = 18/162 (11%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
                ++G G++G +    ++ + + +A+K         +  +L  +     I       
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65

Query: 66  PNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVEF 118
           P    ++G    EGD   + ++L+  SL+  +     K       +L      ++  +E 
Sbjct: 66  PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 119 VHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           +HSK S +HRD+KP N L+       QV + DFG++    D 
Sbjct: 125 LHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 17/169 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
            + +L + IG G FG++ LG       +VA+K             EA +   L+      
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 246

Query: 67  NL-RWFGV---EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
           NL +  GV   E     +V + +  G SL D L +     L    +L  +  +   +E++
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
              +F+HRD+   N L+      N   + DFGL K    T     +P +
Sbjct: 306 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 49/180 (27%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           + + + + R I SGS+G +  G +      VAIK      +      + +   IL     
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK------RVFNTVSDGRTVNILSDSFL 72

Query: 65  -------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 110
                  I  L  F      N+L + D+     E   +    KL L T LM  D      
Sbjct: 73  CKRVLREIRLLNHFHHP---NILGLRDIFVHFEEPAMH----KLYLVTELMRTDLAQVIH 125

Query: 111 ----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
                            ++  +  +H    +HRD+ P N L+      N  + I DF LA
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 28/158 (17%), Positives = 70/158 (44%), Gaps = 19/158 (12%)

Query: 14  KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNL-R 69
           +IG G++G +    +  + + +A+K       + +  QL  +     ++   +  P + +
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85

Query: 70  WFG---VEGDYNVLVIDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           ++G    EGD   + ++L+  S +      ++     +  + +  +    +  +  +   
Sbjct: 86  FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
              +HRDIKP N L+    R+  + + DFG++ +  D+
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
              +L +K+G+G FGE+++ T    + +VA+K ++           EA + K LQ     
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242

Query: 66  PNL-RWFGVEGDYNVLVIDLLGP--SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
             L +   V     + +I       SL D L +    K  L  ++  + Q+   + F+  
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++++HRD++  N L+     +    I DFGLA+
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLAR 332

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 39/169 (23%), Positives = 64/169 (37%), Gaps = 30/169 (17%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LQYEAKLY 56
           P         R IG G FG +Y G  I   +     AIK      + +  +    E  L 
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 57  KILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTV 105
           + L      PN+    G+    +    V+      L      DL  F     R  ++K +
Sbjct: 77  RGLNH----PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDL 126

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +    Q+   +E++  + F+HRD+   N ++        V + DFGLA+
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLAR 172

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 32/181 (17%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
            +  LGR IG G FG+++ G  +        VAIK     T     +    EA   +   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 61  GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 111
                P++ +  GV  +  V +I      +E     +L +F       L L ++++ A Q
Sbjct: 450 H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPY 167
           +   + ++ SK F+HRDI   N L+      + V + DFGL++   D     A+   +P 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 168 R 168
           +
Sbjct: 557 K 557

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.3 bits (127), Expect = 5e-08
 Identities = 34/203 (16%), Positives = 60/203 (29%), Gaps = 59/203 (29%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------- 39
             K +   KIG G FGE++       +  VAIK+                          
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 40  ------------------------ENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75
                                     V+  +P L  +A  +     G+      +F  + 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 76  DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNF 134
            + VL  +  G  LE      ++  SL T   +  Q+   +    +   F HRD+   N 
Sbjct: 137 LFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 135 LMGLGRRANQVYIIDFGLAKRYR 157
           L+   ++ +   +      K   
Sbjct: 194 LL---KKTSLKKLHYTLNGKSST 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 52.6 bits (127), Expect = 5e-08
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 28/169 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
            +  LGR IG G FG+++ G  +        VAIK     T     +    EA   +   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 61  GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 111
                P++ +  GV  +  V +I      +E     +L +F       L L ++++ A Q
Sbjct: 75  H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKYSLDLASLILYAYQ 124

Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
           +   + ++ SK F+HRDI   N L+      + V + DFGL++   D+ 
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
            +F+  + +GSG+FG +Y G  I   E+    VAIK     T     +    EA +   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 60  QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
                 P++ R  G+       L+  L+      L ++       +  + +L    Q+  
Sbjct: 75  DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            + ++  +  +HRD+   N L+        V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 43/214 (20%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
           F    ++G+G+ G ++  ++  +   +A K   LE       Q+  E    ++L      
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLHECNS- 90

Query: 66  PNL-RWFG---VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           P +  ++G    +G+   + ++ + G SL+ +     R +  + +  ++  +I  + ++ 
Sbjct: 91  PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148

Query: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
            K   +HRD+KP N L+       ++ + DFG++ +  D+  +  +         GT  Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            S     G   S + D+ S+G  L+    G  P 
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 40/185 (21%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
           PR  N+   G+ +G+G+FG++   T   +  ++    VA+K+   +      + L  E K
Sbjct: 21  PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 55  LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL------------GPSLEDLF 93
           +   L     I NL   G    G    LVI       DLL              +   + 
Sbjct: 79  VLSYLGNHMNIVNL--LGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 94  NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
                 L L+ +L  + Q+   + F+ SK+ +HRD+   N L+  G       I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLA 192

Query: 154 KRYRD 158
              RD
Sbjct: 193 ---RD 194

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLENVKTKHPQ---LQYEAK 54
           PR  N  + G+ +G+G+FG++   T     +E     VA+K+        +   L  E K
Sbjct: 44  PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 55  LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL--------GPSLEDLFNFCS 97
           +   L     I NL   G    G   VLVI       DLL            +  F   +
Sbjct: 102 IMSHLGQHENIVNL--LGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 98  RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
              S + +L  + Q+   + F+ SK+ +HRD+   N L+  G   +   I DFGLA   R
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA---R 212

Query: 158 D 158
           D
Sbjct: 213 D 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 33/166 (19%), Positives = 66/166 (39%), Gaps = 24/166 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKI 58
           +     + IG+G FGE+Y G     + +    VAIK         Q    L  EA +   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102

Query: 59  LQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
                   N+ R  GV  +    +++ + +      L  F      + S+  ++ +   +
Sbjct: 103 FSH----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGI 156

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
              ++++ + +++HRD+   N L+          + DFGL++   D
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 37/183 (20%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
           PR  ++ +LG+ +G G+FG++       I        VA+K+      H +   L  E K
Sbjct: 25  PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 55  LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL----------GPSLEDLFNF 95
           +   +     + NL   G   +    ++VI       +L            P      + 
Sbjct: 83  ILIHIGHHLNVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 96  CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               L+L+ ++  + Q+   +EF+ S+  +HRD+   N L+      N V I DFGLA  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLA-- 195

Query: 156 YRD 158
            RD
Sbjct: 196 -RD 197

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 53/275 (19%), Positives = 96/275 (34%), Gaps = 99/275 (36%)

Query: 3   PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
           P+     F++ R +G+GSFG ++L  +       A+K            +E+        
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60

Query: 45  ---KHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLED 91
               HP   ++        +++ I+   +GG                            +
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----------------------------E 92

Query: 92  LFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
           LF+   +  +         A ++   +E++HSK  ++RD+KP+N L  L +  + + I D
Sbjct: 93  LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKITD 149

Query: 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY-------- 201
           FG AK   D              L GT  Y      +  E      + +  Y        
Sbjct: 150 FGFAKYVPDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWS 188

Query: 202 --VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
             +L+Y  L G  P+         + YEKI   ++
Sbjct: 189 FGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 21/164 (12%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
           ++  + + IGSG  GE+  G      Q +  VAIK         Q +    EA +     
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 61  GGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
                PN+ R  GV   G   ++V + +      L  F      + ++  ++ +   +  
Sbjct: 109 H----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
            + ++    ++HRD+   N L+          + DFGL++   D
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 55/258 (21%), Positives = 94/258 (36%), Gaps = 78/258 (30%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
           F   + +G+GSFG + L  + ++    A+K            +E+             P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 48  --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--C 96
             +L++     + LY ++    GG                            ++F+    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG----------------------------EMFSHLRR 134

Query: 97  SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
             + S       A Q++   E++HS   ++RD+KP+N L+    +   + + DFG AKR 
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191

Query: 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
           +               L GT    +    L    ++  D  +LG VL+Y    G  P+  
Sbjct: 192 KGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF-- 238

Query: 216 LKAGTKKQKYEKISEKKV 233
             A    Q YEKI   KV
Sbjct: 239 -FADQPIQIYEKIVSGKV 255

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 28/169 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LENVKTKHPQ--LQYEAKLY 56
                   +G G+F +I+ G              EV +K L+     + +   +  A + 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMM 66

Query: 57  KILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLAD 110
             L       +L   +GV   GD N+LV + +      L  +       +++   L +A 
Sbjct: 67  SKLSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAK 154
           Q+   + F+   + +H ++   N L              + + D G++ 
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 45/183 (24%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQ-LQYEAKL 55
            R  N   LG+ +G G FG +  G   Q +     VA+K   L+N   +  +    EA  
Sbjct: 32  DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 56  YKILQGGTGIPN-LRWFGV------EGDYNVLVIDLLGPSLE-----DLFNF-------- 95
            K        PN +R  GV      +G    +VI      L      DL  +        
Sbjct: 90  MKDFSH----PNVIRLLGVCIEMSSQGIPKPMVI------LPFMKYGDLHTYLLYSRLET 139

Query: 96  CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
             + + L+T+L     +   +E++ +++FLHRD+   N ++        V + DFGL+  
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLS-- 194

Query: 156 YRD 158
            + 
Sbjct: 195 -KK 196

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 33/162 (20%), Positives = 68/162 (41%), Gaps = 17/162 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
               + + +G+G FGE+  G   + + +E  VAIK   V     Q +    EA +     
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 61  GGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
                PN+ R  GV  +    ++V + +   SL+        + ++  ++ +   + + +
Sbjct: 105 H----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           +++    ++HRD+   N L+          + DFGL +   D
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 20/158 (12%)

Query: 9   FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQY-----EAKLYKILQ 60
            RL  K+G GSFG +  G  +  + +   VA+K                  E      L 
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 61  GGTGIPNL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
                 NL R +GV       +V +L  LG SL D          L T+   A Q+   +
Sbjct: 80  H----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            ++ SK F+HRD+   N L+      + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 58/284 (20%), Positives = 88/284 (30%), Gaps = 92/284 (32%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
           N FR  R +G G FGE+       T +  A K                      LE V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242

Query: 45  KHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF- 93
                  L Y    +  L  +L    GG                            DL  
Sbjct: 243 -SRFVVSLAYAYETKDALCLVLTLMNGG----------------------------DLKF 273

Query: 94  ---NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYI 147
              +           +  A ++   +E +H +  ++RD+KP+N L+   G       + I
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRI 327

Query: 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            D GLA    +  T         K   GT  Y +         +   D  +LG  L+Y  
Sbjct: 328 SDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEM 378

Query: 207 LRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
           + G  P+Q  K   K+++    + E         S +A  LC  
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 39/180 (21%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
            R   K  + R++G GSFG +Y G        +    VAIK   E    +       EA 
Sbjct: 23  AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 55  LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR 98
           + K         ++ R  GV  +G    LVI       DL        P++ +  N    
Sbjct: 81  VMKEFNC----HHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLA 133

Query: 99  KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
             SL  ++ +A ++ + + ++++  F+HRD+   N ++        V I DFG+    RD
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---RD 187

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 40/183 (21%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
            R      L R++G G+FG+++L    N+   ++   VA+K     T   +   Q EA+L
Sbjct: 13  KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 56  YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR- 98
              LQ      ++ +++GV  +GD  ++++       DL       GP    L +   R 
Sbjct: 71  LTNLQH----EHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 99  ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
              +L L  +L +A Q+ + + ++ S+ F+HRD+   N L+G       V I DFG++  
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS-- 180

Query: 156 YRD 158
            RD
Sbjct: 181 -RD 182

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 19/154 (12%)

Query: 11  LGRKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
             +++GSG+FG +  G     +  + VA+K+   +   P L+     EA + + L     
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77

Query: 65  IPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH 120
            P + R  G+ E +  +LV+++    L  L  +   +R +  K ++ L  Q+   ++++ 
Sbjct: 78  -PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             +F+HRD+   N L+      +   I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 35/183 (19%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
                IG G FG +Y GT +  + +    A+K  N  T   ++     E  + K      
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85

Query: 64  GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 112
             PN L   G+    + + LV+      L      DL NF    +   ++K ++    Q+
Sbjct: 86  --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
              ++++ SK F+HRD+   N ++        V + DFGLA   RD   +    Y  +  
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RD--MYDKEYYSVHNK 189

Query: 173 LTG 175
              
Sbjct: 190 TGA 192

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
            +F+  + +GSG+FG +Y G  I   E+    VAIK     T     +    EA +   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 60  QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
                 P++ R  G+       L+  L+      L ++       +  + +L    Q+  
Sbjct: 75  DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            + ++  +  +HRD+   N L+        V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 19/159 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ--LQYEAKLYKI 58
            + R  + +GSG FG ++ G            V IK+  +    +  Q            
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGS 71

Query: 59  LQGGTGIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINR 115
           L       ++ R  G+    ++ ++    P  SL D        L  + +L    Q+   
Sbjct: 72  LDH----AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           + ++     +HR++   N L+      +QV + DFG+A 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 35/178 (19%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
           PR      L R +G G+FGE+Y G      N  +  +VA+K   E    +       EA 
Sbjct: 28  PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85

Query: 55  LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 100
           +           N+ R  GV  +     ++++L+  G    DL +F             L
Sbjct: 86  IISKFNH----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSSL 137

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           ++  +L +A  +    +++    F+HRDI   N L+          I DFG+A   RD
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 192

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
               L R +G G FGE+Y G    +      VA+K           +    EA + K L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 61  GGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
                P++ +  G+ E +   ++++L     L          L + T+++ + Q+   + 
Sbjct: 72  H----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           ++ S + +HRDI   N L+        V + DFGL++
Sbjct: 128 YLESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 46/184 (25%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTK--HPQLQYEAKL 55
           P    +F LGR +G G FG +      Q +     VA+K+   ++       +   EA  
Sbjct: 21  PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78

Query: 56  YKILQGGTGIPN-LRWFGV-------EGDYNVLVIDLLGPSLE-----DLFNF------- 95
            K        P+  +  GV             +VI      L      DL  F       
Sbjct: 79  MKEFDH----PHVAKLVGVSLRSRAKGRLPIPMVI------LPFMKHGDLHAFLLASRIG 128

Query: 96  -CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                L L+T++     +   +E++ S++F+HRD+   N ++        V + DFGL+ 
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLS- 184

Query: 155 RYRD 158
             R 
Sbjct: 185 --RK 186

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 49/285 (17%), Positives = 90/285 (31%), Gaps = 91/285 (31%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
           + F   R +G G FGE++      T +  A K                      L   K 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA--KV 242

Query: 45  KHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF- 93
                  L Y    +  L  ++    GG                            D+  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGG----------------------------DIRY 274

Query: 94  -----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
                +  +        +    Q+++ +E +H ++ ++RD+KP+N L+        V I 
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRIS 331

Query: 149 DFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 205
           D GLA           +   + K     GT  + +    LG E     D  +LG V +Y 
Sbjct: 332 DLGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYE 381

Query: 206 FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
            +    P++      + ++  +++ E+ V      S  +   C  
Sbjct: 382 MIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 39/182 (21%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
            R      L  ++G G+FG+++L    N+   ++   VA+K     ++  +   Q EA+L
Sbjct: 39  KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 56  YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL---------GPSLEDLFNFC 96
             +LQ      ++ R+FGV  EG   +L++       DL             L    +  
Sbjct: 97  LTMLQH----QHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151

Query: 97  SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
              L L  +L +A Q+   + ++    F+HRD+   N L+G G     V I DFG++   
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS--- 205

Query: 157 RD 158
           RD
Sbjct: 206 RD 207

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 33/176 (18%)

Query: 10  RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
                IG G FG +Y GT +  + +    A+K  N  T   ++     E  + K      
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149

Query: 64  GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 112
             PN L   G+    + + LV+      L      DL NF    +   ++K ++    Q+
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
              ++F+ SK F+HRD+   N ++        V + DFGLA   RD    +     
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 15/152 (9%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGTGI 65
              ++G G+FG +  G      ++  VAIK+      K    ++  EA++   L      
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395

Query: 66  PNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           P + R  GV + +  +LV+++  G  L         ++ +  V  L  Q+   ++++  K
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +F+HR++   N L+      +   I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 35/178 (19%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
           PR      L R +G G+FGE+Y G      N  +  +VA+K   E    +       EA 
Sbjct: 69  PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 55  LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 100
           +           N+ R  GV  +     ++++L+  G    DL +F             L
Sbjct: 127 IISKFNH----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSL 178

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
           ++  +L +A  +    +++    F+HRDI   N L+          I DFG+A   RD
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 35/158 (22%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTG 64
           N F     IG G FG++Y G  ++   +VA+K    ++     + + E +     +    
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94

Query: 65  IPNL-RWFG--VEGDYNVLVIDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQMINRV 116
            P+L    G   E +  +L+   +  G +L+  L+  +  +  +S +  L +       +
Sbjct: 95  -PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
            ++H+++ +HRD+K  N L+          I DFG++K
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISK 187

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 36/158 (22%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 7   NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIKL--ENVKTKHPQ--LQYEAKLYKIL 59
           +   +   ++G G+FG +  G   ++  + +VAIK+  +  +    +  ++ EA++   L
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQL 67

Query: 60  QGGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
                 P + R  GV + +  +LV+++  G  L         ++ +  V  L  Q+   +
Sbjct: 68  DN----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
           +++  K+F+HRD+   N L+      +   I DFGL+K
Sbjct: 124 KYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 33/180 (18%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYK 57
               N  +    IG G+FG++            + AIK   E       +    E ++  
Sbjct: 23  DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80

Query: 58  ILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFNFCSRK 99
            L     I NL   G      Y  L I      +LL                + N  +  
Sbjct: 81  KLGHHPNIINL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
           LS + +L  A  +   ++++  K F+HRD+   N L+G         I DFGL+   R  
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLS---RGQ 192

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 3e-06
 Identities = 39/263 (14%), Positives = 78/263 (29%), Gaps = 76/263 (28%)

Query: 30  QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI---DLLG 86
           +    +   L  ++    +  ++     +      IP            +L +   D++ 
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDR--LSVFPPSAHIP----------TILLSLIWFDVIK 401

Query: 87  PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI--KPDNFLMGLGRRANQ 144
             +  + N   +  SL     +  Q       + S   ++ ++  K +N    L R    
Sbjct: 402 SDVMVVVNKLHKY-SL-----VEKQPKESTISIPS---IYLELKVKLEN-EYALHRSIVD 451

Query: 145 VYII-----DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLES 198
            Y I        L   Y D   + HI +                 HL  IE   R  L  
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKNIEHPERMTLFR 494

Query: 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSL 258
           + ++   FL             +K +++  +     + +  L      +   Y  Y    
Sbjct: 495 MVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQLKFYKPYI--- 534

Query: 259 RFDDKPDYAYLKRLFRDL--FIR 279
             D+ P Y   +RL   +  F+ 
Sbjct: 535 -CDNDPKY---ERLVNAILDFLP 553

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 3e-05
 Identities = 36/353 (10%), Positives = 98/353 (27%), Gaps = 107/353 (30%)

Query: 28  NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNVLV-- 81
           +I + EE+      + +K          + +L     +  ++ F VE     +Y  L+  
Sbjct: 44  SILSKEEID---HIIMSKDAVSGTLRLFWTLLSKQEEM--VQKF-VEEVLRINYKFLMSP 97

Query: 82  --IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL-- 135
              +   PS+   ++     +L      + A   ++R++     +  L   ++P   +  
Sbjct: 98  IKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKNVLI 155

Query: 136 --M-GLG----------------RRANQVYIIDFGLAKRYRDTATH-QHIPYRENKNLTG 175
             + G G                +   +++ ++              Q + Y+ + N T 
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 176 TARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF------------ 206
            + ++S   +  H    + RR               ++++       F            
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILLTTRF 274

Query: 207 ----------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP------- 245
                         +            + + +  K +    + L        P       
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334

Query: 246 ---TEFASYFHYCRSLRFD----------DKPDYAYLKRLFRDLFIREGFQFD 285
               +  + +   + +  D          +  + A  +++F  L +   F   
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPS 384

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 35/180 (19%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKLENVKTKHPQLQ---YE 52
           PR  ++  LG+ +G G+FG++ L     +  ++      VA+K+         L     E
Sbjct: 67  PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124

Query: 53  AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 94
            ++ K++     I NL   G   +     +++      +L                +  +
Sbjct: 125 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182

Query: 95  FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
               +LS K ++  A Q+   +E++ SK  +HRD+   N L+      N + I DFGLA+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLAR 239

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 41/184 (22%), Positives = 78/184 (42%), Gaps = 38/184 (20%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
           PR  +K  LG+ +G G+FG++ +     I  ++      VA+K+  ++   K    L  E
Sbjct: 33  PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90

Query: 53  AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 94
            ++ K++     I NL   G   +     +++      +L                D+  
Sbjct: 91  MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148

Query: 95  FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
               +++ K ++    Q+   +E++ S+  +HRD+   N L+      N + I DFGLA 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 204

Query: 155 RYRD 158
             RD
Sbjct: 205 --RD 206

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 98/283 (34%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F     +G GSFG++ L     T+E  A+K            +E             K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 48  QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
            L       Q   +LY +++   GG                            DL     
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 434

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           +  +      +  A ++   + F+ SK  ++RD+K DN ++   G       + I DFG+
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 488

Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            K       T              T  GT  Y +          +  D  + G VL+Y  
Sbjct: 489 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 535

Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
           L G  P++G     + + ++ I E  V      S    A+C+G
Sbjct: 536 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 70/182 (38%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F L R IG GS+ ++ L    +T+   A+K            ++ V+T          HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 48  ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
               L      E++L+ +++   GG                            DL     
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 102

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           R  KL  +     + ++   + ++H +  ++RD+K DN L+   G       + + D+G+
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 156

Query: 153 AK 154
            K
Sbjct: 157 CK 158

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 38/184 (20%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
           PR  +K  LG+ +G G FG++ +     I  ++      VA+K+  ++   K    L  E
Sbjct: 79  PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 53  AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 94
            ++ K++     I NL   G   +     +++      +L                D+  
Sbjct: 137 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 95  FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
               +++ K ++    Q+   +E++ S+  +HRD+   N L+      N + I DFGLA 
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 250

Query: 155 RYRD 158
             RD
Sbjct: 251 --RD 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 60/283 (21%), Positives = 96/283 (33%), Gaps = 98/283 (34%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F     +G GSFG++ L     T+E  A+K            +E             K P
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 48  ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
              QL        +LY +++   GG                            DL     
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 113

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           +  +      +  A ++   + F+ SK  ++RD+K DN ++   G       + I DFG+
Sbjct: 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 167

Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            K       T              T  GT  Y +          +  D  + G VL+Y  
Sbjct: 168 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 214

Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 243
           L G  P++G     + + ++ I E  V    S S EA  +C+G
Sbjct: 215 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 46.4 bits (111), Expect = 8e-06
 Identities = 61/283 (21%), Positives = 96/283 (33%), Gaps = 98/283 (34%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F L + +G GSFG+++L    +TN+  AIK            +E             +HP
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 48  QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
            L       Q +  L+ +++   GG                            DL     
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGG----------------------------DLMYHIQ 110

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
              K  L      A ++I  ++F+HSK  ++RD+K DN L+   G       + I DFG+
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGM 164

Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            K                      T  GT  Y +    LG + +   D  S G VL+Y  
Sbjct: 165 CKENMLGDAKTN------------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEM 211

Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
           L G  P+ G     +++ +  I               + L   
Sbjct: 212 LIGQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 46.0 bits (110), Expect = 9e-06
 Identities = 41/184 (22%), Positives = 64/184 (34%), Gaps = 41/184 (22%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
               +  R   ++G   FG++Y G        E+   VAIK    K + P     ++EA 
Sbjct: 7   SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 55  LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL----------GPSLEDLFN 94
           L   LQ     PN+    GV  +    + +I       DL                D   
Sbjct: 65  LRARLQH----PNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 95  FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
                L     + L  Q+   +E++ S   +H+D+   N L+        V I D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLF- 175

Query: 155 RYRD 158
             R+
Sbjct: 176 --RE 177

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 35/182 (19%), Positives = 67/182 (36%), Gaps = 70/182 (38%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F L R IG GS+ ++ L    +T+   A++            ++ V+T          HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 48  ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
               L      E++L+ +++   GG                            DL     
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 145

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           R  KL  +     + ++   + ++H +  ++RD+K DN L+   G       + + D+G+
Sbjct: 146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 199

Query: 153 AK 154
            K
Sbjct: 200 CK 201

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 80/262 (30%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHPQ 48
           F   + +G G+FG++ L     T    A+K            + +  T        +HP 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 49  L-------QYEAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
           L       Q   +L  ++    GG                            +LF   SR
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 241

Query: 99  --KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               S         ++++ ++++HS K+ ++RD+K +N ++    +   + I DFGL K 
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK- 297

Query: 156 YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 212
                  + I        T  GT  Y +       +  R  D   LG V+MY  + G LP
Sbjct: 298 -------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 348

Query: 213 WQGLKAGTKKQKYEKISEKKVS 234
           +        ++ +E I  +++ 
Sbjct: 349 FYN---QDHEKLFELILMEEIR 367

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 53/264 (20%), Positives = 96/264 (36%), Gaps = 85/264 (32%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------------EN---VKTKHP- 47
           F   + +G G+FG++ L     T    A+K+                 E+     T+HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 48  --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
              L+Y      +L  +++   GG                            +LF   SR
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 98

Query: 99  --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-- 154
               + +       ++++ +E++HS+  ++RDIK +N ++    +   + I DFGL K  
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEG 155

Query: 155 -RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGS 210
                T              T  GT  Y +       +  R  D   LG V+MY  + G 
Sbjct: 156 ISDGATMK------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGR 202

Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
           LP+        ++ +E I  +++ 
Sbjct: 203 LPFYN---QDHERLFELILMEEIR 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 54/283 (19%), Positives = 91/283 (32%), Gaps = 98/283 (34%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F   R +G GSFG++ L    +T +  A+K            +E   T          HP
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 48  ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
              QL        +L+ +++   GG                            DL     
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQ 116

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           +  +         A ++I+ + F+H K  ++RD+K DN L+   G         + DFG+
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGM 170

Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            K       T              T  GT  Y +      +      D  ++G VL+Y  
Sbjct: 171 CKEGICNGVTTA------------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEM 217

Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
           L G  P++      +   +E I   +V            + + 
Sbjct: 218 LCGHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 57/283 (20%), Positives = 93/283 (32%), Gaps = 98/283 (34%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
           F   + IG GSFG++ L  +       A+K             +++ +         KHP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 48  ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
               L +      KLY +L    GG                            +LF    
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG----------------------------ELFYHLQ 131

Query: 98  R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
           R            A ++ + + ++HS + ++RD+KP+N L+   G       + + DFGL
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGL 185

Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
            K    +  T +            T  GT  Y +          R  D   LG  ++Y  
Sbjct: 186 CKENIEHNSTTS------------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEM 232

Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
           L G  P+         + Y+ I  K +      + S   L  G
Sbjct: 233 LYGLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 45/193 (23%), Positives = 70/193 (36%), Gaps = 51/193 (26%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
           PR  N     R IG G+FG ++      +   E    VA+K+  +K +         Q E
Sbjct: 45  PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100

Query: 53  AKLYKILQGGTGIPNL-RWFGV--EGDYNVLVI------DLL------------------ 85
           A L          PN+ +  GV   G    L+       DL                   
Sbjct: 101 AALMAEFDN----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 86  GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145
             +   + +     LS    L +A Q+   + ++  + F+HRD+   N L+G       V
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VV 213

Query: 146 YIIDFGLAKRYRD 158
            I DFGL+   R+
Sbjct: 214 KIADFGLS---RN 223

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 38/197 (19%), Positives = 70/197 (35%), Gaps = 59/197 (29%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
           PR      LG+ +G G FG++   T  +++       VA+K+  +K          L  E
Sbjct: 21  PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76

Query: 53  AKLYKILQGGTGIPNL-RWFGV---------------EGD-----------YNVLVIDLL 85
             + K +      P++ + +G                 G                +    
Sbjct: 77  FNVLKQVNH----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132

Query: 86  GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
             +   L +   R L++  ++  A Q    M    +++     +HRD+   N L+  G  
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG-- 186

Query: 142 ANQVYIIDFGLAKRYRD 158
             ++ I DFGL+   RD
Sbjct: 187 -RKMKISDFGLS---RD 199

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 49/190 (25%), Positives = 70/190 (36%), Gaps = 45/190 (23%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
           PR       G+ +GSG+FG++   T   I        VA+K+  E   +   + L  E K
Sbjct: 43  PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100

Query: 55  LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL-----------------GPS 88
           +   L     I NL   G        + +I       DLL                    
Sbjct: 101 MMTQLGSHENIVNL--LGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 89  LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
                      L+ + +L  A Q+   +EF+  KS +HRD+   N L+  G     V I 
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKIC 214

Query: 149 DFGLAKRYRD 158
           DFGLA   RD
Sbjct: 215 DFGLA---RD 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 43.7 bits (104), Expect = 6e-05
 Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 87/266 (32%)

Query: 9   FRLGRKIGSGSFGEIYL-------GTN------------IQTNEEVAIKLEN---VKTKH 46
           F L + +G GSFG+++L                      ++  + V  K+E    V+  H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85

Query: 47  P---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 96
           P   +L Y    E KLY IL   +GG                            DLF   
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGG----------------------------DLFTRL 117

Query: 97  SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 151
           S+    + + V     ++   ++ +HS   ++RD+KP+N L+   G       + + DFG
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFG 171

Query: 152 LAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
           L+K        + I + E K  +  GT  Y +         ++  D  S G VLM+  L 
Sbjct: 172 LSK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLT 221

Query: 209 GSLPWQGLKAGTKKQKYEKISEKKVS 234
           G+LP+QG     +K+    I + K+ 
Sbjct: 222 GTLPFQG---KDRKETMTMILKAKLG 244

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 93/270 (34%)

Query: 9   FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-------------LENVKT-------- 44
           F L R +G G +G+++     T   T +  A+K               + K         
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 45  KHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN 94
           KHP    L Y      KLY IL    GG                            +LF 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGG----------------------------ELFM 110

Query: 95  FCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIID 149
              R       T      ++   +  +H K  ++RD+KP+N ++   G       V + D
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTD 164

Query: 150 FGLAKR--YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY 205
           FGL K   +  T TH           T  GT  Y +    +    +R  D  SLG  LMY
Sbjct: 165 FGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMY 212

Query: 206 -FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
             L G+ P+ G     +K+  +KI + K++
Sbjct: 213 DMLTGAPPFTG---ENRKKTIDKILKCKLN 239

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)

Query: 87  PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146
              E   +     L+L+ ++  + Q+   +EF+ S+  +HRD+   N L+        V 
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233

Query: 147 IIDFGLAKR-YRD 158
           I DFGLA+  Y+D
Sbjct: 234 ICDFGLARDIYKD 246

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 95/275 (34%)

Query: 9   FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LENV 42
           F L + +G+G++G+++L    +   T +  A+K                       LE++
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 43  KTKHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL 92
           + + P    L Y    E KL+ IL    GG                            +L
Sbjct: 116 R-QSPFLVTLHYAFQTETKLHLILDYINGG----------------------------EL 146

Query: 93  FNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYI 147
           F   S+  + +   V +   +++  +E +H    ++RDIK +N L+   G       V +
Sbjct: 147 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVL 200

Query: 148 IDFGLAKRYRDTATHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLGY 201
            DFGL+K        + +     +     GT  Y +         G +++   D  SLG 
Sbjct: 201 TDFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG- 249

Query: 202 VLMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 234
           VLMY  L G+ P+       ++ +   +I + +  
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	404
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.78
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.62
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.61
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.11
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.95
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.5
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.82
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.25
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.9

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.5e-64  Score=497.14  Aligned_cols=379  Identities=84%  Similarity=1.343  Sum_probs=277.9

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      |+++++++|+++++||+|+||.||+|++..+++.||||++.......++.+|+++++.|+|+++++.+.+++......++
T Consensus         1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            89999999999999999999999999999999999999998888888899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+++......+++.+++.|+.||+.||+|||++|||||||||+||||+.++..+.+||+|||+++.+....
T Consensus        81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            99999999999999878889999999999999999999999999999999999999655578899999999999888776


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .....++.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+.++.........+.+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            66666677777889999999999999999999999999999999999999999998888888889998888888888889


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccccccCCCCccCCCCCCCCCCCCcc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPA  320 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (404)
                      +.++|+++.+|+..||+.||++||++.+|+++|++++.+.+++++..+||+..+.++.....++....+++..++..+++
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~  320 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP  320 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCc
Confidence            89999999999999999999999999999999999999999999999999988887766555443333332223333344


Q ss_pred             cccccccCCCccCCCCCCCCCCcccccCCCCCCCCCccccCCCCCCCCCCCcccceeeccC
Q 015592          321 AANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMVSTFD  381 (404)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (404)
                      ....+++++..+.+.++|.+.+  +++.+.+..+.+..+++++|...+++.+.|.++.++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (483)
T 3sv0_A          321 ALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASN  379 (483)
T ss_dssp             -------------------------------------------------------------
T ss_pred             cccccccCccccccccCCcccc--cccCCcccccccccccccCCCCCCccccccccccccc
Confidence            4455566666777777777653  7777888888889999999999999999988866644

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-60  Score=447.77  Aligned_cols=247  Identities=21%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++.....    +.+.+|++++++|+|+|+|..+..+ .+....||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-EENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-EECCEEEEEE
Confidence            6899999999999999999999999999999998765432    3588999999999987777666554 5677899999


Q ss_pred             ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ ||+|.+++.... ..+++.+++.|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+....
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence            999 899999997543 457999999999999999999999999999999999999   688999999999998775432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .       .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.   +..+.+.++......    .+
T Consensus       180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~----~~  245 (350)
T 4b9d_A          180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFP----PV  245 (350)
T ss_dssp             H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCC----CC
T ss_pred             c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCC----CC
Confidence            1       123467999999999999999999999999999999999999999874   445556666655443    23


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+|+++.+||.+||++||++|||++++++
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4578999999999999999999999887643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.2e-60  Score=438.05  Aligned_cols=269  Identities=20%  Similarity=0.308  Sum_probs=223.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++++.||+|+||+||+|+++.+++.||||+++.     ....+.+.+|+++++.|+|+|+|..+..+ .+.+..||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEEEE
Confidence            3579999999999999999999999999999999863     23446689999999999987777665554 56778999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ ||+|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence            99999 8899999985 4579999999999999999999999999999999999999   68899999999999977543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ...     ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.   +..+.+.++......     
T Consensus       186 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~-----  252 (311)
T 4aw0_A          186 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYD-----  252 (311)
T ss_dssp             TTC-----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred             CCc-----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence            321     1235678999999999999999999999999999999999999999873   445666666655432     


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      ++..+++++++||.+||.+||++|||++++... ..+   ...+|...+||+....+
T Consensus       253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGGGS
T ss_pred             CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHhcCC
Confidence            345789999999999999999999999876322 111   12356667889876543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-58  Score=433.76  Aligned_cols=260  Identities=21%  Similarity=0.241  Sum_probs=214.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++.+..   ..+|+.+++.|+|+|+|..+.. +.++...||||||+ 
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~-~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGA-VREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEE-EEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEE-EEECCEEEEEEeccC
Confidence            569999999999999999999999999999999876543   3579999999998877766654 45677899999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC-eEEEEecCCcccccccCCccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      ||+|.++++. .+.+++.++..|+.||+.||+|||++|||||||||+||||   +.++ .+||+|||+|+.+........
T Consensus       134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC--------
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccc
Confidence            8999999985 4579999999999999999999999999999999999999   4555 699999999987765432111


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                        .......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+........   ++....  .+...++..+
T Consensus       210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~--~~~~~~~~~~  282 (336)
T 4g3f_A          210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEP--PPIREIPPSC  282 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSC--CGGGGSCTTS
T ss_pred             --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCC--CCchhcCccC
Confidence              012235689999999999999999999999999999999999999998866554433   333322  2234556789


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      |+++.++|.+||++||++|||+.+|++.|...+...+
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999999988887644

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7e-58  Score=419.60  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...     ....+.+|+++++.++|+|+|..+..+ .+.+..|++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-KSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEEEEE
Confidence            67999999999999999999999999999999886542     234589999999999987777666554 567788999


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |||++|+|.+++.. .+++++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+...... 
T Consensus        92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCC-
Confidence            99999999999985 5679999999999999999999999999999999999999   688999999999998765432 


Q ss_pred             cccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                             ...+.+||+.|||||++.+..| +.++|||||||++|||+||+.||.+.   +..+.+..+......     +
T Consensus       167 -------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~-----~  231 (275)
T 3hyh_A          167 -------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT-----L  231 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----C
T ss_pred             -------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC-----C
Confidence                   2345789999999999998886 68999999999999999999999873   445555555554432     3


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      +..+|+++++||.+||++||++|||++++   |++.+.+.
T Consensus       232 p~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~  268 (275)
T 3hyh_A          232 PKFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKV  268 (275)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHT
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHH---HcCccccc
Confidence            45789999999999999999999998765   45555553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.7e-58  Score=432.19  Aligned_cols=246  Identities=18%  Similarity=0.269  Sum_probs=208.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++..  ...+.+.+|+.+|+.++|+|+|..+..+ .+.+..||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEeC
Confidence            5699999999999999999999999999999988643  3345689999999999987776666554 567789999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + ||+|.+++..  .++++.++..|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+.....  
T Consensus       153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence            9 8899999984  569999999999999999999999999999999999999   6889999999999987765432  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+   ..+.+..+...... . ......
T Consensus       226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~-~-~~~~~~  295 (346)
T 4fih_A          226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPP-R-LKNLHK  295 (346)
T ss_dssp             -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCC-C-CSCGGG
T ss_pred             -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCC-C-CCcccc
Confidence                 2356789999999999999999999999999999999999999998743   34444444433211 1 122346


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +++++++||.+||.+||++|||+++++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l  322 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELL  322 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            889999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-58  Score=426.22  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=206.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .++|++.++||+|+||+||+|++.   ..||||+++.....    +.|.+|+.++++++|+|+|..+.++.  .+..+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT--KDNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--CCeEEEE
Confidence            367889999999999999999853   36999998754332    35889999999999999888776543  3457899


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +|+|.+++.....++++.+++.|+.||+.||+|||+++||||||||+||||   +.++.+||+|||+|+......
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence            9999 899999998666789999999999999999999999999999999999999   688999999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..     ......+||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+.+..  ......+......+..
T Consensus       187 ~~-----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          187 GS-----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL  259 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS
T ss_pred             cc-----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc
Confidence            21     123456899999999999743   5899999999999999999999999875432  2223333333334444


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..++..+|+++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            556678999999999999999999999999999998765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-57  Score=436.73  Aligned_cols=246  Identities=18%  Similarity=0.269  Sum_probs=208.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|++.++||+|+||.||+|+++.+|+.||||+++...  ..+.+.+|+.+|+.|+|+|+|..+..+ ...+..||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-EECCEEEEEEeC
Confidence            56999999999999999999999999999999986543  345689999999999987777666555 566788999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      | ||+|.++++.  .++++.++..|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+.....  
T Consensus       230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence            9 8899999974  469999999999999999999999999999999999999   6889999999999987765432  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+   ..+.+..+.......  ......
T Consensus       303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~  372 (423)
T 4fie_A          303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK  372 (423)
T ss_dssp             -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCC--CSCTTS
T ss_pred             -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--Cccccc
Confidence                 2356789999999999999999999999999999999999999998743   344444444332111  122346


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +++++++||.+||.+||++|||+++++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell  399 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELL  399 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            899999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.9e-58  Score=424.87  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=213.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++|.+.++||+|+||+||+|++.     .+++.||||+++....  .++|.+|++++++|+|+|+|..++.+ .+.+..
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-VEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeCCEE
Confidence            468999999999999999999875     3578999999875432  34589999999999988877776655 456678


Q ss_pred             EEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           79 VLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      +|||||+ +|+|.++++...            ..+++.+++.|+.||+.||+|||+++||||||||+|||+   +.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcE
Confidence            9999999 999999997532            469999999999999999999999999999999999999   688999


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      ||+|||+|+........     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.   .+.
T Consensus       168 Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~  239 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV  239 (299)
T ss_dssp             EECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH
T ss_pred             EECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            99999999876543321     12334579999999999999999999999999999999999 9999988543   444


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+......    ..+..+|+++.+|+.+||+.||++|||+++|.+.|+++...
T Consensus       240 ~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          240 IECITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            5555544332    23467899999999999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.6e-56  Score=414.43  Aligned_cols=293  Identities=78%  Similarity=1.358  Sum_probs=258.5

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      |+..++++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+.+++.++|++++..+..+.......++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            67789999999999999999999999999999999999988777778899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++......
T Consensus        83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            99999999999998777789999999999999999999999999999999999999555578899999999999887766


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+....
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            55555555666788999999999999999999999999999999999999999987766666667777776767777777


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL  293 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~  293 (404)
                      ...+|+++.+++.+||+.||++||++.++.+.|++++.+.+...+.++||+..
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence            78899999999999999999999999999999999999999999999999865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-55  Score=412.29  Aligned_cols=293  Identities=78%  Similarity=1.358  Sum_probs=264.6

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      |+..++++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+.+++.++|+++++.+..+.......++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            67789999999999999999999999999999999999988877778899999999999999999999999899999999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.++.+||+|||+++......
T Consensus        83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            99999999999998767789999999999999999999999999999999999999544577899999999999877765


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .....++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..+.+..+.........+.+
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence            55555555566788999999999999999999999999999999999999999987666656666666666666667777


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL  293 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~  293 (404)
                      +..+|+++.+++.+||+.||++||++.+|.+.|++++.+.+...+.++||+..
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence            78899999999999999999999999999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-56  Score=415.03  Aligned_cols=248  Identities=21%  Similarity=0.308  Sum_probs=205.2

Q ss_pred             CCce-EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee---CCe
Q 015592            6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDY   77 (404)
Q Consensus         6 ~~~y-~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~   77 (404)
                      .++| ++.++||+|+||+||+|++..+++.||+|++.....    .+.+.+|+++++.|+|+|+|..+..+...   ...
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            3455 888999999999999999999999999998865432    23588999999999999988888776442   456


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+|+|||+ ||+|.++++. .+.+++..+..|+.||+.||+|||++|  ||||||||+||||+  +.++.+||+|||+|+
T Consensus       104 ~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence            89999999 8999999985 457999999999999999999999998  99999999999994  346899999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ......         ..+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+..  .....+..+.....+
T Consensus       181 ~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~~  248 (290)
T 3fpq_A          181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP  248 (290)
T ss_dssp             GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred             eCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCCC
Confidence            544321         245689999999999876 69999999999999999999999997643  233444444443322


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         ..+...+++++.+||.+||++||++|||++++++
T Consensus       249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               2344567899999999999999999999887643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-56  Score=421.75  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=206.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++|.+.++||+|+||+||+|++.     .+++.||||+++....  .++|.+|++++++|+|+|+|..++.+ .+....
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-TEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEE
Confidence            357999999999999999999875     3688999999875432  34589999999999988877776655 456678


Q ss_pred             EEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC
Q 015592           79 VLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~  143 (404)
                      +|||||+ +|+|.++++...              .++++.+++.|+.||+.||+|||+++||||||||+||||   +.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CCCC
Confidence            9999999 999999997432              359999999999999999999999999999999999999   6889


Q ss_pred             eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 015592          144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK  222 (404)
Q Consensus       144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~  222 (404)
                      .+||+|||+|+.+......     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.   .
T Consensus       196 ~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~  267 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---T  267 (329)
T ss_dssp             EEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---H
T ss_pred             cEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---H
Confidence            9999999999876543321     12345679999999999999999999999999999999999 9999988543   4


Q ss_pred             HHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +.+..+......    ..+..+|+++.+|+.+||+.||++|||+.+|.+.|+.+..
T Consensus       268 ~~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          268 EAIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            444455443321    2345789999999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-56  Score=419.71  Aligned_cols=254  Identities=20%  Similarity=0.237  Sum_probs=211.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ..++++.++||+|+||+||+|++.     .+++.||||+++....   .++|.+|+.++++|+|+|+|..++.+. ....
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~  103 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-KDQP  103 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-ECCE
Confidence            457899999999999999999863     4678999999865432   356999999999999888887776654 4567


Q ss_pred             EEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                      .+|||||+ +|+|.+++....               ..+++.+++.|+.||+.||+|||+++||||||||+||||   ++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---CC
Confidence            79999999 999999996421               358999999999999999999999999999999999999   68


Q ss_pred             CCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 015592          142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT  220 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~  220 (404)
                      ++.+||+|||+|+........     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.  
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--  253 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--  253 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred             CCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence            899999999999876543321     13345689999999999999999999999999999999998 8999988543  


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                       .+.+..+......    ..+..+|+++.+|+.+||+.||++||++.+|.+.|+.
T Consensus       254 -~~~~~~i~~~~~~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          254 -QDVVEMIRNRQVL----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             -HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -HHHHHHHHcCCCC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             4444555444332    2346789999999999999999999999999998874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.3e-58  Score=424.40  Aligned_cols=264  Identities=21%  Similarity=0.321  Sum_probs=209.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ++|++++.||+|+||+||+|++.   .+++.||||+++...    ....+.+|+++++.++|+|+|..+..+ .+....|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-QTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-EETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEEE
Confidence            67999999999999999999984   468899999876432    234588999999999988777666554 5677899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ ||+|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....
T Consensus       103 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            999999 8999999985 4579999999999999999999999999999999999999   6889999999999986654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       ...+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.   +..+.+..+......    
T Consensus       179 ~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~----  244 (304)
T 3ubd_A          179 HEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG----  244 (304)
T ss_dssp             --C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred             CCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC----
Confidence            332       234678999999999999999999999999999999999999999874   445556666554432    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                       ++..+|+++.+||.+||++||++||++.  .+.+++++       +|...+||.....++
T Consensus       245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H-------p~f~~idw~~l~~~~  297 (304)
T 3ubd_A          245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH-------SFFSTIDWNKLYRRE  297 (304)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS-------GGGTTCCHHHHHTTC
T ss_pred             -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC-------ccccCCCHHHHHhCC
Confidence             3457899999999999999999999863  23344443       344557888665444

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.2e-55  Score=413.45  Aligned_cols=285  Identities=60%  Similarity=1.073  Sum_probs=256.3

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+++++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+.+++.+.+|+++..+..++......+++|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            46789999999999999999999999999999999999877777789999999999966667777777778888999999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe-----EEEEecCCccccc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKRYR  157 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~-----vkL~DFG~a~~~~  157 (404)
                      ||++++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++   .++.     +||+|||+++.+.
T Consensus        85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred             EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence            9999999999997677899999999999999999999999999999999999994   5554     9999999999877


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ........+++......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..+.+..+.........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            66555555555667789999999999999999999999999999999999999999998877777888888777776777


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT  291 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~  291 (404)
                      +.++..+| ++.+++..||+.||.+||++++|.+.|++++.+.+...+..+||.
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            77777788 999999999999999999999999999999999999999999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-56  Score=424.29  Aligned_cols=261  Identities=20%  Similarity=0.289  Sum_probs=214.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCc-eeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPN-LRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~-~~~~~~~~~   76 (404)
                      .++|+++++||+|+||+||+|++..+     ++.||||+++.....   +.+.+|++++.++.||++|.. ++.+...+.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            36899999999999999999998654     368999998765433   358899999999998765554 455555667


Q ss_pred             eEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                      ..+|||||| +|+|.++++..               ...+++.+++.|+.||+.||+|||+++||||||||+|||+   +
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---C
Confidence            789999999 89999999743               2348999999999999999999999999999999999999   6


Q ss_pred             CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 015592          141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG  219 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~  219 (404)
                      .++.+||+|||+|+.+......     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             CCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            8899999999999876544321     12345689999999999999999999999999999999998 99999886543


Q ss_pred             ChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .  .....+.....    ...+..+|+++.+++.+||+.||++|||+.+|++.|++++...
T Consensus       295 ~--~~~~~i~~g~~----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          295 E--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             H--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H--HHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            2  22233333221    1234568999999999999999999999999999999988653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-54  Score=402.04  Aligned_cols=290  Identities=60%  Similarity=1.015  Sum_probs=259.5

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.++++++.+..+.......+++|
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            46889999999999999999999999999999999999877777889999999999987888888878888889999999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCCeEEEEecCCcccccccC
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~--~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||++++|.+++.....++++.+++.++.||+.||+|||++||+||||||+|||++.+  +....+||+|||+++......
T Consensus        86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            999999999999766779999999999999999999999999999999999999532  122349999999999887765


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .....++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+...........+
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  245 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence            55545555566788999999999999999999999999999999999999999998777777777777777666777777


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI  292 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~  292 (404)
                      ...+|+++.+++.+||+.||++||++++|.+.|++++.+.+...+..+||+.
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  297 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  297 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence            7889999999999999999999999999999999999999999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=418.95  Aligned_cols=259  Identities=20%  Similarity=0.247  Sum_probs=207.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeee-----eC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~   75 (404)
                      ++++|++++.||+|+||+||+|+++.+|+.||||+++.....    +.+.+|+++|+.|+|+|+|..+..+..     +.
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            578999999999999999999999999999999998755432    347789999999999888887766543     34


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...||||||++|+|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.
T Consensus       132 ~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          132 KSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARG  207 (398)
T ss_dssp             CCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred             CEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceeee
Confidence            57899999999999999974 5679999999999999999999999999999999999999   6889999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---  231 (404)
                      +.......   .....+.+||+.|||||++.+.. |+.++||||+|||+|||++|+.||.+.+..+....+......   
T Consensus       208 ~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          208 LCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            65432211   11235679999999999998764 699999999999999999999999885443332222221110   


Q ss_pred             --------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          ........+..++++++.+||.+||.+||++|||+++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  343 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL  343 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                                011122334456789999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.2e-55  Score=410.08  Aligned_cols=267  Identities=21%  Similarity=0.250  Sum_probs=202.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHH--HHHHHHHHHcCCCCCCceeEeeeeC---CeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ--YEAKLYKILQGGTGIPNLRWFGVEG---DYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~   79 (404)
                      |.++|.+.++||+|+||+||+|++  +|+.||||+++.... ..+.  .|+..+.+++|+|++..+..+...+   ...+
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            467899999999999999999996  689999999865432 2333  4555556788888888887776554   3579


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcccccCCCCCCeEEEEec
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      |||||+ +|+|.++++.  .++++..+..|+.|++.||+|||++        +||||||||+||||   +.++.+||+||
T Consensus        78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF  152 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred             EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence            999999 8999999984  4699999999999999999999987        99999999999999   68899999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCC---------
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG---------  215 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlG~il~elltg~~Pf~~---------  215 (404)
                      |+|+..........   ......+||+.|||||++.+.      .++.++|||||||+||||+||..||..         
T Consensus       153 Gla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             TTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             CCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            99987655432111   122356899999999999865      367899999999999999999776543         


Q ss_pred             -CCCC--ChHHHHHHHhhhcccccHhHhhcC--CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015592          216 -LKAG--TKKQKYEKISEKKVSTSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF  282 (404)
Q Consensus       216 -~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  282 (404)
                       ....  ...+....+......+.++.....  ++..+.+|+.+||+.||++|||+.+|.+.|+++...++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i  301 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence             2111  122333334444333333322222  346789999999999999999999999999998776553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-54  Score=403.18  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=189.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeC--------
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--------   75 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--------   75 (404)
                      ++|++++.||+|+||+||+|+++.+++.||||+++....   .+.+.+|+++++.|+|+|+|..+..+...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            569999999999999999999999999999998865443   245889999999999999888887765433        


Q ss_pred             ---CeEEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           76 ---DYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        76 ---~~~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                         .+.|++|||+ +++|.++++....  ..++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEcc
Confidence               2478999999 8999999984321  24567789999999999999999999999999999999   6788999999


Q ss_pred             cCCcccccccCCcccc-----cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 015592          150 FGLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~  224 (404)
                      ||+|+.+.........     ......+.+||+.|||||++.+..|+.++|||||||+||||++   ||.+..  +....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence            9999877654321110     1112345689999999999999999999999999999999996   886421  12223


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +..+.....++    .....++++.+||.+||++||++|||+.++++
T Consensus       237 ~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33333333322    22334567889999999999999999887653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-52  Score=401.02  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      |.+.++|++.++||+|+||+||+|+++   .+++.||||.+.......++.+|+++++.+.+|++|..+..+....+..|
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            457889999999999999999999875   46789999998777666778999999999976767777777777888999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.++++    ++++.++..++.||+.||+|||++|||||||||+|||++  .+.+.+||+|||+|+...+
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCC
Confidence            999999 889999985    499999999999999999999999999999999999995  3448999999999986654


Q ss_pred             cCCcccc---------------------cccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 015592          159 TATHQHI---------------------PYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL  216 (404)
Q Consensus       159 ~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~  216 (404)
                      .......                     ........+||+.|+|||++.+.. |+.++||||+|||+|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            3211000                     001123468999999999998764 899999999999999999999999754


Q ss_pred             CCCChHHHHHHHhhhccc-------------------------------------------------ccHhHhhcCCcHH
Q 015592          217 KAGTKKQKYEKISEKKVS-------------------------------------------------TSIEALCRGYPTE  247 (404)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~  247 (404)
                      ++  ....+..+......                                                 .........++++
T Consensus       251 ~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          251 SD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             SS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            32  12222222110000                                                 0000112357889


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +.+||.+||..||++|||+++++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL  351 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEAL  351 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHCcCChhHCcCHHHHh
Confidence            99999999999999999987654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-52  Score=421.59  Aligned_cols=271  Identities=22%  Similarity=0.279  Sum_probs=216.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~   76 (404)
                      +--++|++++.||+|+||+||+|+++.+|+.||||+++..     ........|..++..+.  +|++|..+..++.+..
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            4457899999999999999999999999999999988642     22334556666665553  3455555666667788


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..||||||+ ||+|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.
T Consensus       266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence            899999999 8999999985 4579999999999999999999999999999999999999   6889999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      +....         ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+....+..+.+..+..... 
T Consensus       342 ~~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-  411 (689)
T 3v5w_A          342 FSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-  411 (689)
T ss_dssp             CSSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-
T ss_pred             cCCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-
Confidence            65432         246789999999999974 5799999999999999999999999987665555555555544333 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeecccccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ  299 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~  299 (404)
                          .++..+++++++||.+||.+||.+|++..  ...++++       .+|...+||.....++..
T Consensus       412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~-------HpfF~~idW~~l~~~~~~  467 (689)
T 3v5w_A          412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-------SPFFRSLDWQMVFLQKYP  467 (689)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT-------SGGGTTCCHHHHHTTCSC
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc-------CccccCCCHHHHHcCCCC
Confidence                23457899999999999999999999831  1222222       355667889876555433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-51  Score=394.56  Aligned_cols=290  Identities=27%  Similarity=0.478  Sum_probs=221.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCC-----CcEEEEEEecCCCCchhHHHHHHHHHHHc---------------CCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQLQYEAKLYKILQ---------------GGT   63 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~E~~~l~~l~---------------~~~   63 (404)
                      ...++|++.+.||+|+||.||+|++..+     ++.||||++....  ..+..|+++++.+.               |++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            3456999999999999999999998664     5889999876543  34566666665554               455


Q ss_pred             CCCceeEeeee---CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           64 GIPNLRWFGVE---GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        64 ~i~~~~~~~~~---~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                      ++..+..+...   ..+.+++|||++++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++. +
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            55555444332   2568999999999999999876678999999999999999999999999999999999999942 1


Q ss_pred             CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 015592          141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT  220 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~  220 (404)
                      .++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            67899999999998776554332222222345679999999999999999999999999999999999999998643322


Q ss_pred             hHHHHHHHh-hhcccccHhHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          221 KKQKYEKIS-EKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      ......... ............  ..+|+++.+++..||+.||++||++.+|.+.|++++...+.+.+..+||+.....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~  347 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENG  347 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC------
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccCC
Confidence            211111111 111111111111  5689999999999999999999999999999999999999999999999976544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-51  Score=414.71  Aligned_cols=251  Identities=18%  Similarity=0.260  Sum_probs=211.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.....  .+.+.+|+.+|+.|+|+|+|..+.. +.+....+|+||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-EECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-EEECCEEEEEEe
Confidence            4689999999999999999999999999999998865432  3458899999999998877666554 456778999999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ ||+|.+++......+++.++..|+.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.+..... 
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~-  312 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-  312 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE-
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc-
Confidence            99 88999999755567999999999999999999999999999999999999952 1357899999999997765432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             ....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.   +..+.+..+........ .....
T Consensus       313 -------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~  381 (573)
T 3uto_A          313 -------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAFS  381 (573)
T ss_dssp             -------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCC-SGGGT
T ss_pred             -------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCC-ccccc
Confidence                   23458999999999999999999999999999999999999999874   34555566655443322 23446


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+++++++||.+||.+||++||++.+++
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l  409 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTIHQAL  409 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            7899999999999999999999988664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=377.74  Aligned_cols=282  Identities=23%  Similarity=0.402  Sum_probs=223.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC--------CcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCc---------
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN---------   67 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~---------   67 (404)
                      .+++|++.+.||+|+||.||+|++..+        ++.||||++...   ..+.+|+.+++.++|++++..         
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            368999999999999999999999874        889999998744   578999999999998665542         


Q ss_pred             -----eeEeee-eCCeEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           68 -----LRWFGV-EGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        68 -----~~~~~~-~~~~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                           +..++. .....+++|||++++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+|||+   +
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~---~  193 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---D  193 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE---E
T ss_pred             cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---c
Confidence                 333333 47889999999999999999854 3679999999999999999999999999999999999999   4


Q ss_pred             CCC--eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 015592          141 RAN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (404)
Q Consensus       141 ~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~  218 (404)
                      .++  .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|+.||.+...
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            566  899999999987765433221111223456899999999999999999999999999999999999999987542


Q ss_pred             CChHHHHHHHh--hhcccccHhH--hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccc
Q 015592          219 GTKKQKYEKIS--EKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL  293 (404)
Q Consensus       219 ~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~  293 (404)
                      .. ........  ..........  ....+++++.+++.+||+.||++||++.+|.+.|++++.+.+...+.++||...
T Consensus       274 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~  351 (352)
T 2jii_A          274 NT-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV  351 (352)
T ss_dssp             CH-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred             CH-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence            21 11111111  1111110000  012568999999999999999999999999999999999999999999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.8e-48  Score=372.35  Aligned_cols=270  Identities=19%  Similarity=0.264  Sum_probs=218.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|+++++||+|+||.||+|++..+++.||||+++...     ....+..|..++..+.+|++|..+..+.......++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999999999999999886432     234588999999998656666666667778888999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence            99999 8899999985 4579999999999999999999999999999999999999   68899999999999854332


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC------ChHHHHHHHhhhcc
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKV  233 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~  233 (404)
                      ..       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      .....+..+.....
T Consensus       207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~  279 (396)
T 4dc2_A          207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI  279 (396)
T ss_dssp             TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred             CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence            21       234678999999999999999999999999999999999999999754321      12223344443332


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCceeeccccccccc
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQS  298 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~---~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~  298 (404)
                           .++..+++++.+||.+||+.||++||++.   .+.+++++       +|...++|......+.
T Consensus       280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H-------pff~~i~w~~l~~~~~  335 (396)
T 4dc2_A          280 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDWDMMEQKQV  335 (396)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS-------TTTTTCCHHHHHTTCS
T ss_pred             -----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC-------ccccCCCHHHHHcCCC
Confidence                 23456899999999999999999999963   34444443       4556688987655443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-48  Score=361.95  Aligned_cols=263  Identities=22%  Similarity=0.362  Sum_probs=213.2

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ...+.++|++.+.||+|+||.||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+. +.....
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID-VDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEE-EEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEE-eeeeCC
Confidence            467889999999999999999999999999999999987543322     35788999999998777666554 456677


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++.. .+++++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTT
T ss_pred             eEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccc
Confidence            889999999 8899999985 3579999999999999999999999999999999999999   6788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ......+........
T Consensus       161 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~  231 (294)
T 4eqm_A          161 LSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIAIKHIQDSVPN  231 (294)
T ss_dssp             C-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHHHHHHHSSCCCC
T ss_pred             cccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhccCCC
Confidence            654322      12334679999999999999999999999999999999999999998743   233333344444444


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI  278 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-~~~~l~~~l~~~~~  278 (404)
                      ........+|+.+.+++.+||+.||++|| +++++.+.|+.++.
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            44555678999999999999999999998 88888888876653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=371.94  Aligned_cols=268  Identities=19%  Similarity=0.254  Sum_probs=214.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.++|++.+.||+|+||.||+|++..+++.||||+++..     .....+..|..+++.+.+|++|..+..+.......+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            347899999999999999999999999999999987642     234557889999999876666777777777888899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeeccc
Confidence            999999 8899999985 4579999999999999999999999999999999999999   6889999999999985443


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+.+..+......    
T Consensus       177 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~----  242 (353)
T 3txo_A          177 NGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVV----  242 (353)
T ss_dssp             ----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred             CCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence            221       234568999999999999988999999999999999999999999874   345555555554432    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCceeeccccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQQS  298 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~---l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~  298 (404)
                       ++..+++++.++|.+||++||++||++.+   ..+++++       +|...++|......+.
T Consensus       243 -~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h-------p~f~~~~w~~l~~~~~  297 (353)
T 3txo_A          243 -YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH-------PFFKEIDWAQLNHRQI  297 (353)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS-------GGGTTCCHHHHHTTCS
T ss_pred             -CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC-------CcccCCCHHHHhcCcC
Confidence             23457899999999999999999999721   1233333       3445578886654443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-47  Score=362.92  Aligned_cols=262  Identities=19%  Similarity=0.265  Sum_probs=213.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.++|++.+.||+|+||.||+|++..+++.||||+++..     .....+.+|+.+++.++|++++.. ..+.......+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l-~~~~~~~~~~~   81 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCE-EEEEECSSEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcce-EEEEEeCCEEE
Confidence            347899999999999999999999999999999987642     344568899999999987665554 44556677889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence            999999 8899999975 4579999999999999999999999999999999999999   6889999999999986433


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +....+..+......    
T Consensus       158 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~----  223 (337)
T 1o6l_A          158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIR----  223 (337)
T ss_dssp             TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred             CCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence            221       234668999999999999999999999999999999999999999874   334444444443322    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                       ++..+++++.++|.+||+.||++||     ++++|+   ++       ++...++|......
T Consensus       224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~---~h-------~~f~~~~~~~~~~~  275 (337)
T 1o6l_A          224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM---EH-------RFFLSINWQDVVQK  275 (337)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH---TS-------GGGTTCCHHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH---cC-------CCcCCCCHHHHHhC
Confidence             3456899999999999999999999     665543   32       34445678765433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9e-48  Score=367.54  Aligned_cols=269  Identities=19%  Similarity=0.237  Sum_probs=220.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++..     .....+..|..++..+.+|++|..+..+.......
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            3457899999999999999999999999999999987642     33456788999998887788888887888888899


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence            9999999 8899999985 3569999999999999999999999999999999999999   688999999999998643


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+.+..+......   
T Consensus       173 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---  239 (353)
T 2i0e_A          173 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---  239 (353)
T ss_dssp             CTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred             cCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC---
Confidence            3221       234668999999999999999999999999999999999999999874   344555555554432   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeeccccccccc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQS  298 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~  298 (404)
                        ++..+++++.+||.+||..||++||++.  .+.+++++       ++...++|......+.
T Consensus       240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h-------~~f~~~~w~~l~~~~~  293 (353)
T 2i0e_A          240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH-------AFFRYIDWEKLERKEI  293 (353)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS-------GGGTTCCHHHHHTTCS
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC-------ccccCCCHHHHHhCCC
Confidence              3357899999999999999999999752  23333333       3444578887654443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-47  Score=375.33  Aligned_cols=268  Identities=21%  Similarity=0.261  Sum_probs=215.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.++||+|+||+||+|++..+++.||||+++.     ......+..|..++..++|++++.. ..+..+....+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l-~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL-HYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE-EEEEECSSEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE-EEEEeeCCEEE
Confidence            35789999999999999999999999999999998754     2334458999999999976665554 45556677899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence            999999 999999998656789999999999999999999999999999999999999   6889999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      ....      .....+||+.|+|||++.     +..++.++|||||||++|||++|+.||.+.   +..+.+.++.....
T Consensus       228 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          228 DGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKE  298 (437)
T ss_dssp             TSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHH
T ss_pred             CCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhccc
Confidence            3321      223468999999999997     556899999999999999999999999874   34455555544322


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCceeecccccc
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY  295 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~  295 (404)
                      ....+.....+++++++||.+||..+|++  ||+++++++          .+|...+||...+.
T Consensus       299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l~~  352 (437)
T 4aw2_A          299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNIRN  352 (437)
T ss_dssp             HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTGGG
T ss_pred             cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHHhh
Confidence            22222223458999999999999988888  898776543          24555678887643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-47  Score=364.70  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=210.9

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      ..+.++|++++.||+|+||.||+|++..+|+.||||+++....        .+.+.+|+.+++.++|++++..+.. ...
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV-YEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE-EEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE-EEe
Confidence            3567889999999999999999999999999999998875432        2468899999999997776666554 456


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC----eEEEEe
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIID  149 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~----~vkL~D  149 (404)
                      ....+++|||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+.   ..+    .+||+|
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D  162 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID  162 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence            77889999999 8999999974 56799999999999999999999999999999999999994   333    799999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      ||+++......        ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   +..+.+..+.
T Consensus       163 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~  231 (361)
T 2yab_A          163 FGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT  231 (361)
T ss_dssp             CSSCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH
T ss_pred             cCCceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence            99998765532        123567999999999999999999999999999999999999999874   3445555555


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ....... ......+++++.+||.+||..||++||++.+++
T Consensus       232 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  271 (361)
T 2yab_A          232 AVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL  271 (361)
T ss_dssp             TTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            5443322 344567899999999999999999999988765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-47  Score=363.43  Aligned_cols=274  Identities=19%  Similarity=0.270  Sum_probs=218.4

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      |++.-.++|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|..+++.+.+|++|..+..+....
T Consensus         3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            566777899999999999999999999999999999999875432     234778999999985555566666666777


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...+++|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence            8899999999 8899999975 4579999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC------ChHHHHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKI  228 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~  228 (404)
                      .......       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      .....+..+
T Consensus       159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred             cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence            6433221       234568999999999999999999999999999999999999999753221      122233334


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~---~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      .....     .++..++.++.++|.+||+.||++||++.   .+.+++++       ++...++|.....++
T Consensus       232 ~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h-------p~f~~~~w~~~~~~~  291 (345)
T 3a8x_A          232 LEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDWDMMEQKQ  291 (345)
T ss_dssp             HHCCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS-------GGGTTCCHHHHHTTC
T ss_pred             HcCCC-----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC-------CccCCCCHHHHHhCC
Confidence            33332     23456899999999999999999999963   33444443       344567887664443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.8e-47  Score=357.34  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=205.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ..++|++.+.||+|+||+||+|++..+++.||||++...  ...+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-EECCEEEEEE
Confidence            346899999999999999999999999999999987543  3345688999999999987777666554 4567789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++..  ..+++.++..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred             ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence            999 9999999984  469999999999999999999999999999999999999   6788999999999987654432


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ......+.......  ...+
T Consensus       172 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~  239 (297)
T 3fxz_A          172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNP  239 (297)
T ss_dssp             -------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCG
T ss_pred             -------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCc
Confidence                   23456899999999999999999999999999999999999999987433   22222222221111  1123


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+++.+.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            467899999999999999999999886643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-47  Score=361.25  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=206.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++......    +.+.+|+++++.++|++++..+..+ ......+
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-ETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCEEE
Confidence            3457899999999999999999999999999999998654322    3478899999999987766665554 5667889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++.. .+++++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred             EEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence            999999 8899999975 4579999999999999999999999999999999999999   6889999999999986654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..        ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+   ..+....+......   
T Consensus       167 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~---  232 (328)
T 3fe3_A          167 GG--------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYR---  232 (328)
T ss_dssp             SC--------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred             CC--------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence            32        12356799999999999988874 89999999999999999999998743   34444444444332   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                        ++..+++++.+|+.+||..||.+|||++++++
T Consensus       233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              23457899999999999999999999876643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-47  Score=365.32  Aligned_cols=265  Identities=21%  Similarity=0.282  Sum_probs=215.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|+++.+++.||||+++..     .....+..|..++..+.+|++|..+..+.......
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            3457899999999999999999999999999999987642     34456888999999885556666666666778889


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence            9999999 8899999985 3579999999999999999999999999999999999999   688899999999998643


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+   ..+.+..+.....    
T Consensus       170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~----  235 (345)
T 1xjd_A          170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNP----  235 (345)
T ss_dssp             CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC----
T ss_pred             cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCC----
Confidence            3221       2346789999999999999999999999999999999999999998743   3444555544332    


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~-~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                       .++..+++++.++|.+||..||++||++. +|++          .++...++|......+
T Consensus       236 -~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~----------hp~f~~~~w~~l~~~~  285 (345)
T 1xjd_A          236 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ----------HPLFREINWEELERKE  285 (345)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG----------SGGGTTCCHHHHHTTC
T ss_pred             -CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc----------CccccCCCHHHHhhCC
Confidence             23356889999999999999999999986 3321          2444567787664443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=361.33  Aligned_cols=259  Identities=18%  Similarity=0.265  Sum_probs=214.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~   80 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-ESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE-ecCCEEEEEE
Confidence            467899999999999999999999999999999998875432 23578999999999987776665554 5677889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+++.+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCc
Confidence            999 789999997555579999999999999999999999999999999999999421 278999999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ..+.+..+........ ....
T Consensus       160 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~  227 (321)
T 1tki_A          160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAF  227 (321)
T ss_dssp             --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHH
T ss_pred             --------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhh
Confidence                    124578999999999999889999999999999999999999998743   3455555555444333 3334


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+++++.+++.+||..||++|||+.+++   ++.+..
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l---~hp~~~  262 (321)
T 1tki_A          228 KEISIEAMDFVDRLLVKERKSRMTASEAL---QHPWLK  262 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHH---HSHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHh---cChhhc
Confidence            67899999999999999999999988664   455544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=354.91  Aligned_cols=257  Identities=18%  Similarity=0.227  Sum_probs=203.5

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHc---CCCCCCceeEee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQ---GGTGIPNLRWFG   72 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~---~~~~i~~~~~~~   72 (404)
                      ..+.++|++.++||+|+||+||+|++..+++.||||++....       ....+.+|+.+++.++   |++++..+..+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            467899999999999999999999999999999999876322       2346888999988887   777777666665


Q ss_pred             eeCC----eEEEEEeccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEE
Q 015592           73 VEGD----YNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        73 ~~~~----~~~lv~e~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                      ....    ..+++||+++++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl  161 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL  161 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred             ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence            4332    5799999999999999985432 39999999999999999999999999999999999999   67889999


Q ss_pred             EecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      +|||+++......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..
T Consensus       162 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          162 ADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             CSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             eeCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999998665432        22356789999999999999999999999999999999999999987544322222222


Q ss_pred             Hhhh-------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          228 ISEK-------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       228 ~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ....                   ............+++++.+||.+||+.||++|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  295 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL  295 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence            1110                   011122344457889999999999999999999988664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=373.43  Aligned_cols=255  Identities=20%  Similarity=0.240  Sum_probs=211.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....    .+.+.+|+.+++.++|++++..+.. ..+....+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS-ISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE-EECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE-EEECCEEE
Confidence            456789999999999999999999999999999999876543    2357899999999988777766554 45677889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+|||++....++.+||+|||+++....
T Consensus        87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            999999 8899999885 56799999999999999999999999999999999999996444678999999999987655


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   +....+..+.......+.+
T Consensus       166 ~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          166 EQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             TCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCTT
T ss_pred             CCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCcc
Confidence            332       223568999999999999999999999999999999999999999874   3445555555544433222


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ....+++++.+||.+||+.||++||++.++++
T Consensus       236 -~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 -EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             23468999999999999999999999987754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-47  Score=364.82  Aligned_cols=256  Identities=18%  Similarity=0.234  Sum_probs=209.8

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++...       ...+.+.+|+.+++.++|++++..+..+ ...
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSD   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-EET
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence            35667899999999999999999999999999999987532       1345689999999999987777666554 567


Q ss_pred             CeEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      ...+++|||+ +++|.+++...   ...+++..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            7889999999 78998877532   3358999999999999999999999999999999999999644445669999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      +++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..    ...+..+...
T Consensus       179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~  247 (351)
T 3c0i_A          179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKG  247 (351)
T ss_dssp             TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHT
T ss_pred             ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcC
Confidence            9987665332       1235679999999999999999999999999999999999999998732    3344444444


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..... ......+++++.+||.+||+.||++||++.++++
T Consensus       248 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            43322 2334578999999999999999999999887654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.2e-47  Score=355.55  Aligned_cols=256  Identities=18%  Similarity=0.260  Sum_probs=206.7

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+.++|++.++||+|+||+||+|++ .+++.||||++......    ..+.+|+.+++.++|++++..+..+ ......+
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~   95 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-HSERCLT   95 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-CCSSCEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-ccCCEEE
Confidence            4678999999999999999999998 46899999988654332    4578999999999987776666554 4667789


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++|||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSC
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCC
Confidence            999999889999998666679999999999999999999999999999999999999   67889999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc----
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS----  234 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----  234 (404)
                      ..       ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..+......    
T Consensus       173 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          173 VR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             cc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            22       2234578999999999987 45899999999999999999999999987766555444443321111    


Q ss_pred             ------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 ------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                        .....+...+++++.+||.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                              1123344567899999999999999999999887653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-47  Score=365.30  Aligned_cols=258  Identities=17%  Similarity=0.305  Sum_probs=209.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCCCCceeEeeee
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKIL-QGGTGIPNLRWFGVE   74 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l-~~~~~i~~~~~~~~~   74 (404)
                      .++|++++.||+|+||.||+|++.       .++..||||+++.....   ..+.+|+.+++.+ +|++++..+ .++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~-~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL-GACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE-EEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE-EEEcc
Confidence            468999999999999999999975       34567999998755332   3588999999999 555555444 45556


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~  138 (404)
                      ....+++|||+ +++|.+++....               ..+++.+++.++.||+.||+|||++||+||||||+|||+  
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--
Confidence            67789999999 789999998543               248999999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                       +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       237 -~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          237 -TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             -CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence             68899999999999866543321     12334567899999999999999999999999999999999 999998855


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ....   +..+.....    ...+..+++++.+++.+||+.||++||++.++++.|++++..
T Consensus       311 ~~~~---~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          311 VEEL---FKLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             GGGH---HHHHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH---HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            4332   333332221    123456889999999999999999999999999999998864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=366.16  Aligned_cols=270  Identities=29%  Similarity=0.454  Sum_probs=203.6

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcC---CCcEEEEEEecCCCC-------------chhHHHHHHHHHHHcCCCCCC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK-------------HPQLQYEAKLYKILQGGTGIP   66 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-------------~~~~~~E~~~l~~l~~~~~i~   66 (404)
                      ...+++|++.+.||+|+||.||+|++..   ++..||||+......             ...+.+|+.+++.++|++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3567899999999999999999999987   788999998775432             223556677777778877777


Q ss_pred             ceeEeeee---CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC
Q 015592           67 NLRWFGVE---GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (404)
Q Consensus        67 ~~~~~~~~---~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~  143 (404)
                      .+..+...   ....+++|||++++|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++   .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~  188 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YKN  188 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SSS
T ss_pred             eecccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cCC
Confidence            76665443   6788999999999999999753 3799999999999999999999999999999999999994   444


Q ss_pred             --eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 015592          144 --QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK  221 (404)
Q Consensus       144 --~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~  221 (404)
                        .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+......
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999987765432211111122456899999999999999999999999999999999999999965322211


Q ss_pred             -HHHHHHHhhhcccccHhHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          222 -KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       222 -~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       .....................  .+|+++.+++.+||+.||++||++.+|.+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence             111111112222222222222  7899999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.6e-47  Score=357.33  Aligned_cols=257  Identities=21%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +..++|++.+.||+|+||.||+|++  +++.||||++......    ..+.+|+.++++++|++++..+..+ ......+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~  110 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-TQPPNLS  110 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSTTCCE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCceE
Confidence            3457899999999999999999986  6889999998765433    3478899999999987777666554 4556689


Q ss_pred             EEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           80 LVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ++|||+ +++|.+++.....  .+++..++.++.||+.||+|||++|  |+||||||+|||+   +.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCc
Confidence            999999 8899999984321  3999999999999999999999999  9999999999999   678899999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .......       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...   .+....+..... 
T Consensus       188 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~-  256 (309)
T 3p86_A          188 LKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCK-  256 (309)
T ss_dssp             ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCC-
T ss_pred             ccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC-
Confidence            5544321       23456799999999999999999999999999999999999999987543   333333322111 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                        ...++..+++++.++|.+||+.||++||++.++.+.|+.++..
T Consensus       257 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 --RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              1234457899999999999999999999999999999998743

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=352.83  Aligned_cols=246  Identities=18%  Similarity=0.201  Sum_probs=199.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.++|++.++||+|+||+||+|++..+++.||||++......    .....|+..+..+.+|+++..+..+...+...++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            347899999999999999999999999999999987654332    2355666666667455566666666678889999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC---
T ss_pred             EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCC
Confidence            99999999999998777789999999999999999999999999999999999999   678899999999998665432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.      .....+.....   ...+
T Consensus       212 ~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~  273 (311)
T 3p1a_A          212 A--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEF  273 (311)
T ss_dssp             -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHH
T ss_pred             C--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Cccc
Confidence            2        234569999999999987 7999999999999999999997776542      12333333222   2345


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+++++.+++.+||+.||++||++.++++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            5678999999999999999999999887754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-47  Score=356.80  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=213.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .-++|++.+.||+|+||.||+|++..+++.||+|+++..     ...+.+.+|..+++.++|++++..+. +..+....+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~-~~~~~~~~~   82 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG-TFQDAQQIF   82 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEE-EEECSSEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeE-EEEeCCEEE
Confidence            357899999999999999999999999999999987643     33456788999999998777666554 445677889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence            999999 8899999985 5679999999999999999999999999999999999999   6889999999999986543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      .          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +....+..+......    
T Consensus       159 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~----  221 (318)
T 1fot_A          159 V----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR----  221 (318)
T ss_dssp             C----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC----
T ss_pred             c----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence            2          23568999999999999999999999999999999999999999874   334455555544332    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                       ++..+++++.++|.+||..||++||     ++++++   +       .+|...++|.....+
T Consensus       222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~---~-------hp~f~~~~~~~~~~~  273 (318)
T 1fot_A          222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK---N-------HPWFKEVVWEKLLSR  273 (318)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH---T-------SGGGSSCCHHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh---c-------CccccCCCHHHHHhC
Confidence             3356889999999999999999999     555443   2       244456778765443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=356.11  Aligned_cols=263  Identities=17%  Similarity=0.244  Sum_probs=211.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++++.||+|+||+||+|++..+++.||+|++....  ....+.+|+.+++.++|++++..+.. ...+...+++||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-LYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-EEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEE-EecCCeeEEEEE
Confidence            578999999999999999999999999999999875432  23458899999999997776665554 456778899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.++++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence            99 889999999767789999999999999999999999999999999999999   68889999999999876544321


Q ss_pred             ccc-------cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHH--HHHHHhhhcc
Q 015592          163 QHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV  233 (404)
Q Consensus       163 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~  233 (404)
                      ...       .........||+.|+|||++.+..++.++|||||||++|||++|..||..........  .......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---  241 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---  241 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence            100       0011125679999999999999999999999999999999999999997644322110  0111111   


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                          ...+..+|+++.+++.+||+.||++||++.++.+.|+.+...
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                122357889999999999999999999999999999988654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=360.87  Aligned_cols=261  Identities=16%  Similarity=0.237  Sum_probs=211.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +..++|++.+.||+|+||.||+|++..+++   .||||+++.....   ..+.+|+.+++.++|++++..+..+ .....
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~  124 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRGRL  124 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CGGGC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCCc
Confidence            456789999999999999999999976554   5999998754332   3588999999999977766665554 56667


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccccc
Confidence            89999999 889999998666789999999999999999999999999999999999999   67899999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ........    ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...   ......+...... 
T Consensus       202 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~-  273 (325)
T 3kul_A          202 EDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRL-  273 (325)
T ss_dssp             C----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC-
T ss_pred             ccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCC-
Confidence            55432111    1233456888999999998899999999999999999999 9999987543   3333333333211 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                         ..+..+|+++.+++..||..||++||++.+|++.|+.++..
T Consensus       274 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          274 ---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence               22346899999999999999999999999999999998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-47  Score=362.00  Aligned_cols=261  Identities=21%  Similarity=0.243  Sum_probs=213.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||+++...  ....+|++++.++.+|++|..+..+..+....+++||
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            35678999999999999999999999999999999987543  2456799999999655666666666678889999999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ |++|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||+...+ ..+.+||+|||+++.......
T Consensus        97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            99 8899999874 56799999999999999999999999999999999999984221 224699999999987654332


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                             ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+........ ....
T Consensus       176 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~  247 (342)
T 2qr7_A          176 -------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYW  247 (342)
T ss_dssp             -------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTT
T ss_pred             -------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-cccc
Confidence                   22356789999999999988899999999999999999999999987655566666666665544322 2233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..+++++.+||.+||..||++||++.++   |++.+.
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~  281 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI  281 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence            5689999999999999999999998765   444444

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=370.81  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=211.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++..     .....+..|..++..++|++++. +..+..+....+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~-l~~~~~~~~~~~  137 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLY  137 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC-EEEEEECSSEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee-EEEEEeeCCEEE
Confidence            457899999999999999999999999999999987642     22345889999999987665554 455556778899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence            999999 999999998766689999999999999999999999999999999999999   6889999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCcccccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ....      .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+.   +..+.+.++...
T Consensus       215 ~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~  285 (412)
T 2vd5_A          215 DGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIVHY  285 (412)
T ss_dssp             TSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTH
T ss_pred             CCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHHHHhc
Confidence            3321      123468999999999997       456899999999999999999999999874   334455555443


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      ......+.....+|+++++||.+||. +|++|+   ++++|   +++       +|...++|....
T Consensus       286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei---~~H-------pff~~i~w~~l~  340 (412)
T 2vd5_A          286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF---RTH-------PFFFGLDWDGLR  340 (412)
T ss_dssp             HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH---HTS-------GGGTTCCSTTST
T ss_pred             ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH---hcC-------CCcCCCCHHHHh
Confidence            22222223345789999999999999 999985   65544   333       444557888664

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-47  Score=366.18  Aligned_cols=262  Identities=19%  Similarity=0.271  Sum_probs=210.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEE-----EcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcC-CCCCCceeEeeee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQG-GTGIPNLRWFGVE   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~-~~~i~~~~~~~~~   74 (404)
                      +..++|++.+.||+|+||.||+|+     +..+++.||||+++.....   +.+.+|++++..+.+ ++++..+..+...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            346789999999999999999999     4556789999998765443   348899999999955 5555555555555


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCC-------------------------------------------------------
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSR-------------------------------------------------------   98 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~-------------------------------------------------------   98 (404)
                      +...+++|||+ +++|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            66689999999 7899999975322                                                       


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccccc
Q 015592           99 ----------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR  168 (404)
Q Consensus        99 ----------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  168 (404)
                                .+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........     .
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~  250 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----V  250 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----E
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----h
Confidence                      18999999999999999999999999999999999999   57889999999999866443221     1


Q ss_pred             CCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHH
Q 015592          169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE  247 (404)
Q Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......  ....+.....    ...+..++++
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~  324 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTR----MRAPDYTTPE  324 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCC----CCCCTTCCHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCC----CCCCCCCCHH
Confidence            2345678999999999999999999999999999999998 9999987554322  2222222211    1223467899


Q ss_pred             HHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          248 FASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       248 l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +.+++.+||+.||++||++.++++.|++++..
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-46  Score=360.98  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=209.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++......    +.+.+|+.+++.++|++++..+.. ..+....++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-~~~~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEeCCEEEE
Confidence            456899999999999999999999999999999998765432    357899999999997776666554 456678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.++.+||+|||+++.....
T Consensus       106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            99999 7899998874 457999999999999999999999999999999999999965445567999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ....+..+.......+. .
T Consensus       185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~  252 (362)
T 2bdw_A          185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-P  252 (362)
T ss_dssp             CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-T
T ss_pred             cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-c
Confidence            21        235679999999999999999999999999999999999999998743   34445555444433222 2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....+++++.+||.+||+.||++||++.++++
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            23467899999999999999999999887653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-46  Score=359.56  Aligned_cols=260  Identities=19%  Similarity=0.288  Sum_probs=214.8

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++.. ..+.......
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~-~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL-EFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCE-EEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeE-EEEEEcCCEE
Confidence            4457899999999999999999999999999999987542     334568889999999987666555 4445567788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence            9999999 89999999853 569999999999999999999999999999999999999   688999999999998664


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..          .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.   +..+.+..+......   
T Consensus       193 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~---  256 (350)
T 1rdq_E          193 GR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR---  256 (350)
T ss_dssp             SC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred             CC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC---
Confidence            42          23568999999999999999999999999999999999999999874   344555555554432   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~-----~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                        ++..+++++.++|.+||+.||++||+     +++|+   ++       ++...+||......
T Consensus       257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~---~h-------~~f~~~~w~~~~~~  308 (350)
T 1rdq_E          257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---NH-------KWFATTDWIAIYQR  308 (350)
T ss_dssp             --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---TS-------GGGTTCCHHHHHTT
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH---hC-------cCcCCCCHHHHhhc
Confidence              34568999999999999999999998     55443   22       44456788765443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=371.47  Aligned_cols=252  Identities=20%  Similarity=0.296  Sum_probs=214.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .++|++.+.||+|+||.||+|.+  .++.||||+++.....+.+.+|+.++++++|++++..+..+.......+++|||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            46899999999999999999997  4789999999887777889999999999999988888877766666789999999


Q ss_pred             -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 -~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                       +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......   
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc---
Confidence             8899999986544 37999999999999999999999999999999999999   578899999999998543321   


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             ....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+....   +.....    ...+.
T Consensus       344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~----~~~p~  409 (450)
T 1k9a_A          344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYK----MDAPD  409 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHTTCC----CCCCT
T ss_pred             -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCC----CCCCC
Confidence                   23357889999999999999999999999999999998 9999998765444333   222211    12345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+|+++.++|.+||+.||++||++.+|.+.|+++...
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            7899999999999999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=354.31  Aligned_cols=254  Identities=19%  Similarity=0.242  Sum_probs=208.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....        .+.+.+|+.+++.++|++++..+.. ....
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-~~~~   86 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-YENK   86 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-EECS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE-EEeC
Confidence            456789999999999999999999999999999998765432        3468899999999998776665554 4566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCCc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA  153 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~a  153 (404)
                      ...+++|||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+..+. ....+||+|||++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            7889999999 8899999974 56799999999999999999999999999999999999994221 1228999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      +.......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ..+.+..+.....
T Consensus       166 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~  234 (326)
T 2y0a_A          166 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY  234 (326)
T ss_dssp             EECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCC
T ss_pred             eECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCC
Confidence            87654321        235679999999999999999999999999999999999999998743   3344444444333


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .. .......+++.+.++|.+||..||++|||+.++++
T Consensus       235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22 23445678999999999999999999999887654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-46  Score=350.47  Aligned_cols=252  Identities=20%  Similarity=0.242  Sum_probs=203.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.++||+|+||+||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+.. .......+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEE-EEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeE-EEeCCEEEEEE
Confidence            6899999999999999999999999999999988754432    457889999999997776665554 45677889999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      ||++++|.+.+....+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence            999889998888767889999999999999999999999999999999999999   6788999999999987654322 


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST------  235 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------  235 (404)
                            ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....  +....+..+.......      
T Consensus       157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred             ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence                  234567899999999998766 8999999999999999999888864422  2233333332211110      


Q ss_pred             ------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 ------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                        ........+++++.+|+.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                              111222357899999999999999999999887653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-47  Score=354.95  Aligned_cols=270  Identities=19%  Similarity=0.202  Sum_probs=209.2

Q ss_pred             cccCCceEEeeeeceeCceeEEEEE----EcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCceeEeee-eC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGV-EG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~   75 (404)
                      .+..++|++.+.||+|+||.||+|+    +..+++.||||++......  +.+.+|+.+++.++|++++..+..+.. ..
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4567899999999999999999998    5678999999988754322  458899999999998888887766543 34


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...+++|||+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcccc
Confidence            5678999999 889999998766679999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC---------ChHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKKQKY  225 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~---------~~~~~~  225 (404)
                      .........    .......++..|+|||++.+..++.++|||||||++|||++|..||......         ......
T Consensus       163 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            765432211    1223456788899999999999999999999999999999999998652110         000000


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+............+..+|+++.+++.+||+.||++||++.++.+.|+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            011110001111123457899999999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.7e-47  Score=357.64  Aligned_cols=255  Identities=24%  Similarity=0.333  Sum_probs=205.8

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      |...+.++|++.+.||+|+||+||+|++..+++.||||++.....   .+.+.+|+.+++.++|++++..+. +......
T Consensus         1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~   79 (323)
T 3tki_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNI   79 (323)
T ss_dssp             -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEE-EEECSSE
T ss_pred             CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEE-EEecCCe
Confidence            667788999999999999999999999999999999998865432   356899999999999877666555 4556778


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence            89999999 7799999873 4569999999999999999999999999999999999999   67889999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .......     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......  .+..........
T Consensus       156 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~  228 (323)
T 3tki_A          156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL  228 (323)
T ss_dssp             EETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTCTTS
T ss_pred             ccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcccccC
Confidence            5332211     2245689999999999988775 7899999999999999999999987544322  222222221111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                         .....+++++.+|+.+||+.||++||++.+++
T Consensus       229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil  260 (323)
T 3tki_A          229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIK  260 (323)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             ---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence               11245789999999999999999999987664

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=360.45  Aligned_cols=255  Identities=19%  Similarity=0.215  Sum_probs=194.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++......+.+.+|+.+++.++|++++..+..+ ......+++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  128 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLE  128 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-ECSSEEEEEEC
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-ecCCeEEEEEE
Confidence            45678999999999999999999999999999999988776667788999999999987776665554 56677899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++......  
T Consensus       129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  205 (349)
T 2w4o_A          129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--  205 (349)
T ss_dssp             CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence            99 8899999974 4569999999999999999999999999999999999999644458899999999998665432  


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...  ....+..+....... ......
T Consensus       206 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~-~~~~~~  276 (349)
T 2w4o_A          206 ------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYF-ISPWWD  276 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCC-CTTTTT
T ss_pred             ------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCcc-CCchhh
Confidence                  12356799999999999999999999999999999999999999976433  222344444433222 223345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .++.++.+||.+||+.||++||++.++++
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            78999999999999999999999876643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-46  Score=350.54  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=200.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|++.+.||+|+||.||+|++ .+++.||||++....    ....+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-ccCCeEEEEE
Confidence            6899999999999999999998 789999999876543    235688999999999987776666554 5567789999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred             EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence            999889999998766789999999999999999999999999999999999999   6788999999999986653321 


Q ss_pred             ccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc--------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------  233 (404)
                            ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+........        
T Consensus       156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence                  12345789999999999864 489999999999999999999999987543222222222111000        


Q ss_pred             -------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ..........+++++.+++.+||+.||++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                         00112333568899999999999999999999887653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=364.98  Aligned_cols=264  Identities=17%  Similarity=0.256  Sum_probs=211.8

Q ss_pred             cccCCceEEeeeeceeCceeEEEEE-----EcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      .+..++|++.+.||+|+||.||+|+     +..+++.||||++......   ..+.+|+.+++.++|++++..+..+ ..
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQ  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-ec
Confidence            3456789999999999999999999     4457789999998654332   3478899999999987777666554 45


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEE
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                      ....+++|||+ +++|.+++....      ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.....+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            56679999999 889999998643      35999999999999999999999999999999999999954445567999


Q ss_pred             EecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHH
Q 015592          148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~  226 (404)
                      +|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+..   ..+.+.
T Consensus       226 ~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~  297 (367)
T 3l9p_A          226 GDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE  297 (367)
T ss_dssp             CCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH
T ss_pred             CCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH
Confidence            999999865443221     12345578999999999999999999999999999999998 999998743   333444


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+......    ..+..+++++.+|+.+||+.||++||++.+|++.|+.+...
T Consensus       298 ~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCCCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            44333221    22356889999999999999999999999999999887643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.9e-47  Score=367.77  Aligned_cols=258  Identities=20%  Similarity=0.284  Sum_probs=212.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.....   ..+.+|+++++.++|++++..+..+ ......+++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~  191 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVM  191 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-CSSSSCEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ecCCCcEEEE
Confidence            46899999999999999999999889999999998754322   3578899999999988777666555 4556789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCce
Confidence            999 899999998666679999999999999999999999999999999999999   5788999999999986543221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...   .+....+.....    ...
T Consensus       269 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~  336 (377)
T 3cbl_A          269 A-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGR----LPC  336 (377)
T ss_dssp             E-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCC----CCC
T ss_pred             e-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCC
Confidence            1     01122346788999999998889999999999999999998 9999987543   222333322221    123


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+|+++.+++.+||+.||++||++.+|.+.|+++..+
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            356899999999999999999999999999999998654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=359.80  Aligned_cols=266  Identities=20%  Similarity=0.283  Sum_probs=217.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++...     .....+.+|+.+++.++|++++..+. ++......
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~~~   90 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY-SFQDEEDM   90 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE-EEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEE-EEEeCCEE
Confidence            4457899999999999999999999999999999987532     33456889999999998776666554 44566788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence            9999999 8899999984 5679999999999999999999999999999999999999   688999999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ...        ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||...........+..+..... 
T Consensus       167 ~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-  237 (384)
T 4fr4_A          167 RET--------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-  237 (384)
T ss_dssp             TTC--------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-
T ss_pred             CCC--------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-
Confidence            432        2346789999999999974   4589999999999999999999999987666655555555444332 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~-~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                          .++..+++++.+||.+||+.||++||+ +++|.          ..++...++|......+
T Consensus       238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~----------~hp~f~~~~w~~~~~~~  287 (384)
T 4fr4_A          238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ----------NFPYMNDINWDAVFQKR  287 (384)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH----------TSGGGTTCCHHHHHTTC
T ss_pred             ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH----------cChhhhcCCHHHHHhCC
Confidence                233568899999999999999999998 44332          23455667887664443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=351.58  Aligned_cols=249  Identities=20%  Similarity=0.276  Sum_probs=201.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------------------------chhHHHHHHH
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLQYEAKL   55 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------------~~~~~~E~~~   55 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.....                            .+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            456889999999999999999999999999999998765431                            2458899999


Q ss_pred             HHHHcCCCCCCceeEeee-eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015592           56 YKILQGGTGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN  133 (404)
Q Consensus        56 l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~N  133 (404)
                      ++.++|++++..+..+.. .....+++|||+ +++|.+++.  ...+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999998888877776654 357889999999 788887654  4579999999999999999999999999999999999


Q ss_pred             ccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCC---CCchhHHHHHHHHHHHHHcCC
Q 015592          134 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGS  210 (404)
Q Consensus       134 ILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~il~elltg~  210 (404)
                      ||+   +.++.+||+|||+++.......       ......||+.|+|||++.+..   ++.++|||||||++|+|++|+
T Consensus       168 il~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          168 LLV---GEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             EEE---CTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             EEE---CCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            999   6788999999999987654322       123457999999999998765   378999999999999999999


Q ss_pred             CCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       211 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .||.+..   .......+.......+   ....+++++.++|.+||+.||++||++.+++
T Consensus       238 ~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l  291 (298)
T 2zv2_A          238 CPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK  291 (298)
T ss_dssp             CSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            9998743   2333333333222211   1246889999999999999999999988764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.3e-47  Score=350.16  Aligned_cols=259  Identities=20%  Similarity=0.294  Sum_probs=202.7

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +..++|++.+.||+|+||.||+|++..+   +..||+|+......   .+.+.+|+.+++.++|++++..+..+  ....
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~   89 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENP   89 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--ccCc
Confidence            4567899999999999999999998654   45799998765432   23578899999999988887777665  3456


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccccc
Confidence            78999999 679999998666679999999999999999999999999999999999999   57889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......      ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.   ...+...... 
T Consensus       167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~~-  236 (281)
T 1mp8_A          167 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERL-  236 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCC-
T ss_pred             Cccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCCC-
Confidence            543321      1234456889999999998899999999999999999997 9999988654433   3333332211 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                         .++..+|+++.+++.+||+.||++||++.++.+.|++++..+
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               234578999999999999999999999999999999988653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-46  Score=363.79  Aligned_cols=262  Identities=21%  Similarity=0.234  Sum_probs=194.0

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHc-CCCCCCceeEeee-e
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQ-GGTGIPNLRWFGV-E   74 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~-~~~~i~~~~~~~~-~   74 (404)
                      ++..+.++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+.+++.+. |++++..+..+.. .
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            345677899999999999999999999999999999998754322    234778999999998 6666655555543 3


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||++++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR  157 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence            347899999999999999984  579999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCccc--------------ccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 015592          155 RYRDTATHQH--------------IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG  219 (404)
Q Consensus       155 ~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~  219 (404)
                      .+........              .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            7643211000              00012245689999999999987 56899999999999999999999999885432


Q ss_pred             ChHHHHHHHhhhcccccHhH------------------------------------------hhcCCcHHHHHHHHHHHc
Q 015592          220 TKKQKYEKISEKKVSTSIEA------------------------------------------LCRGYPTEFASYFHYCRS  257 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~cl~  257 (404)
                         ..+..+......+..+.                                          ....+++++.+|+.+||.
T Consensus       238 ---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 ---NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             ---HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             ---HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence               22322221111111000                                          012678899999999999


Q ss_pred             CCCCCCCCHHHHH
Q 015592          258 LRFDDKPDYAYLK  270 (404)
Q Consensus       258 ~~p~~RP~~~~l~  270 (404)
                      .||++|||+++++
T Consensus       315 ~dP~~R~t~~e~l  327 (388)
T 3oz6_A          315 FNPNKRISANDAL  327 (388)
T ss_dssp             SSGGGSCCHHHHT
T ss_pred             cCcccCCCHHHHh
Confidence            9999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=359.73  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=214.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCC-------CcEEEEEEecCCCCc---hhHHHHHHHHHHH-cCCCCCCceeEee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLQYEAKLYKIL-QGGTGIPNLRWFG   72 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~---~~~~~E~~~l~~l-~~~~~i~~~~~~~   72 (404)
                      +..++|++.+.||+|+||.||+|++..+       +..||||++......   ..+.+|+++++.+ +|++++ .+..+.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv-~~~~~~  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII-NLLGAC  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC-CEEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhh-hheeee
Confidence            3457899999999999999999997643       357999998765433   4588999999999 555554 444455


Q ss_pred             eeCCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccc
Q 015592           73 VEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM  136 (404)
Q Consensus        73 ~~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl  136 (404)
                      ......+++|||+ +++|.+++....               ..+++.+++.|+.||+.||+|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            5667789999999 789999998643               359999999999999999999999999999999999999


Q ss_pred             cCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 015592          137 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQG  215 (404)
Q Consensus       137 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~  215 (404)
                         +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       225 ---~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          225 ---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             ---CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ---cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence               57889999999999876543321     12344567899999999999999999999999999999999 9999987


Q ss_pred             CCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015592          216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ  283 (404)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  283 (404)
                      ...   .+....+......    ..+..+++++.+++.+||+.||++||++.+|++.|+.++.....+
T Consensus       297 ~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          297 VPV---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             CCH---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             CCH---HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            543   3333333332221    223568999999999999999999999999999999998776543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-46  Score=347.82  Aligned_cols=253  Identities=17%  Similarity=0.283  Sum_probs=206.2

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---------hhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      ....++|++.+.||+|+||.||+|++..+++.||||++......         ..+.+|+.+++.++|++++..+..+..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45678999999999999999999999999999999987654322         568899999999998877777665533


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCe-----E
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQ-----V  145 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~-----v  145 (404)
                      .   .+++|||+ +++|.+++......+++..++.++.|++.||+|||++|  |+||||||+|||++   ..+.     +
T Consensus        95 ~---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~~  168 (287)
T 4f0f_A           95 P---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVCA  168 (287)
T ss_dssp             T---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCCE
T ss_pred             C---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCceeE
Confidence            2   26899999 79999988765667999999999999999999999999  99999999999994   4443     9


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCcccccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~  223 (404)
                      ||+|||+++.....          .....||+.|+|||++.  +..++.++|||||||++|+|++|+.||........ .
T Consensus       169 kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~  237 (287)
T 4f0f_A          169 KVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-K  237 (287)
T ss_dssp             EECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-H
T ss_pred             EeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-H
Confidence            99999999754432          23457899999999994  44578999999999999999999999987554322 2


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      ....+......   ..++..+|+++.+++.+||+.||++||++.++++.|++
T Consensus       238 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          238 FINMIREEGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHHSCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHhccCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            22232222222   23345789999999999999999999999999998875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.1e-47  Score=352.56  Aligned_cols=265  Identities=20%  Similarity=0.262  Sum_probs=206.5

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCceeEeeee---C
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVE---G   75 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~~~~---~   75 (404)
                      |+..+.++|++.+.||+|+||+||+|++  +++.||||++... ....+..|.+++..  ++|++++..+..+...   .
T Consensus         2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            6778999999999999999999999986  6899999998643 34456778888877  6777777776554332   3


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcccccCCCCCCeEE
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVY  146 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~givHrDlKp~NILl~~~~~~~~vk  146 (404)
                      ...+++|||+ +++|.++++  ...+++..++.++.||+.||+|||        ++||+||||||+|||+   +.++.+|
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k  153 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC  153 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence            5678999999 789999996  457999999999999999999999        9999999999999999   6788999


Q ss_pred             EEecCCcccccccCCcccccccCCCCCccCcCccccccccCC------CCCchhHHHHHHHHHHHHHcC----------C
Q 015592          147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------S  210 (404)
Q Consensus       147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlG~il~elltg----------~  210 (404)
                      |+|||+++...........   ......||+.|+|||++.+.      .++.++|||||||++|||++|          .
T Consensus       154 l~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             ECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            9999999866554322111   12345799999999999887      455799999999999999999          8


Q ss_pred             CCCCCCCCCCh-HHHHHHHh-hhcccc--cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          211 LPWQGLKAGTK-KQKYEKIS-EKKVST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       211 ~Pf~~~~~~~~-~~~~~~~~-~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      .||.+...... ...+.... ......  +.......+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            99976544322 22222222 111111  11112233568899999999999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-46  Score=365.28  Aligned_cols=267  Identities=21%  Similarity=0.276  Sum_probs=213.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++..     ......+.+|+.+++.++|++++..+ .+..+....+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE-EEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE-EEEEECCEEE
Confidence            35789999999999999999999999999999998754     23445688999999999877666555 4455777899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ |++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeecc
Confidence            999999 8999999974  469999999999999999999999999999999999999   6889999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ...      ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.   +....+.++......
T Consensus       221 ~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~  291 (410)
T 3v8s_A          221 EGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNS  291 (410)
T ss_dssp             TSE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred             CCc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhcccc
Confidence            322      1234568999999999998765    789999999999999999999999874   344555555443211


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~--RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      ...+ ....+++++++||.+||..+|.+  ||++++|++.          +|...++|......+
T Consensus       292 ~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H----------p~f~~~~w~~~~~~~  345 (410)
T 3v8s_A          292 LTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH----------LFFKNDQWAWETLRD  345 (410)
T ss_dssp             CCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS----------GGGCCSSCCSTTGGG
T ss_pred             ccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC----------ccccCCCHHHHhhcc
Confidence            1111 12368899999999999998988  9998766432          344455676544443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.8e-47  Score=363.96  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=207.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKL-YKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...     ....+..|..+ ++.++|++++ .+..+.......
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv-~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV-GLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBC-CEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCC-CEEEEEEeCCEE
Confidence            4568999999999999999999999999999999886542     22345566665 3455655544 455555677889


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred             EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence            9999999 8899999985 4579999999999999999999999999999999999999   688999999999998644


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.   +..+.+..+......   
T Consensus       191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---  257 (373)
T 2r5t_A          191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ---  257 (373)
T ss_dssp             CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC---
T ss_pred             cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC---
Confidence            3221       234678999999999999999999999999999999999999999874   344555555554332   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~-l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                        ++..+++++.+||.+||+.||++||++.+ +.++++       .++...++|......+
T Consensus       258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~-------h~~f~~~~w~~l~~~~  309 (373)
T 2r5t_A          258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS-------HVFFSLINWDDLINKK  309 (373)
T ss_dssp             --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT-------SGGGTTCCHHHHHTTC
T ss_pred             --CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC-------CccccCCCHHHHHhCC
Confidence              33568999999999999999999999853 223332       2445567888665443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-46  Score=357.04  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=203.1

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEE----EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      ....++|++.+.||+|+||.||+|++..+++.+    |+|.+...   .....+.+|+.+++.++|++++..+..+.. .
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-S
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-C
Confidence            455688999999999999999999998777654    77765433   234568999999999998887777666543 4


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      . .+++++++ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCccee
Confidence            4 45556665 999999998777789999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+.......     ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+   .....
T Consensus       166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~  237 (327)
T 3poz_A          166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGER  237 (327)
T ss_dssp             HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCC
T ss_pred             EccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---HcCCC
Confidence            765443211     1234567889999999999999999999999999999999 99999886554332222   22211


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .    ..+..++.++.+++.+||+.||++||++.++++.|+.+..
T Consensus       238 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             C----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             C----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1    1234578999999999999999999999999999988763

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-46  Score=364.77  Aligned_cols=261  Identities=16%  Similarity=0.181  Sum_probs=196.6

Q ss_pred             cCCceEEe-eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC-CCCCCceeEeee---eCCeEE
Q 015592            5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG-GTGIPNLRWFGV---EGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~---~~~~~~   79 (404)
                      +.++|.+. +.||+|+||+||+|++..+++.||||++.   ....+.+|+.++.++.+ ++++..+..+..   .....+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC---cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            34567776 79999999999999999999999999986   34568899999866654 444444444432   256789


Q ss_pred             EEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+ +++|.+++.... ..+++.++..|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++...
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            999999 789999998532 359999999999999999999999999999999999999643347899999999998655


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-HHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~  236 (404)
                      ...        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .....+........
T Consensus       216 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          216 SHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             -------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             CCC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            332        123567899999999999999999999999999999999999999875443211 12222333222221


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      . .....+++++.+||.+||+.||++|||+.+++   ++.+...
T Consensus       288 ~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil---~hp~~~~  327 (400)
T 1nxk_A          288 N-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM---NHPWIMQ  327 (400)
T ss_dssp             T-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH---HSHHHHT
T ss_pred             C-cccccCCHHHHHHHHHHCCCChhHCcCHHHHh---cCccccC
Confidence            1 12246899999999999999999999987664   4455443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-46  Score=386.20  Aligned_cols=268  Identities=19%  Similarity=0.240  Sum_probs=223.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++++.||+|+||.||+|++..+++.||||+++.     ....+.+..|..++..+.++++|..+..+.......+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            35789999999999999999999999999999998763     3345568889999999988899988888888888999


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence            999999 88999999853 579999999999999999999999999999999999999   6889999999999986443


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...       ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.   +..+.+..+......    
T Consensus       495 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~----  560 (674)
T 3pfq_A          495 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA----  560 (674)
T ss_dssp             TTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC----
T ss_pred             CCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence            322       234678999999999999999999999999999999999999999874   445566666655432    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeeccccccccc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQS  298 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~  298 (404)
                       ++..+++++.+||.+||++||++||++.  ...++++       .+|...+||......+.
T Consensus       561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~-------h~ff~~i~w~~l~~~~~  614 (674)
T 3pfq_A          561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-------HAFFRYIDWEKLERKEI  614 (674)
T ss_dssp             -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS-------SGGGSSCCHHHHTTTCS
T ss_pred             -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc-------CccccCCCHHHHHhCCC
Confidence             3457899999999999999999999972  2223332       34556688987755543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=356.56  Aligned_cols=257  Identities=20%  Similarity=0.297  Sum_probs=201.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCC-CCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~   78 (404)
                      +.+++|++.+.||+|+||.||+|.+ .+++.||||++......    +.+.+|+.+++.++|+ ++|..+..+.......
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4578899999999999999999997 57899999998765433    3578899999999874 6677777777788899


Q ss_pred             EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +++||+.+++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||+    .++.+||+|||+++.+..
T Consensus        85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC--
T ss_pred             EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccCc
Confidence            99999889999999985 5679999999999999999999999999999999999999    357899999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      .....     ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.+...  ....+..
T Consensus       160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~  232 (343)
T 3dbq_A          160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA  232 (343)
T ss_dssp             ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred             ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence            33211     1235679999999999865           6689999999999999999999999986432  2222333


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +......   ..++...+.++.+++.+||+.||++||++.+++   ++.+..
T Consensus       233 ~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l---~hp~~~  278 (343)
T 3dbq_A          233 IIDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL---AHPYVQ  278 (343)
T ss_dssp             HHCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH---TSHHHH
T ss_pred             HhcCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH---hCcccc
Confidence            2222111   123345678999999999999999999987664   445544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-46  Score=354.61  Aligned_cols=256  Identities=21%  Similarity=0.270  Sum_probs=189.7

Q ss_pred             cCCceEEe---eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~---~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +.++|++.   +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+.+|++|..+..+..+....+++
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            34678886   7899999999999999999999999998643 3456889999999998566666666666777889999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++.++..|+.||+.||+|||++||+||||||+|||++.++....+||+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            9999 7899999985 5679999999999999999999999999999999999999643344489999999998655433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----CChHHHHHHHhhhccccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~  236 (404)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...    ....+.+..+........
T Consensus       164 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          164 Q-------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             C-------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence            2       22355789999999999999999999999999999999999999987443    223344555554443322


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                       ......+++++.+||.+||+.||++||++.+++
T Consensus       237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence             233357899999999999999999999988664

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=353.32  Aligned_cols=266  Identities=19%  Similarity=0.216  Sum_probs=210.8

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeee-CCeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN   78 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~   78 (404)
                      ..++++|++.+.||+|+||.||+|++..+++.||||++....   ..+.+.+|+++++.++|++++..+..+... ....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            356789999999999999999999999999999999986532   335678999999999988888777665443 3477


Q ss_pred             EEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCCeEEEEecCCcc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK  154 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~-~~~~~~vkL~DFG~a~  154 (404)
                      +++|||+ +++|.+++.....  .+++.+++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999 8899999985332  3999999999999999999999999999999999999732 2356789999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCcccccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-ChHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKY  225 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-~~~~~~  225 (404)
                      .......        .....||+.|+|||++.        +..++.++|||||||++|||++|+.||...... ...+.+
T Consensus       165 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          165 ELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             ECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             ecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            7655432        23457999999999986        567899999999999999999999999764432 223334


Q ss_pred             HHHhhhccccc--------------------HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          226 EKISEKKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       226 ~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                      ..+........                    ...+...++..+.+++.+||+.||++||+++++++...+.
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            44433322110                    0012223467899999999999999999999888777654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.2e-46  Score=350.10  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             cccCCceEEe-eeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            3 PRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         3 ~~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.+.++|++. +.||+|+||.||+|++..+++.||||++....  ....+.+|+.++.++.+|++|..+..+.......+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4577899995 78999999999999999999999999986543  24568899999999765555556655666778899


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++....+||+|||++.....
T Consensus        88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999 7999999985 35799999999999999999999999999999999999995333334599999999986653


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------------h
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------K  221 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------------~  221 (404)
                      ................||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+....+            .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            32111111112234569999999999975     457899999999999999999999998754332            1


Q ss_pred             HHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+..+.......+ ......+++++.+|+.+||+.||++||++.++++
T Consensus       247 ~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            223344444333322 2233568999999999999999999999887654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.7e-47  Score=357.98  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=208.6

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      .....++|++.+.||+|+||.||+|++..+++.||||++..     ......+.+|+.+++.++|++++..+..+ ....
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~   82 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-TTPT   82 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-ECSS
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCC
Confidence            45667899999999999999999999999999999998753     23456789999999999987776665554 5566


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ..+++|||++++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        83 ~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           83 DIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTT
T ss_pred             EEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceec
Confidence            7899999999999999875 4579999999999999999999999999999999999999   67889999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ....        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.......   .     ....
T Consensus       159 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~-----~i~~  222 (336)
T 3h4j_B          159 TDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---K-----KVNS  222 (336)
T ss_dssp             TTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---C-----CCCS
T ss_pred             cCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---H-----HHHc
Confidence            5432        2245679999999999998876 78999999999999999999999875432211   1     1111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ....++..+++++.+|+.+||+.||.+|||+++++   ++.+.+
T Consensus       223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil---~hp~~~  263 (336)
T 3h4j_B          223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR---RDPWFN  263 (336)
T ss_dssp             SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT---TCHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH---hChhhc
Confidence            11223456789999999999999999999987664   444544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.6e-46  Score=361.56  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~~   79 (404)
                      .+++|++.+.||+|+||.||+|.+. +++.||||++......    ..+.+|+.+++.++| +++|..+..+.......+
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3556999999999999999999975 4899999998765433    458899999999986 567777777777788899


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ++||+.+++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||+    .++.+||+|||+++.+...
T Consensus       133 lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC---
T ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccCC
Confidence            9999889999999985 4579999999999999999999999999999999999999    3478999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ....     ......||+.|+|||++.+           ..++.++|||||||+||||++|+.||.+...  ....+..+
T Consensus       208 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~  280 (390)
T 2zmd_A          208 TTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI  280 (390)
T ss_dssp             -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHH
T ss_pred             Cccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHH
Confidence            2211     1235679999999999976           3689999999999999999999999986432  22233333


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .......   .++...+.++.+||.+||+.||++||++.+++   ++.+..
T Consensus       281 ~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell---~hp~~~  325 (390)
T 2zmd_A          281 IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL---AHPYVQ  325 (390)
T ss_dssp             HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH---TSHHHH
T ss_pred             hCccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHh---hCcCcc
Confidence            3222211   22344578999999999999999999988664   444443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-46  Score=353.06  Aligned_cols=255  Identities=21%  Similarity=0.265  Sum_probs=188.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+|+.+++.++|++++..+..+ ......+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv   81 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-HTENKLTLV   81 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-CCTTEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-EECCeEEEE
Confidence            3578999999999999999999999999999999886543   235688999999999987766665554 556788999


Q ss_pred             EeccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           82 IDLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      |||+.++|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEET
T ss_pred             EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceec
Confidence            9999999999987432     359999999999999999999999999999999999999   67889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc-
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-  234 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  234 (404)
                      .....       ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+......... 
T Consensus       159 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  231 (317)
T 2pmi_A          159 GIPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES  231 (317)
T ss_dssp             TSCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred             CCCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            54322       22345789999999999874 5899999999999999999999999875443222222221110000 


Q ss_pred             --------------------cc-----HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          235 --------------------TS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       235 --------------------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          ..     .......++.++.+||.+||+.||++|||+.+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  292 (317)
T 2pmi_A          232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL  292 (317)
T ss_dssp             TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence                                00     0111235788999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-45  Score=341.49  Aligned_cols=260  Identities=21%  Similarity=0.263  Sum_probs=211.9

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.++|++++..+.. .......
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~   80 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFH   80 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEE-EEcCCEE
Confidence            45789999999999999999999999999999999998654432    457889999999987776665554 4567778


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++..+.+||+|||++....
T Consensus        81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999 7899888875 4569999999999999999999999999999999999999654455669999999997665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....        .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..   .......+.......+.
T Consensus       160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  228 (284)
T 3kk8_A          160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS  228 (284)
T ss_dssp             SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT
T ss_pred             cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc
Confidence            4332        234678999999999999999999999999999999999999998743   34444444443333222


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                       .....+++++.+++.+||+.||++||++.+++   ++.+..
T Consensus       229 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l---~h~~~~  266 (284)
T 3kk8_A          229 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL---KVPWIC  266 (284)
T ss_dssp             -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT---TSHHHH
T ss_pred             -hhhcccCHHHHHHHHHHcccChhhCCCHHHHh---cCcccc
Confidence             22346889999999999999999999988664   444444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-46  Score=357.26  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=202.6

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc----CCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ----GGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~   77 (404)
                      ..+.++|++.++||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++    .|++|..+..+......
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            357889999999999999999999999999999999986432 2345778999999997    24445555555566788


Q ss_pred             EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-----------------
Q 015592           78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-----------------  139 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~-----------------  139 (404)
                      .+++||+++++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++..                 
T Consensus       111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            99999999999999998543 359999999999999999999999999999999999999421                 


Q ss_pred             -----CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 015592          140 -----RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ  214 (404)
Q Consensus       140 -----~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~  214 (404)
                           ...+.+||+|||+++.....          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                 12788999999999864432          235678999999999999999999999999999999999999998


Q ss_pred             CCCCCChHHHHHHHhhhccccc--------------------------------------HhHhhcCCcHHHHHHHHHHH
Q 015592          215 GLKAGTKKQKYEKISEKKVSTS--------------------------------------IEALCRGYPTEFASYFHYCR  256 (404)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~l~~li~~cl  256 (404)
                      +....+....+..+........                                      .+......++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            7544332222222211100000                                      00111123477889999999


Q ss_pred             cCCCCCCCCHHHHH
Q 015592          257 SLRFDDKPDYAYLK  270 (404)
Q Consensus       257 ~~~p~~RP~~~~l~  270 (404)
                      +.||++|||+.+++
T Consensus       341 ~~dP~~Rpta~elL  354 (360)
T 3llt_A          341 QIDPTLRPSPAELL  354 (360)
T ss_dssp             CSSGGGSCCHHHHT
T ss_pred             cCChhhCCCHHHHh
Confidence            99999999998775

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-46  Score=348.73  Aligned_cols=260  Identities=22%  Similarity=0.387  Sum_probs=202.1

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+..++|++.++||+|+||.||+|++.   ..||||+++.....    +.+.+|+.+++.++|++++..+.+ . .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-S-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-E-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-c-cCCcc
Confidence            356789999999999999999999853   35999998765433    348899999999998888766653 3 34457


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceeccccc
Confidence            8999999 789999997666779999999999999999999999999999999999999   578899999999997654


Q ss_pred             ccCCcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ......     ......||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+...  .......+......
T Consensus       172 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~  244 (289)
T 3og7_A          172 RWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS  244 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCC
T ss_pred             cccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccC
Confidence            322111     223457899999999987   56689999999999999999999999987543  23334444444555


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      .....+...+|+++.+++.+||+.||++||++.++++.|+++.
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            5555556678999999999999999999999999999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-46  Score=367.54  Aligned_cols=263  Identities=18%  Similarity=0.207  Sum_probs=189.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee----C
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----G   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~   75 (404)
                      .+.++|++++.||+|+||+||+|++..+++.||||++.....    ...+.+|+.+++.++|++++..+..+...    .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            467899999999999999999999999999999998865432    24578999999999988888887766432    3


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...|++|||++++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++.
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          130 DELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART  205 (458)
T ss_dssp             CCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred             ceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence            56899999999999999974 5679999999999999999999999999999999999999   6888999999999987


Q ss_pred             ccccCCcccc--------------------cccCCCCCccCcCcccccccc-CCCCCchhHHHHHHHHHHHHHc------
Q 015592          156 YRDTATHQHI--------------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR------  208 (404)
Q Consensus       156 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~il~ellt------  208 (404)
                      ..........                    ........+||+.|+|||++. +..|+.++||||||||||||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            6543211100                    001234568899999999864 5669999999999999999999      


Q ss_pred             -----CCCCCCCCCCCC-----------------hHHHHHHHhhh--------------------------cccccHhHh
Q 015592          209 -----GSLPWQGLKAGT-----------------KKQKYEKISEK--------------------------KVSTSIEAL  240 (404)
Q Consensus       209 -----g~~Pf~~~~~~~-----------------~~~~~~~~~~~--------------------------~~~~~~~~~  240 (404)
                           |+++|.+.....                 ....+..+...                          .........
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 677776633100                 01111111110                          011111223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ...+++++.+||.+||..||++|||+++++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L  395 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECL  395 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence            345689999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-46  Score=355.44  Aligned_cols=263  Identities=19%  Similarity=0.214  Sum_probs=206.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeC---CeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---DYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~lv   81 (404)
                      .++|++.++||+|+||.||+|++.  ++.||||++..... .....+|+.+++.++|++++..+..+....   ...+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999864  79999999865432 234667888899999888888887766543   347999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCcccccCCCCCCeEEEEec
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      |||+ +++|.++++.  ..+++..++.++.|++.||+|||++          ||+||||||+|||+   +.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccC
Confidence            9999 7899999984  4599999999999999999999999          99999999999999   67889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC-----
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----  220 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~-----  220 (404)
                      |+++.+......     .......||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+.....     
T Consensus       176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            999876654321     123346799999999999873     45678999999999999999999998754321     


Q ss_pred             --------hHHHHHHHhhhcccccHhHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          221 --------KKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       221 --------~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                              .......+......+.......  ..++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                    1112222222222222111111  23567999999999999999999999999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.2e-46  Score=368.75  Aligned_cols=250  Identities=20%  Similarity=0.241  Sum_probs=196.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      +.++|++++.||+|+||+||+|++..+++.||||++....    ....+.+|+.+++.++|++++..+..+....     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            4578999999999999999999999999999999886432    2345789999999999998888887765432     


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|||++++|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  213 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred             CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence            4679999999888888775   359999999999999999999999999999999999999   6788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .....        ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.   ...+..+......+
T Consensus       214 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          214 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP  282 (464)
T ss_dssp             ---CC--------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred             cCCCc--------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence            65432        22456899999999999999999999999999999999999999988543   22333332211111


Q ss_pred             cH-------------------------hHhhc------------CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SI-------------------------EALCR------------GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~-------------------------~~~~~------------~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..                         +....            ..++++.+||.+||..||++|||++++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00                         00000            01567999999999999999999876643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-46  Score=352.37  Aligned_cols=253  Identities=21%  Similarity=0.338  Sum_probs=198.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC--
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD--   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--   76 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.+++.++|++++..+..+.....  
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            5688999999999999999999999999999999998765332     247889999999998888877766544332  


Q ss_pred             -eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           77 -YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        77 -~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ..+++|||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC-
T ss_pred             cccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCcc
Confidence             459999999 7899999985 4579999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .+.......    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ............ 
T Consensus       165 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~-  236 (311)
T 3ork_A          165 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDP-  236 (311)
T ss_dssp             ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCC-
T ss_pred             ccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCC-
Confidence            765432211    123346789999999999999999999999999999999999999987433   222223222222 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY  268 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~  268 (404)
                      .........+++++.+++.+||+.||++||+..+
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~  270 (311)
T 3ork_A          237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAA  270 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence            2233445678999999999999999999997554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-46  Score=343.18  Aligned_cols=256  Identities=20%  Similarity=0.255  Sum_probs=212.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -.++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.++++++|++++..+..+ .+....+++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCceEEEEE
Confidence            3478999999999999999999985 57789999887654 345689999999999987766655544 55667899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH-
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc-
Confidence            99 889999998666679999999999999999999999999999999999999   5778999999999986654321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                           .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+...   .+....+.....    ...+
T Consensus       162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~  229 (269)
T 4hcu_A          162 -----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFR----LYKP  229 (269)
T ss_dssp             -----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCC----CCCC
T ss_pred             -----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCcc----CCCC
Confidence                 12234567889999999998899999999999999999999 9999987433   333444433221    1223


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..+++++.+++.+||+.||++||++.++.+.|+++..
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            4578999999999999999999999999999998864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.9e-46  Score=358.86  Aligned_cols=259  Identities=17%  Similarity=0.236  Sum_probs=202.8

Q ss_pred             cCCceEEeeeecee--CceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      -+++|++.++||+|  +||.||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+..+ ......
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-IADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-EECCEE
Confidence            46789999999999  9999999999999999999998754332    3477899999999987777665554 567788


Q ss_pred             EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      +++|||+ +++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||.+...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence            9999999 89999999854 3569999999999999999999999999999999999999   67889999999998765


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc-
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-  233 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-  233 (404)
                      ..................||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+..........   ..... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~  255 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK---LNGTVP  255 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---hcCCCC
Confidence            4432222111122344578999999999988  57999999999999999999999999875544322111   10000 


Q ss_pred             ----------------------------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 ----------------------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 ----------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                                              ..........+++++.+||.+||+.||++|||+.+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence                                                    0001123456789999999999999999999988765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.5e-46  Score=350.72  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      .+..++|++.+.||+|+||.||+|++.   .+++.||||+++...      ....+.+|+.+++.++|++++..+..+ .
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~   91 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-Q   91 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-E
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-E
Confidence            345688999999999999999999985   689999999886542      234578899999999987776665544 5


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      .....+++|||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~  167 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL  167 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence            567789999999 7899999975 4569999999999999999999999999999999999999   6788999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      ++.......       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+....
T Consensus       168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~  237 (327)
T 3a62_A          168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCK  237 (327)
T ss_dssp             C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC
T ss_pred             ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCC
Confidence            976543322       2235679999999999999999999999999999999999999998743   344444444433


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      ..     ++..+++++.++|.+||+.||++||++.  .+.+++++.+.       ..++|....
T Consensus       238 ~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f-------~~~~~~~~~  289 (327)
T 3a62_A          238 LN-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-------RHINWEELL  289 (327)
T ss_dssp             CC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG-------SSCCHHHHH
T ss_pred             CC-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc-------cCCCHHHHh
Confidence            22     3356789999999999999999999543  34455554443       345676543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-46  Score=355.11  Aligned_cols=257  Identities=18%  Similarity=0.225  Sum_probs=206.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcE----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      .-.++|++.+.||+|+||.||+|++..+++.    ||+|++....   ....+.+|+.+++.++|++++..+..+.  +.
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~   87 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GS   87 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BS
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CC
Confidence            4467899999999999999999999888876    7777764432   2345788999999999888887776553  44


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|+|+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence            577888888 899999998555679999999999999999999999999999999999999   6788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ........     ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.......   ..+......
T Consensus       165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~  236 (325)
T 3kex_A          165 LPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DLLEKGERL  236 (325)
T ss_dssp             SCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HHHHTTCBC
T ss_pred             cCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HHHHcCCCC
Confidence            75543211     2234567889999999999899999999999999999999 99999886543332   222222111


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                          ..+..++.++.+++.+||+.||++||++.++.+.|+.+.
T Consensus       237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                122356889999999999999999999999999998874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=353.61  Aligned_cols=259  Identities=19%  Similarity=0.254  Sum_probs=202.6

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEE----EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .+..++|++.+.||+|+||.||+|++..+++.|    ++|.+...   .....+.+|+.+++.++|++++..+..+.. .
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-S
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-C
Confidence            355789999999999999999999998888765    66655432   234568899999999998887777766643 3


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      . .+++++++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC--
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCccee
Confidence            3 45566666 999999998777789999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .........     ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........   +.....
T Consensus       166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~~  237 (327)
T 3lzb_A          166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGER  237 (327)
T ss_dssp             -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCC
T ss_pred             EccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCC
Confidence            765433211     1234467889999999999999999999999999999999 9999988655433322   222221


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .    ..+..++.++.+++.+||+.||++||++.++++.|+++..
T Consensus       238 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 L----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1    1234578999999999999999999999999999998863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-45  Score=354.55  Aligned_cols=257  Identities=19%  Similarity=0.209  Sum_probs=208.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC----Ce
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG----DY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~   77 (404)
                      ++++|++.+.||+|+||.||+|++..+++.||||++......   ..+.+|+++++.++|++++..+..+....    ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            568999999999999999999999999999999998754332   45789999999999888888777665432    46


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++||+++++|.++++.  ..+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence            899999999999999974  469999999999999999999999999999999999999   678899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc----
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----  232 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----  232 (404)
                      ......    .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.......    
T Consensus       180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            433211    112456899999999987654 48999999999999999999999998865544433332221111    


Q ss_pred             -------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 -------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                         .......+...+++++.+||.+||+.||++|||+.+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  312 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL  312 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence                               11122334456789999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-45  Score=361.87  Aligned_cols=263  Identities=18%  Similarity=0.248  Sum_probs=198.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----   75 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+..+....    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            4789999999999999999999999999999999998654322    45889999999999888888777665443    


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          103 DELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART  178 (432)
T ss_dssp             CCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             CeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence            56899999999999999984 5579999999999999999999999999999999999999   6888999999999987


Q ss_pred             ccccCCcccc---------------cccCCCCCccCcCccccccc-cCCCCCchhHHHHHHHHHHHHHcCCCC-------
Q 015592          156 YRDTATHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLP-------  212 (404)
Q Consensus       156 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlG~il~elltg~~P-------  212 (404)
                      ..........               ........+||+.|+|||++ .+..++.++|||||||++|||++|..|       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6543221000               00112467899999999986 455699999999999999999985444       


Q ss_pred             ----CCCCCCC--------------ChHHHHHHHhh--------------------------hcccccHhHhhcCCcHHH
Q 015592          213 ----WQGLKAG--------------TKKQKYEKISE--------------------------KKVSTSIEALCRGYPTEF  248 (404)
Q Consensus       213 ----f~~~~~~--------------~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~l  248 (404)
                          |.+....              .....+..+..                          ...........+.+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence                4332210              00111111111                          111112223335689999


Q ss_pred             HHHHHHHHcCCCCCCCCHHHHH
Q 015592          249 ASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       249 ~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+||.+||..||++|||+++++
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L  360 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQAL  360 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHhcCCcccCCCHHHHh
Confidence            9999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.8e-46  Score=345.49  Aligned_cols=258  Identities=17%  Similarity=0.262  Sum_probs=210.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -.++|++.+.||+|+||.||+|.+. ++..||||++.... ..+++.+|+++++.++|++++..+..+ ......+++||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-ecCCCeEEEEe
Confidence            3568999999999999999999874 67889999987654 345689999999999977766665544 56667899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH-
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc-
Confidence            99 899999998656679999999999999999999999999999999999999   6788999999999986654321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                           .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.....   ......+......    ..+
T Consensus       176 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~  243 (283)
T 3gen_A          176 -----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRP  243 (283)
T ss_dssp             -----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCC----CCC
T ss_pred             -----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCC----CCC
Confidence                 12234567889999999998899999999999999999998 9999987543   3333443333211    123


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      ..+++.+.+++.+||+.||++||++.++++.|++++.++
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            457899999999999999999999999999999998653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=354.70  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=199.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----   75 (404)
                      .+.++|++.+.||+|+||.||+|++..+|+.||||++......    ..+.+|+.+++.++|++++..+..+....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            3578899999999999999999999999999999988654332    35778999999999888888877765442    


Q ss_pred             -CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ...+++|||++++|.++++.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR  176 (367)
T ss_dssp             CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence             34699999999999999984  579999999999999999999999999999999999999   678899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .....          .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...   ...+..+.....
T Consensus       177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g  243 (367)
T 1cm8_A          177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTG  243 (367)
T ss_dssp             ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred             ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcC
Confidence            65432          235678999999999987 6799999999999999999999999987543   222222222111


Q ss_pred             --------------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 --------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                ......+...+++++.+|+.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                      11122333567899999999999999999999886543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-46  Score=342.89  Aligned_cols=256  Identities=17%  Similarity=0.210  Sum_probs=211.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.+.||+|+||.||+|++. ++..||||++.... ..+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~   82 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-SKEYPIYIVT   82 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCceEEEE
Confidence            34678999999999999999999874 67789999987654 345689999999999987766665544 5666789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++......+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCE
T ss_pred             EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhh
Confidence            999 889999998766679999999999999999999999999999999999999   6888999999999986654432


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....   ......+......    ..
T Consensus       160 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~  226 (268)
T 3sxs_A          160 V------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRL----YR  226 (268)
T ss_dssp             E------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCC----CC
T ss_pred             h------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCC----CC
Confidence            1      1234556788999999998889999999999999999999 9999987443   3333333332211    12


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      +..+++++.+++.+||+.||++||++.++++.|+.+.
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            3457899999999999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=355.20  Aligned_cols=254  Identities=18%  Similarity=0.248  Sum_probs=198.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++|++++..+.. .......+++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI-IHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEE-EECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeE-EeeCCEEEEEec
Confidence            689999999999999999999999999999998764432   2245679999999997776665554 456677899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~--  155 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK--  155 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence            99999999998777779999999999999999999999999999999999999   6788999999999986554322  


Q ss_pred             cccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc---------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------  233 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------  233 (404)
                           ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........         
T Consensus       156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence                 2234578999999999987 5689999999999999999999999988554333332222211111         


Q ss_pred             -------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                   ..........+++++.+||.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                         01112233467899999999999999999999876653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-45  Score=353.17  Aligned_cols=260  Identities=20%  Similarity=0.218  Sum_probs=204.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-------
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-------   74 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-------   74 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+.+++.++|++++..+..+...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4789999999999999999999999999999998755432    33578999999999988888877666543       


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++|||++++|.+.+.....++++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence            45689999999889999988666789999999999999999999999999999999999999   678899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+........   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+........
T Consensus       173 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          173 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             ECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            7654322111   122456789999999999864 589999999999999999999999988544333333332222111


Q ss_pred             cccHhHhh------------------------cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALC------------------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~------------------------~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ........                        ...++++.+||.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11000000                        012678999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=355.33  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=211.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++....   ...+.+|+.+++.++|++++..+..+ ....
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-AVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ccCC
Confidence            4578999999999999999999987     3558999999875543   23588999999999877766666554 4566


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD  132 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~  132 (404)
                      ..+++|||+ +++|.+++....                       ..+++.+++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            789999999 789999998642                       56999999999999999999999999999999999


Q ss_pred             cccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCC
Q 015592          133 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL  211 (404)
Q Consensus       133 NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~  211 (404)
                      |||+   +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       204 NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          204 NCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             GEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eEEE---CCCCeEEEeecCCCcccccCccc-----cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999   57889999999999866543221     12345578999999999998899999999999999999999 999


Q ss_pred             CCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       212 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ||.+...   .+....+......    ..+..+|+++.+++.+||+.||++||++.++.+.|+++..
T Consensus       276 p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAH---EEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCCh---HHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            9987433   3334444333322    2345789999999999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=360.93  Aligned_cols=252  Identities=21%  Similarity=0.231  Sum_probs=207.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||+|++.....  ...+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~lv~  127 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLIL  127 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-EeCCEEEEEE
Confidence            45789999999999999999999999999999999875432  23588999999999887766665544 5677889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence            999 88999999754557999999999999999999999999999999999999942 1357899999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..   ..+.+..+........ ....
T Consensus       207 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~  274 (387)
T 1kob_A          207 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFD-EDAF  274 (387)
T ss_dssp             --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCC-SSTT
T ss_pred             --------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-cccc
Confidence                    123478999999999999999999999999999999999999998743   3344444444332221 2233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..+++++.++|.+||..||++||++.+++
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell  303 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL  303 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            56899999999999999999999988764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-45  Score=345.20  Aligned_cols=262  Identities=20%  Similarity=0.300  Sum_probs=211.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEE-----cCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..++|++.+.||+|+||.||+|++     ..+++.||||++.....   .+.+.+|+.+++.+.+|++|..+..+.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999985     35678999999875543   2458899999999943444444544555667


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~  138 (404)
                      ..+++|||+ +++|.+++.....                 .+++..++.++.||+.||.|||++||+||||||+|||+  
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--  178 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--  178 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--
Confidence            789999999 7799999986432                 48999999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                       +.++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       179 -~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          179 -THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             -ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             -cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence             57899999999999876654321     12334567889999999999899999999999999999999 999998765


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .....   ..........   ..+..+|+++.+++.+||+.||++||++.++.+.|++++.+.
T Consensus       253 ~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          253 VDSKF---YKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             SSHHH---HHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             chhHH---HHHhccCCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            43222   2222211111   123467899999999999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-45  Score=353.42  Aligned_cols=260  Identities=20%  Similarity=0.220  Sum_probs=197.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.+.||+|+||.||++++..+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ......+++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE-eeCCEEEEEEE
Confidence            3578999999999999999999999999999999887543 346789999999999987776655544 56677899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++......  
T Consensus        97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~--  172 (361)
T 3uc3_A           97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--  172 (361)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccC--
Confidence            99 8899999975 457999999999999999999999999999999999999941 122359999999997443322  


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhhcccccHhHh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (404)
                            ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...+..+.......+   .
T Consensus       173 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~  243 (361)
T 3uc3_A          173 ------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---D  243 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC---T
T ss_pred             ------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC---C
Confidence                  1235579999999999998887655 8999999999999999999987554332 333333333322211   1


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ...+++++.+||.+||+.||++|||+.++   +++.+....
T Consensus       244 ~~~~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~~~  281 (361)
T 3uc3_A          244 DIRISPECCHLISRIFVADPATRISIPEI---KTHSWFLKN  281 (361)
T ss_dssp             TSCCCHHHHHHHHHHSCSCTTTSCCHHHH---HTSHHHHTT
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHH---HhCcchhcC
Confidence            12578999999999999999999998765   455555443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.7e-45  Score=345.43  Aligned_cols=246  Identities=17%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .|+..+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+.+++.++|++++..+..+ ......+++|||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY-LVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EECCEEEEEEecC
Confidence            48899999999999999999988999999999875433  34588999999999987777666554 4566789999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++.  ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++........   
T Consensus       125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---  196 (321)
T 2c30_A          125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP---  196 (321)
T ss_dssp             CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred             CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence             889999987  4579999999999999999999999999999999999999   5788999999999987654322   


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   .+.+..+.......  ......+
T Consensus       197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~  267 (321)
T 2c30_A          197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPK--LKNSHKV  267 (321)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSCCC--CTTGGGS
T ss_pred             ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCC--cCccccC
Confidence                22456799999999999999999999999999999999999999987432   33333333322111  1122357


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++++.+++.+||+.||++||++.++++
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            899999999999999999999887654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-45  Score=343.55  Aligned_cols=261  Identities=17%  Similarity=0.253  Sum_probs=210.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..+|++.+.||+|+||.||+|++..++   ..||+|.+......   +.+.+|+.++++++|++++..+..+.......+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            357999999999999999999975433   46899987754432   457899999999999998888888777777889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence            999999 779999998656679999999999999999999999999999999999999   6888999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....   ........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+........   .+......   
T Consensus       181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~---  251 (298)
T 3f66_A          181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRL---  251 (298)
T ss_dssp             GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHTTCCC---
T ss_pred             cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhcCCCC---
Confidence            33211   112345567889999999999999999999999999999999 667777654433322   22222211   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                       ..+..+|+++.+++.+||+.||++||++.++++.|++++..
T Consensus       252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          252 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             12345789999999999999999999999999999998864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-45  Score=345.65  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=208.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....        .+.+.+|+.+++.++|++++..+.. ....
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~   87 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV-YENR   87 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-EECS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE-EecC
Confidence            345689999999999999999999999999999998765432        3458899999999998776665554 4566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCC----eEEEEec
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF  150 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~----~vkL~DF  150 (404)
                      ...+++|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++   .++    .+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF  163 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence            7889999999 8899999974 56799999999999999999999999999999999999994   444    7999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      |+++.......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ..+.+..+..
T Consensus       164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~  232 (321)
T 2a2a_A          164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITS  232 (321)
T ss_dssp             TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHT
T ss_pred             ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence            99987655321        234579999999999999999999999999999999999999998743   3344444444


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .... ........+++.+.++|.+||+.||++||++.++++
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          233 VSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            3322 223445678999999999999999999999887754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.9e-46  Score=350.03  Aligned_cols=264  Identities=19%  Similarity=0.278  Sum_probs=212.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcC-CCCCCceeEeeee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQG-GTGIPNLRWFGVE   74 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~-~~~i~~~~~~~~~   74 (404)
                      ...++|++.+.||+|+||.||+|++.     .+++.||||++......   ..+.+|+.+++.+.+ ++++..+..+...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            34678999999999999999999853     56789999998765433   357899999999965 5555555555555


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~---------------l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~  138 (404)
                      +...+++|||+ +++|.+++......               +++..++.++.||+.||.|||++||+||||||+|||+  
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--  181 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  181 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence            66789999999 78999999854321               8999999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                       +.++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       182 -~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          182 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -CCCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence             578899999999998665432211     2234567899999999999999999999999999999998 999998755


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      ...  .....+.....    ...+..+++++.+++.+||+.||++||++.++.+.|+.++....
T Consensus       256 ~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          256 IDE--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CSH--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hhH--HHHHHhccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            432  22222222211    12234578999999999999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-46  Score=352.45  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=206.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCC---CchhHHHHHHHHHHH-cCCCCCCceeEeeeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLQYEAKLYKIL-QGGTGIPNLRWFGVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~   75 (404)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++....   ....+.+|+.+++.+ +|++++ .+..+....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv-~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV-NLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBC-CEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCee-eEEEEEeeC
Confidence            3478999999999999999999973     456789999986432   345689999999999 555554 444455566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD  132 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~  132 (404)
                      ...+++|||+ +++|.+++.....                      .+++..++.++.||+.||+|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            7789999999 8899999985432                      3799999999999999999999999999999999


Q ss_pred             cccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCC
Q 015592          133 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL  211 (404)
Q Consensus       133 NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~  211 (404)
                      |||+   +.++.+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|+| |..
T Consensus       202 NIll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          202 NVLV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hEEE---cCCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            9999   57889999999999876543321     12234567889999999999899999999999999999998 999


Q ss_pred             CCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       212 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ||.+......   +..........   ..+..+++++.+++.+||+.||++||++.++.+.|+.++..
T Consensus       274 p~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          274 PYPGIPVDAN---FYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SSTTCCCSHH---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcccCCcHHH---HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            9988654322   22222222111   22346789999999999999999999999999999988654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-45  Score=364.80  Aligned_cols=261  Identities=19%  Similarity=0.246  Sum_probs=202.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+ .+.......+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~-~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEE-EEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEE-EEEeeCCEEE
Confidence            447899999999999999999999999999999987632     2334577899999999877666554 4455677889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+ +++|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||+++...
T Consensus       225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTC
T ss_pred             EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceecc
Confidence            999999 8899999975 4579999999999999999999998 999999999999999   678899999999998644


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....       ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+..   ....+..+......   
T Consensus       301 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---  367 (446)
T 4ejn_A          301 KDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR---  367 (446)
T ss_dssp             C------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred             CCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence            3322       2345689999999999999999999999999999999999999998743   34444444443322   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCceeecccccc
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY  295 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~  295 (404)
                        ++..+++++.+||.+||+.||++||     ++.+++   ++       ++...++|.....
T Consensus       368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell---~h-------p~f~~~~~~~~~~  418 (446)
T 4ejn_A          368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM---QH-------RFFAGIVWQHVYE  418 (446)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH---TS-------GGGTTCCHHHHHT
T ss_pred             --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHH---hC-------ccccCCCHHHHhh
Confidence              3456889999999999999999999     766553   33       3334456765443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.3e-46  Score=343.73  Aligned_cols=253  Identities=20%  Similarity=0.288  Sum_probs=205.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++.....+.+.+|+.+++.++|++++..+..+.......+++|||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            457899999999999999999986  588999999987777778999999999999988888887766666678999999


Q ss_pred             c-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc--
Confidence            9 6699999975432 38999999999999999999999999999999999999   578899999999997554322  


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......   ....+.....    ...+
T Consensus       172 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----~~~~  236 (278)
T 1byg_A          172 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK----MDAP  236 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCC----CCCC
T ss_pred             --------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----CCCc
Confidence                    23457889999999999899999999999999999998 999998754432   2333322211    1234


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+|+++.+++.+||+.||++||++.++.+.|+++...
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            57899999999999999999999999999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.6e-45  Score=358.11  Aligned_cols=255  Identities=20%  Similarity=0.254  Sum_probs=201.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCC-----CCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~   77 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++..... ..++.+|+.+++.+++.     +++..+..+......
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            466789999999999999999999999999999999865432 34578899999999754     244445555566788


Q ss_pred             EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe--EEEEecCCcc
Q 015592           78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~--vkL~DFG~a~  154 (404)
                      .+++|||++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.  +||+|||+++
T Consensus       174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccce
Confidence            99999999999999998643 359999999999999999999999999999999999999   45555  9999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .....          .....||+.|+|||++.+..++.++|||||||+||||++|..||.+....+....+.........
T Consensus       251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            54432          23568899999999999999999999999999999999999999885443322222221110000


Q ss_pred             ---------------------------------------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCC
Q 015592          235 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK  263 (404)
Q Consensus       235 ---------------------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~R  263 (404)
                                                                         .....+....++++.+||.+||+.||++|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence                                                               00011222347889999999999999999


Q ss_pred             CCHHHHHH
Q 015592          264 PDYAYLKR  271 (404)
Q Consensus       264 P~~~~l~~  271 (404)
                      ||++++++
T Consensus       401 pta~e~L~  408 (429)
T 3kvw_A          401 MTPGQALR  408 (429)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhC
Confidence            99887653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-45  Score=342.80  Aligned_cols=260  Identities=19%  Similarity=0.313  Sum_probs=216.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +..++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCEEEEE
Confidence            356789999999999999999999999999999998875543 35688999999999987777666554 5566789999


Q ss_pred             ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      ||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCCc
Confidence            999 689999998643 459999999999999999999999999999999999999   578899999999998765433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..      ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+........   .+.....    ..
T Consensus       166 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~---~~~~~~~----~~  232 (288)
T 3kfa_A          166 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LLEKDYR----ME  232 (288)
T ss_dssp             SE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HHHTTCC----CC
T ss_pred             cc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHhccCC----CC
Confidence            21      2234567889999999999899999999999999999999 999998865433322   2222211    12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .+..+|+++.+++.+||+.||++||++.++.+.|+.++...
T Consensus       233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            23568999999999999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.7e-46  Score=349.42  Aligned_cols=262  Identities=16%  Similarity=0.256  Sum_probs=195.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      +..++|++.+.||+|+||.||+|++..++.   .||||++.....    .+.+.+|+.+++.++|++++..+..+.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            356789999999999999999999877665   899998865432    3458899999999988887777766544332


Q ss_pred             -----eEEEEEecc-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           77 -----YNVLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        77 -----~~~lv~e~~-~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                           ..+++|||+ +++|.+++....     ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCCE
Confidence                 238999999 889999986432     259999999999999999999999999999999999999   578899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      ||+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......   
T Consensus       177 kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---  248 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---  248 (323)
T ss_dssp             EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred             EEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence            99999999876543321     12234567889999999999999999999999999999999 9999988654332   


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      +..+......    ..+..+++++.+++.+||+.||++||++.++.+.|++++...
T Consensus       249 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          249 YNYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            3333322211    223568899999999999999999999999999999998653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.5e-46  Score=346.64  Aligned_cols=262  Identities=20%  Similarity=0.247  Sum_probs=209.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEE----EcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeee-CC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~   76 (404)
                      ..++|++.+.||+|+||.||+|+    +..+++.||||++....   ....+.+|+.+++.++|++++..+..+... ..
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            45679999999999999999999    56789999999876543   235688999999999988887777666543 35


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccccc
Confidence            688999999 789999997667789999999999999999999999999999999999999   5788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------CCh-HH
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------GTK-KQ  223 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~-----------~~~-~~  223 (404)
                      ........    .......||..|+|||++.+..++.++|||||||++|+|++|..|+.....           ... ..
T Consensus       176 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          176 IETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CCTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             ccCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            66543211    123456788999999999998899999999999999999999998743210           001 11


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ....+....    ....+..+|+++.+++.+||+.||.+||++.++++.|++++
T Consensus       252 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccC----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111111111    11234568899999999999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6e-45  Score=336.39  Aligned_cols=253  Identities=21%  Similarity=0.240  Sum_probs=209.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++...  ...+.+.+|+.+++.++|++++..+.. .......+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv   84 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-FEDNTDIYLV   84 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEE-EecCCeEEEE
Confidence            3567899999999999999999999999999999987653  344678999999999987776665554 4567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+..++.++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999 7899998875 4569999999999999999999999999999999999999655678899999999998765433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..   ..+....+.......+ ...
T Consensus       164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-~~~  230 (277)
T 3f3z_A          164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP-EKD  230 (277)
T ss_dssp             C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-HHH
T ss_pred             c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC-chh
Confidence            2        2355799999999998764 8999999999999999999999998743   3444444444443332 233


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+++++.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3478999999999999999999999887653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-45  Score=338.47  Aligned_cols=258  Identities=18%  Similarity=0.216  Sum_probs=208.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +..++|++.+.||+|+||.||+|++...   +..||+|++.....   .+.+.+|+.+++.++|++++..+..+.  ...
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~   86 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE--EEP   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--SSS
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCC
Confidence            3457899999999999999999997543   45699998875532   345889999999999888887776653  334


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++||++ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCccc
Confidence            57899998 789999998767779999999999999999999999999999999999999   57889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......      ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+   ...... 
T Consensus       164 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~~~~-  233 (281)
T 3cc6_A          164 EDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKGDRL-  233 (281)
T ss_dssp             ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHTCCC-
T ss_pred             cccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcCCCC-
Confidence            543221      1234567889999999998899999999999999999998 99999875544333222   222111 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                         ..+..+++.+.+++.+||+.||++||++.++.+.|++++..
T Consensus       234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence               12346789999999999999999999999999999998754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-45  Score=340.40  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.++|++.++||+|+||.||+|++..+++.||+|++....   ..+.+.+|+++++.++|++++..+..+ ......++
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~l   97 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYI   97 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-ecCCeEEE
Confidence            35688999999999999999999999999999999876543   235689999999999987766665554 56677899


Q ss_pred             EEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           81 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      +|||+ +++|.+++...   ...+++..++.++.||+.||+|||++||+||||||+|||+...+..+.+||+|||+++.+
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999 78999988532   467999999999999999999999999999999999999965556688999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...   ......+....... 
T Consensus       178 ~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~-  244 (285)
T 3is5_A          178 KSDEH--------STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY-  244 (285)
T ss_dssp             -----------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC-
T ss_pred             CCccc--------CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc-
Confidence            54321        235578999999999864 689999999999999999999999987443   22222222222111 


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ......+++++.+++.+||+.||++||++.++++
T Consensus       245 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 -AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1122357899999999999999999999887753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-45  Score=361.22  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=199.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++....          ....+.+|+.++++++|++++..+..+  .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--D  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE--E
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE--e
Confidence            4578999999999999999999999999999999876432          123588999999999988888877665  3


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ....+++|||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++..+....+||+|||++
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            44578999999 8899888863 567999999999999999999999999999999999999965445667999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      +......        ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+.......  ...+..
T Consensus       290 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~  359 (419)
T 3i6u_A          290 KILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS  359 (419)
T ss_dssp             TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT
T ss_pred             eecCCCc--------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc
Confidence            8765432        1235679999999999864   56889999999999999999999999875433222  222222


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ... .........+++++.+++.+||+.||++||+++++++
T Consensus       360 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            222 2234455678999999999999999999999887653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=343.40  Aligned_cols=252  Identities=19%  Similarity=0.258  Sum_probs=201.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +-.++|++.+.||+|+||.||+|++  .++.||||++......+.+.+|++++++++|++++..+..+.   +..+++||
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e   79 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVME   79 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEE
Confidence            3457899999999999999999996  478999999877666677999999999999888777765543   34789999


Q ss_pred             cc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcccccCCCCCC-eEEEEecCCcccc
Q 015592           84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY  156 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlKp~NILl~~~~~~~-~vkL~DFG~a~~~  156 (404)
                      |+ +++|.+++.....  .+++..++.++.|++.||+|||+   +||+||||||+|||++   .++ .+||+|||++...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDI  156 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC----
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccccc
Confidence            99 8899999984332  47899999999999999999999   8999999999999994   445 4899999999765


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ....          ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.....   
T Consensus       157 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~---  222 (307)
T 2eva_A          157 QTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTR---  222 (307)
T ss_dssp             ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTTCC---
T ss_pred             cccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcCCC---
Confidence            4322          23468999999999999999999999999999999999999998654322 222222222221   


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                       ......+|+.+.+++.+||+.||++||++.++.+.|+.+..
T Consensus       223 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          223 -PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             -CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             -CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence             22345789999999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-45  Score=351.03  Aligned_cols=245  Identities=21%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.+++.++|++++..+.. .......++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC-YLREHTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE-EEETTEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE-EEECCeEEE
Confidence            35699999999999999999999999999999988754332     357899999999998777766554 456778899


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||+.++|.+++......+++.++..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++..... 
T Consensus       132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB-
T ss_pred             EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC-
Confidence            99999999999997667789999999999999999999999999999999999999   57899999999999765432 


Q ss_pred             CcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                                ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.+...   ...+..+.......  
T Consensus       208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~--  272 (348)
T 1u5q_A          208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPA--  272 (348)
T ss_dssp             ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--
T ss_pred             ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC--
Confidence                      2457999999999985   46689999999999999999999999987433   23333333322211  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       .....+++.+.++|.+||+.||++||++.++++
T Consensus       273 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          273 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             112467899999999999999999999887653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.2e-46  Score=351.62  Aligned_cols=254  Identities=18%  Similarity=0.271  Sum_probs=206.1

Q ss_pred             cCCceEEe-eeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +.++|.+. +.||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.+.++++|..+..+.......+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            55678888 89999999999999999999999999876532    23468899999999988777777777777888899


Q ss_pred             EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           80 LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+ +++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999 77999988532 3569999999999999999999999999999999999999533337899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+........ 
T Consensus       186 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-  253 (327)
T 3lm5_A          186 HACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDYS-  253 (327)
T ss_dssp             ----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCC-
T ss_pred             Cccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhcccccC-
Confidence            4321        234579999999999999999999999999999999999999998743   3344444443333222 


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ......+++.+.++|.+||+.||++||++++++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll  286 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL  286 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            233357899999999999999999999987664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.3e-46  Score=350.93  Aligned_cols=256  Identities=21%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      ++.++|++.+.||+|+||.||+|++..+++.||||++.....   .+.+.+|+.+++.++|++++..+..+....     
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            345789999999999999999999999999999999865432   345889999999999988888876654322     


Q ss_pred             ---------------------------------------------------CeEEEEEecc-CCCHHHHHHHcCC--CCC
Q 015592           76 ---------------------------------------------------DYNVLVIDLL-GPSLEDLFNFCSR--KLS  101 (404)
Q Consensus        76 ---------------------------------------------------~~~~lv~e~~-~~sL~~~l~~~~~--~l~  101 (404)
                                                                         .+.+++|||+ +++|.+++.....  ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                               2479999999 8899999985322  356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc-----cccCCCCCccC
Q 015592          102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGT  176 (404)
Q Consensus       102 ~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~-----~~~~~~~~~gt  176 (404)
                      +..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...........     .+.......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            77899999999999999999999999999999999   57889999999999877654321110     01223456799


Q ss_pred             cCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHH
Q 015592          177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR  256 (404)
Q Consensus       177 ~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  256 (404)
                      +.|+|||++.+..++.++|||||||++|||++|..|+..     .......+.....    +......++++.+++.+||
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l  310 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF----PLLFTQKYPQEHMMVQDML  310 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC----CHHHHHHCHHHHHHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC----CcccccCChhHHHHHHHHc
Confidence            999999999999999999999999999999998777532     1222222222222    2222345688899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 015592          257 SLRFDDKPDYAYLKR  271 (404)
Q Consensus       257 ~~~p~~RP~~~~l~~  271 (404)
                      +.||++||++.++++
T Consensus       311 ~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          311 SPSPTERPEATDIIE  325 (332)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCCCCcCCCHHHHhh
Confidence            999999999887754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-45  Score=345.53  Aligned_cols=259  Identities=17%  Similarity=0.275  Sum_probs=211.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++......   ..+.+|+++++.++|++++..+..+ ....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-ecCC
Confidence            4678999999999999999999984     45589999998754432   3578899999999877776666554 4566


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD  132 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~  132 (404)
                      ..+++|||+ +++|.+++....                       ..+++.+++.++.||+.||.|||++||+||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            789999999 799999998532                       23899999999999999999999999999999999


Q ss_pred             cccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCC
Q 015592          133 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL  211 (404)
Q Consensus       133 NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~  211 (404)
                      |||+   +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       180 NIli---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          180 NILV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             GEEE---ETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eEEE---cCCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999   57889999999999866543321     12234567889999999999889999999999999999999 999


Q ss_pred             CCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       212 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ||.+.......   ..+.....    ...+..+++++.+++.+||+.||++||++.++.+.|++++.+
T Consensus       252 p~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          252 PYPGIPPERLF---NLLKTGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SSTTCCGGGHH---HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHH---HHhhcCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            99886543322   22222221    123357899999999999999999999999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=340.02  Aligned_cols=260  Identities=17%  Similarity=0.243  Sum_probs=210.4

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .|++.++||+|+||.||+|++..+++   .||+|++......   +.+.+|+.+++.++|++++..+..+.......+++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            47778999999999999999765554   7999988754432   35789999999999988888888777666666889


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |+|+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence            9988 899999998656779999999999999999999999999999999999999   678899999999998665432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ...   ........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |.......   ....+......    .
T Consensus       179 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~----~  248 (298)
T 3pls_A          179 YYS---VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRL----P  248 (298)
T ss_dssp             GGC---SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCC----C
T ss_pred             ccc---cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCC----C
Confidence            111   1123456788999999999999999999999999999999995554 54433322   22222222211    1


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .+..+++++.+++.+||+.||++||++.++.+.|++++...
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            23467899999999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.6e-46  Score=368.73  Aligned_cols=256  Identities=20%  Similarity=0.350  Sum_probs=210.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.+.||+|+||.||+|++. ++..||||+++... ..+.+.+|+.+++.++|++++..+..+.  ....+++||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEe
Confidence            3467999999999999999999984 57889999987543 3456899999999999888887766553  556789999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCce
Confidence            99 88999999743 2368999999999999999999999999999999999999   5788999999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+...   .+.+..+......    ..
T Consensus       340 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~  406 (454)
T 1qcf_A          340 ------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRM----PR  406 (454)
T ss_dssp             ------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC----CC
T ss_pred             ------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence                  12234456889999999998899999999999999999999 9999987543   3333333332211    12


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+|+++.++|.+||+.||++||++.+|.+.|++++..
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            357899999999999999999999999999999887643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-45  Score=355.34  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=202.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee----------
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----------   73 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----------   73 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....  ....+|+.+++.++|++++..+..+..          
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            35678999999999999999999999999999999876443  234589999999999888888776633          


Q ss_pred             ---------------------------eCCeEEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015592           74 ---------------------------EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS  123 (404)
Q Consensus        74 ---------------------------~~~~~~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g  123 (404)
                                                 ...+.+++|||+.++|.+.+..   .+..+++..+..++.||+.||.|||++|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                       3345889999998898888763   3567999999999999999999999999


Q ss_pred             ceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHH
Q 015592          124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYV  202 (404)
Q Consensus       124 ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~i  202 (404)
                      |+||||||+|||++  ..++.+||+|||+++.+.....        .....||+.|+|||++.+.. ++.++|||||||+
T Consensus       162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999999999994  3578999999999987654332        23557899999999998755 8999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCC
Q 015592          203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD  261 (404)
Q Consensus       203 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~  261 (404)
                      +|||++|+.||.+....+....+.+.....                     .......++..+|+++.+|+.+||+.||+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            999999999998854432222222111100                     00111223445789999999999999999


Q ss_pred             CCCCHHHHHH
Q 015592          262 DKPDYAYLKR  271 (404)
Q Consensus       262 ~RP~~~~l~~  271 (404)
                      +|||+.++++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999987754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.8e-46  Score=355.59  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=187.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee-----C
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~   75 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++.++|++++..+..+...     .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            56899999999999999999999999999999999865432    23577899999999998888887766432     3


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|++++++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH  181 (367)
T ss_dssp             CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred             CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence            55799999999999999873  579999999999999999999999999999999999999   6788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---  231 (404)
                      ....          .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.+....   
T Consensus       182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            5432          234678999999999987 67899999999999999999999999885432222222211110   


Q ss_pred             --------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          ...........++++++.+||.+||..||++|||+.+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L  310 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  310 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence                                011122334456789999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=355.25  Aligned_cols=260  Identities=18%  Similarity=0.254  Sum_probs=202.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .|++.+.||+|+||.||+|++..++   ..||||.++....   ...+.+|+.+++.++|++++..+..+.......+++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5889999999999999999975433   4689998765433   245889999999999988888887776667778999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccccc
Confidence            9999 789999998656679999999999999999999999999999999999999   678899999999998665432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ...   ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+   ......    .
T Consensus       247 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~----~  316 (373)
T 3c1x_A          247 FDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRL----L  316 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCC----C
T ss_pred             ccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCC----C
Confidence            111   011234567889999999999999999999999999999999 78888876554433322   222211    1


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .+..+|+++.+++.+||+.||++||++.++.+.|++++...
T Consensus       317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            23468999999999999999999999999999999998654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-45  Score=359.44  Aligned_cols=250  Identities=20%  Similarity=0.219  Sum_probs=198.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeee-----CCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~~~~~l   80 (404)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....  ....+|+++++.++|++++..+..+...     ..+.++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            347999999999999999999999999999999876433  2345799999999999888877665432     234679


Q ss_pred             EEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           81 VIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        81 v~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +|||+.++|.+++..   ....+++..++.++.||+.||+|||++||+||||||+|||++  .+.+.+||+|||+++.+.
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECC
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcc
Confidence            999998888887753   356799999999999999999999999999999999999994  245678999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ....        .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....   ..+.++......+.
T Consensus       209 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          209 RGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPT  277 (420)
T ss_dssp             TTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCC
T ss_pred             cCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC
Confidence            4321        2356789999999999875 6999999999999999999999999885432   22222221110000


Q ss_pred             ------------------------HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          237 ------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       237 ------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                              ...+...+++++.+||.+||..||++||++.+++
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l  335 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC  335 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence                                    0112345689999999999999999999987664

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.5e-46  Score=358.22  Aligned_cols=260  Identities=16%  Similarity=0.245  Sum_probs=199.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      -.++|++.+.||+|+||.||+|++.   .++..||||+++....   ...+.+|+.++++++|++++..+..+ ......
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-TKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCce
Confidence            3468999999999999999999976   4677899999875433   23588999999999877766665554 556678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccccc
Confidence            9999999 899999998666679999999999999999999999999999999999999   678899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ......    .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+...   .+....+......  
T Consensus       199 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~--  269 (373)
T 2qol_A          199 DDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRL--  269 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEEC--
T ss_pred             cCCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence            432211    01123345788999999999999999999999999999998 9999987543   3333333332211  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                        ..+..+|.++.+++.+||+.||++||++.+|++.|++++..
T Consensus       270 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          270 --PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence              12346889999999999999999999999999999998753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-45  Score=343.17  Aligned_cols=258  Identities=19%  Similarity=0.328  Sum_probs=208.9

Q ss_pred             CCceEEee-eeceeCceeEEEEEE--cCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++|++.+ .||+|+||.||+|.+  ..+++.||||++.....    .+.+.+|+.+++.++|++++..+..+  .....
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--CCCCc
Confidence            46799998 999999999999954  56678999999875433    34588999999999988877777666  45667


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence            8999999 7899999985 5679999999999999999999999999999999999999   578899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ......    .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+...   .+....+.....   
T Consensus       169 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---  238 (291)
T 1xbb_A          169 ADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER---  238 (291)
T ss_dssp             TTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC---
T ss_pred             cCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---
Confidence            433211    11223456789999999998889999999999999999999 9999987543   333333333221   


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                       ...+..+|+++.+++.+||+.||++||++.++.+.|++++...
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          239 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence             1234578999999999999999999999999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=350.16  Aligned_cols=253  Identities=20%  Similarity=0.213  Sum_probs=200.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....       ....+.+|+.+++.++|++++..+..+ .....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-eeCCc
Confidence            4578999999999999999999999999999999876432       134688999999999987777666555 45667


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++|||+.++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred             eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence            89999999889999998656679999999999999999999999999999999999999   678899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc--
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--  234 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  234 (404)
                      ....       ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+...   ...+..+......  
T Consensus       164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT  233 (346)
T ss_dssp             SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence            4332       22356789999999999764 489999999999999999999999987543   3333333321111  


Q ss_pred             ---------------------ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 ---------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                           .+...+...+++++.+||.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                                 1122333567899999999999999999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-45  Score=369.99  Aligned_cols=270  Identities=19%  Similarity=0.204  Sum_probs=214.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ++..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+. +......
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~  258 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY-AYETKDA  258 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE-EEECSSE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE-EEeeCCE
Confidence            35567899999999999999999999999999999987542     33455889999999998776666554 4456778


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      .+++|||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~  335 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence            99999999 899999987433 349999999999999999999999999999999999999   6889999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChH-HHHHHHhhhccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVS  234 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~  234 (404)
                      ......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .....+..... 
T Consensus       336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-  406 (576)
T 2acx_A          336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-  406 (576)
T ss_dssp             CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred             cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence            654321        13458999999999999988999999999999999999999999876543332 23333332221 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                          .++..+++++.+||.+||+.||.+||+..  .+.+++++       +|...++|......
T Consensus       407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H-------pfF~~i~w~~l~~~  459 (576)
T 2acx_A          407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH-------PLFKKLNFKRLGAG  459 (576)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS-------GGGTTCCHHHHHTT
T ss_pred             ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC-------hhhccCCHHHHhcC
Confidence                23356899999999999999999999432  23344443       33445678765443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.9e-45  Score=366.11  Aligned_cols=270  Identities=19%  Similarity=0.215  Sum_probs=216.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+. +.......
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY-AFETKTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE-EEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEE-EEeeCCEE
Confidence            4457899999999999999999999999999999987542     23456889999999998766665544 45567788


Q ss_pred             EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           79 VLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +++|||+ |++|.+++...   ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence            9999999 89999998743   2369999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-ChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~  233 (404)
                      .+.....       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ........+.....
T Consensus       338 ~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          338 ELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             ECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             eccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            7654332       223568999999999999999999999999999999999999999875432 23344444443332


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~--l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                           .++..+++++.++|.+||+.||++||++.+  ..+++++       ++...++|......
T Consensus       411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H-------pff~~i~w~~l~~~  463 (543)
T 3c4z_A          411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH-------PLFRDISWRQLEAG  463 (543)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS-------GGGTTCCHHHHHTT
T ss_pred             -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC-------ccccCCCHHHHHcC
Confidence                 233578999999999999999999998643  2333333       34445678755433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=341.15  Aligned_cols=262  Identities=19%  Similarity=0.296  Sum_probs=213.9

Q ss_pred             CCceEEee-eeceeCceeEEEEEEc--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|.+.+ .||+|+||.||+|++.  .+++.||||+++....   .+.+.+|+.+++.++|++++..+..+  .....+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--cCCCcE
Confidence            45677776 9999999999999864  4688899999876533   24588999999999988877777666  445689


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeecc
Confidence            999999 779999997556679999999999999999999999999999999999999   5788999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....    .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+...   .+....+.....    
T Consensus       163 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~----  231 (287)
T 1u59_A          163 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKR----  231 (287)
T ss_dssp             CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCC----
T ss_pred             Cccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCc----
Confidence            32211    12234567899999999998889999999999999999998 9999987543   233333333221    


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ  283 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  283 (404)
                      ..++..+|+++.+++.+||+.||++||++.++.+.|++++...+.+
T Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            1234578999999999999999999999999999999998775533

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-45  Score=346.17  Aligned_cols=261  Identities=17%  Similarity=0.312  Sum_probs=209.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEc-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      ..++|++.+.||+|+||.||+|++.       .+++.||||++......   ..+.+|+.+++.+..|++|..+..+...
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578999999999999999999985       45678999998755432   3578999999999444444445445556


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL  138 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~  138 (404)
                      ....+++|||+ +++|.+++....               ..+++.+++.++.||+.||.|||++||+||||||+|||+  
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--
Confidence            67789999999 789999998532               248999999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                       +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       191 -~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          191 -TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             -CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence             67889999999999876543221     12234567889999999998889999999999999999999 999998754


Q ss_pred             CCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      .   .+....+......    ..+..+++++.+++.+||+.||++||++.++.+.|+.++...
T Consensus       265 ~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          265 V---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             H---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             H---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            3   3333333332211    233568899999999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=340.88  Aligned_cols=254  Identities=21%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      -++|++.+.||+|+||.||+|++..+++.||||++......    +.+.+|+.+++.++|++++..+..+ ......+++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-RRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-ecCCeEEEE
Confidence            47899999999999999999999999999999987655443    3477899999999987766666554 567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           81 FEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            9999 566777665 45679999999999999999999999999999999999999   678899999999998765433


Q ss_pred             CcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc------
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------  233 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------  233 (404)
                      .       ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........      
T Consensus       157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          157 D-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             c-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            2       1234578999999999986 5689999999999999999999999988554333222222111100      


Q ss_pred             -----------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                       ..........+++++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                             01112223467899999999999999999999886653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=351.94  Aligned_cols=250  Identities=18%  Similarity=0.272  Sum_probs=202.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      .++|++.+.||+|+||.||+|++.   .+++.||||+++..      .....+.+|+.+++.+.++++|..+..+.....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            378999999999999999999984   58999999987542      234557789999999987777777777777888


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            899999999 7899999985 3579999999999999999999999999999999999999   6888999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHH-HHHHHhhhc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKK  232 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~  232 (404)
                      +......      ......||+.|+|||++.+.  .++.++|||||||+||||++|+.||.......... ....+....
T Consensus       209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  282 (355)
T 1vzo_A          209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  282 (355)
T ss_dssp             CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence            6543221      12345799999999999863  47899999999999999999999998654433322 222222221


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLK  270 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~  270 (404)
                           ..++..++..+.+||.+||..||++||     ++++++
T Consensus       283 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell  320 (355)
T 1vzo_A          283 -----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  320 (355)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             -----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence                 123456789999999999999999999     655543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-45  Score=339.53  Aligned_cols=257  Identities=21%  Similarity=0.373  Sum_probs=211.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|+++++.++|++++..+..+.  ....+++||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEEe
Confidence            457899999999999999999997 467789999886544 3456899999999999888777766553  345789999


Q ss_pred             cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCccc
Confidence            99 889999987322 269999999999999999999999999999999999999   5788999999999987654322


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+...   .+....+.....    ...
T Consensus       165 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~  231 (279)
T 1qpc_A          165 ------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYR----MVR  231 (279)
T ss_dssp             ------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCC
T ss_pred             ------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccC----CCC
Confidence                  12234567889999999998889999999999999999999 9999987443   333333332211    122


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      +..+|+++.+++.+||+.||++||++.++.+.|++++...
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            3568899999999999999999999999999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.3e-45  Score=363.00  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=208.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.++|++.++||+|+||+||+|++..+++.||||++..    ......+.+|+.+++.++|++++..+.. .......++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI-LEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE-EEcCCEEEE
Confidence            45789999999999999999999999999999998753    2345568999999999998776666554 456778899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.+...
T Consensus        99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            99999 8899998875 357999999999999999999999999999999999999965556778999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ..+.+..+.........+.
T Consensus       178 ~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~  245 (486)
T 3mwu_A          178 T--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLPQ  245 (486)
T ss_dssp             ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSGG
T ss_pred             C--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCcc
Confidence            2        1235579999999999987 59999999999999999999999998743   3445555555444333222


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ...+++++.++|.+||..||.+|||+.++++
T Consensus       246 -~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          246 -WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             3468899999999999999999999887654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-44  Score=363.04  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=206.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCCCCce
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLQYEAKLYKILQGGTGIPNL   68 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~~~~~i~~~   68 (404)
                      .++++|+++++||+|+||+||+|++..+++.||||++....               ..+.+.+|+.+++.++|++++..+
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            46789999999999999999999999999999999876532               234688999999999977766655


Q ss_pred             eEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEE
Q 015592           69 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                      .. .......+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus       113 ~~-~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DV-FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EE-EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EE-EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            55 45677889999999 8899998875 457999999999999999999999999999999999999964333347999


Q ss_pred             EecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      +|||+++.......        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ..+.+..
T Consensus       191 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~  258 (504)
T 3q5i_A          191 VDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKK  258 (504)
T ss_dssp             CCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred             EECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence            99999987654321        235679999999999875 69999999999999999999999998743   3455555


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      +.........+ ....+++++.+||.+||..||.+|||+.+++
T Consensus       259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l  300 (504)
T 3q5i_A          259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEAL  300 (504)
T ss_dssp             HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            55554433333 3357899999999999999999999988664

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.2e-45  Score=344.90  Aligned_cols=260  Identities=20%  Similarity=0.289  Sum_probs=209.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCc-----EEEEEEecCCCC---chhHHHHHHHHHHH-cCCCCCCceeEeeeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTK---HPQLQYEAKLYKIL-QGGTGIPNLRWFGVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~---~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~   75 (404)
                      ..++|++.+.||+|+||.||+|++..+++     .||+|++.....   .+.+.+|+.+++.+ +|++++. +..+....
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~-~~~~~~~~  122 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN-LLGACTHG  122 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC-EEEEECSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeee-EEEEEecC
Confidence            35789999999999999999999877664     799999876543   24588999999999 5555554 44455566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR  141 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~  141 (404)
                      ...+++|||+ +++|.+++...             ...+++..++.++.||+.||+|||++||+||||||+|||+   +.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CC
Confidence            7789999999 77999998743             3458999999999999999999999999999999999999   57


Q ss_pred             CCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 015592          142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT  220 (404)
Q Consensus       142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~  220 (404)
                      ++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             CCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            889999999999866543321     12334567889999999999899999999999999999999 999998755432


Q ss_pred             hHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..   ..+.......   ..+..+|+++.+++.+||+.||++||++.++.+.|+++...
T Consensus       275 ~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 KF---YKLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HH---HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH---HHHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            22   2222222111   12345789999999999999999999999999999988765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-45  Score=368.80  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=212.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      .++|++.++||+|+||.||+|++..+++.||||+++... ..+.+.+|+.++++++|++++..+..+ ......+++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-ecCCcEEEEEEc
Confidence            457999999999999999999999889999999987554 345689999999999988777766555 455678999999


Q ss_pred             c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~-  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY-  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE-
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce-
Confidence            9 799999998643 459999999999999999999999999999999999999   5788999999999987654321 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                           .......++..|+|||++.+..++.++|||||||+||||++ |..||.+.......   ..+.....    ...+
T Consensus       374 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~----~~~~  441 (495)
T 1opk_A          374 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEKDYR----MERP  441 (495)
T ss_dssp             -----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHTTCC----CCCC
T ss_pred             -----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC----CCCC
Confidence                 12234556889999999998889999999999999999999 99999886544333   22222211    1233


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..+|+++.+||.+||+.||++||++.+|.+.|+.++
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            578999999999999999999999999999998765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.9e-45  Score=337.81  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=210.4

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee--------
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--------   73 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--------   73 (404)
                      +..++++|++.+.||+|+||.||+|++..+++.||||++...  ...+.+|+++++.++|++++..+..+..        
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            456788999999999999999999999989999999988654  3578899999999998888877765532        


Q ss_pred             -------eCCeEEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe
Q 015592           74 -------EGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        74 -------~~~~~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~  144 (404)
                             .....+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCC
Confidence                   245579999999 67999999753 3579999999999999999999999999999999999999   57889


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~  224 (404)
                      +||+|||++........        .....||+.|+|||++.+..++.++|||||||++|+|++|..||...     ...
T Consensus       161 ~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~  227 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKF  227 (284)
T ss_dssp             EEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHH
T ss_pred             EEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHH
Confidence            99999999987655332        23457899999999999999999999999999999999999987531     122


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...+....       +...++.++.+++.+||+.||++||++.++.+.|..+.
T Consensus       228 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          228 FTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            22222221       23457899999999999999999999999999887663

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=359.99  Aligned_cols=268  Identities=20%  Similarity=0.225  Sum_probs=213.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~   79 (404)
                      ..+++|++.++||+|+||.||+|++..+++.||||++....   ..+.+.+|+++++.++|++++..+..+... ....+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            56789999999999999999999999999999999986532   335678999999999988888777665543 34679


Q ss_pred             EEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCCeEEEEecCCccc
Q 015592           80 LVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKR  155 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~-~~~~~~vkL~DFG~a~~  155 (404)
                      ++|||+ +++|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++.
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999 789999997432  23999999999999999999999999999999999999832 23566799999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-CChHHHHH
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYE  226 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~  226 (404)
                      ......        .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus       166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  237 (396)
T 4eut_A          166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (396)
T ss_dssp             CCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred             ccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence            655332        234679999999999875        4578899999999999999999999976443 22334444


Q ss_pred             HHhhhcccccH--------------------hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       227 ~~~~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ++.........                    ..+...++..+.+++.+||+.||++||+++++.+.+++++.+
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            44433221100                    111123567899999999999999999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5e-46  Score=352.15  Aligned_cols=264  Identities=20%  Similarity=0.218  Sum_probs=211.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEE----EcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCceeEee-eeCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~   77 (404)
                      -.++|++.+.||+|+||.||+|+    +..+++.||||++......  +.+.+|+++++.++|++++..+..+. .....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            35789999999999999999999    4678999999998755322  34889999999998887777765543 35667


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccceec
Confidence            89999999 899999998666679999999999999999999999999999999999999   57889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC-----------Ch-HHH
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------TK-KQK  224 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~-----------~~-~~~  224 (404)
                      .......    .......||..|+|||++.+..++.++|||||||++|+|++|..||......           .. ...
T Consensus       178 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          178 PLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            5433211    1233456889999999999988999999999999999999999999653211           00 111


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...+....    ....+..+++++.+++.+||+.||++||++.++++.|+.++..
T Consensus       254 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          254 LELLEEGQ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHhhccc----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11111111    1122356889999999999999999999999999999988654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=340.40  Aligned_cols=252  Identities=19%  Similarity=0.296  Sum_probs=203.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.++|++++..+..+ ......+++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e  104 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSY-FKNTDLWIVME  104 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-EeCCEEEEEee
Confidence            45678999999999999999999999999999999998877778899999999999887766665554 45677899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc-
Confidence            99 679999998667789999999999999999999999999999999999999   5788999999999987654322 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...   ......+.......  ...+.
T Consensus       181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~  249 (314)
T 3com_A          181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPT--FRKPE  249 (314)
T ss_dssp             ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSGG
T ss_pred             ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcc--cCCcc
Confidence                  22355789999999999998999999999999999999999999987433   22222222211111  11234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .+++++.+++.+||+.||++||++.++++
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            57899999999999999999999887644

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.7e-45  Score=345.65  Aligned_cols=259  Identities=17%  Similarity=0.212  Sum_probs=202.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEE-cCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCC-----CCCceeEeeeeC
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGT-----GIPNLRWFGVEG   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~-----~i~~~~~~~~~~   75 (404)
                      ..+.++|++.+.||+|+||.||+|.+ ..+++.||||+++... ..+.+.+|+.+++.++|++     .+..+..+....
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            46788999999999999999999998 5688999999986432 2345889999999998765     344455556677


Q ss_pred             CeEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-------------
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-------------  141 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~-------------  141 (404)
                      ...+++|||++++|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++..+.             
T Consensus        90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            8899999999999999998543 36899999999999999999999999999999999999952211             


Q ss_pred             ---CCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 015592          142 ---ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (404)
Q Consensus       142 ---~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~  218 (404)
                         ++.+||+|||+++.....          .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence               567999999999764432          2356789999999999999999999999999999999999999987544


Q ss_pred             CChHHHHHHHhhhcccccH---------------------------------hH---hhcCCcHHHHHHHHHHHcCCCCC
Q 015592          219 GTKKQKYEKISEKKVSTSI---------------------------------EA---LCRGYPTEFASYFHYCRSLRFDD  262 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~---------------------------------~~---~~~~~~~~l~~li~~cl~~~p~~  262 (404)
                      ......+..+.........                                 ..   .....++++.+|+.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            3333333222211000000                                 00   00123578999999999999999


Q ss_pred             CCCHHHHHH
Q 015592          263 KPDYAYLKR  271 (404)
Q Consensus       263 RP~~~~l~~  271 (404)
                      ||++.++++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999887653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-45  Score=364.52  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.++||+|+||.||+|++.. +..||||+++.... .+.+.+|+.+++.++|++++..+..+..  ...+++||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEeh
Confidence            34679999999999999999999854 56799999876543 4569999999999999888887766543  56789999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCce
Confidence            99 88999999743 3569999999999999999999999999999999999999   5788999999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+...   .+....+......    ..
T Consensus       336 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~  402 (452)
T 1fmk_A          336 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PC  402 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred             ------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence                  12234457889999999998899999999999999999999 9999987543   3333333332211    22


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+|+++.++|.+||+.||++||++++|.+.|++++..
T Consensus       403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            357899999999999999999999999999999887643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=373.70  Aligned_cols=263  Identities=19%  Similarity=0.303  Sum_probs=210.1

Q ss_pred             CceEEee-eeceeCceeEEEEEEc--CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||+++...   ..+.+.+|+++++.++|++++..+..+..  +..++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEE
Confidence            4556666 8999999999999875  356779999987543   34568999999999998888877776543  45899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCC
Confidence            99999 889999997656679999999999999999999999999999999999999   57889999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ...    +.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....   +.+..+.....    .
T Consensus       490 ~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~----~  558 (613)
T 2ozo_A          490 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKR----M  558 (613)
T ss_dssp             ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCC----C
T ss_pred             Cce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCC----C
Confidence            211    111223456789999999998899999999999999999998 99999886543   33333333322    1


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD  285 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  285 (404)
                      ..+..+|+++.+||.+||+.||++||++.+|.+.|++++...+.+.+
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~  605 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  605 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence            23457899999999999999999999999999999999987665443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-45  Score=355.41  Aligned_cols=259  Identities=20%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcC--------CCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQG--------GTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~--------~~~i~~~~~~~~   73 (404)
                      ..+.++|++.++||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+++        ++++..+..+..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            4567899999999999999999999999999999999864422 3458899999999974        334544444432


Q ss_pred             ---eCCeEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCC--------
Q 015592           74 ---EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR--------  140 (404)
Q Consensus        74 ---~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~--------  140 (404)
                         .....+++|||++++|.+.+.... ..+++..++.|+.||+.||+|||++ ||+||||||+|||++.++        
T Consensus       113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence               456789999999988888876543 5699999999999999999999998 999999999999994211        


Q ss_pred             --------------------------------------CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCcccc
Q 015592          141 --------------------------------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM  182 (404)
Q Consensus       141 --------------------------------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  182 (404)
                                                            ....+||+|||+++......          ....||+.|+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~aP  262 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRSL  262 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCCH
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccCC
Confidence                                                  11379999999998665422          345789999999


Q ss_pred             ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh---HHHHHHHhhhcccccHh---------------------
Q 015592          183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYEKISEKKVSTSIE---------------------  238 (404)
Q Consensus       183 E~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~---------------------  238 (404)
                      |++.+..++.++|||||||+||||++|+.||.+......   ...+..+.......+..                     
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            999999999999999999999999999999987554331   11122211111000000                     


Q ss_pred             ----------------HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ----------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ----------------~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      ......++++.+||.+||+.||++|||+.++++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                            001123567899999999999999999887753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.5e-45  Score=363.13  Aligned_cols=252  Identities=21%  Similarity=0.331  Sum_probs=205.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.++|+++++||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.++|++++..+..+ ......++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEEEE
Confidence            3457999999999999999999999999999999876532    345689999999999987777666554 56678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.+...
T Consensus       114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999 8899998875 457999999999999999999999999999999999999965445677999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ..+.+..+......... .
T Consensus       193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~  259 (494)
T 3lij_A          193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDS-P  259 (494)
T ss_dssp             BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCS-G
T ss_pred             cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-h
Confidence            21        235679999999999874 69999999999999999999999998744   34445555554433322 2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....+++++.+||.+||+.||.+|||+.++++
T Consensus       260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            23578999999999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=344.69  Aligned_cols=261  Identities=16%  Similarity=0.213  Sum_probs=205.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      +..++|++.+.||+|+||.||+|++..++    ..||||++......   ..+.+|+.+++.++|++++..+..+ ....
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~  119 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKYK  119 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-ecCC
Confidence            45678999999999999999999986553    45999998754332   3478899999999987776665554 5566


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchh
Confidence            789999999 779999998766789999999999999999999999999999999999999   5788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ........    .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+...   .+....+......
T Consensus       197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~  269 (333)
T 1mqb_A          197 LEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL  269 (333)
T ss_dssp             ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC
T ss_pred             hccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC
Confidence            65432211    01223456889999999999999999999999999999999 9999987543   3333333332211


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                          ..+..+++++.+++.+||+.||++||++.++.+.|++++..
T Consensus       270 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                12346899999999999999999999999999999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-44  Score=348.46  Aligned_cols=204  Identities=26%  Similarity=0.351  Sum_probs=174.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTG-----IPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~~~~~~~~~~~   77 (404)
                      .+.++|++.+.||+|+||+||+|++..+++.||||+++.... ..++..|+.+++.++++++     +..+..+......
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            356889999999999999999999999999999999874322 3457789999999986663     5555566667788


Q ss_pred             EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+++|||++++|.+++.... ..+++..+..++.||+.||.|||  +.||+||||||+|||++. +..+.+||+|||+++
T Consensus       131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred             eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence            99999999999999998653 46999999999999999999999  479999999999999942 246789999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~  218 (404)
                      .....          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus       210 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          210 QLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             ETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            76432          2356789999999999999999999999999999999999999987543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=345.46  Aligned_cols=265  Identities=18%  Similarity=0.202  Sum_probs=192.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHc-CCCCCCceeEee-------eeC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQ-GGTGIPNLRWFG-------VEG   75 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~-~~~~i~~~~~~~-------~~~   75 (404)
                      +.+|++.++||+|+||.||+|++..+++.||||++.....  ...+.+|+.+++.+. |++++..+..+.       ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            4589999999999999999999999999999998754432  345889999999997 666666655552       344


Q ss_pred             CeEEEEEeccCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           76 DYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      ...+++|||++++|.+++..  ....+++.+++.|+.||+.||.|||++|  |+||||||+|||+   +.++.+||+|||
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCT
T ss_pred             ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCc
Confidence            56899999999999999874  2456999999999999999999999999  9999999999999   578899999999


Q ss_pred             CcccccccCCcccc-----cccCCCCCccCcCccccccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 015592          152 LAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (404)
Q Consensus       152 ~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~  223 (404)
                      +++...........     .........||+.|+|||++   .+..++.++|||||||++|+|++|+.||.+....    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            99876543221100     00112245689999999998   5667899999999999999999999999764321    


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ  283 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  283 (404)
                         .+.......   .....++..+.+++.+||+.||++||++.++++.|+.+....+..
T Consensus       260 ---~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          260 ---RIVNGKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ---------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---HhhcCcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence               111111111   112456788999999999999999999999999999998765543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-44  Score=344.76  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=205.5

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....          .+.+.+|+.+++.+.++++|..+..+....
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3679999999999999999999988999999999875432          234778999999995445555555566677


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ...+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC  248 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence            8899999999 7899999975 4579999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      .+.....        .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+..   ....+..+
T Consensus       249 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i  317 (365)
T 2y7j_A          249 HLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMI  317 (365)
T ss_dssp             ECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred             ccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence            7654321        235679999999999863      358899999999999999999999998733   34444445


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .........+ ....++.++.+++.+||+.||++||++.++++
T Consensus       318 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            4444433322 23578899999999999999999999887754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.9e-45  Score=347.03  Aligned_cols=259  Identities=17%  Similarity=0.205  Sum_probs=202.6

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCC-cEEEEEEecCCC-CchhHHHHHHHHHHHcCCCC-----CCceeEeeee
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKT-KHPQLQYEAKLYKILQGGTG-----IPNLRWFGVE   74 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~-----i~~~~~~~~~   74 (404)
                      ...+.++|++.+.||+|+||.||+|++..++ +.||||+++... ..+.+.+|+.+++.++|++.     +..+..+...
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            4567899999999999999999999998776 789999986432 23457889999999987653     4444555667


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--------------
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--------------  139 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~--------------  139 (404)
                      ....+++|||++++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||+...              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence            78899999999999988887543 469999999999999999999999999999999999999432              


Q ss_pred             --CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 015592          140 --RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (404)
Q Consensus       140 --~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~  217 (404)
                        +..+.+||+|||+++.....          .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence              25688999999999764432          235679999999999999999999999999999999999999998754


Q ss_pred             CCChHHHHHHHhhhcccccH--------------------------hHh----------hcCCcHHHHHHHHHHHcCCCC
Q 015592          218 AGTKKQKYEKISEKKVSTSI--------------------------EAL----------CRGYPTEFASYFHYCRSLRFD  261 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~----------~~~~~~~l~~li~~cl~~~p~  261 (404)
                      .......+..+.........                          ...          ....+.++.+||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            43322233222211000000                          000          001245899999999999999


Q ss_pred             CCCCHHHHH
Q 015592          262 DKPDYAYLK  270 (404)
Q Consensus       262 ~RP~~~~l~  270 (404)
                      +|||+.+++
T Consensus       324 ~Rpt~~e~l  332 (355)
T 2eu9_A          324 QRITLAEAL  332 (355)
T ss_dssp             TSCCHHHHT
T ss_pred             hCcCHHHHh
Confidence            999987664

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-45  Score=360.74  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=207.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .+..++|++++.||+|+||.||+|++..+|+.||||++...     .....+.+|+.+++.++|++++..+..+ .....
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~   90 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-STPSD   90 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCE
Confidence            34568899999999999999999999999999999987643     2345688999999999987777666554 55677


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhc
Confidence            89999999 8899999974 5679999999999999999999999999999999999999   67889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ....        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+...   ...+.++...... 
T Consensus       167 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~-  234 (476)
T 2y94_A          167 SDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY-  234 (476)
T ss_dssp             CTTC--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC-
T ss_pred             cccc--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC-
Confidence            5432        1235679999999999998775 7899999999999999999999987433   3444555443322 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                          .+..+++++.+||.+||..||++|||+.++++
T Consensus       235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                23457899999999999999999999887654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.3e-45  Score=336.14  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +-.++|++.+.||+|+||.||+|++  +++.||||++....      ..+.+.+|+.+++.++|++++..+..+ .....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-LKEPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CCC--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-ecCCc
Confidence            3457899999999999999999997  48899999876432      234688999999999987776665554 45667


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcccccCCC-----CCCeEEEE
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYII  148 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlKp~NILl~~~~-----~~~~vkL~  148 (404)
                      .+++|||+ +++|.+++.  .+++++..++.++.|++.||.|||++|   |+||||||+|||++...     ..+.+||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            89999999 889999986  567999999999999999999999999   99999999999995211     26789999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      |||+++......         .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...   ......+
T Consensus       159 Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~  226 (271)
T 3dtc_A          159 DFGLAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGV  226 (271)
T ss_dssp             CCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH
T ss_pred             cCCccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhh
Confidence            999998665432         1245789999999999998999999999999999999999999987432   2223333


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      ......   ...+..+++++.+++.+||+.||++||++.++.+.|++
T Consensus       227 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          227 AMNKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HTSCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hcCCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            322222   12345788999999999999999999999999998875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.6e-45  Score=365.64  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=209.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++....     ....+.+|+.+++.++|++++..+.. .......
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~~~~  101 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-FEDKGYF  101 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE-EECSSEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE-EEeCCEE
Confidence            45678999999999999999999999999999999976432     34568899999999987776666554 4567788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++.+.
T Consensus       102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999998 8999999874 5679999999999999999999999999999999999999655567899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ..+.+..+.........
T Consensus       181 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~  248 (484)
T 3nyv_A          181 ASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFEL  248 (484)
T ss_dssp             CCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred             cccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCC
Confidence            4332        124579999999999987 69999999999999999999999998743   34455555554443332


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      + ....+++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 P-QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             G-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            2 23468899999999999999999999887653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-44  Score=347.95  Aligned_cols=255  Identities=20%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+..+....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            457899999999999999999999999999999998754322    34778999999999888888777665433     


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|||++++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  176 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC---
T ss_pred             cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccc
Confidence            3789999999889999886   359999999999999999999999999999999999999   6788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .....        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ...+..+......+
T Consensus       177 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          177 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP  245 (371)
T ss_dssp             ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCC
T ss_pred             ccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence            55432        12346789999999999999999999999999999999999999987433   23333332211110


Q ss_pred             cH-------------------------hHh------------hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          236 SI-------------------------EAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       236 ~~-------------------------~~~------------~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..                         ...            ....++++.+||.+||..||++|||++++   |++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~  322 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA---LQHPYI  322 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH---hCCcch
Confidence            00                         000            01125789999999999999999998765   455555


Q ss_pred             H
Q 015592          279 R  279 (404)
Q Consensus       279 ~  279 (404)
                      .
T Consensus       323 ~  323 (371)
T 2xrw_A          323 N  323 (371)
T ss_dssp             H
T ss_pred             h
Confidence            4

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3e-45  Score=347.26  Aligned_cols=255  Identities=23%  Similarity=0.222  Sum_probs=195.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ...++|++.++||+|+||+||+|++..+++.||||++.....    ...+.+|+.+++.++|++++..+.. .......+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV-IHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEE-EEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEE-EecCCEEE
Confidence            356789999999999999999999999999999999865433    2346789999999987776665544 45677889


Q ss_pred             EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCCeEEEEecCCccccc
Q 015592           80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~--~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+.++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.+  +..+.+||+|||+++...
T Consensus       110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999998899999985 5579999999999999999999999999999999999999532  244569999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc-
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-  235 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-  235 (404)
                      ....       ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+...   ...+..+......+ 
T Consensus       189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPD  258 (329)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCc
Confidence            4322       223457899999999998754 89999999999999999999999987543   22222222211000 


Q ss_pred             ------------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          236 ------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       236 ------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                              ....+...+++++.+||.+||+.||++|||+.+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  317 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL  317 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence                                    01112233789999999999999999999987664

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=342.05  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=200.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEee---------
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG---------   72 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~---------   72 (404)
                      .++++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+.+++.++|++++..+..+.         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            578999999999999999999999999999999998765432  245789999999999988888776653         


Q ss_pred             ----eeCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEE
Q 015592           73 ----VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        73 ----~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                          ......+++|||++++|.+++.  .+++++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~  163 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIG  163 (320)
T ss_dssp             ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEEC
T ss_pred             cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEc
Confidence                3446789999999889999997  46799999999999999999999999999999999999994  356799999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      |||+++.........    .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...   ...+..
T Consensus       164 Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~  236 (320)
T 2i6l_A          164 DFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQL  236 (320)
T ss_dssp             CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred             cCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            999998765432111    11234567999999999876 6789999999999999999999999987543   222222


Q ss_pred             Hhhhc-------------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          228 ISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       228 ~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +....                         .......+...+++++.+++.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            22111                         112233445678999999999999999999999876643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.2e-44  Score=337.08  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|+.+++.++|++++..+..+ ......
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~  107 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-IEDNEL  107 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-EETTEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCCcE
Confidence            345789999999999999999999999999999998875322     23578899999999877766655544 466788


Q ss_pred             EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           79 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      +++|||+ +++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence            9999999 7799999874   24569999999999999999999999999999999999999   678899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ........+......
T Consensus       185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~  256 (310)
T 2wqm_A          185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP  256 (310)
T ss_dssp             ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred             eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence            6654322       12345789999999999999999999999999999999999999986432 223333333333222


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      ..   ....+++++.+++.+||+.||++||++.++.+.|+++....
T Consensus       257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            11   12467899999999999999999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.8e-45  Score=337.66  Aligned_cols=250  Identities=18%  Similarity=0.180  Sum_probs=201.0

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      |...+.++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+..+..+.+|++|..+..+.....
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            456678899999999999999999999999999999998875432    2357889999999944444555555567778


Q ss_pred             eEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC------------
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR------------  140 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~------------  140 (404)
                      ..+++|||+ +++|.+++...   ...+++.+++.++.||+.||.|||++||+||||||+|||++.+.            
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            899999999 78999999753   25699999999999999999999999999999999999995322            


Q ss_pred             ----CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 015592          141 ----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG  215 (404)
Q Consensus       141 ----~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~  215 (404)
                          ....+||+|||++.......           ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                44589999999998665432           34589999999999876 567899999999999999999987754


Q ss_pred             CCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..      ....+.....    ..++..+++++.+++.+||+.||++||++.++++
T Consensus       234 ~~------~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GD------QWHEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SH------HHHHHHTTCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh------HHHHHHcCCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            21      1333333322    2344578999999999999999999999887653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-45  Score=346.09  Aligned_cols=258  Identities=20%  Similarity=0.257  Sum_probs=208.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEE--EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++.+.||+|+||.||+|++..++..+  |||.+...   .....+.+|+.+++++.+|++|..+..+.......++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            478999999999999999999998888865  89977642   2345689999999999545555555555677788999


Q ss_pred             EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe
Q 015592           81 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ  144 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~  144 (404)
                      +|||+ +++|.+++....               ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCe
Confidence            99999 889999997432               369999999999999999999999999999999999999   57889


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ  223 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~  223 (404)
                      +||+|||+++......        ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+..   ..+
T Consensus       181 ~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~  249 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE  249 (327)
T ss_dssp             EEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH
T ss_pred             EEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHH
Confidence            9999999997443221        1234467889999999998889999999999999999998 999998743   233


Q ss_pred             HHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcC
Q 015592          224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG  281 (404)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  281 (404)
                      .+..+.....    ...+..+++++.+++.+||+.||++||++.++.+.|++++....
T Consensus       250 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          250 LYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HHHHGGGTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHhhcCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            3444333221    12234678999999999999999999999999999999987643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-44  Score=346.57  Aligned_cols=263  Identities=19%  Similarity=0.211  Sum_probs=204.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeee----CC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE----GD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~   76 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++|++++..+..+...    ..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            567899999999999999999999999999999998864432   23477899999999988888777665433    36


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ..+++||+++++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccccc
Confidence            7899999999999999984  579999999999999999999999999999999999999   67889999999999876


Q ss_pred             cccCCccccc---ccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh-
Q 015592          157 RDTATHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-  231 (404)
Q Consensus       157 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-  231 (404)
                      .........+   ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            5432211100   001234578999999998765 67899999999999999999999999875432221111111100 


Q ss_pred             -----------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 -----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 -----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                             ............+++++.+++.+||+.||++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                   0112233444678999999999999999999999886643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-45  Score=333.93  Aligned_cols=255  Identities=20%  Similarity=0.259  Sum_probs=211.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ......+++||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCeEEEEeC
Confidence            468999999999999999999985 67889999987654 345689999999999877766665554 456678999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++......+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++........  
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~--  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY--  159 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH--
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc--
Confidence            9 789999998766779999999999999999999999999999999999999   5788999999999986644321  


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                          .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+..   ..+....+.....    ...+.
T Consensus       160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~----~~~~~  228 (267)
T 3t9t_A          160 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFR----LYKPR  228 (267)
T ss_dssp             ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC----CCCCT
T ss_pred             ----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCc----CCCCc
Confidence                12234567889999999998899999999999999999999 999998743   3333444333221    11234


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .+++++.+++.+||+.||++||++.++.+.|+++..
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            578999999999999999999999999999998864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=347.98  Aligned_cols=240  Identities=20%  Similarity=0.253  Sum_probs=199.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCceeEeeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE   74 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~   74 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++....          ....+.+|+.+++.++|++++..+..+ ..
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-EN  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ee
Confidence            4578999999999999999999999999999999887653          234578899999999877766665544 56


Q ss_pred             CCeEEEEEecc-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           75 GDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        75 ~~~~~lv~e~~-~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      ....+++||++ ++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~  176 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS  176 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence            77889999988 44 99999984 5579999999999999999999999999999999999999   5789999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ++.......        .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....         ....
T Consensus       177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~  239 (335)
T 3dls_A          177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEA  239 (335)
T ss_dssp             CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTT
T ss_pred             ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhh
Confidence            987654332        234579999999999998886 8899999999999999999999976321         1111


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..     ..+..+++++.+||.+||+.||++||++.++++
T Consensus       240 ~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          240 AI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11     123457899999999999999999999876643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.3e-46  Score=350.42  Aligned_cols=258  Identities=20%  Similarity=0.301  Sum_probs=210.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      +..++|++.+.||+|+||.||+|++.     .+++.||||++......   ..+.+|+.+++.++|++++..+..+ ...
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~  100 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQG  100 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-CSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-ccC
Confidence            45678999999999999999999876     35788999998754432   2478899999999988766666554 556


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      ...+++|||+ +++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCeE
Confidence            6789999999 789999987432         457999999999999999999999999999999999999   578899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~  224 (404)
                      ||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...   .+.
T Consensus       178 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~  249 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV  249 (322)
T ss_dssp             EECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH
T ss_pred             EECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH
Confidence            99999999866543221     12234567899999999999899999999999999999999 8999987433   333


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ...+......    ..+..+|+++.+++.+||+.||++||++.++.+.|++.+
T Consensus       250 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          250 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            4443333322    233578999999999999999999999999999988764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-44  Score=333.48  Aligned_cols=254  Identities=20%  Similarity=0.267  Sum_probs=205.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      ++.++|++.+.||+|+||.||+|++..+++.||+|++....        ..+.+.+|+.+++.++|++++..+.. ....
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~   80 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI-FENK   80 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-EECS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe-ecCC
Confidence            45678999999999999999999999999999999876543        23568999999999997776665554 4566


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCCc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA  153 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~a  153 (404)
                      ...+++|||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            7789999999 8999999975 45799999999999999999999999999999999999995221 1238999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      ........        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+..   .......+.....
T Consensus       160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~  228 (283)
T 3bhy_A          160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNY  228 (283)
T ss_dssp             EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCC
T ss_pred             eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhccc
Confidence            87654321        234568999999999999999999999999999999999999998743   3334444433332


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .. .......+++.+.+++.+||..||++||++.++++
T Consensus       229 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            22 23445678999999999999999999999988765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.4e-45  Score=341.11  Aligned_cols=260  Identities=22%  Similarity=0.311  Sum_probs=200.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.....     .+.+.+|+.+++.++|++++..+. ++......
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~~~  109 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD-FGEIDGQL  109 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE-EEEETTEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE-EEeeCCeE
Confidence            345789999999999999999999999999999999865432     245888999999998877666555 44567788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred             EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence            9999999 6799999985 4579999999999999999999999999999999999999   578899999999997665


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ....      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...   . .+........ ...
T Consensus       186 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~~-~~~  254 (309)
T 2h34_A          186 DEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQAI-PRP  254 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSCC-CCG
T ss_pred             cccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccCC-CCc
Confidence            4321      122345789999999999998999999999999999999999999987432   2 2222222221 222


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR  279 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP-~~~~l~~~l~~~~~~  279 (404)
                      ......+|+++.+++.+||+.||++|| +++++.+.|+..+..
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            345567899999999999999999999 999999998876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=349.98  Aligned_cols=252  Identities=21%  Similarity=0.231  Sum_probs=201.5

Q ss_pred             CCceEE--eeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i--~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+.|.+  .+.||+|+||.||+|++..+++.||+|+++...  ..+.+.+|+.+++.++|++++..+.. .......+++
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~~~~~~~lv  164 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLV  164 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEE-EECSSEEEEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEE-EEECCEEEEE
Confidence            344555  678999999999999999999999999987653  23468899999999988776666554 4556788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.+....
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence            9999 78999988765567999999999999999999999999999999999999842 246789999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..   ....+..+........ ...
T Consensus       244 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~~  311 (373)
T 2x4f_A          244 K--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE-DEE  311 (373)
T ss_dssp             B--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SGG
T ss_pred             c--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hhh
Confidence            2        234579999999999999889999999999999999999999998743   3444455544433222 223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+++++.+||.+||+.||++||++.++++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3578999999999999999999999887755

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-44  Score=340.10  Aligned_cols=260  Identities=19%  Similarity=0.296  Sum_probs=201.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcC---CCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC-
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD-   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-   76 (404)
                      ..++|++.+.||+|+||.||+|++..   +++.||||++......    +.+.+|+.+++.++|++++..+..+..... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            35789999999999999999998765   5568999998755433    348889999999998888888776654332 


Q ss_pred             ---eEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEE
Q 015592           77 ---YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        77 ---~~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                         ..+++|+|+ +++|.+++...     ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEE
Confidence               458999999 78999998532     3469999999999999999999999999999999999999   57889999


Q ss_pred             EecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHH
Q 015592          148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~  226 (404)
                      +|||+++........     .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+......   ..
T Consensus       189 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~  260 (313)
T 3brb_A          189 ADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD  260 (313)
T ss_dssp             CSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH
T ss_pred             eecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH
Confidence            999999876543221     12234567889999999999999999999999999999999 9999987554332   23


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+.....    ...+..+++++.+++.+||+.||++||++.++++.|++++..
T Consensus       261 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          261 YLLHGHR----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHHTTCC----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCC----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            3332221    123357889999999999999999999999999999998864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-44  Score=337.43  Aligned_cols=258  Identities=20%  Similarity=0.251  Sum_probs=209.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+|+.+++.++|++++..+.. .......+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-YESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEE-EECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhh-cccCCEEEEE
Confidence            35678999999999999999999999999999999887543  33468899999999998776665554 4566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+...+.++.+||+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            9999 7899999875 4569999999999999999999999999999999999999554577899999999997544321


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                               .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   .......+....... ....
T Consensus       164 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~  230 (304)
T 2jam_A          164 ---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPF  230 (304)
T ss_dssp             ---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTT
T ss_pred             ---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Cccc
Confidence                     123468999999999999999999999999999999999999998743   334444444433222 1233


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...+++++.+++.+||+.||++||++.+++   ++.+..
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l---~h~~~~  266 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKAL---SHPWID  266 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHH---TSHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHh---cCcccc
Confidence            457899999999999999999999987654   444444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.7e-45  Score=344.89  Aligned_cols=267  Identities=19%  Similarity=0.223  Sum_probs=208.8

Q ss_pred             ccCCce-EEeeeeceeCceeEEEEEE----cCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeee-
Q 015592            4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE-   74 (404)
Q Consensus         4 ~~~~~y-~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-   74 (404)
                      .+.++| +++++||+|+||.||++.+    ..+++.||||++.....   ...+.+|+++++.++|++++..+..+... 
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            456666 9999999999999988764    35789999999876543   23588999999999988877777666554 


Q ss_pred             CCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ....+++|||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred             CceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcccc
Confidence            46789999999 7899999974  459999999999999999999999999999999999999   67889999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC--------ChHHHH
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQKY  225 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~  225 (404)
                      +.........    .......||..|+|||++.+..++.++|||||||++|+|++|..||......        ......
T Consensus       182 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          182 KAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             EECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             cccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            8775533211    1233456888999999999988999999999999999999999999753210        000001


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+............+..+|+++.+++.+||+.||++||++.++++.|+.+..+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            111110001111123356889999999999999999999999999999998765

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-45  Score=345.92  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=202.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++....          ....+.+|+.+++.++|++++..+..+..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            35678999999999999999999999999999999876432          12358899999999998888777666533


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                       . ..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus        87 -~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           87 -E-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -S-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -C-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             3 378999999 7799998874 56799999999999999999999999999999999999996444455699999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCcccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      ++.......        .....||+.|+|||++.   +..++.++|||||||++|+|++|..||.........  ...+.
T Consensus       164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~  233 (322)
T 2ycf_A          164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT  233 (322)
T ss_dssp             CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH
T ss_pred             ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH
Confidence            986654321        12346899999999974   456899999999999999999999999875443221  22222


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .... ...+.....+++++.+++.+||+.||++||++.++++
T Consensus       234 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            2222 2234455678999999999999999999999987753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.8e-44  Score=346.24  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=198.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD----   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~----   76 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+..+.....    
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            568999999999999999999999999999999998764432    357889999999999888888777654443    


Q ss_pred             -eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 -~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                       ..+++|||++++|.+++.   ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH  193 (371)
T ss_dssp             CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC--
T ss_pred             eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccc
Confidence             249999999999888774   459999999999999999999999999999999999999   6788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc--
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--  232 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--  232 (404)
                      ....          .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....   +.+..+....  
T Consensus       194 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~  260 (371)
T 4exu_A          194 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV  260 (371)
T ss_dssp             ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             cccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence            5442          234578999999999987 67999999999999999999999999875432   2222222111  


Q ss_pred             ------------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                              .......+...+++++.+||.+||+.||++||++.+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  322 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  322 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence                                    11122333456789999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-45  Score=346.93  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||+|++...       ...+.+.+|+.+++.++|++++..+.. ......
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~~~  102 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQY  102 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh-hccCCe
Confidence            457899999999999999999999999999999987532       233568899999999997776666555 466778


Q ss_pred             EEEEEecc-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015592           78 NVLVIDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVE  117 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~  117 (404)
                      .+++|||+ +++|.+++...                                       ...+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999 99999988411                                       112467889999999999999


Q ss_pred             HHHhCCceeccCCCCcccccCCCCCC--eEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC--CCCCch
Q 015592          118 FVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRR  193 (404)
Q Consensus       118 ~LH~~givHrDlKp~NILl~~~~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  193 (404)
                      |||++||+||||||+|||++   .++  .+||+|||+++.+.......   ........||+.|+|||++.+  ..++.+
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~---~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFS---TNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEES---CSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHCCccccCCChhhEEEe---cCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999994   344  89999999998765432211   112345679999999999976  668999


Q ss_pred             hHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015592          194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF  273 (404)
Q Consensus       194 sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l  273 (404)
                      +|||||||++|||++|+.||.+...   .+....+......... .....+++++.++|.+||+.||++||++.++   |
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l  329 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRA---L  329 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---H
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHH---h
Confidence            9999999999999999999987443   3444444443332222 2224578999999999999999999998766   4


Q ss_pred             HHHHHH
Q 015592          274 RDLFIR  279 (404)
Q Consensus       274 ~~~~~~  279 (404)
                      ++.+.+
T Consensus       330 ~hp~~~  335 (345)
T 3hko_A          330 QHPWIS  335 (345)
T ss_dssp             HSHHHH
T ss_pred             cChhhc
Confidence            455544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-45  Score=340.26  Aligned_cols=253  Identities=19%  Similarity=0.263  Sum_probs=202.3

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCC-------cEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      .+..++|++.+.||+|+||.||+|++..++       +.||+|++....  ..+.+.+|+.+++.++|++++..+..+ .
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC-V   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-C
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-E
Confidence            456789999999999999999999998777       479999875432  235688999999999977777666554 4


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCe--------
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------  144 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~--------  144 (404)
                      .....+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.        
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~~  159 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPPF  159 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCCE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccce
Confidence            566778999999 7899999986555699999999999999999999999999999999999994   4444        


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCChH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKK  222 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg-~~Pf~~~~~~~~~  222 (404)
                      +||+|||++.......           ...||+.|+|||++.+ ..++.++|||||||++|||++| ..||.....   .
T Consensus       160 ~kl~Dfg~~~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~  225 (289)
T 4fvq_A          160 IKLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---Q  225 (289)
T ss_dssp             EEECCCCSCTTTSCHH-----------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H
T ss_pred             eeeccCcccccccCcc-----------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---H
Confidence            9999999997554321           3457899999999998 6699999999999999999995 455544222   1


Q ss_pred             HHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...... ...     ..++..+++++.+++.+||+.||++||++.++++.|++++..
T Consensus       226 ~~~~~~-~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          226 RKLQFY-EDR-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHH-HTT-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHHHh-hcc-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111111 111     122345688999999999999999999999999999887643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7e-45  Score=344.25  Aligned_cols=265  Identities=17%  Similarity=0.256  Sum_probs=207.5

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEE-----EcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      ..+..++|++.+.||+|+||.||+|+     +..+++.||||++.....   ...+.+|+.+++.++|++++..+..+ .
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-L  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-c
Confidence            34567899999999999999999999     556788999999864432   23578899999999877766665554 4


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEE
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY  146 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vk  146 (404)
                      .....+++|||+ +++|.+++....      ..+++.+++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            556679999999 889999998643      3489999999999999999999999999999999999996444566799


Q ss_pred             EEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 015592          147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~  225 (404)
                      |+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...   ....
T Consensus       184 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL  255 (327)
T ss_dssp             ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH
T ss_pred             ECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHH
Confidence            9999999765443221     12234567899999999998899999999999999999998 9999987432   3333


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..+......    ..+..+++.+.+++.+||+.||++||++.++++.|..+...
T Consensus       256 ~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          256 EFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            333333221    22356889999999999999999999999999999887643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-44  Score=342.24  Aligned_cols=255  Identities=22%  Similarity=0.239  Sum_probs=196.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++|++++..+.. .......++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV-CKKKKRWYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-EEETTEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEE-eecCCEEEE
Confidence            457899999999999999999999999999999987655433    236789999999997776665554 457778899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       102 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          102 VFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred             EEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence            99999 455555544 45679999999999999999999999999999999999999   67889999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh-------
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------  231 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------  231 (404)
                      ..       ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......       
T Consensus       178 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          178 GE-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cc-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            22       22345789999999999876 6899999999999999999999999875432222211111100       


Q ss_pred             ----------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 ----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                      ............+++++.+|+.+||+.||++||++.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                            0111222333467899999999999999999999987754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.6e-44  Score=336.65  Aligned_cols=253  Identities=19%  Similarity=0.269  Sum_probs=204.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEc-CCCcEEEEEEecCCC----CchhHHHHHHHHHHH---cCCCCCCceeEeee--
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLQYEAKLYKIL---QGGTGIPNLRWFGV--   73 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~~~~~i~~~~~~~~--   73 (404)
                      ...++|++.+.||+|+||.||+|++. .+++.||||++....    ....+.+|+.+++.+   +|++++..+..+..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45688999999999999999999995 678999999875432    234688999999888   56666666655542  


Q ss_pred             --eCCeEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           74 --EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        74 --~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                        .....+++|||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df  164 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF  164 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence              456789999999899999998643 349999999999999999999999999999999999999   67889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      |+++......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...   ...+..+..
T Consensus       165 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~  233 (326)
T 1blx_A          165 GLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD  233 (326)
T ss_dssp             CSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred             cccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence            9998665332        12356789999999999999999999999999999999999999987543   222333221


Q ss_pred             hc----------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          231 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       231 ~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..                      .......+...++.++.+|+.+||+.||++||++.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  295 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  295 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            10                      01122344467899999999999999999999988664

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=346.29  Aligned_cols=258  Identities=17%  Similarity=0.213  Sum_probs=201.3

Q ss_pred             cCCceEEeeeeceeCceeEEEE-----EEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC--CCCCCceeEeeeeCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~   77 (404)
                      -.++|++.++||+|+||.||+|     .+..+++.||||++... ....+..|+++++.+++  ++++..+..+....+.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            3578999999999999999999     46778999999998654 45578899999999873  2334444455556677


Q ss_pred             EEEEEecc-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC--------CCCCCe
Q 015592           78 NVLVIDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQ  144 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~--------~~~~~~  144 (404)
                      .+++|||+ +++|.++++.    ....+++..++.|+.||+.||+|||++|||||||||+|||++.        ++..+.
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence            89999999 8999999975    2456999999999999999999999999999999999999942        111789


Q ss_pred             EEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 015592          145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (404)
Q Consensus       145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~  224 (404)
                      +||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||........   
T Consensus       222 ~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             EEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence            9999999997654322111     22456799999999999999999999999999999999999999965332110   


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCC-CCHHHHHHHHHHHHHHc
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-P~~~~l~~~l~~~~~~~  280 (404)
                             .........  ..++.+.+++..||+.+|.+| |+++++.+.|++.+...
T Consensus       294 -------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 -------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             -------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                   000111111  246789999999999999998 67889999999988764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6e-45  Score=334.74  Aligned_cols=250  Identities=11%  Similarity=0.171  Sum_probs=205.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeee-CCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~~~   79 (404)
                      ..++|++.+.||+|+||.||+|++  +++.||||++......    +.+.+|+.+++.++|++++..+..+... ....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            457899999999999999999997  4889999998765432    3588899999999988877777665443 36789


Q ss_pred             EEEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ++|||+ +++|.+++..... .+++.+++.++.||+.||.|||++|  |+||||||+|||+   +.++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccceee
Confidence            999999 7899999985433 4899999999999999999999999  9999999999999   6788999999998764


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      ...            ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.+...   ......+....
T Consensus       163 ~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~  227 (271)
T 3kmu_A          163 FQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEG  227 (271)
T ss_dssp             TSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSC
T ss_pred             ecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcC
Confidence            322            2457899999999998866544   89999999999999999999987543   33333333222


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..   ..++..+|+++.+++..||+.||++||++.++.+.|+++.
T Consensus       228 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 LR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            22   2234578999999999999999999999999999998763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-44  Score=343.04  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=209.9

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      +...++|++.+.||+|+||.||++++..+++.||+|++.....     .+.+.+|+.+++.++|++++..+.. ......
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~  115 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDF  115 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-EecCCe
Confidence            4567899999999999999999999999999999998765422     2457889999999988776665554 456678


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceec
Confidence            89999999 7899999875 4579999999999999999999999999999999999999   57889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .....       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ..+.+..+.....   
T Consensus       192 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~---  258 (335)
T 2owb_A          192 EYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEY---  258 (335)
T ss_dssp             CSTTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCC---
T ss_pred             ccCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCC---
Confidence            54322       2234678999999999999999999999999999999999999998743   2333443333322   


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                        .++..+++++.++|.+||+.||++||++.+++   ++.+...
T Consensus       259 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell---~~~~~~~  297 (335)
T 2owb_A          259 --SIPKHINPVAASLIQKMLQTDPTARPTINELL---NDEFFTS  297 (335)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG---GSHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHccCChhHCcCHHHHh---cCccccC
Confidence              12346789999999999999999999988664   4444443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-45  Score=355.76  Aligned_cols=251  Identities=15%  Similarity=0.137  Sum_probs=187.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCcee-------Eee
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLR-------WFG   72 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~--~~~~i~~~~-------~~~   72 (404)
                      .+|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|+.+++.|+  |++++..+.       .+.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            359999999999999999999999999999999887543     234678877777776  666555332       111


Q ss_pred             eeC----------------CeEEEEEeccCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccCC
Q 015592           73 VEG----------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK  130 (404)
Q Consensus        73 ~~~----------------~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~givHrDlK  130 (404)
                      ..+                ...+++|||++++|.+++...+..+++...      +.++.||+.||+|||++||+|||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            111                347999999999999999865555666666      7788999999999999999999999


Q ss_pred             CCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHc
Q 015592          131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR  208 (404)
Q Consensus       131 p~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~ellt  208 (404)
                      |+|||+   +.++.+||+|||+++......          ....+|+.|+|||++.+  ..++.++|||||||+||||++
T Consensus       222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            999999   678899999999998664322          13456799999999987  679999999999999999999


Q ss_pred             CCCCCCCCCCCChHHHHHHHh--hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          209 GSLPWQGLKAGTKKQKYEKIS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       209 g~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      |+.||.+....... .+....  ..............+|+++.+||.+||+.||++||++.++++
T Consensus       289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999876432111 000000  000001111123478999999999999999999999987753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-44  Score=344.66  Aligned_cols=252  Identities=17%  Similarity=0.181  Sum_probs=196.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-------------hhHHHHHHHHHHHcCCCCCCceeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLQYEAKLYKILQGGTGIPNLRW   70 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~E~~~l~~l~~~~~i~~~~~   70 (404)
                      .+.++|++.+.||+|+||.||+|++. +++.||||++......             +.+.+|+.+++.++|++++..+..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            35789999999999999999999974 4999999987543221             568899999999998888888776


Q ss_pred             eee----eCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEE
Q 015592           71 FGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY  146 (404)
Q Consensus        71 ~~~----~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vk  146 (404)
                      +..    .....+++|||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k  174 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT  174 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence            643    234689999999999999998655679999999999999999999999999999999999999   6788999


Q ss_pred             EEecCCcccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 015592          147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~  225 (404)
                      |+|||+++.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....   ..+
T Consensus       175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~  243 (362)
T 3pg1_A          175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL  243 (362)
T ss_dssp             ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred             EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence            999999975444321        234578999999999987 66899999999999999999999999875432   222


Q ss_pred             HHHhhhcc---------------------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          226 EKISEKKV---------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       226 ~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..+.....                           ..........+++.+.+||.+||+.||++|||+.+++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            22221111                           1112234456788999999999999999999987664

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-44  Score=339.02  Aligned_cols=250  Identities=18%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeee--CCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE--GDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~   82 (404)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++. .....+.+|+.+++.+++|++|..+..+...  ....+++|
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            35789999999999999999999999999999999864 3456799999999999855555555444444  66789999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++  .+...+||+|||+++.......
T Consensus       113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC
T ss_pred             eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc
Confidence            999 789988875    389999999999999999999999999999999999994  2344899999999986654332


Q ss_pred             cccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc----
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS----  236 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----  236 (404)
                              .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ....+..+........    
T Consensus       187 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          187 --------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             --------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHH
T ss_pred             --------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhH
Confidence                    234578999999999987 5689999999999999999999999965332  1111111111000000    


Q ss_pred             -----------H-----------------hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 -----------I-----------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 -----------~-----------------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                 .                 ......+++++.+||.+||+.||++|||++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                       0                 0011226899999999999999999999887654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-44  Score=332.60  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ....++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+.. ......
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~   83 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-FHDATR   83 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE-EECSSE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe-EecCCE
Confidence            34568899999999999999999999999999999987532     234568899999999997776665554 456678


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence            89999999 78999999753 569999999999999999999999999999999999999   68889999999998654


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      ....         .....||+.|+|||++.+..++.++||||||+++|+|++|..||....   ....+..+......  
T Consensus       160 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--  225 (279)
T 3fdn_A          160 PSSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT--  225 (279)
T ss_dssp             -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred             Cccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC--
Confidence            4322         234578999999999999999999999999999999999999998743   33344444333222  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         ++..+++++.+++.+||+.||++||++.++++
T Consensus       226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               23457899999999999999999999876654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.2e-44  Score=333.71  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=207.7

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCC
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD   76 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   76 (404)
                      ++...++|++.+.||+|+||.||+|++..+++.||+|++.....     .+.+.+|+.+++.++|++++..+.. .....
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~   88 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDND   88 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE-EECSS
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee-eccCC
Confidence            45678899999999999999999999999999999998765432     2357889999999987776665554 45677


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++.. ...+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK  164 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCcee
Confidence            889999999 7899999875 4579999999999999999999999999999999999999   6788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....   ..+.+..+.....  
T Consensus       165 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~--  232 (294)
T 2rku_A          165 VEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEY--  232 (294)
T ss_dssp             CCSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCC--
T ss_pred             cccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccC--
Confidence            654322       2234578999999999999889999999999999999999999998743   2333444333322  


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         .++..+++++.+++.+||+.||++||++.++++
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               233567899999999999999999999887654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.6e-45  Score=336.32  Aligned_cols=252  Identities=21%  Similarity=0.244  Sum_probs=205.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEee-eeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++......    +.+.+|+.+++.++|++++..+..+. ......
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            3467999999999999999999999999999999998755432    34789999999999888887776553 356788


Q ss_pred             EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcccccCCCCCCeEEEEe
Q 015592           79 VLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      +++|||+ +++|.+++...   ...+++..++.++.|++.||+|||++|     |+||||||+|||+   +.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            9999999 67999999743   234999999999999999999999999     9999999999999   6788999999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      ||+++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....   .......+.
T Consensus       160 fg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~  229 (279)
T 2w5a_A          160 FGLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIR  229 (279)
T ss_dssp             CCHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred             Cchheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHh
Confidence            999986654321       1123468999999999999999999999999999999999999998753   233344444


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL  272 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~  272 (404)
                      .....    .++..+++++.+++.+||+.||++||++.+|++.
T Consensus       230 ~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (279)
T 2w5a_A          230 EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  268 (279)
T ss_dssp             HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            33322    2345689999999999999999999998877653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=339.04  Aligned_cols=252  Identities=20%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc-CCCCCCceeEeeee-----CC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ-GGTGIPNLRWFGVE-----GD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~-----~~   76 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+. |++++..+..+...     ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            35688999999999999999999999999999999886543 4567899999999995 55555555554432     46


Q ss_pred             eEEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ..+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence            789999999 67999999854 2469999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      .......       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+...   ......+.
T Consensus       178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~  247 (326)
T 2x7f_A          178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP  247 (326)
T ss_dssp             --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred             ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence            6654321       123457899999999997     55689999999999999999999999977432   22222232


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......   .....+++.+.++|.+||..||++||++.++++
T Consensus       248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            222111   123467899999999999999999999887654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.4e-45  Score=345.55  Aligned_cols=265  Identities=17%  Similarity=0.223  Sum_probs=209.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++.....  .+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  114 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIY  114 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-CCTTCCEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCeEEEEE
Confidence            468899999999999999999996 5789999998765433  34688999999999987776666554 4566789999


Q ss_pred             ecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ||+ +++|.+++....   ..+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence            999 789999986432   258999999999999999999999999999999999999   6889999999999986543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH----hhhccc
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKVS  234 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~  234 (404)
                      ....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.............    ......
T Consensus       192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            2211     1223456899999999999889999999999999999999999999875543322211111    111110


Q ss_pred             c-----cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          235 T-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       235 ~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .     ....+...++.++.+++.+||+.||++||++.++++.|+.++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            0     01112233567899999999999999999999999999988753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-44  Score=336.32  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=205.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ..+.|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++|++++..+.. .......+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS-YLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE-EEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE-EecCCeEEEE
Confidence            45679999999999999999999999999999999875432   3568899999999987766665554 4566788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred             EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence            9999 779999987  4679999999999999999999999999999999999999   578899999999998765433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ......+.....    ..+
T Consensus       174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~  239 (303)
T 3a7i_A          174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNP----PTL  239 (303)
T ss_dssp             C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC----CCC
T ss_pred             c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCC----CCC
Confidence            2       22356789999999999999999999999999999999999999987433   222223222221    223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...++.++.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            4578999999999999999999999987755

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=336.18  Aligned_cols=247  Identities=23%  Similarity=0.315  Sum_probs=182.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+.. .......++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEE-EECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEE-EccCCeEEE
Confidence            46799999999999999999999999999999987542     233568899999999998776666554 456678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence            99999 789999998655679999999999999999999999999999999999999   67889999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+.....     .
T Consensus       166 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----~  230 (278)
T 3cok_A          166 HE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADY-----E  230 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----C
T ss_pred             CC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhccc-----C
Confidence            22       1234578999999999999889999999999999999999999998754322   1222211111     2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .+..++.++.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            23467899999999999999999999887653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.8e-44  Score=332.29  Aligned_cols=252  Identities=17%  Similarity=0.199  Sum_probs=205.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-----------chhHHHHHHHHHHHcCCCCCCceeEee
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFG   72 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~   72 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....           .+.+.+|+.+++++.+|+++..+..+.
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            356899999999999999999999999999999999865431           234778999999997555555555566


Q ss_pred             eeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           73 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        73 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      ......+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence            7778899999999 7899999985 4579999999999999999999999999999999999999   678899999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCcccccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~  225 (404)
                      ++........        .....||+.|+|||++.      ...++.++|||||||++|+|++|..||.+..   .....
T Consensus       170 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~  238 (298)
T 1phk_A          170 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML  238 (298)
T ss_dssp             TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred             chhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH
Confidence            9987654321        23457899999999985      4568999999999999999999999998743   33334


Q ss_pred             HHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+......... .....++.++.+++.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            444443332222 222467899999999999999999999887653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=368.50  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=211.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      ..++|++.++||+|+||.||+|++.. +..||||+++.... .+.+.+|+++++.++|++++..+..+..  ...+++||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeee
Confidence            35679999999999999999999854 56799999876543 4579999999999999888887766543  56789999


Q ss_pred             cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |+ +++|.+++... ...+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCce
Confidence            99 78999999743 3569999999999999999999999999999999999999   5788999999999987654221


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                            .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+...   .+.+..+......    ..
T Consensus       419 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~  485 (535)
T 2h8h_A          419 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PC  485 (535)
T ss_dssp             ------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred             ------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence                  12234457889999999998899999999999999999999 9999987543   3333333332211    22


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+|+++.+||.+||+.||++||++.+|.+.|++++..
T Consensus       486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            357899999999999999999999999999999887643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-44  Score=343.22  Aligned_cols=255  Identities=16%  Similarity=0.213  Sum_probs=174.6

Q ss_pred             ccCCceEEee-eeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHH-HHHHcCCCCCCceeEeeee---CCeE
Q 015592            4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKL-YKILQGGTGIPNLRWFGVE---GDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~---~~~~   78 (404)
                      .+.++|++.+ .||+|+||.||+|++..+++.||||++...   .....|+.. ++.++|++++..+..+...   ....
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4678999965 699999999999999999999999998642   334444444 4555666666666555432   4558


Q ss_pred             EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      +++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            9999999 779999998543 36999999999999999999999999999999999999965445677999999999865


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH-HHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~  235 (404)
                      ....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... ..+.......
T Consensus       182 ~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
T 3fhr_A          182 TQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF  252 (336)
T ss_dssp             -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred             cccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence            5332         23457899999999998888999999999999999999999999775443221111 1111111111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       .......+++++.+|+.+||+.||++||++.++++
T Consensus       253 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          253 -PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             11122468999999999999999999999886654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-45  Score=353.71  Aligned_cols=263  Identities=18%  Similarity=0.219  Sum_probs=190.6

Q ss_pred             ccCCceEE-eeeeceeCceeEEEEEEc--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee-eCCeEE
Q 015592            4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~   79 (404)
                      .+.+.|++ +++||+|+||.||+|++.  .+++.||||++........+.+|+.+++.++|++++..+..+.. .....+
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            45567888 568999999999999975  57899999999877777789999999999998888888776643 467889


Q ss_pred             EEEeccCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCCeEEEEec
Q 015592           80 LVIDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDF  150 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~-~~~~~vkL~DF  150 (404)
                      ++|||++++|.+++....        ..+++..++.|+.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            999999999999886321        249999999999999999999999999999999999999533 35689999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC------hHH
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQ  223 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~------~~~  223 (404)
                      |+++.+......    ........||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....      ...
T Consensus       177 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          177 GFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             CCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999876543211    1123456899999999999875 48999999999999999999999997644310      111


Q ss_pred             HHHHHhhhccccc---------------------------------HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          224 KYEKISEKKVSTS---------------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       224 ~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+..+......+.                                 ........++++.+||.+||..||.+|||+++++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            2222211100000                                 0000112367899999999999999999987654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7e-44  Score=331.53  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=204.1

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeee---eCCe
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV---EGDY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~---~~~~   77 (404)
                      -++.|++.+.||+|+||.||+|.+..++..||+|++......    ..+.+|+.+++.++|++++..+..+..   ....
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            356799999999999999999999999999999987654322    347889999999998888887766544   2466


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      .+++|||+ +++|.+++.. ...+++..++.|+.||+.||.|||++|  |+||||||+|||++  +.++.+||+|||++.
T Consensus       104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence            89999999 8899999985 356999999999999999999999999  99999999999994  367899999999997


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ......         .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...  ....+..+......
T Consensus       181 ~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~  248 (290)
T 1t4h_A          181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP  248 (290)
T ss_dssp             GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC
T ss_pred             cccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc
Confidence            544332         234578999999999875 599999999999999999999999987433  23333333333222


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         ..+...+++++.+++.+||+.||++||++.++++
T Consensus       249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               2344567899999999999999999999887754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=341.73  Aligned_cols=269  Identities=19%  Similarity=0.198  Sum_probs=210.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEE----cCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeee-CC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~   76 (404)
                      ...++|++.+.||+|+||.||+|++    ..+++.||||++.....  ...+.+|+.+++.++|++++..+..+... ..
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4567799999999999999999984    56899999999876433  23588999999999988888777665443 34


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcchhh
Confidence            678999999 789999998766679999999999999999999999999999999999999   5788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---------CChHHHHH
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA---------GTKKQKYE  226 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~---------~~~~~~~~  226 (404)
                      ........    .......++..|+|||++.+..++.++|||||||++|||++|..||.....         ........
T Consensus       195 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          195 LPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             cccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            65543211    112344678889999999988899999999999999999999999864210         00000000


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+............+..+|+++.+++.+||+.||++||++.+|.+.|+++...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11110000001122356899999999999999999999999999999988653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-44  Score=349.09  Aligned_cols=254  Identities=18%  Similarity=0.230  Sum_probs=196.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeC-----CeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----DYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----~~~~   79 (404)
                      ...+|++.+.||+|+||.||+|++..+++ ||+|.+.....  ...+|+++++.++|++++..+..+...+     .+.+
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            45689999999999999999999876666 88886644322  2347999999999988888877664433     3478


Q ss_pred             EEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           80 LVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ++|||+.+++.+.+..   ....+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+|||+++.+
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccc
Confidence            9999998877766542   256799999999999999999999999999999999999993  26889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---  232 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---  232 (404)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.+.....   
T Consensus       193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          193 IAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            54332        2356789999999999775 48999999999999999999999998854322222222111000   


Q ss_pred             ------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 ------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                        .......+...+++++.+||.+||+.||++||++.++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                              000111223357899999999999999999999876643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.2e-44  Score=336.78  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=196.8

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~   78 (404)
                      +.+++|++.+.||+|+||.||+|++ .+++.||||++......    ..+.+|+.+++.++| ++++..+..+.......
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            4567899999999999999999997 45899999998765433    457899999999986 56666666667778889


Q ss_pred             EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      +++||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++....
T Consensus       104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC---
T ss_pred             EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccC
Confidence            99999889999999985 56799999999999999999999999999999999999993    48899999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~  227 (404)
                      .....     ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....  ....+..
T Consensus       179 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~  251 (313)
T 3cek_A          179 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA  251 (313)
T ss_dssp             ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred             ccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHH
Confidence            32211     1234578999999999876           4688999999999999999999999976432  2222222


Q ss_pred             HhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      +......   ..++..++.++.+++.+||+.||++||++.++++
T Consensus       252 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2222111   1233456889999999999999999999876643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-44  Score=341.18  Aligned_cols=268  Identities=19%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHH--cCCCCCCceeEeeeeC---CeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL--QGGTGIPNLRWFGVEG---DYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l--~~~~~i~~~~~~~~~~---~~~   78 (404)
                      .+.++|++.+.||+|+||.||+|++  +++.||||++... .......|.+++..+  +|++++..+..+....   ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            4567899999999999999999997  4899999987543 233455666666554  6666666655544332   678


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcccccCCCCCCeEEEEe
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                      +++|||+ +++|.++++.  ..+++..++.++.|++.||.|||++        ||+||||||+|||+   +.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEe
Confidence            9999999 7899999974  4699999999999999999999998        99999999999999   5788999999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCC
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPW  213 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDiwSlG~il~elltg----------~~Pf  213 (404)
                      ||+++.+.........   ......||+.|+|||++.+..++.+      +|||||||++|||++|          +.||
T Consensus       186 fg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             CTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             CCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999876554322111   1235679999999999988776654      9999999999999999          7888


Q ss_pred             CCCCCCCh-HHHHHH-HhhhcccccHhH--hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015592          214 QGLKAGTK-KQKYEK-ISEKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF  282 (404)
Q Consensus       214 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  282 (404)
                      ........ ...... +.........+.  ....+++++.+++.+||+.||++||++.++++.|+++......
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  335 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI  335 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence            76543332 122222 222221111111  1224678899999999999999999999999999999876543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-44  Score=334.03  Aligned_cols=251  Identities=18%  Similarity=0.267  Sum_probs=185.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchh---HH-HHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LQ-YEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~-~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +..++|++.+.||+|+||.||+|++..+++.||||++........   .. .+...++.++|++++..+ .+.......+
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~-~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY-GALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEE-EEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEe-eeeeccCCEE
Confidence            456889999999999999999999999999999998875533322   22 333345555655555544 4445667789


Q ss_pred             EEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           80 LVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        80 lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ++|||++++|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||+++.
T Consensus        83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred             EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence            9999998899888764   356799999999999999999999998 99999999999999   5788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ......        .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.....  ....+......
T Consensus       160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~  229 (290)
T 3fme_A          160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEE  229 (290)
T ss_dssp             ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHS
T ss_pred             cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhcc
Confidence            655332        2344789999999996    556689999999999999999999999976432  22223333222


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....   .....+++++.+++.+||+.||++||++.++++
T Consensus       230 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PSPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            2211   112467899999999999999999999988765

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9e-46  Score=357.40  Aligned_cols=239  Identities=13%  Similarity=0.099  Sum_probs=185.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHH---cCCCCCCce-------eE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKIL---QGGTGIPNL-------RW   70 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l---~~~~~i~~~-------~~   70 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++....     ..+.+.+|+.+++.+   +|++++..+       ..
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            578999999999999999999998999999999976432     235588999555544   566665554       22


Q ss_pred             eeeeCC----------------eEEEEEeccCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceec
Q 015592           71 FGVEGD----------------YNVLVIDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR  127 (404)
Q Consensus        71 ~~~~~~----------------~~~lv~e~~~~sL~~~l~~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~givHr  127 (404)
                      +...+.                ..+++|||++++|.+++... +.++       +..++.|+.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            221111                37899999999999999853 2243       48888999999999999999999999


Q ss_pred             cCCCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCC-----------CCCchhHH
Q 015592          128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL  196 (404)
Q Consensus       128 DlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDi  196 (404)
                      ||||+|||+   +.++.+||+|||+++.....          .....| +.|+|||++.+.           .++.++||
T Consensus       231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            999999999   57889999999999854331          124567 999999999987           79999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       197 wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      |||||+||||++|+.||.+.......            ..+......+|+++.++|.+||+.||++||++.++++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGS------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCS------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHHHHHCCCCCcccccccch------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999999999764432111            1111122578999999999999999999999998865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.3e-44  Score=330.03  Aligned_cols=246  Identities=18%  Similarity=0.261  Sum_probs=204.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||||++..     ......+.+|+.+++.++|++++..+.. .......
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY-FHDRKRI   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE-EEcCCEE
Confidence            445789999999999999999999999999999998753     2234568899999999997776665554 4566788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred             EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence            9999999 7799999985 3569999999999999999999999999999999999999   578899999999987554


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ...         .....||+.|+|||++.+..++.++||||||+++|+|++|..||....   .......+.....    
T Consensus       166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~----  229 (284)
T 2vgo_A          166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDL----  229 (284)
T ss_dssp             SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCC----
T ss_pred             ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhcccc----
Confidence            321         234578999999999999999999999999999999999999998743   2333333333222    


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       .++..++.++.++|.+||+.||++||++.++++
T Consensus       230 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 -KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence             233567899999999999999999999887654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-44  Score=370.04  Aligned_cols=251  Identities=20%  Similarity=0.347  Sum_probs=202.1

Q ss_pred             eeeeceeCceeEEEEEE--cCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592           12 GRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      .++||+|+||.||+|.+  ..+++.||||+++....    .+.+.+|+++++.++|++++..+..+.  ....+++|||+
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~lv~E~~  451 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMA  451 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEEEcc
Confidence            34899999999999965  45678999999875432    346899999999999888888777663  34578999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+......  
T Consensus       452 ~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~--  525 (635)
T 4fl3_A          452 ELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY--  525 (635)
T ss_dssp             TTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC------
T ss_pred             CCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccc--
Confidence             8899999974 5679999999999999999999999999999999999999   57889999999999876543321  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                        +.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+...   .+....+.....    ...+..
T Consensus       526 --~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~----~~~p~~  596 (635)
T 4fl3_A          526 --YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER----MGCPAG  596 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCCCTT
T ss_pred             --cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCCC
Confidence              112234457889999999999999999999999999999998 9999988544   333333333322    123457


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +|+++.+||..||+.||++||++.+|.+.|++++..
T Consensus       597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            899999999999999999999999999999998854

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=334.83  Aligned_cols=252  Identities=17%  Similarity=0.281  Sum_probs=202.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCceeEee-eeCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFG-VEGD   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~   76 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++...      .....+.+|+.+++.++|++++..+..+. ....
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            3568999999999999999999999999999999987643      23356889999999999888887776653 4556


Q ss_pred             eEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ..+++|||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA  158 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence            78999999977788888753 4569999999999999999999999999999999999999   5788999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      ........     ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.+..   ..+.+..+.....
T Consensus       159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY  230 (305)
T ss_dssp             CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred             cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence            65432211     123456899999999998754  3789999999999999999999998743   3344444443322


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                           .++..+++++.+++.+||+.||++||++.++++
T Consensus       231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 234568899999999999999999999886653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.5e-44  Score=343.97  Aligned_cols=252  Identities=18%  Similarity=0.258  Sum_probs=201.5

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+|+.+++.++|++++..+.. .......+
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA-FYSDGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEE-EEETTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEE-EEECCEEE
Confidence            4567899999999999999999999999999999999876533   2457899999999987776666554 45677889


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+ +++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||+   +.++.+||+|||++....
T Consensus       108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred             EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcccc
Confidence            999999 7899999985 35699999999999999999999996 99999999999999   578899999999997654


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHH-------------
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-------------  224 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~-------------  224 (404)
                      ...         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........             
T Consensus       184 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          184 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             HHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             ccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence            322         2345789999999999999999999999999999999999999987443211111             


Q ss_pred             --------------------------HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          225 --------------------------YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       225 --------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                ...+.......   .....++.++.+||.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                      11111111000   011246889999999999999999999887654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.6e-44  Score=340.70  Aligned_cols=252  Identities=19%  Similarity=0.197  Sum_probs=189.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCCCCceeEeeeeC------CeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG------DYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~------~~~   78 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++... ........|++.+..++|++++..+..+...+      .+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            46899999999999999999999999999999977544 33456778888889999988888877765432      247


Q ss_pred             EEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           79 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      +++|||+.++|.+.+..   ....+++..+..++.|++.||.|||  ++||+||||||+|||++  ..++.+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence            89999998888776653   2456899999999999999999999  99999999999999994  23789999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      +.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....   ..+..+....
T Consensus       180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~  248 (360)
T 3e3p_A          180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVL  248 (360)
T ss_dssp             BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred             eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHc
Confidence            87665432        23557899999999997655 899999999999999999999999885432   2233322211


Q ss_pred             cccc-----------------------Hh----HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 VSTS-----------------------IE----ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ~~~~-----------------------~~----~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ....                       ..    .....+++++.+||.+||+.||++|||+.+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  313 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL  313 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence            1110                       00    11112578999999999999999999987664

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-44  Score=331.02  Aligned_cols=256  Identities=24%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      |...+.++|++.+.||+|+||.||+|++..+++.||||++.....   .+.+.+|+.+++.++|++++..+. +......
T Consensus         1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~   79 (276)
T 2yex_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNI   79 (276)
T ss_dssp             -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEE-EEEETTE
T ss_pred             CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeee-EEEcCCE
Confidence            445567899999999999999999999999999999998764432   356889999999998777666555 4556778


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||++..+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence            89999999 6799998863 4569999999999999999999999999999999999999   57889999999999866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ......     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........  .+..+...... 
T Consensus       156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-  227 (276)
T 2yex_A          156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTY-  227 (276)
T ss_dssp             EETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTT-
T ss_pred             CCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhcccc-
Confidence            543211     12235678999999999988775 7899999999999999999999987544322  22222222111 


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                        ......+++++.+++.+||+.||++||++.++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              1112467899999999999999999999887653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-44  Score=335.01  Aligned_cols=260  Identities=22%  Similarity=0.257  Sum_probs=200.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcC-CCc--EEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNE--EVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      +..++|++.+.||+|+||.||+|++.. +++  .||||+++...     ..+.+.+|+++++.++|++++..+..+....
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            345789999999999999999998643 333  68999876432     2345889999999999888777776664433


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                        .+++||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        95 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 --MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMR  169 (291)
T ss_dssp             --CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCE
T ss_pred             --ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccc
Confidence              67889998 789999998666679999999999999999999999999999999999999   578899999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .........    .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+...   .+.+..+.....
T Consensus       170 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~  242 (291)
T 1u46_A          170 ALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGE  242 (291)
T ss_dssp             ECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCC
T ss_pred             cccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCC
Confidence            765433211    11234567889999999998889999999999999999999 9999987543   333444433222


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ..   .....+|.++.+++.+||+.||++||++.++.+.|+++..
T Consensus       243 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 RL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            21   2235689999999999999999999999999999987743

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.8e-44  Score=334.34  Aligned_cols=252  Identities=20%  Similarity=0.309  Sum_probs=200.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+|+.+++.++|++++..+..+. .....+++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv   94 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-HDGKLWIM   94 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CC-CEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-eCCeEEEE
Confidence            45688999999999999999999999999999999876543  3456889999999998877776665554 45678999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence            9999 789999988767789999999999999999999999999999999999999   578899999999986433221


Q ss_pred             CcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.....   ...+..+.......
T Consensus       172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~  241 (302)
T 2j7t_A          172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT  241 (302)
T ss_dssp             H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred             c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence            1       123457899999999984     66789999999999999999999999987443   23333333322211


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                        ......++.++.+++.+||+.||++||++.++++
T Consensus       242 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 --LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              1123457899999999999999999999887643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-44  Score=341.29  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=208.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCceeEeeeeC---CeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEG---DYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~~~~~---~~~~   79 (404)
                      +.++|++.+.||+|+||.||+|++  +++.||||++... ....+.+|.+++..  ++|++++..+..+....   ...+
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            457899999999999999999997  5899999998643 34567889999988  67777776666554443   2789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      ++|||+ +++|.++++.  ..+++.+++.++.|++.||.|||        ++||+||||||+|||+   +.++.+||+||
T Consensus       117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df  191 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL  191 (342)
T ss_dssp             EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCC
T ss_pred             EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEEC
Confidence            999999 7799999984  46999999999999999999999        8999999999999999   67889999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCC------CCchhHHHHHHHHHHHHHcC----------CCCCC
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPWQ  214 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~il~elltg----------~~Pf~  214 (404)
                      |++............   ......||+.|+|||++.+..      ++.++|||||||++|||++|          ..||.
T Consensus       192 g~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          192 GLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             TTCEEEETTTTEEEE---CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             CCceecccccccccc---ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            999876554321110   124557999999999998763      34789999999999999999          88997


Q ss_pred             CCCCCC--hHHHHHHHhhhcccccHhHh--hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015592          215 GLKAGT--KKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF  282 (404)
Q Consensus       215 ~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  282 (404)
                      ......  .......+.........+..  ...+++.+.+++.+||+.||++||++.++++.|+++..+.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence            754332  22333333333322222211  123457899999999999999999999999999999876553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-43  Score=326.33  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=197.1

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .+..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++|++++..+.. ......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~   85 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV-ISTPTD   85 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE-EecCCe
Confidence            34568999999999999999999999989999999987542     234568899999999997776666554 456678


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCC
T ss_pred             EEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeeccccccc
Confidence            89999999 7899999975 3569999999999999999999999999999999999999   67889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .....        .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+..   ....+..+.....  
T Consensus       162 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~--  228 (276)
T 2h6d_A          162 SDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVF--  228 (276)
T ss_dssp             CC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC--
T ss_pred             CCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCcc--
Confidence            54321        234578999999999998775 689999999999999999999997743   3333444333221  


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                         .++..++.++.+++.+||+.||++||++.++++
T Consensus       229 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 ---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               123467899999999999999999999887654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.3e-44  Score=337.34  Aligned_cols=243  Identities=24%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCceeEeee
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQG-GTGIPNLRWFGV   73 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~   73 (404)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++....        ....+.+|+.+++.+++ ++++..+..+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            357889999999999999999999999999999999876542        23457889999999985 455555655666


Q ss_pred             eCCeEEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           74 EGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        74 ~~~~~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      .....+++||++.  ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+|||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg  195 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFG  195 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCT
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCc
Confidence            7778899999983  899999985 45799999999999999999999999999999999999993  267899999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      +++......         .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....         .+..
T Consensus       196 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~  257 (320)
T 3a99_A          196 SGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR  257 (320)
T ss_dssp             TCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH
T ss_pred             ccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc
Confidence            998765432         234578999999999987765 789999999999999999999997521         1111


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...     .+...+++++.+++.+||+.||++||++.+|++
T Consensus       258 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111     123568999999999999999999999887754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=340.48  Aligned_cols=264  Identities=16%  Similarity=0.194  Sum_probs=203.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeee---eCCeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~---~~~~~~   79 (404)
                      -.++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|+.+++.++|++++..+..+..   .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            4578999999999999999999999999999999875432  23458899999999998888888776653   234678


Q ss_pred             EEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           80 LVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ++|||+ +++|.+++...   ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchh
Confidence            999999 77999999753   4679999999999999999999999999999999999999   6788999999999876


Q ss_pred             ccccCCccc--ccccCCCCCccCcCccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh
Q 015592          156 YRDTATHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (404)
Q Consensus       156 ~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  230 (404)
                      .........  ..........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||......... ....+..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHHC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhhc
Confidence            543211000  0000011235799999999998655   689999999999999999999999642111100 0111111


Q ss_pred             hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                       ...   ......+++++.+++.+||+.||++||++.++++.|+.+
T Consensus       263 -~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          263 -QLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             -C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -cCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence             111   111246789999999999999999999999999998765

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.5e-44  Score=344.50  Aligned_cols=258  Identities=23%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc-----------CCCCCCceeE
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ-----------GGTGIPNLRW   70 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----------~~~~i~~~~~   70 (404)
                      +...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++           |++++..+..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            445689999999999999999999999999999999986433 2345788999999987           4556666555


Q ss_pred             eeeeC---CeEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCC---CCC
Q 015592           71 FGVEG---DYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRA  142 (404)
Q Consensus        71 ~~~~~---~~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~---~~~  142 (404)
                      +...+   ...+++||+++++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+   +..
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            54432   378999999999999999864 34599999999999999999999998 99999999999999422   234


Q ss_pred             CeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC--
Q 015592          143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--  220 (404)
Q Consensus       143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~--  220 (404)
                      +.+||+|||+++......          ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....  
T Consensus       175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence            489999999998665432          24578999999999999999999999999999999999999998654221  


Q ss_pred             -hHHHHHHHhhhcccccH------------------------------h-------HhhcCCcHHHHHHHHHHHcCCCCC
Q 015592          221 -KKQKYEKISEKKVSTSI------------------------------E-------ALCRGYPTEFASYFHYCRSLRFDD  262 (404)
Q Consensus       221 -~~~~~~~~~~~~~~~~~------------------------------~-------~~~~~~~~~l~~li~~cl~~~p~~  262 (404)
                       ....+..+.......+.                              .       .++..+++++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence             11112222111000000                              0       011234678999999999999999


Q ss_pred             CCCHHHHH
Q 015592          263 KPDYAYLK  270 (404)
Q Consensus       263 RP~~~~l~  270 (404)
                      ||++.+++
T Consensus       325 Rpt~~ell  332 (373)
T 1q8y_A          325 RADAGGLV  332 (373)
T ss_dssp             CBCHHHHH
T ss_pred             cCCHHHHh
Confidence            99988664

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-43  Score=327.91  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +.++|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|++++++++|++++..+.. .......++
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~l   98 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI-LEDSSSFYI   98 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE-EeCCCeEEE
Confidence            457899999999999999999999999999999987543    234568899999999987776666554 456678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +||++ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++......
T Consensus        99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99998 8899998874 357999999999999999999999999999999999999964444568999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+..   .......+.........+ 
T Consensus       178 ~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-  244 (287)
T 2wei_A          178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP-  244 (287)
T ss_dssp             SS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSG-
T ss_pred             Cc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCch-
Confidence            21        234468999999999876 48999999999999999999999998743   334444444443332222 


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....+++++.+++.+||+.||++||++.++++
T Consensus       245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            22568999999999999999999999887765

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=340.56  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=197.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeCC----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD----   76 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~----   76 (404)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++......    ..+.+|+.+++.++|++++..+..+.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            468899999999999999999999999999999998654332    357789999999998888887777655433    


Q ss_pred             -eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           77 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        77 -~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                       ..+++|||++++|.+++.   .++++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH  175 (353)
T ss_dssp             CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC
T ss_pred             eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccC
Confidence             359999999988887764   459999999999999999999999999999999999999   5788999999999986


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc--
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--  232 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--  232 (404)
                      ....          .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....   ..+..+....  
T Consensus       176 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~  242 (353)
T 3coi_A          176 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV  242 (353)
T ss_dssp             ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCB
T ss_pred             CCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence            5432          234578999999999987 67899999999999999999999999875432   2222221110  


Q ss_pred             ------------------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                              .......+...+++++.++|.+||+.||++||++.+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  304 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  304 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                                    01111223346789999999999999999999987664

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=341.94  Aligned_cols=268  Identities=16%  Similarity=0.214  Sum_probs=196.2

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHH--HHcCCCCCCceeEee----eeCCe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--ILQGGTGIPNLRWFG----VEGDY   77 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~--~l~~~~~i~~~~~~~----~~~~~   77 (404)
                      +-.++|++.+.||+|+||.||+|++  +++.||||++.... ...+..|.+++.  .++|++++..+..+.    .....
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            4468899999999999999999985  78999999986432 334455555543  477877777764332    23346


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcccccCCCCCCeEEE
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                      .+++|||+ +++|.+++..  ..+++..++.++.||+.||+|||++         ||+||||||+|||+   +.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence            78999999 8899999974  3469999999999999999999999         99999999999999   57889999


Q ss_pred             EecCCcccccccCCccc-ccccCCCCCccCcCccccccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 015592          148 IDFGLAKRYRDTATHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG  219 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~  219 (404)
                      +|||+++.+........ ..........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987654322110 00112235579999999999987       34678999999999999999997776442221


Q ss_pred             Ch--------------HHHHH-HHhhhcccccHhHhhc---CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          220 TK--------------KQKYE-KISEKKVSTSIEALCR---GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       220 ~~--------------~~~~~-~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ..              ..... .+.........+....   .+++++.++|.+||+.||++|||+.++++.|++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            10              00111 1111111111111111   1345899999999999999999999999999999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-44  Score=352.39  Aligned_cols=239  Identities=15%  Similarity=0.135  Sum_probs=187.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCC----------ceeEe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIP----------NLRWF   71 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~----------~~~~~   71 (404)
                      .+|++.+.||+|+||+||+|++..+++.||||++....     ..+.+.+|+.+++.++|..++.          .+...
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            35889999999999999999999999999999887332     2456889999999887633211          11110


Q ss_pred             -----------ee-----eCCeEEEEEeccCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 015592           72 -----------GV-----EGDYNVLVIDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI  129 (404)
Q Consensus        72 -----------~~-----~~~~~~lv~e~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl  129 (404)
                                 ..     .....+++|++++++|.++++..      ...+++..++.++.||+.||+|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                       01     12346888999999999999633      334788899999999999999999999999999


Q ss_pred             CCCcccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccc----------cCCCCCchhHHHHH
Q 015592          130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL  199 (404)
Q Consensus       130 Kp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDiwSl  199 (404)
                      ||+|||+   +.++.+||+|||+++.....          .....| +.|+|||++          .+..++.++|||||
T Consensus       238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence            9999999   67888999999999865543          134567 999999999          55568999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       200 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ||++|||++|+.||.+.......   .         ..-.....+|+++.+||.+||+.||++||++.++++
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~~---~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGGS---E---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSCS---G---------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCCCCCCCcchhhhH---H---------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999999875432111   1         111122468999999999999999999999877643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-43  Score=364.99  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=209.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC---CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..++|++.+.||+|+||.||+|++..+   +..||||.+......   +.+.+|+.+++.++|++++..+..+  .....
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~~~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCce
Confidence            356899999999999999999998653   467999987654332   4588999999999988888877665  33457


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeecC
Confidence            8999999 789999998666679999999999999999999999999999999999999   578899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .....      ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...   .+.+..+......  
T Consensus       543 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~--  611 (656)
T 2j0j_A          543 DSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL--  611 (656)
T ss_dssp             C----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCC--
T ss_pred             CCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence            43221      1234467889999999998899999999999999999997 9999987543   3333333333221  


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                        ..+..+|+++.+++.+||+.||++||++.+|.+.|++++..+
T Consensus       612 --~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          612 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence              234578999999999999999999999999999999998654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-44  Score=340.26  Aligned_cols=261  Identities=17%  Similarity=0.205  Sum_probs=201.8

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ...++|++.+.||+|+||.||+|++ .+++.||||++....   ....+.+|+.+++.++|++++..+..+ ......++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-CCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-ecCCceEE
Confidence            3568999999999999999999985 578999999876543   233689999999999987777766655 45566789


Q ss_pred             EEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           81 VIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      +|||+ +++|.+++....   ..+++..++.|+.|++.||+|||++   ||+||||||+|||+   +.++.+||+|||++
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA  181 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence            99999 889999998432   2499999999999999999999999   99999999999999   67889999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----CCCChHHHHHHH
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKI  228 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~~  228 (404)
                      +........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...     ............
T Consensus       182 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          182 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             EECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            876543321      123456999999999999888999999999999999999999999521     111111111111


Q ss_pred             hhhc-ccc-----cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          229 SEKK-VST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       229 ~~~~-~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      .... ...     .........+.++.+++.+||+.||++||++.+|++.|+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0000 000     0001112235789999999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-43  Score=330.13  Aligned_cols=259  Identities=19%  Similarity=0.206  Sum_probs=196.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeee---------
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGV---------   73 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~---------   73 (404)
                      ++.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++|++++..+..+..         
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            45678999999999999999999999999999999875432 23458899999999998888887765543         


Q ss_pred             ---eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           74 ---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        74 ---~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                         .....+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence               245789999999 789999998666678999999999999999999999999999999999999   6788999999


Q ss_pred             cCCcccccccCCccc-------ccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 015592          150 FGLAKRYRDTATHQH-------IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK  221 (404)
Q Consensus       150 FG~a~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~  221 (404)
                      ||+++..........       ..........||+.|+|||++.+. .++.++|||||||++|+|++   ||...  .+.
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence            999987653321000       000122355789999999999865 68999999999999999998   66431  111


Q ss_pred             HHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......+..... .....+...+++.+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 VNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            222333322211 1122344567788999999999999999999887754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-42  Score=325.33  Aligned_cols=257  Identities=25%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      |..++.||+|+||.||+|++  +++.||||++....      ..+.+.+|+.+++.++|++++..+..+ ......+++|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-ecCCceEEEE
Confidence            34458999999999999984  68899999876432      134588999999999987766665544 4566789999


Q ss_pred             ecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           83 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        83 e~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            999 89999999743  3469999999999999999999999999999999999999   67889999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc----
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----  235 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----  235 (404)
                      ....     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..........    
T Consensus       187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            2211     1234578999999999876 58999999999999999999999998765543322222211111000    


Q ss_pred             ---cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          236 ---SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       236 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                         ........++..+.+++.+||+.||.+||++.++.+.|+++.
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence               001111234578999999999999999999999999998863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=335.32  Aligned_cols=271  Identities=18%  Similarity=0.254  Sum_probs=199.9

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      +..++|++.+.||+|+||.||+|++..   .||+|+++...    ..+.+.+|+.+++.++|++++..+..+. .....+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-SPPHLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-CSSCEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-cCCceE
Confidence            346889999999999999999999743   49999876532    2345788999999999887776665554 556689


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   + ++.+||+|||+++....
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC----
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCcccccc
Confidence            999999 789999998655579999999999999999999999999999999999999   3 57899999999876543


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHh
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~  229 (404)
                      ......  ........||+.|+|||++.+         ..++.++|||||||++|||++|+.||.+...   ......+.
T Consensus       182 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~  256 (319)
T 2y4i_B          182 LQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMG  256 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHH
T ss_pred             cccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhc
Confidence            221110  112234568999999999875         3579999999999999999999999987433   33333333


Q ss_pred             hhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeec
Q 015592          230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW  290 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w  290 (404)
                      ......   .....+|.++.+++.+||+.||++||++.++.+.|+++..+..........|
T Consensus       257 ~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          257 TGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             TTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             cCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence            322211   1123578999999999999999999999999999998876655444444444

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.4e-44  Score=332.99  Aligned_cols=259  Identities=21%  Similarity=0.272  Sum_probs=183.4

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +..++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+|+.+++.++|++++..+..+ ......++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-VVKDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-ESSSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-eecCCcEE
Confidence            34678999999999999999999998899999999876432   345678899999999877766665544 45567899


Q ss_pred             EEecc-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           81 VIDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      +|||+ +++|.+++..       ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence            99999 8899999874       23459999999999999999999999999999999999999   5788999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      +...........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........   ......
T Consensus       168 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~  242 (303)
T 2vwi_A          168 SAFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQN  242 (303)
T ss_dssp             HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTS
T ss_pred             hheeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhcc
Confidence            976654321110  011234578999999999876 56899999999999999999999999875443222   111111


Q ss_pred             cccc-----cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ....     ........+++++.+++.+||+.||++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111     111223567899999999999999999999887754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=326.19  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=193.4

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS   88 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~s   88 (404)
                      ...||+|+||.||+|++..+++.||||++....  ..+.+.+|+.+++.++|++++..+..+ ......+++|||+ +++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-SENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEEEECCSEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-EeCCcEEEEEEeCCCCC
Confidence            348999999999999999999999999876543  245688999999999987777666554 5667889999999 889


Q ss_pred             HHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccccc
Q 015592           89 LEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP  166 (404)
Q Consensus        89 L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  166 (404)
                      |.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||++  ..++.+||+|||+++.......     
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~-----  178 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP-----  178 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-----
Confidence            9999986433  467999999999999999999999999999999999994  2378999999999987654321     


Q ss_pred             ccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          167 YRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                        ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......  ............   ...++..+
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---~~~~~~~~  251 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKV---HPEIPESM  251 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCC---CCCCCTTS
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhccccc---cccccccC
Confidence              123557899999999997654  899999999999999999999999764321  111111111111   12334578


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ++++.+++.+||+.||++||++.+++
T Consensus       252 ~~~~~~li~~~l~~dp~~Rps~~~ll  277 (295)
T 2clq_A          252 SAEAKAFILKCFEPDPDKRACANDLL  277 (295)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHh
Confidence            99999999999999999999988764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.1e-43  Score=332.05  Aligned_cols=253  Identities=15%  Similarity=0.275  Sum_probs=176.6

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHH-HHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++......   .++..|+. +++.++|++++..+ .+.......++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~-~~~~~~~~~~l   98 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY-GALFREGDCWI   98 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEE-EEEECSSEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeee-eEEEeCCceEE
Confidence            457899999999999999999999999999999998765432   23455555 44455555555544 44456678899


Q ss_pred             EEeccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           81 VIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        81 v~e~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      +|||+.++|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+|||+   +.++.+||+|||+++.
T Consensus        99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC
T ss_pred             EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCcee
Confidence            999998899988863    256799999999999999999999999 99999999999999   5789999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      ......        .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.+....  ...+..+...
T Consensus       176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  245 (327)
T 3aln_A          176 LVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKG  245 (327)
T ss_dssp             --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred             cccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcC
Confidence            654321        2234789999999998    4566899999999999999999999999864321  1111111111


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ............+++++.+++.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111122458899999999999999999999988755

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=327.85  Aligned_cols=241  Identities=22%  Similarity=0.331  Sum_probs=190.1

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHH----cCCCCCCceeEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKIL----QGGTGIPNLRWF   71 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l----~~~~~i~~~~~~   71 (404)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....        ...+.+|+.+++++    +|++++..+..+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            467889999999999999999999999999999999865432        23467899999999    566666555544


Q ss_pred             eeeCCeEEEEEec-c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEe
Q 015592           72 GVEGDYNVLVIDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID  149 (404)
Q Consensus        72 ~~~~~~~~lv~e~-~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~D  149 (404)
                       ......+++|++ + +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+||+|
T Consensus       108 -~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d  183 (312)
T 2iwi_A          108 -ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID  183 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred             -ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence             455667788887 4 8899999985 45699999999999999999999999999999999999993  2678999999


Q ss_pred             cCCcccccccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 015592          150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (404)
Q Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  228 (404)
                      ||+++......         .....||..|+|||++.+..+ +.++|||||||++|+|++|+.||...         ..+
T Consensus       184 fg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---------~~~  245 (312)
T 2iwi_A          184 FGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---------QEI  245 (312)
T ss_dssp             CSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHH
T ss_pred             cchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---------HHH
Confidence            99998765432         234578999999999987665 45999999999999999999999752         112


Q ss_pred             hhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .....     .+...+++++.++|.+||+.||++||++.++++
T Consensus       246 ~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22211     233568899999999999999999999887753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=324.92  Aligned_cols=250  Identities=19%  Similarity=0.288  Sum_probs=182.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCch---hH-HHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QL-QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~-~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .++|++.+.||+|+||.||+|++..+++.||||++.......   +. ..+..+++.++|++++..+ .+.......+++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~-~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF-GTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEE-EEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEE-EEEecCCcEEEE
Confidence            468999999999999999999999999999999987654332   22 3333455556655555544 445567788999


Q ss_pred             EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++.......
T Consensus       103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred             EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCc
Confidence            99998888888876677899999999999999999999995 99999999999999   678899999999997665432


Q ss_pred             CcccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      .        .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||.....  ....+..+.......
T Consensus       180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL  249 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred             c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence            1        23457899999999995     45689999999999999999999999986432  233333333322211


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .  .....+++++.+++.+||+.||++||++.++++
T Consensus       250 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1  112357899999999999999999999988765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.9e-42  Score=338.81  Aligned_cols=260  Identities=20%  Similarity=0.227  Sum_probs=188.5

Q ss_pred             CcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         2 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+.+|++|..+..+.......+++
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            45677889999999999999998754 478999999987643 2346789999999885455555555666777889999


Q ss_pred             EeccCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC----------CCCCeE
Q 015592           82 IDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQV  145 (404)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~----------~~~~~v  145 (404)
                      |||++++|.+++......      .++..++.++.||+.||+|||++||+||||||+|||++..          +....+
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            999988999999743211      1333567899999999999999999999999999999532          234589


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLK  217 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~  217 (404)
                      ||+|||+++..........   .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+..
T Consensus       168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            9999999987765332110   01234579999999999976       568999999999999999999 999997643


Q ss_pred             CCChHHHHHHHhhhccccc-HhH-hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          218 AGTKKQKYEKISEKKVSTS-IEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..  .   ..+........ ... ....+++++.+++.+||+.||++||++.++++
T Consensus       245 ~~--~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SR--E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TH--H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh--H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            21  1   11222111110 000 01134688999999999999999999988753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-42  Score=330.49  Aligned_cols=251  Identities=16%  Similarity=0.235  Sum_probs=201.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-------------------hhHHHHHHHHHHHcCCCC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------------PQLQYEAKLYKILQGGTG   64 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~E~~~l~~l~~~~~   64 (404)
                      ...++|++.+.||+|+||.||+|++  +++.||||++......                   ..+.+|+.+++.++|+++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4557999999999999999999998  8999999987543111                   678999999999997777


Q ss_pred             CCceeEeeeeCCeEEEEEecc-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCccc
Q 015592           65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL  135 (404)
Q Consensus        65 i~~~~~~~~~~~~~~lv~e~~-~~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NIL  135 (404)
                      +..+..+ ......+++|||+ +++|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus       106 ~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          106 LTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCCSEEE-ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             ceEEEEE-eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            6666554 4567889999999 6799988      5422 4579999999999999999999999 99999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLPW  213 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwSlG~il~elltg~~Pf  213 (404)
                      +   +.++.+||+|||++.......         .....||+.|+|||++.+. .++. ++|||||||++|||++|..||
T Consensus       185 ~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  252 (348)
T 2pml_X          185 M---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF  252 (348)
T ss_dssp             E---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             E---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            9   688899999999998765431         2345789999999999987 5666 999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhhhcccccH--------------hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          214 QGLKAGTKKQKYEKISEKKVSTSI--------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ......  .+....+.......+.              ......+++++.+++.+||+.||++||++.++++
T Consensus       253 ~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          253 SLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            875431  3334444333222110              0111468899999999999999999999887754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=337.72  Aligned_cols=253  Identities=17%  Similarity=0.200  Sum_probs=186.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEeccC
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG   86 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   86 (404)
                      .+|++.+.||+|+||+||.. ...+++.||||++... ....+.+|+.+++.+..|++|..+..+.......+++||+++
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            36999999999999997643 3478999999988643 334578999999999544445555556677888999999999


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCCeEEEEecCCcccccccCCccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~--~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                      ++|.+++......+.+.+++.++.||+.||+|||++||+||||||+|||++.++  ....+||+|||+++........  
T Consensus       102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~--  179 (432)
T 3p23_A          102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS--  179 (432)
T ss_dssp             EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred             CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc--
Confidence            999999986555567777889999999999999999999999999999995332  2336889999999876543211  


Q ss_pred             ccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          165 IPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                        +.......||+.|+|||++.+   ..++.++|||||||++|||++ |..||.....   .+ ...+.. .........
T Consensus       180 --~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~-~~~~~~-~~~~~~~~~  252 (432)
T 3p23_A          180 --FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQ-ANILLG-ACSLDCLHP  252 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HH-HHHHTT-CCCCTTSCT
T ss_pred             --eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HH-HHHHhc-cCCccccCc
Confidence              112345679999999999984   567889999999999999999 9999965322   11 111111 111100001


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ....+..+.+||.+||+.||++||++.+++
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            112356789999999999999999998876

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-41  Score=315.34  Aligned_cols=234  Identities=18%  Similarity=0.221  Sum_probs=177.5

Q ss_pred             cCCceEEe-eeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHH-cCCCCCCceeEeee---eCCeEE
Q 015592            5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL-QGGTGIPNLRWFGV---EGDYNV   79 (404)
Q Consensus         5 ~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~---~~~~~~   79 (404)
                      +.++|.+. +.||+|+||.||+|++..+++.||||++.   ....+.+|+.++.++ +|++++..+..+..   .....+
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEec---ccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            45667776 78999999999999999999999999986   345788999998655 44555554444432   256789


Q ss_pred             EEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      ++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            999999 779999998643 369999999999999999999999999999999999999643337899999999986332


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH-HHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~~  236 (404)
                                                   +..++.++|||||||++|||++|+.||.+.......... ..+..... ..
T Consensus       172 -----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~  221 (299)
T 3m2w_A          172 -----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EF  221 (299)
T ss_dssp             -----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC-SS
T ss_pred             -----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc-cC
Confidence                                         134678999999999999999999999764332110000 00111111 11


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .......+++++.+++.+||+.||++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            12223568999999999999999999999886653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.9e-41  Score=313.50  Aligned_cols=231  Identities=11%  Similarity=0.054  Sum_probs=186.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .++++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.++..++|++++..+. ++...+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD-VVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE-EEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE-EEEECCcE
Confidence            6778999999999999999999999999999999998765443     46889999999998777665554 45567788


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ |++|.++++.  + ....++..|+.||+.||+|||++||+||||||+|||+   +.++.+||++++      
T Consensus       107 ~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC------
T ss_pred             EEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc------
Confidence            9999999 7899999862  2 4667889999999999999999999999999999999   578889887443      


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                                           |++       .++.++|||||||++|||+||+.||.+...........+... ......
T Consensus       175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~  225 (286)
T 3uqc_A          175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP  225 (286)
T ss_dssp             ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred             ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence                                 222       378899999999999999999999988654321100001111 112233


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      ..+...+|+++.+++.+||+.||++| |+.++.+.|+++.
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            45556899999999999999999999 9999999998875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.2e-42  Score=346.21  Aligned_cols=267  Identities=17%  Similarity=0.228  Sum_probs=198.8

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeee-----eC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-----EG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~   75 (404)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.....   .+.+.+|+.+++.++|++++..+..+..     ..
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            345889999999999999999999999999999998765433   2357889999999998887777655432     35


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      ...+++|||+ +++|.+++.....  .+++..++.|+.|++.||+|||++||+||||||+|||++.++....+||+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            6779999999 8899999985332  599999999999999999999999999999999999996444445699999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh------HHHHH
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYE  226 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~  226 (404)
                      +........        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......      .....
T Consensus       171 a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          171 AKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE  242 (676)
T ss_dssp             CCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred             ccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence            987654332        2356799999999999999999999999999999999999999975311000      00000


Q ss_pred             HHh-----hh-----cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-----HHHHHHHHHH
Q 015592          227 KIS-----EK-----KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-----LKRLFRDLFI  278 (404)
Q Consensus       227 ~~~-----~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~-----l~~~l~~~~~  278 (404)
                      .+.     ..     ...+....+...+++.+.+++..||..||++||++.+     ..+.+++++.
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            000     00     0000111223346789999999999999999999987     3455665553

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=345.27  Aligned_cols=242  Identities=14%  Similarity=0.179  Sum_probs=193.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcC-CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCC---
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD---   76 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---   76 (404)
                      ++.++|++.+.||+|+||.||+|++.. +++.||||++......   ..+.+|+.+++.++|++++..+..+...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            567899999999999999999999976 7899999987654322   347889999999998888877776655443   


Q ss_pred             -eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           77 -YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        77 -~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                       ..++||||+ |++|.+++.   ..+++.+++.|+.||+.||.|||++|||||||||+|||++   . +.+||+|||+++
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~  229 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred             ceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecccch
Confidence             269999999 789988775   2799999999999999999999999999999999999994   3 489999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      .....           ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+......            .
T Consensus       230 ~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~  285 (681)
T 2pzi_A          230 RINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------P  285 (681)
T ss_dssp             ETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------C
T ss_pred             hcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc------------c
Confidence            66442           345799999999999875 48999999999999999999999876322111            0


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHHHHHHHHHH
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFI  278 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~-~~~l~~~l~~~~~  278 (404)
                      ....  ....++.+.++|.+||+.||++||+ ++++...|..++.
T Consensus       286 ~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 EDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             TTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             cccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            0000  0123578999999999999999995 6667776666553

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-40  Score=315.16  Aligned_cols=238  Identities=19%  Similarity=0.171  Sum_probs=180.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----------hhHHHHHHHHHHHc---------CCCCCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQ---------GGTGIP   66 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~---------~~~~i~   66 (404)
                      .++|++.+.||+|+||+||+|++  +++.||||++......          +.+.+|+.+++.++         |++++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999997  7899999988755322          66899999999997         555555


Q ss_pred             ceeEeee-----------------------------eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 015592           67 NLRWFGV-----------------------------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV  116 (404)
Q Consensus        67 ~~~~~~~-----------------------------~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL  116 (404)
                      ....+..                             .....+++|||+ ++++.+.+.  ...+++.+++.|+.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence            4433221                             267899999998 665555543  35689999999999999999


Q ss_pred             HHHH-hCCceeccCCCCcccccCCCCCC--------------------eEEEEecCCcccccccCCcccccccCCCCCcc
Q 015592          117 EFVH-SKSFLHRDIKPDNFLMGLGRRAN--------------------QVYIIDFGLAKRYRDTATHQHIPYRENKNLTG  175 (404)
Q Consensus       117 ~~LH-~~givHrDlKp~NILl~~~~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~g  175 (404)
                      +||| ++||+||||||+|||++   .++                    .+||+|||+|+.....            ...|
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~g  239 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVF  239 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEEC
T ss_pred             HHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEE
Confidence            9999 99999999999999995   444                    8999999999866542            3479


Q ss_pred             CcCccccccccCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCCCChHHHHHHHhhh-c-ccccHhHhhcCCcHHHHHHH
Q 015592          176 TARYASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEK-K-VSTSIEALCRGYPTEFASYF  252 (404)
Q Consensus       176 t~~y~aPE~~~~~~~~~~sDiwSlG~i-l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~l~~li  252 (404)
                      |+.|+|||++.+.. +.++||||||++ .+++++|..||.+...  .......+... . ...........+++++.+||
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence            99999999999876 999999998777 7788889999854110  01111222211 0 11111223345789999999


Q ss_pred             HHHHcCCCCCCCCHHHHH
Q 015592          253 HYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       253 ~~cl~~~p~~RP~~~~l~  270 (404)
                      .+||++|     |+++++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999976     766554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.4e-34  Score=289.54  Aligned_cols=185  Identities=15%  Similarity=0.134  Sum_probs=132.2

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ..++.|++|.+..++....|+.|+||++.....            .+++.+|+++|+++.++++|+.+..+++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345678888888888778899999998865421            23588999999999888889999999999999999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ||||+ |++|.+++.. .++++..   .|+.||+.||+|+|++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred             EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence            99999 8999999985 5667765   478999999999999999999999999999   68899999999999877654


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~P  212 (404)
                      ..       ...+.+||+.|||||++.+ .+..++|+||+|+++|++.++..+
T Consensus       393 ~~-------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS-------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc-------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32       2345689999999999987 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.8e-29  Score=249.38  Aligned_cols=188  Identities=19%  Similarity=0.153  Sum_probs=140.8

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----------hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      ...+.||+|+||.||+|.  ..++.+++|....+...          +.+.+|++++++++|++++.. ..++......+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~-~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP-YIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCC-CEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCce-EEEEEeCCccE
Confidence            345689999999999995  56789999976543321          236899999999998777643 33333556679


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++..         +..|+.|++.||+|||++||+||||||+|||++   .  .+||+|||+++....
T Consensus       416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred             EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence            999999 7999999873         678999999999999999999999999999993   4  999999999997765


Q ss_pred             cCCcccccccCCCCCccCcCccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ  214 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~il~elltg~~Pf~  214 (404)
                      ........+.......||+.|||||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211000001235689999999999987  558888999999999988888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.2e-25  Score=207.65  Aligned_cols=143  Identities=15%  Similarity=0.227  Sum_probs=113.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCC
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLQYEAKLYKILQGGTGIP   66 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~   66 (404)
                      ..|.+++.||+|+||.||+|++ .+++.||||++.....                    ...+.+|+.+++.++  + +.
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3456669999999999999999 8899999998864321                    234789999999998  3 44


Q ss_pred             ceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        67 ~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      ....+..  ...+++|||+ |++|.+ +.       ..+...++.|++.||.|||++||+||||||+|||+   + ++.+
T Consensus       166 v~~~~~~--~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v  231 (282)
T 1zar_A          166 VPKVYAW--EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI  231 (282)
T ss_dssp             SCCEEEE--ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred             cCeEEec--cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence            4444433  4458999999 779987 32       12355799999999999999999999999999999   5 8899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccC
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG  187 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  187 (404)
                      ||+|||+|+                    .+..|+|||.+.+
T Consensus       232 kl~DFG~a~--------------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          232 WIIDFPQSV--------------------EVGEEGWREILER  253 (282)
T ss_dssp             EECCCTTCE--------------------ETTSTTHHHHHHH
T ss_pred             EEEECCCCe--------------------ECCCCCHHHHHHH
Confidence            999999985                    2345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.1e-22  Score=183.53  Aligned_cols=136  Identities=19%  Similarity=0.270  Sum_probs=107.1

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcE--EEEEEecCCCCc--------------------------hhHHHHHHHHHHH
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--------------------------PQLQYEAKLYKIL   59 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~--------------------------~~~~~E~~~l~~l   59 (404)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                          ..+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778999  999986543111                          2578899999999


Q ss_pred             cCCCC-CCceeEeeeeCCeEEEEEeccC--C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCC
Q 015592           60 QGGTG-IPNLRWFGVEGDYNVLVIDLLG--P----SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP  131 (404)
Q Consensus        60 ~~~~~-i~~~~~~~~~~~~~~lv~e~~~--~----sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlKp  131 (404)
                      .|+++ ++.+..  .  ...+++|||++  +    +|.++...    .++..+..++.|++.+|.||| ++||+||||||
T Consensus       128 ~~~~i~~p~~~~--~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYT--Y--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEE--E--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEE--c--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            87643 232222  2  34689999995  2    77766432    345678899999999999999 99999999999


Q ss_pred             CcccccCCCCCCeEEEEecCCcccc
Q 015592          132 DNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus       132 ~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      +|||++   .  .++|+|||+|...
T Consensus       200 ~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES---S--SEEECCCTTCEET
T ss_pred             HHEEEc---C--cEEEEECcccccC
Confidence            999993   4  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=1.1e-18  Score=165.78  Aligned_cols=137  Identities=17%  Similarity=0.248  Sum_probs=97.9

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------c--------hh--------HHHHHHHHHHHcCCC
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------H--------PQ--------LQYEAKLYKILQGGT   63 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~--------~~--------~~~E~~~l~~l~~~~   63 (404)
                      -|++++.||.|+||.||+|.+ .+|+.||||+.+....        .        ..        ..+|...+.++.+ .
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-E  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-c
Confidence            389999999999999999997 5799999998653210        0        00        2357777888753 3


Q ss_pred             CCCceeEeeeeCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015592           64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA  142 (404)
Q Consensus        64 ~i~~~~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~  142 (404)
                      ++.....+....  .+|+|||+ |.+|.++..       ......++.||+.+|.+||++|||||||||.|||+..+.+.
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence            444433333333  37999999 556654322       23456788999999999999999999999999999532110


Q ss_pred             -------CeEEEEecCCccc
Q 015592          143 -------NQVYIIDFGLAKR  155 (404)
Q Consensus       143 -------~~vkL~DFG~a~~  155 (404)
                             ..+.|+||+-+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                   1489999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=1.2e-12  Score=118.79  Aligned_cols=137  Identities=17%  Similarity=0.284  Sum_probs=108.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|++...++.|+.+.||++..  .++.+++|+....  .....+.+|+.+++.+.++..++.+..++......+++|++
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            4699999999999999999984  4688999987642  23446999999999997666677777777778889999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------  121 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------------  121 (404)
                      + |.+|.+.+.      +......++.+++.+|..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            9 668776531      122345788999999999998                                          


Q ss_pred             -----------------CCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          122 -----------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       122 -----------------~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                                       ..++|+|++|.|||+   +++..+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhcc
Confidence                             458999999999999   344555799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=2e-11  Score=110.37  Aligned_cols=134  Identities=16%  Similarity=0.081  Sum_probs=98.5

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ..|.+....+.|..+.||++.. .+|+.+++|+.... ....+..|+.+++.+.++.+ ++.+..+...+...+++|+++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            4567766555677799999964 56778999987654 34578999999999987655 666666666667789999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-----------------------------------------  123 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----------------------------------------  123 (404)
                       |.+|.  ..    ..+   ...++.+++..|..||+..                                         
T Consensus        98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence             65663  21    122   2356777777888888643                                         


Q ss_pred             -----------------ceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          124 -----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       124 -----------------ivHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                                       ++|+|++|.|||+   ++++.+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhcc
Confidence                             9999999999999   344556799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=2e-10  Score=109.21  Aligned_cols=138  Identities=13%  Similarity=0.209  Sum_probs=99.4

Q ss_pred             EEeeeeceeCceeEEEEEEcCCCcEEEEEEec--CCC---CchhHHHHHHHHHHHcCCCC-CCceeEeeeeC---CeEEE
Q 015592           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKT---KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVL   80 (404)
Q Consensus        10 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~---~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~---~~~~l   80 (404)
                      ...+.|+.|.++.||++..  .+..+++|+..  ...   ....+.+|..+++.|....+ ++.+..++.+.   ...++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            3467889999999999984  35688999765  322   23468999999999986433 55555554444   34789


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------------------------------------  121 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------  121 (404)
                      +||++ |..+.+.   ....++..+...++.+++..|..||+                                      
T Consensus       119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999 5455321   12347888889999999999999997                                      


Q ss_pred             --------------------CCceeccCCCCcccccCCCCC--CeEEEEecCCccc
Q 015592          122 --------------------KSFLHRDIKPDNFLMGLGRRA--NQVYIIDFGLAKR  155 (404)
Q Consensus       122 --------------------~givHrDlKp~NILl~~~~~~--~~vkL~DFG~a~~  155 (404)
                                          .+++|+|++|.|||++   .+  ..+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence                                3689999999999994   33  3468999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=4.4e-11  Score=111.06  Aligned_cols=188  Identities=15%  Similarity=0.198  Sum_probs=119.5

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCC--CceeEeeeeCC---eEEEEEecc-
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI--PNLRWFGVEGD---YNVLVIDLL-   85 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i--~~~~~~~~~~~---~~~lv~e~~-   85 (404)
                      .+.++.|.+..||++.     ..+++|+.........+.+|.++++.+.....+  +.+...+....   ..+++|++. 
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999874     468999865432345689999999999654433  33333333322   347889999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------------------------------------------  121 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------------  121 (404)
                      |.+|.+...   ..++..+...++.|++..|..||+                                            
T Consensus       100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            666654332   247888888889999999988886                                            


Q ss_pred             --------------CCceeccCCCCcccccCCCC--CCeEEEEecCCcccccccCCcccccccCC--------CCCccCc
Q 015592          122 --------------KSFLHRDIKPDNFLMGLGRR--ANQVYIIDFGLAKRYRDTATHQHIPYREN--------KNLTGTA  177 (404)
Q Consensus       122 --------------~givHrDlKp~NILl~~~~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~~~--------~~~~gt~  177 (404)
                                    ..++|+|++|.||+++   .  ...+.|+||+.+..-......... ....        ..+....
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~---~~~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFD---TEKNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEE---TTTTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEe---CCCCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHc
Confidence                          1379999999999994   4  456789999988643221100000 0000        0000000


Q ss_pred             Cccc-cccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 015592          178 RYAS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW  213 (404)
Q Consensus       178 ~y~a-PE~~~~~~~~~~sDiwSlG~il~elltg~~Pf  213 (404)
                      .+.. |+....  .....+.|++|.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1111 222111  122368999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=1.6e-07  Score=87.06  Aligned_cols=135  Identities=24%  Similarity=0.279  Sum_probs=89.7

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCceeEeee-eCCeEEEEEecc-CC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG--IPNLRWFGV-EGDYNVLVIDLL-GP   87 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~~~~~~~-~~~~~~lv~e~~-~~   87 (404)
                      .+.++.|....||+.     +..+++|+-........+.+|.++++.|.++..  ++.+..++. .....+++|++. |.
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456788888899988     567899985332234568899999999986532  444444443 445678999999 55


Q ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 015592           88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------------------------------------------  122 (404)
Q Consensus        88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------------------------  122 (404)
                      +|.+..-   ..++..+...++.++...|..||+.                                             
T Consensus        99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            6654221   1245555555555566555555542                                             


Q ss_pred             ---------------CceeccCCCCcccccCCCCCCe-EEEEecCCcc
Q 015592          123 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAK  154 (404)
Q Consensus       123 ---------------givHrDlKp~NILl~~~~~~~~-vkL~DFG~a~  154 (404)
                                     .++|+|++|.|||++.++.++. +.|+||+.+.
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                           3599999999999952111344 5899999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=2.8e-07  Score=83.53  Aligned_cols=132  Identities=17%  Similarity=0.161  Sum_probs=92.4

Q ss_pred             eeceeCce-eEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CCCHHH
Q 015592           14 KIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLED   91 (404)
Q Consensus        14 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~sL~~   91 (404)
                      .+..|..| .||+......+..+++|+.... ....+.+|...++.|...--++.+..++.+.+..+++|+++ |.++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            34456555 6999887677788999986533 23458899999999986545667777777888899999999 667766


Q ss_pred             HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------------
Q 015592           92 LFNFCSRKLSLKTVLMLADQMINRVEFVHSK-------------------------------------------------  122 (404)
Q Consensus        92 ~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------------------------  122 (404)
                      .....     ......+..+++..|..||+.                                                 
T Consensus       110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            55421     122234455555555555521                                                 


Q ss_pred             ---------CceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          123 ---------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       123 ---------givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                               .++|+|+.+.|||+   +..+.+-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccc
Confidence                     27999999999999   455556799998774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.40  E-value=1.7e-06  Score=83.00  Aligned_cols=75  Identities=13%  Similarity=0.152  Sum_probs=50.4

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCC---------CCchhHHHHHHHHHHHcCC--CCCCceeEeeeeCCeEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNV   79 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~   79 (404)
                      -.+.||.|.++.||++....+++.++||.....         .....+..|.++++.+...  ..++.+..+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            356899999999999976556788999975422         1234578899999998753  345555444  344468


Q ss_pred             EEEeccCC
Q 015592           80 LVIDLLGP   87 (404)
Q Consensus        80 lv~e~~~~   87 (404)
                      ++||++.+
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            99999844

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=9.6e-07  Score=83.46  Aligned_cols=78  Identities=13%  Similarity=0.288  Sum_probs=52.8

Q ss_pred             eEEeeee-ceeCceeEEEEEEc--C----CCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCC--CCCCceeEeeee
Q 015592            9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGG--TGIPNLRWFGVE   74 (404)
Q Consensus         9 y~i~~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~   74 (404)
                      ....+.| +.|....+|++...  .    +++.+++|+.....     ....+.+|..+++.|...  -.++.+..+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445778 88999999998742  0    26789999865432     135689999999999764  235555554443


Q ss_pred             C---CeEEEEEeccC
Q 015592           75 G---DYNVLVIDLLG   86 (404)
Q Consensus        75 ~---~~~~lv~e~~~   86 (404)
                      .   ...+++|+++.
T Consensus       102 ~~~~g~~~~v~e~l~  116 (357)
T 3ats_A          102 GDVLGTPFFLMDYVE  116 (357)
T ss_dssp             STTTSSCEEEEECCC
T ss_pred             CCccCCceEEEEecC
Confidence            3   34678999983

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=1.9e-05  Score=73.82  Aligned_cols=72  Identities=11%  Similarity=0.123  Sum_probs=42.3

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeE------eeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~------~~~~~~~~~lv~e~   84 (404)
                      .+.|+.|..+.||++.. . +..+++|+...  ....+..|..+++.|....+ ++.+..      +.......+++|++
T Consensus        37 ~~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHT-D-SGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEE-T-TEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEe-C-CCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            34566678899999985 3 34589998765  23456677888887763221 222221      22345667899999


Q ss_pred             cCC
Q 015592           85 LGP   87 (404)
Q Consensus        85 ~~~   87 (404)
                      +.|
T Consensus       113 i~G  115 (346)
T 2q83_A          113 IEG  115 (346)
T ss_dssp             CCC
T ss_pred             ecC
Confidence            843

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.99  E-value=9.7e-05  Score=63.58  Aligned_cols=139  Identities=13%  Similarity=0.112  Sum_probs=89.5

Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      -||.++++..+.+|++++++.++.|.+.+|.-+-. +.-..+=+-|..|++   ..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            38999999889999999999999999999877621 111122233566777   4666665543 1110           


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCCc
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP  245 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (404)
                              .....+.+||... ...+.+.=|||||+++|..+--..|=                         .....++
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------------------------~eE~eLS  143 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------------------------NEERELS  143 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------------TEEECCC
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-------------------------ccchhhC
Confidence                    1123456788763 34578889999999999988733331                         1124678


Q ss_pred             HHHHHHHHHHHcCC-------------------------CCCCCCHHHHHHHHH
Q 015592          246 TEFASYFHYCRSLR-------------------------FDDKPDYAYLKRLFR  274 (404)
Q Consensus       246 ~~l~~li~~cl~~~-------------------------p~~RP~~~~l~~~l~  274 (404)
                      +.|.+||..|.+-.                         +..|+++++|.+.-+
T Consensus       144 ~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          144 PPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             HHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence            99999999997652                         357778877766544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.79  E-value=9.2e-05  Score=71.47  Aligned_cols=73  Identities=14%  Similarity=0.281  Sum_probs=44.5

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CC----CchhHHHHHHHHHHHc--CCCCCCceeEeeeeCCeEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KT----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~----~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~   79 (404)
                      -.+.||.|..+.||++.  .+++.++||....     ..    .......|.+++..+.  .+..++.+..++  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            35678999999999996  3567899994211     11    1123344555544442  233455555444  45668


Q ss_pred             EEEecc-CC
Q 015592           80 LVIDLL-GP   87 (404)
Q Consensus        80 lv~e~~-~~   87 (404)
                      ++||++ ++
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999998 65

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.78  E-value=0.00012  Score=67.12  Aligned_cols=68  Identities=12%  Similarity=0.091  Sum_probs=46.8

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-CC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP   87 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   87 (404)
                      .+.|+.|....+|++      ..+++|+..... .......|..+++.+....+.+.+..+.  ....+++++++ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            678889999999999      568999875432 1234578999999998666656655443  33346778887 54

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.65  E-value=0.001  Score=60.49  Aligned_cols=78  Identities=14%  Similarity=0.088  Sum_probs=56.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|.+..-.+.+|.|..+.||+++. .+|+.|.+|+......  ...+..|...|+.|.....++....+....  .+++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--~~lv~   89 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--RTLAM   89 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--TEEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--ceEEE
Confidence            466777889999999999999985 6789999998654332  335889999999997554444444444433  36778


Q ss_pred             ecc
Q 015592           83 DLL   85 (404)
Q Consensus        83 e~~   85 (404)
                      |+.
T Consensus        90 e~l   92 (288)
T 3f7w_A           90 EWV   92 (288)
T ss_dssp             ECC
T ss_pred             Eee
Confidence            877

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.62  E-value=0.00061  Score=62.92  Aligned_cols=139  Identities=17%  Similarity=0.200  Sum_probs=77.7

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEe------eeeCCeEEEEEe
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWF------GVEGDYNVLVID   83 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~------~~~~~~~~lv~e   83 (404)
                      -.+.|+.|....+|++.. .++ .+++|+.........+..|..+++.|....+ ++.+...      .......+++++
T Consensus        26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            356677888899999985 233 6889987754445678889999999875432 3332211      122355688899


Q ss_pred             ccCC-CH-----H------HH---HHHcCCCC--------C---HHHHHH------------HHHHHHHHHHHHHh----
Q 015592           84 LLGP-SL-----E------DL---FNFCSRKL--------S---LKTVLM------------LADQMINRVEFVHS----  121 (404)
Q Consensus        84 ~~~~-sL-----~------~~---l~~~~~~l--------~---~~~~~~------------i~~qi~~aL~~LH~----  121 (404)
                      +..| .+     .      ..   ++.....+        .   +.....            +...+...++.+.+    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            8843 21     1      11   12111111        1   111000            00113344555552    


Q ss_pred             ---CCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592          122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus       122 ---~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                         .+++|+|+.+.|||+   +.++.+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFF---LGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEE---eCCceEEEecchhcc
Confidence               479999999999999   344445799998774

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.62  E-value=0.00022  Score=66.38  Aligned_cols=77  Identities=12%  Similarity=0.027  Sum_probs=40.8

Q ss_pred             eeeeceeCcee-EEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEeeeeCCeEEEEEeccC-CC
Q 015592           12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLG-PS   88 (404)
Q Consensus        12 ~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lv~e~~~-~s   88 (404)
                      .+.|+.|.... +|+... .+++.+++|...... ...+..|+.+++.|....+ ++.+..+.....  +++||.++ ..
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            34565555444 677762 236778888654322 1457788999998875433 444444433333  67888884 45


Q ss_pred             HHHH
Q 015592           89 LEDL   92 (404)
Q Consensus        89 L~~~   92 (404)
                      +.+.
T Consensus        99 l~~~  102 (333)
T 3csv_A           99 FTEV  102 (333)
T ss_dssp             HHHH
T ss_pred             hHHH
Confidence            5443

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.61  E-value=0.00028  Score=65.12  Aligned_cols=72  Identities=21%  Similarity=0.293  Sum_probs=55.1

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCceeEeeeeCCeEEEEEecc
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      -.+.|+.|.+..+|+...  ++..+++|+.... ....+..|...|+.|...  ..++.+..++......+++|+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            356789999999999983  5678999986543 245688999999999753  44566666666667889999998

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0036  Score=57.85  Aligned_cols=73  Identities=11%  Similarity=0.069  Sum_probs=46.8

Q ss_pred             eeeceeCceeEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCC-CCceeEe-----eeeCCeEEEEEecc
Q 015592           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTG-IPNLRWF-----GVEGDYNVLVIDLL   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~~~~~-----~~~~~~~~lv~e~~   85 (404)
                      ..|+ |....||++.. .+|+.+++|+.... .....+..|..+++.|....+ ++.+...     ...++..+++|++.
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3456 78889998863 45667999998643 234568889999999874432 2222211     12244567889988


Q ss_pred             CC
Q 015592           86 GP   87 (404)
Q Consensus        86 ~~   87 (404)
                      .|
T Consensus       110 ~G  111 (328)
T 1zyl_A          110 GG  111 (328)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.11  E-value=0.0035  Score=60.52  Aligned_cols=71  Identities=13%  Similarity=0.083  Sum_probs=49.9

Q ss_pred             EeeeeceeCceeEEEEEEcC-------CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      -.+.|+.|-...||++....       .++.+++|+.... .. ..+..|..+++.|....+.+.+.....  +  .+++
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            35678888889999998642       2578999987432 23 567789999999987666666544332  2  3778


Q ss_pred             eccC
Q 015592           83 DLLG   86 (404)
Q Consensus        83 e~~~   86 (404)
                      +|+.
T Consensus       152 e~l~  155 (429)
T 1nw1_A          152 EYIP  155 (429)
T ss_dssp             CCCC
T ss_pred             EEeC
Confidence            8873

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.10  E-value=0.0012  Score=62.58  Aligned_cols=139  Identities=17%  Similarity=0.172  Sum_probs=80.6

Q ss_pred             eeeeceeCceeEEEEEEcC-------CCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+.|..|-...+|++....       .++.|++|+..... ......+|.++++.|....+.+.+..++..    .++|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            3567778888999998532       35789999853321 234577899999999877776766555433    28888


Q ss_pred             ccCC-CHH--------------HHHH---HcC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 015592           84 LLGP-SLE--------------DLFN---FCS----RKLS--LKTVLMLADQMIN-------------------RVEFVH  120 (404)
Q Consensus        84 ~~~~-sL~--------------~~l~---~~~----~~l~--~~~~~~i~~qi~~-------------------aL~~LH  120 (404)
                      +..| +|.              +.+.   ...    +...  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            8732 221              1111   111    1122  3556666655422                   233332


Q ss_pred             ----h----CCceeccCCCCcccccCC-CCCCeEEEEecCCcc
Q 015592          121 ----S----KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK  154 (404)
Q Consensus       121 ----~----~givHrDlKp~NILl~~~-~~~~~vkL~DFG~a~  154 (404)
                          .    ..++|+|+.+.|||+..+ +..+.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2    258999999999999521 113689999998774

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.95  E-value=0.0025  Score=60.11  Aligned_cols=73  Identities=14%  Similarity=0.008  Sum_probs=44.1

Q ss_pred             EeeeeceeCceeEEEEEEcC--------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      -.+.|+.|....+|++....        .++.+++|+...... ......|..+++.|....+++.+....  .  .+++
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            35567888888999998643        136899998654221 123578999999998665555554332  2  2678


Q ss_pred             EeccCC
Q 015592           82 IDLLGP   87 (404)
Q Consensus        82 ~e~~~~   87 (404)
                      |++..|
T Consensus       113 ~e~i~G  118 (369)
T 3c5i_A          113 EEWLYG  118 (369)
T ss_dssp             EECCCS
T ss_pred             EEEecC
Confidence            888733

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.008  Score=58.43  Aligned_cols=71  Identities=15%  Similarity=0.071  Sum_probs=47.4

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      -.+.|+.|-...+|++.....+..+++|+...... .-...+|..+++.|....+.+.+..++.  .  .++|+|+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            35678889899999998654457899998643321 1123689999999987776666655542  2  3488887

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.82  E-value=0.078  Score=49.20  Aligned_cols=65  Identities=12%  Similarity=0.168  Sum_probs=39.9

Q ss_pred             ceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCceeE------eeeeCCeEEEEEeccC
Q 015592           16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG--IPNLRW------FGVEGDYNVLVIDLLG   86 (404)
Q Consensus        16 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~~~~------~~~~~~~~~lv~e~~~   86 (404)
                      |.|....||++.. .++ .+++|+......    ..|..+++.|....+  ++....      +.......+++|++..
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3444679999984 345 899998765432    567788887764321  222211      1233566789999883

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.25  E-value=0.073  Score=51.03  Aligned_cols=72  Identities=11%  Similarity=0.118  Sum_probs=49.0

Q ss_pred             EeeeeceeCceeEEEEEEcCC-------CcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592           11 LGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      -.+.|..|-...+|++.....       ++.|++|+..... ..-...+|..+++.|....+.+.+....  .  .+++|
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            345677788889999986421       5789999864432 1224578999999998766666665422  2  26788


Q ss_pred             eccC
Q 015592           83 DLLG   86 (404)
Q Consensus        83 e~~~   86 (404)
                      ++..
T Consensus       150 efI~  153 (424)
T 3mes_A          150 EFID  153 (424)
T ss_dssp             ECCC
T ss_pred             EEeC
Confidence            8883

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.90  E-value=0.24  Score=46.99  Aligned_cols=32  Identities=28%  Similarity=0.511  Sum_probs=25.5

Q ss_pred             CceeccCCCCcccccCC---CCCCeEEEEecCCcc
Q 015592          123 SFLHRDIKPDNFLMGLG---RRANQVYIIDFGLAK  154 (404)
Q Consensus       123 givHrDlKp~NILl~~~---~~~~~vkL~DFG~a~  154 (404)
                      .++|+|+.+.|||+..+   +....++++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36899999999999431   356789999998875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	404
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-97
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-93
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-31
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-31
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-30
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-30
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-30
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-29
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-27
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-26
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-25
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-25
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-25
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-24
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-23
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-23
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-23
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-23
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-23
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-23
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-23
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-23
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-22
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-22
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-21
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-20
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-19
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-18
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-16

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  289 bits (741), Expect = 6e-97
 Identities = 231/299 (77%), Positives = 272/299 (90%)

Query: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
           ME RVGN++RLGRKIGSGSFG+IYLGT+I   EEVAIKLE VKTKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD  THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
           S+NTHLGIEQSRRDDLESLGYVLMYF  GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
           C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+  S+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  279 bits (715), Expect = 4e-93
 Identities = 175/291 (60%), Positives = 215/291 (73%), Gaps = 2/291 (0%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
           VG  +++GR+IG GSFG I+ GTN+  N++VAIK E  ++  PQL+ E + YK+L G TG
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           IPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122

Query: 125 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           ++RDIKPDNFL+G    + AN +Y++DFG+ K YRD  T QHIPYRE KNL+GTARY S+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
           NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +  LC 
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
           G+P EF  Y HY R+L FD  PDY YL+ LF  +  R     D  FDW +L
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  119 bits (298), Expect = 6e-31
 Identities = 44/212 (20%), Positives = 93/212 (43%), Gaps = 13/212 (6%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTG 64
           + + +  ++G+G+FG ++  T   T    A K  +   ++    ++ E +   +L+    
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 84

Query: 65  IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           + NL     + +  V++ + + G  L +       K+S    +    Q+   +  +H  +
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           ++H D+KP+N +    +R+N++ +IDFGL        + +          TGTA +A+  
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195

Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              G       D+ S+G +    L G  P+ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-31
 Identities = 45/229 (19%), Positives = 97/229 (42%), Gaps = 15/229 (6%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIP 66
           K+ +   +G G FG ++      + +    K ++   T    ++ E  +  I +    I 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64

Query: 67  NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
           +L       +  V++ + + G  + +  N  + +L+ + ++    Q+   ++F+HS +  
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           H DI+P+N +    RR++ + II+FG A++ +     + +             Y +   H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175

Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
                S   D+ SLG ++   L G  P+      T +Q  E I   + +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYT 221

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (293), Expect = 9e-31
 Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 31/284 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGG 62
            +  +G++IGSGSFG +Y G   + + +VA+K+ NV    PQ     + E  + +  +  
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63

Query: 63  TGIPNL-RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
               N+  + G      + +V     G SL    +    K  +  ++ +A Q    ++++
Sbjct: 64  ---VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H+KS +HRD+K +N  +        V I DFGLA      +          + L+G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILW 172

Query: 180 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
            +       ++   S + D+ + G VL   + G LP+  +    + Q    +    +S  
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPD 230

Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 276
           +  +    P         C   + D++P +    A ++ L R L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 47/271 (17%), Positives = 100/271 (36%), Gaps = 27/271 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
           + F    ++G+G+ G ++  ++  +   +A K   LE       Q+  E ++        
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64

Query: 64  GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
            I              + ++ + G SL+ +    + ++  + +  ++  +I  + ++  K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
              +HRD+KP N L+       ++ + DFG++ +  D+  +  +         GT  Y S
Sbjct: 124 HKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMS 171

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
                G   S + D+ S+G  L+    G  P     A   +  +    E   +       
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA------- 224

Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
              P    +      S   D +P  A  + L
Sbjct: 225 -ETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 4e-30
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 21/233 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
             F +GR +G G FG +YL    Q+   +A+K              QL+ E ++   L+ 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              I  L  +  +     L+++               K   +       ++ N + + HS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           K  +HRDIKP+N L+G    A ++ I DFG +     +               GT  Y  
Sbjct: 125 KRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLP 172

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
                G     + DL SLG +   FL G  P++     T ++ Y++IS  + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-30
 Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 19/233 (8%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
            F+ G+ +G GSF  + L   + T+ E AIK         + K P +  E  +   L   
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67

Query: 63  TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
                L +   + +     +       L                     ++++ +E++H 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           K  +HRD+KP+N L+        + I DFG AK     +           +  GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
                     +  DL +LG ++   + G  P++    G +   ++KI + +  
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  116 bits (292), Expect = 5e-30
 Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 20/235 (8%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
           V + + +  ++GSG+FG ++      T      K   + T +P     ++ E  +   L 
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
               + NL     +    VL+++ L G  L D       K+S   V+    Q    ++ +
Sbjct: 85  -HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H  S +H DIKP+N +    ++A+ V IIDFGLA +       +          T TA +
Sbjct: 144 HEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEF 194

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
           A+             D+ ++G +    L G  P+ G       +  + +      
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 41/232 (17%), Positives = 90/232 (38%), Gaps = 22/232 (9%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIP 66
           + +  ++G G+FG++Y   N +T+   A K+ + K++        E  +         I 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIV 72

Query: 67  NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
            L       +   ++I+   G +++ +     R L+   + ++  Q ++ + ++H    +
Sbjct: 73  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD+K  N L         + + DFG++ +   T   +        +  GT  + +    
Sbjct: 133 HRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEVV 182

Query: 186 LGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
           +      R      D+ SLG  L+       P   L      +   KI++ +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 5e-29
 Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 27/248 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLYKI 58
           +++++G  +GSG FG +Y G  +  N  VAIK                 ++  E  L K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 59  LQGG-TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
           +  G +G+  L  +    D  VL+++   P   DLF+F + +  L  +       Q++  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           V   H+   LHRDIK +N L  +     ++ +IDFG     +DT               G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171

Query: 176 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
           T  Y+            R   + SLG +L   + G +P++      +  + +    ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228

Query: 235 TSIEALCR 242
           +  + L R
Sbjct: 229 SECQHLIR 236

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-28
 Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 19/247 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
             + L + +G G++GE+ L  N  T E VA+K   ++        ++ E  + K+L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
            +        EG+   L ++                +          Q++  V ++H   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
             HRDIKP+N L+      + + I DFGLA  +R     + +       + GT  Y +  
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPE 175

Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTS 236
                E  +   D+ S G VL   L G LPW          +  K++K      KK+ ++
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235

Query: 237 IEALCRG 243
             AL   
Sbjct: 236 PLALLHK 242

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-28
 Identities = 46/235 (19%), Positives = 93/235 (39%), Gaps = 25/235 (10%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
           N F   + +G G+FG++ L     T    A+K     +   K +      E+++ +  + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 62  GTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 118
               P L         ++ L   +   +  +LF   SR+   + +       ++++ +E+
Sbjct: 65  ----PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
           +HS+  ++RDIK +N ++    +   + I DFGL K                    GT  
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170

Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
           Y +       +  R  D   LG V+   + G LP+        ++ +E I  +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  109 bits (272), Expect = 7e-28
 Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
            + +++ LG  +G G   E++L  +++ + +VA+K     L    + + + + EA+    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 59  LQGGTGIPNL-RWFGV------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
           L      P +   +         G    +V++ + G +L D+ +     ++ K  + +  
Sbjct: 64  LNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 118

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
                + F H    +HRD+KP N ++      N V ++DFG+A+   D+         + 
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QT 171

Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
             + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-27
 Identities = 41/211 (19%), Positives = 82/211 (38%), Gaps = 17/211 (8%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-- 68
             + +G G  G++    N +T E+ A+K   +    P+ + E +L+        I  +  
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 69  --RWFGVEGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
                       ++V++ L G  L   + +   +  + +    +   +   ++++HS + 
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
            HRD+KP+N L    R    + + DFG AK      +     Y        T  Y +   
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEV 184

Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
               +  +  D+ SLG ++   L G  P+  
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 2e-27
 Identities = 51/287 (17%), Positives = 110/287 (38%), Gaps = 23/287 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
           + ++L RK+G G + E++   NI  NE+V +K+     K  +++ E K+ + L+GG  I 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNII 93

Query: 67  NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
            L     +       +     +  D      + L+   +     +++  +++ HS   +H
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMH 152

Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
           RD+KP N +  +     ++ +ID+GLA+ Y     +             +  +      +
Sbjct: 153 RDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLV 202

Query: 187 GIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
             +      D+ SLG +L   +    P+          +  +I++   +  +      Y 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 246 TEFASYFH-------YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
            E    F+         R  RF    +   +     D  + +  ++D
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 22/245 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
            K+    KIG G+ G +Y   ++ T +EVAI+  N++   K   +  E  + +  +    
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78

Query: 65  IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
           I N     + GD   +V++ L G SL D+       +    +  +  + +  +EF+HS  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
            +HRDIK DN L+        V + DFG   +     + +         + GT  + +  
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186

Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 237
                    + D+ SLG + +  + G  P+        L         E  + +K+S   
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 238 EALCR 242
                
Sbjct: 247 RDFLN 251

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 5e-27
 Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 28/248 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
            F   R+IG GSFG +Y   +++ +E VAIK      +    K   +  E +  + L+  
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74

Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
                 R   +      LV++    S  DL     + L    +  +    +  + ++HS 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           + +HRD+K  N L+        V + DFG A       +             GT  + + 
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180

Query: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKVS 234
              L +++ + D   D+ SLG   +       P   + A +      + +   +     S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240

Query: 235 TSIEALCR 242
                   
Sbjct: 241 EYFRNFVD 248

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (267), Expect = 7e-27
 Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 19/235 (8%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
           + + +     +G+G+F E+ L  + +T + VAIK    + ++ K   ++ E  +   ++ 
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119
              I  L      G +  L++ L+  S  +LF+    K   + +    L  Q+++ V+++
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H    +HRD+KP+N L       +++ I DFGL+K     +              GT  Y
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGY 175

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
            +         S+  D  S+G +    L G  P+         + +E+I + +  
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 66/293 (22%), Positives = 107/293 (36%), Gaps = 24/293 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQG- 61
           +K+    KIG G+FGE++   + +T ++VA+K   +EN K   P     E K+ ++L+  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 62  ------GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
                          +        LV D     L  L +    K +L  +  +   ++N 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           + ++H    LHRD+K  N L+    R   + + DFGLA+ +      Q   Y    N   
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVV 183

Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
           T  Y      LG        DL   G ++      S   QG    T++ +   IS+   S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240

Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--LFRDLFIREGFQFD 285
            + E        E        +  +   K       R     DL I +    D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 15/214 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
             F L + +G GSFG+++L    +TN+  AIK   ++V      ++      ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 65  IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS 121
            P L   F        L   +   +  DL        K  L      A ++I  ++F+HS
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           K  ++RD+K DN L+    +   + I DFG+ K         +          GT  Y +
Sbjct: 122 KGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIA 171

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
               LG + +   D  S G +L   L G  P+ G
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 27/277 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
              +L  ++G+G FGE+++G     + +VA+K L+           EA L K LQ     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67

Query: 66  PNL-RWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
             L R + V     + ++ + +  G  ++ L      KL++  +L +A Q+   + F+  
Sbjct: 68  QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           ++++HRD++  N L+          I DFGLA+   D            +      ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
                    + + D+ S G +L   +  G +P+ G+   T  +  + +         +  
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233

Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
               P E       C   R +D+P + YL+ +  D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  105 bits (262), Expect = 2e-26
 Identities = 42/238 (17%), Positives = 80/238 (33%), Gaps = 21/238 (8%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQYEAKLY 56
            +     +G G    +    +  T +E A+K            E V+        E  + 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
           + + G   I  L+       +  LV DL+    L D        LS K    +   ++  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           +  +H  + +HRD+KP+N L+        + + DFG + +       + +    +     
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
               +  + H G    +  D+ S G ++   L GS P+       +      I     
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 54/235 (22%), Positives = 86/235 (36%), Gaps = 20/235 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
           N F + R IG G FGE+Y      T +  A+K        +K        E  +  ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 62  GT--GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
           G    I  + +     D    ++DL+               S   +   A ++I  +E +
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
           H++  ++RD+KP N L+        V I D GLA  +     H  +         GT  Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171

Query: 180 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
            +      G+      D  SLG +L   LRG  P++  K   K +         V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 4e-25
 Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 22/233 (9%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQY---EAKLYKILQG 61
             F++ R +G+GSFG ++L  +       A+K+  + +  +  Q+++   E  +  I+  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              I  +     +     +++D +           S++         A ++   +E++HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           K  ++RD+KP+N L+    +   + I DFG AK   D              L GT  Y +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIA 169

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
                    ++  D  S G ++   L G  P+         + YEKI   ++ 
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 7e-25
 Identities = 56/277 (20%), Positives = 92/277 (33%), Gaps = 23/277 (8%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK-----LENVKTKHPQLQYEAKLYKILQ 60
            RL  K+G GSFG +  G     +     VA+K     + +          E      L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
               +  L    +     ++       SL D          L T+   A Q+   + ++ 
Sbjct: 70  H-RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK F+HRD+   N L+      + V I DFGL +       H    Y   ++      + 
Sbjct: 129 SKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWC 181

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
           +  +      S   D    G  L      G  PW GL      Q   KI ++        
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRPE 238

Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
            C   P +  +    C + + +D+P +  L+    + 
Sbjct: 239 DC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 7e-25
 Identities = 57/274 (20%), Positives = 107/274 (39%), Gaps = 21/274 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
              RL  K+G G FGE+++GT   T   VAIK L+           EA++ K L+    +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74

Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSF 124
             L     E    ++   +   SL D     + K   L  ++ +A Q+ + + +V   ++
Sbjct: 75  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD++  N L+G         + DFGLA+   D            +      ++ +   
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185

Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
            L    + + D+ S G +L     +G +P+ G+     ++  +++               
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238

Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            P         C     +++P + YL+    D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 9e-25
 Identities = 48/245 (19%), Positives = 96/245 (39%), Gaps = 23/245 (9%)

Query: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQG 61
           G   +   +IG GSF  +Y G + +T  EVA       +  K++  + + EA++ K LQ 
Sbjct: 8   GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67

Query: 62  GTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
              +     +          VLV +L+       +    + + +K +     Q++  ++F
Sbjct: 68  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 119 VHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
           +H+++   +HRD+K DN    +      V I D GLA   R +           K + GT
Sbjct: 128 LHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGT 176

Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
             + +   +   +     D+ + G  ++       P+         Q Y +++      S
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPAS 233

Query: 237 IEALC 241
            + + 
Sbjct: 234 FDKVA 238

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 30/294 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
           VG ++     IG G++G +    +      VAIK       +T   +   E K+    + 
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 62  GTGIPNL-RWFGV-------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
                N+     +       +     LV  L+G  L  L    ++ LS   +     Q++
Sbjct: 66  ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQIL 119

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             ++++HS + LHRD+KP N L+        + I DFGLA+       H           
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----Y 172

Query: 174 TGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
             T  Y +          ++  D+ S+G +L   L     + G        +   I    
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGIL 229

Query: 233 VSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
            S S E L      +  +Y        +      +        DL + +   F+
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 61/290 (21%), Positives = 102/290 (35%), Gaps = 34/290 (11%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
           +   + IG+GSFG +Y      + E VAIK   V         E ++ + L     I  L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKNRELQIMRKLD-HCNIVRL 78

Query: 69  RWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFV 119
           R+F           Y  LV+D +  ++  +    SR    L +  V +   Q+   + ++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYRENKNLTG 175
           HS    HRDIKP N    L      + + DFG AK+        +      YR  + + G
Sbjct: 139 HSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
              Y           +   D+ S G VL   L G   + G    +   +  +I +   + 
Sbjct: 197 ATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTP 242

Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
           + E +    P      F   ++  +  K            L      ++ 
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 2e-24
 Identities = 54/275 (19%), Positives = 108/275 (39%), Gaps = 27/275 (9%)

Query: 13  RKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
            ++G G+FG +  G      +  +VAIK       K    ++  EA++   L      P 
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70

Query: 68  L-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
           + R  GV + +  +LV+++  G  L         ++ +  V  L  Q+   ++++  K+F
Sbjct: 71  IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD+   N L+      +   I DFGL+K      ++               ++ +   
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183

Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
               + S R D+ S G  +   L  G  P++ +      +    I + K           
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPPE 236

Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278
            P E  +    C   +++D+PD+  +++  R  + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (246), Expect = 2e-24
 Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 27/240 (11%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGT 63
            + +   IG+GS+G           + +  K        + +   L  E  L + L+   
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 64  GIPNLRWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 118
            +          +  + +V++   G  L  +    +++   L  + VL +  Q+   ++ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 119 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
            H +S      LHRD+KP N  +        V + DFGLA+      +         K  
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174

Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
            GT  Y S      +  + + D+ SLG +L        P+      ++K+   KI E K 
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 6e-24
 Identities = 54/295 (18%), Positives = 107/295 (36%), Gaps = 31/295 (10%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHP----QLQYEAKLYKI 58
           R   ++    +IG G++G+++   +++     VA+K   V+T           E  + + 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 59  LQGGTGIPNLRWFGV--------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
           L+       +R F V        E    ++   +       L       +  +T+  +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
           Q++  ++F+HS   +HRD+KP N L+     + Q+ + DFGLA+ Y        +     
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV----- 175

Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
                T  Y +    L    +   DL S+G +     R    ++G    +   +  KI +
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILD 229

Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
                  E   R       ++             D   +  L +DL + +   F+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.9 bits (243), Expect = 8e-24
 Identities = 56/275 (20%), Positives = 113/275 (41%), Gaps = 21/275 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
               +  K+G G +GE+Y G   + +  VA+K L+    +  +   EA + K ++    +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75

Query: 66  PNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
             L           ++ + +  G  L+ L     +++S   +L +A Q+ + +E++  K+
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
           F+HRD+   N L+G     + V + DFGL++         H   +         ++ +  
Sbjct: 136 FIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 186

Query: 184 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
           +    + S + D+ + G +L      G  P+ G+      Q YE + +       E    
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE---- 239

Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
           G P +       C      D+P +A + + F  +F
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 97.3 bits (241), Expect = 1e-23
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 25/218 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGG 62
            K+    KIG G++G +Y   N    E  A+K   ++ +          E  + K L+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
           + I  L          VLV + L   L+ L + C   L   T      Q++N + + H +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH-----QHIPYRENKNLTGTA 177
             LHRD+KP N L+    R  ++ I DFGLA+ +             + YR    L G+ 
Sbjct: 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
           +Y           S   D+ S+G +    + G+  + G
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 1e-23
 Identities = 41/229 (17%), Positives = 88/229 (38%), Gaps = 17/229 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
                 +++G+G FG +  G   +   +VAIK ++       +   EAK+   L     +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKL 61

Query: 66  PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
             L     +     ++ + +    L +       +   + +L +   +   +E++ SK F
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           LHRD+   N L+        V + DFGL++   D      +            R++    
Sbjct: 122 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPEV 172

Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
            +  + S + D+ + G ++      G +P++     T  +  E I++  
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 52/277 (18%), Positives = 97/277 (35%), Gaps = 24/277 (8%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
            +  LGR IG G FG+++ G  +        VAIK        +   +   EA   +   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
               I  L     E    +++       L          L L ++++ A Q+   + ++ 
Sbjct: 67  H-PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
           SK F+HRDI   N L+      + V + DFGL++   D+  ++              ++ 
Sbjct: 126 SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWM 176

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
           +  +      +   D+   G  +   L  G  P+QG+       K   +  +  +     
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGERLP 229

Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
           +    P    S    C +     +P +  LK     +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.3 bits (244), Expect = 2e-23
 Identities = 44/213 (20%), Positives = 90/213 (42%), Gaps = 17/213 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
           ++F   + +G+GSFG + L  + ++    A+K+  +    K  Q+++     +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 65  IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
              ++      D + L + +   +  ++F+   R  + S       A Q++   E++HS 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             ++RD+KP+N L+    +   + + DFG AKR +                 GT    + 
Sbjct: 161 DLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207

Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
              L    ++  D  +LG ++     G  P+  
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 2e-23
 Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 20/283 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGT 63
            F+   KIG G++G +Y   N  T E VA+K        +        E  L K L    
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK 122
            I  L       +   LV + L   L+   +      + L  +     Q++  + F HS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
             LHRD+KP N L+        + + DFGLA+ +                +      A  
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172

Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
                   S   D+ SLG +    +     + G    ++  +  +I  + + T  E +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWP 228

Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
           G  +       + +  R D       L    R L + +   +D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 48/243 (19%), Positives = 89/243 (36%), Gaps = 21/243 (8%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLY 56
           V + +  G ++GSG F  +       T  + A K                  ++ E  + 
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
           K +Q    +  L          +L+++L+       F      L+ +       Q++N V
Sbjct: 68  KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 117 EFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
            ++HS    H D+KP+N ++        ++ IIDFGLA +       ++I         G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178

Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
           T  + +             D+ S+G +    L G+ P+ G    TK++    +S      
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235

Query: 236 SIE 238
             E
Sbjct: 236 EDE 238

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 3e-23
 Identities = 52/274 (18%), Positives = 117/274 (42%), Gaps = 27/274 (9%)

Query: 13  RKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIP 66
           +++GSG+FG +  G     +  + VA+K+   +   P    +L  EA + + L      P
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68

Query: 67  NL-RWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
            + R  G+ E +  +LV+++      + +   +R +  K ++ L  Q+   ++++   +F
Sbjct: 69  YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD+   N L+      +   I DFGL+K  R    +    Y+   +     ++ +   
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181

Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
               + S + D+ S G ++      G  P++G+      +    + + +          G
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----G 234

Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
            P E     + C +   +++P +A ++   R+ +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 5e-23
 Identities = 50/267 (18%), Positives = 91/267 (34%), Gaps = 43/267 (16%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKL---ENVKTKHPQLQYEAKLYKI 58
                G+ +GSG+FG++   T    ++     +VA+K+   +   ++   L  E K+   
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 59  LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK------------------ 99
           L     I NL           L+ +      L +       K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 100 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
               L+ + +L  A Q+   +EF+  KS +HRD+   N L+        V I DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213

Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQ 214
               +      Y    N     ++ +  +      + + D+ S G +L      G  P+ 
Sbjct: 214 IMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 215 GLKAGTKKQKYEKISEKKVSTSIEALC 241
           G+        + K+ +           
Sbjct: 269 GI---PVDANFYKLIQNGFKMDQPFYA 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 6e-23
 Identities = 44/227 (19%), Positives = 84/227 (37%), Gaps = 17/227 (7%)

Query: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
           F+  + +GSG+FG +Y G  I   E+V I               + ++  EA +   +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
              +  L    +     ++   +    L D        +  + +L    Q+   + ++  
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
           +  +HRD+   N L+        V I DFGLAK         H      +      ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181

Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 227
           + + L    + + D+ S G  +   +  GS P+ G+ A       EK
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 95.7 bits (237), Expect = 7e-23
 Identities = 57/307 (18%), Positives = 100/307 (32%), Gaps = 51/307 (16%)

Query: 3   PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK---LENVKTKHPQLQYEAK 54
           PR  N     R IG G+FG ++          +    VA+K    E         Q EA 
Sbjct: 11  PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68

Query: 55  LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL--------------------- 92
           L         +  L      G    L+ + +    L +                      
Sbjct: 69  LMAEFDNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 93  --FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
              +     LS    L +A Q+   + ++  + F+HRD+   N L+G       V I DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 184

Query: 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RG 209
           GL++            Y+ + N     R+    +      +   D+ + G VL      G
Sbjct: 185 GLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269
             P+ G+     ++    + +  +    E      P E  +    C S    D+P +  +
Sbjct: 240 LQPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSI 292

Query: 270 KRLFRDL 276
            R+ + +
Sbjct: 293 HRILQRM 299

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 9e-23
 Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 30/292 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
           V  +++    +GSG++G +    + +T   VA+K  +   +      +   E +L K ++
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75

Query: 61  GGTGIPNLRWF-----GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
               I  L  F       E +   LV  L+G  L ++     +KL+   V  L  Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133

Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
           ++++HS   +HRD+KP N  +       ++ I+DFGLA+   D  T              
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA---------- 180

Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
           T  Y +    L     ++  D+ S+G ++   L G   + G        + + I     +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGT 237

Query: 235 TSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRLFRDLFIREGFQFD 285
              E L +       +Y      + + +    +     L  DL + +    D
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (233), Expect = 1e-22
 Identities = 54/277 (19%), Positives = 98/277 (35%), Gaps = 33/277 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
            + +L + IG G FG++ LG       +VA+K             EA +   L+      
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 60

Query: 67  NL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
           NL +  GV   E     +V + +   SL D L +     L    +L  +  +   +E++ 
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
             +F+HRD+   N L+      N   + DFGL K    T                  ++ 
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWT 167

Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
           +       + S + D+ S G +L      G +P+  +     K    ++ +     + + 
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD- 223

Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
              G P         C  L    +P +  L+     +
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.1 bits (235), Expect = 2e-22
 Identities = 53/288 (18%), Positives = 106/288 (36%), Gaps = 31/288 (10%)

Query: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ 60
           EP    ++ L RK+G G F  ++L  ++  N  VA+K +   K      + E KL + + 
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 61  ----------GGTGIPNLRWFGVEGDYNVLVIDLLG-----PSLEDLFNFCSRKLSLKTV 105
                     G   I  L         N + + ++        L  +  +  R + L  V
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 106 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
             ++ Q++  ++++H +   +H DIKP+N L  +    +   +I   +A         +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
                      T  Y S    LG       D+ S   ++   + G   ++  +  +  + 
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
            + I++      I  L    P+       Y R+  F+ +     + +L
Sbjct: 241 DDHIAQ------IIELLGELPSYLLRNGKYTRTF-FNSRGLLRNISKL 281

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 93.7 bits (232), Expect = 3e-22
 Identities = 36/234 (15%), Positives = 86/234 (36%), Gaps = 17/234 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
           +  ++ + IG+G FGE+  G      +    VAIK       + +      EA +     
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 61  GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
               + +L     +    +++ + +   SL+        + ++  ++ +   +   ++++
Sbjct: 86  H-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
              +++HRD+   N L+          + DFGL++   D  +     Y          R+
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRW 199

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
            +       + +   D+ S G V+   +  G  P+  +   T +     I +  
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 5e-22
 Identities = 53/252 (21%), Positives = 102/252 (40%), Gaps = 26/252 (10%)

Query: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKIL 59
            V  +++  + IGSG+ G +    +   +  VAIK  +   ++     +   E  L K +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 60  QGGTGIPNLRWF-----GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
                I  L  F       E     LV++L+     +L      +L  + +  L  QM+ 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLC 130

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
            ++ +HS   +HRD+KP N ++   +    + I+DFGLA+    +               
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------V 179

Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
            T  Y +    LG+      D+ S+G ++   +R  + + G        ++ K+ E+  +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGT 236

Query: 235 TSIEALCRGYPT 246
              E + +  PT
Sbjct: 237 PCPEFMKKLQPT 248

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.4 bits (229), Expect = 5e-22
 Identities = 51/273 (18%), Positives = 102/273 (37%), Gaps = 21/273 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
           ++    ++IGSG FG ++LG  +   ++VAIK +            EA++   L     +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 62

Query: 66  PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
             L    +E     LV + +    L D         + +T+L +   +   + ++     
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122

Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
           +HRD+   N L+        + + DFG+ +   D         +         ++AS   
Sbjct: 123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEV 173

Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
                 S + D+ S G ++      G +P++     +  +  E IS            R 
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPRL 226

Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
             T      ++C   R +D+P ++ L R   ++
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 8e-22
 Identities = 62/283 (21%), Positives = 97/283 (34%), Gaps = 29/283 (10%)

Query: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGTGI 65
             +G G F  +Y   +  TN+ VAIK        E     +     E KL + L     I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62

Query: 66  PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
             L           LV D +   LE +    S  L+   +       +  +E++H    L
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
           HRD+KP+N L+        + + DFGLAK +         P R   +   T  Y +    
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172

Query: 186 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
            G        D+ ++G +L   L       G    +   +  +I E   + + E      
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW---- 225

Query: 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIREGFQFD 285
             +  S   Y     F   P +        DL   I+  F F+
Sbjct: 226 -PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 9e-22
 Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 36/246 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQG 61
           N  +    IG G+FG++      +     + AIK       K  H     E ++   L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 62  GTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLSLKTV 105
              I NL        Y  L I+     +L D                 N  +  LS + +
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
           L  A  +   ++++  K F+HRD+   N L+G         I DFGL++           
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQK 224
                       R+ ++ +      +   D+ S G +L   +  G  P+ G+   T  + 
Sbjct: 187 --------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235

Query: 225 YEKISE 230
           YEK+ +
Sbjct: 236 YEKLPQ 241

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 1e-21
 Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 32/293 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQ 60
           V   +R  + +GSG++G +    + +T  +VAIK        +    +   E +L K ++
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75

Query: 61  GGTGIPNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
               +  L       +         LV+  +G  L  L      KL    +  L  QM+ 
Sbjct: 76  -HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLK 132

Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ--HIPYRENKN 172
            + ++H+   +HRD+KP N  +       ++ I+DFGLA++     T       YR  + 
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189

Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
           +    RY           ++  D+ S+G ++   + G   ++G     + ++  K++   
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
            +  ++ L       +           F      A    L  +L + +    D
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.6 bits (226), Expect = 1e-21
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 16/212 (7%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGG 62
            K+    KIG G++G ++   N +T+E VA+K     ++ +        E  L K L+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-H 60

Query: 63  TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
             I  L           LV +     L+  F+ C+  L  + V     Q++  + F HS+
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
           + LHRD+KP N L+    R  ++ + +FGLA+ +        IP R       T  Y   
Sbjct: 121 NVLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPP 170

Query: 183 NTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 213
           +   G +  S   D+ S G +         P 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 2e-21
 Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 34/233 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKI 58
           N+   G+ +G+G+FG++   T            VA+K+       T+   L  E K+   
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 59  LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL-----------------FNFCSRKL 100
           L     I NL      G   +++ +      L +                         L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
            L+ +L  + Q+   + F+ SK+ +HRD+   N L+          I DFGLA+  ++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199

Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
            +         N     ++ +  +      +   D+ S G  L          
Sbjct: 200 NYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 5e-21
 Identities = 43/224 (19%), Positives = 91/224 (40%), Gaps = 21/224 (9%)

Query: 4   RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIK------LENVKTKHPQLQYEA 53
           +VG   F L + +G+G++G+++L   I    T +  A+K      +          + E 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 54  KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
           ++ + ++    +  L +         L++D +             + +   V +   +++
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
             +E +H    ++RDIK +N L+        V + DFGL+K +    T +   +      
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191

Query: 174 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 215
            GT  Y + +   G +    +  D  SLG ++   L G+ P+  
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 7e-20
 Identities = 33/233 (14%), Positives = 80/233 (34%), Gaps = 16/233 (6%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK---LENVKTKHPQLQYEAKLYKIL 59
           +     + IG+G FGE+Y G    ++ +    VAIK       + +      EA +    
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 60  QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
                I             ++   +   +L+        + S+  ++ +   +   ++++
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
            + +++HRD+   N L+          + DFGL++   D     +             R+
Sbjct: 127 ANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRW 179

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
            +       + +   D+ S G V+   +            +  +  + I++  
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.1 bits (212), Expect = 2e-19
 Identities = 47/253 (18%), Positives = 99/253 (39%), Gaps = 38/253 (15%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIK---LENVKTKHPQLQYEAKLY 56
           ++  LG+ +G G+FG++ L   I  +++       VA+K    +  +     L  E ++ 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 57  KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKL 100
           K++     I NL     +     ++++     +L +                      +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
           S K ++  A Q+   +E++ SK  +HRD+   N L+      N + I DFGLA+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189

Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 219
            ++        N     ++ +         + + D+ S G +L      G  P+ G+   
Sbjct: 190 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 241

Query: 220 TKKQKYEKISEKK 232
             ++ ++ + E  
Sbjct: 242 PVEELFKLLKEGH 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 1e-18
 Identities = 48/245 (19%), Positives = 89/245 (36%), Gaps = 29/245 (11%)

Query: 7   NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIK---LENVKTKHPQLQYEAKLYKI 58
            K  + R++G GSFG +Y G        +    VAIK         +  +   EA + K 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 59  LQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---------KLSLKTVLMLA 109
                 +  L          V++  +    L+                   SL  ++ +A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
            ++ + + ++++  F+HRD+   N ++        V I DFG+ +   +T       YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191

Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKI 228
                   R+ S  +      +   D+ S G VL         P+QGL   + +Q    +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248

Query: 229 SEKKV 233
            E  +
Sbjct: 249 MEGGL 253

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.7 bits (201), Expect = 5e-18
 Identities = 42/218 (19%), Positives = 86/218 (39%), Gaps = 16/218 (7%)

Query: 8   KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKHPQLQY---EAKLYKILQG 61
                  IG G FG +Y GT +  +      A+K  N  T   ++     E  + K    
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 62  GTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
              + +L    +  + + LV+   +    L +     +   ++K ++    Q+   ++F+
Sbjct: 88  -PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
            SK F+HRD+   N ++        V + DFGLA+   D                   ++
Sbjct: 147 ASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKW 200

Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 216
            ++ +    + + + D+ S G +L   + RG+ P+  +
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 7e-18
 Identities = 41/232 (17%), Positives = 83/232 (35%), Gaps = 33/232 (14%)

Query: 7   NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
           ++ +LG+ +G G+FG++            T   VA+K+      H + +      KIL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 62  GTGIPNLR----WFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLS 101
                N+          G   +++++     +L                   +     L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
           L+ ++  + Q+   +EF+ S+  +HRD+   N L+      N V I DFGLA+       
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189

Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
           +         +     ++ +  T      + + D+ S G +L          
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.3 bits (192), Expect = 1e-17
 Identities = 23/161 (14%), Positives = 55/161 (34%), Gaps = 31/161 (19%)

Query: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------KHPQLQYEAKL--- 55
           +G+ +G G    ++   + +   E  +K   V                      A     
Sbjct: 4   IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 56  --YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
             ++ LQ   G+   + +  EG+  ++         E +      ++ ++    + D ++
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMIL 113

Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
             V   + +  +H D+   N L+        ++IIDF  + 
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 3e-16
 Identities = 58/274 (21%), Positives = 96/274 (35%), Gaps = 28/274 (10%)

Query: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-T 63
           +     L   IG G FGE++ G      EEVA+K+ +   +      EA++Y+ +     
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHE 57

Query: 64  GIPNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSR---------KLSLKTVLMLADQM 112
            I        + +     + L+    E   LF++ +R         KL+L T   LA   
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
           +  V      +  HRD+K  N L+    +     I D GLA R+        I      +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NH 171

Query: 173 LTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
             GT RY               E  +R D+ ++G V     R        +         
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231

Query: 227 KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 259
             S+  V    + +C +       + +  C +LR
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	404
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.11
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.15
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.1
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.09

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-63  Score=464.32  Aligned_cols=297  Identities=77%  Similarity=1.348  Sum_probs=267.6

Q ss_pred             CCcccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         1 m~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ||.++|++|++++.||+|+||+||+|++..+|+.||||++......+++..|+++++.++|+++|..+..+.......++
T Consensus         1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            89999999999999999999999999999999999999988887788899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      +|||++++|.+.+....+.+++..+..++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+....
T Consensus        81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            99999999999988778889999999999999999999999999999999999998765677889999999999888776


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .....+++......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+..........+.+.+
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            66655666677889999999999999999999999999999999999999999987776666666666666666677778


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                      ..++|+++.+++.+||+.||++||++++|.++|++++.+.++..+.++||+..+...
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~  297 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA  297 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCC
Confidence            889999999999999999999999999999999999999999999999999887654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.4e-61  Score=444.85  Aligned_cols=289  Identities=60%  Similarity=1.016  Sum_probs=265.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      +++++|++++.||+|+||+||+|++..+|+.||||+++.....+.+.+|+++++.|+|+++++.+..++..+...+++||
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            67999999999999999999999999999999999988777778899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCCeEEEEecCCcccccccCC
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~--~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      |++++|.+++......+++.++..++.|++.||+|||++||+||||||+|||++...  ..+.+||+|||+|+.+.....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            999999999987777899999999999999999999999999999999999996322  357899999999998877666


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                      ....+.+......||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+.++...+.......++
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC  241 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence            55555566677899999999999999999999999999999999999999999888777777777777777677778888


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccc
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI  292 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~  292 (404)
                      .++|+++.+++..||..+|++||+++.+.++|++++.+.+...+.++||+.
T Consensus       242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~  292 (293)
T d1csna_         242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  292 (293)
T ss_dssp             TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence            899999999999999999999999999999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=406.61  Aligned_cols=244  Identities=22%  Similarity=0.304  Sum_probs=208.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      -++|++++.||+|+||+||+|+++.+++.||||++..     ......+.+|+++++.++|+|++..+.. ..+....++
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-~~~~~~~~i   83 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYL   83 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEE-EEECCEEEE
Confidence            4689999999999999999999999999999998753     3345568899999999998876665554 456778899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +++|.+++.. ..++++.++..|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC
T ss_pred             EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC
Confidence            99999 8899999985 4579999999999999999999999999999999999999   67889999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      .         .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.   +..+.+..+......     
T Consensus       160 ~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~-----  222 (263)
T d2j4za1         160 R---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT-----  222 (263)
T ss_dssp             C---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC-----
T ss_pred             c---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence            2         23467999999999999999999999999999999999999999874   344555555554432     


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ++..+|+++.+||.+||+.||++|||++++++
T Consensus       223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            34568999999999999999999999887754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=412.87  Aligned_cols=269  Identities=19%  Similarity=0.289  Sum_probs=218.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      .++|++++.||+|+||+||+|+++.+++.||||+++.     ....+.+.+|++++++++|++++..+.. ..+.+..++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-~~~~~~~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-FQDDEKLYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-EECSSEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE-EEECCEEEE
Confidence            4679999999999999999999999999999998753     2344568999999999998777766554 456678899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ |++|.+++.. .+.+++..++.++.|++.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence            99999 7899999885 4679999999999999999999999999999999999999   68889999999999877543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ....     ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.   +..+.+.++......     
T Consensus       162 ~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~-----  228 (288)
T d1uu3a_         162 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD-----  228 (288)
T ss_dssp             -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred             Cccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence            3211     234568999999999999999999999999999999999999999874   445555665554432     


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      ++..+++++++||.+||+.||++|||++++.+.. .+   ...+|...++|+....+
T Consensus       229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~-~i---~~Hpff~~i~w~~l~~~  281 (288)
T d1uu3a_         229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-PL---KAHPFFESVTWENLHQQ  281 (288)
T ss_dssp             CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH-HH---HTSGGGTTCCCTTGGGS
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH-HH---HcCCccCCCCHHHhhcC
Confidence            3457899999999999999999999999875421 11   12355566788866543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=410.38  Aligned_cols=247  Identities=21%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .++|++.++||+|+||+||+|++..+|+.||||+++...  ..+.+.+|+.+++.++|+|+|..+..+ ...+..+++||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~ivmE   97 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME   97 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-EECCEEEEEEE
Confidence            358999999999999999999999999999999876433  345689999999999988777666554 56678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ |++|.+++..  +.+++.++..|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+..... 
T Consensus        98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred             ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence            99 8899998874  469999999999999999999999999999999999999   5788999999999987755432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.   ...+..+.......  ...+.
T Consensus       172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~--~~~~~  240 (293)
T d1yhwa1         172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNPE  240 (293)
T ss_dssp             ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSSGG
T ss_pred             ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCcc
Confidence                  23456899999999999999999999999999999999999999987433   33333333222111  12335


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+++++++||.+||+.||++|||+++++
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKELL  268 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            6899999999999999999999988764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=407.65  Aligned_cols=258  Identities=21%  Similarity=0.345  Sum_probs=208.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      .++|+++++||+|+||+||+|++   +..||||+++....    .+.+.+|+.++++++|+|++..+.++ . ....+++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~-~~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-APQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SSSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-e-ccEEEEE
Confidence            47899999999999999999974   34699999865432    24588999999999988888766543 3 3457899


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.....++++.+++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-----
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccccC
Confidence            9999 789999998666789999999999999999999999999999999999999   588999999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ..     .......||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+...  .......+......+..
T Consensus       159 ~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         159 GS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCG
T ss_pred             Cc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcc
Confidence            21     123456899999999999753   489999999999999999999999987543  23333444444445555


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      ......+|+++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            66677899999999999999999999999999999987753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=407.20  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=204.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +.++|+++++||+|+||+||+|+++.+|+.||||+++...   ..+.+.+|++++++++|+|++..+..+ .+....+++
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-ccCceeEEE
Confidence            3578999999999999999999999999999999986543   234689999999999988777665544 567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+....
T Consensus        82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred             EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence            9999 7899999873 5579999999999999999999999999999999999999   577899999999998765433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..     ......+||+.|||||++.+..+ +.++|||||||+||||+||+.||........  .+.........   ..
T Consensus       158 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~~~~~~---~~  227 (271)
T d1nvra_         158 RE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTY---LN  227 (271)
T ss_dssp             EE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHHTTCTT---ST
T ss_pred             cc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCCC---CC
Confidence            21     12345789999999999998876 6789999999999999999999987544322  22222222211   12


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ....+++++.+|+.+||+.||++|||+++++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            2346789999999999999999999988763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=407.33  Aligned_cols=249  Identities=21%  Similarity=0.252  Sum_probs=199.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEee-eeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~l   80 (404)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++......    +.+.+|++++++++|+|++..+..+. ......++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36899999999999999999999999999999998765433    34788999999999998888887664 34566899


Q ss_pred             EEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           81 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                      +|||+ +|+|.+++..   .+..+++..++.++.||+.||+|||++|     ||||||||+|||+   +.++.+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeecc
Confidence            99999 8899999864   2467999999999999999999999976     9999999999999   678999999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  231 (404)
                      +|+.+.....       ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+   ..+.+..+...
T Consensus       160 ~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~  229 (269)
T d2java1         160 LARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREG  229 (269)
T ss_dssp             HHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT
T ss_pred             ceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcC
Confidence            9987765432       2345789999999999999999999999999999999999999998743   34455555554


Q ss_pred             cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...    .++..+|+++.+||.+||+.||++|||+++|++
T Consensus       230 ~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 KFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            432    234578999999999999999999999987753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=407.72  Aligned_cols=250  Identities=18%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+.|++++.||+|+||+||+|++..+++.||||+++....  .+.+.+|+++++.++|+|+|..+..+ .+....+++||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lvmE   89 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLWILIE   89 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCeEEEEEe
Confidence            3569999999999999999999999999999999865433  35689999999999988777666554 56678899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.+++....+.+++.++..|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+....... 
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc-
Confidence            99 889999987667789999999999999999999999999999999999999   5788999999999976554321 


Q ss_pred             ccccccCCCCCccCcCcccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          163 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                            ......||+.|+|||++.     +..|+.++|||||||+||||+||+.||.+.+...   .+.++.......  
T Consensus       166 ------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~~~~~~~--  234 (288)
T d2jfla1         166 ------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIAKSEPPT--  234 (288)
T ss_dssp             ------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHHSCCCC--
T ss_pred             ------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCCCCC--
Confidence                  223568999999999984     4558999999999999999999999998865433   334444332211  


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+..+|+++.+||.+||+.||++|||++++++
T Consensus       235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1223468999999999999999999999887643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-55  Score=410.80  Aligned_cols=253  Identities=19%  Similarity=0.237  Sum_probs=198.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      +.+.|++.+.||+|+||+||+|+++.+++.||||++....   ....+.+|+.+++.++|+|++..+.. ..++...+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-YESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-EECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEE-EEECCEEEEE
Confidence            5677999999999999999999999999999999886543   23457899999999998776666554 4567788999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ |++|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+|+......
T Consensus        86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            9999 7999999974 5679999999999999999999999999999999999999765678899999999998665433


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                      .        ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.   ...+.+..+........ ...
T Consensus       165 ~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~  232 (307)
T d1a06a_         165 V--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFD-SPY  232 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCCC-TTT
T ss_pred             e--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhccCCCCC-Ccc
Confidence            2        23568999999999999999999999999999999999999999874   33455555555443332 223


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ...+|+++.+||.+||++||++|||++++++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            4578999999999999999999999887643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=397.27  Aligned_cols=249  Identities=20%  Similarity=0.304  Sum_probs=205.7

Q ss_pred             cCCce-EEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeee---CC
Q 015592            5 VGNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GD   76 (404)
Q Consensus         5 ~~~~y-~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~   76 (404)
                      ..++| ++.++||+|+||+||+|++..+++.||+|++.....    .+.+.+|++++++++|+|+|..+..+...   ..
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            34555 788899999999999999999999999998765432    23588999999999999888888776442   45


Q ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      ..+++|||+ +++|.+++.. ...+++.+++.|+.||+.||+|||+++  |+||||||+|||++  +.++.+||+|||+|
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             EEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence            679999999 8899999985 457999999999999999999999998  99999999999994  35789999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      +......         .....||+.|||||++.+ .++.++|||||||+||||++|+.||.+..  ...+.+..+.....
T Consensus       163 ~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~  230 (270)
T d1t4ha_         163 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK  230 (270)
T ss_dssp             GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC
T ss_pred             eeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCC
Confidence            7544322         235689999999999976 59999999999999999999999998643  33444455544332


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .   ..+...+++++.+||.+||+.||++|||++++++
T Consensus       231 ~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            2   2344578899999999999999999999987753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-55  Score=405.06  Aligned_cols=260  Identities=15%  Similarity=0.231  Sum_probs=201.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|++.++||+|+||+||+|++..+++   .||||.+......   +.+.+|++++++++|+|+|..++.+ ......+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-TKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeCCEEE
Confidence            4689999999999999999999877664   5888887654332   3588999999999988877766655 5566789


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +|+|.+++....+.+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEccC
Confidence            999999 889999988666679999999999999999999999999999999999999   6889999999999987765


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ......  ........||+.|||||++.+..++.++|||||||+||||+| |+.||.+...   .+.+..+......   
T Consensus       181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~---  252 (299)
T d1jpaa_         181 DTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRL---  252 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC---
T ss_pred             CCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence            432111  112233568999999999999999999999999999999998 8999988543   3444444443222   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                       ..+..+|+++.+|+.+||+.||++||++.+|++.|++++.
T Consensus       253 -~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 -PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             2235689999999999999999999999999999998875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-55  Score=403.40  Aligned_cols=256  Identities=20%  Similarity=0.290  Sum_probs=211.8

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ++|++.++||+|+||+||+|++..+++.||||+++.... .+++.+|++++++++|+|++..++.+ .++...+++|||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-eeCCeeEEEeecc
Confidence            579999999999999999999999999999999865543 45699999999999988877776655 4556778999999


Q ss_pred             -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 -~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                       +|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+........ 
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~-  171 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT-  171 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSE-
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCce-
Confidence             88999998753 4569999999999999999999999999999999999999   67899999999999876554321 


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                           ......||+.|+|||++.+..|+.++|||||||++|||++|..||....  +..+.+..+.... .   ...+..
T Consensus       172 -----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~-~---~~~~~~  240 (287)
T d1opja_         172 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDY-R---MERPEG  240 (287)
T ss_dssp             -----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTC-C---CCCCTT
T ss_pred             -----eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCC-C---CCCCcc
Confidence                 1234568999999999999999999999999999999999776665422  2233333333322 1   233457


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +|+++.+|+.+||+.||++|||+++|.+.|+.++.
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999999998887653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=400.96  Aligned_cols=258  Identities=20%  Similarity=0.294  Sum_probs=213.3

Q ss_pred             CceEEeee-eceeCceeEEEEEEcC--CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGRK-IGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ++|.+.+. ||+|+||+||+|.+..  ++..||||+++.....   +.+.+|++++++++|+|++..++.+.  .+..++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--cCeEEE
Confidence            56888884 9999999999998754  4557999998755432   45889999999999888888776553  345789


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +|+|.+++...+..+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccccc
Confidence            99999 789999987656789999999999999999999999999999999999999   57889999999999877654


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                      ....    .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.   .+.+..+......    
T Consensus       163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~----  231 (285)
T d1u59a_         163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM----  231 (285)
T ss_dssp             SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC----
T ss_pred             cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence            3211    12345678999999999999899999999999999999998 9999988654   3334444443322    


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHc
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE  280 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  280 (404)
                      ..+..+|+++.+|+.+||+.||++||++.+|.+.|++.+...
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            334678999999999999999999999999999999988653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-54  Score=410.30  Aligned_cols=252  Identities=18%  Similarity=0.276  Sum_probs=210.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.....  .+.+.+|+.++++++|+|++..+..+ .+....+++||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-EETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEE
Confidence            4689999999999999999999999999999999865432  24588999999999987777666544 56778999999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ |++|.+++....+++++.++..|+.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+|+.+..... 
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~-  181 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-  181 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC-
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc-
Confidence            99 89999999655667999999999999999999999999999999999999952 2357899999999987665432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.   +..+.+..+........ .....
T Consensus       182 -------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~  250 (350)
T d1koaa2         182 -------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAFS  250 (350)
T ss_dssp             -------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGGGG
T ss_pred             -------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-ccccc
Confidence                   23468999999999999999999999999999999999999999874   34455555555443322 23345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .+++++++||.+||+.||++|||++++++
T Consensus       251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         251 GISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            78999999999999999999999887643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=397.57  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=209.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      .++|++.++||+|+||+||+|++ ++++.||||+++... ..+.+.+|+.++++++|+|++..+..+ .+ +..+++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeee-cc-CCeEEEEEe
Confidence            46899999999999999999997 467899999987544 345699999999999988888877654 33 446899999


Q ss_pred             c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +|+|.+++... ..++++.+++.|+.||+.||.|||+++|+||||||+||||   +.++.+||+|||+|+.+..... 
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCcc-
Confidence            9 89999877532 3369999999999999999999999999999999999999   6889999999999987765432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                           .......||+.|+|||++.+..++.++|||||||+||||+||..||...  ....+.+..+......    ..+.
T Consensus       165 -----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~----~~p~  233 (272)
T d1qpca_         165 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRM----VRPD  233 (272)
T ss_dssp             -----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCT
T ss_pred             -----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCcc
Confidence                 1234567899999999999889999999999999999999965554332  2233444444433221    2345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .+|+++.+|+.+||+.||++|||+++|++.|+++|..
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            7899999999999999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=393.97  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=201.4

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ++|++.+.||+|+||+||+|++. +++.||||+++... ..+++.+|++++++++|+|++..++.+. .....+++|||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-EQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-cCCceEEEEEec
Confidence            68999999999999999999974 67789999987544 3456999999999999888777666554 456678999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++........  
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~--  157 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT--  157 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce--
Confidence             899999988666779999999999999999999999999999999999999   68899999999999876554321  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                          ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...   ...+.+..+......    ..+..
T Consensus       158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~----~~p~~  226 (263)
T d1sm2a_         158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRL----YKPRL  226 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCC----CCCTT
T ss_pred             ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCC----CCccc
Confidence                2234578999999999999999999999999999999999 56666543   334444444443221    22356


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      +|+++.+++.+||+.||++||++++|++.|+++..
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999999998854

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-54  Score=396.96  Aligned_cols=253  Identities=20%  Similarity=0.248  Sum_probs=211.0

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      -+.++|++++.||+|+||+||+|+++.+|+.||||+++...        ..+.+.+|+.++++++|+|+|..+.. ..+.
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~   85 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-YENK   85 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-EECS
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE-EEEC
Confidence            35678999999999999999999999999999999876432        13458899999999998777765554 4667


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCCeEEEEecCCc
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA  153 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~-~~~~vkL~DFG~a  153 (404)
                      ...+++|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||+|
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            7889999999 8899999985 45799999999999999999999999999999999999995322 2236999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      +.......        .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.   +..+.+..+.....
T Consensus       165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~  233 (293)
T d1jksa_         165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY  233 (293)
T ss_dssp             EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCC
T ss_pred             hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCC
Confidence            87754432        34568899999999999999999999999999999999999999874   34455555555443


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ... ......+|+++.+||.+||+.||++|||+++++
T Consensus       234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil  269 (293)
T d1jksa_         234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL  269 (293)
T ss_dssp             CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            332 344567899999999999999999999988764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-54  Score=403.14  Aligned_cols=264  Identities=19%  Similarity=0.255  Sum_probs=215.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      -++|++++.||+|+||.||+|+++.+|+.||||+++.     ......+.+|+.+++.++|++++..+ .+..+.+..++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~~~~~~~~~i   82 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEE-EEEECSSEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEE-eeecccccccc
Confidence            4689999999999999999999999999999998763     23446688999999999876655554 55567778899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus        83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred             ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence            99999 8999999885 4579999999999999999999999999999999999999   68899999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+   ..+.+..+.....     .
T Consensus       159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~-----~  223 (337)
T d1o6la_         159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEI-----R  223 (337)
T ss_dssp             TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC-----C
T ss_pred             Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCC-----C
Confidence            32       2346789999999999999999999999999999999999999998843   3445555554443     2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      ++..+++++++||.+||++||++|++..  .+.+++++.       |...++|.....+
T Consensus       224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp-------~f~~i~~~~l~~~  275 (337)
T d1o6la_         224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR-------FFLSINWQDVVQK  275 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG-------GGTTCCHHHHHTT
T ss_pred             CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc-------ccccCCHHHHHhC
Confidence            3467899999999999999999999622  133334333       3334567655433

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-53  Score=393.11  Aligned_cols=262  Identities=20%  Similarity=0.324  Sum_probs=209.4

Q ss_pred             cccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeC--
Q 015592            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEG--   75 (404)
Q Consensus         3 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--   75 (404)
                      ..+.++|++.+.||+|+||+||+|++..+++.||||+++.....     ..+.+|+++++.++|++++..+..+....  
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            35788999999999999999999999999999999998754332     24789999999999999888887776544  


Q ss_pred             -CeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           76 -DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        76 -~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                       ...|++|||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.++|+|||.+
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  158 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred             CceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence             3578999999 7899998875 4579999999999999999999999999999999999999   58899999999998


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      +.........    .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+   ..+...++.....
T Consensus       159 ~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~  231 (277)
T d1o6ya_         159 RAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDP  231 (277)
T ss_dssp             EECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred             hhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCC
Confidence            7655433211    12345689999999999999999999999999999999999999998743   3333444333332


Q ss_pred             cccHhHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHH
Q 015592          234 STSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL  276 (404)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-~~~~l~~~l~~~  276 (404)
                      . ........+|+++.++|.+||++||++|| +++++.+.|.++
T Consensus       232 ~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 I-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             C-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            2 22334467899999999999999999999 888888777665

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=408.00  Aligned_cols=254  Identities=19%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      +..++|+++++||+|+||+||+|++..+|+.||+|+++....   ..++.+|+.+++.++|+|+|..+..+ .+....++
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~i   81 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISI   81 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-ECSSEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEE
Confidence            346889999999999999999999999999999999875432   24588999999999988777666555 46667899


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ||||+ |++|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        82 VmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred             EEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence            99999 7899999985 4569999999999999999999997 599999999999999   6789999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc------
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------  232 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------  232 (404)
                      ..         ..+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...............      
T Consensus       158 ~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         158 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             HT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             Cc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            32         245689999999999999999999999999999999999999998754322111100000000      


Q ss_pred             -----------------------------ccccHhHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 -----------------------------VSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 -----------------------------~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                                   .....+.++ ..++.++.+||.+||..||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                         000000011 135789999999999999999999987755

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-54  Score=410.20  Aligned_cols=252  Identities=21%  Similarity=0.231  Sum_probs=210.4

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      +.++|++++.||+|+||+||+|++..+|+.||||+++....  ...+.+|+.++++|+|+|+|..+..+ .++...+++|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~ivm  105 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLIL  105 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEE
Confidence            44679999999999999999999999999999999875432  23578899999999987777666554 5677889999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ |++|.+++.....++++.+++.|+.||+.||+|||++|||||||||+|||++. ...+.+||+|||+|+.+.....
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc
Confidence            999 89999988755667999999999999999999999999999999999999942 1568999999999987765432


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+   ..+.+..+.......+ ....
T Consensus       185 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~  252 (352)
T d1koba_         185 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFD-EDAF  252 (352)
T ss_dssp             --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCC-SSTT
T ss_pred             --------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-cccc
Confidence                    234578999999999999999999999999999999999999998743   3444555554443222 2334


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ..+|+++.+||.+||+.||++|||+++++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil  281 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL  281 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            57899999999999999999999988764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=395.30  Aligned_cols=249  Identities=19%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             eeeceeCceeEEEEEEc--CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc-
Q 015592           13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-   85 (404)
Q Consensus        13 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   85 (404)
                      ++||+|+||+||+|.+.  .+++.||||+++....    .+.+.+|++++++++|+|++..++.+ . .+..+++|||+ 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~-~-~~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-AESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-SSSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEe-c-cCCEEEEEEcCC
Confidence            47999999999999864  4567899999865433    24588999999999998888877665 3 34468999999 


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcccc
Q 015592           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI  165 (404)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~  165 (404)
                      +|+|.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++.+.......  
T Consensus        91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~--  164 (277)
T d1xbba_          91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY--  164 (277)
T ss_dssp             TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE--
T ss_pred             CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc--
Confidence            8899999985 5679999999999999999999999999999999999999   688999999999998765443221  


Q ss_pred             cccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcCC
Q 015592          166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY  244 (404)
Q Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (404)
                        .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.   .+....+.....    ...+..+
T Consensus       165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~----~~~p~~~  235 (277)
T d1xbba_         165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER----MGCPAGC  235 (277)
T ss_dssp             --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCCCTTC
T ss_pred             --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCC----CCCCccc
Confidence              12345678999999999999999999999999999999998 9999988543   344444443322    2234578


Q ss_pred             cHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       245 ~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      |+++.+|+.+||+.||++||++++|.+.|++.+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999999999999999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=397.30  Aligned_cols=242  Identities=21%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .|++++.||+|+||+||+|++..+++.||||++......     +.+.+|++++++++|+|+|..+.. ..+....+++|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-~~~~~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC-YLREHTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEE-EEETTEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEE-EEECCEEEEEE
Confidence            599999999999999999999999999999998765432     347899999999998877766655 45677899999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ +++|..++. ..+++++.+++.|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus        95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC--
Confidence            999 566655544 46789999999999999999999999999999999999999   58899999999999865432  


Q ss_pred             cccccccCCCCCccCcCccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE  238 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (404)
                               ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+..   ..+.+..+........  
T Consensus       169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~--  234 (309)
T d1u5ra_         169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPAL--  234 (309)
T ss_dssp             ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCC--
T ss_pred             ---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC--
Confidence                     34579999999999875   358999999999999999999999998743   3344444444333221  


Q ss_pred             HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ....+|+++.+||.+||+.||++|||++++++
T Consensus       235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence             12457999999999999999999999987743

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=390.03  Aligned_cols=251  Identities=18%  Similarity=0.276  Sum_probs=212.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      ++|++.++||+|+||+||+|++ ++++.||||+++... ..+++.+|+.++++++|+|++..++.+ .+....+++|||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-CCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-eeCCceEEEEEcc
Confidence            6899999999999999999998 578899999987654 446799999999999988877777655 4556789999999


Q ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCccc
Q 015592           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH  164 (404)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~  164 (404)
                       +|+|.+++......+++..++.|+.||++||+|||++||+||||||+|||+   +.++.+||+|||+++.+......  
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~--  156 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT--  156 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC--
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce--
Confidence             789999987666789999999999999999999999999999999999999   67899999999999876554321  


Q ss_pred             ccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                          ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.   .+....+......    ..+..
T Consensus       157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~  225 (258)
T d1k2pa_         157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRPHL  225 (258)
T ss_dssp             ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC----CCCTT
T ss_pred             ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCC----CCccc
Confidence                2335678999999999999999999999999999999998 8999988543   4444444443221    23457


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD  275 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~  275 (404)
                      +|+++.+|+.+||+.||++|||+++|++.|.+
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            88999999999999999999999999888754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=400.68  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCc-----EEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ++|+++++||+|+||+||+|++..+++     .||+|.+...   .....+.+|+.++.++.+|++|..+..+.......
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            689999999999999999999876554     6999987543   23456889999999995445555555555667778


Q ss_pred             EEEEecc-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NIL  135 (404)
                      +++|||+ +|+|.++++...                      ..+++.+++.|+.||+.||+|||++|||||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            9999999 899999997432                      24899999999999999999999999999999999999


Q ss_pred             ccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 015592          136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ  214 (404)
Q Consensus       136 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~  214 (404)
                      +   +.++.+||+|||+|+.........     ......||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus       197 l---~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         197 V---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             E---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             c---ccCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9   688999999999998766543211     2235678999999999999999999999999999999998 899998


Q ss_pred             CCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015592          215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR  274 (404)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~  274 (404)
                      +.....   .+.++.......   ..+..+|+++.+||.+||+.||++|||+++|++.|.
T Consensus       269 ~~~~~~---~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDA---NFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSH---HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHH---HHHHHHhcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            865432   223333332222   234578999999999999999999999999998875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=402.92  Aligned_cols=256  Identities=16%  Similarity=0.187  Sum_probs=202.9

Q ss_pred             ccCCceEEee-eeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHH-cCCCCCCceeEeee---eCCeE
Q 015592            4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL-QGGTGIPNLRWFGV---EGDYN   78 (404)
Q Consensus         4 ~~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~---~~~~~   78 (404)
                      .+.++|++.+ .||+|+||+||+|++..+++.||||+++   ....+.+|+.++.++ +|++++..+..+..   .....
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~---~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC---CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            3456898875 5999999999999999999999999986   356788999998776 56666666555533   24678


Q ss_pred             EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      |++|||| ||+|.+++... ...+++.++..|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+..
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence            9999999 78999999753 346999999999999999999999999999999999999975556778999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHH-HHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~  235 (404)
                      .....        .....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.........+ ..+.......
T Consensus       165 ~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         165 TSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             cCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            65432        34568999999999999999999999999999999999999999875543322222 2222222111


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      + ......+++++.+||.+||+.||++|||+.++++
T Consensus       237 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         237 P-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             C-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1 1222357899999999999999999999887643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-53  Score=396.05  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=212.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.     ....+.+.+|+.+++.++|++++..+.. ..+....+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-FQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-EECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-EeeCCeeeeE
Confidence            679999999999999999999999999999998753     2344568899999999998777666554 4567789999


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ |++|..++.. ...+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+......
T Consensus        83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred             eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence            9999 8899988874 6679999999999999999999999999999999999999   688999999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                                ...+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.   +..+.+.++......     +
T Consensus       159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~  220 (316)
T d1fota_         159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----F  220 (316)
T ss_dssp             ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----C
T ss_pred             ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----C
Confidence                      3568999999999999999999999999999999999999999874   344555555554332     3


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCceeeccccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK  294 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~  294 (404)
                      +..+|+++.+++.+||.+||.+|+     ++++++   ++       +|...++|....
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il---~H-------p~f~~i~~~~l~  269 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK---NH-------PWFKEVVWEKLL  269 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH---TS-------GGGSSCCHHHHH
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH---cC-------cccccCCHHHHH
Confidence            356899999999999999999996     665543   33       344456777543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.2e-53  Score=385.89  Aligned_cols=250  Identities=18%  Similarity=0.198  Sum_probs=208.2

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCceeEeee
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGTGIPNLRWFGV   73 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~~~~~~~   73 (404)
                      +.++|++.+.||+|+||+||+|++..+++.||||++......           +.+.+|+.++++++.|++|..+..+..
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            468999999999999999999999999999999998654321           247889999999985555555655667


Q ss_pred             eCCeEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCC
Q 015592           74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (404)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~  152 (404)
                      +.+..+++|||+ +++|.++++. .+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~  156 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF  156 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence            888999999999 8899999985 5579999999999999999999999999999999999999   6889999999999


Q ss_pred             cccccccCCcccccccCCCCCccCcCccccccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 015592          153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  226 (404)
                      ++.+.....        .....||+.|+|||.+.+      ..++.++||||+||+||||++|+.||.+.+   ....+.
T Consensus       157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~  225 (277)
T d1phka_         157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR  225 (277)
T ss_dssp             CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred             eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHH
Confidence            987765332        235689999999999863      346889999999999999999999998744   344445


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      .+.........+ ...++|+++++|+.+||+.||++||++++++
T Consensus       226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil  268 (277)
T d1phka_         226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL  268 (277)
T ss_dssp             HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            555544332222 2347899999999999999999999988764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=396.48  Aligned_cols=254  Identities=19%  Similarity=0.270  Sum_probs=213.3

Q ss_pred             ccCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         4 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      .+-++|++++.||+|+||+||+|+++.+++.||||+++.+... ..+.+|+++|+.++|+|++..+..+ .+....|++|
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~lvm   80 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-ESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEEEEEE
Confidence            4668999999999999999999999999999999998765433 3478999999999987766666554 5677899999


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+ |++|.+++...+.++++.++..|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc
Confidence            999 78999999865557999999999999999999999999999999999999942 2456899999999987654321


Q ss_pred             cccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhh
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC  241 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (404)
                              .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.   +..+.+..+.......+ ....
T Consensus       160 --------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~  227 (321)
T d1tkia_         160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAF  227 (321)
T ss_dssp             --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHH
T ss_pred             --------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhhc
Confidence                    23457899999999999999999999999999999999999999874   34555666665554433 3444


Q ss_pred             cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       242 ~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      ..+++++.+||.+||..||++|||++++++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            678999999999999999999999887643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=389.33  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=202.6

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV   79 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   79 (404)
                      .++|++++.||+|+||+||+|++..++   ..||||.++.....   +.+.+|+.++++++|+|++..++.+.  ....+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEE
Confidence            368999999999999999999986543   46888887644332   35889999999999988888877663  45678


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheeccC
Confidence            999999 889999887667789999999999999999999999999999999999999   5888999999999987654


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      ...      .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.....   .+..+......   
T Consensus       161 ~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~~---  228 (273)
T d1mp8a_         161 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERL---  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCC---
T ss_pred             Ccc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC---
Confidence            332      12345578999999999999999999999999999999998 899998865543   33344433322   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                       .++.++|+++.+||.+||+.||++|||+.+|++.|++++..
T Consensus       229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             24567899999999999999999999999999999998765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=393.30  Aligned_cols=260  Identities=20%  Similarity=0.275  Sum_probs=201.8

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEe-eeeCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWF-GVEGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~-~~~~~   76 (404)
                      .++|+++++||+|+||.||+|++..     +++.||||+++.....   ..+..|..++.++.||++|..+..+ ...+.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4689999999999999999999754     3478999988654332   3477888899999877766665444 44566


Q ss_pred             eEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015592           77 YNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR  140 (404)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~  140 (404)
                      ..+++|||+ +|+|.+++....               ..+++.+++.++.||+.||+|||++|||||||||+|||+   +
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---C
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---C
Confidence            789999999 899999997432               348999999999999999999999999999999999999   6


Q ss_pred             CCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCC
Q 015592          141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG  219 (404)
Q Consensus       141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg-~~Pf~~~~~~  219 (404)
                      .++.+||+|||+|+.........     ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.+....
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             CCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            78999999999998765443211     23456899999999999999999999999999999999996 5688765433


Q ss_pred             ChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      .  .....+.....    ...+..+|+++.+++.+||+.||++|||+++|++.|++++..
T Consensus       244 ~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 E--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             H--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHHHhcCCC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2  22222222221    123456899999999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.1e-53  Score=398.46  Aligned_cols=257  Identities=19%  Similarity=0.296  Sum_probs=213.6

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..     ....+.+.+|+++++.++|+++|..+..+ ......+++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-ccccccccc
Confidence            689999999999999999999999999999998753     23345688999999999988776665554 556677888


Q ss_pred             Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccC
Q 015592           82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA  160 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~  160 (404)
                      |||+ +++|.+++.. .+.+++.+++.|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.+....
T Consensus       120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred             cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence            8888 8999999875 4579999999999999999999999999999999999999   678899999999998765432


Q ss_pred             CcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHh
Q 015592          161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL  240 (404)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (404)
                                ....||+.|||||++.+..|+.++|||||||+||||+||+.||.+.   +....+..+......     .
T Consensus       196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~  257 (350)
T d1rdqe_         196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR-----F  257 (350)
T ss_dssp             ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----C
T ss_pred             ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCC-----C
Confidence                      3568999999999999999999999999999999999999999874   345555555554432     2


Q ss_pred             hcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCceeeccccccc
Q 015592          241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ  296 (404)
Q Consensus       241 ~~~~~~~l~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~~w~~~~~~  296 (404)
                      +..+++++.+||.+||..||.+|+     ++++|++          .+|...++|.....+
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----------Hp~f~~~~~~~~~~~  308 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQR  308 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHTT
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc----------CccccCCCHHHHHhc
Confidence            356899999999999999999995     6666542          244455678765443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=396.18  Aligned_cols=243  Identities=22%  Similarity=0.292  Sum_probs=203.0

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecC-----CCCchhHHHHHHHHHH-HcCCCCCCceeEeeeeCCeEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKI-LQGGTGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~-l~~~~~i~~~~~~~~~~~~~~l   80 (404)
                      ++|++++.||+|+||+||+|+++.+++.||||+++.     ....+.+..|..++.+ ++|++++ .+..+..++...|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv-~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT-HMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBC-CEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEE-EEEEEEccCCceeE
Confidence            579999999999999999999999999999999853     2334457778887764 5655555 45455567778999


Q ss_pred             EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      +|||+ +|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.....
T Consensus        81 vmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccc
Confidence            99999 8899999985 4579999999999999999999999999999999999999   68899999999999866543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhH
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA  239 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (404)
                      ..       ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+   ..+.+.++.....     .
T Consensus       157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~-----~  221 (320)
T d1xjda_         157 DA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNP-----F  221 (320)
T ss_dssp             TC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC-----C
T ss_pred             cc-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----C
Confidence            32       2345689999999999999999999999999999999999999998743   4445555544332     2


Q ss_pred             hhcCCcHHHHHHHHHHHcCCCCCCCCHH-HH
Q 015592          240 LCRGYPTEFASYFHYCRSLRFDDKPDYA-YL  269 (404)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~~p~~RP~~~-~l  269 (404)
                      ++..+|+++.+||.+||++||++||++. +|
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l  252 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI  252 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence            3457899999999999999999999985 44

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-52  Score=400.12  Aligned_cols=266  Identities=22%  Similarity=0.278  Sum_probs=208.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc---CCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQ---GGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~---~~~~i~~~~~~~~~~~~   77 (404)
                      -++|++++.||+|+||.||+|++..+|+.||||++...     .....+.+|..+++.++   |+++ ..+..+......
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnI-v~l~~~~~~~~~   81 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-VCMSYAFHTPDK   81 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTB-CCEEEEEECSSE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcE-EEEEEEEEECCE
Confidence            36899999999999999999999999999999987532     22334566666665554   4444 445555567778


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .|++|||+ |++|.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+
T Consensus        82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeec
Confidence            89999999 8999999985 4579999999999999999999999999999999999999   68899999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST  235 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  235 (404)
                      ....         .....||+.|+|||++.+ ..|+.++|||||||+||||+||+.||.+....+.......+....   
T Consensus       158 ~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---  225 (364)
T d1omwa3         158 SKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---  225 (364)
T ss_dssp             SSSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC---
T ss_pred             CCCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC---
Confidence            5432         235689999999999975 568999999999999999999999998866555444333322221   


Q ss_pred             cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCceeecccccccc
Q 015592          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQQ  297 (404)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~--l~~~l~~~~~~~~~~~~~~~~w~~~~~~~  297 (404)
                        ..++..+|+++.+||.+||+.||++||+...  +.+++++       +|...++|.....++
T Consensus       226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H-------p~f~~i~~~~~~~~~  280 (364)
T d1omwa3         226 --VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES-------PFFRSLDWQMVFLQK  280 (364)
T ss_dssp             --CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS-------GGGTTCCHHHHHTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC-------ccccCCCHHHHhcCC
Confidence              2234578999999999999999999999411  2233333       344456787654443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=392.55  Aligned_cols=256  Identities=19%  Similarity=0.256  Sum_probs=203.7

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCc----EEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ..+|+++++||+|+||+||+|++..+|+    .||+|.++..   ...+.+.+|+.++++++|+|++..++.+ .++...
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~~   86 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQ   86 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCee
Confidence            4579999999999999999999988876    5788876543   2345689999999999988888777665 445555


Q ss_pred             EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccc
Q 015592           79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD  158 (404)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~  158 (404)
                      ++++++++++|.+.+......+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceeccc
Confidence            5555555999999988777789999999999999999999999999999999999999   6889999999999987655


Q ss_pred             cCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .....     ......||+.|+|||++.+..|+.++|||||||+||||+| |..||.+.+......   .+......   
T Consensus       164 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~i~~~~~~---  232 (317)
T d1xkka_         164 EEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEKGERL---  232 (317)
T ss_dssp             TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---HHHHTCCC---
T ss_pred             ccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCCC---
Confidence            43211     2234578999999999999999999999999999999998 899998865544333   23222211   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                       ..+..+|+++.+|+.+||+.||++|||+.+|++.|..+.
T Consensus       233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence             223568899999999999999999999999999888765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=385.39  Aligned_cols=259  Identities=15%  Similarity=0.170  Sum_probs=201.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      .+.|++.++||+|+||+||+|.+..++    ..||||+++.....   .++.+|++++++++|+|++..++.+ ......
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-~~~~~~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKYKPM   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-ecCCce
Confidence            457999999999999999999987654    47999988654432   3578999999999988777766555 455667


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhccc
Confidence            8899998 888998888767789999999999999999999999999999999999999   688999999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccH
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI  237 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (404)
                      .......    ......||+.|+|||++.+..++.++|||||||+||||++|..||...  ....+.+..+......   
T Consensus       162 ~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~---  232 (283)
T d1mqba_         162 DDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRL---  232 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCC---
T ss_pred             CCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCCC---
Confidence            5432111    123456899999999999999999999999999999999965555432  2233444444443322   


Q ss_pred             hHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                       ..+..+|.++.+|+.+||+.||++||++.+|.+.|+++..
T Consensus       233 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         233 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence             2345689999999999999999999999999999998774

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-53  Score=383.29  Aligned_cols=251  Identities=20%  Similarity=0.288  Sum_probs=205.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEecc
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      -++|++++.||+|+||.||+|++  +|+.||||+++.+...+.+.+|++++++++|+|++..++.+.......+++|||+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            35799999999999999999997  4789999999887778889999999999998888888776655556679999999


Q ss_pred             -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        86 -~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                       +|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++......   
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC---
Confidence             999999986432 359999999999999999999999999999999999999   688999999999998655432   


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                             ....+|..|+|||++.+..++.++|||||||++|||+| |+.||......   +.+..+......    .++.
T Consensus       158 -------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~~----~~~~  223 (262)
T d1byga_         158 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKM----DAPD  223 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCCC----CCCT
T ss_pred             -------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----CCCc
Confidence                   24467899999999999999999999999999999998 78898875443   334444443322    2345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                      .+++++.+|+.+||+.||++|||+.+|.+.|+++-.
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            788999999999999999999999999999988754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=384.03  Aligned_cols=241  Identities=25%  Similarity=0.370  Sum_probs=198.3

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCceeEeeeeC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQG-GTGIPNLRWFGVEG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~   75 (404)
                      +.++|++++.||+|+||+||+|++..+++.||||+++...        ...++.+|+.+++++++ |++|..+..+..+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            5688999999999999999999999999999999876432        22347799999999983 44555565666777


Q ss_pred             CeEEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCc
Q 015592           76 DYNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (404)
Q Consensus        76 ~~~~lv~e~~-~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a  153 (404)
                      +..+++|||+ + +++.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++  .+.+.+||+|||+|
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG  158 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred             CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence            7889999998 3 578888875 45799999999999999999999999999999999999994  34579999999999


Q ss_pred             ccccccCCcccccccCCCCCccCcCccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc
Q 015592          154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (404)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  232 (404)
                      +......         .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.         ..+....
T Consensus       159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~  220 (273)
T d1xwsa_         159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ  220 (273)
T ss_dssp             EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred             eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence            8654432         245689999999999987765 67899999999999999999999762         1222222


Q ss_pred             ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                      .     .+...+|+++.+||.+||+.||++|||++++++
T Consensus       221 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1     234578999999999999999999999887643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=384.94  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=201.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      .++|++++.||+|+||+||+|++..+ +.||||+++.... .+.+.+|+.++++++|+|++..+..+ .+ +..+++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-ec-CCeEEEEEe
Confidence            36899999999999999999998544 6799999875543 35699999999999999888887765 33 346889999


Q ss_pred             c-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        85 ~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      + +|+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+||||   +.++.+||+|||+++........
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCce
Confidence            9 8899988763 34569999999999999999999999999999999999999   67899999999999876543321


Q ss_pred             ccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhc
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR  242 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (404)
                            ......||+.|+|||++.+..++.++|||||||+||||++|..||...  ....+.+..+......    ..+.
T Consensus       170 ------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~----~~~~  237 (285)
T d1fmka3         170 ------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM----PCPP  237 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCT
T ss_pred             ------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCCc
Confidence                  223457899999999999999999999999999999999965555432  2234444444433221    2345


Q ss_pred             CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       243 ~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      .+|+++.+++.+||+.||++||++++|.+.|++.+
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            78999999999999999999999999999888765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=381.86  Aligned_cols=255  Identities=22%  Similarity=0.265  Sum_probs=199.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCC-C--cEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN   78 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   78 (404)
                      ++|++.+.||+|+||+||+|++..+ +  ..||||+++....     .+.+.+|+.++++++|+|++..++++. + ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-e-cch
Confidence            5699999999999999999986533 2  4689998764321     245899999999999888887777664 3 345


Q ss_pred             EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      +++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence            7889988 889999887666779999999999999999999999999999999999999   578899999999999876


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHHHhhhccccc
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS  236 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  236 (404)
                      .......    ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+   ..+.+..+....... 
T Consensus       163 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         163 QNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERL-  234 (273)
T ss_dssp             C-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCC-
T ss_pred             cCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCC-
Confidence            5433221    2234567889999999999999999999999999999998 899998744   344445554443322 


Q ss_pred             HhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015592          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL  276 (404)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~  276 (404)
                        ..+..+|+++.+|+.+||+.||++|||+.+|.+.|++.
T Consensus       235 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              23457899999999999999999999999999988764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=380.52  Aligned_cols=251  Identities=21%  Similarity=0.251  Sum_probs=202.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+++++||+|+||+||+|++..+++.||||+++...    ...++.+|++++++++|+++|..+..+ .+....+++|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-ccccceeEEE
Confidence            58999999999999999999999999999999886543    345689999999999987776665554 6677899999


Q ss_pred             eccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      ||+++++.+++... ...+++.++..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.......
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence            99988877776543 4569999999999999999999999999999999999999   6788999999999987654332


Q ss_pred             cccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------  231 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------  231 (404)
                             ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..   ..+.++...         
T Consensus       158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~  227 (298)
T d1gz8a_         158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVW  227 (298)
T ss_dssp             -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTS
T ss_pred             -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhc
Confidence                   234568999999999988766 589999999999999999999999875432   222222110         


Q ss_pred             ---------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                     ............+++++.+|+.+||+.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                           0111122333467889999999999999999999887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-52  Score=386.71  Aligned_cols=256  Identities=20%  Similarity=0.310  Sum_probs=210.1

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|++++.||+|+||+||+|++.     .+++.||||+++.....   +++.+|+.+++.++|++++..+..+. ....
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-VGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-cCCc
Confidence            367999999999999999999975     35678999998754433   45899999999999888777776665 4566


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN  133 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~N  133 (404)
                      .+++|||+ +++|.+++....                       ..+++..++.|+.|++.||+|||+++||||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            78899998 899999986432                       248999999999999999999999999999999999


Q ss_pred             ccccCCCCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCC-CC
Q 015592          134 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LP  212 (404)
Q Consensus       134 ILl~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~-~P  212 (404)
                      ||+   +.++.+||+|||+|+.+.......     ......||+.|+|||.+.+..|+.++|||||||++|||++|. .|
T Consensus       171 ILl---d~~~~~Kl~DFGls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         171 CLV---GENMVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             EEE---CGGGCEEECCCSCHHHHTGGGCBC---------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEE---CCCCcEEEccchhheeccCCcccc-----ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999   678999999999998765543211     234567899999999999999999999999999999999985 67


Q ss_pred             CCCCCCCChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      |.+..   ..+.+..+......    ..+..+|+++.+|+.+||+.||++|||+.+|.+.|+++.
T Consensus       243 ~~~~~---~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            87743   34445555544432    345678999999999999999999999999999998763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=384.57  Aligned_cols=249  Identities=19%  Similarity=0.189  Sum_probs=196.6

Q ss_pred             EeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEe
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID   83 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   83 (404)
                      .+++||+|+||+||+|++..+|+.||||+++....       ...+.+|+.+++.++|+++|..+..+ ......+++||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCceeehhh
Confidence            56899999999999999999999999998764322       34588999999999988877776655 45567899999


Q ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      |+.+++...+...+..+++.++..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|+.......  
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence            99666655555456679999999999999999999999999999999999999   6889999999999987665432  


Q ss_pred             cccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc----------
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------  232 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------  232 (404)
                           .....+||+.|+|||++.+. .|+.++|||||||++|||+||..||.+....+....+.+.....          
T Consensus       156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence                 23456899999999998754 58999999999999999999999998754433222222221100          


Q ss_pred             ----------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                ...........+++++.+||.+||+.||++|||+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L  278 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL  278 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence                      01122334456789999999999999999999988764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=381.09  Aligned_cols=255  Identities=18%  Similarity=0.253  Sum_probs=200.9

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCC-CcEEEEEEecCC----CCchhHHHHHHHHHHH---cCCCCCCceeEeee---
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVK----TKHPQLQYEAKLYKIL---QGGTGIPNLRWFGV---   73 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~~~~~i~~~~~~~~---   73 (404)
                      ..++|+++++||+|+||+||+|++..+ ++.||||+++..    .....+.+|+.+++.|   +|++++..+..+..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            467999999999999999999999766 677999987543    2344678899998887   47777776666542   


Q ss_pred             -eCCeEEEEEeccCCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecC
Q 015592           74 -EGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (404)
Q Consensus        74 -~~~~~~lv~e~~~~sL~~~l~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG  151 (404)
                       .....+++||++.+++..+.. .....+++..+..++.|++.||+|||++|||||||||+|||+   +..+.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence             335689999999666555443 345569999999999999999999999999999999999999   688899999999


Q ss_pred             CcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh-
Q 015592          152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-  230 (404)
Q Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-  230 (404)
                      +++......        ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..... 
T Consensus       162 ~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         162 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            998655432        23467899999999999999999999999999999999999999987543322222222111 


Q ss_pred             ------------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          231 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       231 ------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                        .........+...+++.+.+||.+||+.||++|||+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L  291 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  291 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                              0111223344556789999999999999999999988764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=380.39  Aligned_cols=258  Identities=20%  Similarity=0.318  Sum_probs=206.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCC-------cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG   75 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   75 (404)
                      .++|++++.||+|+||.||+|++..++       ..||||+++.+...   ..+.+|...+.++.+|++|..+..+..+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            478999999999999999999976554       47999988765443   34778999999995555555555555667


Q ss_pred             CeEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015592           76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~  139 (404)
                      ...+++|||+ +|+|.+++....               ..+++.+++.++.||+.||+|||+++||||||||+|||+   
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence            7889999999 899999997432               358999999999999999999999999999999999999   


Q ss_pred             CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 015592          140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~  218 (404)
                      +.++.+||+|||+++.........     ......||+.|+|||.+.+..|+.++|||||||++|||++ |..||.+...
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            688999999999999776644321     2345678999999999999999999999999999999998 7999987443


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI  278 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  278 (404)
                         .+.+..+.....    ...+..+|+++.+||.+||+.||.+|||+.+|++.|++++.
T Consensus       244 ---~~~~~~i~~~~~----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 ---EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ---HHHHHHHHTTCC----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCC----CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence               344444433322    12345789999999999999999999999999999998864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=382.74  Aligned_cols=258  Identities=20%  Similarity=0.220  Sum_probs=203.5

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeC----Ce
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG----DY   77 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~   77 (404)
                      ++.+|+++++||+|+||+||+|++..+|+.||||+++.....   +.+.+|+.+|+.++|++++..+..+....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            678999999999999999999999999999999998754432   35789999999999998888877764432    35


Q ss_pred             EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccc
Q 015592           78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR  157 (404)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~  157 (404)
                      .+++|++++++|.+++..  +++++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence            678888889999999974  469999999999999999999999999999999999999   578899999999998765


Q ss_pred             ccCCcccccccCCCCCccCcCccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh------
Q 015592          158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------  230 (404)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------  230 (404)
                      ......    .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+..........      
T Consensus       161 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         161 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             GGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            543221    12345679999999999855 4579999999999999999999999987543222222111110      


Q ss_pred             -----------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 -----------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 -----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                       .........+...+++++.+|+.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                             01111223444567889999999999999999999887753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=377.53  Aligned_cols=257  Identities=18%  Similarity=0.230  Sum_probs=207.9

Q ss_pred             EeeeeceeCceeEEEEEEcCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592           11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus        11 i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.++||+|+||+||+|++..++   ..||||.++.....   +++.+|++++++++|+|++..++.+.......+++|||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            4679999999999999986543   36899988643332   45899999999999988888887776667788999999


Q ss_pred             c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCcc
Q 015592           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ  163 (404)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~~  163 (404)
                      + +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+   +.++.+||+|||+++.........
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence            9 899999998666678899999999999999999999999999999999999   688999999999998776543322


Q ss_pred             cccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccccHhHhhcC
Q 015592          164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG  243 (404)
Q Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (404)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||+||..||.....  ..+....+......    ..+..
T Consensus       188 ~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~----~~p~~  258 (311)
T d1r0pa_         188 V---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRL----LQPEY  258 (311)
T ss_dssp             T---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCC----CCCTT
T ss_pred             c---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCC----CCccc
Confidence            1   123456789999999999999999999999999999999998777765322  22223333333222    23356


Q ss_pred             CcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       244 ~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +|+++.+|+.+||+.||++||++.+|++.|+.++..
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            889999999999999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-51  Score=379.66  Aligned_cols=255  Identities=20%  Similarity=0.253  Sum_probs=206.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcE--EEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV   81 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   81 (404)
                      ++|++.++||+|+||+||+|++..++..  ||||.++..   ...+.+.+|+++++++.+|++|..+..+.......+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6899999999999999999999888875  667765432   23456899999999995444444444455677889999


Q ss_pred             Eecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeE
Q 015592           82 IDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV  145 (404)
Q Consensus        82 ~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~v  145 (404)
                      |||+ +|+|.+++...               ...+++..++.++.||+.||.|||+++|+||||||+|||+   +.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence            9999 89999998632               2569999999999999999999999999999999999999   688899


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCCChHHH
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK  224 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~-~Pf~~~~~~~~~~~  224 (404)
                      ||+|||+++.......        .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.   +..+.
T Consensus       167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~  235 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL  235 (309)
T ss_dssp             EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred             EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH
Confidence            9999999986554332        23457899999999999999999999999999999999965 577663   34455


Q ss_pred             HHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      +..+.....    ...+..+|+++.+||.+||+.||++||++.+|++.|++++..
T Consensus       236 ~~~i~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         236 YEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHGGGTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHhcCC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            555544322    223456899999999999999999999999999999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=374.51  Aligned_cols=260  Identities=20%  Similarity=0.311  Sum_probs=211.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEc-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|+++++||+|+||.||+|++.     .+++.||||+++.....   ..+.+|+.+++.+.+|++|..+..+......
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            478999999999999999999863     46679999998765432   3478999999999756666666666667777


Q ss_pred             EEEEEecc-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG  139 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~  139 (404)
                      .+++|||+ +++|.+++....                 ..+++..++.|+.||+.||+|||++|||||||||+|||+   
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc---
Confidence            89999999 889999987532                 258999999999999999999999999999999999999   


Q ss_pred             CCCCeEEEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 015592          140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (404)
Q Consensus       140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~ellt-g~~Pf~~~~~  218 (404)
                      +..+.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+...
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            58899999999999877654331     13345789999999999999999999999999999999999 6666666443


Q ss_pred             CChHHHHHHHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015592          219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR  279 (404)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  279 (404)
                      ...   +.++.......   ..+..+|+++.+||.+||+.||++|||+++|++.|++.+..
T Consensus       254 ~~~---~~~~i~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 DSK---FYKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SHH---HHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH---HHHHHhcCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            322   22222222222   22346789999999999999999999999999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=381.09  Aligned_cols=252  Identities=20%  Similarity=0.285  Sum_probs=200.0

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeeeeC-----
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG-----   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----   75 (404)
                      +.++|+++++||+|+||+||+|++..+|+.||||+++.....    +.+.+|+++|+.++|+++|..+..+...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            678999999999999999999999999999999998754433    35788999999999998888877765433     


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|||++.+|..+++.  .++++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence            35799999999999998873  579999999999999999999999999999999999999   6889999999999987


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhh----
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----  230 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~----  230 (404)
                      .....          ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.....    
T Consensus       171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence            65432          356899999999999875 469999999999999999999999987543222222111111    


Q ss_pred             -------------------hcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          231 -------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       231 -------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                                         .........+...+++++.+||.+||..||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                               01111222334567899999999999999999999887754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-50  Score=372.29  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=198.2

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+++++||+|+||+||+|++ .+++.||||+++...    ...++.+|+.++++++|++++..+..+ ......+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-ccCCceeEEE
Confidence            6899999999999999999998 488999999986543    245689999999999987777655444 5666788999


Q ss_pred             eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      +++++++...+....+.+++..+..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||.+........ 
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc-
Confidence            999777777776667789999999999999999999999999999999999999   6789999999999987655432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhc---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------  232 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  232 (404)
                            ......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..+....+.......         
T Consensus       156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence                  223457899999999998654 6999999999999999999999998754322222222111100         


Q ss_pred             ------------ccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          233 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       233 ------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                  ...........+++++.+||.+||+.||++|||+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                        00111233456788999999999999999999988774

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=377.44  Aligned_cols=248  Identities=21%  Similarity=0.218  Sum_probs=196.6

Q ss_pred             ceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeee-----eCCeEEEEE
Q 015592            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDYNVLVI   82 (404)
Q Consensus         8 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~~~lv~   82 (404)
                      +|+..++||+|+||+||+|++..+|+.||||++....  ....+|++++++++|++++..+..+..     ...+.+++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            6999999999999999999999999999999986543  234589999999999988888766643     334678999


Q ss_pred             eccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccccccc
Q 015592           83 DLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT  159 (404)
Q Consensus        83 e~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~  159 (404)
                      ||+++++.+.+.   .....+++.+++.|+.||+.||+|||++||+||||||+|||++  .+...+||+|||+++.+...
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTT
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCC
Confidence            999777666553   2355799999999999999999999999999999999999994  23458999999999876543


Q ss_pred             CCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcccc---
Q 015592          160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST---  235 (404)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---  235 (404)
                      ..        .....||+.|+|||.+.+. .|+.++|||||||++|||++|+.||......   ..+..+.......   
T Consensus       177 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         177 EP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             SC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred             cc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHH
Confidence            32        2356899999999998764 6899999999999999999999999875432   2222222110000   


Q ss_pred             ---------------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          236 ---------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       236 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                           ........+++++.+||.+||..||++|||+.+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  301 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC  301 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                                 00111234688999999999999999999988764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=372.11  Aligned_cols=259  Identities=20%  Similarity=0.223  Sum_probs=199.4

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCceeEeee-------e
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-------E   74 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------~   74 (404)
                      .++|+++++||+|+||+||+|++..+|+.||||++....    ...++.+|+.+++.++|++++..+..+..       .
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999999999999999875432    33468899999999999988888766543       2


Q ss_pred             CCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcc
Q 015592           75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (404)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~  154 (404)
                      ....+++||++++.+..........+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceee
Confidence            34679999999777777776556789999999999999999999999999999999999999   688999999999998


Q ss_pred             cccccCCcccccccCCCCCccCcCccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc
Q 015592          155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (404)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  233 (404)
                      .+........   .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+........
T Consensus       166 ~~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         166 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             ECCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            7664332111   123456799999999999865 589999999999999999999999987544333333333221111


Q ss_pred             ccc----------------------Hh-Hh-hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 STS----------------------IE-AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 ~~~----------------------~~-~~-~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                      ...                      .. .+ ....++++.+||.+||+.||++|||+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL  303 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  303 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence            000                      00 00 011356788999999999999999988654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=373.18  Aligned_cols=268  Identities=21%  Similarity=0.233  Sum_probs=203.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHH--HHHHHcCCCCCCceeEeeeeC---CeEE
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAK--LYKILQGGTGIPNLRWFGVEG---DYNV   79 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~--~l~~l~~~~~i~~~~~~~~~~---~~~~   79 (404)
                      |.++|.+.++||+|+||.||+|++  +|+.||||+++... .....+|.+  .+..++|+|++..+..+...+   ...+
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            467899999999999999999985  68999999986543 233444444  445678888888776665544   3578


Q ss_pred             EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcccccCCCCCCeEEEEec
Q 015592           80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (404)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~givHrDlKp~NILl~~~~~~~~vkL~DF  150 (404)
                      ++|||+ +++|.++++.  .++++..++.++.|++.||.|||+        +|||||||||+|||+   +.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence            999999 8899999984  469999999999999999999996        599999999999999   68899999999


Q ss_pred             CCcccccccCCcccccccCCCCCccCcCccccccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCCC-----
Q 015592          151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----  219 (404)
Q Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~il~elltg~~Pf~~~~~~-----  219 (404)
                      |+++..........   .......||+.|+|||++.+..      ++.++|||||||+||||+||..||......     
T Consensus       153 Gl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             TTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             CccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            99987765433211   1234568999999999988653      577999999999999999998887432211     


Q ss_pred             -------ChHHHHHHHhhhcccccHhHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015592          220 -------TKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ  283 (404)
Q Consensus       220 -------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  283 (404)
                             ........+......+.++...  ...+..+.+|+.+||+.||++|||+.+|.+.|+++...++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~  302 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK  302 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence                   1122222233333322222211  123457999999999999999999999999999998887754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=373.42  Aligned_cols=272  Identities=18%  Similarity=0.267  Sum_probs=216.3

Q ss_pred             CceEEeeeeceeCceeEEEEEEc---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      ++|++++.||+|+||+||+|++.   .+|+.||||+++..      ...+.+.+|++++++++|+++|..+..+..+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999974   46899999987532      2345688999999999998888888888888889


Q ss_pred             EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      .+++|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence            99999999 8999999985 4568899999999999999999999999999999999999   67889999999999876


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhccc
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS  234 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  234 (404)
                      ......      ......|++.|+|||.+.+..  ++.++|||||||+||||++|+.||.+....+....+........ 
T Consensus       180 ~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-  252 (322)
T d1vzoa_         180 VADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-  252 (322)
T ss_dssp             CGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-
T ss_pred             cccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-
Confidence            543321      233567999999999998654  68899999999999999999999988766555544433322221 


Q ss_pred             ccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCceeecccccccccc
Q 015592          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ  299 (404)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~--~l~~~l~~~~~~~~~~~~~~~~w~~~~~~~~~  299 (404)
                         ..++..+++++.+|+.+||+.||++||+..  .+.++|++.|       ...++|.....+..+
T Consensus       253 ---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf-------f~~i~~~~l~~~~~~  309 (322)
T d1vzoa_         253 ---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF-------FQKINWDDLAAKKVP  309 (322)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG-------GTTCCHHHHHTTCSC
T ss_pred             ---CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh-------hcCCCHHHHHhCCCC
Confidence               123456899999999999999999999632  2334444433       234566655444443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=373.76  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=210.0

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcC-----CCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCceeEeeeeCCe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDY   77 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   77 (404)
                      .++|+++++||+|+||+||+|++..     +++.||||+++......   .+.+|+.++++++|++++..++.+. ....
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-SSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-cCCc
Confidence            3789999999999999999998753     35789999987544333   3789999999999888777776654 5556


Q ss_pred             EEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEE
Q 015592           78 NVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI  147 (404)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL  147 (404)
                      .+++|||+ +|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||+   +.++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEE
Confidence            78999999 899999886432         247899999999999999999999999999999999999   68899999


Q ss_pred             EecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCChHHHHH
Q 015592          148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYE  226 (404)
Q Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg-~~Pf~~~~~~~~~~~~~  226 (404)
                      +|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||+||||+|| ..||.+.   +..+.+.
T Consensus       175 ~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~  246 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLR  246 (308)
T ss_dssp             CCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHH
T ss_pred             eecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHH
Confidence            9999998776543311     23445789999999999999999999999999999999997 5788764   3344555


Q ss_pred             HHhhhcccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015592          227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF  277 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~~l~~~~  277 (404)
                      .+......    ..+..+|+.+.+++.+||+.||++|||+.+|++.|++.+
T Consensus       247 ~i~~~~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         247 FVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHhCCCC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            55444332    234578999999999999999999999999999887653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=370.81  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             cCCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeee-----eC
Q 015592            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EG   75 (404)
Q Consensus         5 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~   75 (404)
                      +.++|+++++||+|+||+||+|++..+|+.||||+++.....    +.+.+|+++++.++|++++..+..+..     +.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            357899999999999999999999999999999998755432    357899999999999988887776643     33


Q ss_pred             CeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCccc
Q 015592           76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR  155 (404)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~  155 (404)
                      ...+++|++++++|.+++.  .+++++.++..++.||+.||+|||++||+||||||+|||+   +.++.+|++|||++..
T Consensus        96 ~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH  170 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----C
T ss_pred             ceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcc
Confidence            4567777777999999996  4679999999999999999999999999999999999999   6889999999999976


Q ss_pred             ccccCCcccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh---
Q 015592          156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---  231 (404)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---  231 (404)
                      ....          .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+......   
T Consensus       171 ~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         171 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             CTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            5443          23568999999999987765 689999999999999999999999875432222222111110   


Q ss_pred             --------------------cccccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                          ...........++++++.+||.+||..||.+|||+.+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL  299 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  299 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence                                001112223356789999999999999999999988664

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.4e-48  Score=365.04  Aligned_cols=251  Identities=18%  Similarity=0.291  Sum_probs=194.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCce-eEeee-eCCeEEEEEe
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-RWFGV-EGDYNVLVID   83 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~-~~~~~-~~~~~~lv~e   83 (404)
                      .++|+++++||+|+||+||+|+++.+++.||||+++.. ..+++.+|+.+|+.+++|++|..+ ..+.. .....+++||
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            46799999999999999999999999999999998643 456789999999999855555554 44432 3456899999


Q ss_pred             cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCCc
Q 015592           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH  162 (404)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~~  162 (404)
                      |+ +++|.++    .+.+++.++..++.||+.||+|||++||+||||||+|||++  .+++.+||+|||+|+....... 
T Consensus       113 ~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~-  185 (328)
T d3bqca1         113 HVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE-  185 (328)
T ss_dssp             CCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred             ecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence            99 6777654    34699999999999999999999999999999999999995  3455799999999987655432 


Q ss_pred             ccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh-HHHHHHHhhh---------
Q 015592          163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEK---------  231 (404)
Q Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~---------  231 (404)
                             .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||........ ...+..+...         
T Consensus       186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence                   34567899999999988765 79999999999999999999999976443211 1111111000         


Q ss_pred             -cc--cc-----------------cHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015592          232 -KV--ST-----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR  271 (404)
Q Consensus       232 -~~--~~-----------------~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~~  271 (404)
                       ..  ..                 ........+++++.+||.+||..||++|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00  00                 000111346789999999999999999999887643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=356.16  Aligned_cols=250  Identities=20%  Similarity=0.211  Sum_probs=198.7

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEE
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI   82 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   82 (404)
                      ++|+++++||+|+||+||+|++..+++.||||+++....    ..++.+|+.+++.++|++++..+ .+.......+++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~-~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-DVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEE-EEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeec-cccccccceeEEe
Confidence            589999999999999999999999999999999865443    24578999999999988776655 4456666778899


Q ss_pred             ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccccccCC
Q 015592           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT  161 (404)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~~~~~~  161 (404)
                      +++ +++|..++. ..+.+++..+..++.|++.||+|||++||+||||||+|||+   +..+.+||+|||.++.......
T Consensus        81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            988 555555554 57789999999999999999999999999999999999999   5788999999999987765433


Q ss_pred             cccccccCCCCCccCcCccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhhcc-------
Q 015592          162 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------  233 (404)
Q Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------  233 (404)
                             ......++..|+|||.+.+.. ++.++|||||||++|||++|+.||....  +..+.+..+.....       
T Consensus       157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTC
T ss_pred             -------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhh
Confidence                   223456788999999988765 6999999999999999999999975432  22333333222111       


Q ss_pred             -----------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                       ..........+++.+.+|+.+||+.||.+|||+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L  281 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL  281 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                             1111223345678999999999999999999988764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=367.39  Aligned_cols=251  Identities=19%  Similarity=0.201  Sum_probs=189.9

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCceeEeee-----eCC
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD   76 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~   76 (404)
                      .++|+++++||+|+||+||+|+++.+|+.||||++......    ..+.+|+.+++.++|++++..+..+..     ...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            36899999999999999999999999999999998765433    247899999999998888888777653     346


Q ss_pred             eEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEEecCCcccc
Q 015592           77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY  156 (404)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~DFG~a~~~  156 (404)
                      ..|++|||+.+++.+.+.   ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||+++..
T Consensus        96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhcc
Confidence            789999999888777664   469999999999999999999999999999999999999   67889999999998866


Q ss_pred             cccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHhhh-----
Q 015592          157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-----  231 (404)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  231 (404)
                      ....        ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......     
T Consensus       170 ~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         170 GTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccc--------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            5533        234567899999999999999999999999999999999999999875432222211111100     


Q ss_pred             --------------cc---------------cccHhHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015592          232 --------------KV---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK  270 (404)
Q Consensus       232 --------------~~---------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP~~~~l~  270 (404)
                                    ..               ...........++++.+||.+||..||++|||+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                          00               0000001112367899999999999999999988764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-43  Score=335.50  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=183.3

Q ss_pred             CCceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----------CCCceeEee-
Q 015592            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGT-----------GIPNLRWFG-   72 (404)
Q Consensus         6 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~-----------~i~~~~~~~-   72 (404)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++.... .+.+.+|+++++.+.|++           ++..+..+. 
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4579999999999999999999999999999999875432 345788999999987643           344444433 


Q ss_pred             eeCCeEEEEEecc--CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCC---CCeE
Q 015592           73 VEGDYNVLVIDLL--GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR---ANQV  145 (404)
Q Consensus        73 ~~~~~~~lv~e~~--~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlKp~NILl~~~~~---~~~v  145 (404)
                      ......+++|+++  +++....... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.   ...+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence            2344555666555  4444444432 34579999999999999999999998 89999999999999953211   1258


Q ss_pred             EEEecCCcccccccCCcccccccCCCCCccCcCccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCh---H
Q 015592          146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---K  222 (404)
Q Consensus       146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~il~elltg~~Pf~~~~~~~~---~  222 (404)
                      +|+|||.+......          .....||+.|+|||++.+..++.++||||+||++++|++|+.||........   .
T Consensus       172 kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         172 KIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             eEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence            99999999765432          2356799999999999999999999999999999999999999976432211   1


Q ss_pred             HHHHHHhhhcccc------------------------------cHh-------HhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015592          223 QKYEKISEKKVST------------------------------SIE-------ALCRGYPTEFASYFHYCRSLRFDDKPD  265 (404)
Q Consensus       223 ~~~~~~~~~~~~~------------------------------~~~-------~~~~~~~~~l~~li~~cl~~~p~~RP~  265 (404)
                      .............                              ...       ......++++.+||.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            1111110000000                              000       001123678999999999999999999


Q ss_pred             HHHHH
Q 015592          266 YAYLK  270 (404)
Q Consensus       266 ~~~l~  270 (404)
                      +++++
T Consensus       322 a~e~L  326 (362)
T d1q8ya_         322 AGGLV  326 (362)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            88663

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=7e-26  Score=195.01  Aligned_cols=163  Identities=17%  Similarity=0.219  Sum_probs=113.7

Q ss_pred             eEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCCce
Q 015592            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLQYEAKLYKILQGGTGIPNL   68 (404)
Q Consensus         9 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~~~   68 (404)
                      +.++++||+|+||+||+|++ .+|+.||||+++....                    ......|...+.++.+.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            56899999999999999998 5789999998653211                    01234577788888766544332


Q ss_pred             eEeeeeCCeEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCCeEEEE
Q 015592           69 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (404)
Q Consensus        69 ~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlKp~NILl~~~~~~~~vkL~  148 (404)
                         ....  .+++||++++...       ..++...+..++.|++.+|.|||++||+||||||+|||++    ++.++|+
T Consensus        81 ---~~~~--~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li  144 (191)
T d1zara2          81 ---AWEG--NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  144 (191)
T ss_dssp             ---EEET--TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             ---EecC--CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence               2222  3799999955321       1255666788999999999999999999999999999993    3569999


Q ss_pred             ecCCcccccccCCcccccccCCCCCccCcCcccc--c---cccCCCCCchhHHHHHHHHH
Q 015592          149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASM--N---THLGIEQSRRDDLESLGYVL  203 (404)
Q Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDiwSlG~il  203 (404)
                      |||+|........               ..|...  +   .+....|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999976543321               011111  0   01234578899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.51  E-value=4.3e-07  Score=79.65  Aligned_cols=83  Identities=17%  Similarity=0.269  Sum_probs=61.1

Q ss_pred             CceEEeeeeceeCceeEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus         7 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      +.|++.+..+.++.+.||+..  ..++.++||+.....  ....+.+|...+..+...-.++.+..+...+...+++|++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            567777776666667999987  566778889765432  3345889999999998665567777777778888999999


Q ss_pred             c-CCCHHH
Q 015592           85 L-GPSLED   91 (404)
Q Consensus        85 ~-~~sL~~   91 (404)
                      . |.++.+
T Consensus        92 l~G~~~~~   99 (263)
T d1j7la_          92 ADGVLCSE   99 (263)
T ss_dssp             CSSEEHHH
T ss_pred             cccccccc
Confidence            8 555543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.11  E-value=5.6e-06  Score=77.03  Aligned_cols=74  Identities=14%  Similarity=0.174  Sum_probs=48.2

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecC------C---CCchhHHHHHHHHHHHcCC--CCCCceeEeeeeCCeEEE
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV------K---TKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVL   80 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~------~---~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~l   80 (404)
                      .+.||.|....||++.+..+++.|+||.-..      +   ....+...|.+.++.+...  ..++.+..+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999999877788999995321      1   1223467799999888643  334444444  4555688


Q ss_pred             EEeccCC
Q 015592           81 VIDLLGP   87 (404)
Q Consensus        81 v~e~~~~   87 (404)
                      +||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999843

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=1e-05  Score=70.11  Aligned_cols=69  Identities=14%  Similarity=0.019  Sum_probs=50.2

Q ss_pred             eceeC-ceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCceeEeeeeCCeEEEEEecc
Q 015592           15 IGSGS-FGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL   85 (404)
Q Consensus        15 lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lv~e~~   85 (404)
                      +..|. .+.||+... ..+..+++|..... ....+..|...++.|....+ ++.+..+..++...+++|+++
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            34444 468999984 56777899976544 34568999999999886544 555666666777889999998

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.15  E-value=0.00081  Score=61.96  Aligned_cols=70  Identities=13%  Similarity=0.096  Sum_probs=51.0

Q ss_pred             eeeeceeCceeEEEEEEcC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCceeEeeeeCCeEEEEEec
Q 015592           12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL   84 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   84 (404)
                      ++.|+.|-.-.+|++....       ..+.|.+++.......-...+|..+++.+....+.+.+.+++..    .++|+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            4678888889999998643       24568888766433444577899999999888887777666532    567787


Q ss_pred             c
Q 015592           85 L   85 (404)
Q Consensus        85 ~   85 (404)
                      .
T Consensus       123 i  123 (395)
T d1nw1a_         123 I  123 (395)
T ss_dssp             C
T ss_pred             e
Confidence            7

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.10  E-value=0.0016  Score=58.17  Aligned_cols=66  Identities=11%  Similarity=0.067  Sum_probs=43.8

Q ss_pred             ceeEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCC--ce----eEeeeeCCeEEEEEeccC
Q 015592           20 FGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIP--NL----RWFGVEGDYNVLVIDLLG   86 (404)
Q Consensus        20 ~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~--~~----~~~~~~~~~~~lv~e~~~   86 (404)
                      --.||+++. .+|+.|++|+..... ..+++..|...+..|....+..  .+    ......+...+.++++.+
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            347999984 678899999986553 3466889999999987433211  11    122234566777888774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.09  E-value=0.00076  Score=59.95  Aligned_cols=49  Identities=14%  Similarity=0.182  Sum_probs=31.8

Q ss_pred             eeeeceeCceeEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 015592           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG   62 (404)
Q Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~   62 (404)
                      .+.|..|---+.|+.+. ..| .+++|+.......+.+..|.+++..|...
T Consensus        23 ~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~   71 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAK   71 (316)
T ss_dssp             EEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred             eecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence            34455666678899984 334 58999987655667788899999988754